data_2l68_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l68 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.6 m -76.82 101.82 6.04 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 121.43 1.923 . . . . 0.0 111.004 -176.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.75 168.19 39.0 Favored Glycine 0 CA--C 1.546 2.011 0 CA-C-O 122.34 0.966 . . . . 0.0 112.86 -172.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.69 97.39 5.61 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -173.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -100.55 105.54 16.98 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -160.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -92.13 138.93 31.13 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.557 0.694 . . . . 0.0 111.612 -175.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.0 tp -65.86 130.17 42.34 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.304 1.042 . . . . 0.0 113.389 -172.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -109.37 -65.53 1.14 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.069 0.948 . . . . 0.0 109.745 -178.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.5 t -127.36 121.2 30.35 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.895 0.878 . . . . 0.0 108.94 -176.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -114.93 120.13 38.89 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -79.51 -70.44 0.51 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 118.485 -0.769 . . . . 0.0 112.789 -171.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 46.7 m-20 -121.64 73.82 1.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 118.848 0.749 . . . . 0.0 110.774 -170.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -81.98 -46.37 14.08 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 172.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -59.03 -50.02 75.66 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 172.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.08 -38.28 90.54 Favored 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 116.636 2.087 . . . . 0.0 116.636 175.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -77.54 -51.21 11.07 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -43.71 98.21 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -65.04 -35.65 81.86 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 168.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.6 -30.46 70.7 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 169.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.266 24.7 pt -88.59 -59.55 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-N 119.717 1.144 . . . . 0.0 111.214 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.01 71.55 0.01 OUTLIER Glycine 0 CA--C 1.54 1.644 0 CA-C-N 118.642 0.655 . . . . 0.0 111.909 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.93 153.28 78.51 Favored Pre-proline 0 CA--C 1.571 1.768 0 C-N-CA 123.617 0.767 . . . . 0.0 111.675 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.95 151.05 30.67 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 123.254 2.636 . . . . 0.0 114.048 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -59.48 -31.82 69.69 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 116.623 2.083 . . . . 0.0 116.623 170.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -61.73 -51.1 69.75 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 117.301 -1.333 . . . . 0.0 114.583 170.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.7 mt -68.36 -23.81 64.72 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 173.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 84.9 mt -68.42 -55.0 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 124.356 1.062 . . . . 0.0 111.197 170.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -66.1 -23.05 66.43 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -77.52 -56.5 4.48 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 124.356 1.063 . . . . 0.0 112.037 170.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.37 -15.54 70.42 Favored Glycine 0 CA--C 1.553 2.454 0 N-CA-C 119.667 2.627 . . . . 0.0 119.667 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -65.45 -44.04 88.48 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 120.317 2.058 . . . . 0.0 114.654 168.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -67.65 -35.96 79.86 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 170.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 53.3 mt -75.43 122.24 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -86.34 107.27 17.91 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 174.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.56 130.9 10.3 Favored Glycine 0 CA--C 1.54 1.621 0 CA-C-N 116.178 -0.465 . . . . 0.0 113.561 -173.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.1 t -80.8 114.85 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 71.0 m -104.62 99.37 9.04 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -81.66 145.53 30.52 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.532 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.2 mt -143.45 128.89 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 176.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 87.4 t -124.02 107.42 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 178.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -88.26 122.07 31.38 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.548 0.689 . . . . 0.0 109.444 170.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -87.35 -60.49 1.96 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.406 159.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.56 -88.94 0.07 OUTLIER Glycine 0 N--CA 1.476 1.312 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 170.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -74.0 -39.6 63.51 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 164.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -75.23 135.61 40.99 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 119.897 1.226 . . . . 0.0 111.527 176.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -134.12 108.5 8.34 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm -102.47 103.76 14.16 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -111.95 136.71 50.93 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.789 0.836 . . . . 0.0 110.537 -173.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.3 m -127.88 106.24 8.97 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -176.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.9 mm -97.21 120.14 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.5 p . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 174.713 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 90.4 mt . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -116.22 130.98 57.06 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.02 0.928 . . . . 0.0 110.478 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -143.01 173.65 11.37 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.872 0.869 . . . . 0.0 109.212 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -143.11 134.06 25.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.983 -1.073 . . . . 0.0 112.313 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -110.25 149.16 30.55 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.8 0.84 . . . . 0.0 111.315 172.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.1 m -108.55 125.45 51.83 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 169.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.9 t -69.5 123.9 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 C-N-CA 123.831 0.852 . . . . 0.0 109.595 -176.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.42 -44.58 2.11 Favored Glycine 0 CA--C 1.552 2.356 0 N-CA-C 116.857 1.503 . . . . 0.0 116.857 -172.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -102.42 132.67 48.29 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.277 1.031 . . . . 0.0 110.145 -173.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -50.81 134.73 24.98 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 116.466 2.025 . . . . 0.0 116.466 -172.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 20.6 p -133.71 137.84 45.5 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 122.187 0.994 . . . . 0.0 111.039 -174.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -96.13 95.21 8.0 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.22 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.1 mt . . . . . 0 N--CA 1.489 1.494 0 C-N-CA 123.591 0.756 . . . . 0.0 109.665 179.458 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 87.7 mttt . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 122.76 1.266 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.5 p -145.42 125.84 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.318 0 CA-C-N 113.925 -1.488 . . . . 0.0 107.659 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -83.04 107.62 15.76 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 171.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.9 t -155.72 105.8 2.44 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 -170.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.252 11.2 p -103.98 136.52 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-O 122.893 1.33 . . . . 0.0 110.718 -176.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.1 t -90.25 136.35 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 CA-C-N 113.346 -1.752 . . . . 0.0 108.742 -172.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -107.0 134.93 49.42 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 171.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 33.5 tp -105.06 110.07 22.31 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.23 -175.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -105.69 128.04 53.43 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.485 0.714 . . . . 0.0 109.198 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.53 7.51 64.74 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 121.344 3.297 . . . . 0.0 121.344 172.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.292 5.0 t70 54.91 45.62 26.13 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 -161.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -157.48 -44.64 0.07 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -92.81 125.6 37.49 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 120.086 1.312 . . . . 0.0 110.934 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.0 mt -111.29 102.05 10.49 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 170.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.1 m -109.05 126.6 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 C-N-CA 123.5 0.72 . . . . 0.0 109.533 -172.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.0 t -149.03 156.25 41.97 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.262 0.553 . . . . 0.0 112.29 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 89.4 m -112.5 105.42 13.64 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 175.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.266 36.7 t80 -91.3 -101.05 0.11 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.109 0.964 . . . . 0.0 108.928 -163.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -110.39 78.12 1.1 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 170.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.4 m120 50.32 42.15 25.44 Favored 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -166.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 23.4 mt -133.79 115.25 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 103.455 -2.795 . . . . 0.0 103.455 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -85.73 93.92 8.98 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 174.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.4 t -86.37 96.25 9.94 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.821 0.849 . . . . 0.0 109.901 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 62.3 t -104.19 105.04 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 -174.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 62.9 m -116.24 90.84 3.43 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -168.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -96.12 140.53 30.7 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.132 0.573 . . . . 0.0 110.906 -172.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 tt -105.94 110.56 22.88 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -110.94 91.77 3.79 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -178.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.52 -110.7 3.1 Favored Glycine 0 CA--C 1.544 1.857 0 CA-C-O 119.757 -0.468 . . . . 0.0 113.407 176.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -118.86 52.63 1.04 Allowed 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.272 0.558 . . . . 0.0 111.686 171.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.7 pt -134.87 -166.21 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.783 0 C-N-CA 124.554 1.142 . . . . 0.0 108.136 166.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.3 tt -157.94 126.34 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 O-C-N 120.352 -1.467 . . . . 0.0 107.426 159.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 t -83.44 149.5 26.62 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 120.627 0.251 . . . . 0.0 110.724 164.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -133.83 97.12 3.82 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 169.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' THR . . . . . 0.409 ' HG1' ' HG3' ' A' ' 121' ' ' LYS . 23.3 m -104.2 91.46 3.94 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -173.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 40.2 mtt -93.79 103.34 15.48 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.211 1.004 . . . . 0.0 109.078 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 75.1 p -99.98 106.57 18.38 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -172.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 42.0 tp -102.95 82.26 2.08 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.94 -99.81 0.88 Allowed Glycine 0 CA--C 1.545 1.925 0 N-CA-C 114.326 0.49 . . . . 0.0 114.326 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -89.72 -25.8 21.0 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 171.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 14.0 mm -67.2 138.76 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.651 0 C-N-CA 125.057 1.343 . . . . 0.0 109.751 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.95 93.94 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 172.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -87.65 98.92 11.69 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.487 0.715 . . . . 0.0 109.752 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.409 ' HG3' ' HG1' ' A' ' 112' ' ' THR . 81.8 tttt -108.9 104.97 14.31 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 123.605 0.566 . . . . 0.0 110.056 -177.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -85.59 142.19 29.29 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.522 164.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -125.41 105.56 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 103.37 -2.826 . . . . 0.0 103.37 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 62.5 m -120.84 120.86 36.78 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.168 0.587 . . . . 0.0 109.459 -174.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -86.03 139.93 30.73 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.317 0.647 . . . . 0.0 111.941 -170.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -69.59 113.9 7.3 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.662 0.785 . . . . 0.0 111.741 -176.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.5 mt . . . . . 0 N--CA 1.482 1.173 0 N-CA-C 102.428 -3.175 . . . . 0.0 102.428 -163.424 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 . . . . . 0 N--CA 1.495 1.812 0 N-CA-C 117.711 2.486 . . . . 0.0 117.711 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.2 m -69.73 107.74 3.61 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 120.857 1.662 . . . . 0.0 110.909 176.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.97 162.11 24.5 Favored Glycine 0 CA--C 1.544 1.873 0 CA-C-O 122.425 1.014 . . . . 0.0 114.233 -171.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -105.36 115.43 30.24 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -113.64 98.49 7.08 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 -169.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -93.51 138.91 31.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.936 -0.478 . . . . 0.0 111.067 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.1 tp -63.82 137.96 58.27 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -171.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -121.57 -64.8 1.19 Allowed 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.536 -175.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.8 t -128.77 115.36 17.83 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.617 0.767 . . . . 0.0 109.263 -174.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -105.3 128.72 53.6 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.958 0.903 . . . . 0.0 109.654 175.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -88.52 -70.18 0.66 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.607 -177.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -114.63 68.66 0.7 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.278 0.631 . . . . 0.0 110.398 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -74.61 -52.32 12.07 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 118.496 -0.764 . . . . 0.0 112.448 169.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -63.39 -47.61 81.3 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -173.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.5 -39.67 94.21 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 171.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -66.52 -50.95 61.49 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 176.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 20.7 mmt -62.72 -42.17 99.53 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -175.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -61.75 -45.31 94.45 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 168.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.5 -29.63 70.69 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.262 39.5 pt -76.02 -53.43 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 119.901 1.228 . . . . 0.0 112.132 170.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.31 67.77 0.01 OUTLIER Glycine 0 CA--C 1.538 1.493 0 CA-C-O 118.887 -0.952 . . . . 0.0 112.33 173.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.8 mt -130.06 141.28 41.32 Favored Pre-proline 0 CA--C 1.568 1.637 0 CA-C-N 117.918 0.859 . . . . 0.0 110.561 175.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.66 151.62 84.08 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 123.306 2.671 . . . . 0.0 114.034 172.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -49.93 -37.21 30.77 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 116.5 2.037 . . . . 0.0 116.5 172.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -63.11 -51.06 68.05 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 169.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.5 mt -70.98 -14.31 62.31 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 174.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.3 mt -71.66 -54.68 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-N 120.191 1.36 . . . . 0.0 110.267 166.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -64.2 -27.1 68.83 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 174.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -79.96 -49.47 11.81 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 119.612 1.096 . . . . 0.0 112.594 170.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.55 -24.72 68.08 Favored Glycine 0 CA--C 1.551 2.314 0 N-CA-C 118.951 2.34 . . . . 0.0 118.951 174.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -65.2 -44.42 88.43 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-N 120.509 2.154 . . . . 0.0 114.194 167.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -66.94 -31.4 71.95 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 171.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.0 mt -75.69 107.18 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 172.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.33 105.25 17.44 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -172.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.0 127.97 8.58 Favored Glycine 0 CA--C 1.54 1.618 0 N-CA-C 115.036 0.774 . . . . 0.0 115.036 -160.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.2 t -81.13 116.45 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 172.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.4 m -106.65 105.41 15.42 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -79.62 143.06 35.04 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 121.865 0.841 . . . . 0.0 110.782 175.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 54.2 mt -142.02 124.18 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 103.676 -2.713 . . . . 0.0 103.676 170.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.6 t -122.1 103.72 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -89.82 127.79 36.04 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 121.202 0.525 . . . . 0.0 110.252 176.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -126.72 82.25 2.07 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 165.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.91 -123.62 10.99 Favored Glycine 0 CA--C 1.547 2.058 0 C-N-CA 123.286 0.469 . . . . 0.0 113.939 -176.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -73.62 -35.15 65.3 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 169.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -73.44 147.88 43.78 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 122.724 1.249 . . . . 0.0 111.731 176.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -137.91 148.9 45.74 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 113.613 -1.63 . . . . 0.0 109.498 -177.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.21 110.98 8.71 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 164.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -104.05 147.38 27.46 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.069 172.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.5 m -135.59 92.53 2.84 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.0 tt -96.14 126.88 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 123.437 0.695 . . . . 0.0 109.809 -177.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.6 p . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 175.016 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.7 mt . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -118.33 137.02 53.37 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.296 0.638 . . . . 0.0 111.224 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -137.81 145.98 42.97 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.941 0.877 . . . . 0.0 109.786 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -106.28 128.18 53.79 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.251 169.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -134.75 159.48 41.18 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.722 0.773 . . . . 0.0 111.479 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.5 m -124.2 131.83 53.56 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 173.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.9 m -74.11 130.41 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 123.582 0.753 . . . . 0.0 111.7 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.38 -48.21 1.72 Allowed Glycine 0 CA--C 1.549 2.206 0 N-CA-C 114.964 0.746 . . . . 0.0 114.964 -168.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -67.7 146.44 53.79 Favored 'General case' 0 CA--C 1.564 1.517 0 C-N-CA 124.536 1.134 . . . . 0.0 112.159 172.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -78.86 92.2 4.85 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.872 0.869 . . . . 0.0 109.615 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 25.5 p -107.2 140.08 40.62 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -154.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -67.23 127.49 32.85 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.635 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.5 mt . . . . . 0 N--CA 1.486 1.339 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -178.257 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.2 mptt . . . . . 0 N--CA 1.486 1.349 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.2 m -92.67 126.09 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.379 -177.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -84.6 96.37 9.16 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.5 p -138.34 125.45 21.45 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -162.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.6 t -85.6 125.22 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -160.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.0 t -100.59 118.97 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -99.71 134.27 42.84 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.735 0.779 . . . . 0.0 109.754 176.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.1 tp -101.53 112.31 24.82 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.443 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -118.08 121.28 40.17 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.37 12.76 66.81 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 121.215 3.246 . . . . 0.0 121.215 175.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.302 9.0 t70 52.16 48.75 22.06 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -162.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -155.6 -43.34 0.08 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 117.651 -1.166 . . . . 0.0 113.584 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -98.73 122.0 41.39 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 120.469 1.486 . . . . 0.0 110.373 -175.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 77.3 mt -110.69 98.95 7.99 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 168.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.7 m -103.71 124.57 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 123.707 0.803 . . . . 0.0 109.525 -172.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.1 t -148.22 132.39 17.36 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.047 0.451 . . . . 0.0 110.971 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.7 p -95.66 119.83 34.85 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 172.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -84.64 -85.05 0.14 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.074 0.55 . . . . 0.0 109.909 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.74 -75.28 0.59 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 167.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -100.89 -19.07 16.07 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 167.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 mp -82.03 115.99 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-N 120.275 1.398 . . . . 0.0 108.106 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -99.31 101.78 13.19 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 168.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.9 t -85.66 99.4 11.27 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.617 0.767 . . . . 0.0 110.458 -177.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 70.2 t -99.52 97.76 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.7 m -105.52 86.24 2.38 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -166.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -97.04 131.6 43.68 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.888 0.875 . . . . 0.0 110.106 -171.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 tt -101.68 106.28 17.29 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -175.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -106.18 86.66 2.4 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -172.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.74 -108.09 2.68 Favored Glycine 0 N--CA 1.482 1.74 0 O-C-N 122.101 -0.374 . . . . 0.0 112.882 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -121.46 52.65 1.22 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.314 0.578 . . . . 0.0 111.615 170.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.5 pt -131.21 -163.17 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 C-N-CA 124.337 1.055 . . . . 0.0 108.163 163.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.3 tt -154.88 119.57 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 120.363 -1.46 . . . . 0.0 107.952 157.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 29.3 m -95.06 101.02 12.75 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -94.81 99.34 11.43 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 30.3 m -101.93 91.17 4.24 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -172.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 36.3 mtt -93.17 103.36 15.64 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.224 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.3 p -97.86 95.94 7.87 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.489 -171.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 19.3 tp -93.72 81.97 4.3 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.723 0.809 . . . . 0.0 109.079 177.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.8 -101.95 1.16 Allowed Glycine 0 CA--C 1.544 1.879 0 CA-C-N 116.191 -0.458 . . . . 0.0 113.043 -174.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -98.06 -11.52 22.84 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 170.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 62.4 mt -86.71 106.46 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -174.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.9 t -98.84 94.17 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -175.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -82.3 92.73 7.0 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.231 0.613 . . . . 0.0 109.659 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -92.41 109.47 20.86 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.3 ttt-85 -118.23 104.9 11.23 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -164.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.9 mp -98.44 116.33 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 105.593 -2.002 . . . . 0.0 105.593 -172.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.9 m -130.33 115.14 16.51 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -176.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -87.38 137.33 32.43 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.228 0.611 . . . . 0.0 112.135 -168.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.3 ttt85 -67.58 124.88 24.46 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 123.914 0.886 . . . . 0.0 111.524 177.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.5 pt . . . . . 0 N--CA 1.484 1.258 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 -172.576 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 . . . . . 0 N--CA 1.495 1.801 0 N-CA-C 117.027 2.232 . . . . 0.0 117.027 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.7 m -73.29 109.21 6.64 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 120.704 1.593 . . . . 0.0 110.648 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.15 162.21 23.09 Favored Glycine 0 CA--C 1.544 1.877 0 CA-C-O 122.306 0.948 . . . . 0.0 114.134 -171.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -97.18 125.88 41.98 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 114.402 -0.899 . . . . 0.0 108.605 175.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -121.52 104.37 9.6 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -172.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -95.62 137.85 34.11 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.129 0.49 . . . . 0.0 110.892 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.7 tp -66.11 130.69 44.11 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.082 0.953 . . . . 0.0 112.987 -173.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -114.64 -64.79 1.26 Allowed 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.879 -175.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.7 m -125.49 112.05 15.78 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -105.74 110.4 22.69 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -97.41 127.42 43.36 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.263 85.5 m-20 67.4 52.51 0.8 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 173.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -78.65 -43.95 24.94 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 168.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -68.65 -50.86 47.83 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -175.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.91 -40.74 85.44 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 170.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -69.44 -56.54 7.13 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -44.24 96.61 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -61.96 -38.13 87.37 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 170.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.66 -34.39 77.74 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.819 2.155 . . . . 0.0 116.819 172.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.5 pt -82.33 -53.8 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 CA-C-N 119.327 0.967 . . . . 0.0 112.384 176.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.52 68.68 0.01 OUTLIER Glycine 0 CA--C 1.539 1.535 0 CA-C-N 119.017 0.826 . . . . 0.0 112.894 172.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.32 153.11 81.56 Favored Pre-proline 0 CA--C 1.57 1.721 0 C-N-CA 123.513 0.725 . . . . 0.0 111.813 175.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.81 152.84 25.53 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 123.264 2.643 . . . . 0.0 113.489 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -59.18 -28.84 66.99 Favored 'General case' 0 CA--C 1.565 1.526 0 N-CA-C 116.723 2.119 . . . . 0.0 116.723 168.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -63.02 -51.81 65.35 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 120.543 1.52 . . . . 0.0 114.055 170.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.4 mt -67.93 -28.28 67.35 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 116.604 2.075 . . . . 0.0 116.604 173.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.3 mt -70.38 -49.94 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 C-N-CA 124.297 1.039 . . . . 0.0 111.621 173.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -64.23 -22.62 67.01 Favored 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 116.315 1.969 . . . . 0.0 116.315 170.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -73.08 -57.99 3.63 Favored 'General case' 0 CA--C 1.565 1.519 0 CA-C-N 119.272 0.942 . . . . 0.0 111.74 167.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.5 -22.16 67.46 Favored Glycine 0 CA--C 1.548 2.143 0 N-CA-C 120.418 2.927 . . . . 0.0 120.418 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -64.68 -43.53 93.24 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 119.661 1.731 . . . . 0.0 114.64 170.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -67.24 -27.85 67.57 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 168.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 53.1 mt -83.03 121.75 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-N 120.144 1.338 . . . . 0.0 107.506 178.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.64 102.46 15.09 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 173.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.54 132.74 11.42 Favored Glycine 0 CA--C 1.541 1.707 0 N-CA-C 114.509 0.564 . . . . 0.0 114.509 -167.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.3 t -85.33 110.21 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 54.2 p -109.79 112.16 24.03 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.5 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -89.63 152.32 21.44 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 121.632 0.729 . . . . 0.0 111.058 -177.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.2 mt -136.35 132.8 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 105.437 -2.06 . . . . 0.0 105.437 173.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.6 t -126.57 102.77 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -80.18 120.7 24.65 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.122 0.569 . . . . 0.0 110.148 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -122.99 73.0 1.12 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 169.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.83 -117.48 7.56 Favored Glycine 0 CA--C 1.546 1.996 0 C-N-CA 123.117 0.389 . . . . 0.0 113.67 -175.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -76.87 -34.36 57.8 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 169.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -79.95 112.99 17.78 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 119.941 1.246 . . . . 0.0 110.761 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -105.74 117.98 35.42 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -104.12 104.65 14.62 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 176.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -133.29 134.45 43.9 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.297 -166.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.96 147.71 22.84 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.669 0.747 . . . . 0.0 110.029 165.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.0 tp -130.68 121.91 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.5 m . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 172.74 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.3 tt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.857 0.837 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -94.81 125.48 39.49 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.774 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -127.38 159.19 35.21 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 124.007 0.923 . . . . 0.0 110.257 -177.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -139.34 136.69 35.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.543 -0.723 . . . . 0.0 110.244 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.49 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 28.5 p90 -126.96 159.71 33.23 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 122.012 0.91 . . . . 0.0 112.324 167.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 96.3 m -116.07 139.7 50.03 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 163.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.6 t -75.62 123.35 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.13 34.21 21.49 Favored Glycine 0 CA--C 1.549 2.198 0 N-CA-C 117.044 1.578 . . . . 0.0 117.044 -168.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -149.89 138.57 20.83 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -177.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -69.32 105.71 2.65 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.176 0.512 . . . . 0.0 109.954 160.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 63' ' ' PHE . 3.2 p -129.25 131.76 47.09 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 122.402 1.096 . . . . 0.0 110.649 -162.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -79.65 123.75 27.92 Favored 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 113.962 -1.472 . . . . 0.0 112.631 -168.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.8 mt . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 -177.926 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 121.045 0.45 . . . . 0.0 110.676 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.9 p -140.12 121.19 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -169.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -92.85 123.63 36.26 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.189 0.596 . . . . 0.0 109.985 -175.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.2 p -132.84 128.65 37.13 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -164.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.5 t -93.39 108.68 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -175.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.3 t -96.56 127.09 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -172.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -115.52 132.16 56.71 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 168.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.9 tp -98.67 108.62 21.36 Favored 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -102.79 125.5 49.56 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.78 0.8 . . . . 0.0 109.159 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.09 11.13 66.57 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 121.173 3.229 . . . . 0.0 121.173 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.274 25.9 m-20 57.77 43.52 21.77 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -166.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -158.65 -38.79 0.06 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 117.744 -1.122 . . . . 0.0 114.0 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -103.99 119.33 38.71 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 120.458 1.481 . . . . 0.0 110.411 -172.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.6 mt -101.03 99.46 9.92 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 174.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.1 t -100.68 110.59 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -170.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.6 t -137.26 159.58 41.51 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 122.863 1.316 . . . . 0.0 113.629 -167.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 58.9 m -80.47 -78.42 0.17 Allowed 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.914 -161.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 65.0 171.38 0.2 Allowed 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 119.613 1.097 . . . . 0.0 113.749 -169.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -79.21 95.06 5.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.195 -0.94 . . . . 0.0 108.569 165.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 55.8 t30 47.44 47.41 17.16 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.9 mt -137.81 88.54 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 102.926 -2.99 . . . . 0.0 102.926 174.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -84.5 98.41 10.09 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -174.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.9 t -96.62 117.65 31.42 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.933 -165.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 56.1 t -113.36 101.83 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 104.832 -2.285 . . . . 0.0 104.832 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.7 m -98.36 83.96 3.14 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -89.99 130.97 36.12 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.967 0.907 . . . . 0.0 110.214 -172.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 tt -101.27 110.38 22.38 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -110.68 85.52 2.13 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -174.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.82 -108.31 2.72 Favored Glycine 0 N--CA 1.483 1.771 0 O-C-N 122.081 -0.387 . . . . 0.0 112.952 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -121.36 56.5 1.04 Allowed 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.337 0.589 . . . . 0.0 111.188 168.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.8 pt -131.39 -166.11 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.687 0 C-N-CA 124.331 1.052 . . . . 0.0 108.522 161.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.6 tt -154.62 123.04 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.305 0 O-C-N 120.196 -1.565 . . . . 0.0 108.545 158.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 46.1 m -101.64 103.13 13.92 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 -176.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -93.0 98.56 11.43 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.5 m -99.34 87.25 3.58 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.662 0.744 . . . . 0.0 109.018 -171.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 33.5 mtt -92.46 105.43 17.61 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.129 0.972 . . . . 0.0 109.704 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.9 p -98.89 101.27 12.61 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -172.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.5 tp -95.25 83.77 3.93 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.57 -97.31 0.78 Allowed Glycine 0 CA--C 1.543 1.83 0 CA-C-N 116.437 -0.347 . . . . 0.0 112.685 -171.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -106.95 -9.3 16.31 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.319 1.599 . . . . 0.0 115.319 169.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 48.5 mt -85.75 107.31 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-N 120.692 1.587 . . . . 0.0 107.091 -173.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.3 t -94.7 95.61 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -174.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -86.74 100.75 12.72 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.905 0.882 . . . . 0.0 109.245 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -111.18 107.72 17.15 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.76 -172.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -99.72 114.33 27.37 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 75.6 mt -102.75 103.09 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 -177.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.4 m -120.47 114.98 22.58 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -171.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -84.2 135.83 34.2 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.172 0.589 . . . . 0.0 112.168 -168.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -69.91 133.46 47.35 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-O 122.014 0.912 . . . . 0.0 112.184 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.7 pt . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 -172.281 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.365 90.7 m-85 . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 117.381 2.363 . . . . 0.0 117.381 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.9 m -71.94 107.22 4.57 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 120.496 1.498 . . . . 0.0 111.248 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.69 161.31 24.28 Favored Glycine 0 CA--C 1.544 1.88 0 CA-C-O 122.652 1.14 . . . . 0.0 114.044 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -96.58 125.67 41.21 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 168.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -121.05 116.66 25.45 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -174.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -91.83 125.78 36.67 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 122.943 0.497 . . . . 0.0 110.092 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 28.6 tp -64.02 131.79 48.64 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.75 0.82 . . . . 0.0 112.781 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -126.33 -58.22 1.36 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 118.569 -0.729 . . . . 0.0 110.742 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.8 m -107.35 136.99 46.22 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 119.067 0.849 . . . . 0.0 109.664 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -139.53 106.35 5.4 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -96.47 134.2 39.95 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.081 0.952 . . . . 0.0 109.365 176.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.26 13.5 m-20 66.67 47.65 1.55 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 174.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -77.82 -49.51 14.15 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 176.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -62.79 -46.78 86.41 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 177.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.74 -42.39 93.06 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 173.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -72.49 -52.8 14.17 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -52.09 66.81 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -56.92 -39.24 74.09 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 171.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.12 -37.48 87.59 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 116.588 2.069 . . . . 0.0 116.588 174.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.278 48.5 pt -77.36 -48.88 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-N 119.516 1.053 . . . . 0.0 112.955 175.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.81 57.72 0.01 OUTLIER Glycine 0 N--CA 1.483 1.815 0 CA-C-N 119.473 1.033 . . . . 0.0 114.5 166.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -110.3 154.03 43.1 Favored Pre-proline 0 CA--C 1.566 1.575 0 CA-C-N 118.009 0.904 . . . . 0.0 112.084 -175.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.16 154.93 33.0 Favored 'Trans proline' 0 CA--C 1.557 1.659 0 C-N-CA 123.296 2.664 . . . . 0.0 113.384 172.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -61.62 -35.49 78.04 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 170.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.05 -54.18 50.03 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 173.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.6 mt -70.97 -24.07 62.34 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 116.558 2.058 . . . . 0.0 116.558 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 60.6 mt -70.2 -52.14 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-N 119.94 1.245 . . . . 0.0 110.974 169.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -62.84 -19.7 64.36 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 116.912 2.19 . . . . 0.0 116.912 173.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -81.38 -53.91 5.91 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-N 119.483 1.038 . . . . 0.0 112.182 167.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.45 -7.2 57.36 Favored Glycine 0 CA--C 1.553 2.463 0 N-CA-C 120.279 2.872 . . . . 0.0 120.279 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.77 -47.03 61.73 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 120.21 2.005 . . . . 0.0 113.273 170.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -69.43 -31.91 70.56 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 168.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.2 mt -78.29 119.79 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -85.13 116.25 23.39 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.86 131.16 10.59 Favored Glycine 0 CA--C 1.54 1.608 0 CA-C-N 116.096 -0.502 . . . . 0.0 113.723 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.8 t -81.26 114.53 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 175.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.2 m -96.51 110.98 23.26 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 176.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.39 141.3 30.64 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.81 0.814 . . . . 0.0 109.954 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 67.2 mt -141.53 132.34 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 170.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.8 t -120.87 113.39 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 174.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -82.41 123.73 29.4 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.262 0.625 . . . . 0.0 110.168 173.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -128.07 72.02 1.4 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 163.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.88 -114.43 5.29 Favored Glycine 0 CA--C 1.545 1.933 0 C-N-CA 123.4 0.524 . . . . 0.0 113.385 -177.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -77.53 -33.51 54.22 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 167.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -76.54 102.94 6.27 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 120.072 1.305 . . . . 0.0 111.008 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -109.13 109.21 20.14 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.95 127.89 44.98 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 168.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -116.34 152.14 34.49 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.747 178.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.1 m -136.28 92.63 2.8 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 173.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.8 mm -91.12 116.61 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 -175.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -174.816 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.4 mt . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -117.09 130.72 56.83 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.768 0.827 . . . . 0.0 110.966 -176.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -148.31 149.13 31.27 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.553 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -118.4 128.36 54.55 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.826 0.85 . . . . 0.0 110.222 -176.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -116.12 144.47 44.11 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.962 0.905 . . . . 0.0 111.425 170.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.2 m -105.3 124.11 48.98 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 166.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.4 t -67.04 124.88 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 C-N-CA 123.735 0.814 . . . . 0.0 110.662 -174.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.18 -49.97 2.45 Favored Glycine 0 CA--C 1.549 2.167 0 N-CA-C 115.999 1.16 . . . . 0.0 115.999 -170.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -93.22 124.13 36.98 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.728 0.811 . . . . 0.0 110.231 -172.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -57.44 123.81 16.75 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 -168.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 72.6 m -144.08 146.53 32.88 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.099 0.96 . . . . 0.0 109.609 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -80.04 134.59 36.23 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.2 mt . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 175.107 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 49.5 mttm . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 122.393 1.092 . . . . 0.0 109.685 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.8 p -114.39 134.52 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 113.157 -1.838 . . . . 0.0 108.773 -164.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -78.02 106.39 9.85 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.14 0.576 . . . . 0.0 110.794 -171.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.6 t -152.64 130.81 11.94 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -173.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.25 145.26 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 123.374 1.559 . . . . 0.0 110.587 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.8 t -98.49 142.18 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.302 0 CA-C-N 112.985 -1.916 . . . . 0.0 108.347 -167.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -112.48 132.98 54.79 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 172.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.7 tp -98.07 109.71 22.42 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.841 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -95.65 114.93 26.73 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 122.127 0.965 . . . . 0.0 108.929 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.44 -128.64 10.65 Favored Glycine 0 CA--C 1.545 1.919 0 CA-C-N 114.019 -1.446 . . . . 0.0 112.265 -168.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -135.82 58.55 1.75 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 156.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -158.49 -32.0 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -173.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -114.39 106.21 14.03 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 120.925 1.693 . . . . 0.0 108.976 -174.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 42.4 mt -95.78 103.91 15.81 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.0 m -102.35 125.56 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 C-N-CA 123.372 0.669 . . . . 0.0 109.87 -172.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 t -149.66 151.43 33.71 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.324 0.583 . . . . 0.0 111.771 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 29.7 p -119.71 112.72 19.64 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.405 0.682 . . . . 0.0 109.215 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -83.38 37.43 0.56 Allowed 'General case' 0 CA--C 1.58 2.106 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 168.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.344 11.8 tmtt? 69.99 -81.04 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.952 1.301 . . . . 0.0 111.236 -163.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -81.14 -42.6 20.63 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.8 mp -85.64 123.05 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-N 119.585 1.084 . . . . 0.0 108.167 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -102.57 98.77 8.78 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 172.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.9 t -89.67 132.88 34.94 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.478 0.711 . . . . 0.0 110.958 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.1 t -132.95 102.3 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 20.6 m -93.14 95.71 9.58 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -80.84 145.21 31.51 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.111 0.964 . . . . 0.0 110.703 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.2 tt -128.35 109.37 11.38 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 174.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -113.21 80.49 1.36 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -175.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.93 -109.24 3.26 Favored Glycine 0 N--CA 1.484 1.861 0 O-C-N 121.835 -0.541 . . . . 0.0 113.068 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.47 50.39 0.95 Allowed 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 122.965 0.506 . . . . 0.0 111.362 173.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.6 pt -133.8 -168.74 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.786 0 C-N-CA 124.047 0.939 . . . . 0.0 108.938 171.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.1 tt -156.85 115.44 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.272 -1.517 . . . . 0.0 107.45 159.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 90.0 m -103.15 99.7 9.58 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -90.19 108.81 19.98 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 39.7 m -108.48 100.14 9.45 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 -173.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.8 mtt -101.28 100.39 10.89 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.2 p -88.65 113.38 24.16 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.009 -173.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.3 tp -117.87 75.43 1.0 Allowed 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.35 -107.4 2.34 Favored Glycine 0 CA--C 1.545 1.958 0 CA-C-N 116.404 -0.362 . . . . 0.0 112.369 -172.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -93.62 -10.7 33.7 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 167.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 61.8 mt -86.52 103.67 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -173.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 48.4 t -97.81 97.78 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -85.55 96.33 9.6 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.163 0.585 . . . . 0.0 109.446 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -105.26 101.67 11.19 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -176.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.6 113.98 27.22 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 50.2 mt -107.02 112.91 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -172.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 54.5 m -114.76 119.03 35.26 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 176.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -83.81 147.3 27.66 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.965 -0.459 . . . . 0.0 110.937 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -76.03 107.18 8.06 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 121.538 0.685 . . . . 0.0 111.295 -169.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.7 mt . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 102.336 -3.209 . . . . 0.0 102.336 -158.505 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 . . . . . 0 N--CA 1.494 1.743 0 N-CA-C 117.569 2.433 . . . . 0.0 117.569 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.2 m -69.39 112.26 5.81 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 120.822 1.646 . . . . 0.0 110.792 173.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.03 145.22 4.95 Favored Glycine 0 CA--C 1.541 1.675 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.062 -171.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -102.21 106.8 17.69 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -107.64 104.05 13.49 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -162.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -83.19 131.24 35.13 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.123 0.487 . . . . 0.0 111.633 -177.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.9 tp -76.14 115.71 16.13 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.675 -168.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -98.6 -65.24 0.97 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.507 0.723 . . . . 0.0 111.444 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.0 m -131.89 135.66 46.83 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.245 0.618 . . . . 0.0 110.336 -163.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -129.29 134.68 48.05 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.649 0.737 . . . . 0.0 109.799 -175.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -76.28 -58.55 3.22 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.356 171.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -127.35 68.94 1.29 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.584 0.629 . . . . 0.0 110.799 -176.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -75.12 -54.26 7.45 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.526 -0.734 . . . . 0.0 112.553 170.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -65.21 -49.55 69.3 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.22 -39.21 82.0 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 116.89 2.182 . . . . 0.0 116.89 174.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -65.96 -54.07 30.89 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 174.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 37.4 mtt -60.7 -45.61 93.52 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -55.67 -42.1 74.63 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 167.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.4 -34.47 78.02 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 117.06 2.244 . . . . 0.0 117.06 175.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.7 pt -78.48 -43.94 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-N 119.822 1.192 . . . . 0.0 113.599 175.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.36 62.78 0.09 OUTLIER Glycine 0 N--CA 1.481 1.664 0 CA-C-N 118.881 0.764 . . . . 0.0 112.682 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.42 151.33 46.8 Favored Pre-proline 0 CA--C 1.568 1.649 0 C-N-CA 123.8 0.84 . . . . 0.0 110.745 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -75.65 156.99 40.21 Favored 'Trans proline' 0 CA--C 1.555 1.559 0 C-N-CA 123.264 2.642 . . . . 0.0 113.637 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -60.35 -29.53 68.96 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.692 1.738 . . . . 0.0 115.692 168.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -60.2 -57.75 11.48 Favored 'General case' 0 CA--C 1.564 1.495 0 CA-C-O 117.297 -1.335 . . . . 0.0 113.803 169.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.8 mt -68.69 -24.16 64.47 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 117.19 2.293 . . . . 0.0 117.19 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.4 mt -73.38 -54.29 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-N 119.491 1.042 . . . . 0.0 110.711 173.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -69.18 -27.85 65.88 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 177.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -76.69 -53.77 7.54 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.04 0.936 . . . . 0.0 112.109 171.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.9 -19.78 69.99 Favored Glycine 0 CA--C 1.551 2.316 0 N-CA-C 119.652 2.621 . . . . 0.0 119.652 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -65.72 -43.71 88.24 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 120.251 2.025 . . . . 0.0 114.434 170.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -68.4 -31.47 70.83 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 170.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.9 mt -77.33 129.86 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-N 119.532 1.06 . . . . 0.0 108.508 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.52 94.97 9.94 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 171.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.12 131.06 10.36 Favored Glycine 0 N--CA 1.481 1.635 0 CA-C-N 116.558 -0.292 . . . . 0.0 113.322 -172.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.7 t -79.75 120.81 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.9 m -108.29 100.21 9.54 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 107.167 -1.419 . . . . 0.0 107.167 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -83.89 147.9 27.26 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.842 0.829 . . . . 0.0 111.011 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.9 mt -143.91 129.42 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 172.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 67.8 t -120.88 117.49 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 176.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -81.2 122.11 26.98 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.404 0.681 . . . . 0.0 111.31 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -131.0 64.11 1.58 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 171.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.58 -113.73 5.9 Favored Glycine 0 CA--C 1.547 2.059 0 O-C-N 121.629 -0.669 . . . . 0.0 113.746 -174.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -73.29 -40.46 64.54 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 169.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -69.63 135.59 50.12 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 119.407 1.003 . . . . 0.0 111.387 175.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -127.6 108.72 11.02 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -87.04 92.59 9.1 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.673 0.749 . . . . 0.0 109.017 176.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -104.64 136.5 44.05 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.42 -175.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.8 m -131.55 102.58 5.98 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -177.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.6 mm -95.22 105.08 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 174.34 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.8 mp . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.78 120.85 42.22 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.203 0.601 . . . . 0.0 110.538 -177.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -149.62 161.33 42.38 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.175 0.99 . . . . 0.0 109.968 -175.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -117.47 128.58 55.13 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.57 0.748 . . . . 0.0 109.871 175.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.418 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 18.2 p90 -107.89 145.07 34.25 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.467 0.651 . . . . 0.0 110.392 158.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.4 m -109.15 131.89 54.64 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 171.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.2 t -73.55 130.1 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 123.797 0.839 . . . . 0.0 109.702 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.27 8.52 87.52 Favored Glycine 0 CA--C 1.553 2.452 0 N-CA-C 118.706 2.242 . . . . 0.0 118.706 -170.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -139.73 135.7 33.41 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 119.272 1.536 . . . . 0.0 108.251 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.75 121.93 18.18 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.257 0.623 . . . . 0.0 112.5 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 63' ' ' PHE . 0.9 OUTLIER -136.86 126.85 25.93 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.693 0.797 . . . . 0.0 110.479 -165.502 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.3 128.3 34.09 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.03 -0.987 . . . . 0.0 111.685 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.9 mt . . . . . 0 N--CA 1.487 1.421 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -175.43 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 mptt . . . . . 0 N--CA 1.487 1.408 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.7 m -80.54 -47.43 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -168.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . 0.265 53.9 mtpt 64.36 86.32 0.13 Allowed 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 124.821 1.248 . . . . 0.0 111.648 -172.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.7 t -134.68 147.17 50.06 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.707 0.803 . . . . 0.0 110.033 -171.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.8 t -85.5 -56.98 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.776 -0.578 . . . . 0.0 111.427 -169.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . 0.307 3.1 t 80.25 127.24 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 125.382 1.473 . . . . 0.0 109.866 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -121.26 135.17 55.16 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 39.2 tp -96.68 102.57 14.37 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -86.23 114.43 23.05 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 121.799 0.809 . . . . 0.0 109.309 173.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.53 -122.42 8.54 Favored Glycine 0 CA--C 1.542 1.724 0 CA-C-N 114.394 -1.276 . . . . 0.0 112.89 -175.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -142.04 60.42 1.46 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 155.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -151.51 -39.29 0.12 Allowed 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 117.267 -1.349 . . . . 0.0 114.218 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -106.27 126.65 52.49 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 120.686 1.584 . . . . 0.0 110.288 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 37.2 mt -107.74 100.0 9.43 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 165.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.8 m -94.9 122.85 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 123.876 0.871 . . . . 0.0 109.274 -172.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.2 t -152.51 132.82 13.65 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 120.92 0.39 . . . . 0.0 111.907 -172.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 44.8 p -100.58 121.54 41.78 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -84.18 -70.74 0.55 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.031 0.532 . . . . 0.0 111.339 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -120.7 -77.3 0.58 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 165.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -126.74 66.98 1.25 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 159.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 62.9 mt -142.33 101.21 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 103.411 -2.811 . . . . 0.0 103.411 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -88.08 98.4 11.51 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.345 0.593 . . . . 0.0 109.571 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.3 t -88.25 102.64 15.02 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.307 1.043 . . . . 0.0 109.947 -176.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.7 t -101.0 97.23 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 -177.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.9 m -91.65 83.49 5.33 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -168.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -98.66 129.13 45.14 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.626 0.77 . . . . 0.0 110.129 -161.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 tt -113.09 114.07 26.31 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -167.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -119.27 103.33 9.41 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.01 -118.18 4.65 Favored Glycine 0 N--CA 1.484 1.862 0 C-N-CA 123.123 0.392 . . . . 0.0 112.714 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -124.93 60.16 1.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.986 0.898 . . . . 0.0 110.107 161.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.6 pt -123.62 -164.64 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.789 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 157.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.3 tt -155.9 125.19 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 120.147 -1.596 . . . . 0.0 108.283 160.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 88.9 m -109.76 98.65 7.95 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -93.86 123.79 37.44 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.371 0.605 . . . . 0.0 109.691 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 27.8 m -114.59 93.84 4.51 Favored 'General case' 0 CA--C 1.557 1.236 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 -170.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 63.5 mtt -93.22 99.81 12.3 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.813 0.845 . . . . 0.0 109.102 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 73.8 p -94.84 100.22 12.14 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -171.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 35.0 tp -96.4 84.96 3.81 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.31 -100.0 0.93 Allowed Glycine 0 CA--C 1.544 1.881 0 CA-C-N 116.743 -0.208 . . . . 0.0 112.852 -174.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -102.36 -10.5 19.4 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 169.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 71.9 mt -87.09 108.19 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-N 120.601 1.546 . . . . 0.0 107.453 -172.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.3 t -97.83 93.13 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -172.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -82.84 109.18 16.75 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 122.967 0.507 . . . . 0.0 110.285 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -88.77 142.79 27.37 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.818 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 45.7 mtm180 -134.62 93.57 3.06 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 174.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 58.3 mt -94.73 104.87 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 105.499 -2.038 . . . . 0.0 105.499 -174.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.5 m -130.75 112.92 13.51 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -163.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -90.87 138.95 31.2 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.351 0.595 . . . . 0.0 112.186 -172.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.2 136.71 56.29 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 123.748 0.819 . . . . 0.0 113.114 -177.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.9 pt . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 -175.53 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 . . . . . 0 CA--C 1.57 1.74 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.2 m 62.0 88.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.04 1.336 . . . . 0.0 112.848 -176.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.44 167.05 31.93 Favored Glycine 0 CA--C 1.54 1.646 0 CA-C-O 122.993 1.33 . . . . 0.0 115.095 -177.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -94.26 122.22 36.58 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 113.313 -1.444 . . . . 0.0 107.658 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -114.62 105.58 13.24 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -175.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -77.58 117.09 18.67 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.121 0.969 . . . . 0.0 111.052 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 55.5 tp -69.67 107.15 3.33 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.112 0.565 . . . . 0.0 112.185 -174.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -85.89 -58.86 2.48 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.903 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.2 t -134.14 142.32 47.43 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.682 0.793 . . . . 0.0 110.016 -169.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -120.97 133.88 55.28 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.841 0.829 . . . . 0.0 108.931 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -76.03 -61.86 1.8 Allowed 'General case' 0 CA--C 1.561 1.387 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.835 169.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -128.28 67.89 1.36 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 118.628 0.649 . . . . 0.0 111.132 -172.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -75.06 -52.08 11.94 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 175.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -66.74 -43.22 84.75 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 -175.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.25 -44.0 95.64 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 169.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -67.82 -51.93 42.85 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.28 -49.07 75.31 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -60.97 -42.35 98.16 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 171.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.64 -29.61 69.67 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 117.242 2.312 . . . . 0.0 117.242 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.267 37.8 pt -77.29 -48.84 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 120.1 1.318 . . . . 0.0 112.587 171.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 137.22 65.13 0.05 OUTLIER Glycine 0 CA--C 1.541 1.686 0 C-N-CA 123.826 0.727 . . . . 0.0 112.312 175.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.4 mt -131.25 147.74 67.4 Favored Pre-proline 0 CA--C 1.568 1.64 0 C-N-CA 123.958 0.903 . . . . 0.0 110.437 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.44 149.04 80.25 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 123.39 2.727 . . . . 0.0 114.397 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -59.47 -28.09 66.69 Favored 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 171.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -61.95 -46.43 89.35 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 166.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.14 -16.49 64.02 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 116.984 2.216 . . . . 0.0 116.984 167.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 72.9 mt -74.62 -55.35 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-N 120.414 1.461 . . . . 0.0 110.534 168.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -67.2 -29.28 68.91 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -75.73 -56.4 4.72 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 119.546 1.066 . . . . 0.0 111.517 168.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.22 -19.74 59.85 Favored Glycine 0 CA--C 1.55 2.223 0 N-CA-C 120.619 3.008 . . . . 0.0 120.619 178.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -67.16 -44.84 78.74 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 119.654 1.727 . . . . 0.0 113.852 168.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -68.71 -37.95 79.89 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 169.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.6 mt -74.33 126.41 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 119.455 1.025 . . . . 0.0 108.355 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.08 99.25 11.36 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.69 111.48 3.72 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-N 116.023 -0.535 . . . . 0.0 113.13 -172.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.7 t -67.15 129.26 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 123.813 0.845 . . . . 0.0 110.481 -176.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.0 p -98.82 105.7 17.88 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -86.61 151.06 23.77 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.473 176.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.6 mt -140.84 138.8 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.7 t -129.8 103.93 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 171.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -90.22 113.13 24.88 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 172.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -121.64 62.63 0.92 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.173 0.589 . . . . 0.0 109.523 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.12 -111.53 3.86 Favored Glycine 0 CA--C 1.546 1.975 0 O-C-N 121.852 -0.53 . . . . 0.0 113.161 -173.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -75.65 -43.0 49.93 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 169.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -73.73 110.73 8.26 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 119.42 1.009 . . . . 0.0 109.814 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.61 97.47 2.98 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -155.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.27 160.35 19.88 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.019 0.928 . . . . 0.0 111.463 -172.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -145.38 130.35 18.3 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.796 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.4 m -99.83 93.88 6.03 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 174.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.9 tp -86.6 118.55 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.4 p . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 174.745 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.6 mt . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -92.94 120.62 33.45 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 167.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -123.32 113.23 18.58 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -176.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -97.98 124.11 42.29 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.321 0.648 . . . . 0.0 109.256 -171.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -125.12 149.81 47.5 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.567 0.698 . . . . 0.0 111.351 176.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.0 m -105.94 132.17 52.36 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 168.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.8 t -79.53 119.35 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 175.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.32 0.22 73.86 Favored Glycine 0 CA--C 1.556 2.609 0 N-CA-C 118.885 2.314 . . . . 0.0 118.885 -171.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -145.46 132.14 19.95 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 120.278 2.039 . . . . 0.0 108.605 167.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -73.08 113.26 9.93 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -174.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 90.9 m -96.72 156.02 16.53 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.745 173.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -77.66 101.65 6.7 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.455 0.702 . . . . 0.0 111.145 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.6 mt . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 121.299 0.571 . . . . 0.0 110.942 -165.592 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.9 127.78 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -169.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -75.96 119.68 20.25 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.368 0.604 . . . . 0.0 111.383 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.7 t -145.9 141.6 27.96 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.485 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.14 136.4 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-O 122.515 1.15 . . . . 0.0 109.311 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.5 t -91.0 129.84 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.256 0 CA-C-N 113.833 -1.53 . . . . 0.0 107.833 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -100.56 134.97 42.72 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.062 0.935 . . . . 0.0 109.112 171.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.5 tp -97.84 102.66 14.47 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 114.352 -1.294 . . . . 0.0 107.961 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -101.55 116.96 33.94 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.91 11.38 85.55 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 120.946 3.138 . . . . 0.0 120.946 171.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.283 20.3 m-20 57.85 43.29 21.88 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -165.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -158.63 -43.55 0.06 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 118.118 -0.944 . . . . 0.0 113.521 -177.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -95.8 138.43 33.46 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 120.142 1.337 . . . . 0.0 111.237 -175.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.0 mt -123.36 101.91 7.62 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 172.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.2 m -106.27 117.53 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 123.439 0.696 . . . . 0.0 109.181 -171.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.6 t -151.7 142.1 22.51 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 122.421 0.288 . . . . 0.0 111.346 -175.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 83.7 m -120.68 113.53 20.35 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -70.03 -76.82 0.09 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.796 0.838 . . . . 0.0 111.42 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -120.97 -72.58 0.68 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 165.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -128.73 60.17 1.53 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 118.662 0.665 . . . . 0.0 109.69 161.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 77.0 mt -131.47 97.5 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 102.615 -3.106 . . . . 0.0 102.615 172.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -92.02 91.07 7.67 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.7 t -84.41 109.62 18.01 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.983 0.913 . . . . 0.0 109.377 -174.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 72.0 t -116.77 97.16 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 -175.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.0 m -110.68 87.1 2.45 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -166.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -91.92 133.8 35.36 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.131 0.972 . . . . 0.0 110.621 -174.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.4 tt -102.36 110.01 21.83 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -175.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -110.51 90.47 3.33 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -172.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.71 -109.91 2.91 Favored Glycine 0 CA--C 1.544 1.85 0 CA-C-O 119.926 -0.374 . . . . 0.0 113.03 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -121.51 53.16 1.19 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.304 0.573 . . . . 0.0 111.694 167.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.4 pt -126.77 -165.44 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.799 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 159.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.5 tt -154.26 124.89 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 O-C-N 120.532 -1.355 . . . . 0.0 108.37 160.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 55.4 m -100.76 97.78 8.38 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -91.08 104.28 16.88 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.8 m -108.57 93.18 4.38 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -176.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 49.6 mtt -93.02 105.15 17.3 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.726 0.81 . . . . 0.0 109.098 177.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.4 p -95.33 100.64 12.39 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 51.3 tp -94.66 82.92 3.99 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 175.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.21 -99.75 0.9 Allowed Glycine 0 CA--C 1.542 1.751 0 CA-C-N 116.288 -0.415 . . . . 0.0 113.104 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -98.59 -15.9 19.3 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 170.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 62.4 mt -83.77 107.67 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 120.343 1.428 . . . . 0.0 107.563 -173.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.8 t -95.71 96.5 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -88.87 99.04 12.08 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.981 0.512 . . . . 0.0 109.999 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -102.27 109.67 21.41 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.046 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 25.2 mtm180 -101.64 125.79 48.36 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.73 0.812 . . . . 0.0 108.864 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.59 103.39 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 104.74 -2.318 . . . . 0.0 104.74 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 54.8 m -120.78 114.82 22.19 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 122.686 0.394 . . . . 0.0 110.065 -173.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -92.64 133.03 36.39 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.127 0.571 . . . . 0.0 111.628 -170.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -66.47 136.69 56.07 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 121.789 0.804 . . . . 0.0 113.087 -174.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.7 pt . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 -175.393 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 . . . . . 0 N--CA 1.495 1.776 0 N-CA-C 117.489 2.403 . . . . 0.0 117.489 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.7 m -70.44 109.67 4.91 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 121.093 1.769 . . . . 0.0 110.67 172.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.43 156.91 13.86 Favored Glycine 0 CA--C 1.543 1.79 0 CA-C-O 122.11 0.839 . . . . 0.0 113.873 -173.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.18 114.01 27.95 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 176.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -112.51 97.99 6.96 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -167.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -92.13 138.32 31.63 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.492 0.663 . . . . 0.0 111.003 -176.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.8 tp -74.78 126.46 30.95 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.515 -167.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.5 mm-40 -104.88 -64.68 1.1 Allowed 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.768 -175.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.5 m -129.36 140.36 51.4 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.657 0.783 . . . . 0.0 109.831 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -125.47 130.66 52.26 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.496 1.141 . . . . 0.0 110.841 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -99.44 129.12 45.6 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 113.594 -1.639 . . . . 0.0 107.221 168.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.251 69.8 m-20 67.28 40.47 2.75 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 170.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -67.64 -62.97 1.16 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.029 -1.044 . . . . 0.0 113.795 170.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -59.98 -34.98 74.03 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 117.18 2.289 . . . . 0.0 117.18 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.69 -47.17 84.81 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 166.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -65.99 -47.76 73.46 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -45.01 95.06 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 176.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -57.13 -48.26 79.11 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 166.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.71 -26.19 68.55 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 117.757 2.502 . . . . 0.0 117.757 177.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.3 pt -88.63 -49.28 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-N 119.178 0.899 . . . . 0.0 112.005 174.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 141.36 73.64 0.04 OUTLIER Glycine 0 CA--C 1.539 1.591 0 CA-C-N 118.903 0.774 . . . . 0.0 112.427 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.87 153.41 78.67 Favored Pre-proline 0 CA--C 1.571 1.763 0 C-N-CA 123.359 0.664 . . . . 0.0 112.602 176.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -76.44 158.78 36.46 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 123.354 2.703 . . . . 0.0 113.55 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -62.55 -31.6 72.41 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 169.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -60.06 -52.25 66.19 Favored 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 171.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 88.8 mt -72.43 -18.6 61.69 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 117.071 2.248 . . . . 0.0 117.071 175.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 93.3 mt -67.81 -61.28 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-N 119.631 1.105 . . . . 0.0 110.017 165.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -64.82 -25.27 67.83 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -78.58 -52.03 9.06 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.878 0.871 . . . . 0.0 112.376 171.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.78 -18.98 72.86 Favored Glycine 0 CA--C 1.551 2.33 0 N-CA-C 119.89 2.716 . . . . 0.0 119.89 177.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -65.06 -42.84 93.84 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 120.087 1.944 . . . . 0.0 114.732 169.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -66.46 -37.21 84.64 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 168.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.5 mt -72.01 115.46 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -85.98 106.72 17.36 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -174.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.04 131.76 10.91 Favored Glycine 0 CA--C 1.54 1.643 0 CA-C-N 115.966 -0.561 . . . . 0.0 114.471 -167.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.3 t -89.64 117.81 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 175.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.5 m -100.49 101.61 12.6 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 174.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.22 146.61 30.38 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.379 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 55.4 mt -142.1 123.3 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 104.5 -2.408 . . . . 0.0 104.5 174.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.6 t -115.54 108.87 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -93.99 120.31 34.07 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.012 0.525 . . . . 0.0 109.813 176.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 -122.25 74.85 1.19 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 164.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.42 -118.77 9.56 Favored Glycine 0 CA--C 1.548 2.127 0 C-N-CA 123.215 0.436 . . . . 0.0 113.757 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -75.47 -32.67 60.67 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 167.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -78.12 135.38 37.67 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 120.116 1.325 . . . . 0.0 111.592 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -137.19 150.77 48.13 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.97 0.89 . . . . 0.0 111.26 -175.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -136.78 115.15 11.78 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 161.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -107.41 125.72 51.58 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.559 173.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 50.8 m -119.44 99.92 6.98 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -173.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 88.1 mt -91.21 126.76 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.9 p . . . . . 0 N--CA 1.485 1.31 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 170.584 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 80.5 mt . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -107.97 127.06 53.42 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.549 0.74 . . . . 0.0 109.057 173.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -139.61 142.69 37.05 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.137 0.975 . . . . 0.0 109.822 -170.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -126.64 148.77 49.77 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.146 0.974 . . . . 0.0 110.543 -176.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -151.65 144.78 24.61 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.537 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.3 m -101.91 132.19 47.85 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 164.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.8 t -75.93 131.71 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.57 0.7 . . . . 0.0 109.863 -175.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.85 6.18 89.19 Favored Glycine 0 CA--C 1.553 2.435 0 N-CA-C 118.669 2.228 . . . . 0.0 118.669 -169.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -137.32 140.75 41.71 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 119.233 1.517 . . . . 0.0 108.332 -175.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -76.62 117.0 17.82 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.147 0.579 . . . . 0.0 111.019 -173.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.6 p -126.42 149.43 49.27 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 122.335 1.064 . . . . 0.0 112.871 -162.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -84.82 118.88 24.74 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.271 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 C-N-CA 123.654 0.781 . . . . 0.0 109.843 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 45.2 tptt . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.5 p -117.25 136.82 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 121.894 0.855 . . . . 0.0 110.489 -157.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -81.75 120.55 25.28 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.119 -177.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.4 t -148.07 135.5 20.6 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.932 0.493 . . . . 0.0 111.089 -167.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 75.5 t -88.99 119.44 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.1 t -104.28 112.54 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -116.3 143.41 45.57 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.803 0.811 . . . . 0.0 110.907 -176.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.6 tp -101.61 130.95 48.05 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.953 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -128.83 125.75 38.37 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 174.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.4 12.52 73.1 Favored Glycine 0 CA--C 1.55 2.265 0 N-CA-C 120.688 3.035 . . . . 0.0 120.688 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.268 24.2 m-20 58.74 37.92 24.98 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -167.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -160.84 -18.47 0.05 Allowed 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -176.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -119.1 101.22 7.85 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 121.101 1.773 . . . . 0.0 109.279 -171.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 79.3 mt -94.73 101.89 13.75 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 171.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.4 m -104.21 124.75 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 123.961 0.905 . . . . 0.0 108.744 -171.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.9 t -143.57 133.56 24.15 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.514 0.673 . . . . 0.0 111.425 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.8 t -131.79 134.67 46.07 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.211 1.005 . . . . 0.0 109.081 -175.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.334 14.2 p90 -136.03 -116.4 0.17 Allowed 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 118.612 -0.709 . . . . 0.0 109.497 -171.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -73.59 -68.5 0.5 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 119.6 1.091 . . . . 0.0 111.227 -178.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -126.86 -27.0 3.1 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 176.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 mp -86.34 121.95 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.574 0 CA-C-N 119.91 1.232 . . . . 0.0 108.417 -171.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -78.57 153.53 31.11 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.545 155.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.2 t -143.31 97.16 3.03 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 172.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 73.7 t -100.21 100.24 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.8 m -95.49 94.0 7.53 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -171.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -104.82 117.51 34.25 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.504 0.722 . . . . 0.0 109.073 -162.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 tt -106.47 117.8 34.99 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 -170.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -94.33 -99.77 0.15 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 118.236 -0.888 . . . . 0.0 108.88 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -103.05 -105.93 3.01 Favored Glycine 0 N--CA 1.485 1.912 0 CA-C-N 119.53 1.059 . . . . 0.0 111.276 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -96.39 49.26 1.11 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.074 0.464 . . . . 0.0 112.001 168.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.7 pt -142.38 -174.95 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.678 0 C-N-CA 124.64 1.176 . . . . 0.0 109.459 176.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.4 tt -150.1 127.69 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 120.917 -1.114 . . . . 0.0 108.719 161.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 29.8 m -103.61 92.24 4.37 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -88.7 106.81 18.59 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -177.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 39.1 m -111.9 97.49 6.72 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -169.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 46.0 mtt -98.48 104.26 16.28 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.351 0.66 . . . . 0.0 109.371 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 59.6 p -97.12 102.08 13.78 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.292 0.567 . . . . 0.0 109.765 -172.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 50.1 tp -101.51 83.94 2.52 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.45 -99.91 1.03 Allowed Glycine 0 CA--C 1.543 1.832 0 CA-C-N 116.437 -0.347 . . . . 0.0 112.793 -174.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -99.52 -16.34 18.34 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 169.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 70.1 mt -84.26 108.54 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-N 120.476 1.489 . . . . 0.0 107.86 -172.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.6 t -97.03 95.46 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -85.84 96.13 9.66 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.201 0.6 . . . . 0.0 109.739 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -104.36 106.54 17.08 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.871 -175.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -89.04 127.21 35.68 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.777 0.831 . . . . 0.0 109.014 170.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -108.64 104.01 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 174.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.5 m -127.92 116.73 20.55 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -171.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.256 17.3 ptpt -88.6 148.54 24.01 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 122.098 0.951 . . . . 0.0 113.538 -172.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -81.15 124.58 29.37 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.028 -172.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.0 pt . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 -169.499 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 116.985 2.217 . . . . 0.0 116.985 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.6 p -65.74 125.31 24.89 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 120.77 1.623 . . . . 0.0 113.612 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 153.98 167.16 15.74 Favored Glycine 0 CA--C 1.545 1.946 0 CA-C-O 122.54 1.078 . . . . 0.0 113.862 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -89.88 145.12 25.37 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 114.243 -0.978 . . . . 0.0 109.994 169.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -142.01 104.87 4.56 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -175.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.6 tm0? -87.92 127.32 35.36 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.592 -0.693 . . . . 0.0 111.356 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 50.8 tp -69.75 109.79 4.58 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.888 0.875 . . . . 0.0 113.228 -174.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -100.19 -60.63 1.49 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.331 0.653 . . . . 0.0 112.231 -172.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.1 t -127.74 138.56 52.81 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.566 0.746 . . . . 0.0 110.28 -168.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -133.26 133.46 42.68 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.521 0.677 . . . . 0.0 109.706 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -74.18 -64.5 1.0 Allowed 'General case' 0 CA--C 1.561 1.38 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.773 168.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -122.29 67.1 0.93 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.217 0.607 . . . . 0.0 110.746 -174.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -75.23 -52.04 11.86 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.416 -0.803 . . . . 0.0 111.993 168.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -60.6 -46.44 90.26 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.09 -36.22 82.61 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 174.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -73.37 -55.88 5.8 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 119.973 1.261 . . . . 0.0 113.672 175.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.25 -42.94 82.47 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.4 tmtm? -62.99 -43.97 97.31 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 169.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.7 -29.01 69.07 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 117.688 2.477 . . . . 0.0 117.688 173.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.25 38.2 pt -82.59 -54.53 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 119.248 0.931 . . . . 0.0 111.844 173.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.32 67.11 0.01 OUTLIER Glycine 0 N--CA 1.479 1.564 0 CA-C-O 118.898 -0.946 . . . . 0.0 113.134 171.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.8 mt -130.38 146.08 60.15 Favored Pre-proline 0 CA--C 1.569 1.695 0 CA-C-N 117.918 0.859 . . . . 0.0 111.138 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -69.11 150.65 72.43 Favored 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 123.577 2.851 . . . . 0.0 114.791 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -52.61 -36.49 56.47 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 171.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -63.22 -53.27 55.65 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 171.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.7 mt -66.85 -24.91 66.2 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.707 2.114 . . . . 0.0 116.707 176.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 87.3 mt -67.42 -53.9 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 124.347 1.059 . . . . 0.0 111.142 170.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -61.34 -24.01 66.15 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 172.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -75.69 -59.19 2.86 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 119.594 1.088 . . . . 0.0 111.503 169.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.39 -21.44 59.96 Favored Glycine 0 CA--C 1.552 2.355 0 N-CA-C 119.947 2.739 . . . . 0.0 119.947 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -66.95 -46.23 75.35 Favored 'General case' 0 CA--C 1.569 1.702 0 CA-C-N 120.28 2.04 . . . . 0.0 114.202 170.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -71.55 -36.96 71.13 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 174.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.9 mt -66.77 135.22 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-N 119.687 1.131 . . . . 0.0 109.612 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -74.87 104.42 5.47 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.603 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -98.19 102.97 2.73 Favored Glycine 0 N--CA 1.478 1.436 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.805 -175.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.8 t -84.49 114.85 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -176.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.501 ' HG ' HG13 ' A' ' 52' ' ' ILE . 43.6 m -98.6 104.85 16.92 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.087 177.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.17 149.49 26.13 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.026 174.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 55.5 mt -140.42 131.52 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 172.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.4 t -119.03 101.78 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -83.17 115.84 22.1 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.966 0.507 . . . . 0.0 109.8 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -124.98 69.62 1.13 Allowed 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 167.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.07 -112.17 4.65 Favored Glycine 0 CA--C 1.546 2.01 0 C-N-CA 123.272 0.463 . . . . 0.0 113.699 -174.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -74.14 -33.4 63.53 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 171.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -79.31 129.33 34.36 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 119.276 0.944 . . . . 0.0 110.726 -177.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -132.05 105.82 7.63 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -177.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -95.24 106.24 18.25 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 170.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -104.31 120.23 40.73 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.017 174.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 78.7 m -108.45 91.98 3.87 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.501 HG13 ' HG ' ' A' ' 39' ' ' SER . 11.6 tt -99.32 120.86 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.362 -167.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.0 m . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.55 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.4 mt . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -89.07 126.15 35.32 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.39 0.614 . . . . 0.0 109.868 175.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -134.77 106.9 7.13 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -174.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.51 132.15 56.59 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.919 0.887 . . . . 0.0 110.389 -175.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -141.6 173.69 11.27 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.942 -172.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.0 m -127.58 132.91 49.77 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 166.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.3 m -68.66 132.47 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 122.979 0.511 . . . . 0.0 111.616 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 107.59 -58.09 0.42 Allowed Glycine 0 CA--C 1.545 1.952 0 CA-C-N 115.583 -0.735 . . . . 0.0 113.233 -160.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -85.92 148.49 25.76 Favored 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 124.117 0.967 . . . . 0.0 112.101 -172.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -83.6 117.07 22.91 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.844 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 77.3 m -116.1 147.99 40.74 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 122.07 0.938 . . . . 0.0 111.664 -174.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -84.24 97.82 9.62 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.847 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 61.5 mt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.597 0.713 . . . . 0.0 109.679 -171.091 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 85.4 mttt . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 121.866 0.841 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 19.5 m -100.19 -13.46 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 117.236 2.31 . . . . 0.0 117.236 -164.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . 0.25 93.4 mttt 76.85 112.4 0.07 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 121.06 1.755 . . . . 0.0 110.242 -173.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.4 t -150.02 129.82 13.3 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.121 0.568 . . . . 0.0 109.548 -168.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.2 t -100.64 118.34 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.6 t -102.74 135.97 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -115.87 155.06 28.61 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.513 0.673 . . . . 0.0 110.591 166.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.4 tp -106.29 103.57 13.07 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 173.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -103.25 120.1 40.12 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.66 6.27 84.54 Favored Glycine 0 CA--C 1.549 2.164 0 N-CA-C 120.744 3.058 . . . . 0.0 120.744 173.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.316 4.7 t70 71.92 -10.38 0.87 Allowed 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 -167.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -116.15 -18.34 10.61 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 116.574 2.065 . . . . 0.0 116.574 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -112.65 124.85 53.48 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 121.151 1.796 . . . . 0.0 109.784 -176.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 47.3 mt -103.31 103.07 13.05 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 166.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.8 t -101.53 118.92 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -167.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.5 t -149.45 155.68 40.8 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.536 0.684 . . . . 0.0 112.363 -173.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 91.9 m -122.06 107.72 12.54 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 174.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -71.81 -81.83 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.435 0.694 . . . . 0.0 111.143 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -139.3 87.9 2.23 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 170.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.259 70.2 m-80 53.56 43.28 31.43 Favored 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -169.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 44.0 mm -125.24 105.37 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 104.462 -2.421 . . . . 0.0 104.462 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -79.96 94.14 5.84 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.571 0.7 . . . . 0.0 109.653 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.6 t -106.42 95.91 6.09 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.478 -165.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 73.8 t -101.44 107.8 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.9 m -93.86 85.42 4.78 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -173.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -94.66 127.53 40.69 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.357 0.663 . . . . 0.0 109.717 -165.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 tt -112.86 111.12 21.66 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -173.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -98.94 -101.84 0.22 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 118.406 -0.807 . . . . 0.0 109.291 -170.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -87.15 -110.58 0.91 Allowed Glycine 0 N--CA 1.484 1.877 0 CA-C-N 119.698 1.135 . . . . 0.0 112.395 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -101.36 61.4 0.92 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.567 0.698 . . . . 0.0 110.145 166.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 11.9 pt -148.94 -176.77 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.759 0 C-N-CA 124.619 1.167 . . . . 0.0 108.927 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.1 tt -148.54 125.32 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 120.753 -1.217 . . . . 0.0 108.217 155.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.0 m -111.1 106.99 16.21 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.02 110.56 23.12 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 34.7 m -96.91 99.65 11.2 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -176.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 66.3 mtt -104.2 97.15 7.15 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 -176.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.9 p -96.44 113.58 25.17 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -174.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.2 tp -103.08 83.08 2.16 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 170.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.77 -103.69 1.25 Allowed Glycine 0 CA--C 1.545 1.952 0 N-CA-C 114.571 0.588 . . . . 0.0 114.571 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -82.09 -27.02 33.11 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 114.708 1.374 . . . . 0.0 114.708 171.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 29.7 mm -65.34 136.1 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.542 0 C-N-CA 124.904 1.281 . . . . 0.0 109.562 174.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.4 t -127.94 96.47 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 172.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -86.56 102.47 14.16 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -102.91 104.85 15.11 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -113.72 122.35 46.84 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.869 0.868 . . . . 0.0 109.199 -175.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.7 mp -111.14 102.95 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 -171.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.0 m -102.23 112.43 25.11 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -84.08 142.29 30.51 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.817 0.447 . . . . 0.0 110.774 -169.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -74.14 134.06 42.82 Favored 'General case' 0 CA--C 1.559 1.304 0 CA-C-O 121.916 0.865 . . . . 0.0 112.725 -169.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 45.0 mm . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 -162.581 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 . . . . . 0 N--CA 1.496 1.831 0 N-CA-C 117.616 2.451 . . . . 0.0 117.616 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 75.6 m -71.45 115.22 10.37 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 121.437 1.926 . . . . 0.0 111.025 172.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.44 160.29 19.64 Favored Glycine 0 CA--C 1.54 1.655 0 CA-C-O 122.217 0.898 . . . . 0.0 114.295 -175.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -111.14 106.56 15.63 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -111.48 105.77 14.46 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -162.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -93.18 135.63 34.2 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 122.941 0.496 . . . . 0.0 111.583 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.5 tp -71.46 115.04 10.17 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.478 0.711 . . . . 0.0 112.584 -171.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -99.23 -55.33 2.72 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.164 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.1 m -125.07 110.51 14.24 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -173.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -111.48 119.58 39.25 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 122.075 0.941 . . . . 0.0 109.844 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -109.2 120.29 42.07 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 170.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.259 69.1 m-80 67.37 50.49 0.95 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -175.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -72.13 -63.26 1.18 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.922 . . . . 0.0 111.289 162.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -65.58 -35.23 80.21 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 117.33 2.344 . . . . 0.0 117.33 -174.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.41 -45.57 93.76 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 166.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -65.11 -51.91 58.55 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 174.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 23.5 mmt -62.18 -43.02 99.77 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -176.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -60.15 -47.28 86.6 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 167.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.57 -29.5 70.63 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 117.729 2.492 . . . . 0.0 117.729 176.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.8 pt -80.5 -47.04 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 CA-C-N 119.781 1.173 . . . . 0.0 112.706 173.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 142.67 69.62 0.03 OUTLIER Glycine 0 CA--C 1.54 1.595 0 CA-C-N 119.134 0.879 . . . . 0.0 113.034 174.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.55 153.37 79.4 Favored Pre-proline 0 CA--C 1.568 1.668 0 C-N-CA 123.456 0.702 . . . . 0.0 111.84 172.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.79 152.59 47.44 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 123.168 2.579 . . . . 0.0 113.031 172.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -61.03 -24.69 66.37 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 173.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -61.86 -57.19 12.75 Favored 'General case' 0 CA--C 1.563 1.455 0 CA-C-O 117.489 -1.243 . . . . 0.0 113.433 165.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.8 mt -68.93 -18.39 64.09 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.1 mt -74.23 -55.45 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-N 119.727 1.149 . . . . 0.0 110.477 170.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -67.93 -24.56 65.2 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -79.13 -51.21 9.84 Favored 'General case' 0 CA--C 1.562 1.419 0 CA-C-N 119.547 1.067 . . . . 0.0 112.217 167.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.2 -14.79 59.94 Favored Glycine 0 CA--C 1.552 2.366 0 N-CA-C 119.864 2.706 . . . . 0.0 119.864 176.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -71.34 -49.86 38.16 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 119.957 1.879 . . . . 0.0 113.88 171.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -63.8 -30.76 71.82 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.533 2.049 . . . . 0.0 116.533 167.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 53.8 mt -75.69 113.7 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 173.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -81.22 108.57 14.97 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.64 123.77 6.31 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 116.299 -0.41 . . . . 0.0 113.884 -167.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t -83.05 110.99 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.3 t -92.57 103.26 15.68 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 166.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.85 142.83 36.53 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.162 169.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.0 mt -142.17 125.96 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 90.6 t -114.15 105.21 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -81.75 118.23 22.69 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.059 0.544 . . . . 0.0 109.816 174.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -123.98 68.35 1.05 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 165.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.3 -107.51 2.1 Favored Glycine 0 CA--C 1.546 1.986 0 C-N-CA 123.24 0.448 . . . . 0.0 113.362 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -78.22 -29.35 48.24 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 170.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -84.57 104.61 14.71 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 120.394 1.452 . . . . 0.0 109.605 -173.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -105.69 95.32 5.73 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.052 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -93.7 106.7 18.65 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -103.76 132.24 50.19 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.941 -176.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.7 m -107.27 98.62 8.23 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 172.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.4 tp -87.16 127.91 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.41 0.684 . . . . 0.0 109.568 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 48.1 p . . . . . 0 N--CA 1.486 1.367 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 174.942 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.3 tt . . . . . 0 N--CA 1.495 1.821 0 CA-C-O 121.367 0.604 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -112.31 127.05 55.88 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.002 0.921 . . . . 0.0 109.025 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -139.87 128.95 23.65 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -171.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.25 135.45 54.27 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.458 0.703 . . . . 0.0 112.3 -175.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -125.27 149.11 48.34 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.044 0.938 . . . . 0.0 111.021 171.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.3 m -111.62 132.6 54.46 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 169.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.0 t -70.26 132.61 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 123.805 0.842 . . . . 0.0 110.274 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.76 10.88 85.93 Favored Glycine 0 CA--C 1.554 2.473 0 N-CA-C 118.987 2.355 . . . . 0.0 118.987 -170.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -138.59 150.7 46.58 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 119.29 1.545 . . . . 0.0 109.828 -171.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -80.89 103.0 10.42 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.519 0.728 . . . . 0.0 109.118 177.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 63.1 m -134.44 134.29 41.43 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.692 0.758 . . . . 0.0 110.766 -171.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.55 143.38 40.36 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -171.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 N--CA 1.486 1.33 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 175.123 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.7 mptt . . . . . 0 N--CA 1.486 1.37 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . 0.261 8.4 p -86.57 -43.84 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.607 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . 0.253 5.6 ttpm? 76.06 107.49 0.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.751 1.221 . . . . 0.0 111.747 173.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.4 p -128.38 139.5 52.34 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.033 0.533 . . . . 0.0 110.381 -165.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 89.7 t -109.76 101.44 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 173.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.3 t -94.9 138.48 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -173.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -114.89 135.49 54.15 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.839 0.828 . . . . 0.0 109.302 176.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 50.7 tp -94.69 102.68 14.59 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 173.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -88.08 114.16 24.42 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 121.891 0.853 . . . . 0.0 109.112 174.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.41 -117.28 5.48 Favored Glycine 0 CA--C 1.542 1.729 0 CA-C-N 114.354 -1.293 . . . . 0.0 113.047 -176.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -130.25 -8.58 4.26 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 170.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -134.34 35.02 3.24 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -173.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -147.41 116.77 6.97 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 119.996 1.271 . . . . 0.0 108.077 175.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 67.0 mt -107.66 101.73 11.02 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 171.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 32.7 m -99.42 124.3 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -171.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.3 t -151.48 135.95 16.94 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.243 0.545 . . . . 0.0 111.482 -174.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 67.9 p -83.55 -41.88 17.43 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 177.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.378 22.5 m-85 74.21 -94.48 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 119.259 0.936 . . . . 0.0 109.676 -169.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -116.38 -76.18 0.57 Allowed 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 163.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -135.63 71.6 1.43 Allowed 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 119.276 0.944 . . . . 0.0 109.317 170.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.1 mp -143.66 93.46 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 102.87 -3.011 . . . . 0.0 102.87 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -80.74 97.2 7.2 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 119.156 0.889 . . . . 0.0 109.818 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.4 t -100.29 102.34 13.58 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.266 -171.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.8 t -96.05 106.63 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.2 m -93.56 83.87 4.57 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -174.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.63 118.42 32.29 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.415 0.686 . . . . 0.0 109.251 -168.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tt -106.72 112.06 24.87 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -172.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -81.19 -59.05 2.79 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -172.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -158.83 -87.74 0.06 OUTLIER Glycine 0 N--CA 1.479 1.505 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 175.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -71.35 -37.98 71.65 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 166.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.8 pt -87.52 178.54 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.553 0 CA-C-N 119.636 1.107 . . . . 0.0 112.785 -171.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.5 tt -141.59 118.83 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 165.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.0 m -99.57 99.98 10.92 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -97.03 104.32 16.32 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -178.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.9 m -102.44 94.85 5.89 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -168.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 28.1 mtt -93.37 99.28 11.82 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.59 0.71 . . . . 0.0 109.377 -178.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 48.0 p -94.18 103.83 15.86 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.003 -174.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.0 tp -102.73 82.86 2.18 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.51 -99.62 1.01 Allowed Glycine 0 CA--C 1.544 1.879 0 O-C-N 122.348 -0.22 . . . . 0.0 113.12 -174.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -102.95 -12.29 17.6 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 170.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 72.4 mt -85.3 108.92 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-N 120.526 1.512 . . . . 0.0 107.157 -175.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.2 t -100.34 96.47 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 -175.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -82.77 97.6 8.67 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -93.06 107.44 19.23 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -108.15 98.78 8.29 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -172.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 85.2 mt -97.93 104.71 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 -173.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 67.9 m -121.53 114.96 21.96 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -172.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -91.05 139.74 30.48 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 122.941 0.496 . . . . 0.0 111.131 -172.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.4 ttp85 -68.37 130.01 41.61 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.331 0.653 . . . . 0.0 112.509 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.2 pt . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 123.047 1.403 . . . . 0.0 108.365 -173.959 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . 0.45 ' H ' HD13 ' A' ' 104' ' ' LEU 0.353 84.1 m-85 . . . . . 0 N--CA 1.496 1.83 0 N-CA-C 117.973 2.583 . . . . 0.0 117.973 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.2 m -72.23 103.53 3.38 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 120.527 1.512 . . . . 0.0 110.924 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.1 149.27 8.69 Favored Glycine 0 CA--C 1.541 1.709 0 CA-C-O 122.016 0.787 . . . . 0.0 113.624 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -92.31 117.51 29.97 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 171.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -116.62 104.54 11.49 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -172.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -86.68 140.03 30.19 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-O 121.675 0.75 . . . . 0.0 111.622 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.2 tp -66.25 137.3 56.86 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -170.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -116.13 -65.48 1.18 Allowed 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.58 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.5 p -126.94 137.58 53.15 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.906 0.882 . . . . 0.0 109.401 174.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -132.35 101.96 5.56 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.807 0.813 . . . . 0.0 109.136 -178.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -90.94 135.47 33.72 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.606 1.162 . . . . 0.0 109.722 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 m120 62.24 40.39 11.59 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -72.51 -45.77 57.8 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.921 -1.112 . . . . 0.0 113.048 172.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -62.37 -45.92 90.99 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.52 -43.58 96.76 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -76.16 -55.14 5.86 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 118.325 -0.845 . . . . 0.0 113.24 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -44.71 95.83 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -178.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -61.97 -42.77 99.5 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 171.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.92 -36.3 76.71 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 116.925 2.194 . . . . 0.0 116.925 175.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.275 46.2 pt -79.34 -47.17 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 119.086 0.857 . . . . 0.0 112.768 174.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 142.92 52.57 0.03 OUTLIER Glycine 0 N--CA 1.485 1.935 0 N-CA-C 115.678 1.031 . . . . 0.0 115.678 165.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.45 155.51 36.71 Favored Pre-proline 0 CA--C 1.566 1.563 0 CA-C-N 118.211 1.006 . . . . 0.0 111.673 175.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.38 146.59 45.3 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.99 2.46 . . . . 0.0 113.256 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -62.87 -22.45 66.71 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 116.072 1.879 . . . . 0.0 116.072 171.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -59.43 -53.29 59.81 Favored 'General case' 0 CA--C 1.566 1.565 0 CA-C-N 119.754 1.161 . . . . 0.0 113.969 164.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.29 -24.47 63.96 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 117.072 2.249 . . . . 0.0 117.072 174.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.3 mt -75.18 -51.66 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-N 119.623 1.101 . . . . 0.0 111.305 175.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -67.84 -28.52 67.62 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.91 -51.21 14.4 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.603 0.761 . . . . 0.0 112.348 169.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.78 -18.58 72.45 Favored Glycine 0 CA--C 1.546 2.011 0 N-CA-C 120.226 2.85 . . . . 0.0 120.226 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -65.34 -41.82 93.51 Favored 'General case' 0 CA--C 1.57 1.712 0 CA-C-N 120.334 2.067 . . . . 0.0 114.427 168.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -67.68 -39.83 84.45 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 170.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.5 mt -73.19 130.36 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 119.292 0.951 . . . . 0.0 108.929 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -89.73 98.59 11.86 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 170.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.58 140.01 15.42 Favored Glycine 0 CA--C 1.542 1.722 0 CA-C-N 116.056 -0.52 . . . . 0.0 113.949 -172.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.3 t -83.18 115.7 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 71.2 m -102.33 109.17 20.76 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.776 177.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.86 148.89 21.71 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-O 122.064 0.935 . . . . 0.0 111.094 -177.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.4 mt -138.61 133.16 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 166.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.7 t -114.33 112.25 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 175.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -78.58 118.53 20.78 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 170.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -133.52 67.27 1.53 Allowed 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.64 -122.54 9.41 Favored Glycine 0 CA--C 1.548 2.107 0 O-C-N 121.975 -0.453 . . . . 0.0 113.533 -173.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.03 -35.58 74.41 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 164.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -69.43 139.01 53.99 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 119.291 0.95 . . . . 0.0 111.99 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -138.5 97.27 3.32 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -91.32 106.08 18.24 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 175.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -83.65 148.94 26.83 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.128 169.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.8 m -133.96 87.06 2.33 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 166.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.5 pp -91.07 127.67 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -173.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.4 m . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 177.483 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -116.06 131.31 56.98 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.441 0.696 . . . . 0.0 111.822 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -151.32 149.94 29.94 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 123.399 0.68 . . . . 0.0 109.831 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -109.39 132.3 54.26 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.646 0.778 . . . . 0.0 110.833 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -117.25 141.07 48.74 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.919 0.888 . . . . 0.0 111.189 170.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.6 m -94.88 135.87 35.87 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 169.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.0 t -86.18 117.76 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 174.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.25 -5.44 63.01 Favored Glycine 0 CA--C 1.556 2.653 0 N-CA-C 119.057 2.383 . . . . 0.0 119.057 -171.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -142.23 134.48 27.68 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 120.38 2.09 . . . . 0.0 108.593 169.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.98 119.76 17.67 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -174.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 80.6 m -116.99 148.16 41.68 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 122.326 1.06 . . . . 0.0 110.557 -177.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.65 121.86 22.31 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.058 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.1 mt . . . . . 0 N--CA 1.486 1.371 0 C-N-CA 123.827 0.851 . . . . 0.0 108.857 -175.909 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.1 t -123.14 121.07 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -169.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -86.17 99.97 11.9 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.1 t -135.73 145.9 47.12 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.654 0.782 . . . . 0.0 110.016 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.0 p -109.76 138.02 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-O 122.798 1.285 . . . . 0.0 109.461 175.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.7 t -99.74 138.89 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.437 0 CA-C-N 113.413 -1.721 . . . . 0.0 107.78 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 -109.58 133.26 53.32 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 50.1 tp -98.55 113.49 25.54 Favored 'General case' 0 CA--C 1.553 1.076 0 CA-C-N 115.175 -0.921 . . . . 0.0 108.573 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -114.64 121.84 44.63 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.719 0.808 . . . . 0.0 109.041 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.88 14.45 73.14 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 120.667 3.027 . . . . 0.0 120.667 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.282 15.9 t70 59.7 33.3 21.83 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -168.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -158.87 -26.07 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -103.91 104.27 14.23 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 121.324 1.875 . . . . 0.0 109.368 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 44.1 mt -96.64 101.97 13.68 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 171.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.0 m -111.49 128.8 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 123.896 0.878 . . . . 0.0 109.966 -167.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.8 t -152.42 148.85 27.94 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.258 0.552 . . . . 0.0 111.956 -176.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 33.7 p -113.38 120.47 41.19 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -82.69 -86.14 0.11 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.13 0.572 . . . . 0.0 109.785 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -120.7 -71.71 0.72 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 171.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -127.54 64.19 1.35 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 118.88 0.764 . . . . 0.0 109.036 160.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.1 mp -135.7 108.23 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 174.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.23 93.49 9.4 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.6 t -97.67 104.11 16.1 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.669 0.787 . . . . 0.0 109.513 -168.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.9 t -120.44 98.44 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 -168.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.5 m -95.96 100.24 11.94 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -174.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.37 128.95 38.4 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.884 0.874 . . . . 0.0 109.992 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.45 HD13 ' H ' ' A' ' 3' ' ' PHE . 0.8 OUTLIER -97.94 111.15 23.56 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -110.65 178.55 4.33 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.534 0.734 . . . . 0.0 110.448 174.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -68.1 112.8 4.95 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 116.477 1.351 . . . . 0.0 116.477 -166.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.263 19.6 m-20 50.1 25.83 1.87 Allowed 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 117.38 2.363 . . . . 0.0 117.38 -166.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.3 pt -139.36 -178.46 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.619 0 C-N-CA 124.366 1.067 . . . . 0.0 109.866 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.1 tt -150.54 127.72 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.826 -1.172 . . . . 0.0 108.839 168.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.2 m -111.13 104.7 13.26 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -93.91 111.45 23.16 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 176.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 39.8 m -109.4 101.3 10.29 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -175.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 29.5 mtt -105.95 103.29 12.75 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.9 p -95.75 105.4 17.39 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 32.3 tp -96.52 84.73 3.73 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.09 -103.44 1.15 Allowed Glycine 0 CA--C 1.544 1.893 0 C-N-CA 122.954 0.312 . . . . 0.0 113.627 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -94.92 -16.42 22.85 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 171.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 66.2 mt -80.14 114.23 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 120.084 1.311 . . . . 0.0 107.563 -177.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.4 t -101.92 94.97 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -77.26 127.05 31.93 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 169.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -136.6 109.41 7.58 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -110.31 110.02 20.67 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -174.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.6 mp -104.25 115.66 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 104.983 -2.228 . . . . 0.0 104.983 -177.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.9 m -131.97 122.16 25.11 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -175.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -96.18 137.64 34.96 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.734 0.814 . . . . 0.0 110.992 -171.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.7 ttp180 -63.18 123.95 19.94 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 124.372 1.069 . . . . 0.0 113.165 -175.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 13.3 pt . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 123.007 1.384 . . . . 0.0 108.858 -178.382 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 118.359 2.726 . . . . 0.0 118.359 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.5 m -70.8 112.32 6.91 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 121.179 1.809 . . . . 0.0 110.784 172.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.4 149.49 7.37 Favored Glycine 0 CA--C 1.542 1.73 0 CA-C-O 121.926 0.737 . . . . 0.0 113.343 -175.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -96.25 122.74 39.43 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 170.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -118.11 102.24 8.86 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -167.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.6 tm0? -88.28 122.88 32.31 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.14 0.576 . . . . 0.0 110.013 -175.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.6 tp -61.94 115.45 4.06 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -175.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -95.99 -63.07 1.19 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.496 0.718 . . . . 0.0 110.748 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.7 m -120.88 108.56 14.06 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -89.11 123.84 33.76 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 122.524 1.154 . . . . 0.0 109.15 164.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -115.24 117.28 30.05 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 -178.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.278 7.7 m-20 70.23 43.74 0.82 Allowed 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 -174.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -68.15 -60.27 2.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.158 -0.964 . . . . 0.0 113.06 168.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -62.24 -33.96 75.59 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 117.345 2.35 . . . . 0.0 117.345 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.57 -46.31 86.45 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 166.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -67.19 -51.81 49.01 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 177.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.29 -49.85 74.77 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -59.15 -42.22 90.22 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 170.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.57 -32.2 73.59 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 117.305 2.335 . . . . 0.0 117.305 174.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.28 37.7 pt -78.53 -53.51 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-N 119.747 1.158 . . . . 0.0 111.599 172.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.68 69.98 0.01 OUTLIER Glycine 0 CA--C 1.538 1.516 0 CA-C-O 119.17 -0.794 . . . . 0.0 112.468 169.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mp -121.21 155.76 58.09 Favored Pre-proline 0 CA--C 1.57 1.733 0 C-N-CA 123.408 0.683 . . . . 0.0 112.591 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.29 158.56 33.27 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 123.367 2.712 . . . . 0.0 113.655 177.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -56.51 -32.86 65.48 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 168.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -61.59 -58.3 8.63 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 117.786 -1.102 . . . . 0.0 113.604 171.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.8 mt -68.67 -17.61 64.12 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 88.3 mt -75.67 -55.03 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 119.592 1.087 . . . . 0.0 110.619 169.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -70.81 -27.27 63.75 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -80.61 -50.12 10.39 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 119.8 1.182 . . . . 0.0 111.802 167.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.59 -18.17 58.49 Favored Glycine 0 CA--C 1.551 2.329 0 N-CA-C 120.16 2.824 . . . . 0.0 120.16 176.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -66.15 -43.7 86.24 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 120.401 2.1 . . . . 0.0 114.446 170.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.89 -35.74 80.7 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 167.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 42.7 mt -77.69 113.26 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -108.27 102.67 11.78 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -171.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.96 163.29 34.63 Favored Glycine 0 CA--C 1.544 1.902 0 N-CA-C 115.581 0.993 . . . . 0.0 115.581 -172.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.2 t -98.46 120.46 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.9 p -100.08 116.45 32.13 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.45 0.7 . . . . 0.0 109.171 172.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.77 149.71 23.07 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 121.902 0.858 . . . . 0.0 110.759 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.7 mt -141.93 130.21 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 170.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 85.6 t -118.35 104.09 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 -178.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -79.4 122.53 26.52 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.102 0.561 . . . . 0.0 111.138 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -132.45 68.18 1.51 Allowed 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 170.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.85 -114.07 5.64 Favored Glycine 0 CA--C 1.547 2.038 0 O-C-N 121.625 -0.672 . . . . 0.0 113.788 -176.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -77.62 -34.15 53.43 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 169.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -71.84 135.31 46.57 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 119.872 1.214 . . . . 0.0 111.211 173.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -139.47 105.97 5.32 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -91.84 103.32 15.88 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -80.58 147.83 30.59 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.882 169.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.9 m -138.77 88.92 2.33 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 170.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.5 tt -93.25 119.49 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 123.283 0.633 . . . . 0.0 109.44 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 39.0 m . . . . . 0 N--CA 1.487 1.405 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 179.378 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -128.62 129.49 45.96 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.321 0.648 . . . . 0.0 111.4 -177.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -153.02 143.63 22.71 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 123.609 0.764 . . . . 0.0 109.385 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -103.03 117.98 35.79 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.024 0.53 . . . . 0.0 110.276 176.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -101.47 141.29 34.56 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.664 0.786 . . . . 0.0 111.307 172.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.9 m -97.69 129.68 44.73 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 167.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.6 t -73.84 131.09 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 123.586 0.754 . . . . 0.0 109.718 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.31 -54.21 0.56 Allowed Glycine 0 CA--C 1.549 2.218 0 CA-C-N 115.09 -0.959 . . . . 0.0 114.222 -165.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -78.84 147.4 33.21 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.805 0.842 . . . . 0.0 112.506 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -77.14 98.29 5.02 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.955 169.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 59.4 m -98.74 140.62 32.67 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.143 -173.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.19 114.35 19.95 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.144 0.578 . . . . 0.0 110.297 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.0 mt . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -165.945 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.9 t -132.91 126.25 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -73.26 105.97 4.89 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.152 0.501 . . . . 0.0 109.764 170.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.9 t -142.93 134.96 27.08 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.932 -169.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.7 t -83.77 120.21 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.8 t -94.57 117.48 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 169.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -109.01 141.93 40.42 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 122.05 0.928 . . . . 0.0 110.339 176.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.6 tp -101.08 110.08 22.06 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.165 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -109.67 119.62 39.94 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.71 14.85 75.49 Favored Glycine 0 CA--C 1.548 2.134 0 N-CA-C 120.487 2.955 . . . . 0.0 120.487 176.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.321 7.9 t70 66.9 1.1 2.15 Favored 'General case' 0 CA--C 1.577 1.996 0 N-CA-C 117.392 2.367 . . . . 0.0 117.392 -168.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -142.24 33.75 1.51 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -150.23 104.65 3.28 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 120.877 1.671 . . . . 0.0 107.757 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.9 mt -98.68 102.74 14.56 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 173.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.0 m -109.5 124.26 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 123.735 0.814 . . . . 0.0 109.685 -165.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.1 t -151.01 129.32 12.0 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 122.249 -0.282 . . . . 0.0 111.066 -178.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 52.4 m -103.58 111.52 24.02 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 175.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -69.62 -79.02 0.06 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.702 0.801 . . . . 0.0 110.49 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -116.25 -75.94 0.58 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 169.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -112.45 3.59 16.96 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 162.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.0 mp -85.98 100.47 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -92.91 90.93 7.18 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -84.33 97.03 9.23 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.878 0.871 . . . . 0.0 110.596 -173.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 81.3 t -97.19 96.76 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.5 m -94.02 90.12 6.31 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -171.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -103.51 129.85 50.78 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.865 0.466 . . . . 0.0 109.851 -169.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 tt -109.71 107.7 17.82 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -176.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -95.16 -93.46 0.19 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 118.671 -0.681 . . . . 0.0 109.611 -170.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -85.4 -96.81 0.73 Allowed Glycine 0 N--CA 1.483 1.767 0 CA-C-N 119.028 0.831 . . . . 0.0 112.211 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -126.74 55.93 1.51 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.448 0.642 . . . . 0.0 110.28 166.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.09 -156.89 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.539 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 174.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.0 tt -155.93 119.36 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.192 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 159.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.1 m -97.76 93.94 6.65 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -92.07 112.12 23.93 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.4 m -111.4 94.5 5.0 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -168.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 37.3 mtt -92.14 98.67 11.68 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.743 0.817 . . . . 0.0 108.818 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.6 p -92.09 104.94 17.28 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -174.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.4 tp -102.86 81.54 2.01 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.71 -101.27 1.17 Allowed Glycine 0 CA--C 1.545 1.929 0 CA-C-N 116.479 -0.328 . . . . 0.0 112.92 -173.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -98.82 -16.08 19.01 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 169.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 55.7 mt -82.66 111.97 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 120.274 1.397 . . . . 0.0 107.782 -173.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 61.9 t -99.31 95.73 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -175.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -86.63 94.61 9.52 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.265 0.626 . . . . 0.0 109.84 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -103.36 109.54 21.21 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.286 -173.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -101.53 117.82 35.71 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.791 0.837 . . . . 0.0 109.046 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.9 mp -104.75 102.87 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 -178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.9 m -122.87 110.74 15.81 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -168.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.9 tttp -81.66 136.92 35.5 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -166.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 71.9 ttt-85 -70.78 120.49 16.45 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 124.175 0.99 . . . . 0.0 111.474 -176.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.0 pt . . . . . 0 N--CA 1.484 1.248 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -173.078 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 118.175 2.658 . . . . 0.0 118.175 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.6 m -68.77 110.73 4.47 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 120.865 1.666 . . . . 0.0 111.525 176.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.78 155.64 10.67 Favored Glycine 0 CA--C 1.541 1.671 0 CA-C-O 122.252 0.918 . . . . 0.0 113.798 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -89.01 124.45 34.28 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 166.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -111.35 102.82 11.18 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -174.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -81.71 130.38 35.04 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.264 1.026 . . . . 0.0 110.764 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.4 tp -62.21 131.3 48.99 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -170.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -91.24 -62.76 1.37 Allowed 'General case' 0 CA--C 1.561 1.382 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.967 169.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.6 m -150.61 144.66 25.39 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.459 0.704 . . . . 0.0 110.968 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -111.83 115.66 29.39 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.605 0.762 . . . . 0.0 108.951 169.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -95.25 122.61 38.12 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 160.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.286 84.2 m-20 67.85 41.01 2.24 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 178.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -70.48 -44.79 66.99 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.667 -1.271 . . . . 0.0 113.306 157.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -63.13 -50.85 68.84 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.74 -40.28 96.73 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 173.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -70.5 -51.44 28.95 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -43.9 98.19 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -178.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -60.42 -40.71 92.02 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 167.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.41 -23.5 65.55 Favored 'General case' 0 CA--C 1.564 1.512 0 N-CA-C 117.516 2.413 . . . . 0.0 117.516 174.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.262 28.2 pt -92.01 -49.73 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 CA-C-N 120.082 1.31 . . . . 0.0 112.414 173.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 142.96 71.18 0.02 OUTLIER Glycine 0 N--CA 1.482 1.703 0 CA-C-N 119.699 1.136 . . . . 0.0 113.393 173.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 mp -128.58 157.17 75.86 Favored Pre-proline 0 CA--C 1.572 1.806 0 C-N-CA 123.555 0.742 . . . . 0.0 112.109 177.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -76.64 155.11 35.38 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 123.331 2.687 . . . . 0.0 113.884 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -59.64 -31.33 69.42 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 170.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -62.45 -49.62 74.71 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 171.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.6 mt -68.74 -26.24 65.15 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 116.986 2.217 . . . . 0.0 116.986 173.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 81.3 mt -78.06 -49.7 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 124.329 1.052 . . . . 0.0 111.256 178.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -75.7 -29.72 59.09 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 178.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -78.65 -47.07 17.76 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.568 1.076 . . . . 0.0 112.397 169.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.41 -22.41 65.55 Favored Glycine 0 CA--C 1.549 2.185 0 N-CA-C 120.09 2.796 . . . . 0.0 120.09 175.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -65.43 -42.07 92.84 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-N 120.252 2.026 . . . . 0.0 114.771 170.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -64.41 -40.88 96.64 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 167.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.27 128.9 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-N 119.39 0.995 . . . . 0.0 108.88 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -80.23 105.1 11.25 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 171.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -84.99 121.11 5.5 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-N 115.718 -0.674 . . . . 0.0 113.141 -173.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.6 t -79.49 118.88 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.4 m -98.62 115.59 28.99 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -101.15 148.2 25.36 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 121.823 0.821 . . . . 0.0 110.737 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 74.0 mt -140.67 130.33 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 169.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 88.9 t -115.08 103.13 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -81.01 120.93 25.42 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.321 0.582 . . . . 0.0 111.124 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -130.21 72.06 1.48 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 163.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.04 -115.96 7.68 Favored Glycine 0 CA--C 1.546 2.03 0 C-N-CA 123.305 0.479 . . . . 0.0 113.848 -173.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -34.12 63.31 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 171.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -73.89 117.81 16.11 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 119.92 1.236 . . . . 0.0 110.55 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -124.2 103.17 8.09 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -90.87 105.18 17.65 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 122.426 1.108 . . . . 0.0 108.619 175.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -106.29 123.9 48.76 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 113.536 -1.665 . . . . 0.0 109.508 -172.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.597 ' HG1' ' HG2' ' A' ' 60' ' ' GLN . 28.9 m -120.62 90.69 3.37 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -172.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.6 mm -101.75 112.46 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 -165.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.509 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.5 mm . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.597 ' HG2' ' HG1' ' A' ' 51' ' ' THR . 0.6 OUTLIER -113.23 121.77 45.44 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.377 0.608 . . . . 0.0 110.008 -172.539 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -142.03 178.31 7.62 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 124.02 0.928 . . . . 0.0 109.302 173.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -141.22 135.65 30.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.802 -1.186 . . . . 0.0 111.236 169.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -118.28 141.85 48.09 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.045 0.938 . . . . 0.0 110.798 175.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.4 m -99.29 125.84 45.0 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 167.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.9 133.3 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 123.667 0.787 . . . . 0.0 110.345 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.27 -55.82 0.55 Allowed Glycine 0 CA--C 1.548 2.147 0 CA-C-N 115.172 -0.922 . . . . 0.0 113.856 -165.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -86.89 151.9 22.91 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.903 0.881 . . . . 0.0 112.307 -174.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -80.67 114.88 19.87 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.82 173.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 60.0 m -114.46 140.03 49.05 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.389 0.675 . . . . 0.0 110.349 -175.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.82 107.42 16.21 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.824 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.1 mt . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -167.344 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 86.5 mttt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.715 0.769 . . . . 0.0 110.601 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.1 m -139.44 125.61 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.305 -167.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -75.61 114.02 13.72 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.165 0.586 . . . . 0.0 110.653 -177.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.3 t -141.51 133.84 28.07 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.483 -166.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.9 t -89.94 124.16 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.4 t -99.79 126.15 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 170.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -119.96 140.22 51.25 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 122.141 0.972 . . . . 0.0 110.017 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.4 tp -101.27 116.79 33.62 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 114.545 -1.207 . . . . 0.0 109.081 -175.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -102.96 115.71 31.13 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 172.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.97 -133.11 13.71 Favored Glycine 0 CA--C 1.545 1.922 0 CA-C-N 114.783 -1.099 . . . . 0.0 113.394 -171.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -131.49 59.33 1.7 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 162.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -161.38 -40.66 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -174.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -109.74 99.02 8.25 Favored 'General case' 0 CA--C 1.558 1.263 0 CA-C-N 119.844 1.202 . . . . 0.0 111.118 -162.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 64.2 mt -95.24 105.78 17.75 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.5 t -105.79 125.09 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -169.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.2 t -151.87 136.83 17.26 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 22.8 p -111.2 106.56 15.6 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.809 0.844 . . . . 0.0 108.897 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -65.78 -69.6 0.29 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 123.824 0.849 . . . . 0.0 113.239 -173.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -127.72 -78.45 0.58 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 170.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -124.43 73.39 1.25 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 156.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 17.0 mt -148.33 105.63 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 103.646 -2.724 . . . . 0.0 103.646 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -75.01 142.14 43.87 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 171.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.0 t -143.05 99.8 3.52 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -178.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 84.4 t -102.62 98.28 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 177.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.0 m -95.26 90.92 6.03 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -174.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -108.98 126.98 53.67 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -165.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 tt -100.56 104.43 15.78 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -173.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -102.28 94.9 5.96 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -173.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.63 -111.58 3.31 Favored Glycine 0 N--CA 1.485 1.949 0 CA-C-O 119.864 -0.409 . . . . 0.0 112.252 -177.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -127.96 58.93 1.5 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.779 0.8 . . . . 0.0 110.615 160.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.8 pt -123.06 -154.62 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.762 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 159.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.5 tt -159.61 116.87 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 O-C-N 120.368 -1.457 . . . . 0.0 107.319 161.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 67.9 m -99.76 99.47 10.29 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 176.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -94.32 103.23 15.24 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.8 m -106.37 97.6 7.38 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -172.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 68.0 mtp -101.91 106.91 17.92 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.8 p -100.5 107.68 19.44 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -173.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 28.9 tp -71.93 -70.49 0.33 Allowed 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.159 0.583 . . . . 0.0 112.195 -176.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -123.52 -87.36 0.79 Allowed Glycine 0 CA--C 1.538 1.499 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 158.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -89.9 -11.11 42.81 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 167.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 68.5 mt -85.09 110.79 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -172.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.77 95.11 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 -175.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -82.07 93.04 6.92 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.076 0.55 . . . . 0.0 109.785 177.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -95.77 110.78 22.88 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -113.74 103.82 11.59 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -175.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.0 mp -98.9 121.16 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 -172.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.7 m -141.62 122.83 14.75 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 122.765 0.426 . . . . 0.0 109.962 -172.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -94.41 135.75 35.47 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.673 0.789 . . . . 0.0 112.276 -170.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.5 ttp180 -68.87 133.71 48.63 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.17 0.588 . . . . 0.0 112.569 -177.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.2 pt . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 -173.846 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 118.497 2.777 . . . . 0.0 118.497 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.452 ' HG ' ' HB3' ' A' ' 43' ' ' GLN . 73.6 m -73.83 112.12 9.64 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 121.631 2.014 . . . . 0.0 110.643 173.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.84 139.32 4.17 Favored Glycine 0 CA--C 1.542 1.739 0 CA-C-O 121.221 0.345 . . . . 0.0 113.561 -174.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -89.73 113.92 25.51 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 169.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -107.85 105.71 15.65 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -167.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -79.28 124.02 27.99 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.034 0.934 . . . . 0.0 110.837 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.9 tp -65.73 124.45 22.46 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.384 0.611 . . . . 0.0 112.576 -176.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -106.12 -65.84 1.04 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.095 0.958 . . . . 0.0 109.801 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.8 t -130.22 115.79 17.49 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -175.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -106.49 108.05 19.37 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -90.64 135.92 33.4 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.944 0.898 . . . . 0.0 110.171 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.7 m120 61.81 46.07 7.19 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 174.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -77.44 -46.25 23.22 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.27 -50.99 67.94 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 171.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.58 -38.91 78.91 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 177.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -76.67 -56.34 4.7 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 119.096 0.862 . . . . 0.0 112.903 178.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.07 -53.29 59.76 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -59.24 -36.05 74.77 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 174.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.42 -36.01 80.4 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 171.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.274 45.7 pt -78.79 -48.75 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 119.972 1.26 . . . . 0.0 112.975 175.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 143.73 61.62 0.02 OUTLIER Glycine 0 CA--C 1.543 1.824 0 CA-C-N 119.116 0.871 . . . . 0.0 113.253 171.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.8 151.97 58.38 Favored Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 123.828 0.851 . . . . 0.0 111.123 -174.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.04 144.53 30.21 Favored 'Trans proline' 0 C--N 1.369 1.654 0 C-N-CA 123.226 2.618 . . . . 0.0 113.633 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -65.07 -20.24 66.38 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 171.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -62.46 -54.64 37.09 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 120.28 1.4 . . . . 0.0 113.483 166.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.85 -21.32 66.77 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 117.258 2.318 . . . . 0.0 117.258 173.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.3 mt -78.61 -50.74 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 124.237 1.015 . . . . 0.0 110.927 173.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -74.88 -26.6 59.78 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -78.38 -48.36 15.69 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 119.673 1.124 . . . . 0.0 111.67 165.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.18 -17.02 60.88 Favored Glycine 0 CA--C 1.55 2.258 0 N-CA-C 120.445 2.938 . . . . 0.0 120.445 176.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -68.2 -43.39 78.18 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 120.473 2.136 . . . . 0.0 114.036 168.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -66.44 -31.75 72.7 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 167.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.3 mt -85.27 113.87 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -87.06 107.84 18.61 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.77 128.56 8.97 Favored Glycine 0 CA--C 1.54 1.599 0 CA-C-N 115.984 -0.553 . . . . 0.0 113.683 -170.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.6 t -80.01 114.58 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 174.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 51.4 m -113.88 118.08 33.22 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -173.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -95.54 153.84 17.51 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 122.122 0.963 . . . . 0.0 111.801 -174.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 69.1 mt -138.03 126.08 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 103.585 -2.746 . . . . 0.0 103.585 160.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 69.0 t -111.1 102.37 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . 0.452 ' HB3' ' HG ' ' A' ' 4' ' ' SER . 51.5 tt0 -80.33 120.0 23.81 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.132 0.573 . . . . 0.0 110.781 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -129.75 72.6 1.48 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 165.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.62 -111.48 4.1 Favored Glycine 0 CA--C 1.545 1.963 0 C-N-CA 123.35 0.5 . . . . 0.0 114.181 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -74.65 -37.21 62.8 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 172.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -72.39 139.51 47.86 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 119.625 1.102 . . . . 0.0 111.624 175.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -141.65 96.66 3.01 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -87.99 102.99 15.28 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 122.015 0.912 . . . . 0.0 108.852 174.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -97.0 130.42 44.33 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.053 178.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.9 m -120.18 84.72 2.26 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 176.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.6 tt -91.26 115.47 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 C-N-CA 123.395 0.678 . . . . 0.0 109.515 -169.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 39.1 m . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.067 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.0 mp . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -101.1 122.95 44.5 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.27 0.557 . . . . 0.0 109.876 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -145.46 165.08 29.61 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.936 0.895 . . . . 0.0 109.155 169.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.18 143.18 48.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.407 -0.808 . . . . 0.0 110.716 164.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -118.5 138.76 52.29 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.999 0.904 . . . . 0.0 110.072 166.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.3 m -97.32 125.32 41.84 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 168.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.3 t -72.23 131.75 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 C-N-CA 123.662 0.785 . . . . 0.0 109.525 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.27 -56.41 0.66 Allowed Glycine 0 CA--C 1.547 2.076 0 CA-C-N 115.44 -0.8 . . . . 0.0 113.534 -163.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -71.83 147.9 46.72 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.175 0.99 . . . . 0.0 112.965 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -81.19 103.39 10.94 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.086 169.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 56.6 m -100.54 137.86 38.38 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 121.752 0.787 . . . . 0.0 111.837 -166.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -80.15 115.38 19.68 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.903 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -167.146 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.275 38.2 ttmt . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.318 0.104 . . . . 0.0 111.016 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.3 t -112.35 124.5 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -83.85 106.42 15.52 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 171.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.9 t -141.35 139.84 33.64 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.854 0.862 . . . . 0.0 110.462 -168.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.4 t -91.12 130.13 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -174.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.6 t -106.14 126.17 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -106.95 154.29 21.29 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.691 0.758 . . . . 0.0 111.402 170.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.0 tp -119.62 123.37 43.72 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -122.33 127.52 49.91 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.688 0.756 . . . . 0.0 109.083 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.25 13.68 67.76 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 120.877 3.111 . . . . 0.0 120.877 175.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.279 4.4 t70 54.08 41.4 32.03 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -163.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -157.91 -26.18 0.08 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 115.672 1.731 . . . . 0.0 115.672 -176.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -113.75 101.22 9.09 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 121.112 1.778 . . . . 0.0 109.293 -173.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 57.7 mt -95.25 103.37 15.22 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 172.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.7 m -112.17 124.34 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 123.784 0.834 . . . . 0.0 109.477 -165.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 t -155.62 133.81 11.53 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 122.693 0.397 . . . . 0.0 110.384 -176.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 42.6 m -103.73 113.92 27.8 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -83.16 79.38 9.4 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.744 0.818 . . . . 0.0 109.768 176.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.351 12.0 tmtt? 69.93 -81.22 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.544 1.137 . . . . 0.0 111.836 -173.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -104.51 -34.05 8.35 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 170.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.0 mp -84.75 117.86 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-N 119.754 1.161 . . . . 0.0 108.685 -161.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -91.22 103.62 16.27 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 122.371 0.268 . . . . 0.0 110.496 -169.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.7 m -88.0 117.19 26.7 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.331 0.652 . . . . 0.0 109.243 178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 78.7 t -120.58 103.23 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.9 m -100.49 91.8 4.85 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -172.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -84.7 146.48 27.41 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.29 1.036 . . . . 0.0 111.421 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 tt -131.04 106.94 8.72 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -85.99 -89.96 0.11 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.243 -170.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.23 -108.05 2.56 Favored Glycine 0 N--CA 1.483 1.795 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -106.69 63.06 0.64 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.765 0.793 . . . . 0.0 109.606 164.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.4 pt -140.3 -161.71 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.83 0 C-N-CA 124.7 1.2 . . . . 0.0 108.284 176.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.9 tt -159.8 130.65 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.372 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 160.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.7 m -111.93 89.04 2.95 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -84.07 103.25 13.15 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.719 0.808 . . . . 0.0 109.179 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.3 m -109.85 96.17 6.08 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -169.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 59.6 mtt -96.84 104.75 16.78 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 44.7 p -92.22 110.0 21.38 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -174.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.9 tp -104.23 76.97 1.37 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 175.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.18 -105.84 1.74 Allowed Glycine 0 CA--C 1.546 2.008 0 C-N-CA 123.025 0.345 . . . . 0.0 113.228 -171.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -94.42 -7.96 40.04 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 169.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 78.0 mt -89.28 101.43 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -174.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 39.2 t -98.19 97.47 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -172.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -85.51 98.51 10.66 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.494 0.717 . . . . 0.0 109.351 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -109.29 105.24 14.56 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.387 -173.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 45.1 mtp85 -87.01 120.98 28.85 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 172.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 73.1 mt -109.32 100.8 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 103.471 -2.789 . . . . 0.0 103.471 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.8 m -126.06 116.64 21.72 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -168.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -88.77 132.92 34.42 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.596 0.758 . . . . 0.0 112.04 -168.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -68.64 134.25 49.63 Favored 'General case' 0 CA--C 1.556 1.191 0 CA-C-O 121.934 0.873 . . . . 0.0 112.587 -175.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.0 pt . . . . . 0 N--CA 1.485 1.3 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 -174.459 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 117.856 2.539 . . . . 0.0 117.856 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.9 p -68.47 114.93 7.31 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 121.176 1.807 . . . . 0.0 112.171 176.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 166.23 167.73 27.33 Favored Glycine 0 CA--C 1.543 1.806 0 CA-C-N 114.634 -1.166 . . . . 0.0 113.731 -168.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -126.24 106.72 9.74 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 106.841 -1.541 . . . . 0.0 106.841 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -107.15 102.45 11.77 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -159.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -94.96 141.91 28.1 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.808 0.813 . . . . 0.0 111.704 -176.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 31.9 tp -66.98 128.45 36.4 Favored 'General case' 0 CA--C 1.558 1.261 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -167.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -94.72 -62.74 1.27 Allowed 'General case' 0 CA--C 1.561 1.382 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.926 169.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.2 t -139.34 135.56 33.88 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.666 0.786 . . . . 0.0 109.751 -170.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -131.92 119.8 21.64 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -173.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -93.45 -70.95 0.68 Allowed 'General case' 0 CA--C 1.556 1.185 0 CA-C-O 118.068 -0.967 . . . . 0.0 112.336 -164.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -105.24 76.8 1.25 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 119.591 1.087 . . . . 0.0 110.032 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -88.14 -47.06 8.76 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.575 0.75 . . . . 0.0 112.935 170.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -64.35 -51.09 65.07 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.3 -38.97 88.71 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 116.675 2.102 . . . . 0.0 116.675 173.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -70.14 -54.75 11.6 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 119.318 0.963 . . . . 0.0 113.555 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 32.9 mtt -60.53 -47.13 87.51 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -58.27 -37.45 74.99 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 115.948 1.832 . . . . 0.0 115.948 169.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.5 -38.43 84.33 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 173.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.5 pt -76.96 -39.88 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.55 59.44 0.13 Allowed Glycine 0 CA--C 1.543 1.834 0 C-N-CA 124.223 0.915 . . . . 0.0 112.91 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.24 149.75 52.47 Favored Pre-proline 0 CA--C 1.566 1.58 0 C-N-CA 124.213 1.005 . . . . 0.0 109.889 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -71.73 141.12 36.93 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 123.109 2.54 . . . . 0.0 113.528 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -61.08 -33.47 73.38 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -60.56 -47.32 86.7 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 170.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.5 mt -67.77 -18.9 65.02 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 172.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.0 mt -68.92 -53.51 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-N 119.79 1.177 . . . . 0.0 110.756 169.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -63.96 -27.56 69.22 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 173.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.7 ttpm? -74.37 -56.7 4.56 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-N 119.733 1.152 . . . . 0.0 112.091 172.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.95 -16.42 66.28 Favored Glycine 0 CA--C 1.552 2.397 0 N-CA-C 119.822 2.689 . . . . 0.0 119.822 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -69.08 -44.62 72.16 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 120.37 2.085 . . . . 0.0 114.264 171.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -66.74 -34.89 78.83 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 170.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 55.6 mt -73.2 123.43 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 175.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -84.01 104.94 14.49 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 174.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -85.1 131.67 10.58 Favored Glycine 0 CA--C 1.539 1.587 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.715 -170.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.2 t -84.99 113.51 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.4 m -96.55 100.46 12.03 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.92 142.16 31.64 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.402 0.62 . . . . 0.0 110.181 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.5 mt -142.43 119.91 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 174.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 94.3 t -109.58 109.73 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 175.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -85.65 123.1 30.67 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.18 0.592 . . . . 0.0 110.261 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -123.6 69.57 1.04 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 166.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.95 -114.35 6.06 Favored Glycine 0 CA--C 1.545 1.941 0 C-N-CA 123.41 0.528 . . . . 0.0 113.981 -177.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -77.68 -31.86 52.75 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 170.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -75.27 114.6 13.98 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 119.723 1.147 . . . . 0.0 110.136 175.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -112.44 105.83 14.18 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -84.17 138.48 32.97 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.705 162.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -141.48 146.65 36.71 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.819 0.448 . . . . 0.0 110.993 172.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.1 m -132.25 97.55 4.15 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 176.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.3 tt -94.56 115.54 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 75.8 p . . . . . 0 N--CA 1.487 1.387 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.753 -170.111 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.5 mm . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -105.67 131.64 52.79 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.993 0.517 . . . . 0.0 110.825 173.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -136.73 137.33 39.81 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.727 0.775 . . . . 0.0 109.04 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -118.46 126.84 52.9 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -174.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -139.81 173.13 11.84 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.838 0.828 . . . . 0.0 112.406 -176.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.2 m -133.11 131.8 40.94 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 170.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.1 m -69.12 134.01 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 123.262 0.625 . . . . 0.0 111.793 175.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.73 -53.24 0.77 Allowed Glycine 0 CA--C 1.546 2.03 0 CA-C-O 119.681 -0.511 . . . . 0.0 114.095 -166.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -75.21 152.66 38.35 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.742 0.817 . . . . 0.0 112.368 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -87.03 99.48 11.93 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 173.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.0 m -100.97 150.67 22.64 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 121.515 0.674 . . . . 0.0 112.203 -172.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.96 127.76 35.67 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.92 174.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -175.863 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.4 mptt . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.5 m -98.36 119.07 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -175.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -87.78 98.79 11.66 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -177.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.8 t -139.78 144.33 37.34 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.307 0.643 . . . . 0.0 110.745 -167.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.0 t -97.6 124.21 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -176.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.3 t -106.3 133.1 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -112.11 137.6 49.93 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.516 0.674 . . . . 0.0 109.902 174.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.4 tp -94.72 117.58 30.36 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 171.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -119.03 119.38 34.11 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 177.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.09 12.16 79.31 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 121.378 3.311 . . . . 0.0 121.378 173.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.276 5.9 t70 55.9 43.82 26.82 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -164.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -156.67 -40.91 0.07 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 117.91 -1.043 . . . . 0.0 113.749 -176.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -101.75 132.82 47.27 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 120.193 1.36 . . . . 0.0 110.458 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 38.6 mt -116.78 99.48 7.14 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 165.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 29.0 m -98.93 121.27 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 123.564 0.745 . . . . 0.0 109.659 -170.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.1 t -154.49 128.87 9.1 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 122.212 -0.305 . . . . 0.0 110.983 -177.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.6 t -109.79 129.04 55.67 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.37 0.668 . . . . 0.0 110.219 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -148.51 120.68 8.32 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.63 0.772 . . . . 0.0 109.226 -169.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.321 28.1 mtpp 74.6 -94.66 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 124.389 1.076 . . . . 0.0 108.239 -170.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -146.3 66.77 1.19 Allowed 'General case' 0 CA--C 1.562 1.405 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 151.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 57.9 mt -135.35 96.47 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 103.787 -2.672 . . . . 0.0 103.787 -172.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -88.25 95.28 10.12 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.388 0.613 . . . . 0.0 109.425 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.0 t -84.04 102.09 12.25 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.803 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 69.3 t -100.28 98.47 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 175.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.7 m -94.69 84.2 4.2 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -172.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -97.42 125.91 42.35 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.542 0.737 . . . . 0.0 109.215 -166.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 tt -103.28 103.45 13.48 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -172.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -100.99 92.35 4.98 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -171.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.79 -109.8 2.97 Favored Glycine 0 CA--C 1.543 1.824 0 N-CA-C 112.056 -0.418 . . . . 0.0 112.056 -176.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -126.75 58.31 1.41 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.614 0.721 . . . . 0.0 110.822 162.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.8 pt -125.06 -158.55 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.688 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 160.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.0 tt -157.78 118.84 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 120.06 -1.65 . . . . 0.0 108.861 163.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.0 m -102.48 94.55 5.73 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -91.08 110.96 22.24 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.491 0.716 . . . . 0.0 109.299 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.6 m -113.93 95.39 5.29 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -168.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 42.4 mtt -96.66 101.2 12.76 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.754 0.822 . . . . 0.0 109.09 -178.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.6 p -93.05 103.17 15.49 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -173.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.2 tp -99.51 82.48 2.65 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 175.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.85 -104.67 1.66 Allowed Glycine 0 CA--C 1.544 1.847 0 CA-C-N 116.427 -0.351 . . . . 0.0 112.623 -173.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -100.2 -2.82 32.95 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 168.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 61.2 mt -90.18 103.09 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -175.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.1 t -97.72 91.67 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -172.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -80.97 92.68 6.22 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.584 0.754 . . . . 0.0 109.661 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -111.83 105.76 14.32 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.63 -171.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -111.88 122.15 46.99 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.76 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.7 mp -102.83 118.42 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 -172.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.7 m -137.65 117.56 13.28 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -171.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.9 ttpp -88.16 138.18 31.67 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -171.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -68.46 122.93 19.47 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.793 0.837 . . . . 0.0 112.081 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 24.4 pt . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 123.102 1.43 . . . . 0.0 108.438 -174.655 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 . . . . . 0 N--CA 1.494 1.736 0 N-CA-C 118.016 2.599 . . . . 0.0 118.016 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.3 m -73.66 116.16 13.92 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 121.275 1.852 . . . . 0.0 110.399 168.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.88 158.53 22.25 Favored Glycine 0 CA--C 1.541 1.708 0 CA-C-O 122.34 0.967 . . . . 0.0 114.516 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.9 mptt -98.75 116.79 31.78 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 166.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.485 ' HH ' HD11 ' A' ' 104' ' ' LEU . 88.3 m-85 -108.4 101.91 11.05 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -168.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -88.8 121.97 31.72 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.713 0.805 . . . . 0.0 109.779 -173.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.8 tp -61.7 119.36 8.55 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -92.88 -67.19 0.87 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.354 173.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.6 m -122.4 144.3 49.12 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.184 0.994 . . . . 0.0 109.625 -176.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -134.27 103.4 5.73 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -178.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -85.53 137.51 32.83 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.224 1.01 . . . . 0.0 110.329 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.8 m120 60.03 46.7 10.55 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 175.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -76.32 -49.45 16.88 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -64.52 -44.07 92.07 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 171.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.0 -46.36 88.37 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 173.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -71.93 -55.48 7.4 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 119.16 0.891 . . . . 0.0 113.184 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.93 -46.4 90.81 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -177.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -60.03 -40.31 88.88 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.192 1.552 . . . . 0.0 115.192 170.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.14 -28.74 66.72 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 117.371 2.36 . . . . 0.0 117.371 174.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.264 20.1 pt -81.08 -48.04 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-N 120.313 1.415 . . . . 0.0 112.776 172.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 143.59 66.61 0.02 OUTLIER Glycine 0 N--CA 1.48 1.623 0 CA-C-N 119.12 0.873 . . . . 0.0 112.975 173.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mp -130.47 154.99 81.73 Favored Pre-proline 0 CA--C 1.567 1.619 0 C-N-CA 123.558 0.743 . . . . 0.0 111.806 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.35 155.87 32.66 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.079 2.519 . . . . 0.0 113.383 175.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -63.38 -24.16 67.72 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 165.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -59.63 -53.49 57.44 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 119.974 1.261 . . . . 0.0 114.265 168.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 98.6 mt -69.58 -24.9 63.75 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 117.077 2.251 . . . . 0.0 117.077 175.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 41.3 mt -75.71 -53.76 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-N 119.725 1.148 . . . . 0.0 110.485 173.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 46.1 mm-40 -71.67 -22.86 61.61 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 116.485 2.031 . . . . 0.0 116.485 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.66 -45.47 12.45 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.736 1.153 . . . . 0.0 112.717 167.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.52 -20.34 55.63 Favored Glycine 0 CA--C 1.553 2.454 0 N-CA-C 119.881 2.713 . . . . 0.0 119.881 173.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -64.71 -43.65 92.76 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 120.144 1.972 . . . . 0.0 114.772 168.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -63.11 -38.86 92.86 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 167.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 69.7 mt -72.94 128.7 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 123.943 0.897 . . . . 0.0 108.706 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -76.78 111.92 12.82 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.307 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.66 105.89 3.14 Favored Glycine 0 N--CA 1.478 1.437 0 CA-C-N 115.865 -0.607 . . . . 0.0 113.553 -170.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.0 t -94.61 111.62 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 174.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 70.6 m -117.25 109.16 16.52 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.89 159.87 22.25 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.98 -173.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.3 mt -136.02 131.56 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 160.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.6 t -115.09 102.43 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -79.29 120.99 24.53 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.195 0.598 . . . . 0.0 110.684 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -127.26 73.22 1.41 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 166.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.14 -119.08 9.22 Favored Glycine 0 CA--C 1.546 2.031 0 C-N-CA 123.209 0.433 . . . . 0.0 113.598 -174.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.252 0.0 OUTLIER -71.41 -28.7 64.19 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 116.568 2.062 . . . . 0.0 116.568 169.294 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -75.55 132.01 40.42 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 120.015 1.28 . . . . 0.0 110.965 175.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -132.99 99.98 4.75 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -93.95 104.99 17.03 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 121.944 0.878 . . . . 0.0 108.875 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -90.46 134.26 34.47 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.927 176.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.7 m -119.54 98.91 6.36 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.4 mt -82.71 141.91 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 173.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.5 p . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 170.352 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -108.54 124.89 51.15 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.53 0.732 . . . . 0.0 109.939 -176.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -150.87 144.84 25.27 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 122.76 0.424 . . . . 0.0 110.9 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -118.12 132.59 56.33 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.937 0.895 . . . . 0.0 110.534 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -117.55 142.58 47.01 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.787 0.835 . . . . 0.0 111.509 171.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.8 m -89.38 140.5 29.45 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 159.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.7 t -76.37 122.3 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 172.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.22 40.31 9.29 Favored Glycine 0 CA--C 1.549 2.167 0 N-CA-C 116.784 1.473 . . . . 0.0 116.784 -168.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -151.62 143.16 23.55 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.184 0.994 . . . . 0.0 108.318 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -74.0 106.88 5.89 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.325 0.583 . . . . 0.0 109.659 168.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 40.8 m -110.51 136.32 49.83 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.048 -171.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -83.58 93.49 7.87 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.863 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.8 mt . . . . . 0 N--CA 1.485 1.315 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -171.277 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.058 0.456 . . . . 0.0 111.596 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.9 m -139.84 136.69 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 123.734 0.814 . . . . 0.0 109.407 -169.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -72.05 133.66 45.39 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.023 0.929 . . . . 0.0 112.461 -176.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 t -154.14 142.0 20.1 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 122.974 0.51 . . . . 0.0 110.287 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.29 123.16 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.4 t -99.32 137.03 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -177.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 17.1 mp0 -124.41 136.78 54.32 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 173.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 42.0 tp -91.16 105.97 18.18 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 174.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -93.98 115.35 27.69 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.59 -127.51 9.14 Favored Glycine 0 CA--C 1.546 1.981 0 CA-C-N 114.428 -1.26 . . . . 0.0 113.021 -170.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -118.54 -11.95 9.85 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 173.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -123.87 -13.0 7.48 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 117.424 2.379 . . . . 0.0 117.424 -173.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -113.51 96.46 5.89 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 121.398 1.908 . . . . 0.0 110.472 -165.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 70.5 mt -86.37 105.16 16.52 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.1 m -99.0 125.88 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 123.862 0.865 . . . . 0.0 109.225 -174.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.6 t -152.65 125.93 8.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 122.138 -0.351 . . . . 0.0 110.376 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.3 t -112.62 131.29 55.7 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.487 0.715 . . . . 0.0 110.16 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -84.45 -82.37 0.17 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.623 0.769 . . . . 0.0 108.967 175.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -130.57 -77.69 0.53 Allowed 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 167.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -86.42 -36.25 19.24 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 174.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 52.4 mt -69.45 129.25 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 C-N-CA 124.455 1.102 . . . . 0.0 109.01 176.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -128.18 97.14 4.66 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.7 t -89.97 106.07 18.23 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.719 0.807 . . . . 0.0 110.717 -170.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.9 t -105.08 95.7 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.2 m -97.28 88.17 4.37 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -168.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -87.7 139.98 29.98 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.03 0.932 . . . . 0.0 110.194 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.485 HD11 ' HH ' ' A' ' 7' ' ' TYR . 2.0 tt -119.86 98.33 6.05 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -99.47 94.51 6.45 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -172.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.94 -112.7 3.51 Favored Glycine 0 N--CA 1.483 1.789 0 CA-C-O 119.879 -0.4 . . . . 0.0 112.118 -176.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -123.77 59.3 1.13 Allowed 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.397 0.618 . . . . 0.0 111.134 169.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.73 -154.09 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.736 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 164.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.5 tt -160.23 117.01 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 157.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.5 m -98.41 95.89 7.64 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -94.6 106.84 18.83 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.6 m -105.36 101.79 11.31 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -173.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 44.5 mtt -97.71 101.68 13.25 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.0 p -90.98 115.4 27.96 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . 0.265 24.3 tp -84.5 -104.36 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -177.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -90.97 -94.94 1.26 Allowed Glycine 0 N--CA 1.48 1.596 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 168.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -88.83 -8.09 54.98 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 164.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 42.2 mt -84.21 119.32 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-N 119.808 1.186 . . . . 0.0 107.809 -173.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.1 t -102.73 97.41 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -76.61 135.49 39.18 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 166.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -145.6 101.52 3.58 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -95.05 129.24 42.22 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.2 0.6 . . . . 0.0 110.152 173.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 88.8 mt -110.88 112.54 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 104.083 -2.562 . . . . 0.0 104.083 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.0 m -131.88 118.01 19.26 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -172.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -79.82 130.03 34.98 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -166.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 55.4 ttp85 -73.66 119.04 17.34 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.316 0.646 . . . . 0.0 111.141 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 33.0 pt . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 123.013 1.387 . . . . 0.0 109.026 -170.131 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 . . . . . 0 N--CA 1.494 1.747 0 N-CA-C 117.522 2.416 . . . . 0.0 117.522 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.8 m -69.21 120.29 14.81 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 121.222 1.828 . . . . 0.0 111.622 174.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.67 156.79 8.51 Favored Glycine 0 CA--C 1.54 1.653 0 CA-C-O 122.507 1.06 . . . . 0.0 113.898 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -79.93 140.94 36.49 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 113.979 -1.111 . . . . 0.0 108.934 162.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -135.51 105.97 6.43 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.32 122.68 28.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 122.032 -0.417 . . . . 0.0 110.658 -176.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.8 tp -66.65 120.28 13.2 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.348 0.659 . . . . 0.0 112.114 -178.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -109.64 -63.53 1.36 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 118.556 -0.735 . . . . 0.0 110.499 -176.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.9 m -110.07 107.96 18.0 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -178.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -100.11 121.34 41.26 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 122.189 0.995 . . . . 0.0 108.485 170.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -85.75 -64.6 1.13 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.115 -169.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -115.67 67.06 0.7 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 118.379 0.536 . . . . 0.0 110.73 175.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -72.02 -51.7 20.52 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 166.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -63.67 -48.78 75.79 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.34 -40.01 92.67 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 116.498 2.036 . . . . 0.0 116.498 171.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -66.54 -51.9 51.49 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 177.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.9 -47.94 70.64 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 174.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -57.22 -41.29 79.2 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 169.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.76 -33.21 72.1 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 117.056 2.243 . . . . 0.0 117.056 175.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.3 pt -76.74 -41.85 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 CA-C-N 120.129 1.331 . . . . 0.0 113.481 172.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.58 62.05 0.15 Allowed Glycine 0 CA--C 1.542 1.765 0 C-N-CA 124.205 0.907 . . . . 0.0 112.674 175.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.17 150.39 51.26 Favored Pre-proline 0 CA--C 1.568 1.669 0 C-N-CA 124.026 0.93 . . . . 0.0 110.764 -176.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.53 148.47 37.6 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 123.205 2.604 . . . . 0.0 113.84 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -61.86 -26.05 67.9 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 173.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -61.28 -50.14 74.23 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 166.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.3 mt -70.99 -16.88 62.65 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 116.916 2.191 . . . . 0.0 116.916 171.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 84.8 mt -73.82 -54.06 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 120.152 1.342 . . . . 0.0 110.584 169.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -66.79 -27.96 68.0 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 116.353 1.982 . . . . 0.0 116.353 176.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -73.86 -60.92 2.03 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-N 119.463 1.028 . . . . 0.0 111.097 166.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.94 -15.32 57.97 Favored Glycine 0 CA--C 1.553 2.415 0 N-CA-C 120.53 2.972 . . . . 0.0 120.53 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -66.99 -47.31 71.91 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 119.985 1.892 . . . . 0.0 113.862 169.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -72.78 -35.65 67.45 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 171.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 37.8 mt -73.5 121.33 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.021 -1.104 . . . . 0.0 108.021 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -89.77 119.12 29.89 Favored 'General case' 0 CA--C 1.557 1.225 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.52 135.3 12.72 Favored Glycine 0 CA--C 1.542 1.76 0 CA-C-N 116.714 -0.221 . . . . 0.0 113.593 -177.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.35 116.23 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.1 p -94.35 102.63 14.62 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 121.477 0.656 . . . . 0.0 109.262 174.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.02 142.33 27.88 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.829 176.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.1 mt -139.1 128.9 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.3 t -117.39 103.98 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 -178.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -85.06 131.68 34.42 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.302 0.641 . . . . 0.0 110.771 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -135.99 72.63 1.44 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 168.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.81 -105.15 1.82 Allowed Glycine 0 CA--C 1.544 1.902 0 O-C-N 121.886 -0.509 . . . . 0.0 113.571 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.253 0.0 OUTLIER -97.54 -15.56 20.48 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 166.123 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -77.71 149.99 34.52 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 119.772 1.169 . . . . 0.0 111.412 171.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -146.23 142.66 28.6 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.754 0.822 . . . . 0.0 110.1 -174.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -136.33 113.44 10.54 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 165.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -91.82 148.19 22.42 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.502 169.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.5 m -133.9 91.85 2.88 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 173.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.1 mm -91.92 110.62 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.9 p . . . . . 0 N--CA 1.487 1.396 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -176.484 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.3 mp . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -110.72 117.69 34.14 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -147.74 133.61 19.07 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -108.16 145.64 33.88 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 122.193 0.997 . . . . 0.0 111.7 -175.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -133.26 167.14 20.92 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.631 174.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.0 m -129.56 132.22 46.76 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 169.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.3 t -71.41 127.47 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 C-N-CA 123.467 0.707 . . . . 0.0 109.508 -177.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.73 -55.66 0.8 Allowed Glycine 0 CA--C 1.545 1.949 0 CA-C-N 115.606 -0.725 . . . . 0.0 113.891 -166.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -81.15 147.16 30.17 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.715 0.769 . . . . 0.0 112.219 -177.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -84.08 116.05 22.68 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.087 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.7 m -130.31 150.21 51.64 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.773 0.797 . . . . 0.0 111.987 -174.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.97 128.13 35.58 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.839 0.856 . . . . 0.0 113.055 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.2 mt . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.771 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.2 mptt . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.311 0.576 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.0 m -80.87 -38.79 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 177.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . 0.286 37.5 ttmt 74.0 106.06 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.909 1.284 . . . . 0.0 111.113 -177.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.3 t -145.06 152.03 39.46 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.844 0.831 . . . . 0.0 110.4 -172.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.4 t -98.5 127.89 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 -176.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 t -104.91 129.79 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -178.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.7 mp0 -110.91 134.58 52.44 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 172.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.1 tp -95.84 104.39 16.32 Favored 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -98.96 121.0 40.35 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 122.135 0.969 . . . . 0.0 108.914 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.14 9.68 72.38 Favored Glycine 0 CA--C 1.55 2.269 0 N-CA-C 120.563 2.985 . . . . 0.0 120.563 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.305 2.3 t70 64.61 16.5 10.36 Favored 'General case' 0 CA--C 1.577 2.007 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 -165.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -157.39 44.84 0.36 Allowed 'General case' 0 CA--C 1.568 1.655 0 O-C-N 121.018 -1.051 . . . . 0.0 113.401 175.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -160.28 112.69 2.03 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 173.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 38.8 mt -98.74 98.24 9.38 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 173.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.8 t -98.27 113.84 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -167.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.7 t -153.51 134.82 14.17 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -176.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.9 m -103.31 112.51 25.42 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -74.84 -84.45 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.061 0.544 . . . . 0.0 110.984 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -93.73 -82.77 0.34 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 169.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -127.59 62.69 1.38 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 152.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 69.0 mt -120.73 95.3 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 103.246 -2.872 . . . . 0.0 103.246 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -84.28 90.97 7.64 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 122.138 0.97 . . . . 0.0 109.21 -174.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.0 t -95.83 117.52 30.72 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.185 -168.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 74.5 t -116.9 106.28 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 104.616 -2.364 . . . . 0.0 104.616 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.3 m -91.77 88.5 6.7 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -175.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -96.37 119.88 35.65 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.232 0.613 . . . . 0.0 109.866 -166.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 tt -101.59 106.56 17.65 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -176.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -90.13 -87.39 0.18 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 118.926 -0.559 . . . . 0.0 110.237 -170.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -101.67 -109.7 3.27 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 178.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -106.05 64.06 0.67 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.95 0.881 . . . . 0.0 109.5 163.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.5 pt -144.19 -170.41 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.574 1.887 0 C-N-CA 125.184 1.394 . . . . 0.0 107.713 175.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.3 tt -152.11 125.02 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 120.326 -1.483 . . . . 0.0 108.866 156.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 81.7 m -103.69 99.65 9.45 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -93.38 107.66 19.45 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 32.6 m -107.46 100.68 10.09 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -170.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 40.7 mtt -101.88 100.79 11.15 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.903 0.881 . . . . 0.0 109.194 -176.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 73.8 p -94.63 104.47 16.41 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -175.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 49.4 tp -103.66 84.88 2.35 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.88 -102.71 1.46 Allowed Glycine 0 CA--C 1.545 1.94 0 CA-C-N 116.231 -0.441 . . . . 0.0 112.12 -171.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -103.92 -4.98 22.73 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 169.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 80.6 mt -90.35 109.5 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-N 120.543 1.52 . . . . 0.0 107.048 -172.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 49.7 t -97.78 95.08 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -173.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -84.42 96.39 9.07 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.353 0.661 . . . . 0.0 109.419 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -101.33 109.07 20.85 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.549 -173.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.9 mtm180 -103.08 109.04 20.45 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.0 mp -99.79 99.19 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 105.037 -2.208 . . . . 0.0 105.037 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.4 m -110.73 115.76 30.13 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -177.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -79.08 146.01 33.48 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 122.933 0.493 . . . . 0.0 110.89 -174.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -79.39 139.58 37.69 Favored 'General case' 0 CA--C 1.559 1.319 0 CA-C-O 121.895 0.855 . . . . 0.0 112.142 -171.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.9 mm . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 -159.193 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.5 m 59.0 93.6 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.168 1.387 . . . . 0.0 113.897 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.13 150.35 7.0 Favored Glycine 0 CA--C 1.542 1.736 0 CA-C-O 121.916 0.731 . . . . 0.0 114.266 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -83.83 130.8 34.92 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.72 -0.74 . . . . 0.0 109.357 170.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -132.47 105.13 7.07 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -173.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -92.67 134.49 34.97 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 122.962 0.505 . . . . 0.0 111.554 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.2 tp -73.44 114.24 11.44 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.344 0.658 . . . . 0.0 112.557 -170.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -95.86 -61.88 1.38 Allowed 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.88 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.2 t -117.42 114.21 23.19 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -98.3 138.8 35.03 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 123.091 1.424 . . . . 0.0 109.433 167.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -128.77 113.06 14.85 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.292 18.7 m-20 72.68 50.94 0.17 Allowed 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -173.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -76.22 -64.23 1.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.383 -0.823 . . . . 0.0 112.101 174.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.03 -28.26 69.67 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 117.163 2.282 . . . . 0.0 117.163 174.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.8 -44.26 86.23 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 168.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -67.28 -57.3 6.93 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 173.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 38.1 mtt -59.45 -45.78 90.62 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -176.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -62.05 -39.09 91.18 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 169.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.96 -33.18 73.81 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 117.25 2.315 . . . . 0.0 117.25 172.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.255 20.9 pt -81.55 -53.77 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 CA-C-N 119.328 0.967 . . . . 0.0 112.31 176.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.1 61.23 0.01 OUTLIER Glycine 0 CA--C 1.542 1.78 0 CA-C-N 119.019 0.827 . . . . 0.0 113.416 172.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.12 153.42 42.59 Favored Pre-proline 0 CA--C 1.568 1.645 0 C-N-CA 123.648 0.779 . . . . 0.0 111.277 -179.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.86 155.2 43.61 Favored 'Trans proline' 0 CA--C 1.556 1.582 0 C-N-CA 123.168 2.579 . . . . 0.0 113.338 173.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -56.95 -34.59 68.19 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 169.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -59.82 -54.26 48.34 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 172.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.9 mt -71.2 -26.2 62.85 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 116.84 2.163 . . . . 0.0 116.84 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.1 mt -69.39 -55.36 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-N 119.683 1.129 . . . . 0.0 110.627 171.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -70.05 -25.22 63.45 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -76.01 -57.67 3.74 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 119.753 1.161 . . . . 0.0 111.537 168.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.38 -15.96 62.07 Favored Glycine 0 CA--C 1.553 2.414 0 N-CA-C 119.869 2.708 . . . . 0.0 119.869 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -68.02 -44.68 75.98 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 120.145 1.972 . . . . 0.0 114.138 170.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -68.34 -40.82 81.43 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 168.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.1 mt -74.17 124.09 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-N 119.484 1.038 . . . . 0.0 108.317 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -84.26 107.51 16.6 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -88.1 128.77 9.22 Favored Glycine 0 CA--C 1.541 1.659 0 CA-C-N 116.359 -0.382 . . . . 0.0 113.771 -171.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.0 t -88.56 115.01 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -177.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 62.7 m -96.87 106.21 18.48 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 170.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.54 150.05 23.97 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.794 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 86.8 mt -132.96 134.92 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 170.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 43.7 t -132.29 96.19 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 104.008 -2.589 . . . . 0.0 104.008 169.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -84.1 124.08 30.74 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.239 0.615 . . . . 0.0 110.354 -176.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -118.21 74.62 0.96 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 171.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.66 -116.89 8.23 Favored Glycine 0 CA--C 1.546 2.004 0 C-N-CA 123.374 0.511 . . . . 0.0 113.488 -173.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? -81.9 -33.19 30.59 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 169.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -73.41 116.64 14.22 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 119.825 1.193 . . . . 0.0 109.877 174.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -126.74 91.83 3.43 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -151.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -94.43 96.9 9.8 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.17 0.509 . . . . 0.0 110.193 -167.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -110.01 133.27 53.37 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.904 -176.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.8 m -116.13 99.09 6.99 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 -177.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.3 tt -89.31 118.21 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.7 0.8 . . . . 0.0 109.437 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 49.4 m . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 176.44 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.9 mp . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -91.12 124.83 35.64 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.673 0.749 . . . . 0.0 109.877 170.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -131.75 155.27 48.0 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.313 172.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -139.97 139.1 36.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.347 -0.846 . . . . 0.0 112.304 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -117.68 150.75 38.54 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.98 0.912 . . . . 0.0 111.23 173.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.2 m -98.51 128.42 44.84 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 166.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 86.7 t -74.72 128.96 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 123.539 0.735 . . . . 0.0 109.762 -173.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.51 10.34 84.58 Favored Glycine 0 CA--C 1.554 2.512 0 N-CA-C 118.716 2.246 . . . . 0.0 118.716 -170.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -137.67 153.35 49.83 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 119.087 1.443 . . . . 0.0 109.29 -176.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -69.63 115.3 8.72 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.312 0.577 . . . . 0.0 111.143 177.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.7 p -122.04 135.81 54.86 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.642 -175.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.03 106.92 18.18 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 113.937 -1.483 . . . . 0.0 110.215 -175.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.3 mt . . . . . 0 N--CA 1.49 1.56 0 C-N-CA 123.42 0.688 . . . . 0.0 110.11 -166.645 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.557 1.23 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.9 m -96.73 130.67 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 C-N-CA 123.516 0.726 . . . . 0.0 110.094 -171.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -75.6 114.99 14.81 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.177 0.591 . . . . 0.0 110.895 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.5 t -146.2 140.33 26.51 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.717 0.807 . . . . 0.0 109.421 -173.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.4 t -87.11 117.1 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.43 100.62 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -100.21 141.09 33.51 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.185 0.993 . . . . 0.0 110.423 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.6 tp -95.92 104.89 16.86 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 114.155 -1.384 . . . . 0.0 108.313 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -96.23 113.16 24.73 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 122.259 1.028 . . . . 0.0 108.641 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.44 -129.81 9.87 Favored Glycine 0 CA--C 1.546 1.98 0 CA-C-N 113.683 -1.599 . . . . 0.0 111.975 -165.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -135.19 51.69 2.07 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 120.863 0.363 . . . . 0.0 110.216 160.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -158.16 -20.76 0.08 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -177.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -118.32 113.34 21.29 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 121.963 2.165 . . . . 0.0 109.851 -174.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 15.6 mt -97.86 104.79 16.85 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 175.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 66.8 t -105.48 113.73 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -167.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.8 t -146.05 133.99 21.36 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.895 0.478 . . . . 0.0 110.592 -174.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 53.4 m -106.46 107.35 18.32 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -84.31 76.7 10.09 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.175 0.59 . . . . 0.0 109.786 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.341 38.4 ttmt 69.53 -75.96 0.07 Allowed 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 124.56 1.144 . . . . 0.0 112.659 -167.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -115.47 -23.47 8.81 Favored 'General case' 0 CA--C 1.567 1.628 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 174.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.2 mt -79.0 106.61 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-N 120.592 1.542 . . . . 0.0 108.657 -171.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -82.52 96.01 7.9 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-O 121.802 0.81 . . . . 0.0 109.694 176.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.4 m -93.09 116.75 29.33 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.307 1.043 . . . . 0.0 109.707 -176.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.1 t -118.39 102.75 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 104.786 -2.301 . . . . 0.0 104.786 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.2 m -92.01 92.16 8.17 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -174.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -83.16 140.49 32.56 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.65 0.78 . . . . 0.0 110.43 -175.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.67 107.47 13.73 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 172.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -88.81 -98.74 0.09 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 118.432 -0.794 . . . . 0.0 109.128 -176.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -92.31 -103.79 1.49 Allowed Glycine 0 N--CA 1.485 1.924 0 CA-C-N 119.466 1.03 . . . . 0.0 111.394 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -111.03 59.61 0.61 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.825 0.821 . . . . 0.0 109.798 164.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.7 pt -139.4 -163.62 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.809 0 C-N-CA 124.903 1.281 . . . . 0.0 108.048 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.6 tt -157.29 116.36 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.362 -1.461 . . . . 0.0 107.336 165.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.4 m -100.03 87.49 3.5 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -177.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -88.06 106.82 18.41 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 109.416 -0.586 . . . . 0.0 109.416 -176.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 19.1 m -108.08 97.78 7.43 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -167.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 82.1 mtp -99.6 94.57 6.45 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -172.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 59.2 p -97.65 112.2 24.17 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.668 -167.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.1 tp -112.49 86.18 2.31 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 174.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.45 -103.97 1.8 Allowed Glycine 0 CA--C 1.544 1.876 0 C-N-CA 122.848 0.261 . . . . 0.0 113.657 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -86.29 -24.28 25.99 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 169.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 24.7 mm -67.59 137.36 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.597 0 C-N-CA 124.945 1.298 . . . . 0.0 109.725 176.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.7 t -131.22 93.98 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 172.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -89.2 95.06 10.15 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 120.96 0.409 . . . . 0.0 110.704 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -97.29 108.44 21.16 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 121.356 0.598 . . . . 0.0 109.567 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 88.0 mtt180 -94.01 120.04 33.72 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.969 0.908 . . . . 0.0 108.615 171.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -105.64 99.28 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 175.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.4 m -114.49 115.44 27.26 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -175.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -88.51 140.54 29.35 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.279 0.561 . . . . 0.0 111.709 -170.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.8 ttm-85 -64.21 119.69 10.72 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.794 -176.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.7 pt . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -178.002 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.366 96.2 m-85 . . . . . 0 N--CA 1.499 1.991 0 N-CA-C 118.26 2.689 . . . . 0.0 118.26 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 72.1 m -75.37 114.42 13.88 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 121.157 1.799 . . . . 0.0 110.071 170.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.67 145.86 5.31 Favored Glycine 0 CA--C 1.542 1.755 0 CA-C-O 121.84 0.689 . . . . 0.0 112.831 -173.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -97.75 121.79 40.08 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 170.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -117.29 103.11 9.83 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -166.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.8 tp60 -80.56 121.92 26.4 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.749 0.82 . . . . 0.0 110.614 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.7 tp -62.77 127.39 31.04 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -110.78 -66.38 1.08 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.812 0.845 . . . . 0.0 109.606 -176.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.3 t -118.89 114.64 22.92 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.827 0.851 . . . . 0.0 108.847 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -104.2 105.11 15.15 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -102.61 133.79 47.03 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.83 0.852 . . . . 0.0 109.074 -171.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.252 22.2 m120 63.88 47.98 3.32 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -171.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -81.92 -46.17 14.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.827 -1.171 . . . . 0.0 113.956 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.29 -48.54 77.67 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 176.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.3 -40.62 96.89 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 116.566 2.061 . . . . 0.0 116.566 172.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -70.94 -52.74 18.07 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 118.005 -0.997 . . . . 0.0 113.647 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -40.89 93.08 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 177.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -40.82 94.86 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 167.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.57 -35.99 80.07 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 174.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.259 36.0 pt -79.58 -48.26 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-N 119.829 1.195 . . . . 0.0 112.846 175.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.68 58.28 0.12 Allowed Glycine 0 CA--C 1.546 2.003 0 C-N-CA 124.128 0.871 . . . . 0.0 113.631 -178.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.07 152.5 56.81 Favored Pre-proline 0 CA--C 1.571 1.776 0 C-N-CA 124.37 1.068 . . . . 0.0 110.24 173.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.32 154.08 31.79 Favored 'Trans proline' 0 C--N 1.366 1.495 0 C-N-CA 123.104 2.536 . . . . 0.0 114.103 -173.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -60.88 -24.92 66.32 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 168.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -57.5 -55.73 31.02 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 119.669 1.122 . . . . 0.0 113.5 164.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.1 mt -71.87 -16.42 62.14 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 175.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.0 mt -73.54 -56.85 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-N 120.165 1.348 . . . . 0.0 110.165 167.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -70.31 -27.56 64.48 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 116.477 2.028 . . . . 0.0 116.477 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -81.99 -50.72 8.81 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 119.155 0.889 . . . . 0.0 112.447 170.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.18 -7.18 62.54 Favored Glycine 0 CA--C 1.554 2.517 0 N-CA-C 119.932 2.733 . . . . 0.0 119.932 177.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -69.12 -45.19 70.79 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 120.137 1.968 . . . . 0.0 114.087 170.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -68.23 -36.06 78.89 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 169.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 42.8 mt -75.28 120.52 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 119.542 1.065 . . . . 0.0 108.232 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -88.75 114.83 25.79 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 176.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.1 133.25 11.38 Favored Glycine 0 CA--C 1.542 1.742 0 CA-C-N 116.473 -0.33 . . . . 0.0 113.291 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.7 t -81.91 122.3 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.0 m -96.0 105.34 17.35 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 170.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.78 144.78 26.43 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.582 0.706 . . . . 0.0 109.989 177.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 40.3 mt -146.68 129.24 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.1 t -125.94 115.31 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 -178.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -79.2 131.5 36.22 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.205 0.602 . . . . 0.0 111.048 172.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -135.55 64.92 1.56 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 172.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.38 -104.67 1.88 Allowed Glycine 0 CA--C 1.546 1.997 0 O-C-N 121.211 -0.931 . . . . 0.0 113.401 -177.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -89.35 -39.44 13.43 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 161.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -62.47 152.55 34.16 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.656 1.182 . . . . 0.0 113.806 178.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -139.49 150.61 45.36 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.905 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -134.32 109.54 8.88 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 164.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -117.49 131.64 56.69 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.475 -178.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.2 m -123.69 97.71 5.5 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -172.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.4 mm -88.06 113.44 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.6 p . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.853 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 67.1 mt . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -115.85 118.04 31.88 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -175.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -136.5 171.99 13.68 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.0 0.905 . . . . 0.0 110.1 178.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -136.05 137.27 40.96 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.484 -0.76 . . . . 0.0 110.079 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -133.64 134.89 43.76 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.551 0.691 . . . . 0.0 112.274 176.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.3 m -92.11 127.89 37.75 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 163.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.0 t -74.31 124.52 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.28 -53.67 0.59 Allowed Glycine 0 CA--C 1.548 2.109 0 CA-C-N 115.237 -0.892 . . . . 0.0 114.124 -165.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -81.87 155.98 25.05 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.793 0.837 . . . . 0.0 112.809 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -76.38 111.79 12.2 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.079 0.552 . . . . 0.0 110.62 169.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 61.6 m -108.7 143.07 38.29 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.605 0.762 . . . . 0.0 111.421 -167.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -81.62 98.16 8.22 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.345 -176.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.2 mt . . . . . 0 N--CA 1.489 1.496 0 C-N-CA 123.295 0.638 . . . . 0.0 109.906 -167.175 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.301 31.8 ttmt . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.7 m -125.87 142.93 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 C-N-CA 124.188 0.995 . . . . 0.0 109.472 -168.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.75 108.97 14.86 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.1 t -140.27 133.4 29.54 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.441 0.696 . . . . 0.0 109.642 -168.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 64.3 t -84.85 120.03 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -175.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.6 t -97.94 111.9 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 172.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -112.46 145.16 40.69 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.93 0.872 . . . . 0.0 110.853 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 54.2 tp -96.44 105.31 17.37 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.67 178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -90.92 120.13 31.68 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 170.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.4 -124.16 8.71 Favored Glycine 0 CA--C 1.544 1.876 0 CA-C-N 114.327 -1.306 . . . . 0.0 113.276 -174.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -122.75 -14.64 7.66 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 171.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -132.87 27.77 4.25 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 -172.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -138.15 103.14 4.86 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 121.446 1.93 . . . . 0.0 108.508 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 57.4 mt -96.79 106.05 18.28 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 173.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 87.4 t -106.62 122.96 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -165.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.4 t -150.56 127.61 11.17 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 122.589 0.356 . . . . 0.0 111.047 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.8 t -104.24 122.89 46.33 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.215 0.606 . . . . 0.0 109.848 175.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -80.76 -79.7 0.15 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 123.28 0.632 . . . . 0.0 110.189 -173.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -98.08 -78.88 0.48 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 163.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -130.86 61.47 1.63 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 156.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.9 mp -123.49 91.91 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 103.367 -2.827 . . . . 0.0 103.367 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -87.66 92.06 8.97 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.142 0.496 . . . . 0.0 110.303 -172.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.3 t -83.99 103.7 13.46 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.156 0.982 . . . . 0.0 110.49 -175.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 88.1 t -103.34 103.86 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 -177.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.8 m -93.48 92.69 7.73 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -166.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -94.45 109.4 21.27 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.153 0.581 . . . . 0.0 110.498 -166.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.71 98.13 10.24 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 118.726 0.694 . . . . 0.0 109.504 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -83.34 -74.58 0.36 Allowed 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 122.981 0.512 . . . . 0.0 111.606 -172.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -168.78 107.02 0.26 Allowed Glycine 0 N--CA 1.479 1.542 0 CA-C-O 121.796 0.665 . . . . 0.0 112.191 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.275 23.8 m-20 48.71 32.53 3.63 Favored 'General case' 0 CA--C 1.57 1.712 0 N-CA-C 116.944 2.202 . . . . 0.0 116.944 -165.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.7 pt -142.15 -171.09 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.815 0 C-N-CA 124.806 1.242 . . . . 0.0 108.604 175.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.5 tt -154.39 124.16 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 120.4 -1.438 . . . . 0.0 107.902 160.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.5 m -102.02 88.75 3.42 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -87.65 105.45 17.36 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.6 m -109.07 99.05 8.41 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -165.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 59.3 mtt -92.51 102.34 14.79 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.72 0.808 . . . . 0.0 109.268 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 77.5 p -94.09 103.14 15.21 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -176.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.2 tp -101.26 83.81 2.53 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 174.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.88 -104.77 1.6 Allowed Glycine 0 CA--C 1.544 1.882 0 CA-C-N 116.375 -0.375 . . . . 0.0 113.181 -176.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -97.15 -12.35 23.2 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 169.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 51.6 mt -84.55 112.39 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -175.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.8 t -103.29 90.71 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -174.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -83.6 94.12 8.01 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.428 0.691 . . . . 0.0 110.483 -177.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -106.6 108.14 19.5 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.075 -169.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 -96.53 110.72 23.06 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 63.2 mt -103.45 102.55 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 104.344 -2.465 . . . . 0.0 104.344 -173.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.7 m -127.79 116.67 20.55 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -163.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.5 mttm -77.8 138.28 38.89 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.55 0.74 . . . . 0.0 112.431 -171.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 70.9 ttt-85 -75.25 116.5 16.04 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.821 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 16.7 pt . . . . . 0 N--CA 1.486 1.336 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -174.858 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 117.619 2.452 . . . . 0.0 117.619 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.0 m -76.59 114.34 15.22 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 121.066 1.757 . . . . 0.0 111.116 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.98 169.23 31.21 Favored Glycine 0 CA--C 1.545 1.926 0 CA-C-O 122.821 1.234 . . . . 0.0 114.368 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -92.01 123.01 35.05 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 113.739 -1.23 . . . . 0.0 108.337 170.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -116.11 97.55 6.13 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -175.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.7 tm0? -91.86 125.53 36.6 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 122.987 0.515 . . . . 0.0 110.36 -170.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 38.6 tp -65.37 114.74 5.01 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -169.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -93.54 -65.78 0.97 Allowed 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.219 -176.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.6 m -121.55 117.09 25.92 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -177.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -104.06 130.44 51.75 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.234 1.013 . . . . 0.0 109.128 176.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.63 -69.12 0.75 Allowed 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.357 -177.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -115.38 69.93 0.74 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.25 0.62 . . . . 0.0 110.522 178.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -75.94 -60.88 2.13 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.522 0.729 . . . . 0.0 111.561 171.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.12 -31.65 72.24 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 176.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.55 -44.5 78.14 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 169.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -67.49 -56.68 8.58 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 176.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 51.2 mtt -59.17 -48.45 81.58 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -177.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -57.42 -44.58 84.76 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 170.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.18 -29.63 70.73 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 117.338 2.347 . . . . 0.0 117.338 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 47.0 pt -81.24 -49.33 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-N 119.549 1.068 . . . . 0.0 112.503 173.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.77 67.27 0.03 OUTLIER Glycine 0 CA--C 1.541 1.666 0 CA-C-N 118.79 0.723 . . . . 0.0 112.471 173.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.73 152.32 45.42 Favored Pre-proline 0 CA--C 1.568 1.651 0 C-N-CA 123.967 0.907 . . . . 0.0 110.714 178.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.14 155.04 52.32 Favored 'Trans proline' 0 CA--C 1.557 1.652 0 C-N-CA 123.199 2.599 . . . . 0.0 113.394 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -57.08 -33.22 67.06 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 169.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -60.72 -55.57 31.64 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 117.227 -1.368 . . . . 0.0 113.961 170.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.99 -21.81 63.19 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 178.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.2 mt -76.1 -55.3 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-N 119.846 1.203 . . . . 0.0 110.509 171.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 52.3 mm-40 -76.21 -29.06 57.47 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -176.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -79.88 -45.7 18.16 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 118.832 0.742 . . . . 0.0 112.181 168.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.63 -28.01 67.17 Favored Glycine 0 CA--C 1.547 2.033 0 N-CA-C 119.678 2.631 . . . . 0.0 119.678 174.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -62.79 -41.01 99.08 Favored 'General case' 0 CA--C 1.568 1.66 0 CA-C-N 119.537 1.668 . . . . 0.0 114.965 170.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -68.77 -37.3 79.23 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 167.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.3 mt -68.22 139.43 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-N 119.651 1.114 . . . . 0.0 110.077 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -72.5 108.88 5.8 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.206 174.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.62 101.62 2.82 Favored Glycine 0 N--CA 1.479 1.526 0 CA-C-N 116.059 -0.518 . . . . 0.0 112.228 -174.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.2 t -85.95 107.32 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -176.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.0 m -99.43 95.11 6.8 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 114.269 -1.332 . . . . 0.0 107.517 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -80.56 148.73 30.23 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 121.88 0.848 . . . . 0.0 111.092 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.7 mt -140.56 122.41 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 173.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.0 t -118.45 100.53 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -83.43 126.74 33.07 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.161 0.584 . . . . 0.0 110.625 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -123.8 77.59 1.54 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 167.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.59 -119.0 6.36 Favored Glycine 0 CA--C 1.546 1.995 0 C-N-CA 123.092 0.377 . . . . 0.0 113.154 -173.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -76.6 -16.81 59.48 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 167.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -78.94 148.4 32.66 Favored 'General case' 0 CA--C 1.557 1.218 0 CA-C-N 119.335 0.971 . . . . 0.0 111.577 176.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -142.5 109.39 5.48 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -101.36 95.7 6.68 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 173.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -94.65 129.56 41.47 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.846 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.9 m -113.74 92.46 3.99 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.3 tp -85.06 120.91 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.804 0.841 . . . . 0.0 110.09 -175.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 56.8 m . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 171.834 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.0 mm . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -92.08 126.77 37.3 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.451 0.643 . . . . 0.0 110.139 173.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -138.81 131.9 29.74 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -126.66 150.06 49.18 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 122.077 0.941 . . . . 0.0 112.56 -171.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -147.15 155.27 41.99 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.334 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.1 m -107.37 137.73 44.88 Favored 'General case' 0 CA--C 1.565 1.533 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 166.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.7 t -75.08 126.1 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 170.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.91 -54.23 0.56 Allowed Glycine 0 CA--C 1.547 2.057 0 CA-C-N 115.659 -0.701 . . . . 0.0 114.353 -167.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -88.62 154.52 20.25 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.599 0.76 . . . . 0.0 112.418 -173.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -77.5 106.63 9.4 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.151 0.501 . . . . 0.0 109.927 164.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 68.7 m -110.03 140.68 43.81 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.756 0.789 . . . . 0.0 111.07 -169.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.44 125.16 30.1 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.484 -177.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 122.105 0.955 . . . . 0.0 109.796 179.874 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 70.3 t -117.86 -77.97 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt 61.29 90.49 0.07 Allowed 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 124.355 1.062 . . . . 0.0 112.04 -164.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.2 t -143.39 145.12 32.39 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.543 0.687 . . . . 0.0 110.58 -175.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.1 t -98.17 125.06 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -178.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.1 t -107.38 136.22 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.7 mp0 -119.18 137.88 53.32 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.495 0.718 . . . . 0.0 109.082 172.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.1 tp -104.55 119.48 39.08 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.981 0.912 . . . . 0.0 108.976 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -97.88 122.86 41.5 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 167.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.02 -125.73 11.3 Favored Glycine 0 CA--C 1.544 1.904 0 CA-C-N 114.664 -1.153 . . . . 0.0 113.478 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -137.96 63.06 1.55 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 155.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -152.72 -44.39 0.1 Allowed 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 117.204 -1.379 . . . . 0.0 114.067 -178.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -108.33 111.3 23.16 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 120.536 1.516 . . . . 0.0 111.461 -168.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 24.2 mt -106.72 109.07 20.88 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 174.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.2 t -105.52 121.51 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -174.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 t -156.45 135.43 11.91 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 45.8 m -103.11 113.79 27.55 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -75.9 -83.51 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.225 0.61 . . . . 0.0 111.226 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -133.4 81.83 1.95 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 173.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.257 33.4 t30 49.85 44.87 25.21 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 115.691 1.738 . . . . 0.0 115.691 -163.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 55.7 mt -137.13 95.1 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 -177.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -85.43 98.31 10.51 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.398 0.618 . . . . 0.0 109.691 -178.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.2 t -82.77 102.81 11.81 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.209 1.004 . . . . 0.0 109.542 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 79.8 t -103.24 92.19 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 52.3 m -96.37 97.09 9.19 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -166.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -106.88 124.26 49.36 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.364 1.066 . . . . 0.0 110.681 -165.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.9 107.17 17.91 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -177.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -89.96 -103.23 0.09 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 118.24 -0.886 . . . . 0.0 109.271 -174.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -90.5 -106.41 1.3 Allowed Glycine 0 N--CA 1.485 1.937 0 CA-C-N 119.942 1.246 . . . . 0.0 111.803 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -102.72 56.87 0.77 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.097 0.475 . . . . 0.0 110.437 165.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.2 pt -142.5 -170.66 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.574 1.866 0 C-N-CA 124.557 1.143 . . . . 0.0 108.879 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.4 tt -148.73 125.13 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 120.526 -1.359 . . . . 0.0 107.885 155.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 55.9 m -93.15 96.27 9.92 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 174.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.81 101.6 13.22 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -174.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.2 m -105.17 92.12 4.08 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -165.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 16.8 mtp -91.95 102.48 15.05 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.487 0.715 . . . . 0.0 109.5 -177.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 60.7 p -97.18 104.05 16.04 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -171.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.2 tp -90.89 80.63 5.78 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 176.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.22 -97.67 0.68 Allowed Glycine 0 CA--C 1.546 1.993 0 O-C-N 122.297 -0.252 . . . . 0.0 113.046 -171.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -102.27 -12.37 18.02 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 171.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 95.1 mt -85.84 106.36 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-N 120.854 1.661 . . . . 0.0 107.467 -175.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 96.8 t -94.91 98.73 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -173.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -84.6 94.84 8.7 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.331 0.586 . . . . 0.0 109.554 176.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -96.14 109.36 21.81 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.787 -175.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 30.7 mtm180 -104.62 107.89 19.06 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.0 mp -96.47 107.13 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.2 m -131.1 114.34 15.02 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -164.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -75.33 131.4 40.25 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.595 0.758 . . . . 0.0 112.623 -168.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -74.34 117.6 16.33 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.936 0.895 . . . . 0.0 110.643 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.9 pt . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 -168.601 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 . . . . . 0 N--CA 1.494 1.767 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.5 m -74.41 104.61 5.21 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 121.605 2.002 . . . . 0.0 110.918 175.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.55 148.93 8.66 Favored Glycine 0 CA--C 1.542 1.765 0 CA-C-O 121.84 0.689 . . . . 0.0 113.201 -173.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -102.6 110.1 21.93 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -112.34 105.01 13.19 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -163.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -91.93 137.12 32.62 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.151 0.501 . . . . 0.0 111.322 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.1 tp -72.48 117.62 14.37 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.553 0.741 . . . . 0.0 112.342 -169.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -100.39 -61.96 1.3 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.54 0.736 . . . . 0.0 110.992 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.3 m -119.61 148.86 42.84 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.79 0.836 . . . . 0.0 110.058 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -142.59 134.6 27.2 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 122.039 0.923 . . . . 0.0 109.95 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -87.88 -67.94 0.79 Allowed 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.546 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 50.0 m-20 -120.93 68.9 0.88 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 118.534 0.606 . . . . 0.0 110.711 -175.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -76.46 -54.38 6.8 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.377 0.671 . . . . 0.0 112.335 172.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.44 -49.22 77.69 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 178.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.39 -40.1 85.5 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -67.02 -52.9 36.66 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 175.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -58.94 -51.85 68.28 Favored 'General case' 0 CA--C 1.562 1.423 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -58.02 -38.64 76.59 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 171.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.04 -29.81 69.71 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 116.909 2.189 . . . . 0.0 116.909 174.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.271 46.4 pt -80.65 -54.34 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-N 119.868 1.213 . . . . 0.0 111.768 171.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.83 67.06 0.01 OUTLIER Glycine 0 CA--C 1.543 1.795 0 CA-C-N 119.264 0.938 . . . . 0.0 112.971 170.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.75 154.85 55.15 Favored Pre-proline 0 CA--C 1.57 1.744 0 C-N-CA 123.653 0.781 . . . . 0.0 111.839 -175.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -76.36 152.03 34.17 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 123.326 2.684 . . . . 0.0 113.844 176.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -56.72 -37.2 70.62 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 171.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -64.01 -54.28 36.79 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.8 mt -67.0 -23.77 65.96 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 116.716 2.117 . . . . 0.0 116.716 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 74.9 mt -68.72 -55.43 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 124.176 0.99 . . . . 0.0 110.663 169.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -64.87 -25.64 67.98 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 116.893 2.183 . . . . 0.0 116.893 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -74.8 -59.7 2.61 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 119.346 0.975 . . . . 0.0 111.681 168.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.48 -11.72 60.12 Favored Glycine 0 CA--C 1.553 2.417 0 N-CA-C 119.995 2.758 . . . . 0.0 119.995 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -71.27 -46.18 61.49 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 120.272 2.036 . . . . 0.0 114.174 170.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -69.83 -35.66 74.95 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 170.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.2 mt -73.89 126.19 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.27 105.44 16.64 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -85.53 129.57 9.38 Favored Glycine 0 CA--C 1.54 1.614 0 CA-C-N 116.338 -0.392 . . . . 0.0 113.3 -174.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.9 t -85.72 113.49 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.2 t -99.86 112.26 24.53 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 172.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -88.59 151.68 22.33 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 114.614 -1.176 . . . . 0.0 110.309 175.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.2 mt -142.97 131.39 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 166.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.3 t -114.98 109.3 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -78.1 117.6 19.55 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.999 0.52 . . . . 0.0 110.908 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -129.58 62.85 1.53 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.818 169.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.9 -108.69 2.57 Favored Glycine 0 CA--C 1.547 2.035 0 O-C-N 121.614 -0.679 . . . . 0.0 113.714 -177.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -74.18 -42.96 59.03 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 169.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -73.96 121.48 21.08 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 119.24 0.927 . . . . 0.0 111.236 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -122.27 97.11 5.32 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -84.86 100.27 11.47 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 121.676 0.751 . . . . 0.0 109.569 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -87.9 137.91 31.92 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.386 174.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.1 m -128.15 89.46 2.92 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 173.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.0 tt -91.66 119.53 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 121.37 0.605 . . . . 0.0 109.643 -176.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.3 p . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -178.184 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.3 mm . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -119.37 119.72 34.78 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -170.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -144.96 148.03 33.35 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.531 0.733 . . . . 0.0 109.231 173.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.97 122.28 46.92 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.536 0.734 . . . . 0.0 110.724 175.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -101.9 134.32 45.29 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 121.619 0.723 . . . . 0.0 111.38 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.1 m -97.97 131.18 44.64 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 175.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.5 t -82.18 119.07 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 174.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.99 0.71 71.05 Favored Glycine 0 CA--C 1.557 2.701 0 N-CA-C 119.063 2.385 . . . . 0.0 119.063 -170.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -144.21 138.14 27.84 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 120.176 1.988 . . . . 0.0 109.079 166.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.66 123.32 21.6 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.37 0.605 . . . . 0.0 112.45 -176.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 99.7 m -108.95 150.9 27.05 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.614 171.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.85 115.08 22.08 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.948 175.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 N--CA 1.492 1.626 0 C-N-CA 122.812 0.445 . . . . 0.0 109.91 -162.811 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.1 mptt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.1 p -116.58 132.71 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.011 0.925 . . . . 0.0 109.23 -171.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -84.03 112.22 20.0 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.243 0.617 . . . . 0.0 109.976 -171.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.0 t -145.16 149.5 35.08 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.407 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.3 p -112.31 136.37 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 CA-C-O 122.538 1.161 . . . . 0.0 108.506 174.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.08 139.2 18.51 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 CA-C-N 113.931 -1.486 . . . . 0.0 108.166 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -111.61 133.26 54.0 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.4 tp -94.0 107.87 19.74 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -87.84 114.27 24.29 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 170.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.72 -119.12 8.07 Favored Glycine 0 CA--C 1.543 1.826 0 CA-C-N 114.52 -1.218 . . . . 0.0 113.635 -175.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -126.85 -5.45 6.29 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 171.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -123.42 -13.33 7.63 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.342 2.349 . . . . 0.0 117.342 -173.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -116.91 94.36 4.56 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-N 121.493 1.951 . . . . 0.0 110.351 -166.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 39.4 mt -93.19 107.31 19.14 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.557 0.743 . . . . 0.0 110.008 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 29.8 m -106.77 131.34 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 123.937 0.895 . . . . 0.0 110.801 -171.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.1 t -153.74 145.12 23.08 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.6 p -109.89 110.06 20.9 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 174.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -76.14 -87.45 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.235 0.614 . . . . 0.0 110.957 -177.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -112.81 -74.56 0.63 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 174.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -129.05 65.08 1.45 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 154.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.4 mp -137.96 103.31 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 176.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -92.04 94.21 9.14 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -95.09 110.61 22.52 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.59 -167.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.0 t -107.2 100.6 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 -177.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.6 m -96.24 91.25 5.8 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -172.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -87.99 141.83 28.27 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.914 0.885 . . . . 0.0 110.46 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 tt -121.91 102.95 8.5 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 172.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -81.07 -82.11 0.12 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.123 0.569 . . . . 0.0 110.988 -168.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.65 -103.63 2.26 Favored Glycine 0 N--CA 1.482 1.739 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 176.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -111.66 54.02 0.7 Allowed 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.676 0.75 . . . . 0.0 109.833 159.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.4 pp -149.75 136.49 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -175.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.9 tt -108.11 117.4 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.4 m -103.92 98.58 8.4 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 177.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -93.79 116.33 28.79 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.5 m -113.14 94.23 4.79 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -170.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 27.2 mtt -94.2 99.06 11.39 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.735 0.814 . . . . 0.0 109.381 -177.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.4 p -90.94 107.0 18.91 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.246 -174.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.3 tp -101.41 79.86 2.02 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.43 -100.97 1.01 Allowed Glycine 0 CA--C 1.545 1.908 0 CA-C-N 116.579 -0.282 . . . . 0.0 112.772 -171.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -103.1 -6.07 22.63 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 169.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 76.3 mt -87.18 103.86 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 120.668 1.576 . . . . 0.0 106.914 -176.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 49.1 t -93.8 96.58 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -84.83 93.59 8.53 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.199 0.523 . . . . 0.0 109.774 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -99.17 103.02 14.87 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.552 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -107.12 122.86 47.33 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.876 0.87 . . . . 0.0 109.141 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.0 mp -111.16 107.92 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 -171.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.3 m -118.91 119.93 35.78 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -175.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -89.85 141.91 28.19 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.659 0.742 . . . . 0.0 111.414 -174.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 33.3 ttm-85 -66.63 124.76 23.74 Favored 'General case' 0 CA--C 1.559 1.316 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.263 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 16.6 pt . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 123.05 1.405 . . . . 0.0 108.542 -176.638 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.4 t . . . . . 0 CA--C 1.55 0.943 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -85.93 -11.0 54.26 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 -175.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.6 m -76.82 101.82 6.04 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 121.43 1.923 . . . . 0.0 111.004 -176.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.75 168.19 39.0 Favored Glycine 0 CA--C 1.546 2.011 0 CA-C-O 122.34 0.966 . . . . 0.0 112.86 -172.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.69 97.39 5.61 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -173.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -100.55 105.54 16.98 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -160.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -92.13 138.93 31.13 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.557 0.694 . . . . 0.0 111.612 -175.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.0 tp -65.86 130.17 42.34 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.304 1.042 . . . . 0.0 113.389 -172.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -109.37 -65.53 1.14 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.069 0.948 . . . . 0.0 109.745 -178.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.5 t -127.36 121.2 30.35 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.895 0.878 . . . . 0.0 108.94 -176.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -114.93 120.13 38.89 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -79.51 -70.44 0.51 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 118.485 -0.769 . . . . 0.0 112.789 -171.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 46.7 m-20 -121.64 73.82 1.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 118.848 0.749 . . . . 0.0 110.774 -170.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -81.98 -46.37 14.08 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 172.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -59.03 -50.02 75.66 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 172.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.08 -38.28 90.54 Favored 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 116.636 2.087 . . . . 0.0 116.636 175.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -77.54 -51.21 11.07 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -43.71 98.21 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -65.04 -35.65 81.86 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 168.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.6 -30.46 70.7 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 169.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.266 24.7 pt -88.59 -59.55 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-N 119.717 1.144 . . . . 0.0 111.214 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.01 71.55 0.01 OUTLIER Glycine 0 CA--C 1.54 1.644 0 CA-C-N 118.642 0.655 . . . . 0.0 111.909 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.93 153.28 78.51 Favored Pre-proline 0 CA--C 1.571 1.768 0 C-N-CA 123.617 0.767 . . . . 0.0 111.675 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.95 151.05 30.67 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 123.254 2.636 . . . . 0.0 114.048 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -59.48 -31.82 69.69 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 116.623 2.083 . . . . 0.0 116.623 170.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -61.73 -51.1 69.75 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 117.301 -1.333 . . . . 0.0 114.583 170.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.7 mt -68.36 -23.81 64.72 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 173.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 84.9 mt -68.42 -55.0 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 124.356 1.062 . . . . 0.0 111.197 170.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -66.1 -23.05 66.43 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -77.52 -56.5 4.48 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 124.356 1.063 . . . . 0.0 112.037 170.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.37 -15.54 70.42 Favored Glycine 0 CA--C 1.553 2.454 0 N-CA-C 119.667 2.627 . . . . 0.0 119.667 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -65.45 -44.04 88.48 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 120.317 2.058 . . . . 0.0 114.654 168.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -67.65 -35.96 79.86 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 170.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 53.3 mt -75.43 122.24 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -86.34 107.27 17.91 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 174.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.56 130.9 10.3 Favored Glycine 0 CA--C 1.54 1.621 0 CA-C-N 116.178 -0.465 . . . . 0.0 113.561 -173.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.1 t -80.8 114.85 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 71.0 m -104.62 99.37 9.04 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -81.66 145.53 30.52 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.532 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.2 mt -143.45 128.89 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 176.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 87.4 t -124.02 107.42 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 178.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -88.26 122.07 31.38 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.548 0.689 . . . . 0.0 109.444 170.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -87.35 -60.49 1.96 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.406 159.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.56 -88.94 0.07 OUTLIER Glycine 0 N--CA 1.476 1.312 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 170.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -74.0 -39.6 63.51 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 164.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -75.23 135.61 40.99 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 119.897 1.226 . . . . 0.0 111.527 176.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -134.12 108.5 8.34 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm -102.47 103.76 14.16 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -111.95 136.71 50.93 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.789 0.836 . . . . 0.0 110.537 -173.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.3 m -127.88 106.24 8.97 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -176.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.9 mm -97.21 120.14 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.5 p -90.87 90.64 8.0 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 174.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -101.01 92.8 5.18 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.006 0.522 . . . . 0.0 110.655 -167.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.26 -102.04 1.32 Allowed Glycine 0 CA--C 1.543 1.821 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.991 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.5 m -96.28 -57.34 2.36 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.442 0.697 . . . . 0.0 112.053 169.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -80.89 137.95 36.16 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 119.21 0.914 . . . . 0.0 112.336 -173.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.9 t -95.82 119.89 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 90.4 mt -111.33 107.63 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -116.22 130.98 57.06 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.02 0.928 . . . . 0.0 110.478 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -143.01 173.65 11.37 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.872 0.869 . . . . 0.0 109.212 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -143.11 134.06 25.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.983 -1.073 . . . . 0.0 112.313 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -110.25 149.16 30.55 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.8 0.84 . . . . 0.0 111.315 172.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.1 m -108.55 125.45 51.83 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 169.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.9 t -69.5 123.9 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 C-N-CA 123.831 0.852 . . . . 0.0 109.595 -176.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.42 -44.58 2.11 Favored Glycine 0 CA--C 1.552 2.356 0 N-CA-C 116.857 1.503 . . . . 0.0 116.857 -172.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -102.42 132.67 48.29 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.277 1.031 . . . . 0.0 110.145 -173.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -50.81 134.73 24.98 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 116.466 2.025 . . . . 0.0 116.466 -172.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 20.6 p -133.71 137.84 45.5 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 122.187 0.994 . . . . 0.0 111.039 -174.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -96.13 95.21 8.0 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.22 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.1 mt -98.05 144.78 27.2 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.591 0.756 . . . . 0.0 109.665 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -72.72 116.93 13.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.746 -0.596 . . . . 0.0 111.265 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.5 t -82.66 150.92 26.52 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 123.012 1.387 . . . . 0.0 110.861 166.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -65.39 -55.09 20.06 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 113.238 -1.801 . . . . 0.0 114.096 -172.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.2 m -71.63 -48.34 48.56 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 118.366 -0.826 . . . . 0.0 112.832 175.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -82.48 -112.63 0.46 Allowed Glycine 0 CA--C 1.544 1.87 0 CA-C-N 119.357 0.981 . . . . 0.0 114.153 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -166.88 -46.07 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.893 0.877 . . . . 0.0 112.501 -169.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -145.08 146.79 31.98 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.76 1.266 . . . . 0.0 109.707 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.5 p -145.42 125.84 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.318 0 CA-C-N 113.925 -1.488 . . . . 0.0 107.659 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -83.04 107.62 15.76 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 171.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.9 t -155.72 105.8 2.44 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 -170.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.252 11.2 p -103.98 136.52 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-O 122.893 1.33 . . . . 0.0 110.718 -176.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.1 t -90.25 136.35 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 CA-C-N 113.346 -1.752 . . . . 0.0 108.742 -172.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -107.0 134.93 49.42 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 171.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 33.5 tp -105.06 110.07 22.31 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.23 -175.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -105.69 128.04 53.43 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.485 0.714 . . . . 0.0 109.198 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.53 7.51 64.74 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 121.344 3.297 . . . . 0.0 121.344 172.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.292 5.0 t70 54.91 45.62 26.13 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 -161.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -157.48 -44.64 0.07 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -92.81 125.6 37.49 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 120.086 1.312 . . . . 0.0 110.934 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.0 mt -111.29 102.05 10.49 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 170.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.1 m -109.05 126.6 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 C-N-CA 123.5 0.72 . . . . 0.0 109.533 -172.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.0 t -149.03 156.25 41.97 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.262 0.553 . . . . 0.0 112.29 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 89.4 m -112.5 105.42 13.64 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 175.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.266 36.7 t80 -91.3 -101.05 0.11 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.109 0.964 . . . . 0.0 108.928 -163.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -110.39 78.12 1.1 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 170.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.4 m120 50.32 42.15 25.44 Favored 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -166.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 23.4 mt -133.79 115.25 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 103.455 -2.795 . . . . 0.0 103.455 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -85.73 93.92 8.98 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 174.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.4 t -86.37 96.25 9.94 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.821 0.849 . . . . 0.0 109.901 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 62.3 t -104.19 105.04 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 -174.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 62.9 m -116.24 90.84 3.43 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -168.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -96.12 140.53 30.7 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.132 0.573 . . . . 0.0 110.906 -172.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 tt -105.94 110.56 22.88 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -110.94 91.77 3.79 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -178.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.52 -110.7 3.1 Favored Glycine 0 CA--C 1.544 1.857 0 CA-C-O 119.757 -0.468 . . . . 0.0 113.407 176.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -118.86 52.63 1.04 Allowed 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.272 0.558 . . . . 0.0 111.686 171.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.7 pt -134.87 -166.21 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.783 0 C-N-CA 124.554 1.142 . . . . 0.0 108.136 166.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.3 tt -157.94 126.34 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 O-C-N 120.352 -1.467 . . . . 0.0 107.426 159.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 t -83.44 149.5 26.62 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 120.627 0.251 . . . . 0.0 110.724 164.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -133.83 97.12 3.82 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 169.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' THR . . . . . 0.409 ' HG1' ' HG3' ' A' ' 121' ' ' LYS . 23.3 m -104.2 91.46 3.94 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -173.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 40.2 mtt -93.79 103.34 15.48 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.211 1.004 . . . . 0.0 109.078 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 75.1 p -99.98 106.57 18.38 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -172.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 42.0 tp -102.95 82.26 2.08 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.94 -99.81 0.88 Allowed Glycine 0 CA--C 1.545 1.925 0 N-CA-C 114.326 0.49 . . . . 0.0 114.326 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -89.72 -25.8 21.0 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 171.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 14.0 mm -67.2 138.76 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.651 0 C-N-CA 125.057 1.343 . . . . 0.0 109.751 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.95 93.94 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 172.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -87.65 98.92 11.69 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.487 0.715 . . . . 0.0 109.752 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.409 ' HG3' ' HG1' ' A' ' 112' ' ' THR . 81.8 tttt -108.9 104.97 14.31 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 123.605 0.566 . . . . 0.0 110.056 -177.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -85.59 142.19 29.29 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.522 164.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -125.41 105.56 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 103.37 -2.826 . . . . 0.0 103.37 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 62.5 m -120.84 120.86 36.78 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.168 0.587 . . . . 0.0 109.459 -174.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -86.03 139.93 30.73 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.317 0.647 . . . . 0.0 111.941 -170.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -69.59 113.9 7.3 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.662 0.785 . . . . 0.0 111.741 -176.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.5 mt . . . . . 0 N--CA 1.482 1.173 0 N-CA-C 102.428 -3.175 . . . . 0.0 102.428 -163.424 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.9 m . . . . . 0 CA--C 1.549 0.915 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -70.98 -22.24 62.21 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 117.711 2.486 . . . . 0.0 117.711 -177.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.2 m -69.73 107.74 3.61 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 120.857 1.662 . . . . 0.0 110.909 176.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.97 162.11 24.5 Favored Glycine 0 CA--C 1.544 1.873 0 CA-C-O 122.425 1.014 . . . . 0.0 114.233 -171.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -105.36 115.43 30.24 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -113.64 98.49 7.08 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 -169.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -93.51 138.91 31.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.936 -0.478 . . . . 0.0 111.067 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.1 tp -63.82 137.96 58.27 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -171.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -121.57 -64.8 1.19 Allowed 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.536 -175.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.8 t -128.77 115.36 17.83 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.617 0.767 . . . . 0.0 109.263 -174.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -105.3 128.72 53.6 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.958 0.903 . . . . 0.0 109.654 175.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -88.52 -70.18 0.66 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.607 -177.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -114.63 68.66 0.7 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.278 0.631 . . . . 0.0 110.398 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -74.61 -52.32 12.07 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 118.496 -0.764 . . . . 0.0 112.448 169.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -63.39 -47.61 81.3 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -173.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.5 -39.67 94.21 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 171.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -66.52 -50.95 61.49 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 176.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 20.7 mmt -62.72 -42.17 99.53 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -175.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -61.75 -45.31 94.45 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 168.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.5 -29.63 70.69 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.262 39.5 pt -76.02 -53.43 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 119.901 1.228 . . . . 0.0 112.132 170.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.31 67.77 0.01 OUTLIER Glycine 0 CA--C 1.538 1.493 0 CA-C-O 118.887 -0.952 . . . . 0.0 112.33 173.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.8 mt -130.06 141.28 41.32 Favored Pre-proline 0 CA--C 1.568 1.637 0 CA-C-N 117.918 0.859 . . . . 0.0 110.561 175.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.66 151.62 84.08 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 123.306 2.671 . . . . 0.0 114.034 172.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -49.93 -37.21 30.77 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 116.5 2.037 . . . . 0.0 116.5 172.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -63.11 -51.06 68.05 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 169.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.5 mt -70.98 -14.31 62.31 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 174.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.3 mt -71.66 -54.68 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-N 120.191 1.36 . . . . 0.0 110.267 166.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -64.2 -27.1 68.83 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 174.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -79.96 -49.47 11.81 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 119.612 1.096 . . . . 0.0 112.594 170.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.55 -24.72 68.08 Favored Glycine 0 CA--C 1.551 2.314 0 N-CA-C 118.951 2.34 . . . . 0.0 118.951 174.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -65.2 -44.42 88.43 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-N 120.509 2.154 . . . . 0.0 114.194 167.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -66.94 -31.4 71.95 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 171.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.0 mt -75.69 107.18 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 172.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.33 105.25 17.44 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -172.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.0 127.97 8.58 Favored Glycine 0 CA--C 1.54 1.618 0 N-CA-C 115.036 0.774 . . . . 0.0 115.036 -160.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.2 t -81.13 116.45 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 172.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.4 m -106.65 105.41 15.42 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -79.62 143.06 35.04 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 121.865 0.841 . . . . 0.0 110.782 175.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 54.2 mt -142.02 124.18 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 103.676 -2.713 . . . . 0.0 103.676 170.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.6 t -122.1 103.72 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -89.82 127.79 36.04 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 121.202 0.525 . . . . 0.0 110.252 176.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -126.72 82.25 2.07 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 165.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.91 -123.62 10.99 Favored Glycine 0 CA--C 1.547 2.058 0 C-N-CA 123.286 0.469 . . . . 0.0 113.939 -176.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -73.62 -35.15 65.3 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 169.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -73.44 147.88 43.78 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 122.724 1.249 . . . . 0.0 111.731 176.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -137.91 148.9 45.74 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 113.613 -1.63 . . . . 0.0 109.498 -177.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.21 110.98 8.71 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 164.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -104.05 147.38 27.46 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.069 172.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.5 m -135.59 92.53 2.84 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.0 tt -96.14 126.88 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 123.437 0.695 . . . . 0.0 109.809 -177.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.6 p -84.29 99.78 10.81 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 175.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -92.5 85.74 5.42 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.455 0.645 . . . . 0.0 109.866 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.59 -116.05 6.71 Favored Glycine 0 CA--C 1.545 1.934 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.265 -169.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.8 m -82.25 -54.4 5.28 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 173.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -80.62 125.06 29.54 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 119.114 0.87 . . . . 0.0 111.27 -173.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.9 p -84.76 133.41 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 123.922 0.889 . . . . 0.0 111.067 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.7 mt -121.44 114.61 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 -175.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -118.33 137.02 53.37 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.296 0.638 . . . . 0.0 111.224 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -137.81 145.98 42.97 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.941 0.877 . . . . 0.0 109.786 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -106.28 128.18 53.79 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.251 169.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -134.75 159.48 41.18 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.722 0.773 . . . . 0.0 111.479 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.5 m -124.2 131.83 53.56 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 173.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.9 m -74.11 130.41 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 123.582 0.753 . . . . 0.0 111.7 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.38 -48.21 1.72 Allowed Glycine 0 CA--C 1.549 2.206 0 N-CA-C 114.964 0.746 . . . . 0.0 114.964 -168.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -67.7 146.44 53.79 Favored 'General case' 0 CA--C 1.564 1.517 0 C-N-CA 124.536 1.134 . . . . 0.0 112.159 172.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -78.86 92.2 4.85 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.872 0.869 . . . . 0.0 109.615 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 25.5 p -107.2 140.08 40.62 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -154.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -67.23 127.49 32.85 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.635 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.5 mt -143.67 109.7 5.31 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -178.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -83.51 145.26 29.01 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -174.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.0 t -86.29 -175.72 5.61 Favored 'General case' 0 CA--C 1.568 1.65 0 CA-C-O 122.118 0.961 . . . . 0.0 111.506 170.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.5 ptp -85.76 52.16 2.39 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 175.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . 0.291 7.6 t -164.22 -71.39 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 173.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 166.14 85.76 0.06 OUTLIER Glycine 0 N--CA 1.478 1.453 0 CA-C-N 118.955 0.798 . . . . 0.0 111.377 171.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -153.33 112.69 3.81 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 172.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -92.88 101.24 13.6 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.2 m -92.67 126.09 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.379 -177.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -84.6 96.37 9.16 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.5 p -138.34 125.45 21.45 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -162.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.6 t -85.6 125.22 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -160.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.0 t -100.59 118.97 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -99.71 134.27 42.84 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.735 0.779 . . . . 0.0 109.754 176.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.1 tp -101.53 112.31 24.82 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.443 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -118.08 121.28 40.17 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.37 12.76 66.81 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 121.215 3.246 . . . . 0.0 121.215 175.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.302 9.0 t70 52.16 48.75 22.06 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -162.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -155.6 -43.34 0.08 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 117.651 -1.166 . . . . 0.0 113.584 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -98.73 122.0 41.39 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 120.469 1.486 . . . . 0.0 110.373 -175.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 77.3 mt -110.69 98.95 7.99 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 168.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.7 m -103.71 124.57 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 123.707 0.803 . . . . 0.0 109.525 -172.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.1 t -148.22 132.39 17.36 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.047 0.451 . . . . 0.0 110.971 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.7 p -95.66 119.83 34.85 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 172.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -84.64 -85.05 0.14 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.074 0.55 . . . . 0.0 109.909 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.74 -75.28 0.59 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 167.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -100.89 -19.07 16.07 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 167.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 mp -82.03 115.99 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-N 120.275 1.398 . . . . 0.0 108.106 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -99.31 101.78 13.19 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 168.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.9 t -85.66 99.4 11.27 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.617 0.767 . . . . 0.0 110.458 -177.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 70.2 t -99.52 97.76 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.7 m -105.52 86.24 2.38 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -166.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -97.04 131.6 43.68 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.888 0.875 . . . . 0.0 110.106 -171.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 tt -101.68 106.28 17.29 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -175.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -106.18 86.66 2.4 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -172.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.74 -108.09 2.68 Favored Glycine 0 N--CA 1.482 1.74 0 O-C-N 122.101 -0.374 . . . . 0.0 112.882 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -121.46 52.65 1.22 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.314 0.578 . . . . 0.0 111.615 170.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.5 pt -131.21 -163.17 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 C-N-CA 124.337 1.055 . . . . 0.0 108.163 163.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.3 tt -154.88 119.57 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 120.363 -1.46 . . . . 0.0 107.952 157.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 29.3 m -95.06 101.02 12.75 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -94.81 99.34 11.43 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 30.3 m -101.93 91.17 4.24 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -172.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 36.3 mtt -93.17 103.36 15.64 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.224 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.3 p -97.86 95.94 7.87 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.489 -171.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 19.3 tp -93.72 81.97 4.3 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.723 0.809 . . . . 0.0 109.079 177.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.8 -101.95 1.16 Allowed Glycine 0 CA--C 1.544 1.879 0 CA-C-N 116.191 -0.458 . . . . 0.0 113.043 -174.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -98.06 -11.52 22.84 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 170.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 62.4 mt -86.71 106.46 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -174.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.9 t -98.84 94.17 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -175.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -82.3 92.73 7.0 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.231 0.613 . . . . 0.0 109.659 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -92.41 109.47 20.86 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.3 ttt-85 -118.23 104.9 11.23 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -164.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.9 mp -98.44 116.33 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 105.593 -2.002 . . . . 0.0 105.593 -172.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.9 m -130.33 115.14 16.51 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -176.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -87.38 137.33 32.43 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.228 0.611 . . . . 0.0 112.135 -168.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.3 ttt85 -67.58 124.88 24.46 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 123.914 0.886 . . . . 0.0 111.524 177.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.5 pt . . . . . 0 N--CA 1.484 1.258 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 -172.576 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.0 m . . . . . 0 CA--C 1.549 0.915 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -68.2 -23.71 64.86 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 117.027 2.232 . . . . 0.0 117.027 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.7 m -73.29 109.21 6.64 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 120.704 1.593 . . . . 0.0 110.648 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.15 162.21 23.09 Favored Glycine 0 CA--C 1.544 1.877 0 CA-C-O 122.306 0.948 . . . . 0.0 114.134 -171.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -97.18 125.88 41.98 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 114.402 -0.899 . . . . 0.0 108.605 175.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -121.52 104.37 9.6 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -172.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -95.62 137.85 34.11 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.129 0.49 . . . . 0.0 110.892 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.7 tp -66.11 130.69 44.11 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.082 0.953 . . . . 0.0 112.987 -173.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -114.64 -64.79 1.26 Allowed 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.879 -175.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.7 m -125.49 112.05 15.78 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -105.74 110.4 22.69 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -97.41 127.42 43.36 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.263 85.5 m-20 67.4 52.51 0.8 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 173.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -78.65 -43.95 24.94 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 168.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -68.65 -50.86 47.83 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -175.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.91 -40.74 85.44 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 170.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -69.44 -56.54 7.13 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -44.24 96.61 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -61.96 -38.13 87.37 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 170.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.66 -34.39 77.74 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.819 2.155 . . . . 0.0 116.819 172.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.5 pt -82.33 -53.8 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 CA-C-N 119.327 0.967 . . . . 0.0 112.384 176.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.52 68.68 0.01 OUTLIER Glycine 0 CA--C 1.539 1.535 0 CA-C-N 119.017 0.826 . . . . 0.0 112.894 172.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.32 153.11 81.56 Favored Pre-proline 0 CA--C 1.57 1.721 0 C-N-CA 123.513 0.725 . . . . 0.0 111.813 175.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.81 152.84 25.53 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 123.264 2.643 . . . . 0.0 113.489 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -59.18 -28.84 66.99 Favored 'General case' 0 CA--C 1.565 1.526 0 N-CA-C 116.723 2.119 . . . . 0.0 116.723 168.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -63.02 -51.81 65.35 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 120.543 1.52 . . . . 0.0 114.055 170.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.4 mt -67.93 -28.28 67.35 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 116.604 2.075 . . . . 0.0 116.604 173.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.3 mt -70.38 -49.94 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 C-N-CA 124.297 1.039 . . . . 0.0 111.621 173.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -64.23 -22.62 67.01 Favored 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 116.315 1.969 . . . . 0.0 116.315 170.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -73.08 -57.99 3.63 Favored 'General case' 0 CA--C 1.565 1.519 0 CA-C-N 119.272 0.942 . . . . 0.0 111.74 167.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.5 -22.16 67.46 Favored Glycine 0 CA--C 1.548 2.143 0 N-CA-C 120.418 2.927 . . . . 0.0 120.418 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -64.68 -43.53 93.24 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 119.661 1.731 . . . . 0.0 114.64 170.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -67.24 -27.85 67.57 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 168.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 53.1 mt -83.03 121.75 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-N 120.144 1.338 . . . . 0.0 107.506 178.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.64 102.46 15.09 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 173.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.54 132.74 11.42 Favored Glycine 0 CA--C 1.541 1.707 0 N-CA-C 114.509 0.564 . . . . 0.0 114.509 -167.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.3 t -85.33 110.21 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 54.2 p -109.79 112.16 24.03 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.5 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -89.63 152.32 21.44 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 121.632 0.729 . . . . 0.0 111.058 -177.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.2 mt -136.35 132.8 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 105.437 -2.06 . . . . 0.0 105.437 173.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.6 t -126.57 102.77 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -80.18 120.7 24.65 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.122 0.569 . . . . 0.0 110.148 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -122.99 73.0 1.12 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 169.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.83 -117.48 7.56 Favored Glycine 0 CA--C 1.546 1.996 0 C-N-CA 123.117 0.389 . . . . 0.0 113.67 -175.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -76.87 -34.36 57.8 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 169.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -79.95 112.99 17.78 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 119.941 1.246 . . . . 0.0 110.761 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -105.74 117.98 35.42 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -104.12 104.65 14.62 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 176.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -133.29 134.45 43.9 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.297 -166.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.96 147.71 22.84 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.669 0.747 . . . . 0.0 110.029 165.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.0 tp -130.68 121.91 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.5 m -94.02 105.68 17.68 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 172.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.22 82.93 4.55 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 171.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.67 -101.96 1.95 Allowed Glycine 0 CA--C 1.54 1.621 0 CA-C-N 115.941 -0.572 . . . . 0.0 113.556 -177.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 93.0 p -89.08 -55.62 3.61 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.64 130.48 35.07 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 119.171 0.896 . . . . 0.0 111.673 -173.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.6 p -101.99 129.13 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.279 175.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.3 tt -129.92 143.22 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 123.799 0.84 . . . . 0.0 109.361 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -94.81 125.48 39.49 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.774 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -127.38 159.19 35.21 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 124.007 0.923 . . . . 0.0 110.257 -177.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -139.34 136.69 35.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.543 -0.723 . . . . 0.0 110.244 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.49 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 28.5 p90 -126.96 159.71 33.23 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 122.012 0.91 . . . . 0.0 112.324 167.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 96.3 m -116.07 139.7 50.03 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 163.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.6 t -75.62 123.35 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.13 34.21 21.49 Favored Glycine 0 CA--C 1.549 2.198 0 N-CA-C 117.044 1.578 . . . . 0.0 117.044 -168.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -149.89 138.57 20.83 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -177.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -69.32 105.71 2.65 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.176 0.512 . . . . 0.0 109.954 160.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.49 ' SG ' ' HB2' ' A' ' 63' ' ' PHE . 3.2 p -129.25 131.76 47.09 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 122.402 1.096 . . . . 0.0 110.649 -162.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -79.65 123.75 27.92 Favored 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 113.962 -1.472 . . . . 0.0 112.631 -168.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.8 mt -118.51 119.56 34.9 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 -177.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -86.67 92.54 8.96 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.647 0.737 . . . . 0.0 109.228 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.8 m -90.89 159.44 16.23 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.446 1.098 . . . . 0.0 109.707 -172.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . 0.282 55.4 mtt 68.74 -100.27 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 124.623 1.169 . . . . 0.0 109.674 -175.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.8 p -127.9 -44.05 1.49 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.716 1.206 . . . . 0.0 110.725 162.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -141.82 82.02 0.23 Allowed Glycine 0 N--CA 1.481 1.645 0 CA-C-N 120.033 1.288 . . . . 0.0 111.55 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -142.57 99.75 3.55 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 177.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.96 122.08 31.96 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.045 0.45 . . . . 0.0 110.676 -171.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.9 p -140.12 121.19 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -169.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -92.85 123.63 36.26 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.189 0.596 . . . . 0.0 109.985 -175.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.2 p -132.84 128.65 37.13 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -164.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.5 t -93.39 108.68 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -175.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.3 t -96.56 127.09 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -172.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -115.52 132.16 56.71 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 168.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.9 tp -98.67 108.62 21.36 Favored 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -102.79 125.5 49.56 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.78 0.8 . . . . 0.0 109.159 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.09 11.13 66.57 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 121.173 3.229 . . . . 0.0 121.173 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.274 25.9 m-20 57.77 43.52 21.77 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -166.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -158.65 -38.79 0.06 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 117.744 -1.122 . . . . 0.0 114.0 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -103.99 119.33 38.71 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 120.458 1.481 . . . . 0.0 110.411 -172.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.6 mt -101.03 99.46 9.92 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 174.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.1 t -100.68 110.59 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -170.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.6 t -137.26 159.58 41.51 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 122.863 1.316 . . . . 0.0 113.629 -167.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 58.9 m -80.47 -78.42 0.17 Allowed 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.914 -161.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 65.0 171.38 0.2 Allowed 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 119.613 1.097 . . . . 0.0 113.749 -169.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -79.21 95.06 5.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.195 -0.94 . . . . 0.0 108.569 165.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 55.8 t30 47.44 47.41 17.16 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.9 mt -137.81 88.54 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 102.926 -2.99 . . . . 0.0 102.926 174.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -84.5 98.41 10.09 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -174.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.9 t -96.62 117.65 31.42 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.933 -165.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 56.1 t -113.36 101.83 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 104.832 -2.285 . . . . 0.0 104.832 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.7 m -98.36 83.96 3.14 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -89.99 130.97 36.12 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.967 0.907 . . . . 0.0 110.214 -172.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 tt -101.27 110.38 22.38 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -110.68 85.52 2.13 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -174.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.82 -108.31 2.72 Favored Glycine 0 N--CA 1.483 1.771 0 O-C-N 122.081 -0.387 . . . . 0.0 112.952 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -121.36 56.5 1.04 Allowed 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.337 0.589 . . . . 0.0 111.188 168.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.8 pt -131.39 -166.11 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.687 0 C-N-CA 124.331 1.052 . . . . 0.0 108.522 161.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.6 tt -154.62 123.04 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.305 0 O-C-N 120.196 -1.565 . . . . 0.0 108.545 158.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 46.1 m -101.64 103.13 13.92 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 -176.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -93.0 98.56 11.43 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.5 m -99.34 87.25 3.58 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.662 0.744 . . . . 0.0 109.018 -171.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 33.5 mtt -92.46 105.43 17.61 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.129 0.972 . . . . 0.0 109.704 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.9 p -98.89 101.27 12.61 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -172.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.5 tp -95.25 83.77 3.93 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.57 -97.31 0.78 Allowed Glycine 0 CA--C 1.543 1.83 0 CA-C-N 116.437 -0.347 . . . . 0.0 112.685 -171.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -106.95 -9.3 16.31 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.319 1.599 . . . . 0.0 115.319 169.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 48.5 mt -85.75 107.31 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-N 120.692 1.587 . . . . 0.0 107.091 -173.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.3 t -94.7 95.61 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -174.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -86.74 100.75 12.72 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.905 0.882 . . . . 0.0 109.245 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -111.18 107.72 17.15 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.76 -172.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -99.72 114.33 27.37 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 75.6 mt -102.75 103.09 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 -177.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.4 m -120.47 114.98 22.58 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -171.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -84.2 135.83 34.2 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.172 0.589 . . . . 0.0 112.168 -168.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -69.91 133.46 47.35 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-O 122.014 0.912 . . . . 0.0 112.184 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.7 pt . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 -172.281 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 CA--C 1.553 1.079 0 CA-C-O 119.01 -0.519 . . . . 0.0 110.771 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.365 90.7 m-85 80.39 -35.4 0.13 Allowed 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 117.381 2.363 . . . . 0.0 117.381 173.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.9 m -71.94 107.22 4.57 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 120.496 1.498 . . . . 0.0 111.248 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.69 161.31 24.28 Favored Glycine 0 CA--C 1.544 1.88 0 CA-C-O 122.652 1.14 . . . . 0.0 114.044 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -96.58 125.67 41.21 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 168.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -121.05 116.66 25.45 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -174.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -91.83 125.78 36.67 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 122.943 0.497 . . . . 0.0 110.092 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 28.6 tp -64.02 131.79 48.64 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.75 0.82 . . . . 0.0 112.781 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -126.33 -58.22 1.36 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 118.569 -0.729 . . . . 0.0 110.742 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.8 m -107.35 136.99 46.22 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 119.067 0.849 . . . . 0.0 109.664 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -139.53 106.35 5.4 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -96.47 134.2 39.95 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.081 0.952 . . . . 0.0 109.365 176.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.26 13.5 m-20 66.67 47.65 1.55 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 174.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -77.82 -49.51 14.15 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 176.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -62.79 -46.78 86.41 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 177.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.74 -42.39 93.06 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 173.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -72.49 -52.8 14.17 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -52.09 66.81 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -56.92 -39.24 74.09 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 171.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.12 -37.48 87.59 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 116.588 2.069 . . . . 0.0 116.588 174.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.278 48.5 pt -77.36 -48.88 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-N 119.516 1.053 . . . . 0.0 112.955 175.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.81 57.72 0.01 OUTLIER Glycine 0 N--CA 1.483 1.815 0 CA-C-N 119.473 1.033 . . . . 0.0 114.5 166.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -110.3 154.03 43.1 Favored Pre-proline 0 CA--C 1.566 1.575 0 CA-C-N 118.009 0.904 . . . . 0.0 112.084 -175.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.16 154.93 33.0 Favored 'Trans proline' 0 CA--C 1.557 1.659 0 C-N-CA 123.296 2.664 . . . . 0.0 113.384 172.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -61.62 -35.49 78.04 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 170.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.05 -54.18 50.03 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 173.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.6 mt -70.97 -24.07 62.34 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 116.558 2.058 . . . . 0.0 116.558 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 60.6 mt -70.2 -52.14 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-N 119.94 1.245 . . . . 0.0 110.974 169.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -62.84 -19.7 64.36 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 116.912 2.19 . . . . 0.0 116.912 173.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -81.38 -53.91 5.91 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-N 119.483 1.038 . . . . 0.0 112.182 167.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.45 -7.2 57.36 Favored Glycine 0 CA--C 1.553 2.463 0 N-CA-C 120.279 2.872 . . . . 0.0 120.279 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.77 -47.03 61.73 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 120.21 2.005 . . . . 0.0 113.273 170.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -69.43 -31.91 70.56 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 168.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.2 mt -78.29 119.79 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -85.13 116.25 23.39 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.86 131.16 10.59 Favored Glycine 0 CA--C 1.54 1.608 0 CA-C-N 116.096 -0.502 . . . . 0.0 113.723 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.8 t -81.26 114.53 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 175.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.2 m -96.51 110.98 23.26 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 176.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.39 141.3 30.64 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.81 0.814 . . . . 0.0 109.954 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 67.2 mt -141.53 132.34 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 170.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.8 t -120.87 113.39 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 174.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -82.41 123.73 29.4 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.262 0.625 . . . . 0.0 110.168 173.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -128.07 72.02 1.4 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 163.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.88 -114.43 5.29 Favored Glycine 0 CA--C 1.545 1.933 0 C-N-CA 123.4 0.524 . . . . 0.0 113.385 -177.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -77.53 -33.51 54.22 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 167.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -76.54 102.94 6.27 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 120.072 1.305 . . . . 0.0 111.008 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -109.13 109.21 20.14 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.95 127.89 44.98 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 168.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -116.34 152.14 34.49 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.747 178.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.1 m -136.28 92.63 2.8 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 173.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.8 mm -91.12 116.61 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 -175.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.4 m -93.91 102.14 14.24 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -174.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -92.06 140.9 29.18 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 162.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -44.57 -39.02 5.67 Favored Glycine 0 CA--C 1.555 2.581 0 N-CA-C 119.805 2.682 . . . . 0.0 119.805 175.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.5 t -69.44 -59.74 2.79 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 168.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -145.49 135.12 23.34 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 119.223 0.92 . . . . 0.0 109.913 -176.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.7 p -75.7 125.18 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 123.482 0.713 . . . . 0.0 110.236 169.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.4 mt -119.71 110.51 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 -173.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -117.09 130.72 56.83 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.768 0.827 . . . . 0.0 110.966 -176.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -148.31 149.13 31.27 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.553 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -118.4 128.36 54.55 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.826 0.85 . . . . 0.0 110.222 -176.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -116.12 144.47 44.11 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.962 0.905 . . . . 0.0 111.425 170.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.2 m -105.3 124.11 48.98 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 166.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.4 t -67.04 124.88 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 C-N-CA 123.735 0.814 . . . . 0.0 110.662 -174.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.18 -49.97 2.45 Favored Glycine 0 CA--C 1.549 2.167 0 N-CA-C 115.999 1.16 . . . . 0.0 115.999 -170.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -93.22 124.13 36.98 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.728 0.811 . . . . 0.0 110.231 -172.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -57.44 123.81 16.75 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 -168.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 72.6 m -144.08 146.53 32.88 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.099 0.96 . . . . 0.0 109.609 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -80.04 134.59 36.23 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.2 mt -130.04 127.4 39.84 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 175.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -85.22 141.73 29.93 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.423 0.63 . . . . 0.0 111.473 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.2 p -73.06 172.95 10.07 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.767 164.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 90.3 mtp -61.06 -53.83 52.29 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.555 -1.341 . . . . 0.0 114.142 175.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.6 p -127.54 111.02 13.31 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 167.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 173.26 -108.11 0.27 Allowed Glycine 0 CA--C 1.535 1.335 0 N-CA-C 111.979 -0.449 . . . . 0.0 111.979 175.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -149.79 151.17 33.12 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.613 0.721 . . . . 0.0 109.544 -168.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 49.5 mttm -71.4 103.56 2.94 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.393 1.092 . . . . 0.0 109.685 167.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.8 p -114.39 134.52 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 113.157 -1.838 . . . . 0.0 108.773 -164.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -78.02 106.39 9.85 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.14 0.576 . . . . 0.0 110.794 -171.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.6 t -152.64 130.81 11.94 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -173.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.25 145.26 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 123.374 1.559 . . . . 0.0 110.587 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.8 t -98.49 142.18 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.302 0 CA-C-N 112.985 -1.916 . . . . 0.0 108.347 -167.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -112.48 132.98 54.79 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 172.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.7 tp -98.07 109.71 22.42 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.841 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -95.65 114.93 26.73 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 122.127 0.965 . . . . 0.0 108.929 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.44 -128.64 10.65 Favored Glycine 0 CA--C 1.545 1.919 0 CA-C-N 114.019 -1.446 . . . . 0.0 112.265 -168.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -135.82 58.55 1.75 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 156.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -158.49 -32.0 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -173.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -114.39 106.21 14.03 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 120.925 1.693 . . . . 0.0 108.976 -174.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 42.4 mt -95.78 103.91 15.81 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.0 m -102.35 125.56 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 C-N-CA 123.372 0.669 . . . . 0.0 109.87 -172.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 t -149.66 151.43 33.71 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.324 0.583 . . . . 0.0 111.771 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 29.7 p -119.71 112.72 19.64 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.405 0.682 . . . . 0.0 109.215 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -83.38 37.43 0.56 Allowed 'General case' 0 CA--C 1.58 2.106 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 168.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.344 11.8 tmtt? 69.99 -81.04 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.952 1.301 . . . . 0.0 111.236 -163.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -81.14 -42.6 20.63 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.8 mp -85.64 123.05 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-N 119.585 1.084 . . . . 0.0 108.167 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -102.57 98.77 8.78 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 172.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.9 t -89.67 132.88 34.94 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.478 0.711 . . . . 0.0 110.958 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.1 t -132.95 102.3 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 20.6 m -93.14 95.71 9.58 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -80.84 145.21 31.51 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.111 0.964 . . . . 0.0 110.703 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.2 tt -128.35 109.37 11.38 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 174.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -113.21 80.49 1.36 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -175.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.93 -109.24 3.26 Favored Glycine 0 N--CA 1.484 1.861 0 O-C-N 121.835 -0.541 . . . . 0.0 113.068 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.47 50.39 0.95 Allowed 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 122.965 0.506 . . . . 0.0 111.362 173.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.6 pt -133.8 -168.74 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.786 0 C-N-CA 124.047 0.939 . . . . 0.0 108.938 171.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.1 tt -156.85 115.44 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.272 -1.517 . . . . 0.0 107.45 159.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 90.0 m -103.15 99.7 9.58 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -90.19 108.81 19.98 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 39.7 m -108.48 100.14 9.45 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 -173.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.8 mtt -101.28 100.39 10.89 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.2 p -88.65 113.38 24.16 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.009 -173.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.3 tp -117.87 75.43 1.0 Allowed 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.35 -107.4 2.34 Favored Glycine 0 CA--C 1.545 1.958 0 CA-C-N 116.404 -0.362 . . . . 0.0 112.369 -172.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -93.62 -10.7 33.7 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 167.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 61.8 mt -86.52 103.67 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -173.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 48.4 t -97.81 97.78 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -85.55 96.33 9.6 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.163 0.585 . . . . 0.0 109.446 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -105.26 101.67 11.19 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -176.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.6 113.98 27.22 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 50.2 mt -107.02 112.91 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -172.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 54.5 m -114.76 119.03 35.26 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 176.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -83.81 147.3 27.66 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.965 -0.459 . . . . 0.0 110.937 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -76.03 107.18 8.06 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 121.538 0.685 . . . . 0.0 111.295 -169.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.7 mt . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 102.336 -3.209 . . . . 0.0 102.336 -158.505 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.5 t . . . . . 0 CA--C 1.55 0.947 0 CA-C-O 121.249 0.547 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -65.8 -17.24 64.5 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 117.569 2.433 . . . . 0.0 117.569 174.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.2 m -69.39 112.26 5.81 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 120.822 1.646 . . . . 0.0 110.792 173.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.03 145.22 4.95 Favored Glycine 0 CA--C 1.541 1.675 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.062 -171.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -102.21 106.8 17.69 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -107.64 104.05 13.49 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -162.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -83.19 131.24 35.13 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.123 0.487 . . . . 0.0 111.633 -177.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.9 tp -76.14 115.71 16.13 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.675 -168.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -98.6 -65.24 0.97 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.507 0.723 . . . . 0.0 111.444 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.0 m -131.89 135.66 46.83 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.245 0.618 . . . . 0.0 110.336 -163.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -129.29 134.68 48.05 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.649 0.737 . . . . 0.0 109.799 -175.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -76.28 -58.55 3.22 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.356 171.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -127.35 68.94 1.29 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.584 0.629 . . . . 0.0 110.799 -176.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -75.12 -54.26 7.45 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.526 -0.734 . . . . 0.0 112.553 170.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -65.21 -49.55 69.3 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.22 -39.21 82.0 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 116.89 2.182 . . . . 0.0 116.89 174.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -65.96 -54.07 30.89 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 174.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 37.4 mtt -60.7 -45.61 93.52 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -55.67 -42.1 74.63 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 167.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.4 -34.47 78.02 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 117.06 2.244 . . . . 0.0 117.06 175.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.7 pt -78.48 -43.94 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-N 119.822 1.192 . . . . 0.0 113.599 175.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.36 62.78 0.09 OUTLIER Glycine 0 N--CA 1.481 1.664 0 CA-C-N 118.881 0.764 . . . . 0.0 112.682 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.42 151.33 46.8 Favored Pre-proline 0 CA--C 1.568 1.649 0 C-N-CA 123.8 0.84 . . . . 0.0 110.745 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -75.65 156.99 40.21 Favored 'Trans proline' 0 CA--C 1.555 1.559 0 C-N-CA 123.264 2.642 . . . . 0.0 113.637 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -60.35 -29.53 68.96 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.692 1.738 . . . . 0.0 115.692 168.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -60.2 -57.75 11.48 Favored 'General case' 0 CA--C 1.564 1.495 0 CA-C-O 117.297 -1.335 . . . . 0.0 113.803 169.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.8 mt -68.69 -24.16 64.47 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 117.19 2.293 . . . . 0.0 117.19 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.4 mt -73.38 -54.29 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-N 119.491 1.042 . . . . 0.0 110.711 173.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -69.18 -27.85 65.88 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 177.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -76.69 -53.77 7.54 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.04 0.936 . . . . 0.0 112.109 171.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.9 -19.78 69.99 Favored Glycine 0 CA--C 1.551 2.316 0 N-CA-C 119.652 2.621 . . . . 0.0 119.652 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -65.72 -43.71 88.24 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 120.251 2.025 . . . . 0.0 114.434 170.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -68.4 -31.47 70.83 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 170.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.9 mt -77.33 129.86 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-N 119.532 1.06 . . . . 0.0 108.508 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.52 94.97 9.94 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 171.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.12 131.06 10.36 Favored Glycine 0 N--CA 1.481 1.635 0 CA-C-N 116.558 -0.292 . . . . 0.0 113.322 -172.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.7 t -79.75 120.81 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.9 m -108.29 100.21 9.54 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 107.167 -1.419 . . . . 0.0 107.167 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -83.89 147.9 27.26 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.842 0.829 . . . . 0.0 111.011 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.9 mt -143.91 129.42 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 172.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 67.8 t -120.88 117.49 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 176.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -81.2 122.11 26.98 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.404 0.681 . . . . 0.0 111.31 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -131.0 64.11 1.58 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 171.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.58 -113.73 5.9 Favored Glycine 0 CA--C 1.547 2.059 0 O-C-N 121.629 -0.669 . . . . 0.0 113.746 -174.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -73.29 -40.46 64.54 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 169.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -69.63 135.59 50.12 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 119.407 1.003 . . . . 0.0 111.387 175.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -127.6 108.72 11.02 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -87.04 92.59 9.1 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.673 0.749 . . . . 0.0 109.017 176.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -104.64 136.5 44.05 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.42 -175.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.8 m -131.55 102.58 5.98 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -177.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.6 mm -95.22 105.08 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.1 t -105.05 102.3 11.81 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 174.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -106.11 86.39 2.36 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.28 -107.49 2.63 Favored Glycine 0 CA--C 1.541 1.688 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.852 -176.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 63.2 m -87.95 -47.76 8.31 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -75.21 133.6 41.37 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 119.438 1.017 . . . . 0.0 111.698 -174.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.5 t -117.95 109.21 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 -175.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.8 mp -104.36 97.12 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 -174.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.78 120.85 42.22 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.203 0.601 . . . . 0.0 110.538 -177.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -149.62 161.33 42.38 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.175 0.99 . . . . 0.0 109.968 -175.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -117.47 128.58 55.13 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.57 0.748 . . . . 0.0 109.871 175.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.418 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 18.2 p90 -107.89 145.07 34.25 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.467 0.651 . . . . 0.0 110.392 158.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.4 m -109.15 131.89 54.64 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 171.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.2 t -73.55 130.1 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 123.797 0.839 . . . . 0.0 109.702 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.27 8.52 87.52 Favored Glycine 0 CA--C 1.553 2.452 0 N-CA-C 118.706 2.242 . . . . 0.0 118.706 -170.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -139.73 135.7 33.41 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 119.272 1.536 . . . . 0.0 108.251 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.75 121.93 18.18 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.257 0.623 . . . . 0.0 112.5 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 63' ' ' PHE . 0.9 OUTLIER -136.86 126.85 25.93 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.693 0.797 . . . . 0.0 110.479 -165.502 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.3 128.3 34.09 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.03 -0.987 . . . . 0.0 111.685 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.9 mt -129.36 112.71 14.11 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -175.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -71.81 121.27 18.67 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.5 0.72 . . . . 0.0 110.191 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.1 p -83.11 171.07 14.11 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.818 0.818 . . . . 0.0 111.703 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 17.2 ptt? -55.1 -44.07 74.59 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 117.136 2.273 . . . . 0.0 117.136 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 48.9 p -73.67 -63.44 1.2 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 118.584 0.629 . . . . 0.0 111.598 168.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 152.96 92.92 0.09 OUTLIER Glycine 0 N--CA 1.478 1.467 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -155.69 119.66 4.52 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -88.84 109.49 20.25 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 170.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.7 m -80.54 -47.43 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -168.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . 0.265 53.9 mtpt 64.36 86.32 0.13 Allowed 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 124.821 1.248 . . . . 0.0 111.648 -172.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.7 t -134.68 147.17 50.06 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.707 0.803 . . . . 0.0 110.033 -171.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.8 t -85.5 -56.98 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.776 -0.578 . . . . 0.0 111.427 -169.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . 0.307 3.1 t 80.25 127.24 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 125.382 1.473 . . . . 0.0 109.866 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -121.26 135.17 55.16 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 39.2 tp -96.68 102.57 14.37 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -86.23 114.43 23.05 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 121.799 0.809 . . . . 0.0 109.309 173.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.53 -122.42 8.54 Favored Glycine 0 CA--C 1.542 1.724 0 CA-C-N 114.394 -1.276 . . . . 0.0 112.89 -175.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -142.04 60.42 1.46 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 155.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -151.51 -39.29 0.12 Allowed 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 117.267 -1.349 . . . . 0.0 114.218 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -106.27 126.65 52.49 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 120.686 1.584 . . . . 0.0 110.288 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 37.2 mt -107.74 100.0 9.43 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 165.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.8 m -94.9 122.85 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 123.876 0.871 . . . . 0.0 109.274 -172.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.2 t -152.51 132.82 13.65 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 120.92 0.39 . . . . 0.0 111.907 -172.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 44.8 p -100.58 121.54 41.78 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -84.18 -70.74 0.55 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.031 0.532 . . . . 0.0 111.339 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -120.7 -77.3 0.58 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 165.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -126.74 66.98 1.25 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 159.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 62.9 mt -142.33 101.21 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 103.411 -2.811 . . . . 0.0 103.411 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -88.08 98.4 11.51 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.345 0.593 . . . . 0.0 109.571 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.3 t -88.25 102.64 15.02 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.307 1.043 . . . . 0.0 109.947 -176.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.7 t -101.0 97.23 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 -177.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.9 m -91.65 83.49 5.33 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -168.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -98.66 129.13 45.14 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.626 0.77 . . . . 0.0 110.129 -161.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 tt -113.09 114.07 26.31 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -167.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -119.27 103.33 9.41 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.01 -118.18 4.65 Favored Glycine 0 N--CA 1.484 1.862 0 C-N-CA 123.123 0.392 . . . . 0.0 112.714 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -124.93 60.16 1.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.986 0.898 . . . . 0.0 110.107 161.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.6 pt -123.62 -164.64 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.789 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 157.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.3 tt -155.9 125.19 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 120.147 -1.596 . . . . 0.0 108.283 160.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 88.9 m -109.76 98.65 7.95 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -93.86 123.79 37.44 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.371 0.605 . . . . 0.0 109.691 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 27.8 m -114.59 93.84 4.51 Favored 'General case' 0 CA--C 1.557 1.236 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 -170.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 63.5 mtt -93.22 99.81 12.3 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.813 0.845 . . . . 0.0 109.102 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 73.8 p -94.84 100.22 12.14 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -171.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 35.0 tp -96.4 84.96 3.81 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.31 -100.0 0.93 Allowed Glycine 0 CA--C 1.544 1.881 0 CA-C-N 116.743 -0.208 . . . . 0.0 112.852 -174.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -102.36 -10.5 19.4 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 169.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 71.9 mt -87.09 108.19 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-N 120.601 1.546 . . . . 0.0 107.453 -172.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.3 t -97.83 93.13 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -172.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -82.84 109.18 16.75 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 122.967 0.507 . . . . 0.0 110.285 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -88.77 142.79 27.37 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.818 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 45.7 mtm180 -134.62 93.57 3.06 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 174.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 58.3 mt -94.73 104.87 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 105.499 -2.038 . . . . 0.0 105.499 -174.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.5 m -130.75 112.92 13.51 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -163.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -90.87 138.95 31.2 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.351 0.595 . . . . 0.0 112.186 -172.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.2 136.71 56.29 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 123.748 0.819 . . . . 0.0 113.114 -177.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.9 pt . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 -175.53 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 87.7 p . . . . . 0 CA--C 1.551 1.006 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -87.45 -152.52 0.2 Allowed 'General case' 0 CA--C 1.57 1.74 0 C-N-CA 123.517 0.727 . . . . 0.0 110.17 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.2 m 62.0 88.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.04 1.336 . . . . 0.0 112.848 -176.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.44 167.05 31.93 Favored Glycine 0 CA--C 1.54 1.646 0 CA-C-O 122.993 1.33 . . . . 0.0 115.095 -177.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -94.26 122.22 36.58 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 113.313 -1.444 . . . . 0.0 107.658 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -114.62 105.58 13.24 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -175.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -77.58 117.09 18.67 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.121 0.969 . . . . 0.0 111.052 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 55.5 tp -69.67 107.15 3.33 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.112 0.565 . . . . 0.0 112.185 -174.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -85.89 -58.86 2.48 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.903 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.2 t -134.14 142.32 47.43 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.682 0.793 . . . . 0.0 110.016 -169.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -120.97 133.88 55.28 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.841 0.829 . . . . 0.0 108.931 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -76.03 -61.86 1.8 Allowed 'General case' 0 CA--C 1.561 1.387 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.835 169.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -128.28 67.89 1.36 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 118.628 0.649 . . . . 0.0 111.132 -172.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -75.06 -52.08 11.94 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 175.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -66.74 -43.22 84.75 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 -175.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.25 -44.0 95.64 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 169.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -67.82 -51.93 42.85 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.28 -49.07 75.31 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -60.97 -42.35 98.16 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 171.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.64 -29.61 69.67 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 117.242 2.312 . . . . 0.0 117.242 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.267 37.8 pt -77.29 -48.84 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 120.1 1.318 . . . . 0.0 112.587 171.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 137.22 65.13 0.05 OUTLIER Glycine 0 CA--C 1.541 1.686 0 C-N-CA 123.826 0.727 . . . . 0.0 112.312 175.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.4 mt -131.25 147.74 67.4 Favored Pre-proline 0 CA--C 1.568 1.64 0 C-N-CA 123.958 0.903 . . . . 0.0 110.437 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.44 149.04 80.25 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 123.39 2.727 . . . . 0.0 114.397 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -59.47 -28.09 66.69 Favored 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 171.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -61.95 -46.43 89.35 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 166.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.14 -16.49 64.02 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 116.984 2.216 . . . . 0.0 116.984 167.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 72.9 mt -74.62 -55.35 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-N 120.414 1.461 . . . . 0.0 110.534 168.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -67.2 -29.28 68.91 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -75.73 -56.4 4.72 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 119.546 1.066 . . . . 0.0 111.517 168.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.22 -19.74 59.85 Favored Glycine 0 CA--C 1.55 2.223 0 N-CA-C 120.619 3.008 . . . . 0.0 120.619 178.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -67.16 -44.84 78.74 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 119.654 1.727 . . . . 0.0 113.852 168.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -68.71 -37.95 79.89 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 169.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.6 mt -74.33 126.41 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 119.455 1.025 . . . . 0.0 108.355 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.08 99.25 11.36 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.69 111.48 3.72 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-N 116.023 -0.535 . . . . 0.0 113.13 -172.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.7 t -67.15 129.26 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 123.813 0.845 . . . . 0.0 110.481 -176.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.0 p -98.82 105.7 17.88 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -86.61 151.06 23.77 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.473 176.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.6 mt -140.84 138.8 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.7 t -129.8 103.93 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 171.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -90.22 113.13 24.88 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 172.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -121.64 62.63 0.92 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.173 0.589 . . . . 0.0 109.523 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.12 -111.53 3.86 Favored Glycine 0 CA--C 1.546 1.975 0 O-C-N 121.852 -0.53 . . . . 0.0 113.161 -173.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -75.65 -43.0 49.93 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 169.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -73.73 110.73 8.26 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 119.42 1.009 . . . . 0.0 109.814 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.61 97.47 2.98 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -155.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.27 160.35 19.88 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.019 0.928 . . . . 0.0 111.463 -172.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -145.38 130.35 18.3 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.796 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.4 m -99.83 93.88 6.03 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 174.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.9 tp -86.6 118.55 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.4 p -96.38 95.43 8.05 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 174.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -90.18 86.2 6.47 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.343 0.592 . . . . 0.0 110.522 -171.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.32 -98.3 1.11 Allowed Glycine 0 CA--C 1.54 1.654 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.297 -170.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.4 t -127.08 81.46 2.02 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 163.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.99 100.18 0.87 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 178.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -85.44 114.54 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -174.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.6 mt -130.49 104.92 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 -167.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -92.94 120.62 33.45 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 167.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -123.32 113.23 18.58 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -176.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -97.98 124.11 42.29 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.321 0.648 . . . . 0.0 109.256 -171.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -125.12 149.81 47.5 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.567 0.698 . . . . 0.0 111.351 176.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.0 m -105.94 132.17 52.36 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 168.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.8 t -79.53 119.35 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 175.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.32 0.22 73.86 Favored Glycine 0 CA--C 1.556 2.609 0 N-CA-C 118.885 2.314 . . . . 0.0 118.885 -171.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -145.46 132.14 19.95 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 120.278 2.039 . . . . 0.0 108.605 167.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -73.08 113.26 9.93 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -174.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 90.9 m -96.72 156.02 16.53 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.745 173.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -77.66 101.65 6.7 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.455 0.702 . . . . 0.0 111.145 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.6 mt -109.95 129.18 55.7 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.299 0.571 . . . . 0.0 110.942 -165.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.6 pm0 -83.61 141.86 31.23 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.499 174.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.0 p -67.99 -65.88 0.64 Allowed 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 123.097 0.559 . . . . 0.0 111.732 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 21.7 mmt -118.1 -72.8 0.67 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 155.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.5 t -149.15 119.32 7.24 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 163.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 149.67 -75.84 0.25 Allowed Glycine 0 N--CA 1.48 1.624 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.572 -174.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.6 99.44 10.18 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.166 0.586 . . . . 0.0 110.737 -171.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -91.28 105.66 17.95 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.9 127.78 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -169.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -75.96 119.68 20.25 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.368 0.604 . . . . 0.0 111.383 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.7 t -145.9 141.6 27.96 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.485 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.14 136.4 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-O 122.515 1.15 . . . . 0.0 109.311 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.5 t -91.0 129.84 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.256 0 CA-C-N 113.833 -1.53 . . . . 0.0 107.833 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -100.56 134.97 42.72 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.062 0.935 . . . . 0.0 109.112 171.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.5 tp -97.84 102.66 14.47 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 114.352 -1.294 . . . . 0.0 107.961 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -101.55 116.96 33.94 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.91 11.38 85.55 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 120.946 3.138 . . . . 0.0 120.946 171.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.283 20.3 m-20 57.85 43.29 21.88 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -165.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -158.63 -43.55 0.06 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 118.118 -0.944 . . . . 0.0 113.521 -177.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -95.8 138.43 33.46 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 120.142 1.337 . . . . 0.0 111.237 -175.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.0 mt -123.36 101.91 7.62 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 172.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.2 m -106.27 117.53 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 123.439 0.696 . . . . 0.0 109.181 -171.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.6 t -151.7 142.1 22.51 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 122.421 0.288 . . . . 0.0 111.346 -175.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 83.7 m -120.68 113.53 20.35 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -70.03 -76.82 0.09 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.796 0.838 . . . . 0.0 111.42 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -120.97 -72.58 0.68 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 165.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -128.73 60.17 1.53 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 118.662 0.665 . . . . 0.0 109.69 161.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 77.0 mt -131.47 97.5 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 102.615 -3.106 . . . . 0.0 102.615 172.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -92.02 91.07 7.67 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.7 t -84.41 109.62 18.01 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.983 0.913 . . . . 0.0 109.377 -174.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 72.0 t -116.77 97.16 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 -175.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.0 m -110.68 87.1 2.45 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -166.074 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -91.92 133.8 35.36 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.131 0.972 . . . . 0.0 110.621 -174.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.4 tt -102.36 110.01 21.83 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -175.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -110.51 90.47 3.33 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -172.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.71 -109.91 2.91 Favored Glycine 0 CA--C 1.544 1.85 0 CA-C-O 119.926 -0.374 . . . . 0.0 113.03 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -121.51 53.16 1.19 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.304 0.573 . . . . 0.0 111.694 167.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.4 pt -126.77 -165.44 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.799 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 159.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.5 tt -154.26 124.89 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 O-C-N 120.532 -1.355 . . . . 0.0 108.37 160.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 55.4 m -100.76 97.78 8.38 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -91.08 104.28 16.88 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.8 m -108.57 93.18 4.38 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -176.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 49.6 mtt -93.02 105.15 17.3 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.726 0.81 . . . . 0.0 109.098 177.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.4 p -95.33 100.64 12.39 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 51.3 tp -94.66 82.92 3.99 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 175.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.21 -99.75 0.9 Allowed Glycine 0 CA--C 1.542 1.751 0 CA-C-N 116.288 -0.415 . . . . 0.0 113.104 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -98.59 -15.9 19.3 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 170.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 62.4 mt -83.77 107.67 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 120.343 1.428 . . . . 0.0 107.563 -173.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.8 t -95.71 96.5 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -88.87 99.04 12.08 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.981 0.512 . . . . 0.0 109.999 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -102.27 109.67 21.41 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.046 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 25.2 mtm180 -101.64 125.79 48.36 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.73 0.812 . . . . 0.0 108.864 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.59 103.39 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 104.74 -2.318 . . . . 0.0 104.74 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 54.8 m -120.78 114.82 22.19 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 122.686 0.394 . . . . 0.0 110.065 -173.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -92.64 133.03 36.39 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.127 0.571 . . . . 0.0 111.628 -170.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -66.47 136.69 56.07 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 121.789 0.804 . . . . 0.0 113.087 -174.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.7 pt . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 -175.393 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.8 m . . . . . 0 CA--C 1.547 0.839 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -68.49 -18.52 64.41 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 117.489 2.403 . . . . 0.0 117.489 -177.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.7 m -70.44 109.67 4.91 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 121.093 1.769 . . . . 0.0 110.67 172.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.43 156.91 13.86 Favored Glycine 0 CA--C 1.543 1.79 0 CA-C-O 122.11 0.839 . . . . 0.0 113.873 -173.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.18 114.01 27.95 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 176.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -112.51 97.99 6.96 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -167.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -92.13 138.32 31.63 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.492 0.663 . . . . 0.0 111.003 -176.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.8 tp -74.78 126.46 30.95 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.515 -167.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.5 mm-40 -104.88 -64.68 1.1 Allowed 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.768 -175.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.5 m -129.36 140.36 51.4 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.657 0.783 . . . . 0.0 109.831 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -125.47 130.66 52.26 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.496 1.141 . . . . 0.0 110.841 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -99.44 129.12 45.6 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 113.594 -1.639 . . . . 0.0 107.221 168.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.251 69.8 m-20 67.28 40.47 2.75 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 170.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -67.64 -62.97 1.16 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.029 -1.044 . . . . 0.0 113.795 170.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -59.98 -34.98 74.03 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 117.18 2.289 . . . . 0.0 117.18 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.69 -47.17 84.81 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 166.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -65.99 -47.76 73.46 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -45.01 95.06 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 176.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -57.13 -48.26 79.11 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 166.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.71 -26.19 68.55 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 117.757 2.502 . . . . 0.0 117.757 177.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.3 pt -88.63 -49.28 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-N 119.178 0.899 . . . . 0.0 112.005 174.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 141.36 73.64 0.04 OUTLIER Glycine 0 CA--C 1.539 1.591 0 CA-C-N 118.903 0.774 . . . . 0.0 112.427 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.87 153.41 78.67 Favored Pre-proline 0 CA--C 1.571 1.763 0 C-N-CA 123.359 0.664 . . . . 0.0 112.602 176.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -76.44 158.78 36.46 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 123.354 2.703 . . . . 0.0 113.55 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -62.55 -31.6 72.41 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 169.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -60.06 -52.25 66.19 Favored 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 171.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 88.8 mt -72.43 -18.6 61.69 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 117.071 2.248 . . . . 0.0 117.071 175.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 93.3 mt -67.81 -61.28 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-N 119.631 1.105 . . . . 0.0 110.017 165.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -64.82 -25.27 67.83 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -78.58 -52.03 9.06 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.878 0.871 . . . . 0.0 112.376 171.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.78 -18.98 72.86 Favored Glycine 0 CA--C 1.551 2.33 0 N-CA-C 119.89 2.716 . . . . 0.0 119.89 177.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -65.06 -42.84 93.84 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 120.087 1.944 . . . . 0.0 114.732 169.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -66.46 -37.21 84.64 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 168.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.5 mt -72.01 115.46 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -85.98 106.72 17.36 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -174.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.04 131.76 10.91 Favored Glycine 0 CA--C 1.54 1.643 0 CA-C-N 115.966 -0.561 . . . . 0.0 114.471 -167.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.3 t -89.64 117.81 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 175.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.5 m -100.49 101.61 12.6 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 174.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.22 146.61 30.38 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.379 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 55.4 mt -142.1 123.3 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 104.5 -2.408 . . . . 0.0 104.5 174.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.6 t -115.54 108.87 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -93.99 120.31 34.07 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.012 0.525 . . . . 0.0 109.813 176.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 -122.25 74.85 1.19 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 164.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.42 -118.77 9.56 Favored Glycine 0 CA--C 1.548 2.127 0 C-N-CA 123.215 0.436 . . . . 0.0 113.757 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -75.47 -32.67 60.67 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 167.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -78.12 135.38 37.67 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 120.116 1.325 . . . . 0.0 111.592 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -137.19 150.77 48.13 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.97 0.89 . . . . 0.0 111.26 -175.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -136.78 115.15 11.78 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 161.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -107.41 125.72 51.58 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.559 173.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 50.8 m -119.44 99.92 6.98 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -173.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 88.1 mt -91.21 126.76 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.9 p -103.47 114.27 28.42 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 170.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -127.49 147.1 50.31 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.67 0.748 . . . . 0.0 110.081 178.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -53.84 -30.44 44.61 Favored Glycine 0 CA--C 1.555 2.586 0 N-CA-C 118.838 2.295 . . . . 0.0 118.838 167.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.6 m -68.45 -63.22 1.1 Allowed 'General case' 0 CA--C 1.565 1.521 0 CA-C-N 118.438 1.119 . . . . 0.0 112.994 165.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -155.08 136.24 13.91 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 119.338 0.972 . . . . 0.0 110.158 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.2 p -77.17 123.0 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 123.329 0.651 . . . . 0.0 109.755 166.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 80.5 mt -131.04 119.41 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -169.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -107.97 127.06 53.42 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.549 0.74 . . . . 0.0 109.057 173.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -139.61 142.69 37.05 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.137 0.975 . . . . 0.0 109.822 -170.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -126.64 148.77 49.77 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.146 0.974 . . . . 0.0 110.543 -176.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -151.65 144.78 24.61 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.537 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.3 m -101.91 132.19 47.85 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 164.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.8 t -75.93 131.71 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.57 0.7 . . . . 0.0 109.863 -175.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.85 6.18 89.19 Favored Glycine 0 CA--C 1.553 2.435 0 N-CA-C 118.669 2.228 . . . . 0.0 118.669 -169.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -137.32 140.75 41.71 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 119.233 1.517 . . . . 0.0 108.332 -175.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -76.62 117.0 17.82 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.147 0.579 . . . . 0.0 111.019 -173.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.6 p -126.42 149.43 49.27 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 122.335 1.064 . . . . 0.0 112.871 -162.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -84.82 118.88 24.74 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.271 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.72 142.61 22.98 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.654 0.781 . . . . 0.0 109.843 175.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -91.3 127.57 36.78 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.907 -172.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.8 t -68.91 173.79 5.03 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.954 0.883 . . . . 0.0 112.855 170.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 68.5 mtp -85.47 54.87 3.27 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.9 m -151.0 -76.71 0.14 Allowed 'General case' 0 CA--C 1.563 1.478 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 172.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 168.19 75.3 0.04 OUTLIER Glycine 0 CA--C 1.539 1.551 0 CA-C-N 118.593 0.633 . . . . 0.0 111.631 172.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -155.43 114.03 3.5 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -81.21 99.41 8.57 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 175.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.5 p -117.25 136.82 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 121.894 0.855 . . . . 0.0 110.489 -157.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -81.75 120.55 25.28 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.119 -177.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.4 t -148.07 135.5 20.6 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.932 0.493 . . . . 0.0 111.089 -167.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 75.5 t -88.99 119.44 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.1 t -104.28 112.54 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -116.3 143.41 45.57 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.803 0.811 . . . . 0.0 110.907 -176.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.6 tp -101.61 130.95 48.05 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.953 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -128.83 125.75 38.37 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 174.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.4 12.52 73.1 Favored Glycine 0 CA--C 1.55 2.265 0 N-CA-C 120.688 3.035 . . . . 0.0 120.688 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.268 24.2 m-20 58.74 37.92 24.98 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -167.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -160.84 -18.47 0.05 Allowed 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -176.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -119.1 101.22 7.85 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 121.101 1.773 . . . . 0.0 109.279 -171.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 79.3 mt -94.73 101.89 13.75 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 171.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.4 m -104.21 124.75 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 123.961 0.905 . . . . 0.0 108.744 -171.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.9 t -143.57 133.56 24.15 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.514 0.673 . . . . 0.0 111.425 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.8 t -131.79 134.67 46.07 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.211 1.005 . . . . 0.0 109.081 -175.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.334 14.2 p90 -136.03 -116.4 0.17 Allowed 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 118.612 -0.709 . . . . 0.0 109.497 -171.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -73.59 -68.5 0.5 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 119.6 1.091 . . . . 0.0 111.227 -178.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -126.86 -27.0 3.1 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 176.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 mp -86.34 121.95 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.574 0 CA-C-N 119.91 1.232 . . . . 0.0 108.417 -171.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -78.57 153.53 31.11 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.545 155.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.2 t -143.31 97.16 3.03 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 172.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 73.7 t -100.21 100.24 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.8 m -95.49 94.0 7.53 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -171.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -104.82 117.51 34.25 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.504 0.722 . . . . 0.0 109.073 -162.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 tt -106.47 117.8 34.99 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 -170.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -94.33 -99.77 0.15 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 118.236 -0.888 . . . . 0.0 108.88 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -103.05 -105.93 3.01 Favored Glycine 0 N--CA 1.485 1.912 0 CA-C-N 119.53 1.059 . . . . 0.0 111.276 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -96.39 49.26 1.11 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.074 0.464 . . . . 0.0 112.001 168.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.7 pt -142.38 -174.95 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.678 0 C-N-CA 124.64 1.176 . . . . 0.0 109.459 176.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.4 tt -150.1 127.69 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 120.917 -1.114 . . . . 0.0 108.719 161.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 29.8 m -103.61 92.24 4.37 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -88.7 106.81 18.59 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -177.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 39.1 m -111.9 97.49 6.72 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -169.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 46.0 mtt -98.48 104.26 16.28 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.351 0.66 . . . . 0.0 109.371 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 59.6 p -97.12 102.08 13.78 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.292 0.567 . . . . 0.0 109.765 -172.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 50.1 tp -101.51 83.94 2.52 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.45 -99.91 1.03 Allowed Glycine 0 CA--C 1.543 1.832 0 CA-C-N 116.437 -0.347 . . . . 0.0 112.793 -174.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -99.52 -16.34 18.34 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 169.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 70.1 mt -84.26 108.54 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-N 120.476 1.489 . . . . 0.0 107.86 -172.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.6 t -97.03 95.46 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -85.84 96.13 9.66 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.201 0.6 . . . . 0.0 109.739 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -104.36 106.54 17.08 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.871 -175.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -89.04 127.21 35.68 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.777 0.831 . . . . 0.0 109.014 170.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -108.64 104.01 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 174.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.5 m -127.92 116.73 20.55 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -171.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.256 17.3 ptpt -88.6 148.54 24.01 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 122.098 0.951 . . . . 0.0 113.538 -172.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -81.15 124.58 29.37 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.028 -172.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.0 pt . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 -169.499 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.8 t . . . . . 0 CA--C 1.549 0.93 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -69.02 -29.1 67.21 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 116.985 2.217 . . . . 0.0 116.985 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.6 p -65.74 125.31 24.89 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 120.77 1.623 . . . . 0.0 113.612 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 153.98 167.16 15.74 Favored Glycine 0 CA--C 1.545 1.946 0 CA-C-O 122.54 1.078 . . . . 0.0 113.862 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -89.88 145.12 25.37 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 114.243 -0.978 . . . . 0.0 109.994 169.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -142.01 104.87 4.56 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -175.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.6 tm0? -87.92 127.32 35.36 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.592 -0.693 . . . . 0.0 111.356 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 50.8 tp -69.75 109.79 4.58 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.888 0.875 . . . . 0.0 113.228 -174.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -100.19 -60.63 1.49 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.331 0.653 . . . . 0.0 112.231 -172.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.1 t -127.74 138.56 52.81 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.566 0.746 . . . . 0.0 110.28 -168.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -133.26 133.46 42.68 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.521 0.677 . . . . 0.0 109.706 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -74.18 -64.5 1.0 Allowed 'General case' 0 CA--C 1.561 1.38 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.773 168.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -122.29 67.1 0.93 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.217 0.607 . . . . 0.0 110.746 -174.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -75.23 -52.04 11.86 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.416 -0.803 . . . . 0.0 111.993 168.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -60.6 -46.44 90.26 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.09 -36.22 82.61 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 174.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -73.37 -55.88 5.8 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 119.973 1.261 . . . . 0.0 113.672 175.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.25 -42.94 82.47 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.4 tmtm? -62.99 -43.97 97.31 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 169.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.7 -29.01 69.07 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 117.688 2.477 . . . . 0.0 117.688 173.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.25 38.2 pt -82.59 -54.53 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 119.248 0.931 . . . . 0.0 111.844 173.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.32 67.11 0.01 OUTLIER Glycine 0 N--CA 1.479 1.564 0 CA-C-O 118.898 -0.946 . . . . 0.0 113.134 171.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.8 mt -130.38 146.08 60.15 Favored Pre-proline 0 CA--C 1.569 1.695 0 CA-C-N 117.918 0.859 . . . . 0.0 111.138 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -69.11 150.65 72.43 Favored 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 123.577 2.851 . . . . 0.0 114.791 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -52.61 -36.49 56.47 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 171.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -63.22 -53.27 55.65 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 171.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.7 mt -66.85 -24.91 66.2 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.707 2.114 . . . . 0.0 116.707 176.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 87.3 mt -67.42 -53.9 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 124.347 1.059 . . . . 0.0 111.142 170.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -61.34 -24.01 66.15 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 172.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -75.69 -59.19 2.86 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 119.594 1.088 . . . . 0.0 111.503 169.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.39 -21.44 59.96 Favored Glycine 0 CA--C 1.552 2.355 0 N-CA-C 119.947 2.739 . . . . 0.0 119.947 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -66.95 -46.23 75.35 Favored 'General case' 0 CA--C 1.569 1.702 0 CA-C-N 120.28 2.04 . . . . 0.0 114.202 170.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -71.55 -36.96 71.13 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 174.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.9 mt -66.77 135.22 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-N 119.687 1.131 . . . . 0.0 109.612 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -74.87 104.42 5.47 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.603 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -98.19 102.97 2.73 Favored Glycine 0 N--CA 1.478 1.436 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.805 -175.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.8 t -84.49 114.85 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -176.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.501 ' HG ' HG13 ' A' ' 52' ' ' ILE . 43.6 m -98.6 104.85 16.92 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.087 177.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.17 149.49 26.13 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.026 174.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 55.5 mt -140.42 131.52 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 172.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.4 t -119.03 101.78 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -83.17 115.84 22.1 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.966 0.507 . . . . 0.0 109.8 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -124.98 69.62 1.13 Allowed 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 167.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.07 -112.17 4.65 Favored Glycine 0 CA--C 1.546 2.01 0 C-N-CA 123.272 0.463 . . . . 0.0 113.699 -174.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -74.14 -33.4 63.53 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 171.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -79.31 129.33 34.36 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 119.276 0.944 . . . . 0.0 110.726 -177.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -132.05 105.82 7.63 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -177.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -95.24 106.24 18.25 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 170.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -104.31 120.23 40.73 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.017 174.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 78.7 m -108.45 91.98 3.87 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.501 HG13 ' HG ' ' A' ' 39' ' ' SER . 11.6 tt -99.32 120.86 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.362 -167.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.0 m -89.98 101.02 13.73 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.56 88.03 4.92 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.53 -108.99 2.66 Favored Glycine 0 CA--C 1.542 1.773 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.382 -173.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.5 t -86.59 -56.12 3.56 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 175.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -80.64 125.05 29.53 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 119.021 0.828 . . . . 0.0 111.342 -169.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.3 p -89.1 131.36 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 123.534 0.733 . . . . 0.0 110.93 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.4 mt -119.52 111.21 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 -167.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -89.07 126.15 35.32 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.39 0.614 . . . . 0.0 109.868 175.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -134.77 106.9 7.13 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -174.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.51 132.15 56.59 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.919 0.887 . . . . 0.0 110.389 -175.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -141.6 173.69 11.27 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.942 -172.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.0 m -127.58 132.91 49.77 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 166.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.3 m -68.66 132.47 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 122.979 0.511 . . . . 0.0 111.616 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 107.59 -58.09 0.42 Allowed Glycine 0 CA--C 1.545 1.952 0 CA-C-N 115.583 -0.735 . . . . 0.0 113.233 -160.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -85.92 148.49 25.76 Favored 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 124.117 0.967 . . . . 0.0 112.101 -172.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -83.6 117.07 22.91 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.844 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 77.3 m -116.1 147.99 40.74 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 122.07 0.938 . . . . 0.0 111.664 -174.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -84.24 97.82 9.62 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.847 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 61.5 mt -123.0 133.55 54.36 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.597 0.713 . . . . 0.0 109.679 -171.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -80.66 135.8 36.1 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.65 0.78 . . . . 0.0 111.468 -171.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.1 p -83.19 173.92 11.23 Favored 'General case' 0 CA--C 1.569 1.692 0 CA-C-O 121.784 0.802 . . . . 0.0 112.168 -175.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.0 mmt -59.81 -41.03 90.34 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 169.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 54.1 p -62.41 -51.84 65.96 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 162.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 139.19 166.28 10.55 Favored Glycine 0 CA--C 1.545 1.96 0 CA-C-O 122.692 1.162 . . . . 0.0 111.847 -168.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . 0.279 9.6 tm-20 76.31 139.91 0.07 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.109 1.364 . . . . 0.0 113.187 175.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -89.64 115.9 27.37 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.848 -176.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 19.5 m -100.19 -13.46 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 117.236 2.31 . . . . 0.0 117.236 -164.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . 0.25 93.4 mttt 76.85 112.4 0.07 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 121.06 1.755 . . . . 0.0 110.242 -173.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.4 t -150.02 129.82 13.3 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.121 0.568 . . . . 0.0 109.548 -168.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.2 t -100.64 118.34 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.6 t -102.74 135.97 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -115.87 155.06 28.61 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.513 0.673 . . . . 0.0 110.591 166.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.4 tp -106.29 103.57 13.07 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 173.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -103.25 120.1 40.12 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.66 6.27 84.54 Favored Glycine 0 CA--C 1.549 2.164 0 N-CA-C 120.744 3.058 . . . . 0.0 120.744 173.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.316 4.7 t70 71.92 -10.38 0.87 Allowed 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 -167.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -116.15 -18.34 10.61 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 116.574 2.065 . . . . 0.0 116.574 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -112.65 124.85 53.48 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 121.151 1.796 . . . . 0.0 109.784 -176.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 47.3 mt -103.31 103.07 13.05 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 166.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.8 t -101.53 118.92 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -167.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.5 t -149.45 155.68 40.8 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.536 0.684 . . . . 0.0 112.363 -173.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 91.9 m -122.06 107.72 12.54 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 174.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -71.81 -81.83 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.435 0.694 . . . . 0.0 111.143 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -139.3 87.9 2.23 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 170.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.259 70.2 m-80 53.56 43.28 31.43 Favored 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -169.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 44.0 mm -125.24 105.37 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 104.462 -2.421 . . . . 0.0 104.462 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -79.96 94.14 5.84 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.571 0.7 . . . . 0.0 109.653 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.6 t -106.42 95.91 6.09 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.478 -165.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 73.8 t -101.44 107.8 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.9 m -93.86 85.42 4.78 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -173.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -94.66 127.53 40.69 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.357 0.663 . . . . 0.0 109.717 -165.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 tt -112.86 111.12 21.66 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -173.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -98.94 -101.84 0.22 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 118.406 -0.807 . . . . 0.0 109.291 -170.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -87.15 -110.58 0.91 Allowed Glycine 0 N--CA 1.484 1.877 0 CA-C-N 119.698 1.135 . . . . 0.0 112.395 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -101.36 61.4 0.92 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.567 0.698 . . . . 0.0 110.145 166.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 11.9 pt -148.94 -176.77 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.759 0 C-N-CA 124.619 1.167 . . . . 0.0 108.927 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.1 tt -148.54 125.32 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 120.753 -1.217 . . . . 0.0 108.217 155.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.0 m -111.1 106.99 16.21 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.02 110.56 23.12 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 34.7 m -96.91 99.65 11.2 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -176.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 66.3 mtt -104.2 97.15 7.15 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 -176.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.9 p -96.44 113.58 25.17 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -174.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.2 tp -103.08 83.08 2.16 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 170.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.77 -103.69 1.25 Allowed Glycine 0 CA--C 1.545 1.952 0 N-CA-C 114.571 0.588 . . . . 0.0 114.571 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -82.09 -27.02 33.11 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 114.708 1.374 . . . . 0.0 114.708 171.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 29.7 mm -65.34 136.1 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.542 0 C-N-CA 124.904 1.281 . . . . 0.0 109.562 174.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.4 t -127.94 96.47 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 172.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -86.56 102.47 14.16 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -102.91 104.85 15.11 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -113.72 122.35 46.84 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.869 0.868 . . . . 0.0 109.199 -175.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.7 mp -111.14 102.95 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 -171.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.0 m -102.23 112.43 25.11 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -84.08 142.29 30.51 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.817 0.447 . . . . 0.0 110.774 -169.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -74.14 134.06 42.82 Favored 'General case' 0 CA--C 1.559 1.304 0 CA-C-O 121.916 0.865 . . . . 0.0 112.725 -169.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 45.0 mm . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 -162.581 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.4 m . . . . . 0 CA--C 1.549 0.907 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -69.19 -15.84 63.49 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 117.616 2.451 . . . . 0.0 117.616 -178.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 75.6 m -71.45 115.22 10.37 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 121.437 1.926 . . . . 0.0 111.025 172.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.44 160.29 19.64 Favored Glycine 0 CA--C 1.54 1.655 0 CA-C-O 122.217 0.898 . . . . 0.0 114.295 -175.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -111.14 106.56 15.63 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -111.48 105.77 14.46 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -162.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -93.18 135.63 34.2 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 122.941 0.496 . . . . 0.0 111.583 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.5 tp -71.46 115.04 10.17 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.478 0.711 . . . . 0.0 112.584 -171.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -99.23 -55.33 2.72 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.164 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.1 m -125.07 110.51 14.24 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -173.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -111.48 119.58 39.25 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 122.075 0.941 . . . . 0.0 109.844 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -109.2 120.29 42.07 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 170.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.259 69.1 m-80 67.37 50.49 0.95 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -175.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -72.13 -63.26 1.18 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.922 . . . . 0.0 111.289 162.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -65.58 -35.23 80.21 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 117.33 2.344 . . . . 0.0 117.33 -174.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.41 -45.57 93.76 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 166.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -65.11 -51.91 58.55 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 174.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 23.5 mmt -62.18 -43.02 99.77 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -176.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -60.15 -47.28 86.6 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 167.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.57 -29.5 70.63 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 117.729 2.492 . . . . 0.0 117.729 176.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.8 pt -80.5 -47.04 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 CA-C-N 119.781 1.173 . . . . 0.0 112.706 173.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 142.67 69.62 0.03 OUTLIER Glycine 0 CA--C 1.54 1.595 0 CA-C-N 119.134 0.879 . . . . 0.0 113.034 174.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.55 153.37 79.4 Favored Pre-proline 0 CA--C 1.568 1.668 0 C-N-CA 123.456 0.702 . . . . 0.0 111.84 172.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.79 152.59 47.44 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 123.168 2.579 . . . . 0.0 113.031 172.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -61.03 -24.69 66.37 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 173.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -61.86 -57.19 12.75 Favored 'General case' 0 CA--C 1.563 1.455 0 CA-C-O 117.489 -1.243 . . . . 0.0 113.433 165.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.8 mt -68.93 -18.39 64.09 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.1 mt -74.23 -55.45 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-N 119.727 1.149 . . . . 0.0 110.477 170.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -67.93 -24.56 65.2 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -79.13 -51.21 9.84 Favored 'General case' 0 CA--C 1.562 1.419 0 CA-C-N 119.547 1.067 . . . . 0.0 112.217 167.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.2 -14.79 59.94 Favored Glycine 0 CA--C 1.552 2.366 0 N-CA-C 119.864 2.706 . . . . 0.0 119.864 176.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -71.34 -49.86 38.16 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 119.957 1.879 . . . . 0.0 113.88 171.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -63.8 -30.76 71.82 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.533 2.049 . . . . 0.0 116.533 167.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 53.8 mt -75.69 113.7 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 173.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -81.22 108.57 14.97 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.64 123.77 6.31 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 116.299 -0.41 . . . . 0.0 113.884 -167.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t -83.05 110.99 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.3 t -92.57 103.26 15.68 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 166.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.85 142.83 36.53 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.162 169.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.0 mt -142.17 125.96 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 90.6 t -114.15 105.21 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -81.75 118.23 22.69 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.059 0.544 . . . . 0.0 109.816 174.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -123.98 68.35 1.05 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 165.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.3 -107.51 2.1 Favored Glycine 0 CA--C 1.546 1.986 0 C-N-CA 123.24 0.448 . . . . 0.0 113.362 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -78.22 -29.35 48.24 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 170.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -84.57 104.61 14.71 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 120.394 1.452 . . . . 0.0 109.605 -173.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -105.69 95.32 5.73 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.052 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -93.7 106.7 18.65 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -103.76 132.24 50.19 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.941 -176.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.7 m -107.27 98.62 8.23 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 172.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.4 tp -87.16 127.91 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.41 0.684 . . . . 0.0 109.568 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 48.1 p -111.36 87.35 2.53 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -99.0 91.44 5.02 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 122.902 0.481 . . . . 0.0 110.228 -174.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.72 -100.74 1.12 Allowed Glycine 0 CA--C 1.543 1.787 0 CA-C-N 116.162 -0.472 . . . . 0.0 113.113 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.0 m -87.17 -51.42 6.0 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 174.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -79.12 131.78 36.35 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 119.095 0.861 . . . . 0.0 113.021 -167.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.8 t -106.87 119.91 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.3 tt -140.46 144.26 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-O 121.367 0.604 . . . . 0.0 110.431 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -112.31 127.05 55.88 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.002 0.921 . . . . 0.0 109.025 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -139.87 128.95 23.65 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -171.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.25 135.45 54.27 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.458 0.703 . . . . 0.0 112.3 -175.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -125.27 149.11 48.34 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.044 0.938 . . . . 0.0 111.021 171.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.3 m -111.62 132.6 54.46 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 169.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.0 t -70.26 132.61 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 123.805 0.842 . . . . 0.0 110.274 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.76 10.88 85.93 Favored Glycine 0 CA--C 1.554 2.473 0 N-CA-C 118.987 2.355 . . . . 0.0 118.987 -170.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -138.59 150.7 46.58 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 119.29 1.545 . . . . 0.0 109.828 -171.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -80.89 103.0 10.42 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.519 0.728 . . . . 0.0 109.118 177.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 63.1 m -134.44 134.29 41.43 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.692 0.758 . . . . 0.0 110.766 -171.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.55 143.38 40.36 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -171.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.9 mt -129.75 121.63 27.25 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 175.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -84.45 114.04 21.63 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.102 0.477 . . . . 0.0 109.945 -173.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 76.8 p -80.71 -78.02 0.19 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 118.27 -0.872 . . . . 0.0 112.707 -158.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 66.5 mtt -118.13 -80.18 0.61 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 119.291 0.951 . . . . 0.0 108.858 -173.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.8 p -81.07 -67.61 0.76 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 118.88 0.764 . . . . 0.0 110.877 177.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -169.81 76.63 0.1 Allowed Glycine 0 N--CA 1.476 1.302 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 172.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -129.06 131.46 47.33 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -96.49 112.88 24.46 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.862 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . 0.261 8.4 p -86.57 -43.84 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.607 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . 0.253 5.6 ttpm? 76.06 107.49 0.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.751 1.221 . . . . 0.0 111.747 173.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 16.4 p -128.38 139.5 52.34 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.033 0.533 . . . . 0.0 110.381 -165.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 89.7 t -109.76 101.44 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 173.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.3 t -94.9 138.48 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -173.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -114.89 135.49 54.15 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.839 0.828 . . . . 0.0 109.302 176.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 50.7 tp -94.69 102.68 14.59 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 173.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -88.08 114.16 24.42 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 121.891 0.853 . . . . 0.0 109.112 174.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.41 -117.28 5.48 Favored Glycine 0 CA--C 1.542 1.729 0 CA-C-N 114.354 -1.293 . . . . 0.0 113.047 -176.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -130.25 -8.58 4.26 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 170.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -134.34 35.02 3.24 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -173.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -147.41 116.77 6.97 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 119.996 1.271 . . . . 0.0 108.077 175.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 67.0 mt -107.66 101.73 11.02 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 171.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 32.7 m -99.42 124.3 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -171.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.3 t -151.48 135.95 16.94 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.243 0.545 . . . . 0.0 111.482 -174.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 67.9 p -83.55 -41.88 17.43 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 177.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.378 22.5 m-85 74.21 -94.48 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 119.259 0.936 . . . . 0.0 109.676 -169.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -116.38 -76.18 0.57 Allowed 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 163.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -135.63 71.6 1.43 Allowed 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 119.276 0.944 . . . . 0.0 109.317 170.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.1 mp -143.66 93.46 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 102.87 -3.011 . . . . 0.0 102.87 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -80.74 97.2 7.2 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 119.156 0.889 . . . . 0.0 109.818 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.4 t -100.29 102.34 13.58 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.266 -171.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.8 t -96.05 106.63 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.2 m -93.56 83.87 4.57 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -174.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.63 118.42 32.29 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.415 0.686 . . . . 0.0 109.251 -168.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tt -106.72 112.06 24.87 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -172.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -81.19 -59.05 2.79 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -172.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -158.83 -87.74 0.06 OUTLIER Glycine 0 N--CA 1.479 1.505 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 175.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -71.35 -37.98 71.65 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 166.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.8 pt -87.52 178.54 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.553 0 CA-C-N 119.636 1.107 . . . . 0.0 112.785 -171.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.5 tt -141.59 118.83 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 165.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.0 m -99.57 99.98 10.92 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -97.03 104.32 16.32 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -178.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.9 m -102.44 94.85 5.89 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -168.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 28.1 mtt -93.37 99.28 11.82 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.59 0.71 . . . . 0.0 109.377 -178.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 48.0 p -94.18 103.83 15.86 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.003 -174.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.0 tp -102.73 82.86 2.18 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.51 -99.62 1.01 Allowed Glycine 0 CA--C 1.544 1.879 0 O-C-N 122.348 -0.22 . . . . 0.0 113.12 -174.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -102.95 -12.29 17.6 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 170.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 72.4 mt -85.3 108.92 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-N 120.526 1.512 . . . . 0.0 107.157 -175.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.2 t -100.34 96.47 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 -175.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -82.77 97.6 8.67 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -93.06 107.44 19.23 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -108.15 98.78 8.29 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -172.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 85.2 mt -97.93 104.71 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 -173.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 67.9 m -121.53 114.96 21.96 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -172.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -91.05 139.74 30.48 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 122.941 0.496 . . . . 0.0 111.131 -172.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.4 ttp85 -68.37 130.01 41.61 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.331 0.653 . . . . 0.0 112.509 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.2 pt . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 123.047 1.403 . . . . 0.0 108.365 -173.959 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.3 m . . . . . 0 CA--C 1.552 1.021 0 CA-C-O 118.888 -0.577 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.45 ' H ' HD13 ' A' ' 104' ' ' LEU 0.353 84.1 m-85 75.69 -32.34 0.21 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 117.973 2.583 . . . . 0.0 117.973 172.815 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.2 m -72.23 103.53 3.38 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 120.527 1.512 . . . . 0.0 110.924 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.1 149.27 8.69 Favored Glycine 0 CA--C 1.541 1.709 0 CA-C-O 122.016 0.787 . . . . 0.0 113.624 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -92.31 117.51 29.97 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 171.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -116.62 104.54 11.49 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -172.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -86.68 140.03 30.19 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-O 121.675 0.75 . . . . 0.0 111.622 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.2 tp -66.25 137.3 56.86 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -170.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -116.13 -65.48 1.18 Allowed 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.58 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.5 p -126.94 137.58 53.15 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.906 0.882 . . . . 0.0 109.401 174.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -132.35 101.96 5.56 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.807 0.813 . . . . 0.0 109.136 -178.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -90.94 135.47 33.72 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.606 1.162 . . . . 0.0 109.722 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 m120 62.24 40.39 11.59 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -72.51 -45.77 57.8 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.921 -1.112 . . . . 0.0 113.048 172.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -62.37 -45.92 90.99 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.52 -43.58 96.76 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -76.16 -55.14 5.86 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 118.325 -0.845 . . . . 0.0 113.24 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -44.71 95.83 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -178.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -61.97 -42.77 99.5 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 171.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.92 -36.3 76.71 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 116.925 2.194 . . . . 0.0 116.925 175.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.275 46.2 pt -79.34 -47.17 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 119.086 0.857 . . . . 0.0 112.768 174.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 142.92 52.57 0.03 OUTLIER Glycine 0 N--CA 1.485 1.935 0 N-CA-C 115.678 1.031 . . . . 0.0 115.678 165.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.45 155.51 36.71 Favored Pre-proline 0 CA--C 1.566 1.563 0 CA-C-N 118.211 1.006 . . . . 0.0 111.673 175.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.38 146.59 45.3 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.99 2.46 . . . . 0.0 113.256 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -62.87 -22.45 66.71 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 116.072 1.879 . . . . 0.0 116.072 171.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -59.43 -53.29 59.81 Favored 'General case' 0 CA--C 1.566 1.565 0 CA-C-N 119.754 1.161 . . . . 0.0 113.969 164.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.29 -24.47 63.96 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 117.072 2.249 . . . . 0.0 117.072 174.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.3 mt -75.18 -51.66 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-N 119.623 1.101 . . . . 0.0 111.305 175.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -67.84 -28.52 67.62 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.91 -51.21 14.4 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.603 0.761 . . . . 0.0 112.348 169.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.78 -18.58 72.45 Favored Glycine 0 CA--C 1.546 2.011 0 N-CA-C 120.226 2.85 . . . . 0.0 120.226 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -65.34 -41.82 93.51 Favored 'General case' 0 CA--C 1.57 1.712 0 CA-C-N 120.334 2.067 . . . . 0.0 114.427 168.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -67.68 -39.83 84.45 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 170.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.5 mt -73.19 130.36 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 119.292 0.951 . . . . 0.0 108.929 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -89.73 98.59 11.86 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 170.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.58 140.01 15.42 Favored Glycine 0 CA--C 1.542 1.722 0 CA-C-N 116.056 -0.52 . . . . 0.0 113.949 -172.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.3 t -83.18 115.7 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 71.2 m -102.33 109.17 20.76 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.776 177.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.86 148.89 21.71 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-O 122.064 0.935 . . . . 0.0 111.094 -177.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.4 mt -138.61 133.16 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 166.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.7 t -114.33 112.25 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 175.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -78.58 118.53 20.78 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 170.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -133.52 67.27 1.53 Allowed 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.64 -122.54 9.41 Favored Glycine 0 CA--C 1.548 2.107 0 O-C-N 121.975 -0.453 . . . . 0.0 113.533 -173.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.03 -35.58 74.41 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 164.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -69.43 139.01 53.99 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 119.291 0.95 . . . . 0.0 111.99 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -138.5 97.27 3.32 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -91.32 106.08 18.24 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 175.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -83.65 148.94 26.83 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.128 169.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.8 m -133.96 87.06 2.33 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 166.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.5 pp -91.07 127.67 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -173.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.4 m -100.49 102.31 13.46 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -92.74 85.14 5.14 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 172.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.68 -109.67 2.89 Favored Glycine 0 CA--C 1.538 1.499 0 CA-C-N 115.705 -0.68 . . . . 0.0 113.679 -175.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 91.1 p -91.96 -44.16 9.05 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 171.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -77.02 123.25 26.08 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 119.393 0.997 . . . . 0.0 111.225 -176.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.5 p -102.19 128.98 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 123.903 0.881 . . . . 0.0 109.671 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.2 mt -123.79 116.47 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -174.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -116.06 131.31 56.98 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.441 0.696 . . . . 0.0 111.822 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -151.32 149.94 29.94 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 123.399 0.68 . . . . 0.0 109.831 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -109.39 132.3 54.26 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.646 0.778 . . . . 0.0 110.833 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -117.25 141.07 48.74 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.919 0.888 . . . . 0.0 111.189 170.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.6 m -94.88 135.87 35.87 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 169.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.0 t -86.18 117.76 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 174.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.25 -5.44 63.01 Favored Glycine 0 CA--C 1.556 2.653 0 N-CA-C 119.057 2.383 . . . . 0.0 119.057 -171.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -142.23 134.48 27.68 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 120.38 2.09 . . . . 0.0 108.593 169.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.98 119.76 17.67 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -174.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 80.6 m -116.99 148.16 41.68 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 122.326 1.06 . . . . 0.0 110.557 -177.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.65 121.86 22.31 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.058 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.1 mt -123.44 125.41 44.89 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.827 0.851 . . . . 0.0 108.857 -175.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -84.43 122.79 29.46 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 173.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.7 p -75.11 174.27 9.64 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.651 0.738 . . . . 0.0 112.513 -175.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -51.05 -42.16 60.35 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 172.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.3 m -71.26 -75.35 0.13 Allowed 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.33 0.652 . . . . 0.0 110.51 165.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 157.15 85.87 0.05 OUTLIER Glycine 0 N--CA 1.476 1.347 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -176.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -148.96 115.38 5.86 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -170.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? -86.34 105.14 16.48 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -175.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.1 t -123.14 121.07 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -169.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -86.17 99.97 11.9 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.1 t -135.73 145.9 47.12 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.654 0.782 . . . . 0.0 110.016 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.0 p -109.76 138.02 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-O 122.798 1.285 . . . . 0.0 109.461 175.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.7 t -99.74 138.89 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.437 0 CA-C-N 113.413 -1.721 . . . . 0.0 107.78 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 -109.58 133.26 53.32 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 50.1 tp -98.55 113.49 25.54 Favored 'General case' 0 CA--C 1.553 1.076 0 CA-C-N 115.175 -0.921 . . . . 0.0 108.573 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -114.64 121.84 44.63 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.719 0.808 . . . . 0.0 109.041 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.88 14.45 73.14 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 120.667 3.027 . . . . 0.0 120.667 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.282 15.9 t70 59.7 33.3 21.83 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -168.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -158.87 -26.07 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -103.91 104.27 14.23 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 121.324 1.875 . . . . 0.0 109.368 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 44.1 mt -96.64 101.97 13.68 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 171.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.0 m -111.49 128.8 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 123.896 0.878 . . . . 0.0 109.966 -167.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.8 t -152.42 148.85 27.94 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.258 0.552 . . . . 0.0 111.956 -176.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 33.7 p -113.38 120.47 41.19 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -82.69 -86.14 0.11 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.13 0.572 . . . . 0.0 109.785 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -120.7 -71.71 0.72 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 171.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -127.54 64.19 1.35 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 118.88 0.764 . . . . 0.0 109.036 160.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.1 mp -135.7 108.23 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 174.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.23 93.49 9.4 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.6 t -97.67 104.11 16.1 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.669 0.787 . . . . 0.0 109.513 -168.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.9 t -120.44 98.44 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 -168.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.5 m -95.96 100.24 11.94 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -174.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.37 128.95 38.4 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.884 0.874 . . . . 0.0 109.992 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.45 HD13 ' H ' ' A' ' 3' ' ' PHE . 0.8 OUTLIER -97.94 111.15 23.56 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.91 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -110.65 178.55 4.33 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.534 0.734 . . . . 0.0 110.448 174.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -68.1 112.8 4.95 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 116.477 1.351 . . . . 0.0 116.477 -166.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.263 19.6 m-20 50.1 25.83 1.87 Allowed 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 117.38 2.363 . . . . 0.0 117.38 -166.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.3 pt -139.36 -178.46 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.619 0 C-N-CA 124.366 1.067 . . . . 0.0 109.866 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.1 tt -150.54 127.72 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.826 -1.172 . . . . 0.0 108.839 168.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.2 m -111.13 104.7 13.26 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -93.91 111.45 23.16 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 176.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 39.8 m -109.4 101.3 10.29 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -175.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 29.5 mtt -105.95 103.29 12.75 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.9 p -95.75 105.4 17.39 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 32.3 tp -96.52 84.73 3.73 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.09 -103.44 1.15 Allowed Glycine 0 CA--C 1.544 1.893 0 C-N-CA 122.954 0.312 . . . . 0.0 113.627 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -94.92 -16.42 22.85 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 171.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 66.2 mt -80.14 114.23 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 120.084 1.311 . . . . 0.0 107.563 -177.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.4 t -101.92 94.97 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -77.26 127.05 31.93 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 169.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -136.6 109.41 7.58 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -110.31 110.02 20.67 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -174.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.6 mp -104.25 115.66 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 104.983 -2.228 . . . . 0.0 104.983 -177.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.9 m -131.97 122.16 25.11 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -175.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -96.18 137.64 34.96 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.734 0.814 . . . . 0.0 110.992 -171.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.7 ttp180 -63.18 123.95 19.94 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 124.372 1.069 . . . . 0.0 113.165 -175.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 13.3 pt . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 123.007 1.384 . . . . 0.0 108.858 -178.382 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.0 t . . . . . 0 CA--C 1.553 1.078 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -76.37 -5.95 49.47 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 118.359 2.726 . . . . 0.0 118.359 -172.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.5 m -70.8 112.32 6.91 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 121.179 1.809 . . . . 0.0 110.784 172.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.4 149.49 7.37 Favored Glycine 0 CA--C 1.542 1.73 0 CA-C-O 121.926 0.737 . . . . 0.0 113.343 -175.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -96.25 122.74 39.43 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 170.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -118.11 102.24 8.86 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -167.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.6 tm0? -88.28 122.88 32.31 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.14 0.576 . . . . 0.0 110.013 -175.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.6 tp -61.94 115.45 4.06 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -175.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -95.99 -63.07 1.19 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.496 0.718 . . . . 0.0 110.748 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.7 m -120.88 108.56 14.06 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -89.11 123.84 33.76 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 122.524 1.154 . . . . 0.0 109.15 164.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -115.24 117.28 30.05 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 -178.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.278 7.7 m-20 70.23 43.74 0.82 Allowed 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 -174.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -68.15 -60.27 2.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.158 -0.964 . . . . 0.0 113.06 168.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -62.24 -33.96 75.59 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 117.345 2.35 . . . . 0.0 117.345 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.57 -46.31 86.45 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 166.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -67.19 -51.81 49.01 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 177.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.29 -49.85 74.77 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -59.15 -42.22 90.22 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 170.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.57 -32.2 73.59 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 117.305 2.335 . . . . 0.0 117.305 174.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.28 37.7 pt -78.53 -53.51 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-N 119.747 1.158 . . . . 0.0 111.599 172.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.68 69.98 0.01 OUTLIER Glycine 0 CA--C 1.538 1.516 0 CA-C-O 119.17 -0.794 . . . . 0.0 112.468 169.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mp -121.21 155.76 58.09 Favored Pre-proline 0 CA--C 1.57 1.733 0 C-N-CA 123.408 0.683 . . . . 0.0 112.591 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.29 158.56 33.27 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 123.367 2.712 . . . . 0.0 113.655 177.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -56.51 -32.86 65.48 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 168.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -61.59 -58.3 8.63 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 117.786 -1.102 . . . . 0.0 113.604 171.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.8 mt -68.67 -17.61 64.12 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 88.3 mt -75.67 -55.03 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 119.592 1.087 . . . . 0.0 110.619 169.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -70.81 -27.27 63.75 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -80.61 -50.12 10.39 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 119.8 1.182 . . . . 0.0 111.802 167.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.59 -18.17 58.49 Favored Glycine 0 CA--C 1.551 2.329 0 N-CA-C 120.16 2.824 . . . . 0.0 120.16 176.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -66.15 -43.7 86.24 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 120.401 2.1 . . . . 0.0 114.446 170.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.89 -35.74 80.7 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 167.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 42.7 mt -77.69 113.26 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -108.27 102.67 11.78 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -171.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.96 163.29 34.63 Favored Glycine 0 CA--C 1.544 1.902 0 N-CA-C 115.581 0.993 . . . . 0.0 115.581 -172.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.2 t -98.46 120.46 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.9 p -100.08 116.45 32.13 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.45 0.7 . . . . 0.0 109.171 172.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.77 149.71 23.07 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 121.902 0.858 . . . . 0.0 110.759 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.7 mt -141.93 130.21 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 170.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 85.6 t -118.35 104.09 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 -178.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -79.4 122.53 26.52 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.102 0.561 . . . . 0.0 111.138 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -132.45 68.18 1.51 Allowed 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 170.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.85 -114.07 5.64 Favored Glycine 0 CA--C 1.547 2.038 0 O-C-N 121.625 -0.672 . . . . 0.0 113.788 -176.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -77.62 -34.15 53.43 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 169.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -71.84 135.31 46.57 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 119.872 1.214 . . . . 0.0 111.211 173.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -139.47 105.97 5.32 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -91.84 103.32 15.88 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -80.58 147.83 30.59 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.882 169.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.9 m -138.77 88.92 2.33 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 170.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.5 tt -93.25 119.49 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 123.283 0.633 . . . . 0.0 109.44 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 39.0 m -92.87 96.98 10.46 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -94.11 93.24 7.7 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.388 0.675 . . . . 0.0 109.45 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.33 -109.62 2.84 Favored Glycine 0 CA--C 1.543 1.792 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.538 -174.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 99.3 p -92.65 -49.74 5.94 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 169.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -75.0 130.62 39.67 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 119.181 0.9 . . . . 0.0 111.992 -173.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.5 p -102.45 129.16 54.39 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.446 0 C-N-CA 123.921 0.888 . . . . 0.0 110.0 -177.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.2 mp -114.12 116.06 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -175.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -128.62 129.49 45.96 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.321 0.648 . . . . 0.0 111.4 -177.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -153.02 143.63 22.71 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 123.609 0.764 . . . . 0.0 109.385 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -103.03 117.98 35.79 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.024 0.53 . . . . 0.0 110.276 176.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -101.47 141.29 34.56 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.664 0.786 . . . . 0.0 111.307 172.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.9 m -97.69 129.68 44.73 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 167.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.6 t -73.84 131.09 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 123.586 0.754 . . . . 0.0 109.718 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.31 -54.21 0.56 Allowed Glycine 0 CA--C 1.549 2.218 0 CA-C-N 115.09 -0.959 . . . . 0.0 114.222 -165.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -78.84 147.4 33.21 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.805 0.842 . . . . 0.0 112.506 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -77.14 98.29 5.02 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.955 169.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 59.4 m -98.74 140.62 32.67 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.143 -173.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.19 114.35 19.95 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.144 0.578 . . . . 0.0 110.297 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.0 mt -133.34 123.06 24.75 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -165.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -70.64 129.8 40.11 Favored 'General case' 0 CA--C 1.559 1.312 0 CA-C-O 121.522 0.677 . . . . 0.0 110.744 176.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 90.1 m -81.24 -76.96 0.22 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.567 -171.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.8 ptp -146.74 86.4 1.66 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 173.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . 0.254 2.8 m 65.54 92.3 0.07 Allowed 'General case' 0 CA--C 1.564 1.519 0 C-N-CA 125.278 1.431 . . . . 0.0 111.7 -177.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 75.22 56.75 4.6 Favored Glycine 0 CA--C 1.547 2.061 0 N-CA-C 118.942 2.337 . . . . 0.0 118.942 170.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -152.81 102.45 2.69 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 119.24 1.52 . . . . 0.0 108.755 160.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.66 125.51 43.97 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.691 0.797 . . . . 0.0 109.3 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.9 t -132.91 126.25 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -73.26 105.97 4.89 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.152 0.501 . . . . 0.0 109.764 170.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.9 t -142.93 134.96 27.08 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.932 -169.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.7 t -83.77 120.21 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.8 t -94.57 117.48 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 169.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -109.01 141.93 40.42 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 122.05 0.928 . . . . 0.0 110.339 176.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.6 tp -101.08 110.08 22.06 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.165 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -109.67 119.62 39.94 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.71 14.85 75.49 Favored Glycine 0 CA--C 1.548 2.134 0 N-CA-C 120.487 2.955 . . . . 0.0 120.487 176.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.321 7.9 t70 66.9 1.1 2.15 Favored 'General case' 0 CA--C 1.577 1.996 0 N-CA-C 117.392 2.367 . . . . 0.0 117.392 -168.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -142.24 33.75 1.51 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -150.23 104.65 3.28 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 120.877 1.671 . . . . 0.0 107.757 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.9 mt -98.68 102.74 14.56 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 173.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.0 m -109.5 124.26 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 123.735 0.814 . . . . 0.0 109.685 -165.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.1 t -151.01 129.32 12.0 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 122.249 -0.282 . . . . 0.0 111.066 -178.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 52.4 m -103.58 111.52 24.02 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 175.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -69.62 -79.02 0.06 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.702 0.801 . . . . 0.0 110.49 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -116.25 -75.94 0.58 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 169.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -112.45 3.59 16.96 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 162.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.0 mp -85.98 100.47 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -92.91 90.93 7.18 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -84.33 97.03 9.23 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.878 0.871 . . . . 0.0 110.596 -173.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 81.3 t -97.19 96.76 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.5 m -94.02 90.12 6.31 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -171.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -103.51 129.85 50.78 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.865 0.466 . . . . 0.0 109.851 -169.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 tt -109.71 107.7 17.82 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -176.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -95.16 -93.46 0.19 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 118.671 -0.681 . . . . 0.0 109.611 -170.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -85.4 -96.81 0.73 Allowed Glycine 0 N--CA 1.483 1.767 0 CA-C-N 119.028 0.831 . . . . 0.0 112.211 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -126.74 55.93 1.51 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.448 0.642 . . . . 0.0 110.28 166.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.09 -156.89 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.539 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 174.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.0 tt -155.93 119.36 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.192 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 159.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.1 m -97.76 93.94 6.65 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -92.07 112.12 23.93 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.4 m -111.4 94.5 5.0 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -168.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 37.3 mtt -92.14 98.67 11.68 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.743 0.817 . . . . 0.0 108.818 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.6 p -92.09 104.94 17.28 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -174.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.4 tp -102.86 81.54 2.01 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.71 -101.27 1.17 Allowed Glycine 0 CA--C 1.545 1.929 0 CA-C-N 116.479 -0.328 . . . . 0.0 112.92 -173.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -98.82 -16.08 19.01 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 169.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 55.7 mt -82.66 111.97 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 120.274 1.397 . . . . 0.0 107.782 -173.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 61.9 t -99.31 95.73 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -175.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -86.63 94.61 9.52 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.265 0.626 . . . . 0.0 109.84 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -103.36 109.54 21.21 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.286 -173.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -101.53 117.82 35.71 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.791 0.837 . . . . 0.0 109.046 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.9 mp -104.75 102.87 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 -178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.9 m -122.87 110.74 15.81 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -168.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.9 tttp -81.66 136.92 35.5 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -166.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 71.9 ttt-85 -70.78 120.49 16.45 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 124.175 0.99 . . . . 0.0 111.474 -176.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.0 pt . . . . . 0 N--CA 1.484 1.248 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -173.078 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 98.5 p . . . . . 0 CA--C 1.553 1.069 0 CA-C-O 121.88 0.848 . . . . 0.0 112.022 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -63.51 -24.77 67.96 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 118.175 2.658 . . . . 0.0 118.175 -176.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.6 m -68.77 110.73 4.47 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 120.865 1.666 . . . . 0.0 111.525 176.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.78 155.64 10.67 Favored Glycine 0 CA--C 1.541 1.671 0 CA-C-O 122.252 0.918 . . . . 0.0 113.798 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -89.01 124.45 34.28 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 166.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -111.35 102.82 11.18 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -174.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -81.71 130.38 35.04 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.264 1.026 . . . . 0.0 110.764 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.4 tp -62.21 131.3 48.99 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -170.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -91.24 -62.76 1.37 Allowed 'General case' 0 CA--C 1.561 1.382 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.967 169.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.6 m -150.61 144.66 25.39 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.459 0.704 . . . . 0.0 110.968 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -111.83 115.66 29.39 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.605 0.762 . . . . 0.0 108.951 169.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -95.25 122.61 38.12 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 160.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.286 84.2 m-20 67.85 41.01 2.24 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 178.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -70.48 -44.79 66.99 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.667 -1.271 . . . . 0.0 113.306 157.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -63.13 -50.85 68.84 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.74 -40.28 96.73 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 173.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -70.5 -51.44 28.95 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -43.9 98.19 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -178.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -60.42 -40.71 92.02 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 167.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.41 -23.5 65.55 Favored 'General case' 0 CA--C 1.564 1.512 0 N-CA-C 117.516 2.413 . . . . 0.0 117.516 174.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.262 28.2 pt -92.01 -49.73 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 CA-C-N 120.082 1.31 . . . . 0.0 112.414 173.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 142.96 71.18 0.02 OUTLIER Glycine 0 N--CA 1.482 1.703 0 CA-C-N 119.699 1.136 . . . . 0.0 113.393 173.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 mp -128.58 157.17 75.86 Favored Pre-proline 0 CA--C 1.572 1.806 0 C-N-CA 123.555 0.742 . . . . 0.0 112.109 177.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -76.64 155.11 35.38 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 123.331 2.687 . . . . 0.0 113.884 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -59.64 -31.33 69.42 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 170.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -62.45 -49.62 74.71 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 171.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.6 mt -68.74 -26.24 65.15 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 116.986 2.217 . . . . 0.0 116.986 173.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 81.3 mt -78.06 -49.7 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 124.329 1.052 . . . . 0.0 111.256 178.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -75.7 -29.72 59.09 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 178.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -78.65 -47.07 17.76 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.568 1.076 . . . . 0.0 112.397 169.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.41 -22.41 65.55 Favored Glycine 0 CA--C 1.549 2.185 0 N-CA-C 120.09 2.796 . . . . 0.0 120.09 175.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -65.43 -42.07 92.84 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-N 120.252 2.026 . . . . 0.0 114.771 170.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -64.41 -40.88 96.64 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 167.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.27 128.9 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-N 119.39 0.995 . . . . 0.0 108.88 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -80.23 105.1 11.25 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 171.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -84.99 121.11 5.5 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-N 115.718 -0.674 . . . . 0.0 113.141 -173.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.6 t -79.49 118.88 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.4 m -98.62 115.59 28.99 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -101.15 148.2 25.36 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 121.823 0.821 . . . . 0.0 110.737 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 74.0 mt -140.67 130.33 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 169.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 88.9 t -115.08 103.13 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -81.01 120.93 25.42 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.321 0.582 . . . . 0.0 111.124 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -130.21 72.06 1.48 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 163.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.04 -115.96 7.68 Favored Glycine 0 CA--C 1.546 2.03 0 C-N-CA 123.305 0.479 . . . . 0.0 113.848 -173.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -34.12 63.31 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 171.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -73.89 117.81 16.11 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 119.92 1.236 . . . . 0.0 110.55 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -124.2 103.17 8.09 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -90.87 105.18 17.65 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 122.426 1.108 . . . . 0.0 108.619 175.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -106.29 123.9 48.76 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 113.536 -1.665 . . . . 0.0 109.508 -172.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.597 ' HG1' ' HG2' ' A' ' 60' ' ' GLN . 28.9 m -120.62 90.69 3.37 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -172.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.6 mm -101.75 112.46 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 -165.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.9 m -91.05 91.49 8.31 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.509 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -86.6 89.36 7.89 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.398 0.618 . . . . 0.0 110.134 -177.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.94 -104.69 1.93 Allowed Glycine 0 CA--C 1.54 1.634 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.344 -169.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.0 m -93.31 -55.23 3.38 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 175.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -81.56 137.02 35.58 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 119.477 1.035 . . . . 0.0 112.679 -170.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.6 p -95.74 132.61 39.45 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.473 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.07 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.5 mm -118.71 102.26 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 -175.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.597 ' HG2' ' HG1' ' A' ' 51' ' ' THR . 0.6 OUTLIER -113.23 121.77 45.44 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.377 0.608 . . . . 0.0 110.008 -172.539 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.412 HD22 ' HG2' ' A' ' 72' ' ' GLU . 37.2 m-80 -142.03 178.31 7.62 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 124.02 0.928 . . . . 0.0 109.302 173.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -141.22 135.65 30.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.802 -1.186 . . . . 0.0 111.236 169.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -118.28 141.85 48.09 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.045 0.938 . . . . 0.0 110.798 175.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.4 m -99.29 125.84 45.0 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 167.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.9 133.3 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 123.667 0.787 . . . . 0.0 110.345 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.27 -55.82 0.55 Allowed Glycine 0 CA--C 1.548 2.147 0 CA-C-N 115.172 -0.922 . . . . 0.0 113.856 -165.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -86.89 151.9 22.91 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.903 0.881 . . . . 0.0 112.307 -174.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -80.67 114.88 19.87 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.82 173.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 60.0 m -114.46 140.03 49.05 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.389 0.675 . . . . 0.0 110.349 -175.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.82 107.42 16.21 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.824 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.1 mt -120.32 122.29 40.51 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -167.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.412 ' HG2' HD22 ' A' ' 61' ' ' ASN . 4.4 pt-20 -75.67 125.55 29.28 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.586 0.707 . . . . 0.0 110.559 177.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 77.5 p -74.5 173.98 9.6 Favored 'General case' 0 CA--C 1.566 1.578 0 CA-C-O 121.971 0.891 . . . . 0.0 112.25 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 54.7 mtm -60.06 -28.85 68.12 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 171.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.4 m -68.52 -68.79 0.37 Allowed 'General case' 0 CA--C 1.568 1.642 0 CA-C-N 119.396 0.998 . . . . 0.0 110.261 158.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 140.32 83.91 0.09 OUTLIER Glycine 0 N--CA 1.481 1.7 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 174.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -154.25 111.8 3.45 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -172.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -81.51 118.21 22.55 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.715 0.769 . . . . 0.0 110.601 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.1 m -139.44 125.61 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.305 -167.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -75.61 114.02 13.72 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.165 0.586 . . . . 0.0 110.653 -177.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.3 t -141.51 133.84 28.07 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.483 -166.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.9 t -89.94 124.16 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.4 t -99.79 126.15 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 170.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -119.96 140.22 51.25 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 122.141 0.972 . . . . 0.0 110.017 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.4 tp -101.27 116.79 33.62 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 114.545 -1.207 . . . . 0.0 109.081 -175.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -102.96 115.71 31.13 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 172.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.97 -133.11 13.71 Favored Glycine 0 CA--C 1.545 1.922 0 CA-C-N 114.783 -1.099 . . . . 0.0 113.394 -171.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -131.49 59.33 1.7 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 162.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -161.38 -40.66 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -174.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -109.74 99.02 8.25 Favored 'General case' 0 CA--C 1.558 1.263 0 CA-C-N 119.844 1.202 . . . . 0.0 111.118 -162.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 64.2 mt -95.24 105.78 17.75 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.5 t -105.79 125.09 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -169.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.2 t -151.87 136.83 17.26 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 22.8 p -111.2 106.56 15.6 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.809 0.844 . . . . 0.0 108.897 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -65.78 -69.6 0.29 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 123.824 0.849 . . . . 0.0 113.239 -173.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -127.72 -78.45 0.58 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 170.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -124.43 73.39 1.25 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 156.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 17.0 mt -148.33 105.63 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 103.646 -2.724 . . . . 0.0 103.646 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -75.01 142.14 43.87 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 171.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.0 t -143.05 99.8 3.52 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -178.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 84.4 t -102.62 98.28 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 177.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.0 m -95.26 90.92 6.03 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -174.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -108.98 126.98 53.67 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -165.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 tt -100.56 104.43 15.78 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -173.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -102.28 94.9 5.96 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -173.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.63 -111.58 3.31 Favored Glycine 0 N--CA 1.485 1.949 0 CA-C-O 119.864 -0.409 . . . . 0.0 112.252 -177.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -127.96 58.93 1.5 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.779 0.8 . . . . 0.0 110.615 160.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.8 pt -123.06 -154.62 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.762 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 159.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.5 tt -159.61 116.87 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 O-C-N 120.368 -1.457 . . . . 0.0 107.319 161.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 67.9 m -99.76 99.47 10.29 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 176.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -94.32 103.23 15.24 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.8 m -106.37 97.6 7.38 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -172.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 68.0 mtp -101.91 106.91 17.92 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.8 p -100.5 107.68 19.44 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -173.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 28.9 tp -71.93 -70.49 0.33 Allowed 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.159 0.583 . . . . 0.0 112.195 -176.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -123.52 -87.36 0.79 Allowed Glycine 0 CA--C 1.538 1.499 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 158.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -89.9 -11.11 42.81 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 167.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 68.5 mt -85.09 110.79 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -172.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.77 95.11 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 -175.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -82.07 93.04 6.92 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.076 0.55 . . . . 0.0 109.785 177.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -95.77 110.78 22.88 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -113.74 103.82 11.59 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -175.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.0 mp -98.9 121.16 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 -172.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.7 m -141.62 122.83 14.75 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 122.765 0.426 . . . . 0.0 109.962 -172.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -94.41 135.75 35.47 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.673 0.789 . . . . 0.0 112.276 -170.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.5 ttp180 -68.87 133.71 48.63 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.17 0.588 . . . . 0.0 112.569 -177.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.2 pt . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 -173.846 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.5 t . . . . . 0 CA--C 1.548 0.873 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -74.36 -9.7 58.85 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 118.497 2.777 . . . . 0.0 118.497 -175.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.452 ' HG ' ' HB3' ' A' ' 43' ' ' GLN . 73.6 m -73.83 112.12 9.64 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 121.631 2.014 . . . . 0.0 110.643 173.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.84 139.32 4.17 Favored Glycine 0 CA--C 1.542 1.739 0 CA-C-O 121.221 0.345 . . . . 0.0 113.561 -174.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -89.73 113.92 25.51 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 169.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -107.85 105.71 15.65 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -167.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -79.28 124.02 27.99 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.034 0.934 . . . . 0.0 110.837 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.9 tp -65.73 124.45 22.46 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.384 0.611 . . . . 0.0 112.576 -176.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -106.12 -65.84 1.04 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.095 0.958 . . . . 0.0 109.801 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.8 t -130.22 115.79 17.49 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -175.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -106.49 108.05 19.37 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -90.64 135.92 33.4 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.944 0.898 . . . . 0.0 110.171 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.7 m120 61.81 46.07 7.19 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 174.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -77.44 -46.25 23.22 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.27 -50.99 67.94 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 171.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.58 -38.91 78.91 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 177.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -76.67 -56.34 4.7 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 119.096 0.862 . . . . 0.0 112.903 178.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.07 -53.29 59.76 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -59.24 -36.05 74.77 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 174.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.42 -36.01 80.4 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 171.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.274 45.7 pt -78.79 -48.75 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 119.972 1.26 . . . . 0.0 112.975 175.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 143.73 61.62 0.02 OUTLIER Glycine 0 CA--C 1.543 1.824 0 CA-C-N 119.116 0.871 . . . . 0.0 113.253 171.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.8 151.97 58.38 Favored Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 123.828 0.851 . . . . 0.0 111.123 -174.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.04 144.53 30.21 Favored 'Trans proline' 0 C--N 1.369 1.654 0 C-N-CA 123.226 2.618 . . . . 0.0 113.633 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -65.07 -20.24 66.38 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 171.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -62.46 -54.64 37.09 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 120.28 1.4 . . . . 0.0 113.483 166.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.85 -21.32 66.77 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 117.258 2.318 . . . . 0.0 117.258 173.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.3 mt -78.61 -50.74 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 124.237 1.015 . . . . 0.0 110.927 173.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -74.88 -26.6 59.78 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -78.38 -48.36 15.69 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 119.673 1.124 . . . . 0.0 111.67 165.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.18 -17.02 60.88 Favored Glycine 0 CA--C 1.55 2.258 0 N-CA-C 120.445 2.938 . . . . 0.0 120.445 176.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -68.2 -43.39 78.18 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 120.473 2.136 . . . . 0.0 114.036 168.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -66.44 -31.75 72.7 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 167.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.3 mt -85.27 113.87 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -87.06 107.84 18.61 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.77 128.56 8.97 Favored Glycine 0 CA--C 1.54 1.599 0 CA-C-N 115.984 -0.553 . . . . 0.0 113.683 -170.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.6 t -80.01 114.58 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 174.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 51.4 m -113.88 118.08 33.22 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -173.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -95.54 153.84 17.51 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 122.122 0.963 . . . . 0.0 111.801 -174.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 69.1 mt -138.03 126.08 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 103.585 -2.746 . . . . 0.0 103.585 160.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 69.0 t -111.1 102.37 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.452 ' HB3' ' HG ' ' A' ' 4' ' ' SER . 51.5 tt0 -80.33 120.0 23.81 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.132 0.573 . . . . 0.0 110.781 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -129.75 72.6 1.48 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 165.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.62 -111.48 4.1 Favored Glycine 0 CA--C 1.545 1.963 0 C-N-CA 123.35 0.5 . . . . 0.0 114.181 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -74.65 -37.21 62.8 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 172.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -72.39 139.51 47.86 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 119.625 1.102 . . . . 0.0 111.624 175.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -141.65 96.66 3.01 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -87.99 102.99 15.28 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 122.015 0.912 . . . . 0.0 108.852 174.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -97.0 130.42 44.33 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.053 178.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.9 m -120.18 84.72 2.26 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 176.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.6 tt -91.26 115.47 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 C-N-CA 123.395 0.678 . . . . 0.0 109.515 -169.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 39.1 m -90.46 96.25 10.56 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.473 ' HA ' HH12 ' A' ' 122' ' ' ARG . . . -90.11 91.75 8.68 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.153 0.581 . . . . 0.0 110.084 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.24 -108.16 2.47 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.245 -171.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 91.8 p -87.97 -51.99 5.52 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 167.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -80.43 127.73 32.75 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 118.974 0.806 . . . . 0.0 111.678 -165.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.9 p -95.43 129.88 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 123.722 0.809 . . . . 0.0 110.984 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.0 mp -114.19 105.86 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -101.1 122.95 44.5 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.27 0.557 . . . . 0.0 109.876 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -145.46 165.08 29.61 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.936 0.895 . . . . 0.0 109.155 169.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.18 143.18 48.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.407 -0.808 . . . . 0.0 110.716 164.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -118.5 138.76 52.29 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.999 0.904 . . . . 0.0 110.072 166.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.3 m -97.32 125.32 41.84 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 168.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.3 t -72.23 131.75 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 C-N-CA 123.662 0.785 . . . . 0.0 109.525 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.27 -56.41 0.66 Allowed Glycine 0 CA--C 1.547 2.076 0 CA-C-N 115.44 -0.8 . . . . 0.0 113.534 -163.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -71.83 147.9 46.72 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.175 0.99 . . . . 0.0 112.965 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -81.19 103.39 10.94 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.086 169.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 56.6 m -100.54 137.86 38.38 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 121.752 0.787 . . . . 0.0 111.837 -166.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -80.15 115.38 19.68 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.903 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.7 mt -136.08 110.92 8.75 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -167.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -75.62 138.58 41.51 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.986 0.898 . . . . 0.0 111.15 171.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 70.6 p -91.09 -174.44 3.98 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 114.953 -1.022 . . . . 0.0 111.287 -170.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 51.9 mtt -62.02 -32.04 72.48 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 167.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 69.0 p -68.29 -52.67 31.12 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 119.559 1.072 . . . . 0.0 113.275 163.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.72 94.43 2.36 Favored Glycine 0 N--CA 1.479 1.553 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -176.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -148.65 -36.22 0.19 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -171.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.275 38.2 ttmt 75.38 96.61 0.07 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 125.522 1.529 . . . . 0.0 111.016 -176.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.3 t -112.35 124.5 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -83.85 106.42 15.52 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 171.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.9 t -141.35 139.84 33.64 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.854 0.862 . . . . 0.0 110.462 -168.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.4 t -91.12 130.13 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -174.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.6 t -106.14 126.17 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -106.95 154.29 21.29 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.691 0.758 . . . . 0.0 111.402 170.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.0 tp -119.62 123.37 43.72 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -122.33 127.52 49.91 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.688 0.756 . . . . 0.0 109.083 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.25 13.68 67.76 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 120.877 3.111 . . . . 0.0 120.877 175.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.279 4.4 t70 54.08 41.4 32.03 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -163.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -157.91 -26.18 0.08 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 115.672 1.731 . . . . 0.0 115.672 -176.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -113.75 101.22 9.09 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 121.112 1.778 . . . . 0.0 109.293 -173.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 57.7 mt -95.25 103.37 15.22 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 172.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.7 m -112.17 124.34 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 123.784 0.834 . . . . 0.0 109.477 -165.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 t -155.62 133.81 11.53 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 122.693 0.397 . . . . 0.0 110.384 -176.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 42.6 m -103.73 113.92 27.8 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -83.16 79.38 9.4 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.744 0.818 . . . . 0.0 109.768 176.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.351 12.0 tmtt? 69.93 -81.22 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.544 1.137 . . . . 0.0 111.836 -173.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -104.51 -34.05 8.35 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 170.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.0 mp -84.75 117.86 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-N 119.754 1.161 . . . . 0.0 108.685 -161.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -91.22 103.62 16.27 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 122.371 0.268 . . . . 0.0 110.496 -169.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.7 m -88.0 117.19 26.7 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.331 0.652 . . . . 0.0 109.243 178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 78.7 t -120.58 103.23 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.9 m -100.49 91.8 4.85 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -172.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -84.7 146.48 27.41 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.29 1.036 . . . . 0.0 111.421 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 tt -131.04 106.94 8.72 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -85.99 -89.96 0.11 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.243 -170.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.23 -108.05 2.56 Favored Glycine 0 N--CA 1.483 1.795 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -106.69 63.06 0.64 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.765 0.793 . . . . 0.0 109.606 164.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.4 pt -140.3 -161.71 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.83 0 C-N-CA 124.7 1.2 . . . . 0.0 108.284 176.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.9 tt -159.8 130.65 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.372 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 160.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.7 m -111.93 89.04 2.95 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -84.07 103.25 13.15 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.719 0.808 . . . . 0.0 109.179 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.3 m -109.85 96.17 6.08 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -169.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 59.6 mtt -96.84 104.75 16.78 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 44.7 p -92.22 110.0 21.38 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -174.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.9 tp -104.23 76.97 1.37 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 175.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.18 -105.84 1.74 Allowed Glycine 0 CA--C 1.546 2.008 0 C-N-CA 123.025 0.345 . . . . 0.0 113.228 -171.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -94.42 -7.96 40.04 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 169.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 78.0 mt -89.28 101.43 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -174.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 39.2 t -98.19 97.47 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -172.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -85.51 98.51 10.66 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.494 0.717 . . . . 0.0 109.351 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -109.29 105.24 14.56 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.387 -173.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.473 HH12 ' HA ' ' A' ' 54' ' ' ALA . 45.1 mtp85 -87.01 120.98 28.85 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 172.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 73.1 mt -109.32 100.8 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 103.471 -2.789 . . . . 0.0 103.471 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.8 m -126.06 116.64 21.72 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -168.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -88.77 132.92 34.42 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.596 0.758 . . . . 0.0 112.04 -168.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -68.64 134.25 49.63 Favored 'General case' 0 CA--C 1.556 1.191 0 CA-C-O 121.934 0.873 . . . . 0.0 112.587 -175.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.0 pt . . . . . 0 N--CA 1.485 1.3 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 -174.459 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.1 m . . . . . 0 CA--C 1.547 0.862 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -69.21 -21.79 63.92 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 117.856 2.539 . . . . 0.0 117.856 -176.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.9 p -68.47 114.93 7.31 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 121.176 1.807 . . . . 0.0 112.171 176.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 166.23 167.73 27.33 Favored Glycine 0 CA--C 1.543 1.806 0 CA-C-N 114.634 -1.166 . . . . 0.0 113.731 -168.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -126.24 106.72 9.74 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 106.841 -1.541 . . . . 0.0 106.841 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -107.15 102.45 11.77 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -159.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -94.96 141.91 28.1 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.808 0.813 . . . . 0.0 111.704 -176.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 31.9 tp -66.98 128.45 36.4 Favored 'General case' 0 CA--C 1.558 1.261 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -167.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -94.72 -62.74 1.27 Allowed 'General case' 0 CA--C 1.561 1.382 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.926 169.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.2 t -139.34 135.56 33.88 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.666 0.786 . . . . 0.0 109.751 -170.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -131.92 119.8 21.64 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -173.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -93.45 -70.95 0.68 Allowed 'General case' 0 CA--C 1.556 1.185 0 CA-C-O 118.068 -0.967 . . . . 0.0 112.336 -164.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -105.24 76.8 1.25 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 119.591 1.087 . . . . 0.0 110.032 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -88.14 -47.06 8.76 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.575 0.75 . . . . 0.0 112.935 170.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -64.35 -51.09 65.07 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.3 -38.97 88.71 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 116.675 2.102 . . . . 0.0 116.675 173.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -70.14 -54.75 11.6 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 119.318 0.963 . . . . 0.0 113.555 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 32.9 mtt -60.53 -47.13 87.51 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -58.27 -37.45 74.99 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 115.948 1.832 . . . . 0.0 115.948 169.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.5 -38.43 84.33 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 173.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.5 pt -76.96 -39.88 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.55 59.44 0.13 Allowed Glycine 0 CA--C 1.543 1.834 0 C-N-CA 124.223 0.915 . . . . 0.0 112.91 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.24 149.75 52.47 Favored Pre-proline 0 CA--C 1.566 1.58 0 C-N-CA 124.213 1.005 . . . . 0.0 109.889 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -71.73 141.12 36.93 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 123.109 2.54 . . . . 0.0 113.528 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -61.08 -33.47 73.38 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -60.56 -47.32 86.7 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 170.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.5 mt -67.77 -18.9 65.02 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 172.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.0 mt -68.92 -53.51 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-N 119.79 1.177 . . . . 0.0 110.756 169.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -63.96 -27.56 69.22 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 173.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.7 ttpm? -74.37 -56.7 4.56 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-N 119.733 1.152 . . . . 0.0 112.091 172.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.95 -16.42 66.28 Favored Glycine 0 CA--C 1.552 2.397 0 N-CA-C 119.822 2.689 . . . . 0.0 119.822 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -69.08 -44.62 72.16 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 120.37 2.085 . . . . 0.0 114.264 171.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -66.74 -34.89 78.83 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 170.287 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 55.6 mt -73.2 123.43 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 175.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -84.01 104.94 14.49 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 174.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -85.1 131.67 10.58 Favored Glycine 0 CA--C 1.539 1.587 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.715 -170.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.2 t -84.99 113.51 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.4 m -96.55 100.46 12.03 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.92 142.16 31.64 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.402 0.62 . . . . 0.0 110.181 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.5 mt -142.43 119.91 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 174.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 94.3 t -109.58 109.73 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 175.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -85.65 123.1 30.67 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.18 0.592 . . . . 0.0 110.261 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -123.6 69.57 1.04 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 166.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.95 -114.35 6.06 Favored Glycine 0 CA--C 1.545 1.941 0 C-N-CA 123.41 0.528 . . . . 0.0 113.981 -177.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -77.68 -31.86 52.75 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 170.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -75.27 114.6 13.98 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 119.723 1.147 . . . . 0.0 110.136 175.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -112.44 105.83 14.18 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -84.17 138.48 32.97 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.705 162.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -141.48 146.65 36.71 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.819 0.448 . . . . 0.0 110.993 172.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.1 m -132.25 97.55 4.15 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 176.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.3 tt -94.56 115.54 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 75.8 p -89.37 99.16 12.21 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.753 -170.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.96 143.87 28.08 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.724 170.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -47.62 -50.35 19.42 Favored Glycine 0 CA--C 1.549 2.198 0 N-CA-C 119.682 2.633 . . . . 0.0 119.682 -171.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.7 t -73.16 -61.01 1.97 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 118.032 0.916 . . . . 0.0 113.444 173.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -126.99 129.07 47.38 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 119.14 0.882 . . . . 0.0 109.154 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.9 t -79.06 127.4 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 172.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.5 mm -113.62 103.61 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -171.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -105.67 131.64 52.79 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.993 0.517 . . . . 0.0 110.825 173.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -136.73 137.33 39.81 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.727 0.775 . . . . 0.0 109.04 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -118.46 126.84 52.9 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -174.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -139.81 173.13 11.84 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.838 0.828 . . . . 0.0 112.406 -176.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.2 m -133.11 131.8 40.94 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 170.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.1 m -69.12 134.01 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 123.262 0.625 . . . . 0.0 111.793 175.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.73 -53.24 0.77 Allowed Glycine 0 CA--C 1.546 2.03 0 CA-C-O 119.681 -0.511 . . . . 0.0 114.095 -166.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -75.21 152.66 38.35 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.742 0.817 . . . . 0.0 112.368 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -87.03 99.48 11.93 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 173.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.0 m -100.97 150.67 22.64 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 121.515 0.674 . . . . 0.0 112.203 -172.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.96 127.76 35.67 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.92 174.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mp -134.24 124.36 25.81 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -175.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -75.12 114.19 13.33 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.135 0.574 . . . . 0.0 110.115 176.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.7 t -77.41 -177.53 4.72 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 122.425 1.107 . . . . 0.0 112.827 -176.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 90.6 mmm -62.29 -38.0 87.67 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.6 m -72.26 -69.28 0.41 Allowed 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 119.935 1.243 . . . . 0.0 109.932 168.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.54 83.38 0.04 OUTLIER Glycine 0 N--CA 1.478 1.455 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 174.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -155.07 126.32 7.24 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -175.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -75.95 103.55 6.07 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 171.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.5 m -98.36 119.07 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -175.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -87.78 98.79 11.66 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -177.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.8 t -139.78 144.33 37.34 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.307 0.643 . . . . 0.0 110.745 -167.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.0 t -97.6 124.21 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -176.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.3 t -106.3 133.1 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -112.11 137.6 49.93 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.516 0.674 . . . . 0.0 109.902 174.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.4 tp -94.72 117.58 30.36 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 171.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -119.03 119.38 34.11 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 177.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.09 12.16 79.31 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 121.378 3.311 . . . . 0.0 121.378 173.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.276 5.9 t70 55.9 43.82 26.82 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -164.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -156.67 -40.91 0.07 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 117.91 -1.043 . . . . 0.0 113.749 -176.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -101.75 132.82 47.27 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 120.193 1.36 . . . . 0.0 110.458 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 38.6 mt -116.78 99.48 7.14 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 165.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 29.0 m -98.93 121.27 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 123.564 0.745 . . . . 0.0 109.659 -170.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.1 t -154.49 128.87 9.1 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 122.212 -0.305 . . . . 0.0 110.983 -177.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.6 t -109.79 129.04 55.67 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.37 0.668 . . . . 0.0 110.219 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -148.51 120.68 8.32 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.63 0.772 . . . . 0.0 109.226 -169.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.321 28.1 mtpp 74.6 -94.66 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 124.389 1.076 . . . . 0.0 108.239 -170.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -146.3 66.77 1.19 Allowed 'General case' 0 CA--C 1.562 1.405 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 151.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 57.9 mt -135.35 96.47 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 103.787 -2.672 . . . . 0.0 103.787 -172.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -88.25 95.28 10.12 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.388 0.613 . . . . 0.0 109.425 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.0 t -84.04 102.09 12.25 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.803 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 69.3 t -100.28 98.47 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 175.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.7 m -94.69 84.2 4.2 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -172.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -97.42 125.91 42.35 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.542 0.737 . . . . 0.0 109.215 -166.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 tt -103.28 103.45 13.48 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -172.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -100.99 92.35 4.98 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -171.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.79 -109.8 2.97 Favored Glycine 0 CA--C 1.543 1.824 0 N-CA-C 112.056 -0.418 . . . . 0.0 112.056 -176.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -126.75 58.31 1.41 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.614 0.721 . . . . 0.0 110.822 162.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.8 pt -125.06 -158.55 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.688 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 160.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.0 tt -157.78 118.84 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 120.06 -1.65 . . . . 0.0 108.861 163.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.0 m -102.48 94.55 5.73 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -91.08 110.96 22.24 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.491 0.716 . . . . 0.0 109.299 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.6 m -113.93 95.39 5.29 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -168.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 42.4 mtt -96.66 101.2 12.76 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.754 0.822 . . . . 0.0 109.09 -178.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.6 p -93.05 103.17 15.49 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -173.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.2 tp -99.51 82.48 2.65 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 175.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.85 -104.67 1.66 Allowed Glycine 0 CA--C 1.544 1.847 0 CA-C-N 116.427 -0.351 . . . . 0.0 112.623 -173.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -100.2 -2.82 32.95 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 168.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 61.2 mt -90.18 103.09 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -175.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.1 t -97.72 91.67 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -172.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -80.97 92.68 6.22 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.584 0.754 . . . . 0.0 109.661 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -111.83 105.76 14.32 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.63 -171.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -111.88 122.15 46.99 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.76 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.7 mp -102.83 118.42 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 -172.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.7 m -137.65 117.56 13.28 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -171.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.9 ttpp -88.16 138.18 31.67 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -171.013 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -68.46 122.93 19.47 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.793 0.837 . . . . 0.0 112.081 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 24.4 pt . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 123.102 1.43 . . . . 0.0 108.438 -174.655 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 98.0 p . . . . . 0 CA--C 1.549 0.916 0 CA-C-O 120.975 0.417 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -67.31 -14.43 62.91 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 118.016 2.599 . . . . 0.0 118.016 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.3 m -73.66 116.16 13.92 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 121.275 1.852 . . . . 0.0 110.399 168.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.88 158.53 22.25 Favored Glycine 0 CA--C 1.541 1.708 0 CA-C-O 122.34 0.967 . . . . 0.0 114.516 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.9 mptt -98.75 116.79 31.78 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 166.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.485 ' HH ' HD11 ' A' ' 104' ' ' LEU . 88.3 m-85 -108.4 101.91 11.05 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -168.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -88.8 121.97 31.72 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.713 0.805 . . . . 0.0 109.779 -173.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.8 tp -61.7 119.36 8.55 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -92.88 -67.19 0.87 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.354 173.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.6 m -122.4 144.3 49.12 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.184 0.994 . . . . 0.0 109.625 -176.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -134.27 103.4 5.73 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -178.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -85.53 137.51 32.83 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.224 1.01 . . . . 0.0 110.329 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.8 m120 60.03 46.7 10.55 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 175.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -76.32 -49.45 16.88 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -64.52 -44.07 92.07 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 171.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.0 -46.36 88.37 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 173.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -71.93 -55.48 7.4 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 119.16 0.891 . . . . 0.0 113.184 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.93 -46.4 90.81 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -177.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -60.03 -40.31 88.88 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.192 1.552 . . . . 0.0 115.192 170.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.14 -28.74 66.72 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 117.371 2.36 . . . . 0.0 117.371 174.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.264 20.1 pt -81.08 -48.04 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-N 120.313 1.415 . . . . 0.0 112.776 172.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 143.59 66.61 0.02 OUTLIER Glycine 0 N--CA 1.48 1.623 0 CA-C-N 119.12 0.873 . . . . 0.0 112.975 173.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mp -130.47 154.99 81.73 Favored Pre-proline 0 CA--C 1.567 1.619 0 C-N-CA 123.558 0.743 . . . . 0.0 111.806 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.35 155.87 32.66 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.079 2.519 . . . . 0.0 113.383 175.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -63.38 -24.16 67.72 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 165.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -59.63 -53.49 57.44 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 119.974 1.261 . . . . 0.0 114.265 168.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 98.6 mt -69.58 -24.9 63.75 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 117.077 2.251 . . . . 0.0 117.077 175.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 41.3 mt -75.71 -53.76 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-N 119.725 1.148 . . . . 0.0 110.485 173.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 46.1 mm-40 -71.67 -22.86 61.61 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 116.485 2.031 . . . . 0.0 116.485 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.66 -45.47 12.45 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.736 1.153 . . . . 0.0 112.717 167.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.52 -20.34 55.63 Favored Glycine 0 CA--C 1.553 2.454 0 N-CA-C 119.881 2.713 . . . . 0.0 119.881 173.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -64.71 -43.65 92.76 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 120.144 1.972 . . . . 0.0 114.772 168.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -63.11 -38.86 92.86 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 167.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 69.7 mt -72.94 128.7 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 123.943 0.897 . . . . 0.0 108.706 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -76.78 111.92 12.82 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.307 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.66 105.89 3.14 Favored Glycine 0 N--CA 1.478 1.437 0 CA-C-N 115.865 -0.607 . . . . 0.0 113.553 -170.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.0 t -94.61 111.62 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 174.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 70.6 m -117.25 109.16 16.52 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.89 159.87 22.25 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.98 -173.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.3 mt -136.02 131.56 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 160.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.6 t -115.09 102.43 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -79.29 120.99 24.53 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.195 0.598 . . . . 0.0 110.684 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -127.26 73.22 1.41 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 166.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.14 -119.08 9.22 Favored Glycine 0 CA--C 1.546 2.031 0 C-N-CA 123.209 0.433 . . . . 0.0 113.598 -174.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.252 0.0 OUTLIER -71.41 -28.7 64.19 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 116.568 2.062 . . . . 0.0 116.568 169.294 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -75.55 132.01 40.42 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 120.015 1.28 . . . . 0.0 110.965 175.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -132.99 99.98 4.75 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -93.95 104.99 17.03 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 121.944 0.878 . . . . 0.0 108.875 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -90.46 134.26 34.47 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.927 176.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.7 m -119.54 98.91 6.36 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.4 mt -82.71 141.91 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 173.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.5 p -119.92 92.66 3.84 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 170.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.34 95.53 6.01 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.168 0.587 . . . . 0.0 109.545 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.32 -112.71 3.84 Favored Glycine 0 CA--C 1.545 1.907 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.903 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 99.1 p -87.77 -41.68 13.13 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 168.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -79.26 137.6 37.45 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 119.003 0.82 . . . . 0.0 112.118 -171.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.8 t -110.52 107.51 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -176.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.2 mp -97.09 104.74 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -172.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -108.54 124.89 51.15 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.53 0.732 . . . . 0.0 109.939 -176.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -150.87 144.84 25.27 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 122.76 0.424 . . . . 0.0 110.9 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -118.12 132.59 56.33 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.937 0.895 . . . . 0.0 110.534 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -117.55 142.58 47.01 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.787 0.835 . . . . 0.0 111.509 171.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.8 m -89.38 140.5 29.45 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 159.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.7 t -76.37 122.3 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 172.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.22 40.31 9.29 Favored Glycine 0 CA--C 1.549 2.167 0 N-CA-C 116.784 1.473 . . . . 0.0 116.784 -168.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -151.62 143.16 23.55 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.184 0.994 . . . . 0.0 108.318 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -74.0 106.88 5.89 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.325 0.583 . . . . 0.0 109.659 168.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 40.8 m -110.51 136.32 49.83 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.048 -171.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -83.58 93.49 7.87 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.863 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.8 mt -117.39 122.5 44.0 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -171.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -81.65 121.5 26.44 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.327 0.585 . . . . 0.0 110.267 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 71.1 p -69.16 157.4 36.96 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.315 170.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.9 ttm -40.79 -50.51 3.15 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 118.514 2.783 . . . . 0.0 118.514 -167.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.7 m -129.75 115.02 16.68 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 157.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 173.98 -129.8 1.7 Allowed Glycine 0 CA--C 1.542 1.779 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.241 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -147.91 164.31 34.11 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.58 0.752 . . . . 0.0 111.28 -176.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -65.98 125.06 24.25 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.393 0.677 . . . . 0.0 111.596 175.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.9 m -139.84 136.69 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 123.734 0.814 . . . . 0.0 109.407 -169.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -72.05 133.66 45.39 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.023 0.929 . . . . 0.0 112.461 -176.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 t -154.14 142.0 20.1 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 122.974 0.51 . . . . 0.0 110.287 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.29 123.16 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.4 t -99.32 137.03 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -177.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 17.1 mp0 -124.41 136.78 54.32 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 173.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 42.0 tp -91.16 105.97 18.18 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 174.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -93.98 115.35 27.69 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.59 -127.51 9.14 Favored Glycine 0 CA--C 1.546 1.981 0 CA-C-N 114.428 -1.26 . . . . 0.0 113.021 -170.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -118.54 -11.95 9.85 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 173.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -123.87 -13.0 7.48 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 117.424 2.379 . . . . 0.0 117.424 -173.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -113.51 96.46 5.89 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 121.398 1.908 . . . . 0.0 110.472 -165.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 70.5 mt -86.37 105.16 16.52 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.1 m -99.0 125.88 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 123.862 0.865 . . . . 0.0 109.225 -174.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.6 t -152.65 125.93 8.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 122.138 -0.351 . . . . 0.0 110.376 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.3 t -112.62 131.29 55.7 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.487 0.715 . . . . 0.0 110.16 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -84.45 -82.37 0.17 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.623 0.769 . . . . 0.0 108.967 175.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -130.57 -77.69 0.53 Allowed 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 167.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -86.42 -36.25 19.24 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 174.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 52.4 mt -69.45 129.25 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 C-N-CA 124.455 1.102 . . . . 0.0 109.01 176.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -128.18 97.14 4.66 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.7 t -89.97 106.07 18.23 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.719 0.807 . . . . 0.0 110.717 -170.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.9 t -105.08 95.7 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.2 m -97.28 88.17 4.37 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -168.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -87.7 139.98 29.98 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.03 0.932 . . . . 0.0 110.194 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.485 HD11 ' HH ' ' A' ' 7' ' ' TYR . 2.0 tt -119.86 98.33 6.05 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -99.47 94.51 6.45 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -172.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.94 -112.7 3.51 Favored Glycine 0 N--CA 1.483 1.789 0 CA-C-O 119.879 -0.4 . . . . 0.0 112.118 -176.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -123.77 59.3 1.13 Allowed 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.397 0.618 . . . . 0.0 111.134 169.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.73 -154.09 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.736 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 164.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.5 tt -160.23 117.01 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 157.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.5 m -98.41 95.89 7.64 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -94.6 106.84 18.83 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.6 m -105.36 101.79 11.31 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -173.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 44.5 mtt -97.71 101.68 13.25 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.0 p -90.98 115.4 27.96 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . 0.265 24.3 tp -84.5 -104.36 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -177.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -90.97 -94.94 1.26 Allowed Glycine 0 N--CA 1.48 1.596 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 168.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -88.83 -8.09 54.98 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 164.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 42.2 mt -84.21 119.32 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-N 119.808 1.186 . . . . 0.0 107.809 -173.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.1 t -102.73 97.41 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -76.61 135.49 39.18 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 166.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -145.6 101.52 3.58 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -95.05 129.24 42.22 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.2 0.6 . . . . 0.0 110.152 173.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 88.8 mt -110.88 112.54 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 104.083 -2.562 . . . . 0.0 104.083 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.0 m -131.88 118.01 19.26 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -172.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -79.82 130.03 34.98 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -166.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 55.4 ttp85 -73.66 119.04 17.34 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.316 0.646 . . . . 0.0 111.141 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 33.0 pt . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 123.013 1.387 . . . . 0.0 109.026 -170.131 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.8 t . . . . . 0 CA--C 1.55 0.976 0 CA-C-O 121.2 0.524 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -68.28 -18.56 64.56 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 117.522 2.416 . . . . 0.0 117.522 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.8 m -69.21 120.29 14.81 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 121.222 1.828 . . . . 0.0 111.622 174.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.67 156.79 8.51 Favored Glycine 0 CA--C 1.54 1.653 0 CA-C-O 122.507 1.06 . . . . 0.0 113.898 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -79.93 140.94 36.49 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 113.979 -1.111 . . . . 0.0 108.934 162.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -135.51 105.97 6.43 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.32 122.68 28.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 122.032 -0.417 . . . . 0.0 110.658 -176.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.8 tp -66.65 120.28 13.2 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.348 0.659 . . . . 0.0 112.114 -178.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -109.64 -63.53 1.36 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 118.556 -0.735 . . . . 0.0 110.499 -176.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.9 m -110.07 107.96 18.0 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -178.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -100.11 121.34 41.26 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 122.189 0.995 . . . . 0.0 108.485 170.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -85.75 -64.6 1.13 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.115 -169.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -115.67 67.06 0.7 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 118.379 0.536 . . . . 0.0 110.73 175.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -72.02 -51.7 20.52 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 166.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -63.67 -48.78 75.79 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.34 -40.01 92.67 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 116.498 2.036 . . . . 0.0 116.498 171.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -66.54 -51.9 51.49 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 177.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.9 -47.94 70.64 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 174.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -57.22 -41.29 79.2 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 169.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.76 -33.21 72.1 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 117.056 2.243 . . . . 0.0 117.056 175.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.3 pt -76.74 -41.85 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 CA-C-N 120.129 1.331 . . . . 0.0 113.481 172.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.58 62.05 0.15 Allowed Glycine 0 CA--C 1.542 1.765 0 C-N-CA 124.205 0.907 . . . . 0.0 112.674 175.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.17 150.39 51.26 Favored Pre-proline 0 CA--C 1.568 1.669 0 C-N-CA 124.026 0.93 . . . . 0.0 110.764 -176.264 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.53 148.47 37.6 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 123.205 2.604 . . . . 0.0 113.84 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -61.86 -26.05 67.9 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 173.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -61.28 -50.14 74.23 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 166.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.3 mt -70.99 -16.88 62.65 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 116.916 2.191 . . . . 0.0 116.916 171.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 84.8 mt -73.82 -54.06 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 120.152 1.342 . . . . 0.0 110.584 169.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -66.79 -27.96 68.0 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 116.353 1.982 . . . . 0.0 116.353 176.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -73.86 -60.92 2.03 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-N 119.463 1.028 . . . . 0.0 111.097 166.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.94 -15.32 57.97 Favored Glycine 0 CA--C 1.553 2.415 0 N-CA-C 120.53 2.972 . . . . 0.0 120.53 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -66.99 -47.31 71.91 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 119.985 1.892 . . . . 0.0 113.862 169.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -72.78 -35.65 67.45 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 171.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 37.8 mt -73.5 121.33 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.021 -1.104 . . . . 0.0 108.021 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -89.77 119.12 29.89 Favored 'General case' 0 CA--C 1.557 1.225 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.52 135.3 12.72 Favored Glycine 0 CA--C 1.542 1.76 0 CA-C-N 116.714 -0.221 . . . . 0.0 113.593 -177.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.35 116.23 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.1 p -94.35 102.63 14.62 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 121.477 0.656 . . . . 0.0 109.262 174.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.02 142.33 27.88 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.829 176.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.1 mt -139.1 128.9 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.3 t -117.39 103.98 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 -178.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -85.06 131.68 34.42 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.302 0.641 . . . . 0.0 110.771 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -135.99 72.63 1.44 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 168.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.81 -105.15 1.82 Allowed Glycine 0 CA--C 1.544 1.902 0 O-C-N 121.886 -0.509 . . . . 0.0 113.571 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.253 0.0 OUTLIER -97.54 -15.56 20.48 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 166.123 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -77.71 149.99 34.52 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 119.772 1.169 . . . . 0.0 111.412 171.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -146.23 142.66 28.6 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.754 0.822 . . . . 0.0 110.1 -174.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -136.33 113.44 10.54 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 165.79 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -91.82 148.19 22.42 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.502 169.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.5 m -133.9 91.85 2.88 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 173.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.1 mm -91.92 110.62 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.9 p -100.03 97.23 8.1 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -176.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -96.83 84.3 3.57 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.293 0.568 . . . . 0.0 109.806 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.73 -109.99 2.97 Favored Glycine 0 CA--C 1.541 1.683 0 CA-C-N 115.814 -0.63 . . . . 0.0 113.348 -176.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 96.0 p -82.88 -44.87 14.92 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 175.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -72.82 133.04 44.3 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 119.528 1.058 . . . . 0.0 111.679 -176.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 85.2 t -103.62 111.69 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 177.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.3 mp -100.64 92.8 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -110.72 117.69 34.14 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -147.74 133.61 19.07 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -108.16 145.64 33.88 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 122.193 0.997 . . . . 0.0 111.7 -175.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -133.26 167.14 20.92 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.631 174.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.0 m -129.56 132.22 46.76 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 169.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.3 t -71.41 127.47 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 C-N-CA 123.467 0.707 . . . . 0.0 109.508 -177.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.73 -55.66 0.8 Allowed Glycine 0 CA--C 1.545 1.949 0 CA-C-N 115.606 -0.725 . . . . 0.0 113.891 -166.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -81.15 147.16 30.17 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.715 0.769 . . . . 0.0 112.219 -177.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -84.08 116.05 22.68 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.087 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.7 m -130.31 150.21 51.64 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.773 0.797 . . . . 0.0 111.987 -174.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.97 128.13 35.58 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.839 0.856 . . . . 0.0 113.055 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.2 mt -141.01 126.32 18.6 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -96.45 143.02 27.86 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.854 0.835 . . . . 0.0 110.831 178.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.0 m -73.68 175.24 7.34 Favored 'General case' 0 CA--C 1.578 2.051 0 C-N-CA 124.194 0.998 . . . . 0.0 110.846 173.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 61.0 mtt -52.22 -51.7 56.74 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 -174.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 60.9 p -135.17 98.81 4.08 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 165.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -175.23 -130.35 1.3 Allowed Glycine 0 CA--C 1.541 1.689 0 N-CA-C 113.779 0.272 . . . . 0.0 113.779 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -137.87 155.0 49.42 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.019 0.928 . . . . 0.0 109.884 -169.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -65.94 108.89 2.33 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.501 0.72 . . . . 0.0 111.14 177.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.0 m -80.87 -38.79 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 177.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . 0.286 37.5 ttmt 74.0 106.06 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.909 1.284 . . . . 0.0 111.113 -177.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.3 t -145.06 152.03 39.46 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.844 0.831 . . . . 0.0 110.4 -172.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.4 t -98.5 127.89 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 -176.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 t -104.91 129.79 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -178.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.7 mp0 -110.91 134.58 52.44 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 172.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.1 tp -95.84 104.39 16.32 Favored 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -98.96 121.0 40.35 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 122.135 0.969 . . . . 0.0 108.914 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.14 9.68 72.38 Favored Glycine 0 CA--C 1.55 2.269 0 N-CA-C 120.563 2.985 . . . . 0.0 120.563 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.305 2.3 t70 64.61 16.5 10.36 Favored 'General case' 0 CA--C 1.577 2.007 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 -165.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -157.39 44.84 0.36 Allowed 'General case' 0 CA--C 1.568 1.655 0 O-C-N 121.018 -1.051 . . . . 0.0 113.401 175.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -160.28 112.69 2.03 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 173.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 38.8 mt -98.74 98.24 9.38 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 173.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.8 t -98.27 113.84 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -167.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.7 t -153.51 134.82 14.17 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -176.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.9 m -103.31 112.51 25.42 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -74.84 -84.45 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.061 0.544 . . . . 0.0 110.984 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -93.73 -82.77 0.34 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 169.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -127.59 62.69 1.38 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 152.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 69.0 mt -120.73 95.3 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 103.246 -2.872 . . . . 0.0 103.246 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -84.28 90.97 7.64 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 122.138 0.97 . . . . 0.0 109.21 -174.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.0 t -95.83 117.52 30.72 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.185 -168.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 74.5 t -116.9 106.28 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 104.616 -2.364 . . . . 0.0 104.616 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.3 m -91.77 88.5 6.7 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -175.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -96.37 119.88 35.65 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.232 0.613 . . . . 0.0 109.866 -166.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 tt -101.59 106.56 17.65 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -176.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -90.13 -87.39 0.18 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 118.926 -0.559 . . . . 0.0 110.237 -170.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -101.67 -109.7 3.27 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 178.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -106.05 64.06 0.67 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.95 0.881 . . . . 0.0 109.5 163.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.5 pt -144.19 -170.41 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.574 1.887 0 C-N-CA 125.184 1.394 . . . . 0.0 107.713 175.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.3 tt -152.11 125.02 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 120.326 -1.483 . . . . 0.0 108.866 156.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 81.7 m -103.69 99.65 9.45 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -93.38 107.66 19.45 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 32.6 m -107.46 100.68 10.09 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -170.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 40.7 mtt -101.88 100.79 11.15 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.903 0.881 . . . . 0.0 109.194 -176.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 73.8 p -94.63 104.47 16.41 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -175.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 49.4 tp -103.66 84.88 2.35 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.88 -102.71 1.46 Allowed Glycine 0 CA--C 1.545 1.94 0 CA-C-N 116.231 -0.441 . . . . 0.0 112.12 -171.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -103.92 -4.98 22.73 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 169.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 80.6 mt -90.35 109.5 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-N 120.543 1.52 . . . . 0.0 107.048 -172.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 49.7 t -97.78 95.08 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -173.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -84.42 96.39 9.07 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.353 0.661 . . . . 0.0 109.419 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -101.33 109.07 20.85 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.549 -173.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.9 mtm180 -103.08 109.04 20.45 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.0 mp -99.79 99.19 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 105.037 -2.208 . . . . 0.0 105.037 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.4 m -110.73 115.76 30.13 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -177.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -79.08 146.01 33.48 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 122.933 0.493 . . . . 0.0 110.89 -174.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -79.39 139.58 37.69 Favored 'General case' 0 CA--C 1.559 1.319 0 CA-C-O 121.895 0.855 . . . . 0.0 112.142 -171.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.9 mm . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 -159.193 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.1 t . . . . . 0 CA--C 1.547 0.857 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -135.9 -107.25 0.21 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -176.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.5 m 59.0 93.6 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.168 1.387 . . . . 0.0 113.897 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.13 150.35 7.0 Favored Glycine 0 CA--C 1.542 1.736 0 CA-C-O 121.916 0.731 . . . . 0.0 114.266 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -83.83 130.8 34.92 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.72 -0.74 . . . . 0.0 109.357 170.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -132.47 105.13 7.07 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -173.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -92.67 134.49 34.97 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 122.962 0.505 . . . . 0.0 111.554 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.2 tp -73.44 114.24 11.44 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.344 0.658 . . . . 0.0 112.557 -170.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -95.86 -61.88 1.38 Allowed 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.88 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.2 t -117.42 114.21 23.19 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -98.3 138.8 35.03 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 123.091 1.424 . . . . 0.0 109.433 167.164 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -128.77 113.06 14.85 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.292 18.7 m-20 72.68 50.94 0.17 Allowed 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -173.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -76.22 -64.23 1.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.383 -0.823 . . . . 0.0 112.101 174.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.03 -28.26 69.67 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 117.163 2.282 . . . . 0.0 117.163 174.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.8 -44.26 86.23 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 168.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -67.28 -57.3 6.93 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 173.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 38.1 mtt -59.45 -45.78 90.62 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -176.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -62.05 -39.09 91.18 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 169.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.96 -33.18 73.81 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 117.25 2.315 . . . . 0.0 117.25 172.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.255 20.9 pt -81.55 -53.77 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 CA-C-N 119.328 0.967 . . . . 0.0 112.31 176.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.1 61.23 0.01 OUTLIER Glycine 0 CA--C 1.542 1.78 0 CA-C-N 119.019 0.827 . . . . 0.0 113.416 172.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.12 153.42 42.59 Favored Pre-proline 0 CA--C 1.568 1.645 0 C-N-CA 123.648 0.779 . . . . 0.0 111.277 -179.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.86 155.2 43.61 Favored 'Trans proline' 0 CA--C 1.556 1.582 0 C-N-CA 123.168 2.579 . . . . 0.0 113.338 173.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -56.95 -34.59 68.19 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 169.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -59.82 -54.26 48.34 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 172.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.9 mt -71.2 -26.2 62.85 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 116.84 2.163 . . . . 0.0 116.84 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.1 mt -69.39 -55.36 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-N 119.683 1.129 . . . . 0.0 110.627 171.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -70.05 -25.22 63.45 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -76.01 -57.67 3.74 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 119.753 1.161 . . . . 0.0 111.537 168.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.38 -15.96 62.07 Favored Glycine 0 CA--C 1.553 2.414 0 N-CA-C 119.869 2.708 . . . . 0.0 119.869 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -68.02 -44.68 75.98 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 120.145 1.972 . . . . 0.0 114.138 170.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -68.34 -40.82 81.43 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 168.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.1 mt -74.17 124.09 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-N 119.484 1.038 . . . . 0.0 108.317 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -84.26 107.51 16.6 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -88.1 128.77 9.22 Favored Glycine 0 CA--C 1.541 1.659 0 CA-C-N 116.359 -0.382 . . . . 0.0 113.771 -171.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.0 t -88.56 115.01 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -177.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 62.7 m -96.87 106.21 18.48 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 170.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.54 150.05 23.97 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.794 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 86.8 mt -132.96 134.92 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 170.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 43.7 t -132.29 96.19 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 104.008 -2.589 . . . . 0.0 104.008 169.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -84.1 124.08 30.74 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.239 0.615 . . . . 0.0 110.354 -176.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -118.21 74.62 0.96 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 171.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.66 -116.89 8.23 Favored Glycine 0 CA--C 1.546 2.004 0 C-N-CA 123.374 0.511 . . . . 0.0 113.488 -173.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? -81.9 -33.19 30.59 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 169.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -73.41 116.64 14.22 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 119.825 1.193 . . . . 0.0 109.877 174.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -126.74 91.83 3.43 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -151.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -94.43 96.9 9.8 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.17 0.509 . . . . 0.0 110.193 -167.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -110.01 133.27 53.37 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.904 -176.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.8 m -116.13 99.09 6.99 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 -177.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.3 tt -89.31 118.21 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.7 0.8 . . . . 0.0 109.437 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 49.4 m -101.57 100.68 11.13 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 176.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -101.39 99.97 10.39 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.259 0.624 . . . . 0.0 109.355 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.09 -114.47 4.19 Favored Glycine 0 CA--C 1.542 1.726 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.894 -173.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.2 m -120.57 69.0 0.86 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.476 0.655 . . . . 0.0 109.897 169.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -161.22 122.55 2.88 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 177.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.8 t -99.89 124.58 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -177.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.9 mp -130.87 114.42 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 -177.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -91.12 124.83 35.64 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.673 0.749 . . . . 0.0 109.877 170.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -131.75 155.27 48.0 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.313 172.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -139.97 139.1 36.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.347 -0.846 . . . . 0.0 112.304 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -117.68 150.75 38.54 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.98 0.912 . . . . 0.0 111.23 173.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.2 m -98.51 128.42 44.84 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 166.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 86.7 t -74.72 128.96 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 123.539 0.735 . . . . 0.0 109.762 -173.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.51 10.34 84.58 Favored Glycine 0 CA--C 1.554 2.512 0 N-CA-C 118.716 2.246 . . . . 0.0 118.716 -170.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -137.67 153.35 49.83 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 119.087 1.443 . . . . 0.0 109.29 -176.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -69.63 115.3 8.72 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.312 0.577 . . . . 0.0 111.143 177.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.7 p -122.04 135.81 54.86 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.642 -175.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.03 106.92 18.18 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 113.937 -1.483 . . . . 0.0 110.215 -175.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.3 mt -124.37 126.75 46.49 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.42 0.688 . . . . 0.0 110.11 -166.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -73.81 131.14 41.23 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.219 0.608 . . . . 0.0 111.037 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.3 p -85.23 -165.8 1.32 Allowed 'General case' 0 CA--C 1.575 1.906 0 C-N-CA 123.069 0.548 . . . . 0.0 111.025 -176.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 56.7 mtt -61.64 -50.13 73.77 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 171.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 61.5 p -70.87 -67.9 0.47 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 119.104 0.865 . . . . 0.0 111.494 168.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -179.87 -145.65 6.51 Favored Glycine 0 CA--C 1.542 1.759 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 67.0 112.59 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.862 1.265 . . . . 0.0 112.757 173.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.26 97.66 10.51 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -178.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.9 m -96.73 130.67 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 C-N-CA 123.516 0.726 . . . . 0.0 110.094 -171.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -75.6 114.99 14.81 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.177 0.591 . . . . 0.0 110.895 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.5 t -146.2 140.33 26.51 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.717 0.807 . . . . 0.0 109.421 -173.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.4 t -87.11 117.1 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.43 100.62 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -100.21 141.09 33.51 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.185 0.993 . . . . 0.0 110.423 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.6 tp -95.92 104.89 16.86 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 114.155 -1.384 . . . . 0.0 108.313 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -96.23 113.16 24.73 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 122.259 1.028 . . . . 0.0 108.641 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.44 -129.81 9.87 Favored Glycine 0 CA--C 1.546 1.98 0 CA-C-N 113.683 -1.599 . . . . 0.0 111.975 -165.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -135.19 51.69 2.07 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 120.863 0.363 . . . . 0.0 110.216 160.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -158.16 -20.76 0.08 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -177.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -118.32 113.34 21.29 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 121.963 2.165 . . . . 0.0 109.851 -174.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 15.6 mt -97.86 104.79 16.85 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 175.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 66.8 t -105.48 113.73 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -167.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.8 t -146.05 133.99 21.36 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.895 0.478 . . . . 0.0 110.592 -174.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 53.4 m -106.46 107.35 18.32 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -84.31 76.7 10.09 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.175 0.59 . . . . 0.0 109.786 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.341 38.4 ttmt 69.53 -75.96 0.07 Allowed 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 124.56 1.144 . . . . 0.0 112.659 -167.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -115.47 -23.47 8.81 Favored 'General case' 0 CA--C 1.567 1.628 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 174.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.2 mt -79.0 106.61 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-N 120.592 1.542 . . . . 0.0 108.657 -171.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -82.52 96.01 7.9 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-O 121.802 0.81 . . . . 0.0 109.694 176.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.4 m -93.09 116.75 29.33 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.307 1.043 . . . . 0.0 109.707 -176.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.1 t -118.39 102.75 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 104.786 -2.301 . . . . 0.0 104.786 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.2 m -92.01 92.16 8.17 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -174.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -83.16 140.49 32.56 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.65 0.78 . . . . 0.0 110.43 -175.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.67 107.47 13.73 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 172.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -88.81 -98.74 0.09 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 118.432 -0.794 . . . . 0.0 109.128 -176.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -92.31 -103.79 1.49 Allowed Glycine 0 N--CA 1.485 1.924 0 CA-C-N 119.466 1.03 . . . . 0.0 111.394 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -111.03 59.61 0.61 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.825 0.821 . . . . 0.0 109.798 164.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.7 pt -139.4 -163.62 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.809 0 C-N-CA 124.903 1.281 . . . . 0.0 108.048 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.6 tt -157.29 116.36 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.362 -1.461 . . . . 0.0 107.336 165.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.4 m -100.03 87.49 3.5 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -177.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -88.06 106.82 18.41 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 109.416 -0.586 . . . . 0.0 109.416 -176.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 19.1 m -108.08 97.78 7.43 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -167.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 82.1 mtp -99.6 94.57 6.45 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -172.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 59.2 p -97.65 112.2 24.17 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.668 -167.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.1 tp -112.49 86.18 2.31 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 174.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.45 -103.97 1.8 Allowed Glycine 0 CA--C 1.544 1.876 0 C-N-CA 122.848 0.261 . . . . 0.0 113.657 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -86.29 -24.28 25.99 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 169.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 24.7 mm -67.59 137.36 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.597 0 C-N-CA 124.945 1.298 . . . . 0.0 109.725 176.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.7 t -131.22 93.98 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 172.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -89.2 95.06 10.15 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 120.96 0.409 . . . . 0.0 110.704 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -97.29 108.44 21.16 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 121.356 0.598 . . . . 0.0 109.567 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 88.0 mtt180 -94.01 120.04 33.72 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.969 0.908 . . . . 0.0 108.615 171.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -105.64 99.28 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 175.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.4 m -114.49 115.44 27.26 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -175.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -88.51 140.54 29.35 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.279 0.561 . . . . 0.0 111.709 -170.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.8 ttm-85 -64.21 119.69 10.72 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.794 -176.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.7 pt . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -178.002 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.4 m . . . . . 0 CA--C 1.549 0.907 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.366 96.2 m-85 80.48 -13.05 0.97 Allowed 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 118.26 2.689 . . . . 0.0 118.26 172.285 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 72.1 m -75.37 114.42 13.88 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 121.157 1.799 . . . . 0.0 110.071 170.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.67 145.86 5.31 Favored Glycine 0 CA--C 1.542 1.755 0 CA-C-O 121.84 0.689 . . . . 0.0 112.831 -173.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -97.75 121.79 40.08 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 170.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -117.29 103.11 9.83 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -166.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.8 tp60 -80.56 121.92 26.4 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.749 0.82 . . . . 0.0 110.614 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.7 tp -62.77 127.39 31.04 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -110.78 -66.38 1.08 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.812 0.845 . . . . 0.0 109.606 -176.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.3 t -118.89 114.64 22.92 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.827 0.851 . . . . 0.0 108.847 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -104.2 105.11 15.15 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -102.61 133.79 47.03 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.83 0.852 . . . . 0.0 109.074 -171.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.252 22.2 m120 63.88 47.98 3.32 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -171.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -81.92 -46.17 14.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.827 -1.171 . . . . 0.0 113.956 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.29 -48.54 77.67 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 176.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.3 -40.62 96.89 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 116.566 2.061 . . . . 0.0 116.566 172.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -70.94 -52.74 18.07 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 118.005 -0.997 . . . . 0.0 113.647 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -40.89 93.08 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 177.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -40.82 94.86 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 167.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.57 -35.99 80.07 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 174.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.259 36.0 pt -79.58 -48.26 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-N 119.829 1.195 . . . . 0.0 112.846 175.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.68 58.28 0.12 Allowed Glycine 0 CA--C 1.546 2.003 0 C-N-CA 124.128 0.871 . . . . 0.0 113.631 -178.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.07 152.5 56.81 Favored Pre-proline 0 CA--C 1.571 1.776 0 C-N-CA 124.37 1.068 . . . . 0.0 110.24 173.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.32 154.08 31.79 Favored 'Trans proline' 0 C--N 1.366 1.495 0 C-N-CA 123.104 2.536 . . . . 0.0 114.103 -173.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -60.88 -24.92 66.32 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 168.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -57.5 -55.73 31.02 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 119.669 1.122 . . . . 0.0 113.5 164.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.1 mt -71.87 -16.42 62.14 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 175.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.0 mt -73.54 -56.85 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-N 120.165 1.348 . . . . 0.0 110.165 167.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -70.31 -27.56 64.48 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 116.477 2.028 . . . . 0.0 116.477 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -81.99 -50.72 8.81 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 119.155 0.889 . . . . 0.0 112.447 170.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.18 -7.18 62.54 Favored Glycine 0 CA--C 1.554 2.517 0 N-CA-C 119.932 2.733 . . . . 0.0 119.932 177.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -69.12 -45.19 70.79 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 120.137 1.968 . . . . 0.0 114.087 170.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -68.23 -36.06 78.89 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 169.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 42.8 mt -75.28 120.52 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 119.542 1.065 . . . . 0.0 108.232 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -88.75 114.83 25.79 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 176.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.1 133.25 11.38 Favored Glycine 0 CA--C 1.542 1.742 0 CA-C-N 116.473 -0.33 . . . . 0.0 113.291 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.7 t -81.91 122.3 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.0 m -96.0 105.34 17.35 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 170.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.78 144.78 26.43 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.582 0.706 . . . . 0.0 109.989 177.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 40.3 mt -146.68 129.24 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.1 t -125.94 115.31 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 -178.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -79.2 131.5 36.22 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.205 0.602 . . . . 0.0 111.048 172.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -135.55 64.92 1.56 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 172.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.38 -104.67 1.88 Allowed Glycine 0 CA--C 1.546 1.997 0 O-C-N 121.211 -0.931 . . . . 0.0 113.401 -177.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -89.35 -39.44 13.43 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 161.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -62.47 152.55 34.16 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.656 1.182 . . . . 0.0 113.806 178.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -139.49 150.61 45.36 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.905 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -134.32 109.54 8.88 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 164.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -117.49 131.64 56.69 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.475 -178.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.2 m -123.69 97.71 5.5 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -172.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.4 mm -88.06 113.44 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.6 p -102.92 86.11 2.66 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -103.74 94.67 5.56 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.125 0.57 . . . . 0.0 110.047 -174.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.13 -108.89 2.63 Favored Glycine 0 CA--C 1.543 1.816 0 CA-C-N 116.15 -0.477 . . . . 0.0 113.165 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 94.5 p -87.74 -46.72 9.22 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 171.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -80.53 134.45 35.94 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 119.146 0.885 . . . . 0.0 112.216 -171.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 95.0 t -104.73 112.77 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 177.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 67.1 mt -106.75 98.99 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 -176.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -115.85 118.04 31.88 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -175.061 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -136.5 171.99 13.68 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.0 0.905 . . . . 0.0 110.1 178.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -136.05 137.27 40.96 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.484 -0.76 . . . . 0.0 110.079 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -133.64 134.89 43.76 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.551 0.691 . . . . 0.0 112.274 176.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.3 m -92.11 127.89 37.75 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 163.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.0 t -74.31 124.52 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.28 -53.67 0.59 Allowed Glycine 0 CA--C 1.548 2.109 0 CA-C-N 115.237 -0.892 . . . . 0.0 114.124 -165.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -81.87 155.98 25.05 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.793 0.837 . . . . 0.0 112.809 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -76.38 111.79 12.2 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.079 0.552 . . . . 0.0 110.62 169.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 61.6 m -108.7 143.07 38.29 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.605 0.762 . . . . 0.0 111.421 -167.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -81.62 98.16 8.22 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.345 -176.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.2 mt -128.41 123.23 33.25 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.295 0.638 . . . . 0.0 109.906 -167.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -92.46 130.12 38.21 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.604 0.762 . . . . 0.0 111.311 -175.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.8 m -83.76 167.06 17.49 Favored 'General case' 0 CA--C 1.57 1.732 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.965 174.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 80.4 mtp -56.95 -50.48 72.51 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.4 m -80.38 -44.48 19.33 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 118.349 -0.834 . . . . 0.0 112.605 162.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.54 -175.24 6.52 Favored Glycine 0 CA--C 1.545 1.927 0 N-CA-C 118.172 2.029 . . . . 0.0 118.172 -166.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -123.0 19.42 10.04 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 117.354 2.354 . . . . 0.0 117.354 -157.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.301 31.8 ttmt 82.63 100.77 0.05 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.23 1.412 . . . . 0.0 110.109 178.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.7 m -125.87 142.93 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 C-N-CA 124.188 0.995 . . . . 0.0 109.472 -168.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.75 108.97 14.86 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.1 t -140.27 133.4 29.54 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.441 0.696 . . . . 0.0 109.642 -168.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 64.3 t -84.85 120.03 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -175.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.6 t -97.94 111.9 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 172.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -112.46 145.16 40.69 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.93 0.872 . . . . 0.0 110.853 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 54.2 tp -96.44 105.31 17.37 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.67 178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -90.92 120.13 31.68 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 170.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.4 -124.16 8.71 Favored Glycine 0 CA--C 1.544 1.876 0 CA-C-N 114.327 -1.306 . . . . 0.0 113.276 -174.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -122.75 -14.64 7.66 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 171.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -132.87 27.77 4.25 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 -172.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -138.15 103.14 4.86 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 121.446 1.93 . . . . 0.0 108.508 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 57.4 mt -96.79 106.05 18.28 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 173.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 87.4 t -106.62 122.96 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -165.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.4 t -150.56 127.61 11.17 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 122.589 0.356 . . . . 0.0 111.047 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.8 t -104.24 122.89 46.33 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.215 0.606 . . . . 0.0 109.848 175.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -80.76 -79.7 0.15 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 123.28 0.632 . . . . 0.0 110.189 -173.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -98.08 -78.88 0.48 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 163.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -130.86 61.47 1.63 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 156.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.9 mp -123.49 91.91 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 103.367 -2.827 . . . . 0.0 103.367 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -87.66 92.06 8.97 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.142 0.496 . . . . 0.0 110.303 -172.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.3 t -83.99 103.7 13.46 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.156 0.982 . . . . 0.0 110.49 -175.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 88.1 t -103.34 103.86 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 -177.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 18.8 m -93.48 92.69 7.73 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -166.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -94.45 109.4 21.27 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.153 0.581 . . . . 0.0 110.498 -166.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.71 98.13 10.24 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 118.726 0.694 . . . . 0.0 109.504 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -83.34 -74.58 0.36 Allowed 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 122.981 0.512 . . . . 0.0 111.606 -172.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -168.78 107.02 0.26 Allowed Glycine 0 N--CA 1.479 1.542 0 CA-C-O 121.796 0.665 . . . . 0.0 112.191 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.275 23.8 m-20 48.71 32.53 3.63 Favored 'General case' 0 CA--C 1.57 1.712 0 N-CA-C 116.944 2.202 . . . . 0.0 116.944 -165.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.7 pt -142.15 -171.09 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.815 0 C-N-CA 124.806 1.242 . . . . 0.0 108.604 175.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.5 tt -154.39 124.16 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 120.4 -1.438 . . . . 0.0 107.902 160.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.5 m -102.02 88.75 3.42 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -87.65 105.45 17.36 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.6 m -109.07 99.05 8.41 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -165.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 59.3 mtt -92.51 102.34 14.79 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.72 0.808 . . . . 0.0 109.268 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 77.5 p -94.09 103.14 15.21 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -176.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.2 tp -101.26 83.81 2.53 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 174.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.88 -104.77 1.6 Allowed Glycine 0 CA--C 1.544 1.882 0 CA-C-N 116.375 -0.375 . . . . 0.0 113.181 -176.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -97.15 -12.35 23.2 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 169.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 51.6 mt -84.55 112.39 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -175.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.8 t -103.29 90.71 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -174.338 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -83.6 94.12 8.01 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.428 0.691 . . . . 0.0 110.483 -177.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -106.6 108.14 19.5 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.075 -169.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 -96.53 110.72 23.06 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 63.2 mt -103.45 102.55 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 104.344 -2.465 . . . . 0.0 104.344 -173.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.7 m -127.79 116.67 20.55 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -163.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.5 mttm -77.8 138.28 38.89 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.55 0.74 . . . . 0.0 112.431 -171.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 70.9 ttt-85 -75.25 116.5 16.04 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.821 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 16.7 pt . . . . . 0 N--CA 1.486 1.336 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -174.858 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.9 t . . . . . 0 CA--C 1.549 0.906 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -71.01 -12.67 61.66 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 117.619 2.452 . . . . 0.0 117.619 178.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.0 m -76.59 114.34 15.22 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 121.066 1.757 . . . . 0.0 111.116 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.98 169.23 31.21 Favored Glycine 0 CA--C 1.545 1.926 0 CA-C-O 122.821 1.234 . . . . 0.0 114.368 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -92.01 123.01 35.05 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 113.739 -1.23 . . . . 0.0 108.337 170.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -116.11 97.55 6.13 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -175.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.7 tm0? -91.86 125.53 36.6 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 122.987 0.515 . . . . 0.0 110.36 -170.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 38.6 tp -65.37 114.74 5.01 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -169.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -93.54 -65.78 0.97 Allowed 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.219 -176.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.6 m -121.55 117.09 25.92 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -177.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -104.06 130.44 51.75 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.234 1.013 . . . . 0.0 109.128 176.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.63 -69.12 0.75 Allowed 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.357 -177.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -115.38 69.93 0.74 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.25 0.62 . . . . 0.0 110.522 178.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -75.94 -60.88 2.13 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.522 0.729 . . . . 0.0 111.561 171.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.12 -31.65 72.24 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 176.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.55 -44.5 78.14 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 169.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -67.49 -56.68 8.58 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 176.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 51.2 mtt -59.17 -48.45 81.58 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -177.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -57.42 -44.58 84.76 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 170.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.18 -29.63 70.73 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 117.338 2.347 . . . . 0.0 117.338 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 47.0 pt -81.24 -49.33 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-N 119.549 1.068 . . . . 0.0 112.503 173.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.77 67.27 0.03 OUTLIER Glycine 0 CA--C 1.541 1.666 0 CA-C-N 118.79 0.723 . . . . 0.0 112.471 173.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.73 152.32 45.42 Favored Pre-proline 0 CA--C 1.568 1.651 0 C-N-CA 123.967 0.907 . . . . 0.0 110.714 178.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.14 155.04 52.32 Favored 'Trans proline' 0 CA--C 1.557 1.652 0 C-N-CA 123.199 2.599 . . . . 0.0 113.394 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -57.08 -33.22 67.06 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 169.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -60.72 -55.57 31.64 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 117.227 -1.368 . . . . 0.0 113.961 170.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.99 -21.81 63.19 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 178.148 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.2 mt -76.1 -55.3 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-N 119.846 1.203 . . . . 0.0 110.509 171.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 52.3 mm-40 -76.21 -29.06 57.47 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -176.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -79.88 -45.7 18.16 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 118.832 0.742 . . . . 0.0 112.181 168.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.63 -28.01 67.17 Favored Glycine 0 CA--C 1.547 2.033 0 N-CA-C 119.678 2.631 . . . . 0.0 119.678 174.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -62.79 -41.01 99.08 Favored 'General case' 0 CA--C 1.568 1.66 0 CA-C-N 119.537 1.668 . . . . 0.0 114.965 170.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -68.77 -37.3 79.23 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 167.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.3 mt -68.22 139.43 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-N 119.651 1.114 . . . . 0.0 110.077 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -72.5 108.88 5.8 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.206 174.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.62 101.62 2.82 Favored Glycine 0 N--CA 1.479 1.526 0 CA-C-N 116.059 -0.518 . . . . 0.0 112.228 -174.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.2 t -85.95 107.32 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -176.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.0 m -99.43 95.11 6.8 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 114.269 -1.332 . . . . 0.0 107.517 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -80.56 148.73 30.23 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 121.88 0.848 . . . . 0.0 111.092 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.7 mt -140.56 122.41 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 173.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.0 t -118.45 100.53 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -83.43 126.74 33.07 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.161 0.584 . . . . 0.0 110.625 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -123.8 77.59 1.54 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 167.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.59 -119.0 6.36 Favored Glycine 0 CA--C 1.546 1.995 0 C-N-CA 123.092 0.377 . . . . 0.0 113.154 -173.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -76.6 -16.81 59.48 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 167.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -78.94 148.4 32.66 Favored 'General case' 0 CA--C 1.557 1.218 0 CA-C-N 119.335 0.971 . . . . 0.0 111.577 176.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -142.5 109.39 5.48 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -101.36 95.7 6.68 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 173.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -94.65 129.56 41.47 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.846 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.9 m -113.74 92.46 3.99 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.3 tp -85.06 120.91 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.804 0.841 . . . . 0.0 110.09 -175.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 56.8 m -100.69 98.78 9.29 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 171.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -101.43 80.4 2.07 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.465 0.65 . . . . 0.0 110.125 178.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.18 76.15 0.37 Allowed Glycine 0 CA--C 1.541 1.672 0 CA-C-O 119.076 -0.847 . . . . 0.0 115.149 -178.181 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . 0.308 7.6 t 79.46 -53.68 0.42 Allowed 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -174.613 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -79.82 121.71 25.72 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 119.079 0.854 . . . . 0.0 111.593 -166.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.3 t -99.91 120.11 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -170.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.0 mm -127.1 117.22 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -174.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -92.08 126.77 37.3 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.451 0.643 . . . . 0.0 110.139 173.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -138.81 131.9 29.74 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -126.66 150.06 49.18 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 122.077 0.941 . . . . 0.0 112.56 -171.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -147.15 155.27 41.99 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.334 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.1 m -107.37 137.73 44.88 Favored 'General case' 0 CA--C 1.565 1.533 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 166.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.7 t -75.08 126.1 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 170.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.91 -54.23 0.56 Allowed Glycine 0 CA--C 1.547 2.057 0 CA-C-N 115.659 -0.701 . . . . 0.0 114.353 -167.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -88.62 154.52 20.25 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.599 0.76 . . . . 0.0 112.418 -173.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -77.5 106.63 9.4 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.151 0.501 . . . . 0.0 109.927 164.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 68.7 m -110.03 140.68 43.81 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.756 0.789 . . . . 0.0 111.07 -169.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.44 125.16 30.1 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.484 -177.526 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 mp -134.7 160.49 37.98 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 122.105 0.955 . . . . 0.0 109.796 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.72 125.54 31.99 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.611 -0.681 . . . . 0.0 109.683 166.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 m -74.53 149.52 40.19 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 122.976 0.511 . . . . 0.0 109.753 173.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 91.6 mtp -54.93 -43.22 73.17 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 115.726 1.751 . . . . 0.0 115.726 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 34.5 m -115.06 110.55 19.74 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 151.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 143.76 -155.62 26.24 Favored Glycine 0 CA--C 1.543 1.796 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.872 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -148.93 -35.71 0.19 Allowed 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -169.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.61 137.64 51.79 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.15 0.98 . . . . 0.0 109.262 -174.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 70.3 t -117.86 -77.97 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt 61.29 90.49 0.07 Allowed 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 124.355 1.062 . . . . 0.0 112.04 -164.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.2 t -143.39 145.12 32.39 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.543 0.687 . . . . 0.0 110.58 -175.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.1 t -98.17 125.06 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -178.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.1 t -107.38 136.22 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.7 mp0 -119.18 137.88 53.32 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.495 0.718 . . . . 0.0 109.082 172.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.1 tp -104.55 119.48 39.08 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.981 0.912 . . . . 0.0 108.976 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -97.88 122.86 41.5 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 167.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.02 -125.73 11.3 Favored Glycine 0 CA--C 1.544 1.904 0 CA-C-N 114.664 -1.153 . . . . 0.0 113.478 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -137.96 63.06 1.55 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 155.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -152.72 -44.39 0.1 Allowed 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 117.204 -1.379 . . . . 0.0 114.067 -178.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -108.33 111.3 23.16 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 120.536 1.516 . . . . 0.0 111.461 -168.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 24.2 mt -106.72 109.07 20.88 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 174.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.2 t -105.52 121.51 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -174.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 t -156.45 135.43 11.91 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 45.8 m -103.11 113.79 27.55 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -75.9 -83.51 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.225 0.61 . . . . 0.0 111.226 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -133.4 81.83 1.95 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 173.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.257 33.4 t30 49.85 44.87 25.21 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 115.691 1.738 . . . . 0.0 115.691 -163.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 55.7 mt -137.13 95.1 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 -177.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -85.43 98.31 10.51 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.398 0.618 . . . . 0.0 109.691 -178.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.2 t -82.77 102.81 11.81 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.209 1.004 . . . . 0.0 109.542 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 79.8 t -103.24 92.19 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 52.3 m -96.37 97.09 9.19 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -166.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -106.88 124.26 49.36 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.364 1.066 . . . . 0.0 110.681 -165.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.9 107.17 17.91 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -177.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -89.96 -103.23 0.09 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 118.24 -0.886 . . . . 0.0 109.271 -174.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -90.5 -106.41 1.3 Allowed Glycine 0 N--CA 1.485 1.937 0 CA-C-N 119.942 1.246 . . . . 0.0 111.803 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -102.72 56.87 0.77 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.097 0.475 . . . . 0.0 110.437 165.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.2 pt -142.5 -170.66 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.574 1.866 0 C-N-CA 124.557 1.143 . . . . 0.0 108.879 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.4 tt -148.73 125.13 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 120.526 -1.359 . . . . 0.0 107.885 155.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 55.9 m -93.15 96.27 9.92 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 174.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.81 101.6 13.22 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -174.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.2 m -105.17 92.12 4.08 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -165.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 16.8 mtp -91.95 102.48 15.05 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.487 0.715 . . . . 0.0 109.5 -177.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 60.7 p -97.18 104.05 16.04 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -171.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.2 tp -90.89 80.63 5.78 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 176.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.22 -97.67 0.68 Allowed Glycine 0 CA--C 1.546 1.993 0 O-C-N 122.297 -0.252 . . . . 0.0 113.046 -171.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -102.27 -12.37 18.02 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 171.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 95.1 mt -85.84 106.36 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-N 120.854 1.661 . . . . 0.0 107.467 -175.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 96.8 t -94.91 98.73 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -173.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -84.6 94.84 8.7 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.331 0.586 . . . . 0.0 109.554 176.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -96.14 109.36 21.81 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.787 -175.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 30.7 mtm180 -104.62 107.89 19.06 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.0 mp -96.47 107.13 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.2 m -131.1 114.34 15.02 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -164.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -75.33 131.4 40.25 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.595 0.758 . . . . 0.0 112.623 -168.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -74.34 117.6 16.33 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.936 0.895 . . . . 0.0 110.643 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.9 pt . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 -168.601 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.8 p . . . . . 0 CA--C 1.549 0.937 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -86.17 -4.31 59.14 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 -175.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.5 m -74.41 104.61 5.21 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 121.605 2.002 . . . . 0.0 110.918 175.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.55 148.93 8.66 Favored Glycine 0 CA--C 1.542 1.765 0 CA-C-O 121.84 0.689 . . . . 0.0 113.201 -173.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -102.6 110.1 21.93 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -112.34 105.01 13.19 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -163.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -91.93 137.12 32.62 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.151 0.501 . . . . 0.0 111.322 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.1 tp -72.48 117.62 14.37 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.553 0.741 . . . . 0.0 112.342 -169.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -100.39 -61.96 1.3 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.54 0.736 . . . . 0.0 110.992 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.3 m -119.61 148.86 42.84 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.79 0.836 . . . . 0.0 110.058 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -142.59 134.6 27.2 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 122.039 0.923 . . . . 0.0 109.95 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -87.88 -67.94 0.79 Allowed 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.546 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 50.0 m-20 -120.93 68.9 0.88 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 118.534 0.606 . . . . 0.0 110.711 -175.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -76.46 -54.38 6.8 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.377 0.671 . . . . 0.0 112.335 172.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.44 -49.22 77.69 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 178.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.39 -40.1 85.5 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -67.02 -52.9 36.66 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 175.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -58.94 -51.85 68.28 Favored 'General case' 0 CA--C 1.562 1.423 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -58.02 -38.64 76.59 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 171.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.04 -29.81 69.71 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 116.909 2.189 . . . . 0.0 116.909 174.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.271 46.4 pt -80.65 -54.34 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-N 119.868 1.213 . . . . 0.0 111.768 171.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.83 67.06 0.01 OUTLIER Glycine 0 CA--C 1.543 1.795 0 CA-C-N 119.264 0.938 . . . . 0.0 112.971 170.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.75 154.85 55.15 Favored Pre-proline 0 CA--C 1.57 1.744 0 C-N-CA 123.653 0.781 . . . . 0.0 111.839 -175.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -76.36 152.03 34.17 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 123.326 2.684 . . . . 0.0 113.844 176.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -56.72 -37.2 70.62 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 171.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -64.01 -54.28 36.79 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.8 mt -67.0 -23.77 65.96 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 116.716 2.117 . . . . 0.0 116.716 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 74.9 mt -68.72 -55.43 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 124.176 0.99 . . . . 0.0 110.663 169.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -64.87 -25.64 67.98 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 116.893 2.183 . . . . 0.0 116.893 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -74.8 -59.7 2.61 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 119.346 0.975 . . . . 0.0 111.681 168.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.48 -11.72 60.12 Favored Glycine 0 CA--C 1.553 2.417 0 N-CA-C 119.995 2.758 . . . . 0.0 119.995 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -71.27 -46.18 61.49 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 120.272 2.036 . . . . 0.0 114.174 170.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -69.83 -35.66 74.95 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 170.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.2 mt -73.89 126.19 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.27 105.44 16.64 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -85.53 129.57 9.38 Favored Glycine 0 CA--C 1.54 1.614 0 CA-C-N 116.338 -0.392 . . . . 0.0 113.3 -174.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.9 t -85.72 113.49 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.2 t -99.86 112.26 24.53 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 172.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -88.59 151.68 22.33 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 114.614 -1.176 . . . . 0.0 110.309 175.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.2 mt -142.97 131.39 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 166.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.3 t -114.98 109.3 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -78.1 117.6 19.55 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.999 0.52 . . . . 0.0 110.908 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -129.58 62.85 1.53 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.818 169.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.9 -108.69 2.57 Favored Glycine 0 CA--C 1.547 2.035 0 O-C-N 121.614 -0.679 . . . . 0.0 113.714 -177.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -74.18 -42.96 59.03 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 169.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -73.96 121.48 21.08 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 119.24 0.927 . . . . 0.0 111.236 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -122.27 97.11 5.32 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -84.86 100.27 11.47 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 121.676 0.751 . . . . 0.0 109.569 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -87.9 137.91 31.92 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.386 174.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.1 m -128.15 89.46 2.92 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 173.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.0 tt -91.66 119.53 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 121.37 0.605 . . . . 0.0 109.643 -176.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.3 p -103.59 103.25 13.17 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.85 80.47 1.64 Allowed 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.534 0.683 . . . . 0.0 110.89 -174.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.29 60.58 8.33 Favored Glycine 0 CA--C 1.547 2.086 0 N-CA-C 115.865 1.106 . . . . 0.0 115.865 -175.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.0 m 54.76 60.36 3.55 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -166.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -152.31 97.83 2.33 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.8 t -92.12 104.44 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -166.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.3 mm -110.31 104.24 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 -177.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -119.37 119.72 34.78 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -170.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -144.96 148.03 33.35 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.531 0.733 . . . . 0.0 109.231 173.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.97 122.28 46.92 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.536 0.734 . . . . 0.0 110.724 175.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -101.9 134.32 45.29 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 121.619 0.723 . . . . 0.0 111.38 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.1 m -97.97 131.18 44.64 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 175.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.5 t -82.18 119.07 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 174.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.99 0.71 71.05 Favored Glycine 0 CA--C 1.557 2.701 0 N-CA-C 119.063 2.385 . . . . 0.0 119.063 -170.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -144.21 138.14 27.84 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 120.176 1.988 . . . . 0.0 109.079 166.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.66 123.32 21.6 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.37 0.605 . . . . 0.0 112.45 -176.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 99.7 m -108.95 150.9 27.05 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.614 171.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.85 115.08 22.08 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.948 175.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.4 mt -131.42 128.13 38.9 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 122.812 0.445 . . . . 0.0 109.91 -162.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -79.65 134.84 36.44 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.721 0.772 . . . . 0.0 111.317 174.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.8 p -76.29 -75.22 0.2 Allowed 'General case' 0 CA--C 1.562 1.43 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.658 176.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 57.1 tpp -128.96 -77.0 0.56 Allowed 'General case' 0 CA--C 1.561 1.368 0 CA-C-N 118.904 0.775 . . . . 0.0 109.757 -173.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.1 p -92.73 -60.74 1.74 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 118.279 -0.867 . . . . 0.0 113.013 -169.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -163.51 78.11 0.15 Allowed Glycine 0 N--CA 1.48 1.592 0 CA-C-N 119.536 1.062 . . . . 0.0 114.188 -176.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -138.47 169.06 18.46 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.851 0.86 . . . . 0.0 109.622 163.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -142.08 108.38 5.27 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 162.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.1 p -116.58 132.71 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.011 0.925 . . . . 0.0 109.23 -171.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -84.03 112.22 20.0 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.243 0.617 . . . . 0.0 109.976 -171.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.0 t -145.16 149.5 35.08 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.407 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.3 p -112.31 136.37 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 CA-C-O 122.538 1.161 . . . . 0.0 108.506 174.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.08 139.2 18.51 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 CA-C-N 113.931 -1.486 . . . . 0.0 108.166 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -111.61 133.26 54.0 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.4 tp -94.0 107.87 19.74 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -87.84 114.27 24.29 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 170.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.72 -119.12 8.07 Favored Glycine 0 CA--C 1.543 1.826 0 CA-C-N 114.52 -1.218 . . . . 0.0 113.635 -175.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -126.85 -5.45 6.29 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 171.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -123.42 -13.33 7.63 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.342 2.349 . . . . 0.0 117.342 -173.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -116.91 94.36 4.56 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-N 121.493 1.951 . . . . 0.0 110.351 -166.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 39.4 mt -93.19 107.31 19.14 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.557 0.743 . . . . 0.0 110.008 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 29.8 m -106.77 131.34 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 123.937 0.895 . . . . 0.0 110.801 -171.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.1 t -153.74 145.12 23.08 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.6 p -109.89 110.06 20.9 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 174.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -76.14 -87.45 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.235 0.614 . . . . 0.0 110.957 -177.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -112.81 -74.56 0.63 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 174.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -129.05 65.08 1.45 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 154.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.4 mp -137.96 103.31 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 176.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -92.04 94.21 9.14 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -95.09 110.61 22.52 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.59 -167.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.0 t -107.2 100.6 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 -177.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.6 m -96.24 91.25 5.8 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -172.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -87.99 141.83 28.27 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.914 0.885 . . . . 0.0 110.46 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 tt -121.91 102.95 8.5 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 172.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -81.07 -82.11 0.12 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.123 0.569 . . . . 0.0 110.988 -168.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.65 -103.63 2.26 Favored Glycine 0 N--CA 1.482 1.739 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 176.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -111.66 54.02 0.7 Allowed 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.676 0.75 . . . . 0.0 109.833 159.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.4 pp -149.75 136.49 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -175.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.9 tt -108.11 117.4 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.4 m -103.92 98.58 8.4 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 177.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -93.79 116.33 28.79 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.5 m -113.14 94.23 4.79 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -170.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 27.2 mtt -94.2 99.06 11.39 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.735 0.814 . . . . 0.0 109.381 -177.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.4 p -90.94 107.0 18.91 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.246 -174.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.3 tp -101.41 79.86 2.02 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.43 -100.97 1.01 Allowed Glycine 0 CA--C 1.545 1.908 0 CA-C-N 116.579 -0.282 . . . . 0.0 112.772 -171.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -103.1 -6.07 22.63 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 169.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 76.3 mt -87.18 103.86 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 120.668 1.576 . . . . 0.0 106.914 -176.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 49.1 t -93.8 96.58 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -84.83 93.59 8.53 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.199 0.523 . . . . 0.0 109.774 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -99.17 103.02 14.87 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.552 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -107.12 122.86 47.33 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.876 0.87 . . . . 0.0 109.141 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.0 mp -111.16 107.92 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 -171.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.3 m -118.91 119.93 35.78 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -175.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -89.85 141.91 28.19 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.659 0.742 . . . . 0.0 111.414 -174.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 33.3 ttm-85 -66.63 124.76 23.74 Favored 'General case' 0 CA--C 1.559 1.316 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.263 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 16.6 pt . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 123.05 1.405 . . . . 0.0 108.542 -176.638 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.6 m -76.82 101.82 6.04 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 121.43 1.923 . . . . 0.0 111.004 -176.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.75 168.19 39.0 Favored Glycine 0 CA--C 1.546 2.011 0 CA-C-O 122.34 0.966 . . . . 0.0 112.86 -172.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.69 97.39 5.61 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -173.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -100.55 105.54 16.98 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -160.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -92.13 138.93 31.13 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.557 0.694 . . . . 0.0 111.612 -175.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.0 tp -65.86 130.17 42.34 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.304 1.042 . . . . 0.0 113.389 -172.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -109.37 -65.53 1.14 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.069 0.948 . . . . 0.0 109.745 -178.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.5 t -127.36 121.2 30.35 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.895 0.878 . . . . 0.0 108.94 -176.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -114.93 120.13 38.89 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -79.51 -70.44 0.51 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 118.485 -0.769 . . . . 0.0 112.789 -171.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 46.7 m-20 -121.64 73.82 1.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 118.848 0.749 . . . . 0.0 110.774 -170.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -81.98 -46.37 14.08 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 172.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -59.03 -50.02 75.66 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 172.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.08 -38.28 90.54 Favored 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 116.636 2.087 . . . . 0.0 116.636 175.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -77.54 -51.21 11.07 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -43.71 98.21 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -65.04 -35.65 81.86 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 168.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.6 -30.46 70.7 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 169.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.266 24.7 pt -88.59 -59.55 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-N 119.717 1.144 . . . . 0.0 111.214 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.01 71.55 0.01 OUTLIER Glycine 0 CA--C 1.54 1.644 0 CA-C-N 118.642 0.655 . . . . 0.0 111.909 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.93 153.28 78.51 Favored Pre-proline 0 CA--C 1.571 1.768 0 C-N-CA 123.617 0.767 . . . . 0.0 111.675 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.95 151.05 30.67 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 123.254 2.636 . . . . 0.0 114.048 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -59.48 -31.82 69.69 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 116.623 2.083 . . . . 0.0 116.623 170.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -61.73 -51.1 69.75 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 117.301 -1.333 . . . . 0.0 114.583 170.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.7 mt -68.36 -23.81 64.72 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 173.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 84.9 mt -68.42 -55.0 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 124.356 1.062 . . . . 0.0 111.197 170.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -66.1 -23.05 66.43 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -77.52 -56.5 4.48 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 124.356 1.063 . . . . 0.0 112.037 170.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.37 -15.54 70.42 Favored Glycine 0 CA--C 1.553 2.454 0 N-CA-C 119.667 2.627 . . . . 0.0 119.667 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -65.45 -44.04 88.48 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 120.317 2.058 . . . . 0.0 114.654 168.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -67.65 -35.96 79.86 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 170.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 53.3 mt -75.43 122.24 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -86.34 107.27 17.91 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 174.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.56 130.9 10.3 Favored Glycine 0 CA--C 1.54 1.621 0 CA-C-N 116.178 -0.465 . . . . 0.0 113.561 -173.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.1 t -80.8 114.85 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 71.0 m -104.62 99.37 9.04 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -81.66 145.53 30.52 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.532 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.2 mt -143.45 128.89 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 176.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 87.4 t -124.02 107.42 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 178.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -88.26 122.07 31.38 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.548 0.689 . . . . 0.0 109.444 170.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -87.35 -60.49 1.96 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.406 159.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.56 -88.94 0.07 OUTLIER Glycine 0 N--CA 1.476 1.312 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 170.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -74.0 -39.6 63.51 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 164.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -75.23 135.61 40.99 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 119.897 1.226 . . . . 0.0 111.527 176.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -134.12 108.5 8.34 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm -102.47 103.76 14.16 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -111.95 136.71 50.93 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.789 0.836 . . . . 0.0 110.537 -173.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.3 m -127.88 106.24 8.97 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -176.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.9 mm -97.21 120.14 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.5 p . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 174.713 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 90.4 mt . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -116.22 130.98 57.06 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.02 0.928 . . . . 0.0 110.478 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -143.01 173.65 11.37 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.872 0.869 . . . . 0.0 109.212 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -143.11 134.06 25.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.983 -1.073 . . . . 0.0 112.313 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -110.25 149.16 30.55 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.8 0.84 . . . . 0.0 111.315 172.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.1 m -108.55 125.45 51.83 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 169.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.9 t -69.5 123.9 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 C-N-CA 123.831 0.852 . . . . 0.0 109.595 -176.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.42 -44.58 2.11 Favored Glycine 0 CA--C 1.552 2.356 0 N-CA-C 116.857 1.503 . . . . 0.0 116.857 -172.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -102.42 132.67 48.29 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.277 1.031 . . . . 0.0 110.145 -173.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -50.81 134.73 24.98 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 116.466 2.025 . . . . 0.0 116.466 -172.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 20.6 p -133.71 137.84 45.5 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 122.187 0.994 . . . . 0.0 111.039 -174.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -96.13 95.21 8.0 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.22 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.1 mt . . . . . 0 N--CA 1.489 1.494 0 C-N-CA 123.591 0.756 . . . . 0.0 109.665 179.458 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 87.7 mttt . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 122.76 1.266 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.5 p -145.42 125.84 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.318 0 CA-C-N 113.925 -1.488 . . . . 0.0 107.659 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -83.04 107.62 15.76 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 171.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.402 HG21 ' CD2' ' A' ' 95' ' ' PHE . 6.9 t -155.72 105.8 2.44 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 -170.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.252 11.2 p -103.98 136.52 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-O 122.893 1.33 . . . . 0.0 110.718 -176.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.1 t -90.25 136.35 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 CA-C-N 113.346 -1.752 . . . . 0.0 108.742 -172.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -107.0 134.93 49.42 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 171.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 33.5 tp -105.06 110.07 22.31 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.23 -175.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -105.69 128.04 53.43 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.485 0.714 . . . . 0.0 109.198 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.53 7.51 64.74 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 121.344 3.297 . . . . 0.0 121.344 172.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.292 5.0 t70 54.91 45.62 26.13 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 -161.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -157.48 -44.64 0.07 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -92.81 125.6 37.49 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 120.086 1.312 . . . . 0.0 110.934 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.0 mt -111.29 102.05 10.49 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 170.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.1 m -109.05 126.6 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 C-N-CA 123.5 0.72 . . . . 0.0 109.533 -172.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.0 t -149.03 156.25 41.97 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.262 0.553 . . . . 0.0 112.29 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 89.4 m -112.5 105.42 13.64 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 175.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.402 ' CD2' HG21 ' A' ' 81' ' ' THR 0.266 36.7 t80 -91.3 -101.05 0.11 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.109 0.964 . . . . 0.0 108.928 -163.766 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -110.39 78.12 1.1 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 170.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.4 m120 50.32 42.15 25.44 Favored 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -166.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 23.4 mt -133.79 115.25 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 103.455 -2.795 . . . . 0.0 103.455 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -85.73 93.92 8.98 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 174.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.4 t -86.37 96.25 9.94 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.821 0.849 . . . . 0.0 109.901 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 62.3 t -104.19 105.04 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 -174.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 62.9 m -116.24 90.84 3.43 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -168.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -96.12 140.53 30.7 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.132 0.573 . . . . 0.0 110.906 -172.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 tt -105.94 110.56 22.88 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -110.94 91.77 3.79 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -178.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.52 -110.7 3.1 Favored Glycine 0 CA--C 1.544 1.857 0 CA-C-O 119.757 -0.468 . . . . 0.0 113.407 176.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -118.86 52.63 1.04 Allowed 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.272 0.558 . . . . 0.0 111.686 171.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.7 pt -134.87 -166.21 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.783 0 C-N-CA 124.554 1.142 . . . . 0.0 108.136 166.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.3 tt -157.94 126.34 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 O-C-N 120.352 -1.467 . . . . 0.0 107.426 159.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 t -83.44 149.5 26.62 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 120.627 0.251 . . . . 0.0 110.724 164.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -133.83 97.12 3.82 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 169.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.3 m -104.2 91.46 3.94 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -173.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 40.2 mtt -93.79 103.34 15.48 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.211 1.004 . . . . 0.0 109.078 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 75.1 p -99.98 106.57 18.38 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -172.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 42.0 tp -102.95 82.26 2.08 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.94 -99.81 0.88 Allowed Glycine 0 CA--C 1.545 1.925 0 N-CA-C 114.326 0.49 . . . . 0.0 114.326 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -89.72 -25.8 21.0 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 171.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 14.0 mm -67.2 138.76 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.651 0 C-N-CA 125.057 1.343 . . . . 0.0 109.751 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.95 93.94 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 172.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -87.65 98.92 11.69 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.487 0.715 . . . . 0.0 109.752 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -108.9 104.97 14.31 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 123.605 0.566 . . . . 0.0 110.056 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -85.59 142.19 29.29 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.522 164.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -125.41 105.56 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 103.37 -2.826 . . . . 0.0 103.37 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 62.5 m -120.84 120.86 36.78 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.168 0.587 . . . . 0.0 109.459 -174.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -86.03 139.93 30.73 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.317 0.647 . . . . 0.0 111.941 -170.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -69.59 113.9 7.3 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.662 0.785 . . . . 0.0 111.741 -176.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.5 mt . . . . . 0 N--CA 1.482 1.173 0 N-CA-C 102.428 -3.175 . . . . 0.0 102.428 -163.424 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 . . . . . 0 N--CA 1.495 1.812 0 N-CA-C 117.711 2.486 . . . . 0.0 117.711 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.2 m -69.73 107.74 3.61 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 120.857 1.662 . . . . 0.0 110.909 176.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.97 162.11 24.5 Favored Glycine 0 CA--C 1.544 1.873 0 CA-C-O 122.425 1.014 . . . . 0.0 114.233 -171.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -105.36 115.43 30.24 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -113.64 98.49 7.08 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 -169.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -93.51 138.91 31.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.936 -0.478 . . . . 0.0 111.067 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.1 tp -63.82 137.96 58.27 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -171.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -121.57 -64.8 1.19 Allowed 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.536 -175.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.8 t -128.77 115.36 17.83 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.617 0.767 . . . . 0.0 109.263 -174.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -105.3 128.72 53.6 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.958 0.903 . . . . 0.0 109.654 175.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -88.52 -70.18 0.66 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.607 -177.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -114.63 68.66 0.7 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.278 0.631 . . . . 0.0 110.398 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -74.61 -52.32 12.07 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 118.496 -0.764 . . . . 0.0 112.448 169.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -63.39 -47.61 81.3 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -173.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.5 -39.67 94.21 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 171.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -66.52 -50.95 61.49 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 176.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 20.7 mmt -62.72 -42.17 99.53 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -175.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -61.75 -45.31 94.45 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 168.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.5 -29.63 70.69 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.262 39.5 pt -76.02 -53.43 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 119.901 1.228 . . . . 0.0 112.132 170.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.31 67.77 0.01 OUTLIER Glycine 0 CA--C 1.538 1.493 0 CA-C-O 118.887 -0.952 . . . . 0.0 112.33 173.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.8 mt -130.06 141.28 41.32 Favored Pre-proline 0 CA--C 1.568 1.637 0 CA-C-N 117.918 0.859 . . . . 0.0 110.561 175.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.66 151.62 84.08 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 123.306 2.671 . . . . 0.0 114.034 172.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -49.93 -37.21 30.77 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 116.5 2.037 . . . . 0.0 116.5 172.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -63.11 -51.06 68.05 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 169.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.5 mt -70.98 -14.31 62.31 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 174.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.3 mt -71.66 -54.68 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-N 120.191 1.36 . . . . 0.0 110.267 166.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -64.2 -27.1 68.83 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 174.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -79.96 -49.47 11.81 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 119.612 1.096 . . . . 0.0 112.594 170.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.55 -24.72 68.08 Favored Glycine 0 CA--C 1.551 2.314 0 N-CA-C 118.951 2.34 . . . . 0.0 118.951 174.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -65.2 -44.42 88.43 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-N 120.509 2.154 . . . . 0.0 114.194 167.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -66.94 -31.4 71.95 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 171.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.0 mt -75.69 107.18 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 172.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.33 105.25 17.44 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -172.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.0 127.97 8.58 Favored Glycine 0 CA--C 1.54 1.618 0 N-CA-C 115.036 0.774 . . . . 0.0 115.036 -160.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.2 t -81.13 116.45 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 172.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.4 m -106.65 105.41 15.42 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -79.62 143.06 35.04 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 121.865 0.841 . . . . 0.0 110.782 175.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 54.2 mt -142.02 124.18 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 103.676 -2.713 . . . . 0.0 103.676 170.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.6 t -122.1 103.72 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -89.82 127.79 36.04 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 121.202 0.525 . . . . 0.0 110.252 176.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -126.72 82.25 2.07 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 165.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.91 -123.62 10.99 Favored Glycine 0 CA--C 1.547 2.058 0 C-N-CA 123.286 0.469 . . . . 0.0 113.939 -176.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -73.62 -35.15 65.3 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 169.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -73.44 147.88 43.78 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 122.724 1.249 . . . . 0.0 111.731 176.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -137.91 148.9 45.74 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 113.613 -1.63 . . . . 0.0 109.498 -177.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.21 110.98 8.71 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 164.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -104.05 147.38 27.46 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.069 172.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.5 m -135.59 92.53 2.84 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.0 tt -96.14 126.88 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 123.437 0.695 . . . . 0.0 109.809 -177.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.6 p . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 175.016 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.7 mt . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -118.33 137.02 53.37 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.296 0.638 . . . . 0.0 111.224 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -137.81 145.98 42.97 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.941 0.877 . . . . 0.0 109.786 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -106.28 128.18 53.79 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.251 169.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -134.75 159.48 41.18 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.722 0.773 . . . . 0.0 111.479 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.5 m -124.2 131.83 53.56 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 173.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.9 m -74.11 130.41 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 123.582 0.753 . . . . 0.0 111.7 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.38 -48.21 1.72 Allowed Glycine 0 CA--C 1.549 2.206 0 N-CA-C 114.964 0.746 . . . . 0.0 114.964 -168.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -67.7 146.44 53.79 Favored 'General case' 0 CA--C 1.564 1.517 0 C-N-CA 124.536 1.134 . . . . 0.0 112.159 172.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -78.86 92.2 4.85 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.872 0.869 . . . . 0.0 109.615 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 25.5 p -107.2 140.08 40.62 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -154.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -67.23 127.49 32.85 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.635 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.5 mt . . . . . 0 N--CA 1.486 1.339 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -178.257 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.2 mptt . . . . . 0 N--CA 1.486 1.349 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.2 m -92.67 126.09 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.379 -177.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -84.6 96.37 9.16 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.5 p -138.34 125.45 21.45 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -162.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.6 t -85.6 125.22 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -160.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.0 t -100.59 118.97 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -99.71 134.27 42.84 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.735 0.779 . . . . 0.0 109.754 176.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.1 tp -101.53 112.31 24.82 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.443 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -118.08 121.28 40.17 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.37 12.76 66.81 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 121.215 3.246 . . . . 0.0 121.215 175.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.302 9.0 t70 52.16 48.75 22.06 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -162.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -155.6 -43.34 0.08 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 117.651 -1.166 . . . . 0.0 113.584 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -98.73 122.0 41.39 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 120.469 1.486 . . . . 0.0 110.373 -175.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 77.3 mt -110.69 98.95 7.99 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 168.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.7 m -103.71 124.57 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 123.707 0.803 . . . . 0.0 109.525 -172.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.1 t -148.22 132.39 17.36 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.047 0.451 . . . . 0.0 110.971 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.7 p -95.66 119.83 34.85 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 172.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -84.64 -85.05 0.14 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.074 0.55 . . . . 0.0 109.909 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.74 -75.28 0.59 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 167.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -100.89 -19.07 16.07 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 167.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 mp -82.03 115.99 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-N 120.275 1.398 . . . . 0.0 108.106 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -99.31 101.78 13.19 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 168.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.9 t -85.66 99.4 11.27 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.617 0.767 . . . . 0.0 110.458 -177.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 70.2 t -99.52 97.76 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.7 m -105.52 86.24 2.38 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -166.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -97.04 131.6 43.68 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.888 0.875 . . . . 0.0 110.106 -171.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 tt -101.68 106.28 17.29 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -175.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -106.18 86.66 2.4 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -172.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.74 -108.09 2.68 Favored Glycine 0 N--CA 1.482 1.74 0 O-C-N 122.101 -0.374 . . . . 0.0 112.882 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -121.46 52.65 1.22 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.314 0.578 . . . . 0.0 111.615 170.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.5 pt -131.21 -163.17 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 C-N-CA 124.337 1.055 . . . . 0.0 108.163 163.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.3 tt -154.88 119.57 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 120.363 -1.46 . . . . 0.0 107.952 157.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 29.3 m -95.06 101.02 12.75 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -94.81 99.34 11.43 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 30.3 m -101.93 91.17 4.24 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -172.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 36.3 mtt -93.17 103.36 15.64 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.224 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.3 p -97.86 95.94 7.87 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.489 -171.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 19.3 tp -93.72 81.97 4.3 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.723 0.809 . . . . 0.0 109.079 177.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.8 -101.95 1.16 Allowed Glycine 0 CA--C 1.544 1.879 0 CA-C-N 116.191 -0.458 . . . . 0.0 113.043 -174.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -98.06 -11.52 22.84 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 170.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 62.4 mt -86.71 106.46 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -174.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.9 t -98.84 94.17 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -175.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -82.3 92.73 7.0 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.231 0.613 . . . . 0.0 109.659 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -92.41 109.47 20.86 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.3 ttt-85 -118.23 104.9 11.23 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -164.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.9 mp -98.44 116.33 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 105.593 -2.002 . . . . 0.0 105.593 -172.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.9 m -130.33 115.14 16.51 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -176.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -87.38 137.33 32.43 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.228 0.611 . . . . 0.0 112.135 -168.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.3 ttt85 -67.58 124.88 24.46 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 123.914 0.886 . . . . 0.0 111.524 177.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.5 pt . . . . . 0 N--CA 1.484 1.258 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 -172.576 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 . . . . . 0 N--CA 1.495 1.801 0 N-CA-C 117.027 2.232 . . . . 0.0 117.027 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.7 m -73.29 109.21 6.64 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 120.704 1.593 . . . . 0.0 110.648 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.15 162.21 23.09 Favored Glycine 0 CA--C 1.544 1.877 0 CA-C-O 122.306 0.948 . . . . 0.0 114.134 -171.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -97.18 125.88 41.98 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 114.402 -0.899 . . . . 0.0 108.605 175.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -121.52 104.37 9.6 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -172.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -95.62 137.85 34.11 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.129 0.49 . . . . 0.0 110.892 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.7 tp -66.11 130.69 44.11 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.082 0.953 . . . . 0.0 112.987 -173.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -114.64 -64.79 1.26 Allowed 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.879 -175.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.7 m -125.49 112.05 15.78 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -105.74 110.4 22.69 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -97.41 127.42 43.36 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.263 85.5 m-20 67.4 52.51 0.8 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 173.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -78.65 -43.95 24.94 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 168.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -68.65 -50.86 47.83 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -175.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.91 -40.74 85.44 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 170.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -69.44 -56.54 7.13 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -44.24 96.61 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -61.96 -38.13 87.37 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 170.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.66 -34.39 77.74 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.819 2.155 . . . . 0.0 116.819 172.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.5 pt -82.33 -53.8 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 CA-C-N 119.327 0.967 . . . . 0.0 112.384 176.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.52 68.68 0.01 OUTLIER Glycine 0 CA--C 1.539 1.535 0 CA-C-N 119.017 0.826 . . . . 0.0 112.894 172.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.32 153.11 81.56 Favored Pre-proline 0 CA--C 1.57 1.721 0 C-N-CA 123.513 0.725 . . . . 0.0 111.813 175.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.81 152.84 25.53 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 123.264 2.643 . . . . 0.0 113.489 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -59.18 -28.84 66.99 Favored 'General case' 0 CA--C 1.565 1.526 0 N-CA-C 116.723 2.119 . . . . 0.0 116.723 168.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -63.02 -51.81 65.35 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 120.543 1.52 . . . . 0.0 114.055 170.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.4 mt -67.93 -28.28 67.35 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 116.604 2.075 . . . . 0.0 116.604 173.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.3 mt -70.38 -49.94 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 C-N-CA 124.297 1.039 . . . . 0.0 111.621 173.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -64.23 -22.62 67.01 Favored 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 116.315 1.969 . . . . 0.0 116.315 170.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -73.08 -57.99 3.63 Favored 'General case' 0 CA--C 1.565 1.519 0 CA-C-N 119.272 0.942 . . . . 0.0 111.74 167.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.5 -22.16 67.46 Favored Glycine 0 CA--C 1.548 2.143 0 N-CA-C 120.418 2.927 . . . . 0.0 120.418 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -64.68 -43.53 93.24 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 119.661 1.731 . . . . 0.0 114.64 170.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -67.24 -27.85 67.57 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 168.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 53.1 mt -83.03 121.75 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-N 120.144 1.338 . . . . 0.0 107.506 178.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.64 102.46 15.09 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 173.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.54 132.74 11.42 Favored Glycine 0 CA--C 1.541 1.707 0 N-CA-C 114.509 0.564 . . . . 0.0 114.509 -167.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.3 t -85.33 110.21 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 54.2 p -109.79 112.16 24.03 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.5 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -89.63 152.32 21.44 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 121.632 0.729 . . . . 0.0 111.058 -177.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.2 mt -136.35 132.8 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 105.437 -2.06 . . . . 0.0 105.437 173.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.6 t -126.57 102.77 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -80.18 120.7 24.65 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.122 0.569 . . . . 0.0 110.148 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -122.99 73.0 1.12 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 169.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.83 -117.48 7.56 Favored Glycine 0 CA--C 1.546 1.996 0 C-N-CA 123.117 0.389 . . . . 0.0 113.67 -175.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -76.87 -34.36 57.8 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 169.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -79.95 112.99 17.78 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 119.941 1.246 . . . . 0.0 110.761 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -105.74 117.98 35.42 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -104.12 104.65 14.62 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 176.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -133.29 134.45 43.9 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.297 -166.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.96 147.71 22.84 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.669 0.747 . . . . 0.0 110.029 165.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.0 tp -130.68 121.91 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.5 m . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 172.74 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.3 tt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.857 0.837 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -94.81 125.48 39.49 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.774 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -127.38 159.19 35.21 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 124.007 0.923 . . . . 0.0 110.257 -177.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -139.34 136.69 35.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.543 -0.723 . . . . 0.0 110.244 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.493 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 28.5 p90 -126.96 159.71 33.23 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 122.012 0.91 . . . . 0.0 112.324 167.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 96.3 m -116.07 139.7 50.03 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 163.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.6 t -75.62 123.35 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.13 34.21 21.49 Favored Glycine 0 CA--C 1.549 2.198 0 N-CA-C 117.044 1.578 . . . . 0.0 117.044 -168.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -149.89 138.57 20.83 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -177.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -69.32 105.71 2.65 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.176 0.512 . . . . 0.0 109.954 160.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 63' ' ' PHE . 3.2 p -129.25 131.76 47.09 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 122.402 1.096 . . . . 0.0 110.649 -162.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -79.65 123.75 27.92 Favored 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 113.962 -1.472 . . . . 0.0 112.631 -168.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.8 mt . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 -177.926 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 121.045 0.45 . . . . 0.0 110.676 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.9 p -140.12 121.19 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -169.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -92.85 123.63 36.26 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.189 0.596 . . . . 0.0 109.985 -175.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.2 p -132.84 128.65 37.13 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -164.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.5 t -93.39 108.68 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -175.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.3 t -96.56 127.09 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -172.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -115.52 132.16 56.71 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 168.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.9 tp -98.67 108.62 21.36 Favored 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -102.79 125.5 49.56 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.78 0.8 . . . . 0.0 109.159 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.09 11.13 66.57 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 121.173 3.229 . . . . 0.0 121.173 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.274 25.9 m-20 57.77 43.52 21.77 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -166.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -158.65 -38.79 0.06 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 117.744 -1.122 . . . . 0.0 114.0 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -103.99 119.33 38.71 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 120.458 1.481 . . . . 0.0 110.411 -172.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.6 mt -101.03 99.46 9.92 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 174.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.1 t -100.68 110.59 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -170.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.6 t -137.26 159.58 41.51 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 122.863 1.316 . . . . 0.0 113.629 -167.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 58.9 m -80.47 -78.42 0.17 Allowed 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.914 -161.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 65.0 171.38 0.2 Allowed 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 119.613 1.097 . . . . 0.0 113.749 -169.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -79.21 95.06 5.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.195 -0.94 . . . . 0.0 108.569 165.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 55.8 t30 47.44 47.41 17.16 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.9 mt -137.81 88.54 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 102.926 -2.99 . . . . 0.0 102.926 174.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -84.5 98.41 10.09 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -174.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.9 t -96.62 117.65 31.42 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.933 -165.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 56.1 t -113.36 101.83 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 104.832 -2.285 . . . . 0.0 104.832 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.7 m -98.36 83.96 3.14 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -89.99 130.97 36.12 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.967 0.907 . . . . 0.0 110.214 -172.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 tt -101.27 110.38 22.38 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -110.68 85.52 2.13 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -174.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.82 -108.31 2.72 Favored Glycine 0 N--CA 1.483 1.771 0 O-C-N 122.081 -0.387 . . . . 0.0 112.952 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -121.36 56.5 1.04 Allowed 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.337 0.589 . . . . 0.0 111.188 168.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.8 pt -131.39 -166.11 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.687 0 C-N-CA 124.331 1.052 . . . . 0.0 108.522 161.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.6 tt -154.62 123.04 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.305 0 O-C-N 120.196 -1.565 . . . . 0.0 108.545 158.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 46.1 m -101.64 103.13 13.92 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 -176.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -93.0 98.56 11.43 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.5 m -99.34 87.25 3.58 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.662 0.744 . . . . 0.0 109.018 -171.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 33.5 mtt -92.46 105.43 17.61 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.129 0.972 . . . . 0.0 109.704 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.9 p -98.89 101.27 12.61 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -172.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.5 tp -95.25 83.77 3.93 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.57 -97.31 0.78 Allowed Glycine 0 CA--C 1.543 1.83 0 CA-C-N 116.437 -0.347 . . . . 0.0 112.685 -171.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -106.95 -9.3 16.31 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.319 1.599 . . . . 0.0 115.319 169.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 48.5 mt -85.75 107.31 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-N 120.692 1.587 . . . . 0.0 107.091 -173.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.3 t -94.7 95.61 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -174.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -86.74 100.75 12.72 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.905 0.882 . . . . 0.0 109.245 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -111.18 107.72 17.15 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.76 -172.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -99.72 114.33 27.37 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 75.6 mt -102.75 103.09 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 -177.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.4 m -120.47 114.98 22.58 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -171.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -84.2 135.83 34.2 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.172 0.589 . . . . 0.0 112.168 -168.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -69.91 133.46 47.35 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-O 122.014 0.912 . . . . 0.0 112.184 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.7 pt . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 -172.281 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.365 90.7 m-85 . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 117.381 2.363 . . . . 0.0 117.381 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.9 m -71.94 107.22 4.57 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 120.496 1.498 . . . . 0.0 111.248 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.69 161.31 24.28 Favored Glycine 0 CA--C 1.544 1.88 0 CA-C-O 122.652 1.14 . . . . 0.0 114.044 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -96.58 125.67 41.21 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 168.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -121.05 116.66 25.45 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -174.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -91.83 125.78 36.67 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 122.943 0.497 . . . . 0.0 110.092 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 28.6 tp -64.02 131.79 48.64 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.75 0.82 . . . . 0.0 112.781 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -126.33 -58.22 1.36 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 118.569 -0.729 . . . . 0.0 110.742 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.8 m -107.35 136.99 46.22 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 119.067 0.849 . . . . 0.0 109.664 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -139.53 106.35 5.4 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -96.47 134.2 39.95 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.081 0.952 . . . . 0.0 109.365 176.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.26 13.5 m-20 66.67 47.65 1.55 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 174.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -77.82 -49.51 14.15 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 176.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -62.79 -46.78 86.41 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 177.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.74 -42.39 93.06 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 173.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -72.49 -52.8 14.17 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -52.09 66.81 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -56.92 -39.24 74.09 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 171.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.12 -37.48 87.59 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 116.588 2.069 . . . . 0.0 116.588 174.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.278 48.5 pt -77.36 -48.88 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-N 119.516 1.053 . . . . 0.0 112.955 175.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.81 57.72 0.01 OUTLIER Glycine 0 N--CA 1.483 1.815 0 CA-C-N 119.473 1.033 . . . . 0.0 114.5 166.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -110.3 154.03 43.1 Favored Pre-proline 0 CA--C 1.566 1.575 0 CA-C-N 118.009 0.904 . . . . 0.0 112.084 -175.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.16 154.93 33.0 Favored 'Trans proline' 0 CA--C 1.557 1.659 0 C-N-CA 123.296 2.664 . . . . 0.0 113.384 172.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -61.62 -35.49 78.04 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 170.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.05 -54.18 50.03 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 173.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.6 mt -70.97 -24.07 62.34 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 116.558 2.058 . . . . 0.0 116.558 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 60.6 mt -70.2 -52.14 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-N 119.94 1.245 . . . . 0.0 110.974 169.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -62.84 -19.7 64.36 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 116.912 2.19 . . . . 0.0 116.912 173.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -81.38 -53.91 5.91 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-N 119.483 1.038 . . . . 0.0 112.182 167.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.45 -7.2 57.36 Favored Glycine 0 CA--C 1.553 2.463 0 N-CA-C 120.279 2.872 . . . . 0.0 120.279 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.77 -47.03 61.73 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 120.21 2.005 . . . . 0.0 113.273 170.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -69.43 -31.91 70.56 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 168.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.2 mt -78.29 119.79 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -85.13 116.25 23.39 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.86 131.16 10.59 Favored Glycine 0 CA--C 1.54 1.608 0 CA-C-N 116.096 -0.502 . . . . 0.0 113.723 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.8 t -81.26 114.53 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 175.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.2 m -96.51 110.98 23.26 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 176.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.39 141.3 30.64 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.81 0.814 . . . . 0.0 109.954 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 67.2 mt -141.53 132.34 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 170.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.8 t -120.87 113.39 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 174.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -82.41 123.73 29.4 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.262 0.625 . . . . 0.0 110.168 173.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -128.07 72.02 1.4 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 163.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.88 -114.43 5.29 Favored Glycine 0 CA--C 1.545 1.933 0 C-N-CA 123.4 0.524 . . . . 0.0 113.385 -177.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -77.53 -33.51 54.22 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 167.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -76.54 102.94 6.27 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 120.072 1.305 . . . . 0.0 111.008 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -109.13 109.21 20.14 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.95 127.89 44.98 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 168.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -116.34 152.14 34.49 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.747 178.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.1 m -136.28 92.63 2.8 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 173.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.8 mm -91.12 116.61 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 -175.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -174.816 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.4 mt . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -117.09 130.72 56.83 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.768 0.827 . . . . 0.0 110.966 -176.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -148.31 149.13 31.27 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.553 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -118.4 128.36 54.55 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.826 0.85 . . . . 0.0 110.222 -176.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -116.12 144.47 44.11 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.962 0.905 . . . . 0.0 111.425 170.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.2 m -105.3 124.11 48.98 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 166.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.4 t -67.04 124.88 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 C-N-CA 123.735 0.814 . . . . 0.0 110.662 -174.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.18 -49.97 2.45 Favored Glycine 0 CA--C 1.549 2.167 0 N-CA-C 115.999 1.16 . . . . 0.0 115.999 -170.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -93.22 124.13 36.98 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.728 0.811 . . . . 0.0 110.231 -172.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -57.44 123.81 16.75 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 -168.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 72.6 m -144.08 146.53 32.88 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.099 0.96 . . . . 0.0 109.609 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -80.04 134.59 36.23 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.2 mt . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 175.107 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 49.5 mttm . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 122.393 1.092 . . . . 0.0 109.685 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.8 p -114.39 134.52 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 113.157 -1.838 . . . . 0.0 108.773 -164.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -78.02 106.39 9.85 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.14 0.576 . . . . 0.0 110.794 -171.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.6 t -152.64 130.81 11.94 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -173.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.25 145.26 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 123.374 1.559 . . . . 0.0 110.587 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.8 t -98.49 142.18 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.302 0 CA-C-N 112.985 -1.916 . . . . 0.0 108.347 -167.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -112.48 132.98 54.79 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 172.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.7 tp -98.07 109.71 22.42 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.841 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -95.65 114.93 26.73 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 122.127 0.965 . . . . 0.0 108.929 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.44 -128.64 10.65 Favored Glycine 0 CA--C 1.545 1.919 0 CA-C-N 114.019 -1.446 . . . . 0.0 112.265 -168.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -135.82 58.55 1.75 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 156.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -158.49 -32.0 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -173.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -114.39 106.21 14.03 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 120.925 1.693 . . . . 0.0 108.976 -174.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 42.4 mt -95.78 103.91 15.81 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.0 m -102.35 125.56 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 C-N-CA 123.372 0.669 . . . . 0.0 109.87 -172.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 t -149.66 151.43 33.71 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.324 0.583 . . . . 0.0 111.771 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 29.7 p -119.71 112.72 19.64 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.405 0.682 . . . . 0.0 109.215 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -83.38 37.43 0.56 Allowed 'General case' 0 CA--C 1.58 2.106 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 168.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.344 11.8 tmtt? 69.99 -81.04 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.952 1.301 . . . . 0.0 111.236 -163.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -81.14 -42.6 20.63 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.8 mp -85.64 123.05 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-N 119.585 1.084 . . . . 0.0 108.167 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -102.57 98.77 8.78 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 172.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.9 t -89.67 132.88 34.94 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.478 0.711 . . . . 0.0 110.958 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.1 t -132.95 102.3 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 20.6 m -93.14 95.71 9.58 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -80.84 145.21 31.51 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.111 0.964 . . . . 0.0 110.703 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.2 tt -128.35 109.37 11.38 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 174.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -113.21 80.49 1.36 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -175.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.93 -109.24 3.26 Favored Glycine 0 N--CA 1.484 1.861 0 O-C-N 121.835 -0.541 . . . . 0.0 113.068 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.47 50.39 0.95 Allowed 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 122.965 0.506 . . . . 0.0 111.362 173.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.6 pt -133.8 -168.74 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.786 0 C-N-CA 124.047 0.939 . . . . 0.0 108.938 171.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.1 tt -156.85 115.44 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.272 -1.517 . . . . 0.0 107.45 159.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 90.0 m -103.15 99.7 9.58 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -90.19 108.81 19.98 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 39.7 m -108.48 100.14 9.45 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 -173.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.8 mtt -101.28 100.39 10.89 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.2 p -88.65 113.38 24.16 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.009 -173.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.3 tp -117.87 75.43 1.0 Allowed 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.35 -107.4 2.34 Favored Glycine 0 CA--C 1.545 1.958 0 CA-C-N 116.404 -0.362 . . . . 0.0 112.369 -172.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -93.62 -10.7 33.7 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 167.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 61.8 mt -86.52 103.67 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -173.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 48.4 t -97.81 97.78 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -85.55 96.33 9.6 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.163 0.585 . . . . 0.0 109.446 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -105.26 101.67 11.19 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -176.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.6 113.98 27.22 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 50.2 mt -107.02 112.91 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -172.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 54.5 m -114.76 119.03 35.26 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 176.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -83.81 147.3 27.66 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.965 -0.459 . . . . 0.0 110.937 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -76.03 107.18 8.06 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 121.538 0.685 . . . . 0.0 111.295 -169.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.7 mt . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 102.336 -3.209 . . . . 0.0 102.336 -158.505 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 . . . . . 0 N--CA 1.494 1.743 0 N-CA-C 117.569 2.433 . . . . 0.0 117.569 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.2 m -69.39 112.26 5.81 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 120.822 1.646 . . . . 0.0 110.792 173.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.03 145.22 4.95 Favored Glycine 0 CA--C 1.541 1.675 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.062 -171.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -102.21 106.8 17.69 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -107.64 104.05 13.49 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -162.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -83.19 131.24 35.13 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.123 0.487 . . . . 0.0 111.633 -177.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.9 tp -76.14 115.71 16.13 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.675 -168.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -98.6 -65.24 0.97 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.507 0.723 . . . . 0.0 111.444 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.0 m -131.89 135.66 46.83 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.245 0.618 . . . . 0.0 110.336 -163.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -129.29 134.68 48.05 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.649 0.737 . . . . 0.0 109.799 -175.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -76.28 -58.55 3.22 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.356 171.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -127.35 68.94 1.29 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.584 0.629 . . . . 0.0 110.799 -176.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -75.12 -54.26 7.45 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.526 -0.734 . . . . 0.0 112.553 170.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -65.21 -49.55 69.3 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.22 -39.21 82.0 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 116.89 2.182 . . . . 0.0 116.89 174.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -65.96 -54.07 30.89 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 174.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 37.4 mtt -60.7 -45.61 93.52 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -55.67 -42.1 74.63 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 167.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.4 -34.47 78.02 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 117.06 2.244 . . . . 0.0 117.06 175.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.7 pt -78.48 -43.94 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-N 119.822 1.192 . . . . 0.0 113.599 175.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.36 62.78 0.09 OUTLIER Glycine 0 N--CA 1.481 1.664 0 CA-C-N 118.881 0.764 . . . . 0.0 112.682 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.42 151.33 46.8 Favored Pre-proline 0 CA--C 1.568 1.649 0 C-N-CA 123.8 0.84 . . . . 0.0 110.745 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -75.65 156.99 40.21 Favored 'Trans proline' 0 CA--C 1.555 1.559 0 C-N-CA 123.264 2.642 . . . . 0.0 113.637 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -60.35 -29.53 68.96 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.692 1.738 . . . . 0.0 115.692 168.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -60.2 -57.75 11.48 Favored 'General case' 0 CA--C 1.564 1.495 0 CA-C-O 117.297 -1.335 . . . . 0.0 113.803 169.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.8 mt -68.69 -24.16 64.47 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 117.19 2.293 . . . . 0.0 117.19 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.4 mt -73.38 -54.29 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-N 119.491 1.042 . . . . 0.0 110.711 173.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -69.18 -27.85 65.88 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 177.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -76.69 -53.77 7.54 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.04 0.936 . . . . 0.0 112.109 171.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.9 -19.78 69.99 Favored Glycine 0 CA--C 1.551 2.316 0 N-CA-C 119.652 2.621 . . . . 0.0 119.652 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -65.72 -43.71 88.24 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 120.251 2.025 . . . . 0.0 114.434 170.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -68.4 -31.47 70.83 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 170.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.9 mt -77.33 129.86 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-N 119.532 1.06 . . . . 0.0 108.508 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.52 94.97 9.94 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 171.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.12 131.06 10.36 Favored Glycine 0 N--CA 1.481 1.635 0 CA-C-N 116.558 -0.292 . . . . 0.0 113.322 -172.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.7 t -79.75 120.81 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.9 m -108.29 100.21 9.54 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 107.167 -1.419 . . . . 0.0 107.167 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -83.89 147.9 27.26 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.842 0.829 . . . . 0.0 111.011 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.9 mt -143.91 129.42 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 172.21 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 67.8 t -120.88 117.49 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 176.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -81.2 122.11 26.98 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.404 0.681 . . . . 0.0 111.31 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -131.0 64.11 1.58 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 171.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.58 -113.73 5.9 Favored Glycine 0 CA--C 1.547 2.059 0 O-C-N 121.629 -0.669 . . . . 0.0 113.746 -174.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -73.29 -40.46 64.54 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 169.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -69.63 135.59 50.12 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 119.407 1.003 . . . . 0.0 111.387 175.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -127.6 108.72 11.02 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -87.04 92.59 9.1 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.673 0.749 . . . . 0.0 109.017 176.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -104.64 136.5 44.05 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.42 -175.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.8 m -131.55 102.58 5.98 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -177.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.6 mm -95.22 105.08 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 174.34 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.8 mp . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.78 120.85 42.22 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.203 0.601 . . . . 0.0 110.538 -177.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -149.62 161.33 42.38 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.175 0.99 . . . . 0.0 109.968 -175.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -117.47 128.58 55.13 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.57 0.748 . . . . 0.0 109.871 175.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -107.89 145.07 34.25 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.467 0.651 . . . . 0.0 110.392 158.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.4 m -109.15 131.89 54.64 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 171.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.2 t -73.55 130.1 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 123.797 0.839 . . . . 0.0 109.702 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.27 8.52 87.52 Favored Glycine 0 CA--C 1.553 2.452 0 N-CA-C 118.706 2.242 . . . . 0.0 118.706 -170.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -139.73 135.7 33.41 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 119.272 1.536 . . . . 0.0 108.251 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.75 121.93 18.18 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.257 0.623 . . . . 0.0 112.5 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -136.86 126.85 25.93 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.693 0.797 . . . . 0.0 110.479 -165.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.3 128.3 34.09 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.03 -0.987 . . . . 0.0 111.685 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.9 mt . . . . . 0 N--CA 1.487 1.421 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -175.43 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 mptt . . . . . 0 N--CA 1.487 1.408 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.7 m -80.54 -47.43 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -168.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . 0.265 53.9 mtpt 64.36 86.32 0.13 Allowed 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 124.821 1.248 . . . . 0.0 111.648 -172.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.7 t -134.68 147.17 50.06 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.707 0.803 . . . . 0.0 110.033 -171.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.8 t -85.5 -56.98 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.776 -0.578 . . . . 0.0 111.427 -169.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . 0.307 3.1 t 80.25 127.24 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 125.382 1.473 . . . . 0.0 109.866 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -121.26 135.17 55.16 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 39.2 tp -96.68 102.57 14.37 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -86.23 114.43 23.05 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 121.799 0.809 . . . . 0.0 109.309 173.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.53 -122.42 8.54 Favored Glycine 0 CA--C 1.542 1.724 0 CA-C-N 114.394 -1.276 . . . . 0.0 112.89 -175.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -142.04 60.42 1.46 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 155.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -151.51 -39.29 0.12 Allowed 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 117.267 -1.349 . . . . 0.0 114.218 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -106.27 126.65 52.49 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 120.686 1.584 . . . . 0.0 110.288 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 37.2 mt -107.74 100.0 9.43 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 165.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.8 m -94.9 122.85 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 123.876 0.871 . . . . 0.0 109.274 -172.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.2 t -152.51 132.82 13.65 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 120.92 0.39 . . . . 0.0 111.907 -172.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 44.8 p -100.58 121.54 41.78 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -84.18 -70.74 0.55 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.031 0.532 . . . . 0.0 111.339 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -120.7 -77.3 0.58 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 165.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -126.74 66.98 1.25 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 159.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 62.9 mt -142.33 101.21 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 103.411 -2.811 . . . . 0.0 103.411 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -88.08 98.4 11.51 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.345 0.593 . . . . 0.0 109.571 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.3 t -88.25 102.64 15.02 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.307 1.043 . . . . 0.0 109.947 -176.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.7 t -101.0 97.23 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 -177.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.9 m -91.65 83.49 5.33 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -168.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -98.66 129.13 45.14 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.626 0.77 . . . . 0.0 110.129 -161.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 tt -113.09 114.07 26.31 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -167.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -119.27 103.33 9.41 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.01 -118.18 4.65 Favored Glycine 0 N--CA 1.484 1.862 0 C-N-CA 123.123 0.392 . . . . 0.0 112.714 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -124.93 60.16 1.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.986 0.898 . . . . 0.0 110.107 161.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.6 pt -123.62 -164.64 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.789 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 157.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.3 tt -155.9 125.19 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 120.147 -1.596 . . . . 0.0 108.283 160.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 88.9 m -109.76 98.65 7.95 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -93.86 123.79 37.44 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.371 0.605 . . . . 0.0 109.691 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 27.8 m -114.59 93.84 4.51 Favored 'General case' 0 CA--C 1.557 1.236 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 -170.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 63.5 mtt -93.22 99.81 12.3 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.813 0.845 . . . . 0.0 109.102 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 73.8 p -94.84 100.22 12.14 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -171.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 35.0 tp -96.4 84.96 3.81 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.31 -100.0 0.93 Allowed Glycine 0 CA--C 1.544 1.881 0 CA-C-N 116.743 -0.208 . . . . 0.0 112.852 -174.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -102.36 -10.5 19.4 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 169.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 71.9 mt -87.09 108.19 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-N 120.601 1.546 . . . . 0.0 107.453 -172.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.3 t -97.83 93.13 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -172.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -82.84 109.18 16.75 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 122.967 0.507 . . . . 0.0 110.285 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -88.77 142.79 27.37 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.818 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 45.7 mtm180 -134.62 93.57 3.06 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 174.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 58.3 mt -94.73 104.87 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 105.499 -2.038 . . . . 0.0 105.499 -174.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.5 m -130.75 112.92 13.51 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -163.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -90.87 138.95 31.2 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.351 0.595 . . . . 0.0 112.186 -172.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.2 136.71 56.29 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 123.748 0.819 . . . . 0.0 113.114 -177.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.9 pt . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 -175.53 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 . . . . . 0 CA--C 1.57 1.74 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.2 m 62.0 88.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.04 1.336 . . . . 0.0 112.848 -176.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.44 167.05 31.93 Favored Glycine 0 CA--C 1.54 1.646 0 CA-C-O 122.993 1.33 . . . . 0.0 115.095 -177.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -94.26 122.22 36.58 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 113.313 -1.444 . . . . 0.0 107.658 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -114.62 105.58 13.24 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -175.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -77.58 117.09 18.67 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.121 0.969 . . . . 0.0 111.052 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 55.5 tp -69.67 107.15 3.33 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.112 0.565 . . . . 0.0 112.185 -174.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -85.89 -58.86 2.48 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.903 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.2 t -134.14 142.32 47.43 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.682 0.793 . . . . 0.0 110.016 -169.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -120.97 133.88 55.28 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.841 0.829 . . . . 0.0 108.931 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -76.03 -61.86 1.8 Allowed 'General case' 0 CA--C 1.561 1.387 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.835 169.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -128.28 67.89 1.36 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 118.628 0.649 . . . . 0.0 111.132 -172.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -75.06 -52.08 11.94 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 175.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -66.74 -43.22 84.75 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 -175.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.25 -44.0 95.64 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 169.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -67.82 -51.93 42.85 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.28 -49.07 75.31 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -60.97 -42.35 98.16 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 171.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.64 -29.61 69.67 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 117.242 2.312 . . . . 0.0 117.242 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.267 37.8 pt -77.29 -48.84 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 120.1 1.318 . . . . 0.0 112.587 171.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 137.22 65.13 0.05 OUTLIER Glycine 0 CA--C 1.541 1.686 0 C-N-CA 123.826 0.727 . . . . 0.0 112.312 175.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.4 mt -131.25 147.74 67.4 Favored Pre-proline 0 CA--C 1.568 1.64 0 C-N-CA 123.958 0.903 . . . . 0.0 110.437 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.44 149.04 80.25 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 123.39 2.727 . . . . 0.0 114.397 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -59.47 -28.09 66.69 Favored 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 171.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -61.95 -46.43 89.35 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 166.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.14 -16.49 64.02 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 116.984 2.216 . . . . 0.0 116.984 167.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 72.9 mt -74.62 -55.35 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-N 120.414 1.461 . . . . 0.0 110.534 168.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -67.2 -29.28 68.91 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -75.73 -56.4 4.72 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 119.546 1.066 . . . . 0.0 111.517 168.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.22 -19.74 59.85 Favored Glycine 0 CA--C 1.55 2.223 0 N-CA-C 120.619 3.008 . . . . 0.0 120.619 178.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -67.16 -44.84 78.74 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 119.654 1.727 . . . . 0.0 113.852 168.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -68.71 -37.95 79.89 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 169.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.6 mt -74.33 126.41 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 119.455 1.025 . . . . 0.0 108.355 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.08 99.25 11.36 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.69 111.48 3.72 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-N 116.023 -0.535 . . . . 0.0 113.13 -172.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.7 t -67.15 129.26 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 123.813 0.845 . . . . 0.0 110.481 -176.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.0 p -98.82 105.7 17.88 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -86.61 151.06 23.77 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.473 176.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.6 mt -140.84 138.8 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.7 t -129.8 103.93 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 171.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -90.22 113.13 24.88 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 172.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -121.64 62.63 0.92 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.173 0.589 . . . . 0.0 109.523 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.12 -111.53 3.86 Favored Glycine 0 CA--C 1.546 1.975 0 O-C-N 121.852 -0.53 . . . . 0.0 113.161 -173.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -75.65 -43.0 49.93 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 169.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -73.73 110.73 8.26 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 119.42 1.009 . . . . 0.0 109.814 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.61 97.47 2.98 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -155.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.27 160.35 19.88 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.019 0.928 . . . . 0.0 111.463 -172.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -145.38 130.35 18.3 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.796 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.4 m -99.83 93.88 6.03 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 174.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.9 tp -86.6 118.55 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.4 p . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 174.745 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.6 mt . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -92.94 120.62 33.45 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 167.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -123.32 113.23 18.58 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -176.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -97.98 124.11 42.29 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.321 0.648 . . . . 0.0 109.256 -171.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -125.12 149.81 47.5 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.567 0.698 . . . . 0.0 111.351 176.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.0 m -105.94 132.17 52.36 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 168.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.8 t -79.53 119.35 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 175.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.32 0.22 73.86 Favored Glycine 0 CA--C 1.556 2.609 0 N-CA-C 118.885 2.314 . . . . 0.0 118.885 -171.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -145.46 132.14 19.95 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 120.278 2.039 . . . . 0.0 108.605 167.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -73.08 113.26 9.93 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -174.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 90.9 m -96.72 156.02 16.53 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.745 173.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -77.66 101.65 6.7 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.455 0.702 . . . . 0.0 111.145 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.6 mt . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 121.299 0.571 . . . . 0.0 110.942 -165.592 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.9 127.78 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -169.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -75.96 119.68 20.25 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.368 0.604 . . . . 0.0 111.383 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.7 t -145.9 141.6 27.96 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.485 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.14 136.4 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-O 122.515 1.15 . . . . 0.0 109.311 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.5 t -91.0 129.84 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.256 0 CA-C-N 113.833 -1.53 . . . . 0.0 107.833 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -100.56 134.97 42.72 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.062 0.935 . . . . 0.0 109.112 171.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.5 tp -97.84 102.66 14.47 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 114.352 -1.294 . . . . 0.0 107.961 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -101.55 116.96 33.94 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.91 11.38 85.55 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 120.946 3.138 . . . . 0.0 120.946 171.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.283 20.3 m-20 57.85 43.29 21.88 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -165.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -158.63 -43.55 0.06 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 118.118 -0.944 . . . . 0.0 113.521 -177.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -95.8 138.43 33.46 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 120.142 1.337 . . . . 0.0 111.237 -175.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.0 mt -123.36 101.91 7.62 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 172.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.2 m -106.27 117.53 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 123.439 0.696 . . . . 0.0 109.181 -171.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.6 t -151.7 142.1 22.51 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 122.421 0.288 . . . . 0.0 111.346 -175.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 83.7 m -120.68 113.53 20.35 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -70.03 -76.82 0.09 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.796 0.838 . . . . 0.0 111.42 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -120.97 -72.58 0.68 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 165.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -128.73 60.17 1.53 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 118.662 0.665 . . . . 0.0 109.69 161.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 77.0 mt -131.47 97.5 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 102.615 -3.106 . . . . 0.0 102.615 172.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -92.02 91.07 7.67 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.7 t -84.41 109.62 18.01 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.983 0.913 . . . . 0.0 109.377 -174.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 72.0 t -116.77 97.16 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 -175.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.0 m -110.68 87.1 2.45 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -166.074 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -91.92 133.8 35.36 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.131 0.972 . . . . 0.0 110.621 -174.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.4 tt -102.36 110.01 21.83 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -175.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -110.51 90.47 3.33 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -172.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.71 -109.91 2.91 Favored Glycine 0 CA--C 1.544 1.85 0 CA-C-O 119.926 -0.374 . . . . 0.0 113.03 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -121.51 53.16 1.19 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.304 0.573 . . . . 0.0 111.694 167.056 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.4 pt -126.77 -165.44 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.799 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 159.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.5 tt -154.26 124.89 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 O-C-N 120.532 -1.355 . . . . 0.0 108.37 160.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 55.4 m -100.76 97.78 8.38 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -91.08 104.28 16.88 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.8 m -108.57 93.18 4.38 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -176.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 49.6 mtt -93.02 105.15 17.3 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.726 0.81 . . . . 0.0 109.098 177.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.4 p -95.33 100.64 12.39 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 51.3 tp -94.66 82.92 3.99 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 175.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.21 -99.75 0.9 Allowed Glycine 0 CA--C 1.542 1.751 0 CA-C-N 116.288 -0.415 . . . . 0.0 113.104 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -98.59 -15.9 19.3 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 170.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 62.4 mt -83.77 107.67 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 120.343 1.428 . . . . 0.0 107.563 -173.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.8 t -95.71 96.5 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -88.87 99.04 12.08 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.981 0.512 . . . . 0.0 109.999 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -102.27 109.67 21.41 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.046 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 25.2 mtm180 -101.64 125.79 48.36 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.73 0.812 . . . . 0.0 108.864 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.59 103.39 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 104.74 -2.318 . . . . 0.0 104.74 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 54.8 m -120.78 114.82 22.19 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 122.686 0.394 . . . . 0.0 110.065 -173.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -92.64 133.03 36.39 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.127 0.571 . . . . 0.0 111.628 -170.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -66.47 136.69 56.07 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 121.789 0.804 . . . . 0.0 113.087 -174.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.7 pt . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 -175.393 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 . . . . . 0 N--CA 1.495 1.776 0 N-CA-C 117.489 2.403 . . . . 0.0 117.489 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.7 m -70.44 109.67 4.91 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 121.093 1.769 . . . . 0.0 110.67 172.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.43 156.91 13.86 Favored Glycine 0 CA--C 1.543 1.79 0 CA-C-O 122.11 0.839 . . . . 0.0 113.873 -173.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.18 114.01 27.95 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 176.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -112.51 97.99 6.96 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -167.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -92.13 138.32 31.63 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.492 0.663 . . . . 0.0 111.003 -176.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.8 tp -74.78 126.46 30.95 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.515 -167.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.5 mm-40 -104.88 -64.68 1.1 Allowed 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.768 -175.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.5 m -129.36 140.36 51.4 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.657 0.783 . . . . 0.0 109.831 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -125.47 130.66 52.26 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.496 1.141 . . . . 0.0 110.841 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -99.44 129.12 45.6 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 113.594 -1.639 . . . . 0.0 107.221 168.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.251 69.8 m-20 67.28 40.47 2.75 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 170.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -67.64 -62.97 1.16 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.029 -1.044 . . . . 0.0 113.795 170.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -59.98 -34.98 74.03 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 117.18 2.289 . . . . 0.0 117.18 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.69 -47.17 84.81 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 166.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -65.99 -47.76 73.46 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -45.01 95.06 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 176.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -57.13 -48.26 79.11 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 166.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.71 -26.19 68.55 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 117.757 2.502 . . . . 0.0 117.757 177.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.3 pt -88.63 -49.28 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-N 119.178 0.899 . . . . 0.0 112.005 174.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 141.36 73.64 0.04 OUTLIER Glycine 0 CA--C 1.539 1.591 0 CA-C-N 118.903 0.774 . . . . 0.0 112.427 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.87 153.41 78.67 Favored Pre-proline 0 CA--C 1.571 1.763 0 C-N-CA 123.359 0.664 . . . . 0.0 112.602 176.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -76.44 158.78 36.46 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 123.354 2.703 . . . . 0.0 113.55 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -62.55 -31.6 72.41 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 169.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -60.06 -52.25 66.19 Favored 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 171.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 88.8 mt -72.43 -18.6 61.69 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 117.071 2.248 . . . . 0.0 117.071 175.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 93.3 mt -67.81 -61.28 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-N 119.631 1.105 . . . . 0.0 110.017 165.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -64.82 -25.27 67.83 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -78.58 -52.03 9.06 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.878 0.871 . . . . 0.0 112.376 171.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.78 -18.98 72.86 Favored Glycine 0 CA--C 1.551 2.33 0 N-CA-C 119.89 2.716 . . . . 0.0 119.89 177.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -65.06 -42.84 93.84 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 120.087 1.944 . . . . 0.0 114.732 169.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -66.46 -37.21 84.64 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 168.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.5 mt -72.01 115.46 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -85.98 106.72 17.36 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -174.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.04 131.76 10.91 Favored Glycine 0 CA--C 1.54 1.643 0 CA-C-N 115.966 -0.561 . . . . 0.0 114.471 -167.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.3 t -89.64 117.81 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 175.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.5 m -100.49 101.61 12.6 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 174.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.22 146.61 30.38 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.379 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 55.4 mt -142.1 123.3 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 104.5 -2.408 . . . . 0.0 104.5 174.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.6 t -115.54 108.87 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -93.99 120.31 34.07 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.012 0.525 . . . . 0.0 109.813 176.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 -122.25 74.85 1.19 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 164.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.42 -118.77 9.56 Favored Glycine 0 CA--C 1.548 2.127 0 C-N-CA 123.215 0.436 . . . . 0.0 113.757 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -75.47 -32.67 60.67 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 167.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -78.12 135.38 37.67 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 120.116 1.325 . . . . 0.0 111.592 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -137.19 150.77 48.13 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.97 0.89 . . . . 0.0 111.26 -175.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -136.78 115.15 11.78 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 161.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -107.41 125.72 51.58 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.559 173.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 50.8 m -119.44 99.92 6.98 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -173.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 88.1 mt -91.21 126.76 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.9 p . . . . . 0 N--CA 1.485 1.31 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 170.584 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 80.5 mt . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -107.97 127.06 53.42 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.549 0.74 . . . . 0.0 109.057 173.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -139.61 142.69 37.05 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.137 0.975 . . . . 0.0 109.822 -170.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -126.64 148.77 49.77 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.146 0.974 . . . . 0.0 110.543 -176.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -151.65 144.78 24.61 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.537 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.3 m -101.91 132.19 47.85 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 164.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.8 t -75.93 131.71 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.57 0.7 . . . . 0.0 109.863 -175.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.85 6.18 89.19 Favored Glycine 0 CA--C 1.553 2.435 0 N-CA-C 118.669 2.228 . . . . 0.0 118.669 -169.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -137.32 140.75 41.71 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 119.233 1.517 . . . . 0.0 108.332 -175.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -76.62 117.0 17.82 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.147 0.579 . . . . 0.0 111.019 -173.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.6 p -126.42 149.43 49.27 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 122.335 1.064 . . . . 0.0 112.871 -162.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -84.82 118.88 24.74 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.271 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 C-N-CA 123.654 0.781 . . . . 0.0 109.843 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 45.2 tptt . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.5 p -117.25 136.82 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 121.894 0.855 . . . . 0.0 110.489 -157.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -81.75 120.55 25.28 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.119 -177.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.4 t -148.07 135.5 20.6 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.932 0.493 . . . . 0.0 111.089 -167.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 75.5 t -88.99 119.44 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.1 t -104.28 112.54 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -116.3 143.41 45.57 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.803 0.811 . . . . 0.0 110.907 -176.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.6 tp -101.61 130.95 48.05 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.953 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -128.83 125.75 38.37 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 174.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.4 12.52 73.1 Favored Glycine 0 CA--C 1.55 2.265 0 N-CA-C 120.688 3.035 . . . . 0.0 120.688 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.268 24.2 m-20 58.74 37.92 24.98 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -167.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -160.84 -18.47 0.05 Allowed 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -176.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -119.1 101.22 7.85 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 121.101 1.773 . . . . 0.0 109.279 -171.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 79.3 mt -94.73 101.89 13.75 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 171.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.4 m -104.21 124.75 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 123.961 0.905 . . . . 0.0 108.744 -171.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.9 t -143.57 133.56 24.15 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.514 0.673 . . . . 0.0 111.425 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.8 t -131.79 134.67 46.07 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.211 1.005 . . . . 0.0 109.081 -175.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.334 14.2 p90 -136.03 -116.4 0.17 Allowed 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 118.612 -0.709 . . . . 0.0 109.497 -171.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -73.59 -68.5 0.5 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 119.6 1.091 . . . . 0.0 111.227 -178.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -126.86 -27.0 3.1 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 176.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 mp -86.34 121.95 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.574 0 CA-C-N 119.91 1.232 . . . . 0.0 108.417 -171.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -78.57 153.53 31.11 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.545 155.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.2 t -143.31 97.16 3.03 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 172.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 73.7 t -100.21 100.24 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.8 m -95.49 94.0 7.53 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -171.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -104.82 117.51 34.25 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.504 0.722 . . . . 0.0 109.073 -162.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 tt -106.47 117.8 34.99 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 -170.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -94.33 -99.77 0.15 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 118.236 -0.888 . . . . 0.0 108.88 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -103.05 -105.93 3.01 Favored Glycine 0 N--CA 1.485 1.912 0 CA-C-N 119.53 1.059 . . . . 0.0 111.276 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -96.39 49.26 1.11 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.074 0.464 . . . . 0.0 112.001 168.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.7 pt -142.38 -174.95 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.678 0 C-N-CA 124.64 1.176 . . . . 0.0 109.459 176.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.4 tt -150.1 127.69 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 120.917 -1.114 . . . . 0.0 108.719 161.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 29.8 m -103.61 92.24 4.37 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -88.7 106.81 18.59 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -177.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 39.1 m -111.9 97.49 6.72 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -169.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 46.0 mtt -98.48 104.26 16.28 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.351 0.66 . . . . 0.0 109.371 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 59.6 p -97.12 102.08 13.78 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.292 0.567 . . . . 0.0 109.765 -172.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 50.1 tp -101.51 83.94 2.52 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.45 -99.91 1.03 Allowed Glycine 0 CA--C 1.543 1.832 0 CA-C-N 116.437 -0.347 . . . . 0.0 112.793 -174.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -99.52 -16.34 18.34 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 169.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 70.1 mt -84.26 108.54 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-N 120.476 1.489 . . . . 0.0 107.86 -172.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.6 t -97.03 95.46 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -85.84 96.13 9.66 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.201 0.6 . . . . 0.0 109.739 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -104.36 106.54 17.08 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.871 -175.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -89.04 127.21 35.68 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.777 0.831 . . . . 0.0 109.014 170.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -108.64 104.01 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 174.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.5 m -127.92 116.73 20.55 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -171.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.256 17.3 ptpt -88.6 148.54 24.01 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 122.098 0.951 . . . . 0.0 113.538 -172.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -81.15 124.58 29.37 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.028 -172.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.0 pt . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 -169.499 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 116.985 2.217 . . . . 0.0 116.985 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.6 p -65.74 125.31 24.89 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 120.77 1.623 . . . . 0.0 113.612 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 153.98 167.16 15.74 Favored Glycine 0 CA--C 1.545 1.946 0 CA-C-O 122.54 1.078 . . . . 0.0 113.862 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -89.88 145.12 25.37 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 114.243 -0.978 . . . . 0.0 109.994 169.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -142.01 104.87 4.56 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -175.414 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.6 tm0? -87.92 127.32 35.36 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.592 -0.693 . . . . 0.0 111.356 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 50.8 tp -69.75 109.79 4.58 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.888 0.875 . . . . 0.0 113.228 -174.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -100.19 -60.63 1.49 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.331 0.653 . . . . 0.0 112.231 -172.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.1 t -127.74 138.56 52.81 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.566 0.746 . . . . 0.0 110.28 -168.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -133.26 133.46 42.68 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.521 0.677 . . . . 0.0 109.706 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -74.18 -64.5 1.0 Allowed 'General case' 0 CA--C 1.561 1.38 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.773 168.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -122.29 67.1 0.93 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.217 0.607 . . . . 0.0 110.746 -174.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -75.23 -52.04 11.86 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.416 -0.803 . . . . 0.0 111.993 168.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -60.6 -46.44 90.26 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.09 -36.22 82.61 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 174.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -73.37 -55.88 5.8 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 119.973 1.261 . . . . 0.0 113.672 175.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.25 -42.94 82.47 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.4 tmtm? -62.99 -43.97 97.31 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 169.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.7 -29.01 69.07 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 117.688 2.477 . . . . 0.0 117.688 173.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.25 38.2 pt -82.59 -54.53 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 119.248 0.931 . . . . 0.0 111.844 173.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.32 67.11 0.01 OUTLIER Glycine 0 N--CA 1.479 1.564 0 CA-C-O 118.898 -0.946 . . . . 0.0 113.134 171.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.8 mt -130.38 146.08 60.15 Favored Pre-proline 0 CA--C 1.569 1.695 0 CA-C-N 117.918 0.859 . . . . 0.0 111.138 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -69.11 150.65 72.43 Favored 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 123.577 2.851 . . . . 0.0 114.791 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -52.61 -36.49 56.47 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 171.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -63.22 -53.27 55.65 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 171.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.7 mt -66.85 -24.91 66.2 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.707 2.114 . . . . 0.0 116.707 176.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 87.3 mt -67.42 -53.9 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 124.347 1.059 . . . . 0.0 111.142 170.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -61.34 -24.01 66.15 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 172.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -75.69 -59.19 2.86 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 119.594 1.088 . . . . 0.0 111.503 169.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.39 -21.44 59.96 Favored Glycine 0 CA--C 1.552 2.355 0 N-CA-C 119.947 2.739 . . . . 0.0 119.947 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -66.95 -46.23 75.35 Favored 'General case' 0 CA--C 1.569 1.702 0 CA-C-N 120.28 2.04 . . . . 0.0 114.202 170.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -71.55 -36.96 71.13 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 174.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.9 mt -66.77 135.22 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-N 119.687 1.131 . . . . 0.0 109.612 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -74.87 104.42 5.47 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.603 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -98.19 102.97 2.73 Favored Glycine 0 N--CA 1.478 1.436 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.805 -175.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.8 t -84.49 114.85 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -176.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.6 m -98.6 104.85 16.92 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.087 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.17 149.49 26.13 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.026 174.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 55.5 mt -140.42 131.52 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 172.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.4 t -119.03 101.78 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -83.17 115.84 22.1 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.966 0.507 . . . . 0.0 109.8 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -124.98 69.62 1.13 Allowed 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 167.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.07 -112.17 4.65 Favored Glycine 0 CA--C 1.546 2.01 0 C-N-CA 123.272 0.463 . . . . 0.0 113.699 -174.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -74.14 -33.4 63.53 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 171.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -79.31 129.33 34.36 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 119.276 0.944 . . . . 0.0 110.726 -177.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -132.05 105.82 7.63 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -177.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -95.24 106.24 18.25 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 170.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -104.31 120.23 40.73 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.017 174.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 78.7 m -108.45 91.98 3.87 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.6 tt -99.32 120.86 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.362 -167.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.0 m . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.55 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.4 mt . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -89.07 126.15 35.32 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.39 0.614 . . . . 0.0 109.868 175.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -134.77 106.9 7.13 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -174.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.51 132.15 56.59 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.919 0.887 . . . . 0.0 110.389 -175.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -141.6 173.69 11.27 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.942 -172.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.0 m -127.58 132.91 49.77 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 166.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.3 m -68.66 132.47 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 122.979 0.511 . . . . 0.0 111.616 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 107.59 -58.09 0.42 Allowed Glycine 0 CA--C 1.545 1.952 0 CA-C-N 115.583 -0.735 . . . . 0.0 113.233 -160.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -85.92 148.49 25.76 Favored 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 124.117 0.967 . . . . 0.0 112.101 -172.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -83.6 117.07 22.91 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.844 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 77.3 m -116.1 147.99 40.74 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 122.07 0.938 . . . . 0.0 111.664 -174.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -84.24 97.82 9.62 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.847 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 61.5 mt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.597 0.713 . . . . 0.0 109.679 -171.091 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 85.4 mttt . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 121.866 0.841 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 19.5 m -100.19 -13.46 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 117.236 2.31 . . . . 0.0 117.236 -164.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . 0.25 93.4 mttt 76.85 112.4 0.07 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 121.06 1.755 . . . . 0.0 110.242 -173.26 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.4 t -150.02 129.82 13.3 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.121 0.568 . . . . 0.0 109.548 -168.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.2 t -100.64 118.34 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.6 t -102.74 135.97 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -115.87 155.06 28.61 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.513 0.673 . . . . 0.0 110.591 166.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.4 tp -106.29 103.57 13.07 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 173.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -103.25 120.1 40.12 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.66 6.27 84.54 Favored Glycine 0 CA--C 1.549 2.164 0 N-CA-C 120.744 3.058 . . . . 0.0 120.744 173.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.316 4.7 t70 71.92 -10.38 0.87 Allowed 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 -167.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -116.15 -18.34 10.61 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 116.574 2.065 . . . . 0.0 116.574 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -112.65 124.85 53.48 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 121.151 1.796 . . . . 0.0 109.784 -176.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 47.3 mt -103.31 103.07 13.05 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 166.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.8 t -101.53 118.92 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -167.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.5 t -149.45 155.68 40.8 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.536 0.684 . . . . 0.0 112.363 -173.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 91.9 m -122.06 107.72 12.54 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 174.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -71.81 -81.83 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.435 0.694 . . . . 0.0 111.143 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -139.3 87.9 2.23 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 170.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.259 70.2 m-80 53.56 43.28 31.43 Favored 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -169.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 44.0 mm -125.24 105.37 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 104.462 -2.421 . . . . 0.0 104.462 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -79.96 94.14 5.84 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.571 0.7 . . . . 0.0 109.653 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.6 t -106.42 95.91 6.09 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.478 -165.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 73.8 t -101.44 107.8 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.9 m -93.86 85.42 4.78 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -173.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -94.66 127.53 40.69 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.357 0.663 . . . . 0.0 109.717 -165.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 tt -112.86 111.12 21.66 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -173.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -98.94 -101.84 0.22 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 118.406 -0.807 . . . . 0.0 109.291 -170.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -87.15 -110.58 0.91 Allowed Glycine 0 N--CA 1.484 1.877 0 CA-C-N 119.698 1.135 . . . . 0.0 112.395 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -101.36 61.4 0.92 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.567 0.698 . . . . 0.0 110.145 166.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 11.9 pt -148.94 -176.77 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.759 0 C-N-CA 124.619 1.167 . . . . 0.0 108.927 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.1 tt -148.54 125.32 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 120.753 -1.217 . . . . 0.0 108.217 155.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.0 m -111.1 106.99 16.21 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.02 110.56 23.12 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 34.7 m -96.91 99.65 11.2 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -176.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 66.3 mtt -104.2 97.15 7.15 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 -176.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.9 p -96.44 113.58 25.17 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -174.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.2 tp -103.08 83.08 2.16 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 170.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.77 -103.69 1.25 Allowed Glycine 0 CA--C 1.545 1.952 0 N-CA-C 114.571 0.588 . . . . 0.0 114.571 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -82.09 -27.02 33.11 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 114.708 1.374 . . . . 0.0 114.708 171.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 29.7 mm -65.34 136.1 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.542 0 C-N-CA 124.904 1.281 . . . . 0.0 109.562 174.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.4 t -127.94 96.47 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 172.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -86.56 102.47 14.16 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -102.91 104.85 15.11 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -113.72 122.35 46.84 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.869 0.868 . . . . 0.0 109.199 -175.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.7 mp -111.14 102.95 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 -171.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.0 m -102.23 112.43 25.11 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -84.08 142.29 30.51 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.817 0.447 . . . . 0.0 110.774 -169.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -74.14 134.06 42.82 Favored 'General case' 0 CA--C 1.559 1.304 0 CA-C-O 121.916 0.865 . . . . 0.0 112.725 -169.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 45.0 mm . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 -162.581 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 . . . . . 0 N--CA 1.496 1.831 0 N-CA-C 117.616 2.451 . . . . 0.0 117.616 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 75.6 m -71.45 115.22 10.37 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 121.437 1.926 . . . . 0.0 111.025 172.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.44 160.29 19.64 Favored Glycine 0 CA--C 1.54 1.655 0 CA-C-O 122.217 0.898 . . . . 0.0 114.295 -175.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -111.14 106.56 15.63 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -111.48 105.77 14.46 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -162.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -93.18 135.63 34.2 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 122.941 0.496 . . . . 0.0 111.583 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.5 tp -71.46 115.04 10.17 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.478 0.711 . . . . 0.0 112.584 -171.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -99.23 -55.33 2.72 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.164 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.1 m -125.07 110.51 14.24 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -173.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -111.48 119.58 39.25 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 122.075 0.941 . . . . 0.0 109.844 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -109.2 120.29 42.07 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 170.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.259 69.1 m-80 67.37 50.49 0.95 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -175.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -72.13 -63.26 1.18 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.922 . . . . 0.0 111.289 162.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -65.58 -35.23 80.21 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 117.33 2.344 . . . . 0.0 117.33 -174.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.41 -45.57 93.76 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 166.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -65.11 -51.91 58.55 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 174.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 23.5 mmt -62.18 -43.02 99.77 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -176.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -60.15 -47.28 86.6 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 167.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.57 -29.5 70.63 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 117.729 2.492 . . . . 0.0 117.729 176.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.8 pt -80.5 -47.04 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 CA-C-N 119.781 1.173 . . . . 0.0 112.706 173.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 142.67 69.62 0.03 OUTLIER Glycine 0 CA--C 1.54 1.595 0 CA-C-N 119.134 0.879 . . . . 0.0 113.034 174.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.55 153.37 79.4 Favored Pre-proline 0 CA--C 1.568 1.668 0 C-N-CA 123.456 0.702 . . . . 0.0 111.84 172.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.79 152.59 47.44 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 123.168 2.579 . . . . 0.0 113.031 172.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -61.03 -24.69 66.37 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 173.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -61.86 -57.19 12.75 Favored 'General case' 0 CA--C 1.563 1.455 0 CA-C-O 117.489 -1.243 . . . . 0.0 113.433 165.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.8 mt -68.93 -18.39 64.09 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.1 mt -74.23 -55.45 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-N 119.727 1.149 . . . . 0.0 110.477 170.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -67.93 -24.56 65.2 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -79.13 -51.21 9.84 Favored 'General case' 0 CA--C 1.562 1.419 0 CA-C-N 119.547 1.067 . . . . 0.0 112.217 167.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.2 -14.79 59.94 Favored Glycine 0 CA--C 1.552 2.366 0 N-CA-C 119.864 2.706 . . . . 0.0 119.864 176.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -71.34 -49.86 38.16 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 119.957 1.879 . . . . 0.0 113.88 171.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -63.8 -30.76 71.82 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.533 2.049 . . . . 0.0 116.533 167.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 53.8 mt -75.69 113.7 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 173.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -81.22 108.57 14.97 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.64 123.77 6.31 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 116.299 -0.41 . . . . 0.0 113.884 -167.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t -83.05 110.99 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.3 t -92.57 103.26 15.68 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 166.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.85 142.83 36.53 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.162 169.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.0 mt -142.17 125.96 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 90.6 t -114.15 105.21 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -81.75 118.23 22.69 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.059 0.544 . . . . 0.0 109.816 174.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -123.98 68.35 1.05 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 165.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.3 -107.51 2.1 Favored Glycine 0 CA--C 1.546 1.986 0 C-N-CA 123.24 0.448 . . . . 0.0 113.362 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -78.22 -29.35 48.24 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 170.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -84.57 104.61 14.71 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 120.394 1.452 . . . . 0.0 109.605 -173.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -105.69 95.32 5.73 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.052 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -93.7 106.7 18.65 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -103.76 132.24 50.19 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.941 -176.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.7 m -107.27 98.62 8.23 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 172.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.4 tp -87.16 127.91 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.41 0.684 . . . . 0.0 109.568 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 48.1 p . . . . . 0 N--CA 1.486 1.367 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 174.942 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.3 tt . . . . . 0 N--CA 1.495 1.821 0 CA-C-O 121.367 0.604 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -112.31 127.05 55.88 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.002 0.921 . . . . 0.0 109.025 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -139.87 128.95 23.65 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -171.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.25 135.45 54.27 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.458 0.703 . . . . 0.0 112.3 -175.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -125.27 149.11 48.34 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.044 0.938 . . . . 0.0 111.021 171.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.3 m -111.62 132.6 54.46 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 169.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.0 t -70.26 132.61 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 123.805 0.842 . . . . 0.0 110.274 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.76 10.88 85.93 Favored Glycine 0 CA--C 1.554 2.473 0 N-CA-C 118.987 2.355 . . . . 0.0 118.987 -170.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -138.59 150.7 46.58 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 119.29 1.545 . . . . 0.0 109.828 -171.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -80.89 103.0 10.42 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.519 0.728 . . . . 0.0 109.118 177.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 63.1 m -134.44 134.29 41.43 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.692 0.758 . . . . 0.0 110.766 -171.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.55 143.38 40.36 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -171.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 N--CA 1.486 1.33 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 175.123 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.7 mptt . . . . . 0 N--CA 1.486 1.37 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . 0.261 8.4 p -86.57 -43.84 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.607 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . 0.253 5.6 ttpm? 76.06 107.49 0.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.751 1.221 . . . . 0.0 111.747 173.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . 0.49 HG22 ' HA ' ' A' ' 95' ' ' PHE . 16.4 p -128.38 139.5 52.34 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.033 0.533 . . . . 0.0 110.381 -165.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 89.7 t -109.76 101.44 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 173.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.3 t -94.9 138.48 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -173.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -114.89 135.49 54.15 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.839 0.828 . . . . 0.0 109.302 176.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 50.7 tp -94.69 102.68 14.59 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 173.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -88.08 114.16 24.42 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 121.891 0.853 . . . . 0.0 109.112 174.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.41 -117.28 5.48 Favored Glycine 0 CA--C 1.542 1.729 0 CA-C-N 114.354 -1.293 . . . . 0.0 113.047 -176.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -130.25 -8.58 4.26 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 170.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -134.34 35.02 3.24 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -173.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -147.41 116.77 6.97 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 119.996 1.271 . . . . 0.0 108.077 175.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 67.0 mt -107.66 101.73 11.02 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 171.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 32.7 m -99.42 124.3 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -171.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.3 t -151.48 135.95 16.94 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.243 0.545 . . . . 0.0 111.482 -174.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 67.9 p -83.55 -41.88 17.43 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 177.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.49 ' HA ' HG22 ' A' ' 81' ' ' THR 0.378 22.5 m-85 74.21 -94.48 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 119.259 0.936 . . . . 0.0 109.676 -169.939 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -116.38 -76.18 0.57 Allowed 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 163.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -135.63 71.6 1.43 Allowed 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 119.276 0.944 . . . . 0.0 109.317 170.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.1 mp -143.66 93.46 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 102.87 -3.011 . . . . 0.0 102.87 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -80.74 97.2 7.2 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 119.156 0.889 . . . . 0.0 109.818 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.4 t -100.29 102.34 13.58 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.266 -171.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.8 t -96.05 106.63 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.2 m -93.56 83.87 4.57 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -174.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.63 118.42 32.29 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.415 0.686 . . . . 0.0 109.251 -168.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tt -106.72 112.06 24.87 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -172.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -81.19 -59.05 2.79 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -172.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -158.83 -87.74 0.06 OUTLIER Glycine 0 N--CA 1.479 1.505 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 175.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -71.35 -37.98 71.65 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 166.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.8 pt -87.52 178.54 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.553 0 CA-C-N 119.636 1.107 . . . . 0.0 112.785 -171.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.5 tt -141.59 118.83 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 165.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.0 m -99.57 99.98 10.92 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -97.03 104.32 16.32 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -178.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.9 m -102.44 94.85 5.89 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -168.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 28.1 mtt -93.37 99.28 11.82 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.59 0.71 . . . . 0.0 109.377 -178.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 48.0 p -94.18 103.83 15.86 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.003 -174.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.0 tp -102.73 82.86 2.18 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.51 -99.62 1.01 Allowed Glycine 0 CA--C 1.544 1.879 0 O-C-N 122.348 -0.22 . . . . 0.0 113.12 -174.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -102.95 -12.29 17.6 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 170.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 72.4 mt -85.3 108.92 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-N 120.526 1.512 . . . . 0.0 107.157 -175.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.2 t -100.34 96.47 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 -175.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -82.77 97.6 8.67 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -93.06 107.44 19.23 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -108.15 98.78 8.29 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -172.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 85.2 mt -97.93 104.71 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 -173.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 67.9 m -121.53 114.96 21.96 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -172.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -91.05 139.74 30.48 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 122.941 0.496 . . . . 0.0 111.131 -172.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.4 ttp85 -68.37 130.01 41.61 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.331 0.653 . . . . 0.0 112.509 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.2 pt . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 123.047 1.403 . . . . 0.0 108.365 -173.959 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.353 84.1 m-85 . . . . . 0 N--CA 1.496 1.83 0 N-CA-C 117.973 2.583 . . . . 0.0 117.973 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.2 m -72.23 103.53 3.38 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 120.527 1.512 . . . . 0.0 110.924 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.1 149.27 8.69 Favored Glycine 0 CA--C 1.541 1.709 0 CA-C-O 122.016 0.787 . . . . 0.0 113.624 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -92.31 117.51 29.97 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 171.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -116.62 104.54 11.49 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -172.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -86.68 140.03 30.19 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-O 121.675 0.75 . . . . 0.0 111.622 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.2 tp -66.25 137.3 56.86 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -170.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -116.13 -65.48 1.18 Allowed 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.58 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.5 p -126.94 137.58 53.15 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.906 0.882 . . . . 0.0 109.401 174.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -132.35 101.96 5.56 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.807 0.813 . . . . 0.0 109.136 -178.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -90.94 135.47 33.72 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.606 1.162 . . . . 0.0 109.722 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 m120 62.24 40.39 11.59 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -72.51 -45.77 57.8 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.921 -1.112 . . . . 0.0 113.048 172.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -62.37 -45.92 90.99 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.52 -43.58 96.76 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -76.16 -55.14 5.86 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 118.325 -0.845 . . . . 0.0 113.24 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -44.71 95.83 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -178.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -61.97 -42.77 99.5 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 171.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.92 -36.3 76.71 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 116.925 2.194 . . . . 0.0 116.925 175.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.275 46.2 pt -79.34 -47.17 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 119.086 0.857 . . . . 0.0 112.768 174.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 142.92 52.57 0.03 OUTLIER Glycine 0 N--CA 1.485 1.935 0 N-CA-C 115.678 1.031 . . . . 0.0 115.678 165.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.45 155.51 36.71 Favored Pre-proline 0 CA--C 1.566 1.563 0 CA-C-N 118.211 1.006 . . . . 0.0 111.673 175.837 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.38 146.59 45.3 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.99 2.46 . . . . 0.0 113.256 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -62.87 -22.45 66.71 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 116.072 1.879 . . . . 0.0 116.072 171.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -59.43 -53.29 59.81 Favored 'General case' 0 CA--C 1.566 1.565 0 CA-C-N 119.754 1.161 . . . . 0.0 113.969 164.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.29 -24.47 63.96 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 117.072 2.249 . . . . 0.0 117.072 174.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.3 mt -75.18 -51.66 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-N 119.623 1.101 . . . . 0.0 111.305 175.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -67.84 -28.52 67.62 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.91 -51.21 14.4 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.603 0.761 . . . . 0.0 112.348 169.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.78 -18.58 72.45 Favored Glycine 0 CA--C 1.546 2.011 0 N-CA-C 120.226 2.85 . . . . 0.0 120.226 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -65.34 -41.82 93.51 Favored 'General case' 0 CA--C 1.57 1.712 0 CA-C-N 120.334 2.067 . . . . 0.0 114.427 168.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -67.68 -39.83 84.45 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 170.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.5 mt -73.19 130.36 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 119.292 0.951 . . . . 0.0 108.929 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -89.73 98.59 11.86 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 170.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.58 140.01 15.42 Favored Glycine 0 CA--C 1.542 1.722 0 CA-C-N 116.056 -0.52 . . . . 0.0 113.949 -172.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.3 t -83.18 115.7 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 71.2 m -102.33 109.17 20.76 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.776 177.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.86 148.89 21.71 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-O 122.064 0.935 . . . . 0.0 111.094 -177.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.4 mt -138.61 133.16 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 166.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.7 t -114.33 112.25 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 175.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -78.58 118.53 20.78 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 170.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -133.52 67.27 1.53 Allowed 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.64 -122.54 9.41 Favored Glycine 0 CA--C 1.548 2.107 0 O-C-N 121.975 -0.453 . . . . 0.0 113.533 -173.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.03 -35.58 74.41 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 164.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -69.43 139.01 53.99 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 119.291 0.95 . . . . 0.0 111.99 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -138.5 97.27 3.32 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -91.32 106.08 18.24 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 175.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -83.65 148.94 26.83 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.128 169.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.8 m -133.96 87.06 2.33 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 166.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.5 pp -91.07 127.67 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -173.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.4 m . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 177.483 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -116.06 131.31 56.98 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.441 0.696 . . . . 0.0 111.822 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -151.32 149.94 29.94 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 123.399 0.68 . . . . 0.0 109.831 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -109.39 132.3 54.26 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.646 0.778 . . . . 0.0 110.833 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -117.25 141.07 48.74 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.919 0.888 . . . . 0.0 111.189 170.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.6 m -94.88 135.87 35.87 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 169.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.0 t -86.18 117.76 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 174.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.25 -5.44 63.01 Favored Glycine 0 CA--C 1.556 2.653 0 N-CA-C 119.057 2.383 . . . . 0.0 119.057 -171.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -142.23 134.48 27.68 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 120.38 2.09 . . . . 0.0 108.593 169.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.98 119.76 17.67 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -174.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 80.6 m -116.99 148.16 41.68 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 122.326 1.06 . . . . 0.0 110.557 -177.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.65 121.86 22.31 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.058 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.1 mt . . . . . 0 N--CA 1.486 1.371 0 C-N-CA 123.827 0.851 . . . . 0.0 108.857 -175.909 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.1 t -123.14 121.07 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -169.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -86.17 99.97 11.9 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.1 t -135.73 145.9 47.12 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.654 0.782 . . . . 0.0 110.016 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.0 p -109.76 138.02 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-O 122.798 1.285 . . . . 0.0 109.461 175.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.7 t -99.74 138.89 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.437 0 CA-C-N 113.413 -1.721 . . . . 0.0 107.78 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -109.58 133.26 53.32 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 50.1 tp -98.55 113.49 25.54 Favored 'General case' 0 CA--C 1.553 1.076 0 CA-C-N 115.175 -0.921 . . . . 0.0 108.573 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -114.64 121.84 44.63 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.719 0.808 . . . . 0.0 109.041 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.88 14.45 73.14 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 120.667 3.027 . . . . 0.0 120.667 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.282 15.9 t70 59.7 33.3 21.83 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -168.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -158.87 -26.07 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -103.91 104.27 14.23 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 121.324 1.875 . . . . 0.0 109.368 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 44.1 mt -96.64 101.97 13.68 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 171.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.0 m -111.49 128.8 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 123.896 0.878 . . . . 0.0 109.966 -167.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.8 t -152.42 148.85 27.94 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.258 0.552 . . . . 0.0 111.956 -176.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 33.7 p -113.38 120.47 41.19 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -82.69 -86.14 0.11 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.13 0.572 . . . . 0.0 109.785 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -120.7 -71.71 0.72 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 171.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -127.54 64.19 1.35 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 118.88 0.764 . . . . 0.0 109.036 160.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.1 mp -135.7 108.23 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 174.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.23 93.49 9.4 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.6 t -97.67 104.11 16.1 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.669 0.787 . . . . 0.0 109.513 -168.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.9 t -120.44 98.44 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 -168.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.5 m -95.96 100.24 11.94 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -174.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.37 128.95 38.4 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.884 0.874 . . . . 0.0 109.992 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.94 111.15 23.56 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -110.65 178.55 4.33 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.534 0.734 . . . . 0.0 110.448 174.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -68.1 112.8 4.95 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 116.477 1.351 . . . . 0.0 116.477 -166.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.263 19.6 m-20 50.1 25.83 1.87 Allowed 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 117.38 2.363 . . . . 0.0 117.38 -166.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.3 pt -139.36 -178.46 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.619 0 C-N-CA 124.366 1.067 . . . . 0.0 109.866 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.1 tt -150.54 127.72 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.826 -1.172 . . . . 0.0 108.839 168.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.2 m -111.13 104.7 13.26 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -93.91 111.45 23.16 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 176.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 39.8 m -109.4 101.3 10.29 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -175.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 29.5 mtt -105.95 103.29 12.75 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.9 p -95.75 105.4 17.39 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 32.3 tp -96.52 84.73 3.73 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.09 -103.44 1.15 Allowed Glycine 0 CA--C 1.544 1.893 0 C-N-CA 122.954 0.312 . . . . 0.0 113.627 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -94.92 -16.42 22.85 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 171.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 66.2 mt -80.14 114.23 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 120.084 1.311 . . . . 0.0 107.563 -177.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.4 t -101.92 94.97 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -77.26 127.05 31.93 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 169.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -136.6 109.41 7.58 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -110.31 110.02 20.67 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -174.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.6 mp -104.25 115.66 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 104.983 -2.228 . . . . 0.0 104.983 -177.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.9 m -131.97 122.16 25.11 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -175.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -96.18 137.64 34.96 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.734 0.814 . . . . 0.0 110.992 -171.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.7 ttp180 -63.18 123.95 19.94 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 124.372 1.069 . . . . 0.0 113.165 -175.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 13.3 pt . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 123.007 1.384 . . . . 0.0 108.858 -178.382 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 118.359 2.726 . . . . 0.0 118.359 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.5 m -70.8 112.32 6.91 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 121.179 1.809 . . . . 0.0 110.784 172.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.4 149.49 7.37 Favored Glycine 0 CA--C 1.542 1.73 0 CA-C-O 121.926 0.737 . . . . 0.0 113.343 -175.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -96.25 122.74 39.43 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 170.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -118.11 102.24 8.86 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -167.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.6 tm0? -88.28 122.88 32.31 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.14 0.576 . . . . 0.0 110.013 -175.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.6 tp -61.94 115.45 4.06 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -175.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -95.99 -63.07 1.19 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.496 0.718 . . . . 0.0 110.748 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.7 m -120.88 108.56 14.06 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -89.11 123.84 33.76 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 122.524 1.154 . . . . 0.0 109.15 164.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -115.24 117.28 30.05 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 -178.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.278 7.7 m-20 70.23 43.74 0.82 Allowed 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 -174.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -68.15 -60.27 2.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.158 -0.964 . . . . 0.0 113.06 168.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -62.24 -33.96 75.59 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 117.345 2.35 . . . . 0.0 117.345 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.57 -46.31 86.45 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 166.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -67.19 -51.81 49.01 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 177.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.29 -49.85 74.77 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -59.15 -42.22 90.22 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 170.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.57 -32.2 73.59 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 117.305 2.335 . . . . 0.0 117.305 174.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.28 37.7 pt -78.53 -53.51 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-N 119.747 1.158 . . . . 0.0 111.599 172.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.68 69.98 0.01 OUTLIER Glycine 0 CA--C 1.538 1.516 0 CA-C-O 119.17 -0.794 . . . . 0.0 112.468 169.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mp -121.21 155.76 58.09 Favored Pre-proline 0 CA--C 1.57 1.733 0 C-N-CA 123.408 0.683 . . . . 0.0 112.591 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.29 158.56 33.27 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 123.367 2.712 . . . . 0.0 113.655 177.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -56.51 -32.86 65.48 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 168.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -61.59 -58.3 8.63 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 117.786 -1.102 . . . . 0.0 113.604 171.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.8 mt -68.67 -17.61 64.12 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 88.3 mt -75.67 -55.03 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 119.592 1.087 . . . . 0.0 110.619 169.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -70.81 -27.27 63.75 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -80.61 -50.12 10.39 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 119.8 1.182 . . . . 0.0 111.802 167.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.59 -18.17 58.49 Favored Glycine 0 CA--C 1.551 2.329 0 N-CA-C 120.16 2.824 . . . . 0.0 120.16 176.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -66.15 -43.7 86.24 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 120.401 2.1 . . . . 0.0 114.446 170.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.89 -35.74 80.7 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 167.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 42.7 mt -77.69 113.26 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -108.27 102.67 11.78 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -171.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.96 163.29 34.63 Favored Glycine 0 CA--C 1.544 1.902 0 N-CA-C 115.581 0.993 . . . . 0.0 115.581 -172.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.2 t -98.46 120.46 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.9 p -100.08 116.45 32.13 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.45 0.7 . . . . 0.0 109.171 172.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.77 149.71 23.07 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 121.902 0.858 . . . . 0.0 110.759 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.7 mt -141.93 130.21 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 170.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 85.6 t -118.35 104.09 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 -178.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -79.4 122.53 26.52 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.102 0.561 . . . . 0.0 111.138 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -132.45 68.18 1.51 Allowed 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 170.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.85 -114.07 5.64 Favored Glycine 0 CA--C 1.547 2.038 0 O-C-N 121.625 -0.672 . . . . 0.0 113.788 -176.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -77.62 -34.15 53.43 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 169.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -71.84 135.31 46.57 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 119.872 1.214 . . . . 0.0 111.211 173.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -139.47 105.97 5.32 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -91.84 103.32 15.88 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -80.58 147.83 30.59 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.882 169.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.9 m -138.77 88.92 2.33 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 170.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.5 tt -93.25 119.49 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 123.283 0.633 . . . . 0.0 109.44 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 39.0 m . . . . . 0 N--CA 1.487 1.405 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 179.378 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -128.62 129.49 45.96 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.321 0.648 . . . . 0.0 111.4 -177.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -153.02 143.63 22.71 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 123.609 0.764 . . . . 0.0 109.385 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -103.03 117.98 35.79 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.024 0.53 . . . . 0.0 110.276 176.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.409 ' HB3' HD21 ' A' ' 71' ' ' LEU . 50.5 p90 -101.47 141.29 34.56 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.664 0.786 . . . . 0.0 111.307 172.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.9 m -97.69 129.68 44.73 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 167.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.6 t -73.84 131.09 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 123.586 0.754 . . . . 0.0 109.718 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.31 -54.21 0.56 Allowed Glycine 0 CA--C 1.549 2.218 0 CA-C-N 115.09 -0.959 . . . . 0.0 114.222 -165.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -78.84 147.4 33.21 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.805 0.842 . . . . 0.0 112.506 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -77.14 98.29 5.02 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.955 169.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 59.4 m -98.74 140.62 32.67 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.143 -173.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.19 114.35 19.95 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.144 0.578 . . . . 0.0 110.297 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.409 HD21 ' HB3' ' A' ' 63' ' ' PHE . 69.0 mt . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -165.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.9 t -132.91 126.25 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -73.26 105.97 4.89 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.152 0.501 . . . . 0.0 109.764 170.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.9 t -142.93 134.96 27.08 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.932 -169.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.7 t -83.77 120.21 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.8 t -94.57 117.48 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 169.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -109.01 141.93 40.42 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 122.05 0.928 . . . . 0.0 110.339 176.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.6 tp -101.08 110.08 22.06 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.165 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -109.67 119.62 39.94 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.71 14.85 75.49 Favored Glycine 0 CA--C 1.548 2.134 0 N-CA-C 120.487 2.955 . . . . 0.0 120.487 176.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.321 7.9 t70 66.9 1.1 2.15 Favored 'General case' 0 CA--C 1.577 1.996 0 N-CA-C 117.392 2.367 . . . . 0.0 117.392 -168.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -142.24 33.75 1.51 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -150.23 104.65 3.28 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 120.877 1.671 . . . . 0.0 107.757 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.9 mt -98.68 102.74 14.56 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 173.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.0 m -109.5 124.26 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 123.735 0.814 . . . . 0.0 109.685 -165.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.1 t -151.01 129.32 12.0 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 122.249 -0.282 . . . . 0.0 111.066 -178.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 52.4 m -103.58 111.52 24.02 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 175.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -69.62 -79.02 0.06 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.702 0.801 . . . . 0.0 110.49 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -116.25 -75.94 0.58 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 169.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -112.45 3.59 16.96 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 162.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.0 mp -85.98 100.47 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -92.91 90.93 7.18 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -84.33 97.03 9.23 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.878 0.871 . . . . 0.0 110.596 -173.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 81.3 t -97.19 96.76 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.5 m -94.02 90.12 6.31 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -171.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -103.51 129.85 50.78 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.865 0.466 . . . . 0.0 109.851 -169.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 tt -109.71 107.7 17.82 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -176.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -95.16 -93.46 0.19 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 118.671 -0.681 . . . . 0.0 109.611 -170.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -85.4 -96.81 0.73 Allowed Glycine 0 N--CA 1.483 1.767 0 CA-C-N 119.028 0.831 . . . . 0.0 112.211 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -126.74 55.93 1.51 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.448 0.642 . . . . 0.0 110.28 166.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.09 -156.89 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.539 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 174.63 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.0 tt -155.93 119.36 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.192 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 159.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.1 m -97.76 93.94 6.65 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -92.07 112.12 23.93 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.4 m -111.4 94.5 5.0 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -168.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 37.3 mtt -92.14 98.67 11.68 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.743 0.817 . . . . 0.0 108.818 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.6 p -92.09 104.94 17.28 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -174.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.4 tp -102.86 81.54 2.01 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.71 -101.27 1.17 Allowed Glycine 0 CA--C 1.545 1.929 0 CA-C-N 116.479 -0.328 . . . . 0.0 112.92 -173.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -98.82 -16.08 19.01 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 169.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 55.7 mt -82.66 111.97 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 120.274 1.397 . . . . 0.0 107.782 -173.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 61.9 t -99.31 95.73 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -175.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -86.63 94.61 9.52 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.265 0.626 . . . . 0.0 109.84 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -103.36 109.54 21.21 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.286 -173.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -101.53 117.82 35.71 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.791 0.837 . . . . 0.0 109.046 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.9 mp -104.75 102.87 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 -178.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.9 m -122.87 110.74 15.81 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -168.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.9 tttp -81.66 136.92 35.5 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -166.466 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 71.9 ttt-85 -70.78 120.49 16.45 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 124.175 0.99 . . . . 0.0 111.474 -176.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.0 pt . . . . . 0 N--CA 1.484 1.248 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -173.078 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 118.175 2.658 . . . . 0.0 118.175 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.6 m -68.77 110.73 4.47 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 120.865 1.666 . . . . 0.0 111.525 176.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.78 155.64 10.67 Favored Glycine 0 CA--C 1.541 1.671 0 CA-C-O 122.252 0.918 . . . . 0.0 113.798 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -89.01 124.45 34.28 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 166.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -111.35 102.82 11.18 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -174.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -81.71 130.38 35.04 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.264 1.026 . . . . 0.0 110.764 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.4 tp -62.21 131.3 48.99 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -170.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -91.24 -62.76 1.37 Allowed 'General case' 0 CA--C 1.561 1.382 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.967 169.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.6 m -150.61 144.66 25.39 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.459 0.704 . . . . 0.0 110.968 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -111.83 115.66 29.39 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.605 0.762 . . . . 0.0 108.951 169.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -95.25 122.61 38.12 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 160.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.286 84.2 m-20 67.85 41.01 2.24 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 178.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -70.48 -44.79 66.99 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.667 -1.271 . . . . 0.0 113.306 157.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -63.13 -50.85 68.84 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.74 -40.28 96.73 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 173.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -70.5 -51.44 28.95 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -43.9 98.19 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -178.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -60.42 -40.71 92.02 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 167.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.41 -23.5 65.55 Favored 'General case' 0 CA--C 1.564 1.512 0 N-CA-C 117.516 2.413 . . . . 0.0 117.516 174.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.262 28.2 pt -92.01 -49.73 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 CA-C-N 120.082 1.31 . . . . 0.0 112.414 173.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 142.96 71.18 0.02 OUTLIER Glycine 0 N--CA 1.482 1.703 0 CA-C-N 119.699 1.136 . . . . 0.0 113.393 173.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 mp -128.58 157.17 75.86 Favored Pre-proline 0 CA--C 1.572 1.806 0 C-N-CA 123.555 0.742 . . . . 0.0 112.109 177.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -76.64 155.11 35.38 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 123.331 2.687 . . . . 0.0 113.884 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -59.64 -31.33 69.42 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 170.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -62.45 -49.62 74.71 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 171.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.6 mt -68.74 -26.24 65.15 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 116.986 2.217 . . . . 0.0 116.986 173.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 81.3 mt -78.06 -49.7 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 124.329 1.052 . . . . 0.0 111.256 178.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -75.7 -29.72 59.09 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 178.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -78.65 -47.07 17.76 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.568 1.076 . . . . 0.0 112.397 169.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.41 -22.41 65.55 Favored Glycine 0 CA--C 1.549 2.185 0 N-CA-C 120.09 2.796 . . . . 0.0 120.09 175.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -65.43 -42.07 92.84 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-N 120.252 2.026 . . . . 0.0 114.771 170.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -64.41 -40.88 96.64 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 167.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.27 128.9 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-N 119.39 0.995 . . . . 0.0 108.88 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -80.23 105.1 11.25 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 171.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -84.99 121.11 5.5 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-N 115.718 -0.674 . . . . 0.0 113.141 -173.015 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.6 t -79.49 118.88 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.4 m -98.62 115.59 28.99 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -101.15 148.2 25.36 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 121.823 0.821 . . . . 0.0 110.737 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 74.0 mt -140.67 130.33 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 169.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 88.9 t -115.08 103.13 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -81.01 120.93 25.42 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.321 0.582 . . . . 0.0 111.124 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -130.21 72.06 1.48 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 163.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.04 -115.96 7.68 Favored Glycine 0 CA--C 1.546 2.03 0 C-N-CA 123.305 0.479 . . . . 0.0 113.848 -173.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -34.12 63.31 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 171.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -73.89 117.81 16.11 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 119.92 1.236 . . . . 0.0 110.55 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -124.2 103.17 8.09 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -90.87 105.18 17.65 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 122.426 1.108 . . . . 0.0 108.619 175.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -106.29 123.9 48.76 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 113.536 -1.665 . . . . 0.0 109.508 -172.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.9 m -120.62 90.69 3.37 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -172.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.6 mm -101.75 112.46 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 -165.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.509 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.5 mm . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -113.23 121.77 45.44 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.377 0.608 . . . . 0.0 110.008 -172.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -142.03 178.31 7.62 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 124.02 0.928 . . . . 0.0 109.302 173.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -141.22 135.65 30.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.802 -1.186 . . . . 0.0 111.236 169.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -118.28 141.85 48.09 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.045 0.938 . . . . 0.0 110.798 175.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.4 m -99.29 125.84 45.0 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 167.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.9 133.3 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 123.667 0.787 . . . . 0.0 110.345 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.27 -55.82 0.55 Allowed Glycine 0 CA--C 1.548 2.147 0 CA-C-N 115.172 -0.922 . . . . 0.0 113.856 -165.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -86.89 151.9 22.91 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.903 0.881 . . . . 0.0 112.307 -174.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -80.67 114.88 19.87 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.82 173.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 60.0 m -114.46 140.03 49.05 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.389 0.675 . . . . 0.0 110.349 -175.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.82 107.42 16.21 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.824 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.1 mt . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -167.344 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 86.5 mttt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.715 0.769 . . . . 0.0 110.601 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.1 m -139.44 125.61 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.305 -167.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -75.61 114.02 13.72 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.165 0.586 . . . . 0.0 110.653 -177.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.3 t -141.51 133.84 28.07 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.483 -166.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.9 t -89.94 124.16 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.4 t -99.79 126.15 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 170.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -119.96 140.22 51.25 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 122.141 0.972 . . . . 0.0 110.017 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.4 tp -101.27 116.79 33.62 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 114.545 -1.207 . . . . 0.0 109.081 -175.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -102.96 115.71 31.13 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 172.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.97 -133.11 13.71 Favored Glycine 0 CA--C 1.545 1.922 0 CA-C-N 114.783 -1.099 . . . . 0.0 113.394 -171.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -131.49 59.33 1.7 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 162.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -161.38 -40.66 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -174.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -109.74 99.02 8.25 Favored 'General case' 0 CA--C 1.558 1.263 0 CA-C-N 119.844 1.202 . . . . 0.0 111.118 -162.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 64.2 mt -95.24 105.78 17.75 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.5 t -105.79 125.09 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -169.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.2 t -151.87 136.83 17.26 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 22.8 p -111.2 106.56 15.6 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.809 0.844 . . . . 0.0 108.897 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -65.78 -69.6 0.29 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 123.824 0.849 . . . . 0.0 113.239 -173.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -127.72 -78.45 0.58 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 170.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -124.43 73.39 1.25 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 156.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 17.0 mt -148.33 105.63 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 103.646 -2.724 . . . . 0.0 103.646 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -75.01 142.14 43.87 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 171.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.0 t -143.05 99.8 3.52 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -178.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 84.4 t -102.62 98.28 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 177.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.0 m -95.26 90.92 6.03 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -174.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -108.98 126.98 53.67 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -165.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 tt -100.56 104.43 15.78 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -173.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -102.28 94.9 5.96 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -173.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.63 -111.58 3.31 Favored Glycine 0 N--CA 1.485 1.949 0 CA-C-O 119.864 -0.409 . . . . 0.0 112.252 -177.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -127.96 58.93 1.5 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.779 0.8 . . . . 0.0 110.615 160.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.8 pt -123.06 -154.62 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.762 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 159.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.5 tt -159.61 116.87 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 O-C-N 120.368 -1.457 . . . . 0.0 107.319 161.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 67.9 m -99.76 99.47 10.29 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 176.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -94.32 103.23 15.24 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.8 m -106.37 97.6 7.38 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -172.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 68.0 mtp -101.91 106.91 17.92 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.8 p -100.5 107.68 19.44 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -173.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 28.9 tp -71.93 -70.49 0.33 Allowed 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.159 0.583 . . . . 0.0 112.195 -176.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -123.52 -87.36 0.79 Allowed Glycine 0 CA--C 1.538 1.499 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 158.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -89.9 -11.11 42.81 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 167.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 68.5 mt -85.09 110.79 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -172.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.77 95.11 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 -175.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -82.07 93.04 6.92 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.076 0.55 . . . . 0.0 109.785 177.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -95.77 110.78 22.88 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -113.74 103.82 11.59 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -175.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.0 mp -98.9 121.16 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 -172.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.7 m -141.62 122.83 14.75 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 122.765 0.426 . . . . 0.0 109.962 -172.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -94.41 135.75 35.47 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.673 0.789 . . . . 0.0 112.276 -170.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.5 ttp180 -68.87 133.71 48.63 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.17 0.588 . . . . 0.0 112.569 -177.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.2 pt . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 -173.846 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 118.497 2.777 . . . . 0.0 118.497 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.6 m -73.83 112.12 9.64 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 121.631 2.014 . . . . 0.0 110.643 173.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.84 139.32 4.17 Favored Glycine 0 CA--C 1.542 1.739 0 CA-C-O 121.221 0.345 . . . . 0.0 113.561 -174.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -89.73 113.92 25.51 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 169.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -107.85 105.71 15.65 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -167.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -79.28 124.02 27.99 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.034 0.934 . . . . 0.0 110.837 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.9 tp -65.73 124.45 22.46 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.384 0.611 . . . . 0.0 112.576 -176.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -106.12 -65.84 1.04 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.095 0.958 . . . . 0.0 109.801 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.8 t -130.22 115.79 17.49 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -175.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -106.49 108.05 19.37 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -90.64 135.92 33.4 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.944 0.898 . . . . 0.0 110.171 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.7 m120 61.81 46.07 7.19 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 174.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -77.44 -46.25 23.22 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.27 -50.99 67.94 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 171.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.58 -38.91 78.91 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 177.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -76.67 -56.34 4.7 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 119.096 0.862 . . . . 0.0 112.903 178.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.07 -53.29 59.76 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -59.24 -36.05 74.77 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 174.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.42 -36.01 80.4 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 171.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.274 45.7 pt -78.79 -48.75 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 119.972 1.26 . . . . 0.0 112.975 175.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 143.73 61.62 0.02 OUTLIER Glycine 0 CA--C 1.543 1.824 0 CA-C-N 119.116 0.871 . . . . 0.0 113.253 171.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.8 151.97 58.38 Favored Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 123.828 0.851 . . . . 0.0 111.123 -174.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.04 144.53 30.21 Favored 'Trans proline' 0 C--N 1.369 1.654 0 C-N-CA 123.226 2.618 . . . . 0.0 113.633 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -65.07 -20.24 66.38 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 171.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -62.46 -54.64 37.09 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 120.28 1.4 . . . . 0.0 113.483 166.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.85 -21.32 66.77 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 117.258 2.318 . . . . 0.0 117.258 173.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.3 mt -78.61 -50.74 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 124.237 1.015 . . . . 0.0 110.927 173.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -74.88 -26.6 59.78 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -78.38 -48.36 15.69 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 119.673 1.124 . . . . 0.0 111.67 165.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.18 -17.02 60.88 Favored Glycine 0 CA--C 1.55 2.258 0 N-CA-C 120.445 2.938 . . . . 0.0 120.445 176.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -68.2 -43.39 78.18 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 120.473 2.136 . . . . 0.0 114.036 168.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -66.44 -31.75 72.7 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 167.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.3 mt -85.27 113.87 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -87.06 107.84 18.61 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.77 128.56 8.97 Favored Glycine 0 CA--C 1.54 1.599 0 CA-C-N 115.984 -0.553 . . . . 0.0 113.683 -170.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.6 t -80.01 114.58 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 174.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 51.4 m -113.88 118.08 33.22 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -173.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -95.54 153.84 17.51 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 122.122 0.963 . . . . 0.0 111.801 -174.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 69.1 mt -138.03 126.08 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 103.585 -2.746 . . . . 0.0 103.585 160.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 69.0 t -111.1 102.37 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -80.33 120.0 23.81 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.132 0.573 . . . . 0.0 110.781 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -129.75 72.6 1.48 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 165.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.62 -111.48 4.1 Favored Glycine 0 CA--C 1.545 1.963 0 C-N-CA 123.35 0.5 . . . . 0.0 114.181 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -74.65 -37.21 62.8 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 172.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -72.39 139.51 47.86 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 119.625 1.102 . . . . 0.0 111.624 175.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -141.65 96.66 3.01 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -87.99 102.99 15.28 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 122.015 0.912 . . . . 0.0 108.852 174.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -97.0 130.42 44.33 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.053 178.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.9 m -120.18 84.72 2.26 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 176.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.6 tt -91.26 115.47 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 C-N-CA 123.395 0.678 . . . . 0.0 109.515 -169.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 39.1 m . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.067 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.0 mp . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -101.1 122.95 44.5 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.27 0.557 . . . . 0.0 109.876 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -145.46 165.08 29.61 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.936 0.895 . . . . 0.0 109.155 169.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.18 143.18 48.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.407 -0.808 . . . . 0.0 110.716 164.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -118.5 138.76 52.29 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.999 0.904 . . . . 0.0 110.072 166.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.3 m -97.32 125.32 41.84 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 168.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.3 t -72.23 131.75 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 C-N-CA 123.662 0.785 . . . . 0.0 109.525 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.27 -56.41 0.66 Allowed Glycine 0 CA--C 1.547 2.076 0 CA-C-N 115.44 -0.8 . . . . 0.0 113.534 -163.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -71.83 147.9 46.72 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.175 0.99 . . . . 0.0 112.965 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -81.19 103.39 10.94 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.086 169.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 56.6 m -100.54 137.86 38.38 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 121.752 0.787 . . . . 0.0 111.837 -166.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -80.15 115.38 19.68 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.903 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -167.146 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.275 38.2 ttmt . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.318 0.104 . . . . 0.0 111.016 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.3 t -112.35 124.5 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -83.85 106.42 15.52 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 171.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.9 t -141.35 139.84 33.64 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.854 0.862 . . . . 0.0 110.462 -168.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.4 t -91.12 130.13 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -174.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.6 t -106.14 126.17 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -106.95 154.29 21.29 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.691 0.758 . . . . 0.0 111.402 170.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.0 tp -119.62 123.37 43.72 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -122.33 127.52 49.91 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.688 0.756 . . . . 0.0 109.083 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.25 13.68 67.76 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 120.877 3.111 . . . . 0.0 120.877 175.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.279 4.4 t70 54.08 41.4 32.03 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -163.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -157.91 -26.18 0.08 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 115.672 1.731 . . . . 0.0 115.672 -176.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -113.75 101.22 9.09 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 121.112 1.778 . . . . 0.0 109.293 -173.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 57.7 mt -95.25 103.37 15.22 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 172.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.7 m -112.17 124.34 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 123.784 0.834 . . . . 0.0 109.477 -165.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 t -155.62 133.81 11.53 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 122.693 0.397 . . . . 0.0 110.384 -176.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 42.6 m -103.73 113.92 27.8 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -83.16 79.38 9.4 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.744 0.818 . . . . 0.0 109.768 176.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.351 12.0 tmtt? 69.93 -81.22 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.544 1.137 . . . . 0.0 111.836 -173.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -104.51 -34.05 8.35 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 170.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.0 mp -84.75 117.86 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-N 119.754 1.161 . . . . 0.0 108.685 -161.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -91.22 103.62 16.27 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 122.371 0.268 . . . . 0.0 110.496 -169.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.7 m -88.0 117.19 26.7 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.331 0.652 . . . . 0.0 109.243 178.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 78.7 t -120.58 103.23 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.9 m -100.49 91.8 4.85 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -172.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -84.7 146.48 27.41 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.29 1.036 . . . . 0.0 111.421 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 tt -131.04 106.94 8.72 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -85.99 -89.96 0.11 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.243 -170.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.23 -108.05 2.56 Favored Glycine 0 N--CA 1.483 1.795 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -106.69 63.06 0.64 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.765 0.793 . . . . 0.0 109.606 164.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.4 pt -140.3 -161.71 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.83 0 C-N-CA 124.7 1.2 . . . . 0.0 108.284 176.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.9 tt -159.8 130.65 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.372 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 160.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.7 m -111.93 89.04 2.95 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -84.07 103.25 13.15 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.719 0.808 . . . . 0.0 109.179 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.3 m -109.85 96.17 6.08 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -169.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 59.6 mtt -96.84 104.75 16.78 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 44.7 p -92.22 110.0 21.38 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -174.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.9 tp -104.23 76.97 1.37 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 175.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.18 -105.84 1.74 Allowed Glycine 0 CA--C 1.546 2.008 0 C-N-CA 123.025 0.345 . . . . 0.0 113.228 -171.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -94.42 -7.96 40.04 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 169.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 78.0 mt -89.28 101.43 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -174.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 39.2 t -98.19 97.47 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -172.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -85.51 98.51 10.66 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.494 0.717 . . . . 0.0 109.351 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -109.29 105.24 14.56 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.387 -173.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 45.1 mtp85 -87.01 120.98 28.85 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 172.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 73.1 mt -109.32 100.8 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 103.471 -2.789 . . . . 0.0 103.471 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.8 m -126.06 116.64 21.72 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -168.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -88.77 132.92 34.42 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.596 0.758 . . . . 0.0 112.04 -168.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -68.64 134.25 49.63 Favored 'General case' 0 CA--C 1.556 1.191 0 CA-C-O 121.934 0.873 . . . . 0.0 112.587 -175.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.0 pt . . . . . 0 N--CA 1.485 1.3 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 -174.459 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 117.856 2.539 . . . . 0.0 117.856 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.9 p -68.47 114.93 7.31 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 121.176 1.807 . . . . 0.0 112.171 176.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 166.23 167.73 27.33 Favored Glycine 0 CA--C 1.543 1.806 0 CA-C-N 114.634 -1.166 . . . . 0.0 113.731 -168.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -126.24 106.72 9.74 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 106.841 -1.541 . . . . 0.0 106.841 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -107.15 102.45 11.77 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -159.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -94.96 141.91 28.1 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.808 0.813 . . . . 0.0 111.704 -176.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 31.9 tp -66.98 128.45 36.4 Favored 'General case' 0 CA--C 1.558 1.261 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -167.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -94.72 -62.74 1.27 Allowed 'General case' 0 CA--C 1.561 1.382 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.926 169.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.2 t -139.34 135.56 33.88 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.666 0.786 . . . . 0.0 109.751 -170.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -131.92 119.8 21.64 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -173.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -93.45 -70.95 0.68 Allowed 'General case' 0 CA--C 1.556 1.185 0 CA-C-O 118.068 -0.967 . . . . 0.0 112.336 -164.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -105.24 76.8 1.25 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 119.591 1.087 . . . . 0.0 110.032 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -88.14 -47.06 8.76 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.575 0.75 . . . . 0.0 112.935 170.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -64.35 -51.09 65.07 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.3 -38.97 88.71 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 116.675 2.102 . . . . 0.0 116.675 173.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -70.14 -54.75 11.6 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 119.318 0.963 . . . . 0.0 113.555 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 32.9 mtt -60.53 -47.13 87.51 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -58.27 -37.45 74.99 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 115.948 1.832 . . . . 0.0 115.948 169.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.5 -38.43 84.33 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 173.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.5 pt -76.96 -39.88 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.55 59.44 0.13 Allowed Glycine 0 CA--C 1.543 1.834 0 C-N-CA 124.223 0.915 . . . . 0.0 112.91 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.24 149.75 52.47 Favored Pre-proline 0 CA--C 1.566 1.58 0 C-N-CA 124.213 1.005 . . . . 0.0 109.889 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -71.73 141.12 36.93 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 123.109 2.54 . . . . 0.0 113.528 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -61.08 -33.47 73.38 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -60.56 -47.32 86.7 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 170.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.5 mt -67.77 -18.9 65.02 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 172.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.0 mt -68.92 -53.51 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-N 119.79 1.177 . . . . 0.0 110.756 169.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -63.96 -27.56 69.22 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 173.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.7 ttpm? -74.37 -56.7 4.56 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-N 119.733 1.152 . . . . 0.0 112.091 172.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.95 -16.42 66.28 Favored Glycine 0 CA--C 1.552 2.397 0 N-CA-C 119.822 2.689 . . . . 0.0 119.822 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -69.08 -44.62 72.16 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 120.37 2.085 . . . . 0.0 114.264 171.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -66.74 -34.89 78.83 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 170.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 55.6 mt -73.2 123.43 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 175.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -84.01 104.94 14.49 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 174.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -85.1 131.67 10.58 Favored Glycine 0 CA--C 1.539 1.587 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.715 -170.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.2 t -84.99 113.51 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.4 m -96.55 100.46 12.03 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.92 142.16 31.64 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.402 0.62 . . . . 0.0 110.181 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.5 mt -142.43 119.91 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 174.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 94.3 t -109.58 109.73 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 175.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -85.65 123.1 30.67 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.18 0.592 . . . . 0.0 110.261 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -123.6 69.57 1.04 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 166.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.95 -114.35 6.06 Favored Glycine 0 CA--C 1.545 1.941 0 C-N-CA 123.41 0.528 . . . . 0.0 113.981 -177.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -77.68 -31.86 52.75 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 170.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -75.27 114.6 13.98 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 119.723 1.147 . . . . 0.0 110.136 175.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -112.44 105.83 14.18 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -84.17 138.48 32.97 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.705 162.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -141.48 146.65 36.71 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.819 0.448 . . . . 0.0 110.993 172.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.1 m -132.25 97.55 4.15 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 176.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.3 tt -94.56 115.54 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 75.8 p . . . . . 0 N--CA 1.487 1.387 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.753 -170.111 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.5 mm . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -105.67 131.64 52.79 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.993 0.517 . . . . 0.0 110.825 173.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -136.73 137.33 39.81 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.727 0.775 . . . . 0.0 109.04 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -118.46 126.84 52.9 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -174.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -139.81 173.13 11.84 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.838 0.828 . . . . 0.0 112.406 -176.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.2 m -133.11 131.8 40.94 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 170.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.1 m -69.12 134.01 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 123.262 0.625 . . . . 0.0 111.793 175.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.73 -53.24 0.77 Allowed Glycine 0 CA--C 1.546 2.03 0 CA-C-O 119.681 -0.511 . . . . 0.0 114.095 -166.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -75.21 152.66 38.35 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.742 0.817 . . . . 0.0 112.368 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -87.03 99.48 11.93 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 173.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.0 m -100.97 150.67 22.64 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 121.515 0.674 . . . . 0.0 112.203 -172.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.96 127.76 35.67 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.92 174.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -175.863 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.4 mptt . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.5 m -98.36 119.07 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -175.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -87.78 98.79 11.66 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -177.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.8 t -139.78 144.33 37.34 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.307 0.643 . . . . 0.0 110.745 -167.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.0 t -97.6 124.21 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -176.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.3 t -106.3 133.1 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -112.11 137.6 49.93 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.516 0.674 . . . . 0.0 109.902 174.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.4 tp -94.72 117.58 30.36 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 171.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -119.03 119.38 34.11 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 177.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.09 12.16 79.31 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 121.378 3.311 . . . . 0.0 121.378 173.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.276 5.9 t70 55.9 43.82 26.82 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -164.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -156.67 -40.91 0.07 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 117.91 -1.043 . . . . 0.0 113.749 -176.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -101.75 132.82 47.27 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 120.193 1.36 . . . . 0.0 110.458 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 38.6 mt -116.78 99.48 7.14 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 165.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 29.0 m -98.93 121.27 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 123.564 0.745 . . . . 0.0 109.659 -170.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.1 t -154.49 128.87 9.1 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 122.212 -0.305 . . . . 0.0 110.983 -177.07 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.6 t -109.79 129.04 55.67 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.37 0.668 . . . . 0.0 110.219 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -148.51 120.68 8.32 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.63 0.772 . . . . 0.0 109.226 -169.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.321 28.1 mtpp 74.6 -94.66 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 124.389 1.076 . . . . 0.0 108.239 -170.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -146.3 66.77 1.19 Allowed 'General case' 0 CA--C 1.562 1.405 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 151.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 57.9 mt -135.35 96.47 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 103.787 -2.672 . . . . 0.0 103.787 -172.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -88.25 95.28 10.12 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.388 0.613 . . . . 0.0 109.425 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.0 t -84.04 102.09 12.25 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.803 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 69.3 t -100.28 98.47 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 175.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.7 m -94.69 84.2 4.2 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -172.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -97.42 125.91 42.35 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.542 0.737 . . . . 0.0 109.215 -166.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 tt -103.28 103.45 13.48 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -172.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -100.99 92.35 4.98 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -171.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.79 -109.8 2.97 Favored Glycine 0 CA--C 1.543 1.824 0 N-CA-C 112.056 -0.418 . . . . 0.0 112.056 -176.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -126.75 58.31 1.41 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.614 0.721 . . . . 0.0 110.822 162.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.8 pt -125.06 -158.55 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.688 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 160.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.0 tt -157.78 118.84 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 120.06 -1.65 . . . . 0.0 108.861 163.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.0 m -102.48 94.55 5.73 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -91.08 110.96 22.24 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.491 0.716 . . . . 0.0 109.299 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.6 m -113.93 95.39 5.29 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -168.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 42.4 mtt -96.66 101.2 12.76 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.754 0.822 . . . . 0.0 109.09 -178.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.6 p -93.05 103.17 15.49 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -173.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.2 tp -99.51 82.48 2.65 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 175.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.85 -104.67 1.66 Allowed Glycine 0 CA--C 1.544 1.847 0 CA-C-N 116.427 -0.351 . . . . 0.0 112.623 -173.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -100.2 -2.82 32.95 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 168.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 61.2 mt -90.18 103.09 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -175.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.1 t -97.72 91.67 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -172.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -80.97 92.68 6.22 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.584 0.754 . . . . 0.0 109.661 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -111.83 105.76 14.32 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.63 -171.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -111.88 122.15 46.99 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.76 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.7 mp -102.83 118.42 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 -172.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.7 m -137.65 117.56 13.28 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -171.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.9 ttpp -88.16 138.18 31.67 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -171.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -68.46 122.93 19.47 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.793 0.837 . . . . 0.0 112.081 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 24.4 pt . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 123.102 1.43 . . . . 0.0 108.438 -174.655 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 . . . . . 0 N--CA 1.494 1.736 0 N-CA-C 118.016 2.599 . . . . 0.0 118.016 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.3 m -73.66 116.16 13.92 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 121.275 1.852 . . . . 0.0 110.399 168.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.88 158.53 22.25 Favored Glycine 0 CA--C 1.541 1.708 0 CA-C-O 122.34 0.967 . . . . 0.0 114.516 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.9 mptt -98.75 116.79 31.78 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 166.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -108.4 101.91 11.05 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -168.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -88.8 121.97 31.72 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.713 0.805 . . . . 0.0 109.779 -173.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.8 tp -61.7 119.36 8.55 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -92.88 -67.19 0.87 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.354 173.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.6 m -122.4 144.3 49.12 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.184 0.994 . . . . 0.0 109.625 -176.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -134.27 103.4 5.73 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -178.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -85.53 137.51 32.83 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.224 1.01 . . . . 0.0 110.329 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.8 m120 60.03 46.7 10.55 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 175.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -76.32 -49.45 16.88 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -64.52 -44.07 92.07 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 171.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.0 -46.36 88.37 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 173.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -71.93 -55.48 7.4 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 119.16 0.891 . . . . 0.0 113.184 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.93 -46.4 90.81 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -177.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -60.03 -40.31 88.88 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.192 1.552 . . . . 0.0 115.192 170.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.14 -28.74 66.72 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 117.371 2.36 . . . . 0.0 117.371 174.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.264 20.1 pt -81.08 -48.04 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-N 120.313 1.415 . . . . 0.0 112.776 172.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 143.59 66.61 0.02 OUTLIER Glycine 0 N--CA 1.48 1.623 0 CA-C-N 119.12 0.873 . . . . 0.0 112.975 173.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mp -130.47 154.99 81.73 Favored Pre-proline 0 CA--C 1.567 1.619 0 C-N-CA 123.558 0.743 . . . . 0.0 111.806 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.35 155.87 32.66 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.079 2.519 . . . . 0.0 113.383 175.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -63.38 -24.16 67.72 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 165.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -59.63 -53.49 57.44 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 119.974 1.261 . . . . 0.0 114.265 168.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 98.6 mt -69.58 -24.9 63.75 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 117.077 2.251 . . . . 0.0 117.077 175.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 41.3 mt -75.71 -53.76 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-N 119.725 1.148 . . . . 0.0 110.485 173.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 46.1 mm-40 -71.67 -22.86 61.61 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 116.485 2.031 . . . . 0.0 116.485 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.66 -45.47 12.45 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.736 1.153 . . . . 0.0 112.717 167.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.52 -20.34 55.63 Favored Glycine 0 CA--C 1.553 2.454 0 N-CA-C 119.881 2.713 . . . . 0.0 119.881 173.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -64.71 -43.65 92.76 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 120.144 1.972 . . . . 0.0 114.772 168.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -63.11 -38.86 92.86 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 167.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 69.7 mt -72.94 128.7 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 123.943 0.897 . . . . 0.0 108.706 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -76.78 111.92 12.82 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.307 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.66 105.89 3.14 Favored Glycine 0 N--CA 1.478 1.437 0 CA-C-N 115.865 -0.607 . . . . 0.0 113.553 -170.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.0 t -94.61 111.62 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 174.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 70.6 m -117.25 109.16 16.52 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.89 159.87 22.25 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.98 -173.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.3 mt -136.02 131.56 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 160.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.6 t -115.09 102.43 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -79.29 120.99 24.53 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.195 0.598 . . . . 0.0 110.684 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -127.26 73.22 1.41 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 166.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.14 -119.08 9.22 Favored Glycine 0 CA--C 1.546 2.031 0 C-N-CA 123.209 0.433 . . . . 0.0 113.598 -174.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.252 0.0 OUTLIER -71.41 -28.7 64.19 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 116.568 2.062 . . . . 0.0 116.568 169.294 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -75.55 132.01 40.42 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 120.015 1.28 . . . . 0.0 110.965 175.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -132.99 99.98 4.75 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -93.95 104.99 17.03 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 121.944 0.878 . . . . 0.0 108.875 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -90.46 134.26 34.47 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.927 176.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.7 m -119.54 98.91 6.36 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.4 mt -82.71 141.91 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 173.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.5 p . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 170.352 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -108.54 124.89 51.15 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.53 0.732 . . . . 0.0 109.939 -176.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -150.87 144.84 25.27 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 122.76 0.424 . . . . 0.0 110.9 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -118.12 132.59 56.33 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.937 0.895 . . . . 0.0 110.534 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -117.55 142.58 47.01 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.787 0.835 . . . . 0.0 111.509 171.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.8 m -89.38 140.5 29.45 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 159.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.7 t -76.37 122.3 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 172.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.22 40.31 9.29 Favored Glycine 0 CA--C 1.549 2.167 0 N-CA-C 116.784 1.473 . . . . 0.0 116.784 -168.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -151.62 143.16 23.55 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.184 0.994 . . . . 0.0 108.318 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -74.0 106.88 5.89 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.325 0.583 . . . . 0.0 109.659 168.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 40.8 m -110.51 136.32 49.83 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.048 -171.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -83.58 93.49 7.87 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.863 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.8 mt . . . . . 0 N--CA 1.485 1.315 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -171.277 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.058 0.456 . . . . 0.0 111.596 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.9 m -139.84 136.69 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 123.734 0.814 . . . . 0.0 109.407 -169.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -72.05 133.66 45.39 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.023 0.929 . . . . 0.0 112.461 -176.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 t -154.14 142.0 20.1 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 122.974 0.51 . . . . 0.0 110.287 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.29 123.16 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.4 t -99.32 137.03 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -177.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 17.1 mp0 -124.41 136.78 54.32 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 173.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 42.0 tp -91.16 105.97 18.18 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 174.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -93.98 115.35 27.69 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.59 -127.51 9.14 Favored Glycine 0 CA--C 1.546 1.981 0 CA-C-N 114.428 -1.26 . . . . 0.0 113.021 -170.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -118.54 -11.95 9.85 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 173.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -123.87 -13.0 7.48 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 117.424 2.379 . . . . 0.0 117.424 -173.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -113.51 96.46 5.89 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 121.398 1.908 . . . . 0.0 110.472 -165.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 70.5 mt -86.37 105.16 16.52 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.1 m -99.0 125.88 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 123.862 0.865 . . . . 0.0 109.225 -174.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.6 t -152.65 125.93 8.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 122.138 -0.351 . . . . 0.0 110.376 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.3 t -112.62 131.29 55.7 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.487 0.715 . . . . 0.0 110.16 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -84.45 -82.37 0.17 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.623 0.769 . . . . 0.0 108.967 175.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -130.57 -77.69 0.53 Allowed 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 167.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -86.42 -36.25 19.24 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 174.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 52.4 mt -69.45 129.25 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 C-N-CA 124.455 1.102 . . . . 0.0 109.01 176.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -128.18 97.14 4.66 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.7 t -89.97 106.07 18.23 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.719 0.807 . . . . 0.0 110.717 -170.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.9 t -105.08 95.7 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.2 m -97.28 88.17 4.37 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -168.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -87.7 139.98 29.98 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.03 0.932 . . . . 0.0 110.194 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 tt -119.86 98.33 6.05 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -99.47 94.51 6.45 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -172.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.94 -112.7 3.51 Favored Glycine 0 N--CA 1.483 1.789 0 CA-C-O 119.879 -0.4 . . . . 0.0 112.118 -176.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -123.77 59.3 1.13 Allowed 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.397 0.618 . . . . 0.0 111.134 169.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.73 -154.09 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.736 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 164.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.5 tt -160.23 117.01 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 157.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.5 m -98.41 95.89 7.64 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -94.6 106.84 18.83 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.6 m -105.36 101.79 11.31 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -173.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 44.5 mtt -97.71 101.68 13.25 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.0 p -90.98 115.4 27.96 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . 0.265 24.3 tp -84.5 -104.36 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -177.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -90.97 -94.94 1.26 Allowed Glycine 0 N--CA 1.48 1.596 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 168.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -88.83 -8.09 54.98 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 164.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 42.2 mt -84.21 119.32 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-N 119.808 1.186 . . . . 0.0 107.809 -173.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.1 t -102.73 97.41 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -76.61 135.49 39.18 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 166.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -145.6 101.52 3.58 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -95.05 129.24 42.22 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.2 0.6 . . . . 0.0 110.152 173.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 88.8 mt -110.88 112.54 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 104.083 -2.562 . . . . 0.0 104.083 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.0 m -131.88 118.01 19.26 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -172.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -79.82 130.03 34.98 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -166.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 55.4 ttp85 -73.66 119.04 17.34 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.316 0.646 . . . . 0.0 111.141 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 33.0 pt . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 123.013 1.387 . . . . 0.0 109.026 -170.131 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 . . . . . 0 N--CA 1.494 1.747 0 N-CA-C 117.522 2.416 . . . . 0.0 117.522 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.8 m -69.21 120.29 14.81 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 121.222 1.828 . . . . 0.0 111.622 174.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.67 156.79 8.51 Favored Glycine 0 CA--C 1.54 1.653 0 CA-C-O 122.507 1.06 . . . . 0.0 113.898 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -79.93 140.94 36.49 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 113.979 -1.111 . . . . 0.0 108.934 162.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -135.51 105.97 6.43 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.32 122.68 28.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 122.032 -0.417 . . . . 0.0 110.658 -176.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.8 tp -66.65 120.28 13.2 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.348 0.659 . . . . 0.0 112.114 -178.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -109.64 -63.53 1.36 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 118.556 -0.735 . . . . 0.0 110.499 -176.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.9 m -110.07 107.96 18.0 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -178.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -100.11 121.34 41.26 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 122.189 0.995 . . . . 0.0 108.485 170.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -85.75 -64.6 1.13 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.115 -169.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -115.67 67.06 0.7 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 118.379 0.536 . . . . 0.0 110.73 175.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -72.02 -51.7 20.52 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 166.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -63.67 -48.78 75.79 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.34 -40.01 92.67 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 116.498 2.036 . . . . 0.0 116.498 171.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -66.54 -51.9 51.49 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 177.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.9 -47.94 70.64 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 174.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -57.22 -41.29 79.2 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 169.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.76 -33.21 72.1 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 117.056 2.243 . . . . 0.0 117.056 175.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.3 pt -76.74 -41.85 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 CA-C-N 120.129 1.331 . . . . 0.0 113.481 172.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.58 62.05 0.15 Allowed Glycine 0 CA--C 1.542 1.765 0 C-N-CA 124.205 0.907 . . . . 0.0 112.674 175.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.17 150.39 51.26 Favored Pre-proline 0 CA--C 1.568 1.669 0 C-N-CA 124.026 0.93 . . . . 0.0 110.764 -176.264 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.53 148.47 37.6 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 123.205 2.604 . . . . 0.0 113.84 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -61.86 -26.05 67.9 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 173.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -61.28 -50.14 74.23 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 166.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.3 mt -70.99 -16.88 62.65 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 116.916 2.191 . . . . 0.0 116.916 171.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 84.8 mt -73.82 -54.06 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 120.152 1.342 . . . . 0.0 110.584 169.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -66.79 -27.96 68.0 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 116.353 1.982 . . . . 0.0 116.353 176.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -73.86 -60.92 2.03 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-N 119.463 1.028 . . . . 0.0 111.097 166.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.94 -15.32 57.97 Favored Glycine 0 CA--C 1.553 2.415 0 N-CA-C 120.53 2.972 . . . . 0.0 120.53 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -66.99 -47.31 71.91 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 119.985 1.892 . . . . 0.0 113.862 169.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -72.78 -35.65 67.45 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 171.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 37.8 mt -73.5 121.33 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.021 -1.104 . . . . 0.0 108.021 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -89.77 119.12 29.89 Favored 'General case' 0 CA--C 1.557 1.225 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.52 135.3 12.72 Favored Glycine 0 CA--C 1.542 1.76 0 CA-C-N 116.714 -0.221 . . . . 0.0 113.593 -177.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.35 116.23 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.1 p -94.35 102.63 14.62 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 121.477 0.656 . . . . 0.0 109.262 174.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.02 142.33 27.88 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.829 176.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.1 mt -139.1 128.9 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.3 t -117.39 103.98 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 -178.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -85.06 131.68 34.42 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.302 0.641 . . . . 0.0 110.771 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -135.99 72.63 1.44 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 168.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.81 -105.15 1.82 Allowed Glycine 0 CA--C 1.544 1.902 0 O-C-N 121.886 -0.509 . . . . 0.0 113.571 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.253 0.0 OUTLIER -97.54 -15.56 20.48 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 166.123 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -77.71 149.99 34.52 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 119.772 1.169 . . . . 0.0 111.412 171.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -146.23 142.66 28.6 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.754 0.822 . . . . 0.0 110.1 -174.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -136.33 113.44 10.54 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 165.79 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -91.82 148.19 22.42 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.502 169.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.5 m -133.9 91.85 2.88 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 173.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.1 mm -91.92 110.62 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.9 p . . . . . 0 N--CA 1.487 1.396 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -176.484 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.3 mp . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -110.72 117.69 34.14 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -147.74 133.61 19.07 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -108.16 145.64 33.88 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 122.193 0.997 . . . . 0.0 111.7 -175.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -133.26 167.14 20.92 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.631 174.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.0 m -129.56 132.22 46.76 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 169.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.3 t -71.41 127.47 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 C-N-CA 123.467 0.707 . . . . 0.0 109.508 -177.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.73 -55.66 0.8 Allowed Glycine 0 CA--C 1.545 1.949 0 CA-C-N 115.606 -0.725 . . . . 0.0 113.891 -166.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -81.15 147.16 30.17 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.715 0.769 . . . . 0.0 112.219 -177.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -84.08 116.05 22.68 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.087 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.7 m -130.31 150.21 51.64 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.773 0.797 . . . . 0.0 111.987 -174.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.97 128.13 35.58 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.839 0.856 . . . . 0.0 113.055 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.2 mt . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.771 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.2 mptt . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.311 0.576 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.0 m -80.87 -38.79 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 177.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . 0.286 37.5 ttmt 74.0 106.06 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.909 1.284 . . . . 0.0 111.113 -177.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.3 t -145.06 152.03 39.46 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.844 0.831 . . . . 0.0 110.4 -172.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.4 t -98.5 127.89 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 -176.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 t -104.91 129.79 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -178.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.7 mp0 -110.91 134.58 52.44 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 172.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.1 tp -95.84 104.39 16.32 Favored 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -98.96 121.0 40.35 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 122.135 0.969 . . . . 0.0 108.914 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.14 9.68 72.38 Favored Glycine 0 CA--C 1.55 2.269 0 N-CA-C 120.563 2.985 . . . . 0.0 120.563 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.305 2.3 t70 64.61 16.5 10.36 Favored 'General case' 0 CA--C 1.577 2.007 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 -165.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -157.39 44.84 0.36 Allowed 'General case' 0 CA--C 1.568 1.655 0 O-C-N 121.018 -1.051 . . . . 0.0 113.401 175.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -160.28 112.69 2.03 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 173.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 38.8 mt -98.74 98.24 9.38 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 173.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.8 t -98.27 113.84 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -167.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.7 t -153.51 134.82 14.17 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -176.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.9 m -103.31 112.51 25.42 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -74.84 -84.45 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.061 0.544 . . . . 0.0 110.984 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -93.73 -82.77 0.34 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 169.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -127.59 62.69 1.38 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 152.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 69.0 mt -120.73 95.3 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 103.246 -2.872 . . . . 0.0 103.246 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -84.28 90.97 7.64 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 122.138 0.97 . . . . 0.0 109.21 -174.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.0 t -95.83 117.52 30.72 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.185 -168.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 74.5 t -116.9 106.28 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 104.616 -2.364 . . . . 0.0 104.616 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.3 m -91.77 88.5 6.7 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -175.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -96.37 119.88 35.65 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.232 0.613 . . . . 0.0 109.866 -166.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 tt -101.59 106.56 17.65 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -176.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -90.13 -87.39 0.18 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 118.926 -0.559 . . . . 0.0 110.237 -170.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -101.67 -109.7 3.27 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 178.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -106.05 64.06 0.67 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.95 0.881 . . . . 0.0 109.5 163.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.5 pt -144.19 -170.41 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.574 1.887 0 C-N-CA 125.184 1.394 . . . . 0.0 107.713 175.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.3 tt -152.11 125.02 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 120.326 -1.483 . . . . 0.0 108.866 156.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 81.7 m -103.69 99.65 9.45 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -93.38 107.66 19.45 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 32.6 m -107.46 100.68 10.09 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -170.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 40.7 mtt -101.88 100.79 11.15 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.903 0.881 . . . . 0.0 109.194 -176.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 73.8 p -94.63 104.47 16.41 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -175.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 49.4 tp -103.66 84.88 2.35 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.88 -102.71 1.46 Allowed Glycine 0 CA--C 1.545 1.94 0 CA-C-N 116.231 -0.441 . . . . 0.0 112.12 -171.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -103.92 -4.98 22.73 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 169.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 80.6 mt -90.35 109.5 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-N 120.543 1.52 . . . . 0.0 107.048 -172.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 49.7 t -97.78 95.08 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -173.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -84.42 96.39 9.07 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.353 0.661 . . . . 0.0 109.419 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -101.33 109.07 20.85 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.549 -173.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.9 mtm180 -103.08 109.04 20.45 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.0 mp -99.79 99.19 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 105.037 -2.208 . . . . 0.0 105.037 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.4 m -110.73 115.76 30.13 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -177.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -79.08 146.01 33.48 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 122.933 0.493 . . . . 0.0 110.89 -174.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -79.39 139.58 37.69 Favored 'General case' 0 CA--C 1.559 1.319 0 CA-C-O 121.895 0.855 . . . . 0.0 112.142 -171.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.9 mm . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 -159.193 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.5 m 59.0 93.6 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.168 1.387 . . . . 0.0 113.897 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.13 150.35 7.0 Favored Glycine 0 CA--C 1.542 1.736 0 CA-C-O 121.916 0.731 . . . . 0.0 114.266 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -83.83 130.8 34.92 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.72 -0.74 . . . . 0.0 109.357 170.201 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -132.47 105.13 7.07 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -173.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -92.67 134.49 34.97 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 122.962 0.505 . . . . 0.0 111.554 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.2 tp -73.44 114.24 11.44 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.344 0.658 . . . . 0.0 112.557 -170.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -95.86 -61.88 1.38 Allowed 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.88 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.2 t -117.42 114.21 23.19 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -98.3 138.8 35.03 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 123.091 1.424 . . . . 0.0 109.433 167.164 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -128.77 113.06 14.85 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.292 18.7 m-20 72.68 50.94 0.17 Allowed 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -173.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -76.22 -64.23 1.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.383 -0.823 . . . . 0.0 112.101 174.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.03 -28.26 69.67 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 117.163 2.282 . . . . 0.0 117.163 174.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.8 -44.26 86.23 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 168.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -67.28 -57.3 6.93 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 173.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 38.1 mtt -59.45 -45.78 90.62 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -176.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -62.05 -39.09 91.18 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 169.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.96 -33.18 73.81 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 117.25 2.315 . . . . 0.0 117.25 172.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.255 20.9 pt -81.55 -53.77 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 CA-C-N 119.328 0.967 . . . . 0.0 112.31 176.099 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.1 61.23 0.01 OUTLIER Glycine 0 CA--C 1.542 1.78 0 CA-C-N 119.019 0.827 . . . . 0.0 113.416 172.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.12 153.42 42.59 Favored Pre-proline 0 CA--C 1.568 1.645 0 C-N-CA 123.648 0.779 . . . . 0.0 111.277 -179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.86 155.2 43.61 Favored 'Trans proline' 0 CA--C 1.556 1.582 0 C-N-CA 123.168 2.579 . . . . 0.0 113.338 173.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -56.95 -34.59 68.19 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 169.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -59.82 -54.26 48.34 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 172.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.9 mt -71.2 -26.2 62.85 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 116.84 2.163 . . . . 0.0 116.84 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.1 mt -69.39 -55.36 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-N 119.683 1.129 . . . . 0.0 110.627 171.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -70.05 -25.22 63.45 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -76.01 -57.67 3.74 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 119.753 1.161 . . . . 0.0 111.537 168.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.38 -15.96 62.07 Favored Glycine 0 CA--C 1.553 2.414 0 N-CA-C 119.869 2.708 . . . . 0.0 119.869 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -68.02 -44.68 75.98 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 120.145 1.972 . . . . 0.0 114.138 170.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -68.34 -40.82 81.43 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 168.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.1 mt -74.17 124.09 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-N 119.484 1.038 . . . . 0.0 108.317 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -84.26 107.51 16.6 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -88.1 128.77 9.22 Favored Glycine 0 CA--C 1.541 1.659 0 CA-C-N 116.359 -0.382 . . . . 0.0 113.771 -171.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.0 t -88.56 115.01 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -177.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 62.7 m -96.87 106.21 18.48 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 170.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.54 150.05 23.97 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.794 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 86.8 mt -132.96 134.92 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 170.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 43.7 t -132.29 96.19 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 104.008 -2.589 . . . . 0.0 104.008 169.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -84.1 124.08 30.74 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.239 0.615 . . . . 0.0 110.354 -176.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -118.21 74.62 0.96 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 171.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.66 -116.89 8.23 Favored Glycine 0 CA--C 1.546 2.004 0 C-N-CA 123.374 0.511 . . . . 0.0 113.488 -173.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? -81.9 -33.19 30.59 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 169.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -73.41 116.64 14.22 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 119.825 1.193 . . . . 0.0 109.877 174.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -126.74 91.83 3.43 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -151.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -94.43 96.9 9.8 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.17 0.509 . . . . 0.0 110.193 -167.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -110.01 133.27 53.37 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.904 -176.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.8 m -116.13 99.09 6.99 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 -177.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.3 tt -89.31 118.21 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.7 0.8 . . . . 0.0 109.437 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 49.4 m . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 176.44 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.9 mp . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -91.12 124.83 35.64 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.673 0.749 . . . . 0.0 109.877 170.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -131.75 155.27 48.0 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.313 172.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -139.97 139.1 36.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.347 -0.846 . . . . 0.0 112.304 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -117.68 150.75 38.54 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.98 0.912 . . . . 0.0 111.23 173.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.2 m -98.51 128.42 44.84 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 166.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 86.7 t -74.72 128.96 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 123.539 0.735 . . . . 0.0 109.762 -173.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.51 10.34 84.58 Favored Glycine 0 CA--C 1.554 2.512 0 N-CA-C 118.716 2.246 . . . . 0.0 118.716 -170.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -137.67 153.35 49.83 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 119.087 1.443 . . . . 0.0 109.29 -176.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -69.63 115.3 8.72 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.312 0.577 . . . . 0.0 111.143 177.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.7 p -122.04 135.81 54.86 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.642 -175.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.03 106.92 18.18 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 113.937 -1.483 . . . . 0.0 110.215 -175.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.3 mt . . . . . 0 N--CA 1.49 1.56 0 C-N-CA 123.42 0.688 . . . . 0.0 110.11 -166.645 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.557 1.23 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.9 m -96.73 130.67 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 C-N-CA 123.516 0.726 . . . . 0.0 110.094 -171.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -75.6 114.99 14.81 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.177 0.591 . . . . 0.0 110.895 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.5 t -146.2 140.33 26.51 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.717 0.807 . . . . 0.0 109.421 -173.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.4 t -87.11 117.1 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.43 100.62 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -100.21 141.09 33.51 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.185 0.993 . . . . 0.0 110.423 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.6 tp -95.92 104.89 16.86 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 114.155 -1.384 . . . . 0.0 108.313 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -96.23 113.16 24.73 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 122.259 1.028 . . . . 0.0 108.641 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.44 -129.81 9.87 Favored Glycine 0 CA--C 1.546 1.98 0 CA-C-N 113.683 -1.599 . . . . 0.0 111.975 -165.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -135.19 51.69 2.07 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 120.863 0.363 . . . . 0.0 110.216 160.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -158.16 -20.76 0.08 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -177.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -118.32 113.34 21.29 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 121.963 2.165 . . . . 0.0 109.851 -174.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 15.6 mt -97.86 104.79 16.85 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 175.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 66.8 t -105.48 113.73 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -167.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.8 t -146.05 133.99 21.36 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.895 0.478 . . . . 0.0 110.592 -174.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 53.4 m -106.46 107.35 18.32 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -84.31 76.7 10.09 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.175 0.59 . . . . 0.0 109.786 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.341 38.4 ttmt 69.53 -75.96 0.07 Allowed 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 124.56 1.144 . . . . 0.0 112.659 -167.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -115.47 -23.47 8.81 Favored 'General case' 0 CA--C 1.567 1.628 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 174.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.2 mt -79.0 106.61 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-N 120.592 1.542 . . . . 0.0 108.657 -171.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -82.52 96.01 7.9 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-O 121.802 0.81 . . . . 0.0 109.694 176.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.4 m -93.09 116.75 29.33 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.307 1.043 . . . . 0.0 109.707 -176.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.1 t -118.39 102.75 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 104.786 -2.301 . . . . 0.0 104.786 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.2 m -92.01 92.16 8.17 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -174.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -83.16 140.49 32.56 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.65 0.78 . . . . 0.0 110.43 -175.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.67 107.47 13.73 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 172.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -88.81 -98.74 0.09 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 118.432 -0.794 . . . . 0.0 109.128 -176.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -92.31 -103.79 1.49 Allowed Glycine 0 N--CA 1.485 1.924 0 CA-C-N 119.466 1.03 . . . . 0.0 111.394 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -111.03 59.61 0.61 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.825 0.821 . . . . 0.0 109.798 164.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.7 pt -139.4 -163.62 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.809 0 C-N-CA 124.903 1.281 . . . . 0.0 108.048 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.6 tt -157.29 116.36 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.362 -1.461 . . . . 0.0 107.336 165.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.4 m -100.03 87.49 3.5 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -177.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -88.06 106.82 18.41 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 109.416 -0.586 . . . . 0.0 109.416 -176.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 19.1 m -108.08 97.78 7.43 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -167.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 82.1 mtp -99.6 94.57 6.45 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -172.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 59.2 p -97.65 112.2 24.17 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.668 -167.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.1 tp -112.49 86.18 2.31 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 174.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.45 -103.97 1.8 Allowed Glycine 0 CA--C 1.544 1.876 0 C-N-CA 122.848 0.261 . . . . 0.0 113.657 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -86.29 -24.28 25.99 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 169.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 24.7 mm -67.59 137.36 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.597 0 C-N-CA 124.945 1.298 . . . . 0.0 109.725 176.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.7 t -131.22 93.98 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 172.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -89.2 95.06 10.15 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 120.96 0.409 . . . . 0.0 110.704 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -97.29 108.44 21.16 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 121.356 0.598 . . . . 0.0 109.567 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 88.0 mtt180 -94.01 120.04 33.72 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.969 0.908 . . . . 0.0 108.615 171.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -105.64 99.28 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 175.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.4 m -114.49 115.44 27.26 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -175.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -88.51 140.54 29.35 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.279 0.561 . . . . 0.0 111.709 -170.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.8 ttm-85 -64.21 119.69 10.72 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.794 -176.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.7 pt . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -178.002 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.366 96.2 m-85 . . . . . 0 N--CA 1.499 1.991 0 N-CA-C 118.26 2.689 . . . . 0.0 118.26 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 72.1 m -75.37 114.42 13.88 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 121.157 1.799 . . . . 0.0 110.071 170.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.67 145.86 5.31 Favored Glycine 0 CA--C 1.542 1.755 0 CA-C-O 121.84 0.689 . . . . 0.0 112.831 -173.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -97.75 121.79 40.08 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 170.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -117.29 103.11 9.83 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -166.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.8 tp60 -80.56 121.92 26.4 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.749 0.82 . . . . 0.0 110.614 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.7 tp -62.77 127.39 31.04 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -110.78 -66.38 1.08 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.812 0.845 . . . . 0.0 109.606 -176.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.3 t -118.89 114.64 22.92 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.827 0.851 . . . . 0.0 108.847 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -104.2 105.11 15.15 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -102.61 133.79 47.03 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.83 0.852 . . . . 0.0 109.074 -171.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.252 22.2 m120 63.88 47.98 3.32 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -171.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -81.92 -46.17 14.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.827 -1.171 . . . . 0.0 113.956 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.29 -48.54 77.67 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 176.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.3 -40.62 96.89 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 116.566 2.061 . . . . 0.0 116.566 172.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -70.94 -52.74 18.07 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 118.005 -0.997 . . . . 0.0 113.647 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -40.89 93.08 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 177.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -40.82 94.86 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 167.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.57 -35.99 80.07 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 174.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.259 36.0 pt -79.58 -48.26 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-N 119.829 1.195 . . . . 0.0 112.846 175.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.68 58.28 0.12 Allowed Glycine 0 CA--C 1.546 2.003 0 C-N-CA 124.128 0.871 . . . . 0.0 113.631 -178.065 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.07 152.5 56.81 Favored Pre-proline 0 CA--C 1.571 1.776 0 C-N-CA 124.37 1.068 . . . . 0.0 110.24 173.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.32 154.08 31.79 Favored 'Trans proline' 0 C--N 1.366 1.495 0 C-N-CA 123.104 2.536 . . . . 0.0 114.103 -173.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -60.88 -24.92 66.32 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 168.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -57.5 -55.73 31.02 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 119.669 1.122 . . . . 0.0 113.5 164.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.1 mt -71.87 -16.42 62.14 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 175.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.0 mt -73.54 -56.85 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-N 120.165 1.348 . . . . 0.0 110.165 167.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -70.31 -27.56 64.48 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 116.477 2.028 . . . . 0.0 116.477 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -81.99 -50.72 8.81 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 119.155 0.889 . . . . 0.0 112.447 170.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.18 -7.18 62.54 Favored Glycine 0 CA--C 1.554 2.517 0 N-CA-C 119.932 2.733 . . . . 0.0 119.932 177.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -69.12 -45.19 70.79 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 120.137 1.968 . . . . 0.0 114.087 170.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -68.23 -36.06 78.89 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 169.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 42.8 mt -75.28 120.52 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 119.542 1.065 . . . . 0.0 108.232 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -88.75 114.83 25.79 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 176.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.1 133.25 11.38 Favored Glycine 0 CA--C 1.542 1.742 0 CA-C-N 116.473 -0.33 . . . . 0.0 113.291 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.7 t -81.91 122.3 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.0 m -96.0 105.34 17.35 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 170.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.78 144.78 26.43 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.582 0.706 . . . . 0.0 109.989 177.221 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 40.3 mt -146.68 129.24 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.1 t -125.94 115.31 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 -178.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -79.2 131.5 36.22 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.205 0.602 . . . . 0.0 111.048 172.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -135.55 64.92 1.56 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 172.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.38 -104.67 1.88 Allowed Glycine 0 CA--C 1.546 1.997 0 O-C-N 121.211 -0.931 . . . . 0.0 113.401 -177.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -89.35 -39.44 13.43 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 161.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -62.47 152.55 34.16 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.656 1.182 . . . . 0.0 113.806 178.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -139.49 150.61 45.36 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.905 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -134.32 109.54 8.88 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 164.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -117.49 131.64 56.69 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.475 -178.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.2 m -123.69 97.71 5.5 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -172.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.4 mm -88.06 113.44 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.6 p . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.853 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 67.1 mt . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -115.85 118.04 31.88 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -175.061 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -136.5 171.99 13.68 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.0 0.905 . . . . 0.0 110.1 178.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -136.05 137.27 40.96 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.484 -0.76 . . . . 0.0 110.079 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -133.64 134.89 43.76 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.551 0.691 . . . . 0.0 112.274 176.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.3 m -92.11 127.89 37.75 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 163.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.0 t -74.31 124.52 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.28 -53.67 0.59 Allowed Glycine 0 CA--C 1.548 2.109 0 CA-C-N 115.237 -0.892 . . . . 0.0 114.124 -165.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -81.87 155.98 25.05 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.793 0.837 . . . . 0.0 112.809 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -76.38 111.79 12.2 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.079 0.552 . . . . 0.0 110.62 169.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 61.6 m -108.7 143.07 38.29 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.605 0.762 . . . . 0.0 111.421 -167.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -81.62 98.16 8.22 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.345 -176.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.2 mt . . . . . 0 N--CA 1.489 1.496 0 C-N-CA 123.295 0.638 . . . . 0.0 109.906 -167.175 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.301 31.8 ttmt . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.7 m -125.87 142.93 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 C-N-CA 124.188 0.995 . . . . 0.0 109.472 -168.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.75 108.97 14.86 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.1 t -140.27 133.4 29.54 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.441 0.696 . . . . 0.0 109.642 -168.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 64.3 t -84.85 120.03 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -175.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.6 t -97.94 111.9 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 172.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -112.46 145.16 40.69 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.93 0.872 . . . . 0.0 110.853 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 54.2 tp -96.44 105.31 17.37 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.67 178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -90.92 120.13 31.68 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 170.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.4 -124.16 8.71 Favored Glycine 0 CA--C 1.544 1.876 0 CA-C-N 114.327 -1.306 . . . . 0.0 113.276 -174.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -122.75 -14.64 7.66 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 171.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -132.87 27.77 4.25 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 -172.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -138.15 103.14 4.86 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 121.446 1.93 . . . . 0.0 108.508 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 57.4 mt -96.79 106.05 18.28 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 173.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 87.4 t -106.62 122.96 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -165.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.4 t -150.56 127.61 11.17 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 122.589 0.356 . . . . 0.0 111.047 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.8 t -104.24 122.89 46.33 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.215 0.606 . . . . 0.0 109.848 175.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -80.76 -79.7 0.15 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 123.28 0.632 . . . . 0.0 110.189 -173.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -98.08 -78.88 0.48 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 163.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -130.86 61.47 1.63 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 156.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.9 mp -123.49 91.91 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 103.367 -2.827 . . . . 0.0 103.367 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -87.66 92.06 8.97 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.142 0.496 . . . . 0.0 110.303 -172.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.3 t -83.99 103.7 13.46 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.156 0.982 . . . . 0.0 110.49 -175.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 88.1 t -103.34 103.86 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 -177.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.4 HG22 HD11 ' A' ' 109' ' ' ILE . 18.8 m -93.48 92.69 7.73 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -166.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -94.45 109.4 21.27 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.153 0.581 . . . . 0.0 110.498 -166.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.71 98.13 10.24 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 118.726 0.694 . . . . 0.0 109.504 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -83.34 -74.58 0.36 Allowed 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 122.981 0.512 . . . . 0.0 111.606 -172.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -168.78 107.02 0.26 Allowed Glycine 0 N--CA 1.479 1.542 0 CA-C-O 121.796 0.665 . . . . 0.0 112.191 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.275 23.8 m-20 48.71 32.53 3.63 Favored 'General case' 0 CA--C 1.57 1.712 0 N-CA-C 116.944 2.202 . . . . 0.0 116.944 -165.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.7 pt -142.15 -171.09 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.815 0 C-N-CA 124.806 1.242 . . . . 0.0 108.604 175.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.4 HD11 HG22 ' A' ' 102' ' ' THR . 7.5 tt -154.39 124.16 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 120.4 -1.438 . . . . 0.0 107.902 160.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.5 m -102.02 88.75 3.42 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -87.65 105.45 17.36 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.6 m -109.07 99.05 8.41 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -165.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 59.3 mtt -92.51 102.34 14.79 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.72 0.808 . . . . 0.0 109.268 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 77.5 p -94.09 103.14 15.21 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -176.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.2 tp -101.26 83.81 2.53 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 174.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.88 -104.77 1.6 Allowed Glycine 0 CA--C 1.544 1.882 0 CA-C-N 116.375 -0.375 . . . . 0.0 113.181 -176.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -97.15 -12.35 23.2 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 169.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 51.6 mt -84.55 112.39 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -175.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.8 t -103.29 90.71 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -174.338 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -83.6 94.12 8.01 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.428 0.691 . . . . 0.0 110.483 -177.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -106.6 108.14 19.5 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.075 -169.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 -96.53 110.72 23.06 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 63.2 mt -103.45 102.55 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 104.344 -2.465 . . . . 0.0 104.344 -173.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.7 m -127.79 116.67 20.55 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -163.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.5 mttm -77.8 138.28 38.89 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.55 0.74 . . . . 0.0 112.431 -171.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 70.9 ttt-85 -75.25 116.5 16.04 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.821 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 16.7 pt . . . . . 0 N--CA 1.486 1.336 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -174.858 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 117.619 2.452 . . . . 0.0 117.619 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.0 m -76.59 114.34 15.22 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 121.066 1.757 . . . . 0.0 111.116 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.98 169.23 31.21 Favored Glycine 0 CA--C 1.545 1.926 0 CA-C-O 122.821 1.234 . . . . 0.0 114.368 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -92.01 123.01 35.05 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 113.739 -1.23 . . . . 0.0 108.337 170.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -116.11 97.55 6.13 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -175.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.7 tm0? -91.86 125.53 36.6 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 122.987 0.515 . . . . 0.0 110.36 -170.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 38.6 tp -65.37 114.74 5.01 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -169.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -93.54 -65.78 0.97 Allowed 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.219 -176.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.6 m -121.55 117.09 25.92 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -177.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -104.06 130.44 51.75 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.234 1.013 . . . . 0.0 109.128 176.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.63 -69.12 0.75 Allowed 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.357 -177.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -115.38 69.93 0.74 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.25 0.62 . . . . 0.0 110.522 178.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -75.94 -60.88 2.13 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.522 0.729 . . . . 0.0 111.561 171.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.12 -31.65 72.24 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 176.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.55 -44.5 78.14 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 169.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -67.49 -56.68 8.58 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 176.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 51.2 mtt -59.17 -48.45 81.58 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -177.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -57.42 -44.58 84.76 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 170.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.18 -29.63 70.73 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 117.338 2.347 . . . . 0.0 117.338 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 47.0 pt -81.24 -49.33 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-N 119.549 1.068 . . . . 0.0 112.503 173.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.77 67.27 0.03 OUTLIER Glycine 0 CA--C 1.541 1.666 0 CA-C-N 118.79 0.723 . . . . 0.0 112.471 173.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.73 152.32 45.42 Favored Pre-proline 0 CA--C 1.568 1.651 0 C-N-CA 123.967 0.907 . . . . 0.0 110.714 178.01 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.14 155.04 52.32 Favored 'Trans proline' 0 CA--C 1.557 1.652 0 C-N-CA 123.199 2.599 . . . . 0.0 113.394 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -57.08 -33.22 67.06 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 169.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -60.72 -55.57 31.64 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 117.227 -1.368 . . . . 0.0 113.961 170.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.99 -21.81 63.19 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 178.148 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.2 mt -76.1 -55.3 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-N 119.846 1.203 . . . . 0.0 110.509 171.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 52.3 mm-40 -76.21 -29.06 57.47 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -176.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -79.88 -45.7 18.16 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 118.832 0.742 . . . . 0.0 112.181 168.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.63 -28.01 67.17 Favored Glycine 0 CA--C 1.547 2.033 0 N-CA-C 119.678 2.631 . . . . 0.0 119.678 174.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -62.79 -41.01 99.08 Favored 'General case' 0 CA--C 1.568 1.66 0 CA-C-N 119.537 1.668 . . . . 0.0 114.965 170.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -68.77 -37.3 79.23 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 167.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.3 mt -68.22 139.43 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-N 119.651 1.114 . . . . 0.0 110.077 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -72.5 108.88 5.8 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.206 174.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.62 101.62 2.82 Favored Glycine 0 N--CA 1.479 1.526 0 CA-C-N 116.059 -0.518 . . . . 0.0 112.228 -174.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.2 t -85.95 107.32 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -176.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.0 m -99.43 95.11 6.8 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 114.269 -1.332 . . . . 0.0 107.517 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -80.56 148.73 30.23 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 121.88 0.848 . . . . 0.0 111.092 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.7 mt -140.56 122.41 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 173.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.0 t -118.45 100.53 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -83.43 126.74 33.07 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.161 0.584 . . . . 0.0 110.625 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -123.8 77.59 1.54 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 167.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.59 -119.0 6.36 Favored Glycine 0 CA--C 1.546 1.995 0 C-N-CA 123.092 0.377 . . . . 0.0 113.154 -173.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -76.6 -16.81 59.48 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 167.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -78.94 148.4 32.66 Favored 'General case' 0 CA--C 1.557 1.218 0 CA-C-N 119.335 0.971 . . . . 0.0 111.577 176.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -142.5 109.39 5.48 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -101.36 95.7 6.68 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 173.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -94.65 129.56 41.47 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.846 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.9 m -113.74 92.46 3.99 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.3 tp -85.06 120.91 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.804 0.841 . . . . 0.0 110.09 -175.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 56.8 m . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 171.834 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.0 mm . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -92.08 126.77 37.3 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.451 0.643 . . . . 0.0 110.139 173.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -138.81 131.9 29.74 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -126.66 150.06 49.18 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 122.077 0.941 . . . . 0.0 112.56 -171.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -147.15 155.27 41.99 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.334 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.1 m -107.37 137.73 44.88 Favored 'General case' 0 CA--C 1.565 1.533 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 166.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.7 t -75.08 126.1 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 170.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.91 -54.23 0.56 Allowed Glycine 0 CA--C 1.547 2.057 0 CA-C-N 115.659 -0.701 . . . . 0.0 114.353 -167.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -88.62 154.52 20.25 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.599 0.76 . . . . 0.0 112.418 -173.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -77.5 106.63 9.4 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.151 0.501 . . . . 0.0 109.927 164.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 68.7 m -110.03 140.68 43.81 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.756 0.789 . . . . 0.0 111.07 -169.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.44 125.16 30.1 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.484 -177.526 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 122.105 0.955 . . . . 0.0 109.796 179.874 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 70.3 t -117.86 -77.97 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt 61.29 90.49 0.07 Allowed 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 124.355 1.062 . . . . 0.0 112.04 -164.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.2 t -143.39 145.12 32.39 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.543 0.687 . . . . 0.0 110.58 -175.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.1 t -98.17 125.06 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -178.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.1 t -107.38 136.22 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.7 mp0 -119.18 137.88 53.32 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.495 0.718 . . . . 0.0 109.082 172.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.1 tp -104.55 119.48 39.08 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.981 0.912 . . . . 0.0 108.976 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -97.88 122.86 41.5 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 167.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.02 -125.73 11.3 Favored Glycine 0 CA--C 1.544 1.904 0 CA-C-N 114.664 -1.153 . . . . 0.0 113.478 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -137.96 63.06 1.55 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 155.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -152.72 -44.39 0.1 Allowed 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 117.204 -1.379 . . . . 0.0 114.067 -178.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -108.33 111.3 23.16 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 120.536 1.516 . . . . 0.0 111.461 -168.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 24.2 mt -106.72 109.07 20.88 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 174.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.2 t -105.52 121.51 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -174.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 t -156.45 135.43 11.91 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 45.8 m -103.11 113.79 27.55 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -75.9 -83.51 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.225 0.61 . . . . 0.0 111.226 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -133.4 81.83 1.95 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 173.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.257 33.4 t30 49.85 44.87 25.21 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 115.691 1.738 . . . . 0.0 115.691 -163.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 55.7 mt -137.13 95.1 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 -177.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -85.43 98.31 10.51 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.398 0.618 . . . . 0.0 109.691 -178.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.2 t -82.77 102.81 11.81 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.209 1.004 . . . . 0.0 109.542 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 79.8 t -103.24 92.19 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 52.3 m -96.37 97.09 9.19 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -166.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -106.88 124.26 49.36 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.364 1.066 . . . . 0.0 110.681 -165.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.9 107.17 17.91 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -177.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -89.96 -103.23 0.09 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 118.24 -0.886 . . . . 0.0 109.271 -174.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -90.5 -106.41 1.3 Allowed Glycine 0 N--CA 1.485 1.937 0 CA-C-N 119.942 1.246 . . . . 0.0 111.803 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -102.72 56.87 0.77 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.097 0.475 . . . . 0.0 110.437 165.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.2 pt -142.5 -170.66 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.574 1.866 0 C-N-CA 124.557 1.143 . . . . 0.0 108.879 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.4 tt -148.73 125.13 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 120.526 -1.359 . . . . 0.0 107.885 155.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 55.9 m -93.15 96.27 9.92 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 174.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.81 101.6 13.22 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -174.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.2 m -105.17 92.12 4.08 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -165.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 16.8 mtp -91.95 102.48 15.05 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.487 0.715 . . . . 0.0 109.5 -177.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 60.7 p -97.18 104.05 16.04 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -171.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.2 tp -90.89 80.63 5.78 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 176.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.22 -97.67 0.68 Allowed Glycine 0 CA--C 1.546 1.993 0 O-C-N 122.297 -0.252 . . . . 0.0 113.046 -171.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -102.27 -12.37 18.02 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 171.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 95.1 mt -85.84 106.36 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-N 120.854 1.661 . . . . 0.0 107.467 -175.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 96.8 t -94.91 98.73 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -173.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -84.6 94.84 8.7 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.331 0.586 . . . . 0.0 109.554 176.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -96.14 109.36 21.81 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.787 -175.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 30.7 mtm180 -104.62 107.89 19.06 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.0 mp -96.47 107.13 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.2 m -131.1 114.34 15.02 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -164.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -75.33 131.4 40.25 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.595 0.758 . . . . 0.0 112.623 -168.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -74.34 117.6 16.33 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.936 0.895 . . . . 0.0 110.643 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.9 pt . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 -168.601 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 . . . . . 0 N--CA 1.494 1.767 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.5 m -74.41 104.61 5.21 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 121.605 2.002 . . . . 0.0 110.918 175.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.55 148.93 8.66 Favored Glycine 0 CA--C 1.542 1.765 0 CA-C-O 121.84 0.689 . . . . 0.0 113.201 -173.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -102.6 110.1 21.93 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -112.34 105.01 13.19 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -163.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -91.93 137.12 32.62 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.151 0.501 . . . . 0.0 111.322 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.1 tp -72.48 117.62 14.37 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.553 0.741 . . . . 0.0 112.342 -169.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -100.39 -61.96 1.3 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.54 0.736 . . . . 0.0 110.992 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.3 m -119.61 148.86 42.84 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.79 0.836 . . . . 0.0 110.058 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -142.59 134.6 27.2 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 122.039 0.923 . . . . 0.0 109.95 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -87.88 -67.94 0.79 Allowed 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.546 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 50.0 m-20 -120.93 68.9 0.88 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 118.534 0.606 . . . . 0.0 110.711 -175.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -76.46 -54.38 6.8 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.377 0.671 . . . . 0.0 112.335 172.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.44 -49.22 77.69 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 178.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.39 -40.1 85.5 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -67.02 -52.9 36.66 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 175.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -58.94 -51.85 68.28 Favored 'General case' 0 CA--C 1.562 1.423 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -58.02 -38.64 76.59 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 171.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.04 -29.81 69.71 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 116.909 2.189 . . . . 0.0 116.909 174.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.271 46.4 pt -80.65 -54.34 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-N 119.868 1.213 . . . . 0.0 111.768 171.381 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.83 67.06 0.01 OUTLIER Glycine 0 CA--C 1.543 1.795 0 CA-C-N 119.264 0.938 . . . . 0.0 112.971 170.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.75 154.85 55.15 Favored Pre-proline 0 CA--C 1.57 1.744 0 C-N-CA 123.653 0.781 . . . . 0.0 111.839 -175.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -76.36 152.03 34.17 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 123.326 2.684 . . . . 0.0 113.844 176.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -56.72 -37.2 70.62 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 171.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -64.01 -54.28 36.79 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.8 mt -67.0 -23.77 65.96 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 116.716 2.117 . . . . 0.0 116.716 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 74.9 mt -68.72 -55.43 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 124.176 0.99 . . . . 0.0 110.663 169.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -64.87 -25.64 67.98 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 116.893 2.183 . . . . 0.0 116.893 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -74.8 -59.7 2.61 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 119.346 0.975 . . . . 0.0 111.681 168.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.48 -11.72 60.12 Favored Glycine 0 CA--C 1.553 2.417 0 N-CA-C 119.995 2.758 . . . . 0.0 119.995 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -71.27 -46.18 61.49 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 120.272 2.036 . . . . 0.0 114.174 170.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -69.83 -35.66 74.95 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 170.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.2 mt -73.89 126.19 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.27 105.44 16.64 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -85.53 129.57 9.38 Favored Glycine 0 CA--C 1.54 1.614 0 CA-C-N 116.338 -0.392 . . . . 0.0 113.3 -174.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.9 t -85.72 113.49 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.2 t -99.86 112.26 24.53 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 172.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -88.59 151.68 22.33 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 114.614 -1.176 . . . . 0.0 110.309 175.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.2 mt -142.97 131.39 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 166.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.3 t -114.98 109.3 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -78.1 117.6 19.55 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.999 0.52 . . . . 0.0 110.908 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -129.58 62.85 1.53 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.818 169.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.9 -108.69 2.57 Favored Glycine 0 CA--C 1.547 2.035 0 O-C-N 121.614 -0.679 . . . . 0.0 113.714 -177.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -74.18 -42.96 59.03 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 169.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -73.96 121.48 21.08 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 119.24 0.927 . . . . 0.0 111.236 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -122.27 97.11 5.32 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -84.86 100.27 11.47 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 121.676 0.751 . . . . 0.0 109.569 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -87.9 137.91 31.92 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.386 174.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.1 m -128.15 89.46 2.92 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 173.352 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.0 tt -91.66 119.53 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 121.37 0.605 . . . . 0.0 109.643 -176.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.3 p . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -178.184 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.3 mm . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -119.37 119.72 34.78 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -170.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -144.96 148.03 33.35 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.531 0.733 . . . . 0.0 109.231 173.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.97 122.28 46.92 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.536 0.734 . . . . 0.0 110.724 175.091 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -101.9 134.32 45.29 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 121.619 0.723 . . . . 0.0 111.38 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.1 m -97.97 131.18 44.64 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 175.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.5 t -82.18 119.07 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 174.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.99 0.71 71.05 Favored Glycine 0 CA--C 1.557 2.701 0 N-CA-C 119.063 2.385 . . . . 0.0 119.063 -170.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -144.21 138.14 27.84 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 120.176 1.988 . . . . 0.0 109.079 166.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.66 123.32 21.6 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.37 0.605 . . . . 0.0 112.45 -176.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 99.7 m -108.95 150.9 27.05 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.614 171.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.85 115.08 22.08 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.948 175.001 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 N--CA 1.492 1.626 0 C-N-CA 122.812 0.445 . . . . 0.0 109.91 -162.811 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.1 mptt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.1 p -116.58 132.71 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.011 0.925 . . . . 0.0 109.23 -171.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -84.03 112.22 20.0 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.243 0.617 . . . . 0.0 109.976 -171.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.0 t -145.16 149.5 35.08 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.407 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.3 p -112.31 136.37 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 CA-C-O 122.538 1.161 . . . . 0.0 108.506 174.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.08 139.2 18.51 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 CA-C-N 113.931 -1.486 . . . . 0.0 108.166 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -111.61 133.26 54.0 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.4 tp -94.0 107.87 19.74 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -87.84 114.27 24.29 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 170.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.72 -119.12 8.07 Favored Glycine 0 CA--C 1.543 1.826 0 CA-C-N 114.52 -1.218 . . . . 0.0 113.635 -175.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -126.85 -5.45 6.29 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 171.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -123.42 -13.33 7.63 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.342 2.349 . . . . 0.0 117.342 -173.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -116.91 94.36 4.56 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-N 121.493 1.951 . . . . 0.0 110.351 -166.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 39.4 mt -93.19 107.31 19.14 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.557 0.743 . . . . 0.0 110.008 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 29.8 m -106.77 131.34 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 123.937 0.895 . . . . 0.0 110.801 -171.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.1 t -153.74 145.12 23.08 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.6 p -109.89 110.06 20.9 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 174.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -76.14 -87.45 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.235 0.614 . . . . 0.0 110.957 -177.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -112.81 -74.56 0.63 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 174.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -129.05 65.08 1.45 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 154.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.4 mp -137.96 103.31 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 176.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -92.04 94.21 9.14 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -95.09 110.61 22.52 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.59 -167.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.0 t -107.2 100.6 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 -177.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.6 m -96.24 91.25 5.8 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -172.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -87.99 141.83 28.27 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.914 0.885 . . . . 0.0 110.46 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 tt -121.91 102.95 8.5 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 172.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -81.07 -82.11 0.12 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.123 0.569 . . . . 0.0 110.988 -168.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.65 -103.63 2.26 Favored Glycine 0 N--CA 1.482 1.739 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 176.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -111.66 54.02 0.7 Allowed 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.676 0.75 . . . . 0.0 109.833 159.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.4 pp -149.75 136.49 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -175.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.9 tt -108.11 117.4 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.4 m -103.92 98.58 8.4 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 177.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -93.79 116.33 28.79 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.5 m -113.14 94.23 4.79 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -170.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 27.2 mtt -94.2 99.06 11.39 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.735 0.814 . . . . 0.0 109.381 -177.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.4 p -90.94 107.0 18.91 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.246 -174.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.3 tp -101.41 79.86 2.02 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.43 -100.97 1.01 Allowed Glycine 0 CA--C 1.545 1.908 0 CA-C-N 116.579 -0.282 . . . . 0.0 112.772 -171.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -103.1 -6.07 22.63 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 169.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 76.3 mt -87.18 103.86 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 120.668 1.576 . . . . 0.0 106.914 -176.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 49.1 t -93.8 96.58 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -84.83 93.59 8.53 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.199 0.523 . . . . 0.0 109.774 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -99.17 103.02 14.87 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.552 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -107.12 122.86 47.33 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.876 0.87 . . . . 0.0 109.141 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.0 mp -111.16 107.92 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 -171.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.3 m -118.91 119.93 35.78 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -175.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -89.85 141.91 28.19 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.659 0.742 . . . . 0.0 111.414 -174.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 33.3 ttm-85 -66.63 124.76 23.74 Favored 'General case' 0 CA--C 1.559 1.316 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.263 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 16.6 pt . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 123.05 1.405 . . . . 0.0 108.542 -176.638 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.4 t . . . . . 0 CA--C 1.55 0.943 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -85.93 -11.0 54.26 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 -175.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.6 m -76.82 101.82 6.04 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 121.43 1.923 . . . . 0.0 111.004 -176.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.75 168.19 39.0 Favored Glycine 0 CA--C 1.546 2.011 0 CA-C-O 122.34 0.966 . . . . 0.0 112.86 -172.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.69 97.39 5.61 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -173.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -100.55 105.54 16.98 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -160.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -92.13 138.93 31.13 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.557 0.694 . . . . 0.0 111.612 -175.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.0 tp -65.86 130.17 42.34 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.304 1.042 . . . . 0.0 113.389 -172.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -109.37 -65.53 1.14 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.069 0.948 . . . . 0.0 109.745 -178.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.5 t -127.36 121.2 30.35 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.895 0.878 . . . . 0.0 108.94 -176.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -114.93 120.13 38.89 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -79.51 -70.44 0.51 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 118.485 -0.769 . . . . 0.0 112.789 -171.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 46.7 m-20 -121.64 73.82 1.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 118.848 0.749 . . . . 0.0 110.774 -170.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -81.98 -46.37 14.08 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 172.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -59.03 -50.02 75.66 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 172.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.08 -38.28 90.54 Favored 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 116.636 2.087 . . . . 0.0 116.636 175.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -77.54 -51.21 11.07 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -43.71 98.21 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -65.04 -35.65 81.86 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 168.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.6 -30.46 70.7 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 169.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.266 24.7 pt -88.59 -59.55 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-N 119.717 1.144 . . . . 0.0 111.214 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.01 71.55 0.01 OUTLIER Glycine 0 CA--C 1.54 1.644 0 CA-C-N 118.642 0.655 . . . . 0.0 111.909 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.93 153.28 78.51 Favored Pre-proline 0 CA--C 1.571 1.768 0 C-N-CA 123.617 0.767 . . . . 0.0 111.675 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.95 151.05 30.67 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 123.254 2.636 . . . . 0.0 114.048 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -59.48 -31.82 69.69 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 116.623 2.083 . . . . 0.0 116.623 170.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -61.73 -51.1 69.75 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 117.301 -1.333 . . . . 0.0 114.583 170.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.7 mt -68.36 -23.81 64.72 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 173.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 84.9 mt -68.42 -55.0 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 124.356 1.062 . . . . 0.0 111.197 170.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -66.1 -23.05 66.43 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -77.52 -56.5 4.48 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 124.356 1.063 . . . . 0.0 112.037 170.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.37 -15.54 70.42 Favored Glycine 0 CA--C 1.553 2.454 0 N-CA-C 119.667 2.627 . . . . 0.0 119.667 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -65.45 -44.04 88.48 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 120.317 2.058 . . . . 0.0 114.654 168.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -67.65 -35.96 79.86 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 170.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 53.3 mt -75.43 122.24 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -86.34 107.27 17.91 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 174.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.56 130.9 10.3 Favored Glycine 0 CA--C 1.54 1.621 0 CA-C-N 116.178 -0.465 . . . . 0.0 113.561 -173.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.1 t -80.8 114.85 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 71.0 m -104.62 99.37 9.04 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -81.66 145.53 30.52 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.532 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.2 mt -143.45 128.89 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 176.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 87.4 t -124.02 107.42 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 178.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -88.26 122.07 31.38 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.548 0.689 . . . . 0.0 109.444 170.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -87.35 -60.49 1.96 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.406 159.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.56 -88.94 0.07 OUTLIER Glycine 0 N--CA 1.476 1.312 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 170.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -74.0 -39.6 63.51 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 164.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -75.23 135.61 40.99 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 119.897 1.226 . . . . 0.0 111.527 176.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -134.12 108.5 8.34 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm -102.47 103.76 14.16 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -111.95 136.71 50.93 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.789 0.836 . . . . 0.0 110.537 -173.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.3 m -127.88 106.24 8.97 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -176.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.9 mm -97.21 120.14 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.5 p -90.87 90.64 8.0 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 174.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -101.01 92.8 5.18 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.006 0.522 . . . . 0.0 110.655 -167.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.26 -102.04 1.32 Allowed Glycine 0 CA--C 1.543 1.821 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.991 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.5 m -96.28 -57.34 2.36 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.442 0.697 . . . . 0.0 112.053 169.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -80.89 137.95 36.16 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 119.21 0.914 . . . . 0.0 112.336 -173.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.9 t -95.82 119.89 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 90.4 mt -111.33 107.63 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -116.22 130.98 57.06 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.02 0.928 . . . . 0.0 110.478 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -143.01 173.65 11.37 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.872 0.869 . . . . 0.0 109.212 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -143.11 134.06 25.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.983 -1.073 . . . . 0.0 112.313 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -110.25 149.16 30.55 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.8 0.84 . . . . 0.0 111.315 172.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.1 m -108.55 125.45 51.83 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 169.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.9 t -69.5 123.9 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 C-N-CA 123.831 0.852 . . . . 0.0 109.595 -176.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.42 -44.58 2.11 Favored Glycine 0 CA--C 1.552 2.356 0 N-CA-C 116.857 1.503 . . . . 0.0 116.857 -172.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -102.42 132.67 48.29 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.277 1.031 . . . . 0.0 110.145 -173.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -50.81 134.73 24.98 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 116.466 2.025 . . . . 0.0 116.466 -172.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 20.6 p -133.71 137.84 45.5 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 122.187 0.994 . . . . 0.0 111.039 -174.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -96.13 95.21 8.0 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.22 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.1 mt -98.05 144.78 27.2 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.591 0.756 . . . . 0.0 109.665 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -72.72 116.93 13.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.746 -0.596 . . . . 0.0 111.265 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.5 t -82.66 150.92 26.52 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 123.012 1.387 . . . . 0.0 110.861 166.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -65.39 -55.09 20.06 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 113.238 -1.801 . . . . 0.0 114.096 -172.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.2 m -71.63 -48.34 48.56 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 118.366 -0.826 . . . . 0.0 112.832 175.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -82.48 -112.63 0.46 Allowed Glycine 0 CA--C 1.544 1.87 0 CA-C-N 119.357 0.981 . . . . 0.0 114.153 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -166.88 -46.07 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.893 0.877 . . . . 0.0 112.501 -169.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -145.08 146.79 31.98 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.76 1.266 . . . . 0.0 109.707 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.5 p -145.42 125.84 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.318 0 CA-C-N 113.925 -1.488 . . . . 0.0 107.659 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -83.04 107.62 15.76 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 171.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.402 HG21 ' CD2' ' A' ' 95' ' ' PHE . 6.9 t -155.72 105.8 2.44 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 -170.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.252 11.2 p -103.98 136.52 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-O 122.893 1.33 . . . . 0.0 110.718 -176.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.1 t -90.25 136.35 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 CA-C-N 113.346 -1.752 . . . . 0.0 108.742 -172.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -107.0 134.93 49.42 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 171.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 33.5 tp -105.06 110.07 22.31 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.23 -175.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -105.69 128.04 53.43 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.485 0.714 . . . . 0.0 109.198 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.53 7.51 64.74 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 121.344 3.297 . . . . 0.0 121.344 172.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.292 5.0 t70 54.91 45.62 26.13 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 -161.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -157.48 -44.64 0.07 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -92.81 125.6 37.49 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 120.086 1.312 . . . . 0.0 110.934 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.0 mt -111.29 102.05 10.49 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 170.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.1 m -109.05 126.6 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 C-N-CA 123.5 0.72 . . . . 0.0 109.533 -172.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.0 t -149.03 156.25 41.97 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.262 0.553 . . . . 0.0 112.29 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 89.4 m -112.5 105.42 13.64 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 175.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.402 ' CD2' HG21 ' A' ' 81' ' ' THR 0.266 36.7 t80 -91.3 -101.05 0.11 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.109 0.964 . . . . 0.0 108.928 -163.766 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -110.39 78.12 1.1 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 170.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.4 m120 50.32 42.15 25.44 Favored 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -166.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 23.4 mt -133.79 115.25 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 103.455 -2.795 . . . . 0.0 103.455 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -85.73 93.92 8.98 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 174.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.4 t -86.37 96.25 9.94 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.821 0.849 . . . . 0.0 109.901 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 62.3 t -104.19 105.04 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 -174.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 62.9 m -116.24 90.84 3.43 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -168.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -96.12 140.53 30.7 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.132 0.573 . . . . 0.0 110.906 -172.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 tt -105.94 110.56 22.88 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -110.94 91.77 3.79 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -178.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.52 -110.7 3.1 Favored Glycine 0 CA--C 1.544 1.857 0 CA-C-O 119.757 -0.468 . . . . 0.0 113.407 176.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -118.86 52.63 1.04 Allowed 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.272 0.558 . . . . 0.0 111.686 171.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.7 pt -134.87 -166.21 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.783 0 C-N-CA 124.554 1.142 . . . . 0.0 108.136 166.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.3 tt -157.94 126.34 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 O-C-N 120.352 -1.467 . . . . 0.0 107.426 159.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 t -83.44 149.5 26.62 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 120.627 0.251 . . . . 0.0 110.724 164.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -133.83 97.12 3.82 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 169.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.3 m -104.2 91.46 3.94 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -173.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 40.2 mtt -93.79 103.34 15.48 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.211 1.004 . . . . 0.0 109.078 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 75.1 p -99.98 106.57 18.38 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -172.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 42.0 tp -102.95 82.26 2.08 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.94 -99.81 0.88 Allowed Glycine 0 CA--C 1.545 1.925 0 N-CA-C 114.326 0.49 . . . . 0.0 114.326 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -89.72 -25.8 21.0 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 171.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 14.0 mm -67.2 138.76 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.651 0 C-N-CA 125.057 1.343 . . . . 0.0 109.751 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.95 93.94 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 172.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -87.65 98.92 11.69 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.487 0.715 . . . . 0.0 109.752 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -108.9 104.97 14.31 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 123.605 0.566 . . . . 0.0 110.056 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -85.59 142.19 29.29 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.522 164.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -125.41 105.56 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 103.37 -2.826 . . . . 0.0 103.37 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 62.5 m -120.84 120.86 36.78 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.168 0.587 . . . . 0.0 109.459 -174.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -86.03 139.93 30.73 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.317 0.647 . . . . 0.0 111.941 -170.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -69.59 113.9 7.3 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.662 0.785 . . . . 0.0 111.741 -176.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.5 mt . . . . . 0 N--CA 1.482 1.173 0 N-CA-C 102.428 -3.175 . . . . 0.0 102.428 -163.424 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.9 m . . . . . 0 CA--C 1.549 0.915 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -70.98 -22.24 62.21 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 117.711 2.486 . . . . 0.0 117.711 -177.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.2 m -69.73 107.74 3.61 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 120.857 1.662 . . . . 0.0 110.909 176.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.97 162.11 24.5 Favored Glycine 0 CA--C 1.544 1.873 0 CA-C-O 122.425 1.014 . . . . 0.0 114.233 -171.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -105.36 115.43 30.24 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -113.64 98.49 7.08 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 -169.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -93.51 138.91 31.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.936 -0.478 . . . . 0.0 111.067 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.1 tp -63.82 137.96 58.27 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -171.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -121.57 -64.8 1.19 Allowed 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.536 -175.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.8 t -128.77 115.36 17.83 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.617 0.767 . . . . 0.0 109.263 -174.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -105.3 128.72 53.6 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.958 0.903 . . . . 0.0 109.654 175.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -88.52 -70.18 0.66 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.607 -177.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -114.63 68.66 0.7 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.278 0.631 . . . . 0.0 110.398 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -74.61 -52.32 12.07 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 118.496 -0.764 . . . . 0.0 112.448 169.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -63.39 -47.61 81.3 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -173.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.5 -39.67 94.21 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 171.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -66.52 -50.95 61.49 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 176.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 20.7 mmt -62.72 -42.17 99.53 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -175.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -61.75 -45.31 94.45 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 168.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.5 -29.63 70.69 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.262 39.5 pt -76.02 -53.43 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 119.901 1.228 . . . . 0.0 112.132 170.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.31 67.77 0.01 OUTLIER Glycine 0 CA--C 1.538 1.493 0 CA-C-O 118.887 -0.952 . . . . 0.0 112.33 173.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.8 mt -130.06 141.28 41.32 Favored Pre-proline 0 CA--C 1.568 1.637 0 CA-C-N 117.918 0.859 . . . . 0.0 110.561 175.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.66 151.62 84.08 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 123.306 2.671 . . . . 0.0 114.034 172.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -49.93 -37.21 30.77 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 116.5 2.037 . . . . 0.0 116.5 172.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -63.11 -51.06 68.05 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 169.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.5 mt -70.98 -14.31 62.31 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 174.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.3 mt -71.66 -54.68 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-N 120.191 1.36 . . . . 0.0 110.267 166.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -64.2 -27.1 68.83 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 174.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -79.96 -49.47 11.81 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 119.612 1.096 . . . . 0.0 112.594 170.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.55 -24.72 68.08 Favored Glycine 0 CA--C 1.551 2.314 0 N-CA-C 118.951 2.34 . . . . 0.0 118.951 174.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -65.2 -44.42 88.43 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-N 120.509 2.154 . . . . 0.0 114.194 167.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -66.94 -31.4 71.95 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 171.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.0 mt -75.69 107.18 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 172.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.33 105.25 17.44 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -172.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.0 127.97 8.58 Favored Glycine 0 CA--C 1.54 1.618 0 N-CA-C 115.036 0.774 . . . . 0.0 115.036 -160.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.2 t -81.13 116.45 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 172.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.4 m -106.65 105.41 15.42 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -79.62 143.06 35.04 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 121.865 0.841 . . . . 0.0 110.782 175.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 54.2 mt -142.02 124.18 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 103.676 -2.713 . . . . 0.0 103.676 170.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.6 t -122.1 103.72 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -89.82 127.79 36.04 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 121.202 0.525 . . . . 0.0 110.252 176.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -126.72 82.25 2.07 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 165.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.91 -123.62 10.99 Favored Glycine 0 CA--C 1.547 2.058 0 C-N-CA 123.286 0.469 . . . . 0.0 113.939 -176.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -73.62 -35.15 65.3 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 169.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -73.44 147.88 43.78 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 122.724 1.249 . . . . 0.0 111.731 176.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -137.91 148.9 45.74 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 113.613 -1.63 . . . . 0.0 109.498 -177.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.21 110.98 8.71 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 164.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -104.05 147.38 27.46 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.069 172.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.5 m -135.59 92.53 2.84 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.0 tt -96.14 126.88 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 123.437 0.695 . . . . 0.0 109.809 -177.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.6 p -84.29 99.78 10.81 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 175.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -92.5 85.74 5.42 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.455 0.645 . . . . 0.0 109.866 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.59 -116.05 6.71 Favored Glycine 0 CA--C 1.545 1.934 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.265 -169.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.8 m -82.25 -54.4 5.28 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 173.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -80.62 125.06 29.54 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 119.114 0.87 . . . . 0.0 111.27 -173.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.9 p -84.76 133.41 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 123.922 0.889 . . . . 0.0 111.067 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.7 mt -121.44 114.61 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 -175.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -118.33 137.02 53.37 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.296 0.638 . . . . 0.0 111.224 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -137.81 145.98 42.97 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.941 0.877 . . . . 0.0 109.786 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -106.28 128.18 53.79 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.251 169.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -134.75 159.48 41.18 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.722 0.773 . . . . 0.0 111.479 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.5 m -124.2 131.83 53.56 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 173.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.9 m -74.11 130.41 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 123.582 0.753 . . . . 0.0 111.7 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.38 -48.21 1.72 Allowed Glycine 0 CA--C 1.549 2.206 0 N-CA-C 114.964 0.746 . . . . 0.0 114.964 -168.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -67.7 146.44 53.79 Favored 'General case' 0 CA--C 1.564 1.517 0 C-N-CA 124.536 1.134 . . . . 0.0 112.159 172.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -78.86 92.2 4.85 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.872 0.869 . . . . 0.0 109.615 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 25.5 p -107.2 140.08 40.62 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -154.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -67.23 127.49 32.85 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.635 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.5 mt -143.67 109.7 5.31 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -178.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -83.51 145.26 29.01 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -174.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.0 t -86.29 -175.72 5.61 Favored 'General case' 0 CA--C 1.568 1.65 0 CA-C-O 122.118 0.961 . . . . 0.0 111.506 170.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.5 ptp -85.76 52.16 2.39 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 175.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . 0.291 7.6 t -164.22 -71.39 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 173.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 166.14 85.76 0.06 OUTLIER Glycine 0 N--CA 1.478 1.453 0 CA-C-N 118.955 0.798 . . . . 0.0 111.377 171.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -153.33 112.69 3.81 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 172.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -92.88 101.24 13.6 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.2 m -92.67 126.09 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.379 -177.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -84.6 96.37 9.16 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.5 p -138.34 125.45 21.45 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -162.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.6 t -85.6 125.22 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -160.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.0 t -100.59 118.97 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -99.71 134.27 42.84 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.735 0.779 . . . . 0.0 109.754 176.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.1 tp -101.53 112.31 24.82 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.443 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -118.08 121.28 40.17 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.37 12.76 66.81 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 121.215 3.246 . . . . 0.0 121.215 175.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.302 9.0 t70 52.16 48.75 22.06 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -162.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -155.6 -43.34 0.08 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 117.651 -1.166 . . . . 0.0 113.584 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -98.73 122.0 41.39 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 120.469 1.486 . . . . 0.0 110.373 -175.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 77.3 mt -110.69 98.95 7.99 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 168.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.7 m -103.71 124.57 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 123.707 0.803 . . . . 0.0 109.525 -172.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.1 t -148.22 132.39 17.36 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.047 0.451 . . . . 0.0 110.971 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.7 p -95.66 119.83 34.85 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 172.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -84.64 -85.05 0.14 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.074 0.55 . . . . 0.0 109.909 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.74 -75.28 0.59 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 167.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -100.89 -19.07 16.07 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 167.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 mp -82.03 115.99 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-N 120.275 1.398 . . . . 0.0 108.106 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -99.31 101.78 13.19 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 168.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.9 t -85.66 99.4 11.27 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.617 0.767 . . . . 0.0 110.458 -177.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 70.2 t -99.52 97.76 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.7 m -105.52 86.24 2.38 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -166.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -97.04 131.6 43.68 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.888 0.875 . . . . 0.0 110.106 -171.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 tt -101.68 106.28 17.29 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -175.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -106.18 86.66 2.4 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -172.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.74 -108.09 2.68 Favored Glycine 0 N--CA 1.482 1.74 0 O-C-N 122.101 -0.374 . . . . 0.0 112.882 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -121.46 52.65 1.22 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.314 0.578 . . . . 0.0 111.615 170.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.5 pt -131.21 -163.17 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 C-N-CA 124.337 1.055 . . . . 0.0 108.163 163.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.3 tt -154.88 119.57 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 120.363 -1.46 . . . . 0.0 107.952 157.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 29.3 m -95.06 101.02 12.75 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -94.81 99.34 11.43 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 30.3 m -101.93 91.17 4.24 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -172.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 36.3 mtt -93.17 103.36 15.64 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.224 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.3 p -97.86 95.94 7.87 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.489 -171.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 19.3 tp -93.72 81.97 4.3 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.723 0.809 . . . . 0.0 109.079 177.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.8 -101.95 1.16 Allowed Glycine 0 CA--C 1.544 1.879 0 CA-C-N 116.191 -0.458 . . . . 0.0 113.043 -174.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -98.06 -11.52 22.84 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 170.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 62.4 mt -86.71 106.46 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -174.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.9 t -98.84 94.17 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -175.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -82.3 92.73 7.0 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.231 0.613 . . . . 0.0 109.659 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -92.41 109.47 20.86 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.3 ttt-85 -118.23 104.9 11.23 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -164.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.9 mp -98.44 116.33 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 105.593 -2.002 . . . . 0.0 105.593 -172.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.9 m -130.33 115.14 16.51 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -176.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -87.38 137.33 32.43 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.228 0.611 . . . . 0.0 112.135 -168.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.3 ttt85 -67.58 124.88 24.46 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 123.914 0.886 . . . . 0.0 111.524 177.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.5 pt . . . . . 0 N--CA 1.484 1.258 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 -172.576 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.0 m . . . . . 0 CA--C 1.549 0.915 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -68.2 -23.71 64.86 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 117.027 2.232 . . . . 0.0 117.027 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.7 m -73.29 109.21 6.64 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 120.704 1.593 . . . . 0.0 110.648 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.15 162.21 23.09 Favored Glycine 0 CA--C 1.544 1.877 0 CA-C-O 122.306 0.948 . . . . 0.0 114.134 -171.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -97.18 125.88 41.98 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 114.402 -0.899 . . . . 0.0 108.605 175.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -121.52 104.37 9.6 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -172.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -95.62 137.85 34.11 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.129 0.49 . . . . 0.0 110.892 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.7 tp -66.11 130.69 44.11 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.082 0.953 . . . . 0.0 112.987 -173.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -114.64 -64.79 1.26 Allowed 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.879 -175.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.7 m -125.49 112.05 15.78 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -105.74 110.4 22.69 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -97.41 127.42 43.36 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.263 85.5 m-20 67.4 52.51 0.8 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 173.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -78.65 -43.95 24.94 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 168.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -68.65 -50.86 47.83 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -175.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.91 -40.74 85.44 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 170.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -69.44 -56.54 7.13 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -44.24 96.61 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -61.96 -38.13 87.37 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 170.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.66 -34.39 77.74 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.819 2.155 . . . . 0.0 116.819 172.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.5 pt -82.33 -53.8 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 CA-C-N 119.327 0.967 . . . . 0.0 112.384 176.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.52 68.68 0.01 OUTLIER Glycine 0 CA--C 1.539 1.535 0 CA-C-N 119.017 0.826 . . . . 0.0 112.894 172.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.32 153.11 81.56 Favored Pre-proline 0 CA--C 1.57 1.721 0 C-N-CA 123.513 0.725 . . . . 0.0 111.813 175.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.81 152.84 25.53 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 123.264 2.643 . . . . 0.0 113.489 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -59.18 -28.84 66.99 Favored 'General case' 0 CA--C 1.565 1.526 0 N-CA-C 116.723 2.119 . . . . 0.0 116.723 168.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -63.02 -51.81 65.35 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 120.543 1.52 . . . . 0.0 114.055 170.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.4 mt -67.93 -28.28 67.35 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 116.604 2.075 . . . . 0.0 116.604 173.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.3 mt -70.38 -49.94 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 C-N-CA 124.297 1.039 . . . . 0.0 111.621 173.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -64.23 -22.62 67.01 Favored 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 116.315 1.969 . . . . 0.0 116.315 170.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -73.08 -57.99 3.63 Favored 'General case' 0 CA--C 1.565 1.519 0 CA-C-N 119.272 0.942 . . . . 0.0 111.74 167.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.5 -22.16 67.46 Favored Glycine 0 CA--C 1.548 2.143 0 N-CA-C 120.418 2.927 . . . . 0.0 120.418 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -64.68 -43.53 93.24 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 119.661 1.731 . . . . 0.0 114.64 170.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -67.24 -27.85 67.57 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 168.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 53.1 mt -83.03 121.75 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-N 120.144 1.338 . . . . 0.0 107.506 178.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.64 102.46 15.09 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 173.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.54 132.74 11.42 Favored Glycine 0 CA--C 1.541 1.707 0 N-CA-C 114.509 0.564 . . . . 0.0 114.509 -167.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.3 t -85.33 110.21 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 54.2 p -109.79 112.16 24.03 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.5 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -89.63 152.32 21.44 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 121.632 0.729 . . . . 0.0 111.058 -177.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.2 mt -136.35 132.8 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 105.437 -2.06 . . . . 0.0 105.437 173.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.6 t -126.57 102.77 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -80.18 120.7 24.65 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.122 0.569 . . . . 0.0 110.148 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -122.99 73.0 1.12 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 169.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.83 -117.48 7.56 Favored Glycine 0 CA--C 1.546 1.996 0 C-N-CA 123.117 0.389 . . . . 0.0 113.67 -175.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -76.87 -34.36 57.8 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 169.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -79.95 112.99 17.78 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 119.941 1.246 . . . . 0.0 110.761 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -105.74 117.98 35.42 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -104.12 104.65 14.62 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 176.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -133.29 134.45 43.9 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.297 -166.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.96 147.71 22.84 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.669 0.747 . . . . 0.0 110.029 165.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.0 tp -130.68 121.91 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.5 m -94.02 105.68 17.68 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 172.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.22 82.93 4.55 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 171.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.67 -101.96 1.95 Allowed Glycine 0 CA--C 1.54 1.621 0 CA-C-N 115.941 -0.572 . . . . 0.0 113.556 -177.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 93.0 p -89.08 -55.62 3.61 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.64 130.48 35.07 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 119.171 0.896 . . . . 0.0 111.673 -173.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.6 p -101.99 129.13 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.279 175.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.3 tt -129.92 143.22 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 123.799 0.84 . . . . 0.0 109.361 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -94.81 125.48 39.49 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.774 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -127.38 159.19 35.21 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 124.007 0.923 . . . . 0.0 110.257 -177.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -139.34 136.69 35.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.543 -0.723 . . . . 0.0 110.244 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.493 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 28.5 p90 -126.96 159.71 33.23 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 122.012 0.91 . . . . 0.0 112.324 167.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 96.3 m -116.07 139.7 50.03 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 163.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.6 t -75.62 123.35 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.13 34.21 21.49 Favored Glycine 0 CA--C 1.549 2.198 0 N-CA-C 117.044 1.578 . . . . 0.0 117.044 -168.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -149.89 138.57 20.83 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -177.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -69.32 105.71 2.65 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.176 0.512 . . . . 0.0 109.954 160.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 63' ' ' PHE . 3.2 p -129.25 131.76 47.09 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 122.402 1.096 . . . . 0.0 110.649 -162.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -79.65 123.75 27.92 Favored 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 113.962 -1.472 . . . . 0.0 112.631 -168.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.8 mt -118.51 119.56 34.9 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 -177.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -86.67 92.54 8.96 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.647 0.737 . . . . 0.0 109.228 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.8 m -90.89 159.44 16.23 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.446 1.098 . . . . 0.0 109.707 -172.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . 0.282 55.4 mtt 68.74 -100.27 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 124.623 1.169 . . . . 0.0 109.674 -175.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.8 p -127.9 -44.05 1.49 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.716 1.206 . . . . 0.0 110.725 162.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -141.82 82.02 0.23 Allowed Glycine 0 N--CA 1.481 1.645 0 CA-C-N 120.033 1.288 . . . . 0.0 111.55 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -142.57 99.75 3.55 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 177.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.96 122.08 31.96 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.045 0.45 . . . . 0.0 110.676 -171.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.9 p -140.12 121.19 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -169.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -92.85 123.63 36.26 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.189 0.596 . . . . 0.0 109.985 -175.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.2 p -132.84 128.65 37.13 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -164.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.5 t -93.39 108.68 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -175.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.3 t -96.56 127.09 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -172.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -115.52 132.16 56.71 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 168.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.9 tp -98.67 108.62 21.36 Favored 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -102.79 125.5 49.56 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.78 0.8 . . . . 0.0 109.159 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.09 11.13 66.57 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 121.173 3.229 . . . . 0.0 121.173 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.274 25.9 m-20 57.77 43.52 21.77 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -166.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -158.65 -38.79 0.06 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 117.744 -1.122 . . . . 0.0 114.0 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -103.99 119.33 38.71 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 120.458 1.481 . . . . 0.0 110.411 -172.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.6 mt -101.03 99.46 9.92 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 174.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.1 t -100.68 110.59 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -170.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.6 t -137.26 159.58 41.51 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 122.863 1.316 . . . . 0.0 113.629 -167.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 58.9 m -80.47 -78.42 0.17 Allowed 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.914 -161.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 65.0 171.38 0.2 Allowed 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 119.613 1.097 . . . . 0.0 113.749 -169.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -79.21 95.06 5.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.195 -0.94 . . . . 0.0 108.569 165.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 55.8 t30 47.44 47.41 17.16 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.9 mt -137.81 88.54 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 102.926 -2.99 . . . . 0.0 102.926 174.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -84.5 98.41 10.09 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -174.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.9 t -96.62 117.65 31.42 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.933 -165.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 56.1 t -113.36 101.83 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 104.832 -2.285 . . . . 0.0 104.832 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.7 m -98.36 83.96 3.14 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -89.99 130.97 36.12 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.967 0.907 . . . . 0.0 110.214 -172.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 tt -101.27 110.38 22.38 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -110.68 85.52 2.13 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -174.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.82 -108.31 2.72 Favored Glycine 0 N--CA 1.483 1.771 0 O-C-N 122.081 -0.387 . . . . 0.0 112.952 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -121.36 56.5 1.04 Allowed 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.337 0.589 . . . . 0.0 111.188 168.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.8 pt -131.39 -166.11 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.687 0 C-N-CA 124.331 1.052 . . . . 0.0 108.522 161.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.6 tt -154.62 123.04 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.305 0 O-C-N 120.196 -1.565 . . . . 0.0 108.545 158.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 46.1 m -101.64 103.13 13.92 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 -176.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -93.0 98.56 11.43 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.5 m -99.34 87.25 3.58 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.662 0.744 . . . . 0.0 109.018 -171.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 33.5 mtt -92.46 105.43 17.61 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.129 0.972 . . . . 0.0 109.704 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.9 p -98.89 101.27 12.61 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -172.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.5 tp -95.25 83.77 3.93 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.57 -97.31 0.78 Allowed Glycine 0 CA--C 1.543 1.83 0 CA-C-N 116.437 -0.347 . . . . 0.0 112.685 -171.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -106.95 -9.3 16.31 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.319 1.599 . . . . 0.0 115.319 169.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 48.5 mt -85.75 107.31 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-N 120.692 1.587 . . . . 0.0 107.091 -173.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.3 t -94.7 95.61 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -174.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -86.74 100.75 12.72 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.905 0.882 . . . . 0.0 109.245 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -111.18 107.72 17.15 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.76 -172.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -99.72 114.33 27.37 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 75.6 mt -102.75 103.09 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 -177.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.4 m -120.47 114.98 22.58 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -171.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -84.2 135.83 34.2 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.172 0.589 . . . . 0.0 112.168 -168.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -69.91 133.46 47.35 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-O 122.014 0.912 . . . . 0.0 112.184 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.7 pt . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 -172.281 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 CA--C 1.553 1.079 0 CA-C-O 119.01 -0.519 . . . . 0.0 110.771 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.365 90.7 m-85 80.39 -35.4 0.13 Allowed 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 117.381 2.363 . . . . 0.0 117.381 173.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.9 m -71.94 107.22 4.57 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 120.496 1.498 . . . . 0.0 111.248 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.69 161.31 24.28 Favored Glycine 0 CA--C 1.544 1.88 0 CA-C-O 122.652 1.14 . . . . 0.0 114.044 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -96.58 125.67 41.21 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 168.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -121.05 116.66 25.45 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -174.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -91.83 125.78 36.67 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 122.943 0.497 . . . . 0.0 110.092 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 28.6 tp -64.02 131.79 48.64 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.75 0.82 . . . . 0.0 112.781 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -126.33 -58.22 1.36 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 118.569 -0.729 . . . . 0.0 110.742 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.8 m -107.35 136.99 46.22 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 119.067 0.849 . . . . 0.0 109.664 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -139.53 106.35 5.4 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -96.47 134.2 39.95 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.081 0.952 . . . . 0.0 109.365 176.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.26 13.5 m-20 66.67 47.65 1.55 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 174.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -77.82 -49.51 14.15 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 176.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -62.79 -46.78 86.41 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 177.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.74 -42.39 93.06 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 173.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -72.49 -52.8 14.17 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -52.09 66.81 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -56.92 -39.24 74.09 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 171.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.12 -37.48 87.59 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 116.588 2.069 . . . . 0.0 116.588 174.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.278 48.5 pt -77.36 -48.88 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-N 119.516 1.053 . . . . 0.0 112.955 175.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.81 57.72 0.01 OUTLIER Glycine 0 N--CA 1.483 1.815 0 CA-C-N 119.473 1.033 . . . . 0.0 114.5 166.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -110.3 154.03 43.1 Favored Pre-proline 0 CA--C 1.566 1.575 0 CA-C-N 118.009 0.904 . . . . 0.0 112.084 -175.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.16 154.93 33.0 Favored 'Trans proline' 0 CA--C 1.557 1.659 0 C-N-CA 123.296 2.664 . . . . 0.0 113.384 172.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -61.62 -35.49 78.04 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 170.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.05 -54.18 50.03 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 173.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.6 mt -70.97 -24.07 62.34 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 116.558 2.058 . . . . 0.0 116.558 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 60.6 mt -70.2 -52.14 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-N 119.94 1.245 . . . . 0.0 110.974 169.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -62.84 -19.7 64.36 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 116.912 2.19 . . . . 0.0 116.912 173.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -81.38 -53.91 5.91 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-N 119.483 1.038 . . . . 0.0 112.182 167.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.45 -7.2 57.36 Favored Glycine 0 CA--C 1.553 2.463 0 N-CA-C 120.279 2.872 . . . . 0.0 120.279 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.77 -47.03 61.73 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 120.21 2.005 . . . . 0.0 113.273 170.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -69.43 -31.91 70.56 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 168.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.2 mt -78.29 119.79 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -85.13 116.25 23.39 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.86 131.16 10.59 Favored Glycine 0 CA--C 1.54 1.608 0 CA-C-N 116.096 -0.502 . . . . 0.0 113.723 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.8 t -81.26 114.53 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 175.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.2 m -96.51 110.98 23.26 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 176.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.39 141.3 30.64 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.81 0.814 . . . . 0.0 109.954 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 67.2 mt -141.53 132.34 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 170.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.8 t -120.87 113.39 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 174.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -82.41 123.73 29.4 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.262 0.625 . . . . 0.0 110.168 173.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -128.07 72.02 1.4 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 163.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.88 -114.43 5.29 Favored Glycine 0 CA--C 1.545 1.933 0 C-N-CA 123.4 0.524 . . . . 0.0 113.385 -177.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -77.53 -33.51 54.22 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 167.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -76.54 102.94 6.27 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 120.072 1.305 . . . . 0.0 111.008 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -109.13 109.21 20.14 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.95 127.89 44.98 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 168.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -116.34 152.14 34.49 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.747 178.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.1 m -136.28 92.63 2.8 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 173.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.8 mm -91.12 116.61 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 -175.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.4 m -93.91 102.14 14.24 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -174.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -92.06 140.9 29.18 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 162.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -44.57 -39.02 5.67 Favored Glycine 0 CA--C 1.555 2.581 0 N-CA-C 119.805 2.682 . . . . 0.0 119.805 175.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.5 t -69.44 -59.74 2.79 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 168.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -145.49 135.12 23.34 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 119.223 0.92 . . . . 0.0 109.913 -176.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.7 p -75.7 125.18 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 123.482 0.713 . . . . 0.0 110.236 169.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.4 mt -119.71 110.51 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 -173.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -117.09 130.72 56.83 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.768 0.827 . . . . 0.0 110.966 -176.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -148.31 149.13 31.27 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.553 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -118.4 128.36 54.55 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.826 0.85 . . . . 0.0 110.222 -176.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -116.12 144.47 44.11 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.962 0.905 . . . . 0.0 111.425 170.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.2 m -105.3 124.11 48.98 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 166.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.4 t -67.04 124.88 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 C-N-CA 123.735 0.814 . . . . 0.0 110.662 -174.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.18 -49.97 2.45 Favored Glycine 0 CA--C 1.549 2.167 0 N-CA-C 115.999 1.16 . . . . 0.0 115.999 -170.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -93.22 124.13 36.98 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.728 0.811 . . . . 0.0 110.231 -172.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -57.44 123.81 16.75 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 -168.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 72.6 m -144.08 146.53 32.88 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.099 0.96 . . . . 0.0 109.609 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -80.04 134.59 36.23 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.2 mt -130.04 127.4 39.84 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 175.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -85.22 141.73 29.93 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.423 0.63 . . . . 0.0 111.473 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.2 p -73.06 172.95 10.07 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.767 164.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 90.3 mtp -61.06 -53.83 52.29 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.555 -1.341 . . . . 0.0 114.142 175.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.6 p -127.54 111.02 13.31 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 167.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 173.26 -108.11 0.27 Allowed Glycine 0 CA--C 1.535 1.335 0 N-CA-C 111.979 -0.449 . . . . 0.0 111.979 175.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -149.79 151.17 33.12 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.613 0.721 . . . . 0.0 109.544 -168.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 49.5 mttm -71.4 103.56 2.94 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.393 1.092 . . . . 0.0 109.685 167.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.8 p -114.39 134.52 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 113.157 -1.838 . . . . 0.0 108.773 -164.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -78.02 106.39 9.85 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.14 0.576 . . . . 0.0 110.794 -171.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.6 t -152.64 130.81 11.94 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -173.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.25 145.26 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 123.374 1.559 . . . . 0.0 110.587 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.8 t -98.49 142.18 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.302 0 CA-C-N 112.985 -1.916 . . . . 0.0 108.347 -167.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -112.48 132.98 54.79 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 172.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.7 tp -98.07 109.71 22.42 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.841 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -95.65 114.93 26.73 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 122.127 0.965 . . . . 0.0 108.929 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.44 -128.64 10.65 Favored Glycine 0 CA--C 1.545 1.919 0 CA-C-N 114.019 -1.446 . . . . 0.0 112.265 -168.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -135.82 58.55 1.75 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 156.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -158.49 -32.0 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -173.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -114.39 106.21 14.03 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 120.925 1.693 . . . . 0.0 108.976 -174.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 42.4 mt -95.78 103.91 15.81 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.0 m -102.35 125.56 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 C-N-CA 123.372 0.669 . . . . 0.0 109.87 -172.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 t -149.66 151.43 33.71 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.324 0.583 . . . . 0.0 111.771 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 29.7 p -119.71 112.72 19.64 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.405 0.682 . . . . 0.0 109.215 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -83.38 37.43 0.56 Allowed 'General case' 0 CA--C 1.58 2.106 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 168.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.344 11.8 tmtt? 69.99 -81.04 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.952 1.301 . . . . 0.0 111.236 -163.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -81.14 -42.6 20.63 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.8 mp -85.64 123.05 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-N 119.585 1.084 . . . . 0.0 108.167 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -102.57 98.77 8.78 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 172.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.9 t -89.67 132.88 34.94 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.478 0.711 . . . . 0.0 110.958 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.1 t -132.95 102.3 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 20.6 m -93.14 95.71 9.58 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -80.84 145.21 31.51 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.111 0.964 . . . . 0.0 110.703 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.2 tt -128.35 109.37 11.38 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 174.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -113.21 80.49 1.36 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -175.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.93 -109.24 3.26 Favored Glycine 0 N--CA 1.484 1.861 0 O-C-N 121.835 -0.541 . . . . 0.0 113.068 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.47 50.39 0.95 Allowed 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 122.965 0.506 . . . . 0.0 111.362 173.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.6 pt -133.8 -168.74 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.786 0 C-N-CA 124.047 0.939 . . . . 0.0 108.938 171.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.1 tt -156.85 115.44 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.272 -1.517 . . . . 0.0 107.45 159.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 90.0 m -103.15 99.7 9.58 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -90.19 108.81 19.98 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 39.7 m -108.48 100.14 9.45 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 -173.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.8 mtt -101.28 100.39 10.89 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.2 p -88.65 113.38 24.16 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.009 -173.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.3 tp -117.87 75.43 1.0 Allowed 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.35 -107.4 2.34 Favored Glycine 0 CA--C 1.545 1.958 0 CA-C-N 116.404 -0.362 . . . . 0.0 112.369 -172.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -93.62 -10.7 33.7 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 167.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 61.8 mt -86.52 103.67 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -173.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 48.4 t -97.81 97.78 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -85.55 96.33 9.6 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.163 0.585 . . . . 0.0 109.446 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -105.26 101.67 11.19 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -176.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.6 113.98 27.22 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 50.2 mt -107.02 112.91 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -172.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 54.5 m -114.76 119.03 35.26 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 176.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -83.81 147.3 27.66 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.965 -0.459 . . . . 0.0 110.937 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -76.03 107.18 8.06 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 121.538 0.685 . . . . 0.0 111.295 -169.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.7 mt . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 102.336 -3.209 . . . . 0.0 102.336 -158.505 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.5 t . . . . . 0 CA--C 1.55 0.947 0 CA-C-O 121.249 0.547 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -65.8 -17.24 64.5 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 117.569 2.433 . . . . 0.0 117.569 174.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.2 m -69.39 112.26 5.81 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 120.822 1.646 . . . . 0.0 110.792 173.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.03 145.22 4.95 Favored Glycine 0 CA--C 1.541 1.675 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.062 -171.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -102.21 106.8 17.69 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -107.64 104.05 13.49 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -162.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -83.19 131.24 35.13 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.123 0.487 . . . . 0.0 111.633 -177.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.9 tp -76.14 115.71 16.13 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.675 -168.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -98.6 -65.24 0.97 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.507 0.723 . . . . 0.0 111.444 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.0 m -131.89 135.66 46.83 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.245 0.618 . . . . 0.0 110.336 -163.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -129.29 134.68 48.05 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.649 0.737 . . . . 0.0 109.799 -175.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -76.28 -58.55 3.22 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.356 171.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -127.35 68.94 1.29 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.584 0.629 . . . . 0.0 110.799 -176.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -75.12 -54.26 7.45 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.526 -0.734 . . . . 0.0 112.553 170.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -65.21 -49.55 69.3 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.22 -39.21 82.0 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 116.89 2.182 . . . . 0.0 116.89 174.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -65.96 -54.07 30.89 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 174.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 37.4 mtt -60.7 -45.61 93.52 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -55.67 -42.1 74.63 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 167.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.4 -34.47 78.02 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 117.06 2.244 . . . . 0.0 117.06 175.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.7 pt -78.48 -43.94 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-N 119.822 1.192 . . . . 0.0 113.599 175.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.36 62.78 0.09 OUTLIER Glycine 0 N--CA 1.481 1.664 0 CA-C-N 118.881 0.764 . . . . 0.0 112.682 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.42 151.33 46.8 Favored Pre-proline 0 CA--C 1.568 1.649 0 C-N-CA 123.8 0.84 . . . . 0.0 110.745 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -75.65 156.99 40.21 Favored 'Trans proline' 0 CA--C 1.555 1.559 0 C-N-CA 123.264 2.642 . . . . 0.0 113.637 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -60.35 -29.53 68.96 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.692 1.738 . . . . 0.0 115.692 168.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -60.2 -57.75 11.48 Favored 'General case' 0 CA--C 1.564 1.495 0 CA-C-O 117.297 -1.335 . . . . 0.0 113.803 169.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.8 mt -68.69 -24.16 64.47 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 117.19 2.293 . . . . 0.0 117.19 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.4 mt -73.38 -54.29 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-N 119.491 1.042 . . . . 0.0 110.711 173.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -69.18 -27.85 65.88 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 177.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -76.69 -53.77 7.54 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.04 0.936 . . . . 0.0 112.109 171.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.9 -19.78 69.99 Favored Glycine 0 CA--C 1.551 2.316 0 N-CA-C 119.652 2.621 . . . . 0.0 119.652 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -65.72 -43.71 88.24 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 120.251 2.025 . . . . 0.0 114.434 170.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -68.4 -31.47 70.83 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 170.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.9 mt -77.33 129.86 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-N 119.532 1.06 . . . . 0.0 108.508 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.52 94.97 9.94 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 171.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.12 131.06 10.36 Favored Glycine 0 N--CA 1.481 1.635 0 CA-C-N 116.558 -0.292 . . . . 0.0 113.322 -172.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.7 t -79.75 120.81 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.9 m -108.29 100.21 9.54 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 107.167 -1.419 . . . . 0.0 107.167 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -83.89 147.9 27.26 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.842 0.829 . . . . 0.0 111.011 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.9 mt -143.91 129.42 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 172.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 67.8 t -120.88 117.49 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 176.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -81.2 122.11 26.98 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.404 0.681 . . . . 0.0 111.31 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -131.0 64.11 1.58 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 171.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.58 -113.73 5.9 Favored Glycine 0 CA--C 1.547 2.059 0 O-C-N 121.629 -0.669 . . . . 0.0 113.746 -174.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -73.29 -40.46 64.54 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 169.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -69.63 135.59 50.12 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 119.407 1.003 . . . . 0.0 111.387 175.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -127.6 108.72 11.02 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -87.04 92.59 9.1 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.673 0.749 . . . . 0.0 109.017 176.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -104.64 136.5 44.05 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.42 -175.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.8 m -131.55 102.58 5.98 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -177.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.6 mm -95.22 105.08 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.1 t -105.05 102.3 11.81 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 174.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -106.11 86.39 2.36 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.28 -107.49 2.63 Favored Glycine 0 CA--C 1.541 1.688 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.852 -176.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 63.2 m -87.95 -47.76 8.31 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -75.21 133.6 41.37 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 119.438 1.017 . . . . 0.0 111.698 -174.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.5 t -117.95 109.21 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 -175.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.8 mp -104.36 97.12 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 -174.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.78 120.85 42.22 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.203 0.601 . . . . 0.0 110.538 -177.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -149.62 161.33 42.38 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.175 0.99 . . . . 0.0 109.968 -175.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -117.47 128.58 55.13 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.57 0.748 . . . . 0.0 109.871 175.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -107.89 145.07 34.25 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.467 0.651 . . . . 0.0 110.392 158.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.4 m -109.15 131.89 54.64 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 171.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.2 t -73.55 130.1 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 123.797 0.839 . . . . 0.0 109.702 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.27 8.52 87.52 Favored Glycine 0 CA--C 1.553 2.452 0 N-CA-C 118.706 2.242 . . . . 0.0 118.706 -170.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -139.73 135.7 33.41 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 119.272 1.536 . . . . 0.0 108.251 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.75 121.93 18.18 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.257 0.623 . . . . 0.0 112.5 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -136.86 126.85 25.93 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.693 0.797 . . . . 0.0 110.479 -165.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.3 128.3 34.09 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.03 -0.987 . . . . 0.0 111.685 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.9 mt -129.36 112.71 14.11 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -175.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -71.81 121.27 18.67 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.5 0.72 . . . . 0.0 110.191 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.1 p -83.11 171.07 14.11 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.818 0.818 . . . . 0.0 111.703 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 17.2 ptt? -55.1 -44.07 74.59 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 117.136 2.273 . . . . 0.0 117.136 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 48.9 p -73.67 -63.44 1.2 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 118.584 0.629 . . . . 0.0 111.598 168.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 152.96 92.92 0.09 OUTLIER Glycine 0 N--CA 1.478 1.467 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -155.69 119.66 4.52 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -88.84 109.49 20.25 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 170.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.7 m -80.54 -47.43 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -168.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . 0.265 53.9 mtpt 64.36 86.32 0.13 Allowed 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 124.821 1.248 . . . . 0.0 111.648 -172.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.7 t -134.68 147.17 50.06 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.707 0.803 . . . . 0.0 110.033 -171.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.8 t -85.5 -56.98 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.776 -0.578 . . . . 0.0 111.427 -169.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . 0.307 3.1 t 80.25 127.24 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 125.382 1.473 . . . . 0.0 109.866 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -121.26 135.17 55.16 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 39.2 tp -96.68 102.57 14.37 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -86.23 114.43 23.05 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 121.799 0.809 . . . . 0.0 109.309 173.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.53 -122.42 8.54 Favored Glycine 0 CA--C 1.542 1.724 0 CA-C-N 114.394 -1.276 . . . . 0.0 112.89 -175.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -142.04 60.42 1.46 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 155.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -151.51 -39.29 0.12 Allowed 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 117.267 -1.349 . . . . 0.0 114.218 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -106.27 126.65 52.49 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 120.686 1.584 . . . . 0.0 110.288 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 37.2 mt -107.74 100.0 9.43 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 165.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.8 m -94.9 122.85 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 123.876 0.871 . . . . 0.0 109.274 -172.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.2 t -152.51 132.82 13.65 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 120.92 0.39 . . . . 0.0 111.907 -172.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 44.8 p -100.58 121.54 41.78 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -84.18 -70.74 0.55 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.031 0.532 . . . . 0.0 111.339 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -120.7 -77.3 0.58 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 165.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -126.74 66.98 1.25 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 159.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 62.9 mt -142.33 101.21 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 103.411 -2.811 . . . . 0.0 103.411 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -88.08 98.4 11.51 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.345 0.593 . . . . 0.0 109.571 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.3 t -88.25 102.64 15.02 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.307 1.043 . . . . 0.0 109.947 -176.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.7 t -101.0 97.23 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 -177.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.9 m -91.65 83.49 5.33 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -168.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -98.66 129.13 45.14 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.626 0.77 . . . . 0.0 110.129 -161.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 tt -113.09 114.07 26.31 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -167.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -119.27 103.33 9.41 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.01 -118.18 4.65 Favored Glycine 0 N--CA 1.484 1.862 0 C-N-CA 123.123 0.392 . . . . 0.0 112.714 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -124.93 60.16 1.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.986 0.898 . . . . 0.0 110.107 161.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.6 pt -123.62 -164.64 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.789 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 157.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.3 tt -155.9 125.19 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 120.147 -1.596 . . . . 0.0 108.283 160.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 88.9 m -109.76 98.65 7.95 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -93.86 123.79 37.44 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.371 0.605 . . . . 0.0 109.691 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 27.8 m -114.59 93.84 4.51 Favored 'General case' 0 CA--C 1.557 1.236 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 -170.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 63.5 mtt -93.22 99.81 12.3 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.813 0.845 . . . . 0.0 109.102 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 73.8 p -94.84 100.22 12.14 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -171.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 35.0 tp -96.4 84.96 3.81 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.31 -100.0 0.93 Allowed Glycine 0 CA--C 1.544 1.881 0 CA-C-N 116.743 -0.208 . . . . 0.0 112.852 -174.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -102.36 -10.5 19.4 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 169.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 71.9 mt -87.09 108.19 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-N 120.601 1.546 . . . . 0.0 107.453 -172.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.3 t -97.83 93.13 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -172.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -82.84 109.18 16.75 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 122.967 0.507 . . . . 0.0 110.285 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -88.77 142.79 27.37 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.818 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 45.7 mtm180 -134.62 93.57 3.06 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 174.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 58.3 mt -94.73 104.87 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 105.499 -2.038 . . . . 0.0 105.499 -174.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.5 m -130.75 112.92 13.51 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -163.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -90.87 138.95 31.2 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.351 0.595 . . . . 0.0 112.186 -172.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.2 136.71 56.29 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 123.748 0.819 . . . . 0.0 113.114 -177.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.9 pt . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 -175.53 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 87.7 p . . . . . 0 CA--C 1.551 1.006 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -87.45 -152.52 0.2 Allowed 'General case' 0 CA--C 1.57 1.74 0 C-N-CA 123.517 0.727 . . . . 0.0 110.17 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.2 m 62.0 88.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.04 1.336 . . . . 0.0 112.848 -176.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.44 167.05 31.93 Favored Glycine 0 CA--C 1.54 1.646 0 CA-C-O 122.993 1.33 . . . . 0.0 115.095 -177.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -94.26 122.22 36.58 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 113.313 -1.444 . . . . 0.0 107.658 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -114.62 105.58 13.24 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -175.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -77.58 117.09 18.67 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.121 0.969 . . . . 0.0 111.052 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 55.5 tp -69.67 107.15 3.33 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.112 0.565 . . . . 0.0 112.185 -174.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -85.89 -58.86 2.48 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.903 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.2 t -134.14 142.32 47.43 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.682 0.793 . . . . 0.0 110.016 -169.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -120.97 133.88 55.28 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.841 0.829 . . . . 0.0 108.931 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -76.03 -61.86 1.8 Allowed 'General case' 0 CA--C 1.561 1.387 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.835 169.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -128.28 67.89 1.36 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 118.628 0.649 . . . . 0.0 111.132 -172.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -75.06 -52.08 11.94 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 175.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -66.74 -43.22 84.75 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 -175.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.25 -44.0 95.64 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 169.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -67.82 -51.93 42.85 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.28 -49.07 75.31 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -60.97 -42.35 98.16 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 171.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.64 -29.61 69.67 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 117.242 2.312 . . . . 0.0 117.242 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.267 37.8 pt -77.29 -48.84 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 120.1 1.318 . . . . 0.0 112.587 171.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 137.22 65.13 0.05 OUTLIER Glycine 0 CA--C 1.541 1.686 0 C-N-CA 123.826 0.727 . . . . 0.0 112.312 175.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.4 mt -131.25 147.74 67.4 Favored Pre-proline 0 CA--C 1.568 1.64 0 C-N-CA 123.958 0.903 . . . . 0.0 110.437 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.44 149.04 80.25 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 123.39 2.727 . . . . 0.0 114.397 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -59.47 -28.09 66.69 Favored 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 171.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -61.95 -46.43 89.35 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 166.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.14 -16.49 64.02 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 116.984 2.216 . . . . 0.0 116.984 167.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 72.9 mt -74.62 -55.35 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-N 120.414 1.461 . . . . 0.0 110.534 168.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -67.2 -29.28 68.91 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -75.73 -56.4 4.72 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 119.546 1.066 . . . . 0.0 111.517 168.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.22 -19.74 59.85 Favored Glycine 0 CA--C 1.55 2.223 0 N-CA-C 120.619 3.008 . . . . 0.0 120.619 178.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -67.16 -44.84 78.74 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 119.654 1.727 . . . . 0.0 113.852 168.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -68.71 -37.95 79.89 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 169.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.6 mt -74.33 126.41 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 119.455 1.025 . . . . 0.0 108.355 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.08 99.25 11.36 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.69 111.48 3.72 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-N 116.023 -0.535 . . . . 0.0 113.13 -172.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.7 t -67.15 129.26 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 123.813 0.845 . . . . 0.0 110.481 -176.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.0 p -98.82 105.7 17.88 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -86.61 151.06 23.77 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.473 176.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.6 mt -140.84 138.8 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.7 t -129.8 103.93 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 171.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -90.22 113.13 24.88 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 172.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -121.64 62.63 0.92 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.173 0.589 . . . . 0.0 109.523 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.12 -111.53 3.86 Favored Glycine 0 CA--C 1.546 1.975 0 O-C-N 121.852 -0.53 . . . . 0.0 113.161 -173.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -75.65 -43.0 49.93 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 169.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -73.73 110.73 8.26 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 119.42 1.009 . . . . 0.0 109.814 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.61 97.47 2.98 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -155.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.27 160.35 19.88 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.019 0.928 . . . . 0.0 111.463 -172.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -145.38 130.35 18.3 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.796 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.4 m -99.83 93.88 6.03 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 174.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.9 tp -86.6 118.55 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.4 p -96.38 95.43 8.05 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 174.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -90.18 86.2 6.47 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.343 0.592 . . . . 0.0 110.522 -171.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.32 -98.3 1.11 Allowed Glycine 0 CA--C 1.54 1.654 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.297 -170.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.4 t -127.08 81.46 2.02 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 163.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.99 100.18 0.87 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 178.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -85.44 114.54 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -174.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.6 mt -130.49 104.92 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 -167.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -92.94 120.62 33.45 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 167.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -123.32 113.23 18.58 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -176.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -97.98 124.11 42.29 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.321 0.648 . . . . 0.0 109.256 -171.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -125.12 149.81 47.5 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.567 0.698 . . . . 0.0 111.351 176.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.0 m -105.94 132.17 52.36 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 168.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.8 t -79.53 119.35 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 175.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.32 0.22 73.86 Favored Glycine 0 CA--C 1.556 2.609 0 N-CA-C 118.885 2.314 . . . . 0.0 118.885 -171.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -145.46 132.14 19.95 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 120.278 2.039 . . . . 0.0 108.605 167.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -73.08 113.26 9.93 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -174.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 90.9 m -96.72 156.02 16.53 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.745 173.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -77.66 101.65 6.7 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.455 0.702 . . . . 0.0 111.145 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.6 mt -109.95 129.18 55.7 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.299 0.571 . . . . 0.0 110.942 -165.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.6 pm0 -83.61 141.86 31.23 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.499 174.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.0 p -67.99 -65.88 0.64 Allowed 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 123.097 0.559 . . . . 0.0 111.732 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 21.7 mmt -118.1 -72.8 0.67 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 155.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.5 t -149.15 119.32 7.24 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 163.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 149.67 -75.84 0.25 Allowed Glycine 0 N--CA 1.48 1.624 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.572 -174.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.6 99.44 10.18 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.166 0.586 . . . . 0.0 110.737 -171.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -91.28 105.66 17.95 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.9 127.78 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -169.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -75.96 119.68 20.25 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.368 0.604 . . . . 0.0 111.383 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.7 t -145.9 141.6 27.96 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.485 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.14 136.4 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-O 122.515 1.15 . . . . 0.0 109.311 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.5 t -91.0 129.84 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.256 0 CA-C-N 113.833 -1.53 . . . . 0.0 107.833 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -100.56 134.97 42.72 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.062 0.935 . . . . 0.0 109.112 171.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.5 tp -97.84 102.66 14.47 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 114.352 -1.294 . . . . 0.0 107.961 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -101.55 116.96 33.94 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.91 11.38 85.55 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 120.946 3.138 . . . . 0.0 120.946 171.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.283 20.3 m-20 57.85 43.29 21.88 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -165.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -158.63 -43.55 0.06 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 118.118 -0.944 . . . . 0.0 113.521 -177.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -95.8 138.43 33.46 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 120.142 1.337 . . . . 0.0 111.237 -175.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.0 mt -123.36 101.91 7.62 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 172.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.2 m -106.27 117.53 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 123.439 0.696 . . . . 0.0 109.181 -171.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.6 t -151.7 142.1 22.51 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 122.421 0.288 . . . . 0.0 111.346 -175.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 83.7 m -120.68 113.53 20.35 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -70.03 -76.82 0.09 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.796 0.838 . . . . 0.0 111.42 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -120.97 -72.58 0.68 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 165.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -128.73 60.17 1.53 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 118.662 0.665 . . . . 0.0 109.69 161.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 77.0 mt -131.47 97.5 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 102.615 -3.106 . . . . 0.0 102.615 172.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -92.02 91.07 7.67 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.7 t -84.41 109.62 18.01 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.983 0.913 . . . . 0.0 109.377 -174.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 72.0 t -116.77 97.16 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 -175.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.0 m -110.68 87.1 2.45 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -166.074 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -91.92 133.8 35.36 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.131 0.972 . . . . 0.0 110.621 -174.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.4 tt -102.36 110.01 21.83 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -175.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -110.51 90.47 3.33 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -172.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.71 -109.91 2.91 Favored Glycine 0 CA--C 1.544 1.85 0 CA-C-O 119.926 -0.374 . . . . 0.0 113.03 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -121.51 53.16 1.19 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.304 0.573 . . . . 0.0 111.694 167.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.4 pt -126.77 -165.44 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.799 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 159.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.5 tt -154.26 124.89 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 O-C-N 120.532 -1.355 . . . . 0.0 108.37 160.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 55.4 m -100.76 97.78 8.38 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -91.08 104.28 16.88 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.8 m -108.57 93.18 4.38 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -176.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 49.6 mtt -93.02 105.15 17.3 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.726 0.81 . . . . 0.0 109.098 177.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.4 p -95.33 100.64 12.39 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 51.3 tp -94.66 82.92 3.99 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 175.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.21 -99.75 0.9 Allowed Glycine 0 CA--C 1.542 1.751 0 CA-C-N 116.288 -0.415 . . . . 0.0 113.104 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -98.59 -15.9 19.3 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 170.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 62.4 mt -83.77 107.67 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 120.343 1.428 . . . . 0.0 107.563 -173.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.8 t -95.71 96.5 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -88.87 99.04 12.08 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.981 0.512 . . . . 0.0 109.999 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -102.27 109.67 21.41 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.046 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 25.2 mtm180 -101.64 125.79 48.36 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.73 0.812 . . . . 0.0 108.864 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.59 103.39 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 104.74 -2.318 . . . . 0.0 104.74 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 54.8 m -120.78 114.82 22.19 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 122.686 0.394 . . . . 0.0 110.065 -173.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -92.64 133.03 36.39 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.127 0.571 . . . . 0.0 111.628 -170.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -66.47 136.69 56.07 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 121.789 0.804 . . . . 0.0 113.087 -174.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.7 pt . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 -175.393 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.8 m . . . . . 0 CA--C 1.547 0.839 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -68.49 -18.52 64.41 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 117.489 2.403 . . . . 0.0 117.489 -177.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.7 m -70.44 109.67 4.91 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 121.093 1.769 . . . . 0.0 110.67 172.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.43 156.91 13.86 Favored Glycine 0 CA--C 1.543 1.79 0 CA-C-O 122.11 0.839 . . . . 0.0 113.873 -173.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.18 114.01 27.95 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 176.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -112.51 97.99 6.96 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -167.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -92.13 138.32 31.63 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.492 0.663 . . . . 0.0 111.003 -176.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.8 tp -74.78 126.46 30.95 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.515 -167.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.5 mm-40 -104.88 -64.68 1.1 Allowed 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.768 -175.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.5 m -129.36 140.36 51.4 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.657 0.783 . . . . 0.0 109.831 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -125.47 130.66 52.26 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.496 1.141 . . . . 0.0 110.841 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -99.44 129.12 45.6 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 113.594 -1.639 . . . . 0.0 107.221 168.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.251 69.8 m-20 67.28 40.47 2.75 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 170.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -67.64 -62.97 1.16 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.029 -1.044 . . . . 0.0 113.795 170.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -59.98 -34.98 74.03 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 117.18 2.289 . . . . 0.0 117.18 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.69 -47.17 84.81 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 166.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -65.99 -47.76 73.46 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -45.01 95.06 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 176.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -57.13 -48.26 79.11 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 166.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.71 -26.19 68.55 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 117.757 2.502 . . . . 0.0 117.757 177.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.3 pt -88.63 -49.28 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-N 119.178 0.899 . . . . 0.0 112.005 174.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 141.36 73.64 0.04 OUTLIER Glycine 0 CA--C 1.539 1.591 0 CA-C-N 118.903 0.774 . . . . 0.0 112.427 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.87 153.41 78.67 Favored Pre-proline 0 CA--C 1.571 1.763 0 C-N-CA 123.359 0.664 . . . . 0.0 112.602 176.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -76.44 158.78 36.46 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 123.354 2.703 . . . . 0.0 113.55 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -62.55 -31.6 72.41 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 169.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -60.06 -52.25 66.19 Favored 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 171.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 88.8 mt -72.43 -18.6 61.69 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 117.071 2.248 . . . . 0.0 117.071 175.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 93.3 mt -67.81 -61.28 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-N 119.631 1.105 . . . . 0.0 110.017 165.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -64.82 -25.27 67.83 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -78.58 -52.03 9.06 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.878 0.871 . . . . 0.0 112.376 171.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.78 -18.98 72.86 Favored Glycine 0 CA--C 1.551 2.33 0 N-CA-C 119.89 2.716 . . . . 0.0 119.89 177.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -65.06 -42.84 93.84 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 120.087 1.944 . . . . 0.0 114.732 169.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -66.46 -37.21 84.64 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 168.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.5 mt -72.01 115.46 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -85.98 106.72 17.36 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -174.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.04 131.76 10.91 Favored Glycine 0 CA--C 1.54 1.643 0 CA-C-N 115.966 -0.561 . . . . 0.0 114.471 -167.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.3 t -89.64 117.81 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 175.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.5 m -100.49 101.61 12.6 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 174.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.22 146.61 30.38 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.379 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 55.4 mt -142.1 123.3 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 104.5 -2.408 . . . . 0.0 104.5 174.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.6 t -115.54 108.87 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -93.99 120.31 34.07 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.012 0.525 . . . . 0.0 109.813 176.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 -122.25 74.85 1.19 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 164.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.42 -118.77 9.56 Favored Glycine 0 CA--C 1.548 2.127 0 C-N-CA 123.215 0.436 . . . . 0.0 113.757 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -75.47 -32.67 60.67 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 167.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -78.12 135.38 37.67 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 120.116 1.325 . . . . 0.0 111.592 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -137.19 150.77 48.13 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.97 0.89 . . . . 0.0 111.26 -175.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -136.78 115.15 11.78 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 161.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -107.41 125.72 51.58 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.559 173.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 50.8 m -119.44 99.92 6.98 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -173.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 88.1 mt -91.21 126.76 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.9 p -103.47 114.27 28.42 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 170.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -127.49 147.1 50.31 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.67 0.748 . . . . 0.0 110.081 178.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -53.84 -30.44 44.61 Favored Glycine 0 CA--C 1.555 2.586 0 N-CA-C 118.838 2.295 . . . . 0.0 118.838 167.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.6 m -68.45 -63.22 1.1 Allowed 'General case' 0 CA--C 1.565 1.521 0 CA-C-N 118.438 1.119 . . . . 0.0 112.994 165.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -155.08 136.24 13.91 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 119.338 0.972 . . . . 0.0 110.158 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.2 p -77.17 123.0 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 123.329 0.651 . . . . 0.0 109.755 166.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 80.5 mt -131.04 119.41 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -169.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -107.97 127.06 53.42 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.549 0.74 . . . . 0.0 109.057 173.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -139.61 142.69 37.05 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.137 0.975 . . . . 0.0 109.822 -170.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -126.64 148.77 49.77 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.146 0.974 . . . . 0.0 110.543 -176.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -151.65 144.78 24.61 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.537 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.3 m -101.91 132.19 47.85 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 164.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.8 t -75.93 131.71 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.57 0.7 . . . . 0.0 109.863 -175.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.85 6.18 89.19 Favored Glycine 0 CA--C 1.553 2.435 0 N-CA-C 118.669 2.228 . . . . 0.0 118.669 -169.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -137.32 140.75 41.71 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 119.233 1.517 . . . . 0.0 108.332 -175.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -76.62 117.0 17.82 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.147 0.579 . . . . 0.0 111.019 -173.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.6 p -126.42 149.43 49.27 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 122.335 1.064 . . . . 0.0 112.871 -162.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -84.82 118.88 24.74 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.271 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.72 142.61 22.98 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.654 0.781 . . . . 0.0 109.843 175.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -91.3 127.57 36.78 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.907 -172.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.8 t -68.91 173.79 5.03 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.954 0.883 . . . . 0.0 112.855 170.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 68.5 mtp -85.47 54.87 3.27 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.9 m -151.0 -76.71 0.14 Allowed 'General case' 0 CA--C 1.563 1.478 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 172.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 168.19 75.3 0.04 OUTLIER Glycine 0 CA--C 1.539 1.551 0 CA-C-N 118.593 0.633 . . . . 0.0 111.631 172.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -155.43 114.03 3.5 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -81.21 99.41 8.57 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 175.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.5 p -117.25 136.82 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 121.894 0.855 . . . . 0.0 110.489 -157.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -81.75 120.55 25.28 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.119 -177.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.4 t -148.07 135.5 20.6 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.932 0.493 . . . . 0.0 111.089 -167.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 75.5 t -88.99 119.44 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.1 t -104.28 112.54 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -116.3 143.41 45.57 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.803 0.811 . . . . 0.0 110.907 -176.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.6 tp -101.61 130.95 48.05 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.953 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -128.83 125.75 38.37 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 174.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.4 12.52 73.1 Favored Glycine 0 CA--C 1.55 2.265 0 N-CA-C 120.688 3.035 . . . . 0.0 120.688 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.268 24.2 m-20 58.74 37.92 24.98 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -167.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -160.84 -18.47 0.05 Allowed 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -176.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -119.1 101.22 7.85 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 121.101 1.773 . . . . 0.0 109.279 -171.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 79.3 mt -94.73 101.89 13.75 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 171.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.4 m -104.21 124.75 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 123.961 0.905 . . . . 0.0 108.744 -171.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.9 t -143.57 133.56 24.15 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.514 0.673 . . . . 0.0 111.425 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.8 t -131.79 134.67 46.07 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.211 1.005 . . . . 0.0 109.081 -175.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.334 14.2 p90 -136.03 -116.4 0.17 Allowed 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 118.612 -0.709 . . . . 0.0 109.497 -171.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -73.59 -68.5 0.5 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 119.6 1.091 . . . . 0.0 111.227 -178.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -126.86 -27.0 3.1 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 176.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 mp -86.34 121.95 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.574 0 CA-C-N 119.91 1.232 . . . . 0.0 108.417 -171.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -78.57 153.53 31.11 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.545 155.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.2 t -143.31 97.16 3.03 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 172.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 73.7 t -100.21 100.24 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.8 m -95.49 94.0 7.53 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -171.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -104.82 117.51 34.25 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.504 0.722 . . . . 0.0 109.073 -162.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 tt -106.47 117.8 34.99 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 -170.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -94.33 -99.77 0.15 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 118.236 -0.888 . . . . 0.0 108.88 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -103.05 -105.93 3.01 Favored Glycine 0 N--CA 1.485 1.912 0 CA-C-N 119.53 1.059 . . . . 0.0 111.276 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -96.39 49.26 1.11 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.074 0.464 . . . . 0.0 112.001 168.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.7 pt -142.38 -174.95 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.678 0 C-N-CA 124.64 1.176 . . . . 0.0 109.459 176.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.4 tt -150.1 127.69 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 120.917 -1.114 . . . . 0.0 108.719 161.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 29.8 m -103.61 92.24 4.37 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -88.7 106.81 18.59 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -177.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 39.1 m -111.9 97.49 6.72 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -169.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 46.0 mtt -98.48 104.26 16.28 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.351 0.66 . . . . 0.0 109.371 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 59.6 p -97.12 102.08 13.78 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.292 0.567 . . . . 0.0 109.765 -172.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 50.1 tp -101.51 83.94 2.52 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.45 -99.91 1.03 Allowed Glycine 0 CA--C 1.543 1.832 0 CA-C-N 116.437 -0.347 . . . . 0.0 112.793 -174.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -99.52 -16.34 18.34 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 169.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 70.1 mt -84.26 108.54 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-N 120.476 1.489 . . . . 0.0 107.86 -172.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.6 t -97.03 95.46 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -85.84 96.13 9.66 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.201 0.6 . . . . 0.0 109.739 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -104.36 106.54 17.08 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.871 -175.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -89.04 127.21 35.68 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.777 0.831 . . . . 0.0 109.014 170.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -108.64 104.01 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 174.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.5 m -127.92 116.73 20.55 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -171.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.256 17.3 ptpt -88.6 148.54 24.01 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 122.098 0.951 . . . . 0.0 113.538 -172.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -81.15 124.58 29.37 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.028 -172.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.0 pt . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 -169.499 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.8 t . . . . . 0 CA--C 1.549 0.93 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -69.02 -29.1 67.21 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 116.985 2.217 . . . . 0.0 116.985 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.6 p -65.74 125.31 24.89 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 120.77 1.623 . . . . 0.0 113.612 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 153.98 167.16 15.74 Favored Glycine 0 CA--C 1.545 1.946 0 CA-C-O 122.54 1.078 . . . . 0.0 113.862 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -89.88 145.12 25.37 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 114.243 -0.978 . . . . 0.0 109.994 169.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -142.01 104.87 4.56 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -175.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.6 tm0? -87.92 127.32 35.36 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.592 -0.693 . . . . 0.0 111.356 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 50.8 tp -69.75 109.79 4.58 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.888 0.875 . . . . 0.0 113.228 -174.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -100.19 -60.63 1.49 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.331 0.653 . . . . 0.0 112.231 -172.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.1 t -127.74 138.56 52.81 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.566 0.746 . . . . 0.0 110.28 -168.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -133.26 133.46 42.68 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.521 0.677 . . . . 0.0 109.706 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -74.18 -64.5 1.0 Allowed 'General case' 0 CA--C 1.561 1.38 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.773 168.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -122.29 67.1 0.93 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.217 0.607 . . . . 0.0 110.746 -174.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -75.23 -52.04 11.86 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.416 -0.803 . . . . 0.0 111.993 168.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -60.6 -46.44 90.26 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.09 -36.22 82.61 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 174.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -73.37 -55.88 5.8 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 119.973 1.261 . . . . 0.0 113.672 175.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.25 -42.94 82.47 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.4 tmtm? -62.99 -43.97 97.31 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 169.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.7 -29.01 69.07 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 117.688 2.477 . . . . 0.0 117.688 173.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.25 38.2 pt -82.59 -54.53 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 119.248 0.931 . . . . 0.0 111.844 173.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.32 67.11 0.01 OUTLIER Glycine 0 N--CA 1.479 1.564 0 CA-C-O 118.898 -0.946 . . . . 0.0 113.134 171.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.8 mt -130.38 146.08 60.15 Favored Pre-proline 0 CA--C 1.569 1.695 0 CA-C-N 117.918 0.859 . . . . 0.0 111.138 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -69.11 150.65 72.43 Favored 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 123.577 2.851 . . . . 0.0 114.791 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -52.61 -36.49 56.47 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 171.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -63.22 -53.27 55.65 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 171.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.7 mt -66.85 -24.91 66.2 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.707 2.114 . . . . 0.0 116.707 176.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 87.3 mt -67.42 -53.9 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 124.347 1.059 . . . . 0.0 111.142 170.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -61.34 -24.01 66.15 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 172.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -75.69 -59.19 2.86 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 119.594 1.088 . . . . 0.0 111.503 169.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.39 -21.44 59.96 Favored Glycine 0 CA--C 1.552 2.355 0 N-CA-C 119.947 2.739 . . . . 0.0 119.947 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -66.95 -46.23 75.35 Favored 'General case' 0 CA--C 1.569 1.702 0 CA-C-N 120.28 2.04 . . . . 0.0 114.202 170.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -71.55 -36.96 71.13 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 174.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.9 mt -66.77 135.22 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-N 119.687 1.131 . . . . 0.0 109.612 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -74.87 104.42 5.47 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.603 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -98.19 102.97 2.73 Favored Glycine 0 N--CA 1.478 1.436 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.805 -175.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.8 t -84.49 114.85 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -176.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.6 m -98.6 104.85 16.92 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.087 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.17 149.49 26.13 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.026 174.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 55.5 mt -140.42 131.52 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 172.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.4 t -119.03 101.78 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -83.17 115.84 22.1 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.966 0.507 . . . . 0.0 109.8 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -124.98 69.62 1.13 Allowed 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 167.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.07 -112.17 4.65 Favored Glycine 0 CA--C 1.546 2.01 0 C-N-CA 123.272 0.463 . . . . 0.0 113.699 -174.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -74.14 -33.4 63.53 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 171.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -79.31 129.33 34.36 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 119.276 0.944 . . . . 0.0 110.726 -177.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -132.05 105.82 7.63 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -177.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -95.24 106.24 18.25 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 170.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -104.31 120.23 40.73 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.017 174.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 78.7 m -108.45 91.98 3.87 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.6 tt -99.32 120.86 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.362 -167.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.0 m -89.98 101.02 13.73 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.56 88.03 4.92 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.53 -108.99 2.66 Favored Glycine 0 CA--C 1.542 1.773 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.382 -173.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.5 t -86.59 -56.12 3.56 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 175.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -80.64 125.05 29.53 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 119.021 0.828 . . . . 0.0 111.342 -169.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.3 p -89.1 131.36 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 123.534 0.733 . . . . 0.0 110.93 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.4 mt -119.52 111.21 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 -167.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -89.07 126.15 35.32 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.39 0.614 . . . . 0.0 109.868 175.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -134.77 106.9 7.13 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -174.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.51 132.15 56.59 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.919 0.887 . . . . 0.0 110.389 -175.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -141.6 173.69 11.27 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.942 -172.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.0 m -127.58 132.91 49.77 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 166.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.3 m -68.66 132.47 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 122.979 0.511 . . . . 0.0 111.616 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 107.59 -58.09 0.42 Allowed Glycine 0 CA--C 1.545 1.952 0 CA-C-N 115.583 -0.735 . . . . 0.0 113.233 -160.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -85.92 148.49 25.76 Favored 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 124.117 0.967 . . . . 0.0 112.101 -172.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -83.6 117.07 22.91 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.844 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 77.3 m -116.1 147.99 40.74 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 122.07 0.938 . . . . 0.0 111.664 -174.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -84.24 97.82 9.62 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.847 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 61.5 mt -123.0 133.55 54.36 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.597 0.713 . . . . 0.0 109.679 -171.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -80.66 135.8 36.1 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.65 0.78 . . . . 0.0 111.468 -171.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.1 p -83.19 173.92 11.23 Favored 'General case' 0 CA--C 1.569 1.692 0 CA-C-O 121.784 0.802 . . . . 0.0 112.168 -175.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.0 mmt -59.81 -41.03 90.34 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 169.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 54.1 p -62.41 -51.84 65.96 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 162.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 139.19 166.28 10.55 Favored Glycine 0 CA--C 1.545 1.96 0 CA-C-O 122.692 1.162 . . . . 0.0 111.847 -168.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . 0.279 9.6 tm-20 76.31 139.91 0.07 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.109 1.364 . . . . 0.0 113.187 175.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -89.64 115.9 27.37 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.848 -176.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 19.5 m -100.19 -13.46 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 117.236 2.31 . . . . 0.0 117.236 -164.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . 0.25 93.4 mttt 76.85 112.4 0.07 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 121.06 1.755 . . . . 0.0 110.242 -173.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.4 t -150.02 129.82 13.3 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.121 0.568 . . . . 0.0 109.548 -168.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.2 t -100.64 118.34 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.6 t -102.74 135.97 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -115.87 155.06 28.61 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.513 0.673 . . . . 0.0 110.591 166.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.4 tp -106.29 103.57 13.07 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 173.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -103.25 120.1 40.12 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.66 6.27 84.54 Favored Glycine 0 CA--C 1.549 2.164 0 N-CA-C 120.744 3.058 . . . . 0.0 120.744 173.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.316 4.7 t70 71.92 -10.38 0.87 Allowed 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 -167.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -116.15 -18.34 10.61 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 116.574 2.065 . . . . 0.0 116.574 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -112.65 124.85 53.48 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 121.151 1.796 . . . . 0.0 109.784 -176.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 47.3 mt -103.31 103.07 13.05 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 166.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.8 t -101.53 118.92 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -167.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.5 t -149.45 155.68 40.8 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.536 0.684 . . . . 0.0 112.363 -173.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 91.9 m -122.06 107.72 12.54 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 174.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -71.81 -81.83 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.435 0.694 . . . . 0.0 111.143 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -139.3 87.9 2.23 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 170.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.259 70.2 m-80 53.56 43.28 31.43 Favored 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -169.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 44.0 mm -125.24 105.37 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 104.462 -2.421 . . . . 0.0 104.462 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -79.96 94.14 5.84 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.571 0.7 . . . . 0.0 109.653 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.6 t -106.42 95.91 6.09 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.478 -165.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 73.8 t -101.44 107.8 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.9 m -93.86 85.42 4.78 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -173.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -94.66 127.53 40.69 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.357 0.663 . . . . 0.0 109.717 -165.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 tt -112.86 111.12 21.66 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -173.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -98.94 -101.84 0.22 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 118.406 -0.807 . . . . 0.0 109.291 -170.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -87.15 -110.58 0.91 Allowed Glycine 0 N--CA 1.484 1.877 0 CA-C-N 119.698 1.135 . . . . 0.0 112.395 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -101.36 61.4 0.92 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.567 0.698 . . . . 0.0 110.145 166.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 11.9 pt -148.94 -176.77 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.759 0 C-N-CA 124.619 1.167 . . . . 0.0 108.927 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.1 tt -148.54 125.32 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 120.753 -1.217 . . . . 0.0 108.217 155.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.0 m -111.1 106.99 16.21 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.02 110.56 23.12 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 34.7 m -96.91 99.65 11.2 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -176.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 66.3 mtt -104.2 97.15 7.15 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 -176.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.9 p -96.44 113.58 25.17 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -174.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.2 tp -103.08 83.08 2.16 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 170.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.77 -103.69 1.25 Allowed Glycine 0 CA--C 1.545 1.952 0 N-CA-C 114.571 0.588 . . . . 0.0 114.571 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -82.09 -27.02 33.11 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 114.708 1.374 . . . . 0.0 114.708 171.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 29.7 mm -65.34 136.1 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.542 0 C-N-CA 124.904 1.281 . . . . 0.0 109.562 174.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.4 t -127.94 96.47 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 172.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -86.56 102.47 14.16 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -102.91 104.85 15.11 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -113.72 122.35 46.84 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.869 0.868 . . . . 0.0 109.199 -175.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.7 mp -111.14 102.95 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 -171.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.0 m -102.23 112.43 25.11 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -84.08 142.29 30.51 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.817 0.447 . . . . 0.0 110.774 -169.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -74.14 134.06 42.82 Favored 'General case' 0 CA--C 1.559 1.304 0 CA-C-O 121.916 0.865 . . . . 0.0 112.725 -169.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 45.0 mm . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 -162.581 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.4 m . . . . . 0 CA--C 1.549 0.907 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -69.19 -15.84 63.49 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 117.616 2.451 . . . . 0.0 117.616 -178.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 75.6 m -71.45 115.22 10.37 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 121.437 1.926 . . . . 0.0 111.025 172.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.44 160.29 19.64 Favored Glycine 0 CA--C 1.54 1.655 0 CA-C-O 122.217 0.898 . . . . 0.0 114.295 -175.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -111.14 106.56 15.63 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -111.48 105.77 14.46 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -162.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -93.18 135.63 34.2 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 122.941 0.496 . . . . 0.0 111.583 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.5 tp -71.46 115.04 10.17 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.478 0.711 . . . . 0.0 112.584 -171.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -99.23 -55.33 2.72 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.164 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.1 m -125.07 110.51 14.24 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -173.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -111.48 119.58 39.25 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 122.075 0.941 . . . . 0.0 109.844 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -109.2 120.29 42.07 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 170.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.259 69.1 m-80 67.37 50.49 0.95 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -175.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -72.13 -63.26 1.18 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.922 . . . . 0.0 111.289 162.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -65.58 -35.23 80.21 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 117.33 2.344 . . . . 0.0 117.33 -174.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.41 -45.57 93.76 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 166.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -65.11 -51.91 58.55 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 174.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 23.5 mmt -62.18 -43.02 99.77 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -176.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -60.15 -47.28 86.6 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 167.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.57 -29.5 70.63 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 117.729 2.492 . . . . 0.0 117.729 176.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.8 pt -80.5 -47.04 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 CA-C-N 119.781 1.173 . . . . 0.0 112.706 173.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 142.67 69.62 0.03 OUTLIER Glycine 0 CA--C 1.54 1.595 0 CA-C-N 119.134 0.879 . . . . 0.0 113.034 174.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.55 153.37 79.4 Favored Pre-proline 0 CA--C 1.568 1.668 0 C-N-CA 123.456 0.702 . . . . 0.0 111.84 172.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.79 152.59 47.44 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 123.168 2.579 . . . . 0.0 113.031 172.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -61.03 -24.69 66.37 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 173.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -61.86 -57.19 12.75 Favored 'General case' 0 CA--C 1.563 1.455 0 CA-C-O 117.489 -1.243 . . . . 0.0 113.433 165.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.8 mt -68.93 -18.39 64.09 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.1 mt -74.23 -55.45 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-N 119.727 1.149 . . . . 0.0 110.477 170.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -67.93 -24.56 65.2 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -79.13 -51.21 9.84 Favored 'General case' 0 CA--C 1.562 1.419 0 CA-C-N 119.547 1.067 . . . . 0.0 112.217 167.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.2 -14.79 59.94 Favored Glycine 0 CA--C 1.552 2.366 0 N-CA-C 119.864 2.706 . . . . 0.0 119.864 176.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -71.34 -49.86 38.16 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 119.957 1.879 . . . . 0.0 113.88 171.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -63.8 -30.76 71.82 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.533 2.049 . . . . 0.0 116.533 167.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 53.8 mt -75.69 113.7 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 173.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -81.22 108.57 14.97 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.64 123.77 6.31 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 116.299 -0.41 . . . . 0.0 113.884 -167.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t -83.05 110.99 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.3 t -92.57 103.26 15.68 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 166.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.85 142.83 36.53 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.162 169.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.0 mt -142.17 125.96 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 90.6 t -114.15 105.21 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -81.75 118.23 22.69 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.059 0.544 . . . . 0.0 109.816 174.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -123.98 68.35 1.05 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 165.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.3 -107.51 2.1 Favored Glycine 0 CA--C 1.546 1.986 0 C-N-CA 123.24 0.448 . . . . 0.0 113.362 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -78.22 -29.35 48.24 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 170.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -84.57 104.61 14.71 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 120.394 1.452 . . . . 0.0 109.605 -173.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -105.69 95.32 5.73 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.052 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -93.7 106.7 18.65 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -103.76 132.24 50.19 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.941 -176.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.7 m -107.27 98.62 8.23 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 172.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.4 tp -87.16 127.91 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.41 0.684 . . . . 0.0 109.568 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 48.1 p -111.36 87.35 2.53 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -99.0 91.44 5.02 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 122.902 0.481 . . . . 0.0 110.228 -174.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.72 -100.74 1.12 Allowed Glycine 0 CA--C 1.543 1.787 0 CA-C-N 116.162 -0.472 . . . . 0.0 113.113 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.0 m -87.17 -51.42 6.0 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 174.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -79.12 131.78 36.35 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 119.095 0.861 . . . . 0.0 113.021 -167.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.8 t -106.87 119.91 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.3 tt -140.46 144.26 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-O 121.367 0.604 . . . . 0.0 110.431 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -112.31 127.05 55.88 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.002 0.921 . . . . 0.0 109.025 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -139.87 128.95 23.65 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -171.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.25 135.45 54.27 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.458 0.703 . . . . 0.0 112.3 -175.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -125.27 149.11 48.34 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.044 0.938 . . . . 0.0 111.021 171.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.3 m -111.62 132.6 54.46 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 169.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.0 t -70.26 132.61 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 123.805 0.842 . . . . 0.0 110.274 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.76 10.88 85.93 Favored Glycine 0 CA--C 1.554 2.473 0 N-CA-C 118.987 2.355 . . . . 0.0 118.987 -170.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -138.59 150.7 46.58 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 119.29 1.545 . . . . 0.0 109.828 -171.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -80.89 103.0 10.42 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.519 0.728 . . . . 0.0 109.118 177.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 63.1 m -134.44 134.29 41.43 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.692 0.758 . . . . 0.0 110.766 -171.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.55 143.38 40.36 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -171.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.9 mt -129.75 121.63 27.25 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 175.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -84.45 114.04 21.63 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.102 0.477 . . . . 0.0 109.945 -173.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 76.8 p -80.71 -78.02 0.19 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 118.27 -0.872 . . . . 0.0 112.707 -158.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 66.5 mtt -118.13 -80.18 0.61 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 119.291 0.951 . . . . 0.0 108.858 -173.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.8 p -81.07 -67.61 0.76 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 118.88 0.764 . . . . 0.0 110.877 177.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -169.81 76.63 0.1 Allowed Glycine 0 N--CA 1.476 1.302 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 172.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -129.06 131.46 47.33 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -96.49 112.88 24.46 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.862 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . 0.261 8.4 p -86.57 -43.84 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.607 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . 0.253 5.6 ttpm? 76.06 107.49 0.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.751 1.221 . . . . 0.0 111.747 173.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.49 HG22 ' HA ' ' A' ' 95' ' ' PHE . 16.4 p -128.38 139.5 52.34 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.033 0.533 . . . . 0.0 110.381 -165.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 89.7 t -109.76 101.44 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 173.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.3 t -94.9 138.48 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -173.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -114.89 135.49 54.15 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.839 0.828 . . . . 0.0 109.302 176.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 50.7 tp -94.69 102.68 14.59 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 173.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -88.08 114.16 24.42 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 121.891 0.853 . . . . 0.0 109.112 174.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.41 -117.28 5.48 Favored Glycine 0 CA--C 1.542 1.729 0 CA-C-N 114.354 -1.293 . . . . 0.0 113.047 -176.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -130.25 -8.58 4.26 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 170.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -134.34 35.02 3.24 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -173.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -147.41 116.77 6.97 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 119.996 1.271 . . . . 0.0 108.077 175.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 67.0 mt -107.66 101.73 11.02 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 171.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 32.7 m -99.42 124.3 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -171.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.3 t -151.48 135.95 16.94 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.243 0.545 . . . . 0.0 111.482 -174.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 67.9 p -83.55 -41.88 17.43 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 177.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.49 ' HA ' HG22 ' A' ' 81' ' ' THR 0.378 22.5 m-85 74.21 -94.48 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 119.259 0.936 . . . . 0.0 109.676 -169.939 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -116.38 -76.18 0.57 Allowed 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 163.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -135.63 71.6 1.43 Allowed 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 119.276 0.944 . . . . 0.0 109.317 170.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.1 mp -143.66 93.46 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 102.87 -3.011 . . . . 0.0 102.87 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -80.74 97.2 7.2 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 119.156 0.889 . . . . 0.0 109.818 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.4 t -100.29 102.34 13.58 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.266 -171.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.8 t -96.05 106.63 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.2 m -93.56 83.87 4.57 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -174.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.63 118.42 32.29 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.415 0.686 . . . . 0.0 109.251 -168.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tt -106.72 112.06 24.87 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -172.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -81.19 -59.05 2.79 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -172.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -158.83 -87.74 0.06 OUTLIER Glycine 0 N--CA 1.479 1.505 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 175.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -71.35 -37.98 71.65 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 166.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.8 pt -87.52 178.54 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.553 0 CA-C-N 119.636 1.107 . . . . 0.0 112.785 -171.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.5 tt -141.59 118.83 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 165.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.0 m -99.57 99.98 10.92 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -97.03 104.32 16.32 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -178.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.9 m -102.44 94.85 5.89 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -168.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 28.1 mtt -93.37 99.28 11.82 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.59 0.71 . . . . 0.0 109.377 -178.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 48.0 p -94.18 103.83 15.86 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.003 -174.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.0 tp -102.73 82.86 2.18 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.51 -99.62 1.01 Allowed Glycine 0 CA--C 1.544 1.879 0 O-C-N 122.348 -0.22 . . . . 0.0 113.12 -174.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -102.95 -12.29 17.6 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 170.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 72.4 mt -85.3 108.92 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-N 120.526 1.512 . . . . 0.0 107.157 -175.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.2 t -100.34 96.47 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 -175.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -82.77 97.6 8.67 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -93.06 107.44 19.23 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -108.15 98.78 8.29 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -172.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 85.2 mt -97.93 104.71 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 -173.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 67.9 m -121.53 114.96 21.96 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -172.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -91.05 139.74 30.48 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 122.941 0.496 . . . . 0.0 111.131 -172.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.4 ttp85 -68.37 130.01 41.61 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.331 0.653 . . . . 0.0 112.509 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.2 pt . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 123.047 1.403 . . . . 0.0 108.365 -173.959 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.3 m . . . . . 0 CA--C 1.552 1.021 0 CA-C-O 118.888 -0.577 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.414 ' H ' HD11 ' A' ' 104' ' ' LEU 0.353 84.1 m-85 75.69 -32.34 0.21 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 117.973 2.583 . . . . 0.0 117.973 172.815 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.2 m -72.23 103.53 3.38 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 120.527 1.512 . . . . 0.0 110.924 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.1 149.27 8.69 Favored Glycine 0 CA--C 1.541 1.709 0 CA-C-O 122.016 0.787 . . . . 0.0 113.624 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -92.31 117.51 29.97 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 171.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -116.62 104.54 11.49 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -172.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -86.68 140.03 30.19 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-O 121.675 0.75 . . . . 0.0 111.622 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.2 tp -66.25 137.3 56.86 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -170.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -116.13 -65.48 1.18 Allowed 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.58 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.5 p -126.94 137.58 53.15 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.906 0.882 . . . . 0.0 109.401 174.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -132.35 101.96 5.56 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.807 0.813 . . . . 0.0 109.136 -178.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -90.94 135.47 33.72 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.606 1.162 . . . . 0.0 109.722 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 m120 62.24 40.39 11.59 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -72.51 -45.77 57.8 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.921 -1.112 . . . . 0.0 113.048 172.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -62.37 -45.92 90.99 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.52 -43.58 96.76 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -76.16 -55.14 5.86 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 118.325 -0.845 . . . . 0.0 113.24 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -44.71 95.83 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -178.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -61.97 -42.77 99.5 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 171.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.92 -36.3 76.71 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 116.925 2.194 . . . . 0.0 116.925 175.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.275 46.2 pt -79.34 -47.17 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 119.086 0.857 . . . . 0.0 112.768 174.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 142.92 52.57 0.03 OUTLIER Glycine 0 N--CA 1.485 1.935 0 N-CA-C 115.678 1.031 . . . . 0.0 115.678 165.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.45 155.51 36.71 Favored Pre-proline 0 CA--C 1.566 1.563 0 CA-C-N 118.211 1.006 . . . . 0.0 111.673 175.837 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.38 146.59 45.3 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.99 2.46 . . . . 0.0 113.256 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -62.87 -22.45 66.71 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 116.072 1.879 . . . . 0.0 116.072 171.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -59.43 -53.29 59.81 Favored 'General case' 0 CA--C 1.566 1.565 0 CA-C-N 119.754 1.161 . . . . 0.0 113.969 164.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.29 -24.47 63.96 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 117.072 2.249 . . . . 0.0 117.072 174.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.3 mt -75.18 -51.66 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-N 119.623 1.101 . . . . 0.0 111.305 175.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -67.84 -28.52 67.62 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.91 -51.21 14.4 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.603 0.761 . . . . 0.0 112.348 169.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.78 -18.58 72.45 Favored Glycine 0 CA--C 1.546 2.011 0 N-CA-C 120.226 2.85 . . . . 0.0 120.226 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -65.34 -41.82 93.51 Favored 'General case' 0 CA--C 1.57 1.712 0 CA-C-N 120.334 2.067 . . . . 0.0 114.427 168.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -67.68 -39.83 84.45 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 170.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.5 mt -73.19 130.36 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 119.292 0.951 . . . . 0.0 108.929 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -89.73 98.59 11.86 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 170.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.58 140.01 15.42 Favored Glycine 0 CA--C 1.542 1.722 0 CA-C-N 116.056 -0.52 . . . . 0.0 113.949 -172.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.3 t -83.18 115.7 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 71.2 m -102.33 109.17 20.76 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.776 177.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.86 148.89 21.71 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-O 122.064 0.935 . . . . 0.0 111.094 -177.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.4 mt -138.61 133.16 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 166.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.7 t -114.33 112.25 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 175.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -78.58 118.53 20.78 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 170.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -133.52 67.27 1.53 Allowed 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.64 -122.54 9.41 Favored Glycine 0 CA--C 1.548 2.107 0 O-C-N 121.975 -0.453 . . . . 0.0 113.533 -173.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.03 -35.58 74.41 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 164.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -69.43 139.01 53.99 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 119.291 0.95 . . . . 0.0 111.99 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -138.5 97.27 3.32 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -91.32 106.08 18.24 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 175.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -83.65 148.94 26.83 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.128 169.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.8 m -133.96 87.06 2.33 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 166.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.5 pp -91.07 127.67 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -173.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.4 m -100.49 102.31 13.46 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -92.74 85.14 5.14 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 172.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.68 -109.67 2.89 Favored Glycine 0 CA--C 1.538 1.499 0 CA-C-N 115.705 -0.68 . . . . 0.0 113.679 -175.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 91.1 p -91.96 -44.16 9.05 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 171.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -77.02 123.25 26.08 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 119.393 0.997 . . . . 0.0 111.225 -176.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.5 p -102.19 128.98 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 123.903 0.881 . . . . 0.0 109.671 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.2 mt -123.79 116.47 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -174.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -116.06 131.31 56.98 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.441 0.696 . . . . 0.0 111.822 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -151.32 149.94 29.94 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 123.399 0.68 . . . . 0.0 109.831 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -109.39 132.3 54.26 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.646 0.778 . . . . 0.0 110.833 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -117.25 141.07 48.74 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.919 0.888 . . . . 0.0 111.189 170.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.6 m -94.88 135.87 35.87 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 169.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.0 t -86.18 117.76 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 174.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.25 -5.44 63.01 Favored Glycine 0 CA--C 1.556 2.653 0 N-CA-C 119.057 2.383 . . . . 0.0 119.057 -171.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -142.23 134.48 27.68 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 120.38 2.09 . . . . 0.0 108.593 169.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.98 119.76 17.67 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -174.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 80.6 m -116.99 148.16 41.68 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 122.326 1.06 . . . . 0.0 110.557 -177.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.65 121.86 22.31 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.058 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.1 mt -123.44 125.41 44.89 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.827 0.851 . . . . 0.0 108.857 -175.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -84.43 122.79 29.46 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 173.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.7 p -75.11 174.27 9.64 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.651 0.738 . . . . 0.0 112.513 -175.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -51.05 -42.16 60.35 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 172.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.3 m -71.26 -75.35 0.13 Allowed 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.33 0.652 . . . . 0.0 110.51 165.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 157.15 85.87 0.05 OUTLIER Glycine 0 N--CA 1.476 1.347 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -176.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -148.96 115.38 5.86 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -170.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? -86.34 105.14 16.48 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -175.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.1 t -123.14 121.07 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -169.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -86.17 99.97 11.9 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.1 t -135.73 145.9 47.12 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.654 0.782 . . . . 0.0 110.016 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.0 p -109.76 138.02 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-O 122.798 1.285 . . . . 0.0 109.461 175.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.7 t -99.74 138.89 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.437 0 CA-C-N 113.413 -1.721 . . . . 0.0 107.78 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.6 mp0 -109.58 133.26 53.32 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 50.1 tp -98.55 113.49 25.54 Favored 'General case' 0 CA--C 1.553 1.076 0 CA-C-N 115.175 -0.921 . . . . 0.0 108.573 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -114.64 121.84 44.63 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.719 0.808 . . . . 0.0 109.041 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.88 14.45 73.14 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 120.667 3.027 . . . . 0.0 120.667 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.282 15.9 t70 59.7 33.3 21.83 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -168.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -158.87 -26.07 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -103.91 104.27 14.23 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 121.324 1.875 . . . . 0.0 109.368 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 44.1 mt -96.64 101.97 13.68 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 171.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.0 m -111.49 128.8 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 123.896 0.878 . . . . 0.0 109.966 -167.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.8 t -152.42 148.85 27.94 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.258 0.552 . . . . 0.0 111.956 -176.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 33.7 p -113.38 120.47 41.19 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -82.69 -86.14 0.11 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.13 0.572 . . . . 0.0 109.785 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -120.7 -71.71 0.72 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 171.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -127.54 64.19 1.35 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 118.88 0.764 . . . . 0.0 109.036 160.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.1 mp -135.7 108.23 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 174.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.23 93.49 9.4 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.6 t -97.67 104.11 16.1 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.669 0.787 . . . . 0.0 109.513 -168.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.9 t -120.44 98.44 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 -168.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.5 m -95.96 100.24 11.94 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -174.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.37 128.95 38.4 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.884 0.874 . . . . 0.0 109.992 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.414 HD11 ' H ' ' A' ' 3' ' ' PHE . 0.8 OUTLIER -97.94 111.15 23.56 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.91 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -110.65 178.55 4.33 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.534 0.734 . . . . 0.0 110.448 174.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -68.1 112.8 4.95 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 116.477 1.351 . . . . 0.0 116.477 -166.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.263 19.6 m-20 50.1 25.83 1.87 Allowed 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 117.38 2.363 . . . . 0.0 117.38 -166.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.3 pt -139.36 -178.46 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.619 0 C-N-CA 124.366 1.067 . . . . 0.0 109.866 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.1 tt -150.54 127.72 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.826 -1.172 . . . . 0.0 108.839 168.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.2 m -111.13 104.7 13.26 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -93.91 111.45 23.16 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 176.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 39.8 m -109.4 101.3 10.29 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -175.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 29.5 mtt -105.95 103.29 12.75 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.9 p -95.75 105.4 17.39 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 32.3 tp -96.52 84.73 3.73 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.09 -103.44 1.15 Allowed Glycine 0 CA--C 1.544 1.893 0 C-N-CA 122.954 0.312 . . . . 0.0 113.627 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -94.92 -16.42 22.85 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 171.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 66.2 mt -80.14 114.23 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 120.084 1.311 . . . . 0.0 107.563 -177.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.4 t -101.92 94.97 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -77.26 127.05 31.93 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 169.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -136.6 109.41 7.58 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -110.31 110.02 20.67 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -174.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.6 mp -104.25 115.66 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 104.983 -2.228 . . . . 0.0 104.983 -177.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.9 m -131.97 122.16 25.11 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -175.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -96.18 137.64 34.96 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.734 0.814 . . . . 0.0 110.992 -171.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.7 ttp180 -63.18 123.95 19.94 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 124.372 1.069 . . . . 0.0 113.165 -175.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 13.3 pt . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 123.007 1.384 . . . . 0.0 108.858 -178.382 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.0 t . . . . . 0 CA--C 1.553 1.078 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -76.37 -5.95 49.47 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 118.359 2.726 . . . . 0.0 118.359 -172.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.5 m -70.8 112.32 6.91 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 121.179 1.809 . . . . 0.0 110.784 172.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.4 149.49 7.37 Favored Glycine 0 CA--C 1.542 1.73 0 CA-C-O 121.926 0.737 . . . . 0.0 113.343 -175.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -96.25 122.74 39.43 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 170.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -118.11 102.24 8.86 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -167.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.6 tm0? -88.28 122.88 32.31 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.14 0.576 . . . . 0.0 110.013 -175.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.6 tp -61.94 115.45 4.06 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -175.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -95.99 -63.07 1.19 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.496 0.718 . . . . 0.0 110.748 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.7 m -120.88 108.56 14.06 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -89.11 123.84 33.76 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 122.524 1.154 . . . . 0.0 109.15 164.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -115.24 117.28 30.05 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 -178.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.278 7.7 m-20 70.23 43.74 0.82 Allowed 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 -174.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -68.15 -60.27 2.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.158 -0.964 . . . . 0.0 113.06 168.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -62.24 -33.96 75.59 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 117.345 2.35 . . . . 0.0 117.345 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.57 -46.31 86.45 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 166.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -67.19 -51.81 49.01 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 177.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.29 -49.85 74.77 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -59.15 -42.22 90.22 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 170.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.57 -32.2 73.59 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 117.305 2.335 . . . . 0.0 117.305 174.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.28 37.7 pt -78.53 -53.51 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-N 119.747 1.158 . . . . 0.0 111.599 172.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.68 69.98 0.01 OUTLIER Glycine 0 CA--C 1.538 1.516 0 CA-C-O 119.17 -0.794 . . . . 0.0 112.468 169.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mp -121.21 155.76 58.09 Favored Pre-proline 0 CA--C 1.57 1.733 0 C-N-CA 123.408 0.683 . . . . 0.0 112.591 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.29 158.56 33.27 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 123.367 2.712 . . . . 0.0 113.655 177.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -56.51 -32.86 65.48 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 168.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -61.59 -58.3 8.63 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 117.786 -1.102 . . . . 0.0 113.604 171.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.8 mt -68.67 -17.61 64.12 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 88.3 mt -75.67 -55.03 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 119.592 1.087 . . . . 0.0 110.619 169.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -70.81 -27.27 63.75 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -80.61 -50.12 10.39 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 119.8 1.182 . . . . 0.0 111.802 167.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.59 -18.17 58.49 Favored Glycine 0 CA--C 1.551 2.329 0 N-CA-C 120.16 2.824 . . . . 0.0 120.16 176.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -66.15 -43.7 86.24 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 120.401 2.1 . . . . 0.0 114.446 170.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.89 -35.74 80.7 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 167.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 42.7 mt -77.69 113.26 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -108.27 102.67 11.78 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -171.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.96 163.29 34.63 Favored Glycine 0 CA--C 1.544 1.902 0 N-CA-C 115.581 0.993 . . . . 0.0 115.581 -172.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.2 t -98.46 120.46 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.9 p -100.08 116.45 32.13 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.45 0.7 . . . . 0.0 109.171 172.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.77 149.71 23.07 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 121.902 0.858 . . . . 0.0 110.759 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.7 mt -141.93 130.21 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 170.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 85.6 t -118.35 104.09 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 -178.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -79.4 122.53 26.52 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.102 0.561 . . . . 0.0 111.138 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -132.45 68.18 1.51 Allowed 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 170.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.85 -114.07 5.64 Favored Glycine 0 CA--C 1.547 2.038 0 O-C-N 121.625 -0.672 . . . . 0.0 113.788 -176.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -77.62 -34.15 53.43 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 169.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -71.84 135.31 46.57 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 119.872 1.214 . . . . 0.0 111.211 173.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -139.47 105.97 5.32 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -91.84 103.32 15.88 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -80.58 147.83 30.59 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.882 169.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.9 m -138.77 88.92 2.33 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 170.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.5 tt -93.25 119.49 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 123.283 0.633 . . . . 0.0 109.44 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 39.0 m -92.87 96.98 10.46 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -94.11 93.24 7.7 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.388 0.675 . . . . 0.0 109.45 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.33 -109.62 2.84 Favored Glycine 0 CA--C 1.543 1.792 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.538 -174.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 99.3 p -92.65 -49.74 5.94 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 169.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -75.0 130.62 39.67 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 119.181 0.9 . . . . 0.0 111.992 -173.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.5 p -102.45 129.16 54.39 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.446 0 C-N-CA 123.921 0.888 . . . . 0.0 110.0 -177.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.2 mp -114.12 116.06 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -175.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -128.62 129.49 45.96 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.321 0.648 . . . . 0.0 111.4 -177.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -153.02 143.63 22.71 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 123.609 0.764 . . . . 0.0 109.385 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -103.03 117.98 35.79 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.024 0.53 . . . . 0.0 110.276 176.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.409 ' HB3' HD21 ' A' ' 71' ' ' LEU . 50.5 p90 -101.47 141.29 34.56 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.664 0.786 . . . . 0.0 111.307 172.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.9 m -97.69 129.68 44.73 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 167.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.6 t -73.84 131.09 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 123.586 0.754 . . . . 0.0 109.718 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.31 -54.21 0.56 Allowed Glycine 0 CA--C 1.549 2.218 0 CA-C-N 115.09 -0.959 . . . . 0.0 114.222 -165.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -78.84 147.4 33.21 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.805 0.842 . . . . 0.0 112.506 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -77.14 98.29 5.02 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.955 169.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 59.4 m -98.74 140.62 32.67 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.143 -173.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.19 114.35 19.95 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.144 0.578 . . . . 0.0 110.297 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.409 HD21 ' HB3' ' A' ' 63' ' ' PHE . 69.0 mt -133.34 123.06 24.75 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -165.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -70.64 129.8 40.11 Favored 'General case' 0 CA--C 1.559 1.312 0 CA-C-O 121.522 0.677 . . . . 0.0 110.744 176.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 90.1 m -81.24 -76.96 0.22 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.567 -171.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.8 ptp -146.74 86.4 1.66 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 173.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . 0.254 2.8 m 65.54 92.3 0.07 Allowed 'General case' 0 CA--C 1.564 1.519 0 C-N-CA 125.278 1.431 . . . . 0.0 111.7 -177.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 75.22 56.75 4.6 Favored Glycine 0 CA--C 1.547 2.061 0 N-CA-C 118.942 2.337 . . . . 0.0 118.942 170.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -152.81 102.45 2.69 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 119.24 1.52 . . . . 0.0 108.755 160.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.66 125.51 43.97 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.691 0.797 . . . . 0.0 109.3 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.9 t -132.91 126.25 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -73.26 105.97 4.89 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.152 0.501 . . . . 0.0 109.764 170.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.9 t -142.93 134.96 27.08 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.932 -169.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.7 t -83.77 120.21 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.8 t -94.57 117.48 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 169.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -109.01 141.93 40.42 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 122.05 0.928 . . . . 0.0 110.339 176.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.6 tp -101.08 110.08 22.06 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.165 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -109.67 119.62 39.94 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.71 14.85 75.49 Favored Glycine 0 CA--C 1.548 2.134 0 N-CA-C 120.487 2.955 . . . . 0.0 120.487 176.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.321 7.9 t70 66.9 1.1 2.15 Favored 'General case' 0 CA--C 1.577 1.996 0 N-CA-C 117.392 2.367 . . . . 0.0 117.392 -168.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -142.24 33.75 1.51 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -150.23 104.65 3.28 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 120.877 1.671 . . . . 0.0 107.757 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.9 mt -98.68 102.74 14.56 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 173.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.0 m -109.5 124.26 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 123.735 0.814 . . . . 0.0 109.685 -165.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.1 t -151.01 129.32 12.0 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 122.249 -0.282 . . . . 0.0 111.066 -178.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 52.4 m -103.58 111.52 24.02 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 175.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -69.62 -79.02 0.06 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.702 0.801 . . . . 0.0 110.49 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -116.25 -75.94 0.58 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 169.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -112.45 3.59 16.96 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 162.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.0 mp -85.98 100.47 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -92.91 90.93 7.18 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -84.33 97.03 9.23 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.878 0.871 . . . . 0.0 110.596 -173.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 81.3 t -97.19 96.76 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.5 m -94.02 90.12 6.31 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -171.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -103.51 129.85 50.78 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.865 0.466 . . . . 0.0 109.851 -169.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 tt -109.71 107.7 17.82 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -176.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -95.16 -93.46 0.19 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 118.671 -0.681 . . . . 0.0 109.611 -170.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -85.4 -96.81 0.73 Allowed Glycine 0 N--CA 1.483 1.767 0 CA-C-N 119.028 0.831 . . . . 0.0 112.211 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -126.74 55.93 1.51 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.448 0.642 . . . . 0.0 110.28 166.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.09 -156.89 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.539 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 174.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.0 tt -155.93 119.36 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.192 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 159.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.1 m -97.76 93.94 6.65 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -92.07 112.12 23.93 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.4 m -111.4 94.5 5.0 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -168.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 37.3 mtt -92.14 98.67 11.68 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.743 0.817 . . . . 0.0 108.818 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.6 p -92.09 104.94 17.28 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -174.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.4 tp -102.86 81.54 2.01 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.71 -101.27 1.17 Allowed Glycine 0 CA--C 1.545 1.929 0 CA-C-N 116.479 -0.328 . . . . 0.0 112.92 -173.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -98.82 -16.08 19.01 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 169.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 55.7 mt -82.66 111.97 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 120.274 1.397 . . . . 0.0 107.782 -173.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 61.9 t -99.31 95.73 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -175.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -86.63 94.61 9.52 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.265 0.626 . . . . 0.0 109.84 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -103.36 109.54 21.21 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.286 -173.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -101.53 117.82 35.71 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.791 0.837 . . . . 0.0 109.046 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.9 mp -104.75 102.87 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 -178.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.9 m -122.87 110.74 15.81 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -168.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.9 tttp -81.66 136.92 35.5 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -166.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 71.9 ttt-85 -70.78 120.49 16.45 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 124.175 0.99 . . . . 0.0 111.474 -176.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.0 pt . . . . . 0 N--CA 1.484 1.248 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -173.078 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 98.5 p . . . . . 0 CA--C 1.553 1.069 0 CA-C-O 121.88 0.848 . . . . 0.0 112.022 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -63.51 -24.77 67.96 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 118.175 2.658 . . . . 0.0 118.175 -176.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.6 m -68.77 110.73 4.47 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 120.865 1.666 . . . . 0.0 111.525 176.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.78 155.64 10.67 Favored Glycine 0 CA--C 1.541 1.671 0 CA-C-O 122.252 0.918 . . . . 0.0 113.798 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -89.01 124.45 34.28 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 166.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -111.35 102.82 11.18 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -174.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -81.71 130.38 35.04 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.264 1.026 . . . . 0.0 110.764 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.4 tp -62.21 131.3 48.99 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -170.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -91.24 -62.76 1.37 Allowed 'General case' 0 CA--C 1.561 1.382 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.967 169.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.6 m -150.61 144.66 25.39 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.459 0.704 . . . . 0.0 110.968 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -111.83 115.66 29.39 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.605 0.762 . . . . 0.0 108.951 169.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -95.25 122.61 38.12 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 160.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.286 84.2 m-20 67.85 41.01 2.24 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 178.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -70.48 -44.79 66.99 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.667 -1.271 . . . . 0.0 113.306 157.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -63.13 -50.85 68.84 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.74 -40.28 96.73 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 173.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -70.5 -51.44 28.95 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -43.9 98.19 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -178.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -60.42 -40.71 92.02 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 167.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.41 -23.5 65.55 Favored 'General case' 0 CA--C 1.564 1.512 0 N-CA-C 117.516 2.413 . . . . 0.0 117.516 174.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.262 28.2 pt -92.01 -49.73 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 CA-C-N 120.082 1.31 . . . . 0.0 112.414 173.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 142.96 71.18 0.02 OUTLIER Glycine 0 N--CA 1.482 1.703 0 CA-C-N 119.699 1.136 . . . . 0.0 113.393 173.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 mp -128.58 157.17 75.86 Favored Pre-proline 0 CA--C 1.572 1.806 0 C-N-CA 123.555 0.742 . . . . 0.0 112.109 177.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -76.64 155.11 35.38 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 123.331 2.687 . . . . 0.0 113.884 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -59.64 -31.33 69.42 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 170.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -62.45 -49.62 74.71 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 171.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.6 mt -68.74 -26.24 65.15 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 116.986 2.217 . . . . 0.0 116.986 173.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 81.3 mt -78.06 -49.7 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 124.329 1.052 . . . . 0.0 111.256 178.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -75.7 -29.72 59.09 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 178.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -78.65 -47.07 17.76 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.568 1.076 . . . . 0.0 112.397 169.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.41 -22.41 65.55 Favored Glycine 0 CA--C 1.549 2.185 0 N-CA-C 120.09 2.796 . . . . 0.0 120.09 175.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -65.43 -42.07 92.84 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-N 120.252 2.026 . . . . 0.0 114.771 170.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -64.41 -40.88 96.64 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 167.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.27 128.9 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-N 119.39 0.995 . . . . 0.0 108.88 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -80.23 105.1 11.25 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 171.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -84.99 121.11 5.5 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-N 115.718 -0.674 . . . . 0.0 113.141 -173.015 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.6 t -79.49 118.88 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.4 m -98.62 115.59 28.99 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -101.15 148.2 25.36 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 121.823 0.821 . . . . 0.0 110.737 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 74.0 mt -140.67 130.33 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 169.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 88.9 t -115.08 103.13 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -81.01 120.93 25.42 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.321 0.582 . . . . 0.0 111.124 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -130.21 72.06 1.48 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 163.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.04 -115.96 7.68 Favored Glycine 0 CA--C 1.546 2.03 0 C-N-CA 123.305 0.479 . . . . 0.0 113.848 -173.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -34.12 63.31 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 171.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -73.89 117.81 16.11 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 119.92 1.236 . . . . 0.0 110.55 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -124.2 103.17 8.09 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -90.87 105.18 17.65 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 122.426 1.108 . . . . 0.0 108.619 175.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -106.29 123.9 48.76 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 113.536 -1.665 . . . . 0.0 109.508 -172.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.9 m -120.62 90.69 3.37 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -172.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.6 mm -101.75 112.46 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 -165.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.9 m -91.05 91.49 8.31 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.509 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -86.6 89.36 7.89 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.398 0.618 . . . . 0.0 110.134 -177.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.94 -104.69 1.93 Allowed Glycine 0 CA--C 1.54 1.634 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.344 -169.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.0 m -93.31 -55.23 3.38 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 175.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -81.56 137.02 35.58 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 119.477 1.035 . . . . 0.0 112.679 -170.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.6 p -95.74 132.61 39.45 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.473 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.07 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.5 mm -118.71 102.26 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 -175.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -113.23 121.77 45.44 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.377 0.608 . . . . 0.0 110.008 -172.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -142.03 178.31 7.62 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 124.02 0.928 . . . . 0.0 109.302 173.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -141.22 135.65 30.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.802 -1.186 . . . . 0.0 111.236 169.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -118.28 141.85 48.09 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.045 0.938 . . . . 0.0 110.798 175.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.4 m -99.29 125.84 45.0 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 167.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.9 133.3 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 123.667 0.787 . . . . 0.0 110.345 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.27 -55.82 0.55 Allowed Glycine 0 CA--C 1.548 2.147 0 CA-C-N 115.172 -0.922 . . . . 0.0 113.856 -165.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -86.89 151.9 22.91 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.903 0.881 . . . . 0.0 112.307 -174.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -80.67 114.88 19.87 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.82 173.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 60.0 m -114.46 140.03 49.05 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.389 0.675 . . . . 0.0 110.349 -175.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.82 107.42 16.21 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.824 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.1 mt -120.32 122.29 40.51 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -167.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -75.67 125.55 29.28 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.586 0.707 . . . . 0.0 110.559 177.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 77.5 p -74.5 173.98 9.6 Favored 'General case' 0 CA--C 1.566 1.578 0 CA-C-O 121.971 0.891 . . . . 0.0 112.25 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 54.7 mtm -60.06 -28.85 68.12 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 171.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.4 m -68.52 -68.79 0.37 Allowed 'General case' 0 CA--C 1.568 1.642 0 CA-C-N 119.396 0.998 . . . . 0.0 110.261 158.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 140.32 83.91 0.09 OUTLIER Glycine 0 N--CA 1.481 1.7 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 174.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -154.25 111.8 3.45 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -172.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -81.51 118.21 22.55 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.715 0.769 . . . . 0.0 110.601 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.1 m -139.44 125.61 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.305 -167.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -75.61 114.02 13.72 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.165 0.586 . . . . 0.0 110.653 -177.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.3 t -141.51 133.84 28.07 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.483 -166.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.9 t -89.94 124.16 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.4 t -99.79 126.15 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 170.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -119.96 140.22 51.25 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 122.141 0.972 . . . . 0.0 110.017 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.4 tp -101.27 116.79 33.62 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 114.545 -1.207 . . . . 0.0 109.081 -175.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -102.96 115.71 31.13 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 172.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.97 -133.11 13.71 Favored Glycine 0 CA--C 1.545 1.922 0 CA-C-N 114.783 -1.099 . . . . 0.0 113.394 -171.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -131.49 59.33 1.7 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 162.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -161.38 -40.66 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -174.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -109.74 99.02 8.25 Favored 'General case' 0 CA--C 1.558 1.263 0 CA-C-N 119.844 1.202 . . . . 0.0 111.118 -162.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 64.2 mt -95.24 105.78 17.75 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.5 t -105.79 125.09 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -169.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.2 t -151.87 136.83 17.26 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 22.8 p -111.2 106.56 15.6 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.809 0.844 . . . . 0.0 108.897 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -65.78 -69.6 0.29 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 123.824 0.849 . . . . 0.0 113.239 -173.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -127.72 -78.45 0.58 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 170.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -124.43 73.39 1.25 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 156.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 17.0 mt -148.33 105.63 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 103.646 -2.724 . . . . 0.0 103.646 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -75.01 142.14 43.87 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 171.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.0 t -143.05 99.8 3.52 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -178.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 84.4 t -102.62 98.28 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 177.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.0 m -95.26 90.92 6.03 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -174.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -108.98 126.98 53.67 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -165.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 tt -100.56 104.43 15.78 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -173.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -102.28 94.9 5.96 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -173.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.63 -111.58 3.31 Favored Glycine 0 N--CA 1.485 1.949 0 CA-C-O 119.864 -0.409 . . . . 0.0 112.252 -177.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -127.96 58.93 1.5 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.779 0.8 . . . . 0.0 110.615 160.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.8 pt -123.06 -154.62 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.762 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 159.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.5 tt -159.61 116.87 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 O-C-N 120.368 -1.457 . . . . 0.0 107.319 161.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 67.9 m -99.76 99.47 10.29 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 176.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -94.32 103.23 15.24 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.8 m -106.37 97.6 7.38 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -172.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 68.0 mtp -101.91 106.91 17.92 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.8 p -100.5 107.68 19.44 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -173.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 28.9 tp -71.93 -70.49 0.33 Allowed 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.159 0.583 . . . . 0.0 112.195 -176.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -123.52 -87.36 0.79 Allowed Glycine 0 CA--C 1.538 1.499 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 158.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -89.9 -11.11 42.81 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 167.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 68.5 mt -85.09 110.79 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -172.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.77 95.11 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 -175.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -82.07 93.04 6.92 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.076 0.55 . . . . 0.0 109.785 177.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -95.77 110.78 22.88 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -113.74 103.82 11.59 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -175.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.0 mp -98.9 121.16 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 -172.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.7 m -141.62 122.83 14.75 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 122.765 0.426 . . . . 0.0 109.962 -172.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -94.41 135.75 35.47 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.673 0.789 . . . . 0.0 112.276 -170.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.5 ttp180 -68.87 133.71 48.63 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.17 0.588 . . . . 0.0 112.569 -177.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.2 pt . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 -173.846 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.5 t . . . . . 0 CA--C 1.548 0.873 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -74.36 -9.7 58.85 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 118.497 2.777 . . . . 0.0 118.497 -175.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.6 m -73.83 112.12 9.64 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 121.631 2.014 . . . . 0.0 110.643 173.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.84 139.32 4.17 Favored Glycine 0 CA--C 1.542 1.739 0 CA-C-O 121.221 0.345 . . . . 0.0 113.561 -174.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -89.73 113.92 25.51 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 169.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -107.85 105.71 15.65 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -167.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -79.28 124.02 27.99 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.034 0.934 . . . . 0.0 110.837 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.9 tp -65.73 124.45 22.46 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.384 0.611 . . . . 0.0 112.576 -176.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -106.12 -65.84 1.04 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.095 0.958 . . . . 0.0 109.801 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.8 t -130.22 115.79 17.49 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -175.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -106.49 108.05 19.37 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -90.64 135.92 33.4 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.944 0.898 . . . . 0.0 110.171 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.7 m120 61.81 46.07 7.19 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 174.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -77.44 -46.25 23.22 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.27 -50.99 67.94 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 171.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.58 -38.91 78.91 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 177.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -76.67 -56.34 4.7 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 119.096 0.862 . . . . 0.0 112.903 178.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.07 -53.29 59.76 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -59.24 -36.05 74.77 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 174.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.42 -36.01 80.4 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 171.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.274 45.7 pt -78.79 -48.75 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 119.972 1.26 . . . . 0.0 112.975 175.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 143.73 61.62 0.02 OUTLIER Glycine 0 CA--C 1.543 1.824 0 CA-C-N 119.116 0.871 . . . . 0.0 113.253 171.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.8 151.97 58.38 Favored Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 123.828 0.851 . . . . 0.0 111.123 -174.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.04 144.53 30.21 Favored 'Trans proline' 0 C--N 1.369 1.654 0 C-N-CA 123.226 2.618 . . . . 0.0 113.633 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -65.07 -20.24 66.38 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 171.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -62.46 -54.64 37.09 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 120.28 1.4 . . . . 0.0 113.483 166.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.85 -21.32 66.77 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 117.258 2.318 . . . . 0.0 117.258 173.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.3 mt -78.61 -50.74 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 124.237 1.015 . . . . 0.0 110.927 173.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -74.88 -26.6 59.78 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -78.38 -48.36 15.69 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 119.673 1.124 . . . . 0.0 111.67 165.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.18 -17.02 60.88 Favored Glycine 0 CA--C 1.55 2.258 0 N-CA-C 120.445 2.938 . . . . 0.0 120.445 176.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -68.2 -43.39 78.18 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 120.473 2.136 . . . . 0.0 114.036 168.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -66.44 -31.75 72.7 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 167.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.3 mt -85.27 113.87 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -87.06 107.84 18.61 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.77 128.56 8.97 Favored Glycine 0 CA--C 1.54 1.599 0 CA-C-N 115.984 -0.553 . . . . 0.0 113.683 -170.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.6 t -80.01 114.58 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 174.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 51.4 m -113.88 118.08 33.22 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -173.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -95.54 153.84 17.51 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 122.122 0.963 . . . . 0.0 111.801 -174.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 69.1 mt -138.03 126.08 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 103.585 -2.746 . . . . 0.0 103.585 160.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 69.0 t -111.1 102.37 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -80.33 120.0 23.81 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.132 0.573 . . . . 0.0 110.781 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -129.75 72.6 1.48 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 165.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.62 -111.48 4.1 Favored Glycine 0 CA--C 1.545 1.963 0 C-N-CA 123.35 0.5 . . . . 0.0 114.181 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -74.65 -37.21 62.8 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 172.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -72.39 139.51 47.86 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 119.625 1.102 . . . . 0.0 111.624 175.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -141.65 96.66 3.01 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -87.99 102.99 15.28 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 122.015 0.912 . . . . 0.0 108.852 174.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -97.0 130.42 44.33 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.053 178.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.9 m -120.18 84.72 2.26 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 176.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.6 tt -91.26 115.47 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 C-N-CA 123.395 0.678 . . . . 0.0 109.515 -169.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 39.1 m -90.46 96.25 10.56 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.421 ' HA ' HH12 ' A' ' 122' ' ' ARG . . . -90.11 91.75 8.68 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.153 0.581 . . . . 0.0 110.084 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.24 -108.16 2.47 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.245 -171.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 91.8 p -87.97 -51.99 5.52 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 167.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -80.43 127.73 32.75 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 118.974 0.806 . . . . 0.0 111.678 -165.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.9 p -95.43 129.88 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 123.722 0.809 . . . . 0.0 110.984 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.0 mp -114.19 105.86 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -101.1 122.95 44.5 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.27 0.557 . . . . 0.0 109.876 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -145.46 165.08 29.61 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.936 0.895 . . . . 0.0 109.155 169.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.18 143.18 48.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.407 -0.808 . . . . 0.0 110.716 164.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -118.5 138.76 52.29 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.999 0.904 . . . . 0.0 110.072 166.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.3 m -97.32 125.32 41.84 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 168.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.3 t -72.23 131.75 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 C-N-CA 123.662 0.785 . . . . 0.0 109.525 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.27 -56.41 0.66 Allowed Glycine 0 CA--C 1.547 2.076 0 CA-C-N 115.44 -0.8 . . . . 0.0 113.534 -163.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -71.83 147.9 46.72 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.175 0.99 . . . . 0.0 112.965 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -81.19 103.39 10.94 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.086 169.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 56.6 m -100.54 137.86 38.38 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 121.752 0.787 . . . . 0.0 111.837 -166.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -80.15 115.38 19.68 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.903 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.7 mt -136.08 110.92 8.75 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -167.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -75.62 138.58 41.51 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.986 0.898 . . . . 0.0 111.15 171.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 70.6 p -91.09 -174.44 3.98 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 114.953 -1.022 . . . . 0.0 111.287 -170.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 51.9 mtt -62.02 -32.04 72.48 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 167.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 69.0 p -68.29 -52.67 31.12 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 119.559 1.072 . . . . 0.0 113.275 163.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.72 94.43 2.36 Favored Glycine 0 N--CA 1.479 1.553 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -176.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -148.65 -36.22 0.19 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -171.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.275 38.2 ttmt 75.38 96.61 0.07 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 125.522 1.529 . . . . 0.0 111.016 -176.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.3 t -112.35 124.5 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -83.85 106.42 15.52 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 171.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.9 t -141.35 139.84 33.64 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.854 0.862 . . . . 0.0 110.462 -168.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.4 t -91.12 130.13 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -174.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.6 t -106.14 126.17 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -106.95 154.29 21.29 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.691 0.758 . . . . 0.0 111.402 170.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.0 tp -119.62 123.37 43.72 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -122.33 127.52 49.91 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.688 0.756 . . . . 0.0 109.083 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.25 13.68 67.76 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 120.877 3.111 . . . . 0.0 120.877 175.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.279 4.4 t70 54.08 41.4 32.03 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -163.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -157.91 -26.18 0.08 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 115.672 1.731 . . . . 0.0 115.672 -176.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -113.75 101.22 9.09 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 121.112 1.778 . . . . 0.0 109.293 -173.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 57.7 mt -95.25 103.37 15.22 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 172.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.7 m -112.17 124.34 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 123.784 0.834 . . . . 0.0 109.477 -165.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 t -155.62 133.81 11.53 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 122.693 0.397 . . . . 0.0 110.384 -176.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 42.6 m -103.73 113.92 27.8 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -83.16 79.38 9.4 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.744 0.818 . . . . 0.0 109.768 176.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.351 12.0 tmtt? 69.93 -81.22 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.544 1.137 . . . . 0.0 111.836 -173.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -104.51 -34.05 8.35 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 170.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.0 mp -84.75 117.86 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-N 119.754 1.161 . . . . 0.0 108.685 -161.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -91.22 103.62 16.27 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 122.371 0.268 . . . . 0.0 110.496 -169.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.7 m -88.0 117.19 26.7 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.331 0.652 . . . . 0.0 109.243 178.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 78.7 t -120.58 103.23 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.9 m -100.49 91.8 4.85 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -172.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -84.7 146.48 27.41 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.29 1.036 . . . . 0.0 111.421 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 tt -131.04 106.94 8.72 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -85.99 -89.96 0.11 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.243 -170.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.23 -108.05 2.56 Favored Glycine 0 N--CA 1.483 1.795 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -106.69 63.06 0.64 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.765 0.793 . . . . 0.0 109.606 164.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.4 pt -140.3 -161.71 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.83 0 C-N-CA 124.7 1.2 . . . . 0.0 108.284 176.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.9 tt -159.8 130.65 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.372 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 160.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.7 m -111.93 89.04 2.95 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -84.07 103.25 13.15 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.719 0.808 . . . . 0.0 109.179 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.3 m -109.85 96.17 6.08 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -169.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 59.6 mtt -96.84 104.75 16.78 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 44.7 p -92.22 110.0 21.38 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -174.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.9 tp -104.23 76.97 1.37 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 175.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.18 -105.84 1.74 Allowed Glycine 0 CA--C 1.546 2.008 0 C-N-CA 123.025 0.345 . . . . 0.0 113.228 -171.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -94.42 -7.96 40.04 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 169.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 78.0 mt -89.28 101.43 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -174.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 39.2 t -98.19 97.47 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -172.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -85.51 98.51 10.66 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.494 0.717 . . . . 0.0 109.351 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -109.29 105.24 14.56 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.387 -173.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.421 HH12 ' HA ' ' A' ' 54' ' ' ALA . 45.1 mtp85 -87.01 120.98 28.85 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 172.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 73.1 mt -109.32 100.8 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 103.471 -2.789 . . . . 0.0 103.471 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.8 m -126.06 116.64 21.72 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -168.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -88.77 132.92 34.42 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.596 0.758 . . . . 0.0 112.04 -168.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -68.64 134.25 49.63 Favored 'General case' 0 CA--C 1.556 1.191 0 CA-C-O 121.934 0.873 . . . . 0.0 112.587 -175.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.0 pt . . . . . 0 N--CA 1.485 1.3 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 -174.459 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.1 m . . . . . 0 CA--C 1.547 0.862 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -69.21 -21.79 63.92 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 117.856 2.539 . . . . 0.0 117.856 -176.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.9 p -68.47 114.93 7.31 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 121.176 1.807 . . . . 0.0 112.171 176.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 166.23 167.73 27.33 Favored Glycine 0 CA--C 1.543 1.806 0 CA-C-N 114.634 -1.166 . . . . 0.0 113.731 -168.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -126.24 106.72 9.74 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 106.841 -1.541 . . . . 0.0 106.841 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -107.15 102.45 11.77 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -159.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -94.96 141.91 28.1 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.808 0.813 . . . . 0.0 111.704 -176.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 31.9 tp -66.98 128.45 36.4 Favored 'General case' 0 CA--C 1.558 1.261 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -167.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -94.72 -62.74 1.27 Allowed 'General case' 0 CA--C 1.561 1.382 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.926 169.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.2 t -139.34 135.56 33.88 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.666 0.786 . . . . 0.0 109.751 -170.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -131.92 119.8 21.64 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -173.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -93.45 -70.95 0.68 Allowed 'General case' 0 CA--C 1.556 1.185 0 CA-C-O 118.068 -0.967 . . . . 0.0 112.336 -164.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -105.24 76.8 1.25 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 119.591 1.087 . . . . 0.0 110.032 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -88.14 -47.06 8.76 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.575 0.75 . . . . 0.0 112.935 170.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -64.35 -51.09 65.07 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.3 -38.97 88.71 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 116.675 2.102 . . . . 0.0 116.675 173.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -70.14 -54.75 11.6 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 119.318 0.963 . . . . 0.0 113.555 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 32.9 mtt -60.53 -47.13 87.51 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -58.27 -37.45 74.99 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 115.948 1.832 . . . . 0.0 115.948 169.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.5 -38.43 84.33 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 173.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.5 pt -76.96 -39.88 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.55 59.44 0.13 Allowed Glycine 0 CA--C 1.543 1.834 0 C-N-CA 124.223 0.915 . . . . 0.0 112.91 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.24 149.75 52.47 Favored Pre-proline 0 CA--C 1.566 1.58 0 C-N-CA 124.213 1.005 . . . . 0.0 109.889 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -71.73 141.12 36.93 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 123.109 2.54 . . . . 0.0 113.528 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -61.08 -33.47 73.38 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -60.56 -47.32 86.7 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 170.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.5 mt -67.77 -18.9 65.02 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 172.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.0 mt -68.92 -53.51 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-N 119.79 1.177 . . . . 0.0 110.756 169.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -63.96 -27.56 69.22 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 173.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.7 ttpm? -74.37 -56.7 4.56 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-N 119.733 1.152 . . . . 0.0 112.091 172.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.95 -16.42 66.28 Favored Glycine 0 CA--C 1.552 2.397 0 N-CA-C 119.822 2.689 . . . . 0.0 119.822 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -69.08 -44.62 72.16 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 120.37 2.085 . . . . 0.0 114.264 171.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -66.74 -34.89 78.83 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 170.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 55.6 mt -73.2 123.43 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 175.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -84.01 104.94 14.49 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 174.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -85.1 131.67 10.58 Favored Glycine 0 CA--C 1.539 1.587 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.715 -170.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.2 t -84.99 113.51 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.4 m -96.55 100.46 12.03 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.92 142.16 31.64 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.402 0.62 . . . . 0.0 110.181 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.5 mt -142.43 119.91 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 174.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 94.3 t -109.58 109.73 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 175.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -85.65 123.1 30.67 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.18 0.592 . . . . 0.0 110.261 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -123.6 69.57 1.04 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 166.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.95 -114.35 6.06 Favored Glycine 0 CA--C 1.545 1.941 0 C-N-CA 123.41 0.528 . . . . 0.0 113.981 -177.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -77.68 -31.86 52.75 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 170.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -75.27 114.6 13.98 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 119.723 1.147 . . . . 0.0 110.136 175.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -112.44 105.83 14.18 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -84.17 138.48 32.97 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.705 162.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -141.48 146.65 36.71 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.819 0.448 . . . . 0.0 110.993 172.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.1 m -132.25 97.55 4.15 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 176.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.3 tt -94.56 115.54 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 75.8 p -89.37 99.16 12.21 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.753 -170.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.96 143.87 28.08 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.724 170.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -47.62 -50.35 19.42 Favored Glycine 0 CA--C 1.549 2.198 0 N-CA-C 119.682 2.633 . . . . 0.0 119.682 -171.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.7 t -73.16 -61.01 1.97 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 118.032 0.916 . . . . 0.0 113.444 173.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -126.99 129.07 47.38 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 119.14 0.882 . . . . 0.0 109.154 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.9 t -79.06 127.4 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 172.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.5 mm -113.62 103.61 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -171.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -105.67 131.64 52.79 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.993 0.517 . . . . 0.0 110.825 173.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -136.73 137.33 39.81 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.727 0.775 . . . . 0.0 109.04 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -118.46 126.84 52.9 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -174.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -139.81 173.13 11.84 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.838 0.828 . . . . 0.0 112.406 -176.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.2 m -133.11 131.8 40.94 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 170.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.1 m -69.12 134.01 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 123.262 0.625 . . . . 0.0 111.793 175.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.73 -53.24 0.77 Allowed Glycine 0 CA--C 1.546 2.03 0 CA-C-O 119.681 -0.511 . . . . 0.0 114.095 -166.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -75.21 152.66 38.35 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.742 0.817 . . . . 0.0 112.368 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -87.03 99.48 11.93 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 173.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.0 m -100.97 150.67 22.64 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 121.515 0.674 . . . . 0.0 112.203 -172.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.96 127.76 35.67 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.92 174.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mp -134.24 124.36 25.81 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -175.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -75.12 114.19 13.33 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.135 0.574 . . . . 0.0 110.115 176.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.7 t -77.41 -177.53 4.72 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 122.425 1.107 . . . . 0.0 112.827 -176.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 90.6 mmm -62.29 -38.0 87.67 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.6 m -72.26 -69.28 0.41 Allowed 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 119.935 1.243 . . . . 0.0 109.932 168.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.54 83.38 0.04 OUTLIER Glycine 0 N--CA 1.478 1.455 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 174.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -155.07 126.32 7.24 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -175.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -75.95 103.55 6.07 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 171.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.5 m -98.36 119.07 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -175.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -87.78 98.79 11.66 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -177.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.8 t -139.78 144.33 37.34 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.307 0.643 . . . . 0.0 110.745 -167.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.0 t -97.6 124.21 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -176.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.3 t -106.3 133.1 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -112.11 137.6 49.93 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.516 0.674 . . . . 0.0 109.902 174.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.4 tp -94.72 117.58 30.36 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 171.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -119.03 119.38 34.11 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 177.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.09 12.16 79.31 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 121.378 3.311 . . . . 0.0 121.378 173.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.276 5.9 t70 55.9 43.82 26.82 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -164.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -156.67 -40.91 0.07 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 117.91 -1.043 . . . . 0.0 113.749 -176.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -101.75 132.82 47.27 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 120.193 1.36 . . . . 0.0 110.458 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 38.6 mt -116.78 99.48 7.14 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 165.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 29.0 m -98.93 121.27 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 123.564 0.745 . . . . 0.0 109.659 -170.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.1 t -154.49 128.87 9.1 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 122.212 -0.305 . . . . 0.0 110.983 -177.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.6 t -109.79 129.04 55.67 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.37 0.668 . . . . 0.0 110.219 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -148.51 120.68 8.32 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.63 0.772 . . . . 0.0 109.226 -169.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.321 28.1 mtpp 74.6 -94.66 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 124.389 1.076 . . . . 0.0 108.239 -170.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -146.3 66.77 1.19 Allowed 'General case' 0 CA--C 1.562 1.405 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 151.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 57.9 mt -135.35 96.47 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 103.787 -2.672 . . . . 0.0 103.787 -172.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -88.25 95.28 10.12 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.388 0.613 . . . . 0.0 109.425 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.0 t -84.04 102.09 12.25 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.803 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 69.3 t -100.28 98.47 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 175.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.7 m -94.69 84.2 4.2 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -172.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -97.42 125.91 42.35 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.542 0.737 . . . . 0.0 109.215 -166.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 tt -103.28 103.45 13.48 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -172.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -100.99 92.35 4.98 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -171.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.79 -109.8 2.97 Favored Glycine 0 CA--C 1.543 1.824 0 N-CA-C 112.056 -0.418 . . . . 0.0 112.056 -176.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -126.75 58.31 1.41 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.614 0.721 . . . . 0.0 110.822 162.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.8 pt -125.06 -158.55 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.688 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 160.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.0 tt -157.78 118.84 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 120.06 -1.65 . . . . 0.0 108.861 163.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.0 m -102.48 94.55 5.73 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -91.08 110.96 22.24 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.491 0.716 . . . . 0.0 109.299 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.6 m -113.93 95.39 5.29 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -168.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 42.4 mtt -96.66 101.2 12.76 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.754 0.822 . . . . 0.0 109.09 -178.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.6 p -93.05 103.17 15.49 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -173.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.2 tp -99.51 82.48 2.65 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 175.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.85 -104.67 1.66 Allowed Glycine 0 CA--C 1.544 1.847 0 CA-C-N 116.427 -0.351 . . . . 0.0 112.623 -173.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -100.2 -2.82 32.95 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 168.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 61.2 mt -90.18 103.09 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -175.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.1 t -97.72 91.67 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -172.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -80.97 92.68 6.22 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.584 0.754 . . . . 0.0 109.661 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -111.83 105.76 14.32 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.63 -171.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -111.88 122.15 46.99 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.76 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.7 mp -102.83 118.42 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 -172.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.7 m -137.65 117.56 13.28 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -171.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.9 ttpp -88.16 138.18 31.67 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -171.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -68.46 122.93 19.47 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.793 0.837 . . . . 0.0 112.081 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 24.4 pt . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 123.102 1.43 . . . . 0.0 108.438 -174.655 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 98.0 p . . . . . 0 CA--C 1.549 0.916 0 CA-C-O 120.975 0.417 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -67.31 -14.43 62.91 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 118.016 2.599 . . . . 0.0 118.016 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.3 m -73.66 116.16 13.92 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 121.275 1.852 . . . . 0.0 110.399 168.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.88 158.53 22.25 Favored Glycine 0 CA--C 1.541 1.708 0 CA-C-O 122.34 0.967 . . . . 0.0 114.516 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.9 mptt -98.75 116.79 31.78 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 166.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -108.4 101.91 11.05 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -168.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -88.8 121.97 31.72 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.713 0.805 . . . . 0.0 109.779 -173.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.8 tp -61.7 119.36 8.55 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -92.88 -67.19 0.87 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.354 173.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.6 m -122.4 144.3 49.12 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.184 0.994 . . . . 0.0 109.625 -176.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -134.27 103.4 5.73 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -178.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -85.53 137.51 32.83 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.224 1.01 . . . . 0.0 110.329 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.8 m120 60.03 46.7 10.55 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 175.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -76.32 -49.45 16.88 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -64.52 -44.07 92.07 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 171.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.0 -46.36 88.37 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 173.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -71.93 -55.48 7.4 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 119.16 0.891 . . . . 0.0 113.184 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.93 -46.4 90.81 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -177.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -60.03 -40.31 88.88 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.192 1.552 . . . . 0.0 115.192 170.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.14 -28.74 66.72 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 117.371 2.36 . . . . 0.0 117.371 174.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.264 20.1 pt -81.08 -48.04 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-N 120.313 1.415 . . . . 0.0 112.776 172.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 143.59 66.61 0.02 OUTLIER Glycine 0 N--CA 1.48 1.623 0 CA-C-N 119.12 0.873 . . . . 0.0 112.975 173.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mp -130.47 154.99 81.73 Favored Pre-proline 0 CA--C 1.567 1.619 0 C-N-CA 123.558 0.743 . . . . 0.0 111.806 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.35 155.87 32.66 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.079 2.519 . . . . 0.0 113.383 175.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -63.38 -24.16 67.72 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 165.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -59.63 -53.49 57.44 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 119.974 1.261 . . . . 0.0 114.265 168.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 98.6 mt -69.58 -24.9 63.75 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 117.077 2.251 . . . . 0.0 117.077 175.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 41.3 mt -75.71 -53.76 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-N 119.725 1.148 . . . . 0.0 110.485 173.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 46.1 mm-40 -71.67 -22.86 61.61 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 116.485 2.031 . . . . 0.0 116.485 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.66 -45.47 12.45 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.736 1.153 . . . . 0.0 112.717 167.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.52 -20.34 55.63 Favored Glycine 0 CA--C 1.553 2.454 0 N-CA-C 119.881 2.713 . . . . 0.0 119.881 173.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -64.71 -43.65 92.76 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 120.144 1.972 . . . . 0.0 114.772 168.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -63.11 -38.86 92.86 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 167.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 69.7 mt -72.94 128.7 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 123.943 0.897 . . . . 0.0 108.706 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -76.78 111.92 12.82 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.307 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.66 105.89 3.14 Favored Glycine 0 N--CA 1.478 1.437 0 CA-C-N 115.865 -0.607 . . . . 0.0 113.553 -170.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.0 t -94.61 111.62 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 174.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 70.6 m -117.25 109.16 16.52 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.89 159.87 22.25 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.98 -173.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.3 mt -136.02 131.56 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 160.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.6 t -115.09 102.43 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -79.29 120.99 24.53 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.195 0.598 . . . . 0.0 110.684 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -127.26 73.22 1.41 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 166.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.14 -119.08 9.22 Favored Glycine 0 CA--C 1.546 2.031 0 C-N-CA 123.209 0.433 . . . . 0.0 113.598 -174.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.252 0.0 OUTLIER -71.41 -28.7 64.19 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 116.568 2.062 . . . . 0.0 116.568 169.294 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -75.55 132.01 40.42 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 120.015 1.28 . . . . 0.0 110.965 175.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -132.99 99.98 4.75 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -93.95 104.99 17.03 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 121.944 0.878 . . . . 0.0 108.875 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -90.46 134.26 34.47 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.927 176.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.7 m -119.54 98.91 6.36 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.4 mt -82.71 141.91 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 173.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.5 p -119.92 92.66 3.84 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 170.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.34 95.53 6.01 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.168 0.587 . . . . 0.0 109.545 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.32 -112.71 3.84 Favored Glycine 0 CA--C 1.545 1.907 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.903 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 99.1 p -87.77 -41.68 13.13 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 168.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -79.26 137.6 37.45 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 119.003 0.82 . . . . 0.0 112.118 -171.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.8 t -110.52 107.51 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -176.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.2 mp -97.09 104.74 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -172.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -108.54 124.89 51.15 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.53 0.732 . . . . 0.0 109.939 -176.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -150.87 144.84 25.27 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 122.76 0.424 . . . . 0.0 110.9 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -118.12 132.59 56.33 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.937 0.895 . . . . 0.0 110.534 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -117.55 142.58 47.01 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.787 0.835 . . . . 0.0 111.509 171.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.8 m -89.38 140.5 29.45 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 159.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.7 t -76.37 122.3 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 172.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.22 40.31 9.29 Favored Glycine 0 CA--C 1.549 2.167 0 N-CA-C 116.784 1.473 . . . . 0.0 116.784 -168.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -151.62 143.16 23.55 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.184 0.994 . . . . 0.0 108.318 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -74.0 106.88 5.89 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.325 0.583 . . . . 0.0 109.659 168.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 40.8 m -110.51 136.32 49.83 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.048 -171.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -83.58 93.49 7.87 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.863 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.8 mt -117.39 122.5 44.0 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -171.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -81.65 121.5 26.44 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.327 0.585 . . . . 0.0 110.267 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 71.1 p -69.16 157.4 36.96 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.315 170.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.9 ttm -40.79 -50.51 3.15 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 118.514 2.783 . . . . 0.0 118.514 -167.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.7 m -129.75 115.02 16.68 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 157.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 173.98 -129.8 1.7 Allowed Glycine 0 CA--C 1.542 1.779 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.241 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -147.91 164.31 34.11 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.58 0.752 . . . . 0.0 111.28 -176.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -65.98 125.06 24.25 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.393 0.677 . . . . 0.0 111.596 175.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.9 m -139.84 136.69 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 123.734 0.814 . . . . 0.0 109.407 -169.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -72.05 133.66 45.39 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.023 0.929 . . . . 0.0 112.461 -176.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 t -154.14 142.0 20.1 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 122.974 0.51 . . . . 0.0 110.287 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.29 123.16 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.4 t -99.32 137.03 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -177.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 17.1 mp0 -124.41 136.78 54.32 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 173.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 42.0 tp -91.16 105.97 18.18 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 174.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -93.98 115.35 27.69 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.59 -127.51 9.14 Favored Glycine 0 CA--C 1.546 1.981 0 CA-C-N 114.428 -1.26 . . . . 0.0 113.021 -170.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -118.54 -11.95 9.85 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 173.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -123.87 -13.0 7.48 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 117.424 2.379 . . . . 0.0 117.424 -173.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -113.51 96.46 5.89 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 121.398 1.908 . . . . 0.0 110.472 -165.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 70.5 mt -86.37 105.16 16.52 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.1 m -99.0 125.88 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 123.862 0.865 . . . . 0.0 109.225 -174.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.6 t -152.65 125.93 8.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 122.138 -0.351 . . . . 0.0 110.376 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.3 t -112.62 131.29 55.7 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.487 0.715 . . . . 0.0 110.16 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -84.45 -82.37 0.17 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.623 0.769 . . . . 0.0 108.967 175.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -130.57 -77.69 0.53 Allowed 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 167.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -86.42 -36.25 19.24 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 174.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 52.4 mt -69.45 129.25 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 C-N-CA 124.455 1.102 . . . . 0.0 109.01 176.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -128.18 97.14 4.66 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.7 t -89.97 106.07 18.23 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.719 0.807 . . . . 0.0 110.717 -170.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.9 t -105.08 95.7 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.2 m -97.28 88.17 4.37 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -168.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -87.7 139.98 29.98 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.03 0.932 . . . . 0.0 110.194 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 tt -119.86 98.33 6.05 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -99.47 94.51 6.45 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -172.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.94 -112.7 3.51 Favored Glycine 0 N--CA 1.483 1.789 0 CA-C-O 119.879 -0.4 . . . . 0.0 112.118 -176.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -123.77 59.3 1.13 Allowed 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.397 0.618 . . . . 0.0 111.134 169.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.73 -154.09 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.736 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 164.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.5 tt -160.23 117.01 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 157.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.5 m -98.41 95.89 7.64 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -94.6 106.84 18.83 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.6 m -105.36 101.79 11.31 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -173.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 44.5 mtt -97.71 101.68 13.25 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.0 p -90.98 115.4 27.96 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . 0.265 24.3 tp -84.5 -104.36 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -177.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -90.97 -94.94 1.26 Allowed Glycine 0 N--CA 1.48 1.596 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 168.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -88.83 -8.09 54.98 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 164.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 42.2 mt -84.21 119.32 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-N 119.808 1.186 . . . . 0.0 107.809 -173.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.1 t -102.73 97.41 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -76.61 135.49 39.18 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 166.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -145.6 101.52 3.58 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -95.05 129.24 42.22 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.2 0.6 . . . . 0.0 110.152 173.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 88.8 mt -110.88 112.54 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 104.083 -2.562 . . . . 0.0 104.083 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.0 m -131.88 118.01 19.26 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -172.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -79.82 130.03 34.98 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -166.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 55.4 ttp85 -73.66 119.04 17.34 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.316 0.646 . . . . 0.0 111.141 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 33.0 pt . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 123.013 1.387 . . . . 0.0 109.026 -170.131 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.8 t . . . . . 0 CA--C 1.55 0.976 0 CA-C-O 121.2 0.524 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -68.28 -18.56 64.56 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 117.522 2.416 . . . . 0.0 117.522 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.8 m -69.21 120.29 14.81 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 121.222 1.828 . . . . 0.0 111.622 174.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.67 156.79 8.51 Favored Glycine 0 CA--C 1.54 1.653 0 CA-C-O 122.507 1.06 . . . . 0.0 113.898 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -79.93 140.94 36.49 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 113.979 -1.111 . . . . 0.0 108.934 162.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -135.51 105.97 6.43 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.32 122.68 28.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 122.032 -0.417 . . . . 0.0 110.658 -176.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.8 tp -66.65 120.28 13.2 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.348 0.659 . . . . 0.0 112.114 -178.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -109.64 -63.53 1.36 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 118.556 -0.735 . . . . 0.0 110.499 -176.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.9 m -110.07 107.96 18.0 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -178.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -100.11 121.34 41.26 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 122.189 0.995 . . . . 0.0 108.485 170.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -85.75 -64.6 1.13 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.115 -169.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -115.67 67.06 0.7 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 118.379 0.536 . . . . 0.0 110.73 175.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -72.02 -51.7 20.52 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 166.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -63.67 -48.78 75.79 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.34 -40.01 92.67 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 116.498 2.036 . . . . 0.0 116.498 171.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -66.54 -51.9 51.49 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 177.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.9 -47.94 70.64 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 174.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -57.22 -41.29 79.2 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 169.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.76 -33.21 72.1 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 117.056 2.243 . . . . 0.0 117.056 175.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.3 pt -76.74 -41.85 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 CA-C-N 120.129 1.331 . . . . 0.0 113.481 172.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.58 62.05 0.15 Allowed Glycine 0 CA--C 1.542 1.765 0 C-N-CA 124.205 0.907 . . . . 0.0 112.674 175.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.17 150.39 51.26 Favored Pre-proline 0 CA--C 1.568 1.669 0 C-N-CA 124.026 0.93 . . . . 0.0 110.764 -176.264 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.53 148.47 37.6 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 123.205 2.604 . . . . 0.0 113.84 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -61.86 -26.05 67.9 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 173.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -61.28 -50.14 74.23 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 166.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.3 mt -70.99 -16.88 62.65 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 116.916 2.191 . . . . 0.0 116.916 171.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 84.8 mt -73.82 -54.06 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 120.152 1.342 . . . . 0.0 110.584 169.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -66.79 -27.96 68.0 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 116.353 1.982 . . . . 0.0 116.353 176.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -73.86 -60.92 2.03 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-N 119.463 1.028 . . . . 0.0 111.097 166.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.94 -15.32 57.97 Favored Glycine 0 CA--C 1.553 2.415 0 N-CA-C 120.53 2.972 . . . . 0.0 120.53 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -66.99 -47.31 71.91 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 119.985 1.892 . . . . 0.0 113.862 169.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -72.78 -35.65 67.45 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 171.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 37.8 mt -73.5 121.33 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.021 -1.104 . . . . 0.0 108.021 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -89.77 119.12 29.89 Favored 'General case' 0 CA--C 1.557 1.225 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.52 135.3 12.72 Favored Glycine 0 CA--C 1.542 1.76 0 CA-C-N 116.714 -0.221 . . . . 0.0 113.593 -177.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.35 116.23 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.1 p -94.35 102.63 14.62 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 121.477 0.656 . . . . 0.0 109.262 174.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.02 142.33 27.88 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.829 176.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.1 mt -139.1 128.9 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.3 t -117.39 103.98 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 -178.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -85.06 131.68 34.42 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.302 0.641 . . . . 0.0 110.771 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -135.99 72.63 1.44 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 168.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.81 -105.15 1.82 Allowed Glycine 0 CA--C 1.544 1.902 0 O-C-N 121.886 -0.509 . . . . 0.0 113.571 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.253 0.0 OUTLIER -97.54 -15.56 20.48 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 166.123 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -77.71 149.99 34.52 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 119.772 1.169 . . . . 0.0 111.412 171.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -146.23 142.66 28.6 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.754 0.822 . . . . 0.0 110.1 -174.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -136.33 113.44 10.54 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 165.79 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -91.82 148.19 22.42 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.502 169.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.5 m -133.9 91.85 2.88 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 173.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.1 mm -91.92 110.62 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.9 p -100.03 97.23 8.1 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -176.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -96.83 84.3 3.57 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.293 0.568 . . . . 0.0 109.806 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.73 -109.99 2.97 Favored Glycine 0 CA--C 1.541 1.683 0 CA-C-N 115.814 -0.63 . . . . 0.0 113.348 -176.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 96.0 p -82.88 -44.87 14.92 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 175.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -72.82 133.04 44.3 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 119.528 1.058 . . . . 0.0 111.679 -176.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 85.2 t -103.62 111.69 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 177.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.3 mp -100.64 92.8 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -110.72 117.69 34.14 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -147.74 133.61 19.07 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -108.16 145.64 33.88 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 122.193 0.997 . . . . 0.0 111.7 -175.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -133.26 167.14 20.92 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.631 174.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.0 m -129.56 132.22 46.76 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 169.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.3 t -71.41 127.47 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 C-N-CA 123.467 0.707 . . . . 0.0 109.508 -177.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.73 -55.66 0.8 Allowed Glycine 0 CA--C 1.545 1.949 0 CA-C-N 115.606 -0.725 . . . . 0.0 113.891 -166.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -81.15 147.16 30.17 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.715 0.769 . . . . 0.0 112.219 -177.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -84.08 116.05 22.68 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.087 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.7 m -130.31 150.21 51.64 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.773 0.797 . . . . 0.0 111.987 -174.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.97 128.13 35.58 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.839 0.856 . . . . 0.0 113.055 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.2 mt -141.01 126.32 18.6 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -96.45 143.02 27.86 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.854 0.835 . . . . 0.0 110.831 178.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.0 m -73.68 175.24 7.34 Favored 'General case' 0 CA--C 1.578 2.051 0 C-N-CA 124.194 0.998 . . . . 0.0 110.846 173.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 61.0 mtt -52.22 -51.7 56.74 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 -174.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 60.9 p -135.17 98.81 4.08 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 165.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -175.23 -130.35 1.3 Allowed Glycine 0 CA--C 1.541 1.689 0 N-CA-C 113.779 0.272 . . . . 0.0 113.779 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -137.87 155.0 49.42 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.019 0.928 . . . . 0.0 109.884 -169.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -65.94 108.89 2.33 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.501 0.72 . . . . 0.0 111.14 177.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.0 m -80.87 -38.79 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 177.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . 0.286 37.5 ttmt 74.0 106.06 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.909 1.284 . . . . 0.0 111.113 -177.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.3 t -145.06 152.03 39.46 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.844 0.831 . . . . 0.0 110.4 -172.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.4 t -98.5 127.89 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 -176.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 t -104.91 129.79 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -178.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.7 mp0 -110.91 134.58 52.44 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 172.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.1 tp -95.84 104.39 16.32 Favored 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -98.96 121.0 40.35 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 122.135 0.969 . . . . 0.0 108.914 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.14 9.68 72.38 Favored Glycine 0 CA--C 1.55 2.269 0 N-CA-C 120.563 2.985 . . . . 0.0 120.563 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.305 2.3 t70 64.61 16.5 10.36 Favored 'General case' 0 CA--C 1.577 2.007 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 -165.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -157.39 44.84 0.36 Allowed 'General case' 0 CA--C 1.568 1.655 0 O-C-N 121.018 -1.051 . . . . 0.0 113.401 175.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -160.28 112.69 2.03 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 173.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 38.8 mt -98.74 98.24 9.38 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 173.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.8 t -98.27 113.84 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -167.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.7 t -153.51 134.82 14.17 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -176.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.9 m -103.31 112.51 25.42 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -74.84 -84.45 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.061 0.544 . . . . 0.0 110.984 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -93.73 -82.77 0.34 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 169.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -127.59 62.69 1.38 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 152.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 69.0 mt -120.73 95.3 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 103.246 -2.872 . . . . 0.0 103.246 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -84.28 90.97 7.64 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 122.138 0.97 . . . . 0.0 109.21 -174.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.0 t -95.83 117.52 30.72 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.185 -168.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 74.5 t -116.9 106.28 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 104.616 -2.364 . . . . 0.0 104.616 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.3 m -91.77 88.5 6.7 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -175.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -96.37 119.88 35.65 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.232 0.613 . . . . 0.0 109.866 -166.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 tt -101.59 106.56 17.65 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -176.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -90.13 -87.39 0.18 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 118.926 -0.559 . . . . 0.0 110.237 -170.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -101.67 -109.7 3.27 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 178.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -106.05 64.06 0.67 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.95 0.881 . . . . 0.0 109.5 163.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.5 pt -144.19 -170.41 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.574 1.887 0 C-N-CA 125.184 1.394 . . . . 0.0 107.713 175.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.3 tt -152.11 125.02 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 120.326 -1.483 . . . . 0.0 108.866 156.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 81.7 m -103.69 99.65 9.45 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -93.38 107.66 19.45 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 32.6 m -107.46 100.68 10.09 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -170.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 40.7 mtt -101.88 100.79 11.15 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.903 0.881 . . . . 0.0 109.194 -176.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 73.8 p -94.63 104.47 16.41 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -175.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 49.4 tp -103.66 84.88 2.35 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.88 -102.71 1.46 Allowed Glycine 0 CA--C 1.545 1.94 0 CA-C-N 116.231 -0.441 . . . . 0.0 112.12 -171.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -103.92 -4.98 22.73 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 169.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 80.6 mt -90.35 109.5 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-N 120.543 1.52 . . . . 0.0 107.048 -172.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 49.7 t -97.78 95.08 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -173.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -84.42 96.39 9.07 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.353 0.661 . . . . 0.0 109.419 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -101.33 109.07 20.85 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.549 -173.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.9 mtm180 -103.08 109.04 20.45 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.0 mp -99.79 99.19 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 105.037 -2.208 . . . . 0.0 105.037 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.4 m -110.73 115.76 30.13 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -177.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -79.08 146.01 33.48 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 122.933 0.493 . . . . 0.0 110.89 -174.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -79.39 139.58 37.69 Favored 'General case' 0 CA--C 1.559 1.319 0 CA-C-O 121.895 0.855 . . . . 0.0 112.142 -171.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.9 mm . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 -159.193 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.1 t . . . . . 0 CA--C 1.547 0.857 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -135.9 -107.25 0.21 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -176.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.5 m 59.0 93.6 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.168 1.387 . . . . 0.0 113.897 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.13 150.35 7.0 Favored Glycine 0 CA--C 1.542 1.736 0 CA-C-O 121.916 0.731 . . . . 0.0 114.266 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -83.83 130.8 34.92 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.72 -0.74 . . . . 0.0 109.357 170.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -132.47 105.13 7.07 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -173.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -92.67 134.49 34.97 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 122.962 0.505 . . . . 0.0 111.554 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.2 tp -73.44 114.24 11.44 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.344 0.658 . . . . 0.0 112.557 -170.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -95.86 -61.88 1.38 Allowed 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.88 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.2 t -117.42 114.21 23.19 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -98.3 138.8 35.03 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 123.091 1.424 . . . . 0.0 109.433 167.164 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -128.77 113.06 14.85 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.292 18.7 m-20 72.68 50.94 0.17 Allowed 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -173.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -76.22 -64.23 1.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.383 -0.823 . . . . 0.0 112.101 174.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.03 -28.26 69.67 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 117.163 2.282 . . . . 0.0 117.163 174.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.8 -44.26 86.23 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 168.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -67.28 -57.3 6.93 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 173.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 38.1 mtt -59.45 -45.78 90.62 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -176.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -62.05 -39.09 91.18 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 169.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.96 -33.18 73.81 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 117.25 2.315 . . . . 0.0 117.25 172.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.255 20.9 pt -81.55 -53.77 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 CA-C-N 119.328 0.967 . . . . 0.0 112.31 176.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.1 61.23 0.01 OUTLIER Glycine 0 CA--C 1.542 1.78 0 CA-C-N 119.019 0.827 . . . . 0.0 113.416 172.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.12 153.42 42.59 Favored Pre-proline 0 CA--C 1.568 1.645 0 C-N-CA 123.648 0.779 . . . . 0.0 111.277 -179.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.86 155.2 43.61 Favored 'Trans proline' 0 CA--C 1.556 1.582 0 C-N-CA 123.168 2.579 . . . . 0.0 113.338 173.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -56.95 -34.59 68.19 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 169.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -59.82 -54.26 48.34 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 172.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.9 mt -71.2 -26.2 62.85 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 116.84 2.163 . . . . 0.0 116.84 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.1 mt -69.39 -55.36 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-N 119.683 1.129 . . . . 0.0 110.627 171.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -70.05 -25.22 63.45 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -76.01 -57.67 3.74 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 119.753 1.161 . . . . 0.0 111.537 168.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.38 -15.96 62.07 Favored Glycine 0 CA--C 1.553 2.414 0 N-CA-C 119.869 2.708 . . . . 0.0 119.869 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -68.02 -44.68 75.98 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 120.145 1.972 . . . . 0.0 114.138 170.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -68.34 -40.82 81.43 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 168.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.1 mt -74.17 124.09 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-N 119.484 1.038 . . . . 0.0 108.317 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -84.26 107.51 16.6 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -88.1 128.77 9.22 Favored Glycine 0 CA--C 1.541 1.659 0 CA-C-N 116.359 -0.382 . . . . 0.0 113.771 -171.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.0 t -88.56 115.01 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -177.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 62.7 m -96.87 106.21 18.48 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 170.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.54 150.05 23.97 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.794 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 86.8 mt -132.96 134.92 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 170.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 43.7 t -132.29 96.19 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 104.008 -2.589 . . . . 0.0 104.008 169.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -84.1 124.08 30.74 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.239 0.615 . . . . 0.0 110.354 -176.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -118.21 74.62 0.96 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 171.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.66 -116.89 8.23 Favored Glycine 0 CA--C 1.546 2.004 0 C-N-CA 123.374 0.511 . . . . 0.0 113.488 -173.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? -81.9 -33.19 30.59 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 169.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -73.41 116.64 14.22 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 119.825 1.193 . . . . 0.0 109.877 174.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -126.74 91.83 3.43 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -151.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -94.43 96.9 9.8 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.17 0.509 . . . . 0.0 110.193 -167.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -110.01 133.27 53.37 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.904 -176.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.8 m -116.13 99.09 6.99 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 -177.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.3 tt -89.31 118.21 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.7 0.8 . . . . 0.0 109.437 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 49.4 m -101.57 100.68 11.13 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 176.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -101.39 99.97 10.39 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.259 0.624 . . . . 0.0 109.355 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.09 -114.47 4.19 Favored Glycine 0 CA--C 1.542 1.726 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.894 -173.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.2 m -120.57 69.0 0.86 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.476 0.655 . . . . 0.0 109.897 169.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -161.22 122.55 2.88 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 177.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.8 t -99.89 124.58 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -177.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.9 mp -130.87 114.42 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 -177.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -91.12 124.83 35.64 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.673 0.749 . . . . 0.0 109.877 170.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -131.75 155.27 48.0 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.313 172.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -139.97 139.1 36.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.347 -0.846 . . . . 0.0 112.304 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -117.68 150.75 38.54 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.98 0.912 . . . . 0.0 111.23 173.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.2 m -98.51 128.42 44.84 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 166.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 86.7 t -74.72 128.96 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 123.539 0.735 . . . . 0.0 109.762 -173.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.51 10.34 84.58 Favored Glycine 0 CA--C 1.554 2.512 0 N-CA-C 118.716 2.246 . . . . 0.0 118.716 -170.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -137.67 153.35 49.83 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 119.087 1.443 . . . . 0.0 109.29 -176.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -69.63 115.3 8.72 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.312 0.577 . . . . 0.0 111.143 177.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.7 p -122.04 135.81 54.86 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.642 -175.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.03 106.92 18.18 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 113.937 -1.483 . . . . 0.0 110.215 -175.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.3 mt -124.37 126.75 46.49 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.42 0.688 . . . . 0.0 110.11 -166.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -73.81 131.14 41.23 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.219 0.608 . . . . 0.0 111.037 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.3 p -85.23 -165.8 1.32 Allowed 'General case' 0 CA--C 1.575 1.906 0 C-N-CA 123.069 0.548 . . . . 0.0 111.025 -176.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 56.7 mtt -61.64 -50.13 73.77 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 171.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 61.5 p -70.87 -67.9 0.47 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 119.104 0.865 . . . . 0.0 111.494 168.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -179.87 -145.65 6.51 Favored Glycine 0 CA--C 1.542 1.759 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 67.0 112.59 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.862 1.265 . . . . 0.0 112.757 173.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.26 97.66 10.51 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -178.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.9 m -96.73 130.67 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 C-N-CA 123.516 0.726 . . . . 0.0 110.094 -171.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -75.6 114.99 14.81 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.177 0.591 . . . . 0.0 110.895 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.5 t -146.2 140.33 26.51 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.717 0.807 . . . . 0.0 109.421 -173.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.4 t -87.11 117.1 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.43 100.62 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -100.21 141.09 33.51 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.185 0.993 . . . . 0.0 110.423 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.6 tp -95.92 104.89 16.86 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 114.155 -1.384 . . . . 0.0 108.313 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -96.23 113.16 24.73 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 122.259 1.028 . . . . 0.0 108.641 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.44 -129.81 9.87 Favored Glycine 0 CA--C 1.546 1.98 0 CA-C-N 113.683 -1.599 . . . . 0.0 111.975 -165.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -135.19 51.69 2.07 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 120.863 0.363 . . . . 0.0 110.216 160.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -158.16 -20.76 0.08 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -177.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -118.32 113.34 21.29 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 121.963 2.165 . . . . 0.0 109.851 -174.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 15.6 mt -97.86 104.79 16.85 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 175.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 66.8 t -105.48 113.73 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -167.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.8 t -146.05 133.99 21.36 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.895 0.478 . . . . 0.0 110.592 -174.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 53.4 m -106.46 107.35 18.32 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -84.31 76.7 10.09 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.175 0.59 . . . . 0.0 109.786 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.341 38.4 ttmt 69.53 -75.96 0.07 Allowed 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 124.56 1.144 . . . . 0.0 112.659 -167.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -115.47 -23.47 8.81 Favored 'General case' 0 CA--C 1.567 1.628 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 174.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.2 mt -79.0 106.61 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-N 120.592 1.542 . . . . 0.0 108.657 -171.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -82.52 96.01 7.9 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-O 121.802 0.81 . . . . 0.0 109.694 176.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.4 m -93.09 116.75 29.33 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.307 1.043 . . . . 0.0 109.707 -176.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.1 t -118.39 102.75 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 104.786 -2.301 . . . . 0.0 104.786 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.2 m -92.01 92.16 8.17 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -174.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -83.16 140.49 32.56 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.65 0.78 . . . . 0.0 110.43 -175.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.67 107.47 13.73 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 172.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -88.81 -98.74 0.09 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 118.432 -0.794 . . . . 0.0 109.128 -176.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -92.31 -103.79 1.49 Allowed Glycine 0 N--CA 1.485 1.924 0 CA-C-N 119.466 1.03 . . . . 0.0 111.394 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -111.03 59.61 0.61 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.825 0.821 . . . . 0.0 109.798 164.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.7 pt -139.4 -163.62 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.809 0 C-N-CA 124.903 1.281 . . . . 0.0 108.048 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.6 tt -157.29 116.36 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.362 -1.461 . . . . 0.0 107.336 165.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.4 m -100.03 87.49 3.5 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -177.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -88.06 106.82 18.41 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 109.416 -0.586 . . . . 0.0 109.416 -176.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 19.1 m -108.08 97.78 7.43 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -167.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 82.1 mtp -99.6 94.57 6.45 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -172.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 59.2 p -97.65 112.2 24.17 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.668 -167.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.1 tp -112.49 86.18 2.31 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 174.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.45 -103.97 1.8 Allowed Glycine 0 CA--C 1.544 1.876 0 C-N-CA 122.848 0.261 . . . . 0.0 113.657 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -86.29 -24.28 25.99 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 169.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 24.7 mm -67.59 137.36 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.597 0 C-N-CA 124.945 1.298 . . . . 0.0 109.725 176.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.7 t -131.22 93.98 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 172.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -89.2 95.06 10.15 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 120.96 0.409 . . . . 0.0 110.704 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -97.29 108.44 21.16 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 121.356 0.598 . . . . 0.0 109.567 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 88.0 mtt180 -94.01 120.04 33.72 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.969 0.908 . . . . 0.0 108.615 171.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -105.64 99.28 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 175.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.4 m -114.49 115.44 27.26 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -175.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -88.51 140.54 29.35 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.279 0.561 . . . . 0.0 111.709 -170.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.8 ttm-85 -64.21 119.69 10.72 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.794 -176.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.7 pt . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -178.002 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.4 m . . . . . 0 CA--C 1.549 0.907 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.366 96.2 m-85 80.48 -13.05 0.97 Allowed 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 118.26 2.689 . . . . 0.0 118.26 172.285 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 72.1 m -75.37 114.42 13.88 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 121.157 1.799 . . . . 0.0 110.071 170.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.67 145.86 5.31 Favored Glycine 0 CA--C 1.542 1.755 0 CA-C-O 121.84 0.689 . . . . 0.0 112.831 -173.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -97.75 121.79 40.08 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 170.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -117.29 103.11 9.83 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -166.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.8 tp60 -80.56 121.92 26.4 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.749 0.82 . . . . 0.0 110.614 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.7 tp -62.77 127.39 31.04 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -110.78 -66.38 1.08 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.812 0.845 . . . . 0.0 109.606 -176.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.3 t -118.89 114.64 22.92 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.827 0.851 . . . . 0.0 108.847 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -104.2 105.11 15.15 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -102.61 133.79 47.03 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.83 0.852 . . . . 0.0 109.074 -171.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.252 22.2 m120 63.88 47.98 3.32 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -171.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -81.92 -46.17 14.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.827 -1.171 . . . . 0.0 113.956 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.29 -48.54 77.67 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 176.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.3 -40.62 96.89 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 116.566 2.061 . . . . 0.0 116.566 172.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -70.94 -52.74 18.07 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 118.005 -0.997 . . . . 0.0 113.647 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -40.89 93.08 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 177.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -40.82 94.86 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 167.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.57 -35.99 80.07 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 174.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.259 36.0 pt -79.58 -48.26 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-N 119.829 1.195 . . . . 0.0 112.846 175.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.68 58.28 0.12 Allowed Glycine 0 CA--C 1.546 2.003 0 C-N-CA 124.128 0.871 . . . . 0.0 113.631 -178.065 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.07 152.5 56.81 Favored Pre-proline 0 CA--C 1.571 1.776 0 C-N-CA 124.37 1.068 . . . . 0.0 110.24 173.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.32 154.08 31.79 Favored 'Trans proline' 0 C--N 1.366 1.495 0 C-N-CA 123.104 2.536 . . . . 0.0 114.103 -173.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -60.88 -24.92 66.32 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 168.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -57.5 -55.73 31.02 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 119.669 1.122 . . . . 0.0 113.5 164.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.1 mt -71.87 -16.42 62.14 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 175.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.0 mt -73.54 -56.85 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-N 120.165 1.348 . . . . 0.0 110.165 167.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -70.31 -27.56 64.48 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 116.477 2.028 . . . . 0.0 116.477 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -81.99 -50.72 8.81 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 119.155 0.889 . . . . 0.0 112.447 170.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.18 -7.18 62.54 Favored Glycine 0 CA--C 1.554 2.517 0 N-CA-C 119.932 2.733 . . . . 0.0 119.932 177.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -69.12 -45.19 70.79 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 120.137 1.968 . . . . 0.0 114.087 170.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -68.23 -36.06 78.89 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 169.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 42.8 mt -75.28 120.52 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 119.542 1.065 . . . . 0.0 108.232 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -88.75 114.83 25.79 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 176.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.1 133.25 11.38 Favored Glycine 0 CA--C 1.542 1.742 0 CA-C-N 116.473 -0.33 . . . . 0.0 113.291 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.7 t -81.91 122.3 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.0 m -96.0 105.34 17.35 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 170.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.78 144.78 26.43 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.582 0.706 . . . . 0.0 109.989 177.221 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 40.3 mt -146.68 129.24 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.1 t -125.94 115.31 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 -178.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -79.2 131.5 36.22 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.205 0.602 . . . . 0.0 111.048 172.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -135.55 64.92 1.56 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 172.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.38 -104.67 1.88 Allowed Glycine 0 CA--C 1.546 1.997 0 O-C-N 121.211 -0.931 . . . . 0.0 113.401 -177.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -89.35 -39.44 13.43 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 161.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -62.47 152.55 34.16 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.656 1.182 . . . . 0.0 113.806 178.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -139.49 150.61 45.36 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.905 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -134.32 109.54 8.88 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 164.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -117.49 131.64 56.69 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.475 -178.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.2 m -123.69 97.71 5.5 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -172.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.4 mm -88.06 113.44 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.6 p -102.92 86.11 2.66 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -103.74 94.67 5.56 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.125 0.57 . . . . 0.0 110.047 -174.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.13 -108.89 2.63 Favored Glycine 0 CA--C 1.543 1.816 0 CA-C-N 116.15 -0.477 . . . . 0.0 113.165 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 94.5 p -87.74 -46.72 9.22 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 171.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -80.53 134.45 35.94 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 119.146 0.885 . . . . 0.0 112.216 -171.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 95.0 t -104.73 112.77 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 177.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 67.1 mt -106.75 98.99 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 -176.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -115.85 118.04 31.88 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -175.061 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -136.5 171.99 13.68 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.0 0.905 . . . . 0.0 110.1 178.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -136.05 137.27 40.96 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.484 -0.76 . . . . 0.0 110.079 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -133.64 134.89 43.76 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.551 0.691 . . . . 0.0 112.274 176.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.3 m -92.11 127.89 37.75 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 163.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.0 t -74.31 124.52 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.28 -53.67 0.59 Allowed Glycine 0 CA--C 1.548 2.109 0 CA-C-N 115.237 -0.892 . . . . 0.0 114.124 -165.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -81.87 155.98 25.05 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.793 0.837 . . . . 0.0 112.809 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -76.38 111.79 12.2 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.079 0.552 . . . . 0.0 110.62 169.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 61.6 m -108.7 143.07 38.29 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.605 0.762 . . . . 0.0 111.421 -167.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -81.62 98.16 8.22 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.345 -176.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.2 mt -128.41 123.23 33.25 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.295 0.638 . . . . 0.0 109.906 -167.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -92.46 130.12 38.21 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.604 0.762 . . . . 0.0 111.311 -175.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.8 m -83.76 167.06 17.49 Favored 'General case' 0 CA--C 1.57 1.732 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.965 174.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 80.4 mtp -56.95 -50.48 72.51 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.4 m -80.38 -44.48 19.33 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 118.349 -0.834 . . . . 0.0 112.605 162.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.54 -175.24 6.52 Favored Glycine 0 CA--C 1.545 1.927 0 N-CA-C 118.172 2.029 . . . . 0.0 118.172 -166.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -123.0 19.42 10.04 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 117.354 2.354 . . . . 0.0 117.354 -157.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.301 31.8 ttmt 82.63 100.77 0.05 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.23 1.412 . . . . 0.0 110.109 178.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.7 m -125.87 142.93 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 C-N-CA 124.188 0.995 . . . . 0.0 109.472 -168.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.75 108.97 14.86 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.1 t -140.27 133.4 29.54 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.441 0.696 . . . . 0.0 109.642 -168.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 64.3 t -84.85 120.03 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -175.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.6 t -97.94 111.9 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 172.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -112.46 145.16 40.69 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.93 0.872 . . . . 0.0 110.853 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 54.2 tp -96.44 105.31 17.37 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.67 178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -90.92 120.13 31.68 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 170.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.4 -124.16 8.71 Favored Glycine 0 CA--C 1.544 1.876 0 CA-C-N 114.327 -1.306 . . . . 0.0 113.276 -174.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -122.75 -14.64 7.66 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 171.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -132.87 27.77 4.25 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 -172.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -138.15 103.14 4.86 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 121.446 1.93 . . . . 0.0 108.508 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 57.4 mt -96.79 106.05 18.28 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 173.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 87.4 t -106.62 122.96 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -165.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.4 t -150.56 127.61 11.17 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 122.589 0.356 . . . . 0.0 111.047 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.8 t -104.24 122.89 46.33 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.215 0.606 . . . . 0.0 109.848 175.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -80.76 -79.7 0.15 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 123.28 0.632 . . . . 0.0 110.189 -173.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -98.08 -78.88 0.48 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 163.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -130.86 61.47 1.63 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 156.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.9 mp -123.49 91.91 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 103.367 -2.827 . . . . 0.0 103.367 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -87.66 92.06 8.97 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.142 0.496 . . . . 0.0 110.303 -172.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.3 t -83.99 103.7 13.46 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.156 0.982 . . . . 0.0 110.49 -175.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 88.1 t -103.34 103.86 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 -177.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.4 HG22 HD11 ' A' ' 109' ' ' ILE . 18.8 m -93.48 92.69 7.73 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -166.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -94.45 109.4 21.27 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.153 0.581 . . . . 0.0 110.498 -166.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.71 98.13 10.24 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 118.726 0.694 . . . . 0.0 109.504 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -83.34 -74.58 0.36 Allowed 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 122.981 0.512 . . . . 0.0 111.606 -172.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -168.78 107.02 0.26 Allowed Glycine 0 N--CA 1.479 1.542 0 CA-C-O 121.796 0.665 . . . . 0.0 112.191 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.275 23.8 m-20 48.71 32.53 3.63 Favored 'General case' 0 CA--C 1.57 1.712 0 N-CA-C 116.944 2.202 . . . . 0.0 116.944 -165.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.7 pt -142.15 -171.09 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.815 0 C-N-CA 124.806 1.242 . . . . 0.0 108.604 175.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.4 HD11 HG22 ' A' ' 102' ' ' THR . 7.5 tt -154.39 124.16 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 120.4 -1.438 . . . . 0.0 107.902 160.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.5 m -102.02 88.75 3.42 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -87.65 105.45 17.36 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.6 m -109.07 99.05 8.41 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -165.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 59.3 mtt -92.51 102.34 14.79 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.72 0.808 . . . . 0.0 109.268 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 77.5 p -94.09 103.14 15.21 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -176.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.2 tp -101.26 83.81 2.53 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 174.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.88 -104.77 1.6 Allowed Glycine 0 CA--C 1.544 1.882 0 CA-C-N 116.375 -0.375 . . . . 0.0 113.181 -176.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -97.15 -12.35 23.2 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 169.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 51.6 mt -84.55 112.39 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -175.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.8 t -103.29 90.71 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -174.338 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -83.6 94.12 8.01 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.428 0.691 . . . . 0.0 110.483 -177.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -106.6 108.14 19.5 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.075 -169.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 -96.53 110.72 23.06 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 63.2 mt -103.45 102.55 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 104.344 -2.465 . . . . 0.0 104.344 -173.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.7 m -127.79 116.67 20.55 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -163.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.5 mttm -77.8 138.28 38.89 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.55 0.74 . . . . 0.0 112.431 -171.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 70.9 ttt-85 -75.25 116.5 16.04 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.821 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 16.7 pt . . . . . 0 N--CA 1.486 1.336 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -174.858 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.9 t . . . . . 0 CA--C 1.549 0.906 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -71.01 -12.67 61.66 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 117.619 2.452 . . . . 0.0 117.619 178.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.0 m -76.59 114.34 15.22 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 121.066 1.757 . . . . 0.0 111.116 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.98 169.23 31.21 Favored Glycine 0 CA--C 1.545 1.926 0 CA-C-O 122.821 1.234 . . . . 0.0 114.368 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -92.01 123.01 35.05 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 113.739 -1.23 . . . . 0.0 108.337 170.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -116.11 97.55 6.13 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -175.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.7 tm0? -91.86 125.53 36.6 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 122.987 0.515 . . . . 0.0 110.36 -170.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 38.6 tp -65.37 114.74 5.01 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -169.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -93.54 -65.78 0.97 Allowed 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.219 -176.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.6 m -121.55 117.09 25.92 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -177.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -104.06 130.44 51.75 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.234 1.013 . . . . 0.0 109.128 176.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.63 -69.12 0.75 Allowed 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.357 -177.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -115.38 69.93 0.74 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.25 0.62 . . . . 0.0 110.522 178.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -75.94 -60.88 2.13 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.522 0.729 . . . . 0.0 111.561 171.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.12 -31.65 72.24 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 176.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.55 -44.5 78.14 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 169.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -67.49 -56.68 8.58 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 176.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 51.2 mtt -59.17 -48.45 81.58 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -177.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -57.42 -44.58 84.76 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 170.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.18 -29.63 70.73 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 117.338 2.347 . . . . 0.0 117.338 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 47.0 pt -81.24 -49.33 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-N 119.549 1.068 . . . . 0.0 112.503 173.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.77 67.27 0.03 OUTLIER Glycine 0 CA--C 1.541 1.666 0 CA-C-N 118.79 0.723 . . . . 0.0 112.471 173.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.73 152.32 45.42 Favored Pre-proline 0 CA--C 1.568 1.651 0 C-N-CA 123.967 0.907 . . . . 0.0 110.714 178.01 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.14 155.04 52.32 Favored 'Trans proline' 0 CA--C 1.557 1.652 0 C-N-CA 123.199 2.599 . . . . 0.0 113.394 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -57.08 -33.22 67.06 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 169.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -60.72 -55.57 31.64 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 117.227 -1.368 . . . . 0.0 113.961 170.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.99 -21.81 63.19 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 178.148 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.2 mt -76.1 -55.3 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-N 119.846 1.203 . . . . 0.0 110.509 171.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 52.3 mm-40 -76.21 -29.06 57.47 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -176.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -79.88 -45.7 18.16 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 118.832 0.742 . . . . 0.0 112.181 168.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.63 -28.01 67.17 Favored Glycine 0 CA--C 1.547 2.033 0 N-CA-C 119.678 2.631 . . . . 0.0 119.678 174.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -62.79 -41.01 99.08 Favored 'General case' 0 CA--C 1.568 1.66 0 CA-C-N 119.537 1.668 . . . . 0.0 114.965 170.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -68.77 -37.3 79.23 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 167.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.3 mt -68.22 139.43 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-N 119.651 1.114 . . . . 0.0 110.077 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -72.5 108.88 5.8 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.206 174.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.62 101.62 2.82 Favored Glycine 0 N--CA 1.479 1.526 0 CA-C-N 116.059 -0.518 . . . . 0.0 112.228 -174.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.2 t -85.95 107.32 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -176.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.0 m -99.43 95.11 6.8 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 114.269 -1.332 . . . . 0.0 107.517 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -80.56 148.73 30.23 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 121.88 0.848 . . . . 0.0 111.092 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.7 mt -140.56 122.41 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 173.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.0 t -118.45 100.53 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -83.43 126.74 33.07 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.161 0.584 . . . . 0.0 110.625 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -123.8 77.59 1.54 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 167.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.59 -119.0 6.36 Favored Glycine 0 CA--C 1.546 1.995 0 C-N-CA 123.092 0.377 . . . . 0.0 113.154 -173.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -76.6 -16.81 59.48 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 167.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -78.94 148.4 32.66 Favored 'General case' 0 CA--C 1.557 1.218 0 CA-C-N 119.335 0.971 . . . . 0.0 111.577 176.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -142.5 109.39 5.48 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -101.36 95.7 6.68 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 173.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -94.65 129.56 41.47 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.846 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.9 m -113.74 92.46 3.99 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.3 tp -85.06 120.91 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.804 0.841 . . . . 0.0 110.09 -175.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 56.8 m -100.69 98.78 9.29 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 171.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -101.43 80.4 2.07 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.465 0.65 . . . . 0.0 110.125 178.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.18 76.15 0.37 Allowed Glycine 0 CA--C 1.541 1.672 0 CA-C-O 119.076 -0.847 . . . . 0.0 115.149 -178.181 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . 0.308 7.6 t 79.46 -53.68 0.42 Allowed 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -174.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -79.82 121.71 25.72 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 119.079 0.854 . . . . 0.0 111.593 -166.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.3 t -99.91 120.11 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -170.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.0 mm -127.1 117.22 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -174.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -92.08 126.77 37.3 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.451 0.643 . . . . 0.0 110.139 173.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -138.81 131.9 29.74 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -126.66 150.06 49.18 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 122.077 0.941 . . . . 0.0 112.56 -171.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -147.15 155.27 41.99 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.334 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.1 m -107.37 137.73 44.88 Favored 'General case' 0 CA--C 1.565 1.533 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 166.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.7 t -75.08 126.1 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 170.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.91 -54.23 0.56 Allowed Glycine 0 CA--C 1.547 2.057 0 CA-C-N 115.659 -0.701 . . . . 0.0 114.353 -167.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -88.62 154.52 20.25 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.599 0.76 . . . . 0.0 112.418 -173.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -77.5 106.63 9.4 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.151 0.501 . . . . 0.0 109.927 164.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 68.7 m -110.03 140.68 43.81 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.756 0.789 . . . . 0.0 111.07 -169.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.44 125.16 30.1 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.484 -177.526 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 mp -134.7 160.49 37.98 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 122.105 0.955 . . . . 0.0 109.796 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.72 125.54 31.99 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.611 -0.681 . . . . 0.0 109.683 166.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 m -74.53 149.52 40.19 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 122.976 0.511 . . . . 0.0 109.753 173.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 91.6 mtp -54.93 -43.22 73.17 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 115.726 1.751 . . . . 0.0 115.726 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 34.5 m -115.06 110.55 19.74 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 151.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 143.76 -155.62 26.24 Favored Glycine 0 CA--C 1.543 1.796 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.872 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -148.93 -35.71 0.19 Allowed 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -169.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.61 137.64 51.79 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.15 0.98 . . . . 0.0 109.262 -174.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 70.3 t -117.86 -77.97 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt 61.29 90.49 0.07 Allowed 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 124.355 1.062 . . . . 0.0 112.04 -164.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.2 t -143.39 145.12 32.39 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.543 0.687 . . . . 0.0 110.58 -175.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.1 t -98.17 125.06 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -178.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.1 t -107.38 136.22 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.7 mp0 -119.18 137.88 53.32 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.495 0.718 . . . . 0.0 109.082 172.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.1 tp -104.55 119.48 39.08 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.981 0.912 . . . . 0.0 108.976 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -97.88 122.86 41.5 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 167.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.02 -125.73 11.3 Favored Glycine 0 CA--C 1.544 1.904 0 CA-C-N 114.664 -1.153 . . . . 0.0 113.478 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -137.96 63.06 1.55 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 155.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -152.72 -44.39 0.1 Allowed 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 117.204 -1.379 . . . . 0.0 114.067 -178.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -108.33 111.3 23.16 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 120.536 1.516 . . . . 0.0 111.461 -168.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 24.2 mt -106.72 109.07 20.88 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 174.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.2 t -105.52 121.51 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -174.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 t -156.45 135.43 11.91 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 45.8 m -103.11 113.79 27.55 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -75.9 -83.51 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.225 0.61 . . . . 0.0 111.226 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -133.4 81.83 1.95 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 173.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.257 33.4 t30 49.85 44.87 25.21 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 115.691 1.738 . . . . 0.0 115.691 -163.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 55.7 mt -137.13 95.1 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 -177.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -85.43 98.31 10.51 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.398 0.618 . . . . 0.0 109.691 -178.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.2 t -82.77 102.81 11.81 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.209 1.004 . . . . 0.0 109.542 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 79.8 t -103.24 92.19 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 52.3 m -96.37 97.09 9.19 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -166.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -106.88 124.26 49.36 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.364 1.066 . . . . 0.0 110.681 -165.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.9 107.17 17.91 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -177.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -89.96 -103.23 0.09 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 118.24 -0.886 . . . . 0.0 109.271 -174.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -90.5 -106.41 1.3 Allowed Glycine 0 N--CA 1.485 1.937 0 CA-C-N 119.942 1.246 . . . . 0.0 111.803 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -102.72 56.87 0.77 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.097 0.475 . . . . 0.0 110.437 165.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.2 pt -142.5 -170.66 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.574 1.866 0 C-N-CA 124.557 1.143 . . . . 0.0 108.879 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.4 tt -148.73 125.13 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 120.526 -1.359 . . . . 0.0 107.885 155.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 55.9 m -93.15 96.27 9.92 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 174.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.81 101.6 13.22 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -174.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.2 m -105.17 92.12 4.08 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -165.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 16.8 mtp -91.95 102.48 15.05 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.487 0.715 . . . . 0.0 109.5 -177.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 60.7 p -97.18 104.05 16.04 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -171.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.2 tp -90.89 80.63 5.78 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 176.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.22 -97.67 0.68 Allowed Glycine 0 CA--C 1.546 1.993 0 O-C-N 122.297 -0.252 . . . . 0.0 113.046 -171.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -102.27 -12.37 18.02 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 171.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 95.1 mt -85.84 106.36 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-N 120.854 1.661 . . . . 0.0 107.467 -175.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 96.8 t -94.91 98.73 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -173.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -84.6 94.84 8.7 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.331 0.586 . . . . 0.0 109.554 176.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -96.14 109.36 21.81 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.787 -175.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 30.7 mtm180 -104.62 107.89 19.06 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.0 mp -96.47 107.13 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.2 m -131.1 114.34 15.02 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -164.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -75.33 131.4 40.25 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.595 0.758 . . . . 0.0 112.623 -168.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -74.34 117.6 16.33 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.936 0.895 . . . . 0.0 110.643 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.9 pt . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 -168.601 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.8 p . . . . . 0 CA--C 1.549 0.937 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -86.17 -4.31 59.14 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 -175.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.5 m -74.41 104.61 5.21 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 121.605 2.002 . . . . 0.0 110.918 175.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.55 148.93 8.66 Favored Glycine 0 CA--C 1.542 1.765 0 CA-C-O 121.84 0.689 . . . . 0.0 113.201 -173.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -102.6 110.1 21.93 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -112.34 105.01 13.19 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -163.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -91.93 137.12 32.62 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.151 0.501 . . . . 0.0 111.322 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.1 tp -72.48 117.62 14.37 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.553 0.741 . . . . 0.0 112.342 -169.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -100.39 -61.96 1.3 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.54 0.736 . . . . 0.0 110.992 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.3 m -119.61 148.86 42.84 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.79 0.836 . . . . 0.0 110.058 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -142.59 134.6 27.2 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 122.039 0.923 . . . . 0.0 109.95 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -87.88 -67.94 0.79 Allowed 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.546 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 50.0 m-20 -120.93 68.9 0.88 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 118.534 0.606 . . . . 0.0 110.711 -175.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -76.46 -54.38 6.8 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.377 0.671 . . . . 0.0 112.335 172.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.44 -49.22 77.69 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 178.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.39 -40.1 85.5 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -67.02 -52.9 36.66 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 175.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -58.94 -51.85 68.28 Favored 'General case' 0 CA--C 1.562 1.423 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -58.02 -38.64 76.59 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 171.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.04 -29.81 69.71 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 116.909 2.189 . . . . 0.0 116.909 174.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.271 46.4 pt -80.65 -54.34 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-N 119.868 1.213 . . . . 0.0 111.768 171.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.83 67.06 0.01 OUTLIER Glycine 0 CA--C 1.543 1.795 0 CA-C-N 119.264 0.938 . . . . 0.0 112.971 170.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.75 154.85 55.15 Favored Pre-proline 0 CA--C 1.57 1.744 0 C-N-CA 123.653 0.781 . . . . 0.0 111.839 -175.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -76.36 152.03 34.17 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 123.326 2.684 . . . . 0.0 113.844 176.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -56.72 -37.2 70.62 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 171.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -64.01 -54.28 36.79 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.8 mt -67.0 -23.77 65.96 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 116.716 2.117 . . . . 0.0 116.716 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 74.9 mt -68.72 -55.43 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 124.176 0.99 . . . . 0.0 110.663 169.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -64.87 -25.64 67.98 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 116.893 2.183 . . . . 0.0 116.893 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -74.8 -59.7 2.61 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 119.346 0.975 . . . . 0.0 111.681 168.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.48 -11.72 60.12 Favored Glycine 0 CA--C 1.553 2.417 0 N-CA-C 119.995 2.758 . . . . 0.0 119.995 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -71.27 -46.18 61.49 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 120.272 2.036 . . . . 0.0 114.174 170.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -69.83 -35.66 74.95 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 170.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.2 mt -73.89 126.19 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.27 105.44 16.64 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -85.53 129.57 9.38 Favored Glycine 0 CA--C 1.54 1.614 0 CA-C-N 116.338 -0.392 . . . . 0.0 113.3 -174.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.9 t -85.72 113.49 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.2 t -99.86 112.26 24.53 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 172.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -88.59 151.68 22.33 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 114.614 -1.176 . . . . 0.0 110.309 175.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.2 mt -142.97 131.39 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 166.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.3 t -114.98 109.3 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -78.1 117.6 19.55 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.999 0.52 . . . . 0.0 110.908 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -129.58 62.85 1.53 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.818 169.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.9 -108.69 2.57 Favored Glycine 0 CA--C 1.547 2.035 0 O-C-N 121.614 -0.679 . . . . 0.0 113.714 -177.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -74.18 -42.96 59.03 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 169.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -73.96 121.48 21.08 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 119.24 0.927 . . . . 0.0 111.236 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -122.27 97.11 5.32 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -84.86 100.27 11.47 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 121.676 0.751 . . . . 0.0 109.569 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -87.9 137.91 31.92 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.386 174.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.1 m -128.15 89.46 2.92 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 173.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.0 tt -91.66 119.53 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 121.37 0.605 . . . . 0.0 109.643 -176.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.3 p -103.59 103.25 13.17 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.85 80.47 1.64 Allowed 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.534 0.683 . . . . 0.0 110.89 -174.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.29 60.58 8.33 Favored Glycine 0 CA--C 1.547 2.086 0 N-CA-C 115.865 1.106 . . . . 0.0 115.865 -175.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.0 m 54.76 60.36 3.55 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -166.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -152.31 97.83 2.33 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.8 t -92.12 104.44 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -166.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.3 mm -110.31 104.24 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 -177.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -119.37 119.72 34.78 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -170.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -144.96 148.03 33.35 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.531 0.733 . . . . 0.0 109.231 173.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.97 122.28 46.92 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.536 0.734 . . . . 0.0 110.724 175.091 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -101.9 134.32 45.29 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 121.619 0.723 . . . . 0.0 111.38 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.1 m -97.97 131.18 44.64 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 175.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.5 t -82.18 119.07 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 174.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.99 0.71 71.05 Favored Glycine 0 CA--C 1.557 2.701 0 N-CA-C 119.063 2.385 . . . . 0.0 119.063 -170.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -144.21 138.14 27.84 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 120.176 1.988 . . . . 0.0 109.079 166.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.66 123.32 21.6 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.37 0.605 . . . . 0.0 112.45 -176.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 99.7 m -108.95 150.9 27.05 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.614 171.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.85 115.08 22.08 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.948 175.001 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.4 mt -131.42 128.13 38.9 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 122.812 0.445 . . . . 0.0 109.91 -162.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -79.65 134.84 36.44 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.721 0.772 . . . . 0.0 111.317 174.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.8 p -76.29 -75.22 0.2 Allowed 'General case' 0 CA--C 1.562 1.43 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.658 176.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 57.1 tpp -128.96 -77.0 0.56 Allowed 'General case' 0 CA--C 1.561 1.368 0 CA-C-N 118.904 0.775 . . . . 0.0 109.757 -173.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.1 p -92.73 -60.74 1.74 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 118.279 -0.867 . . . . 0.0 113.013 -169.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -163.51 78.11 0.15 Allowed Glycine 0 N--CA 1.48 1.592 0 CA-C-N 119.536 1.062 . . . . 0.0 114.188 -176.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -138.47 169.06 18.46 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.851 0.86 . . . . 0.0 109.622 163.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -142.08 108.38 5.27 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 162.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.1 p -116.58 132.71 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.011 0.925 . . . . 0.0 109.23 -171.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -84.03 112.22 20.0 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.243 0.617 . . . . 0.0 109.976 -171.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.0 t -145.16 149.5 35.08 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.407 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.3 p -112.31 136.37 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 CA-C-O 122.538 1.161 . . . . 0.0 108.506 174.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.08 139.2 18.51 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 CA-C-N 113.931 -1.486 . . . . 0.0 108.166 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -111.61 133.26 54.0 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.4 tp -94.0 107.87 19.74 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -87.84 114.27 24.29 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 170.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.72 -119.12 8.07 Favored Glycine 0 CA--C 1.543 1.826 0 CA-C-N 114.52 -1.218 . . . . 0.0 113.635 -175.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -126.85 -5.45 6.29 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 171.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -123.42 -13.33 7.63 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.342 2.349 . . . . 0.0 117.342 -173.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -116.91 94.36 4.56 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-N 121.493 1.951 . . . . 0.0 110.351 -166.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 39.4 mt -93.19 107.31 19.14 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.557 0.743 . . . . 0.0 110.008 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 29.8 m -106.77 131.34 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 123.937 0.895 . . . . 0.0 110.801 -171.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.1 t -153.74 145.12 23.08 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.6 p -109.89 110.06 20.9 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 174.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -76.14 -87.45 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.235 0.614 . . . . 0.0 110.957 -177.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -112.81 -74.56 0.63 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 174.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -129.05 65.08 1.45 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 154.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.4 mp -137.96 103.31 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 176.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -92.04 94.21 9.14 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -95.09 110.61 22.52 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.59 -167.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.0 t -107.2 100.6 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 -177.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.6 m -96.24 91.25 5.8 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -172.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -87.99 141.83 28.27 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.914 0.885 . . . . 0.0 110.46 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 tt -121.91 102.95 8.5 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 172.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -81.07 -82.11 0.12 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.123 0.569 . . . . 0.0 110.988 -168.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.65 -103.63 2.26 Favored Glycine 0 N--CA 1.482 1.739 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 176.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -111.66 54.02 0.7 Allowed 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.676 0.75 . . . . 0.0 109.833 159.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.4 pp -149.75 136.49 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -175.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.9 tt -108.11 117.4 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.4 m -103.92 98.58 8.4 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 177.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -93.79 116.33 28.79 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.5 m -113.14 94.23 4.79 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -170.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 27.2 mtt -94.2 99.06 11.39 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.735 0.814 . . . . 0.0 109.381 -177.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.4 p -90.94 107.0 18.91 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.246 -174.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.3 tp -101.41 79.86 2.02 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.43 -100.97 1.01 Allowed Glycine 0 CA--C 1.545 1.908 0 CA-C-N 116.579 -0.282 . . . . 0.0 112.772 -171.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -103.1 -6.07 22.63 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 169.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 76.3 mt -87.18 103.86 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 120.668 1.576 . . . . 0.0 106.914 -176.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 49.1 t -93.8 96.58 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -84.83 93.59 8.53 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.199 0.523 . . . . 0.0 109.774 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -99.17 103.02 14.87 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.552 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -107.12 122.86 47.33 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.876 0.87 . . . . 0.0 109.141 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.0 mp -111.16 107.92 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 -171.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.3 m -118.91 119.93 35.78 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -175.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -89.85 141.91 28.19 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.659 0.742 . . . . 0.0 111.414 -174.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 33.3 ttm-85 -66.63 124.76 23.74 Favored 'General case' 0 CA--C 1.559 1.316 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.263 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 16.6 pt . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 123.05 1.405 . . . . 0.0 108.542 -176.638 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 . . . . . 0 N--CA 1.494 1.765 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.6 m -76.82 101.82 6.04 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 121.43 1.923 . . . . 0.0 111.004 -176.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.75 168.19 39.0 Favored Glycine 0 CA--C 1.546 2.011 0 CA-C-O 122.34 0.966 . . . . 0.0 112.86 -172.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.69 97.39 5.61 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -173.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -100.55 105.54 16.98 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -160.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -92.13 138.93 31.13 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.557 0.694 . . . . 0.0 111.612 -175.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.0 tp -65.86 130.17 42.34 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.304 1.042 . . . . 0.0 113.389 -172.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -109.37 -65.53 1.14 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.069 0.948 . . . . 0.0 109.745 -178.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.5 t -127.36 121.2 30.35 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.895 0.878 . . . . 0.0 108.94 -176.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -114.93 120.13 38.89 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -79.51 -70.44 0.51 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 118.485 -0.769 . . . . 0.0 112.789 -171.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 46.7 m-20 -121.64 73.82 1.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 118.848 0.749 . . . . 0.0 110.774 -170.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -81.98 -46.37 14.08 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 172.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -59.03 -50.02 75.66 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 172.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.08 -38.28 90.54 Favored 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 116.636 2.087 . . . . 0.0 116.636 175.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -77.54 -51.21 11.07 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -43.71 98.21 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -65.04 -35.65 81.86 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 168.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.6 -30.46 70.7 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 169.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.266 24.7 pt -88.59 -59.55 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-N 119.717 1.144 . . . . 0.0 111.214 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.01 71.55 0.01 OUTLIER Glycine 0 CA--C 1.54 1.644 0 CA-C-N 118.642 0.655 . . . . 0.0 111.909 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.93 153.28 78.51 Favored Pre-proline 0 CA--C 1.571 1.768 0 C-N-CA 123.617 0.767 . . . . 0.0 111.675 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.95 151.05 30.67 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 123.254 2.636 . . . . 0.0 114.048 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -59.48 -31.82 69.69 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 116.623 2.083 . . . . 0.0 116.623 170.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -61.73 -51.1 69.75 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 117.301 -1.333 . . . . 0.0 114.583 170.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.7 mt -68.36 -23.81 64.72 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 173.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 84.9 mt -68.42 -55.0 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 124.356 1.062 . . . . 0.0 111.197 170.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -66.1 -23.05 66.43 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -77.52 -56.5 4.48 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 124.356 1.063 . . . . 0.0 112.037 170.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.37 -15.54 70.42 Favored Glycine 0 CA--C 1.553 2.454 0 N-CA-C 119.667 2.627 . . . . 0.0 119.667 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -65.45 -44.04 88.48 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 120.317 2.058 . . . . 0.0 114.654 168.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -67.65 -35.96 79.86 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 170.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 53.3 mt -75.43 122.24 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -86.34 107.27 17.91 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 174.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.56 130.9 10.3 Favored Glycine 0 CA--C 1.54 1.621 0 CA-C-N 116.178 -0.465 . . . . 0.0 113.561 -173.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.1 t -80.8 114.85 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 71.0 m -104.62 99.37 9.04 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -81.66 145.53 30.52 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.532 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.2 mt -143.45 128.89 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 176.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 87.4 t -124.02 107.42 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 178.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -88.26 122.07 31.38 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.548 0.689 . . . . 0.0 109.444 170.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -87.35 -60.49 1.96 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.406 159.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.56 -88.94 0.07 OUTLIER Glycine 0 N--CA 1.476 1.312 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 170.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -74.0 -39.6 63.51 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 164.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -75.23 135.61 40.99 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 119.897 1.226 . . . . 0.0 111.527 176.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -134.12 108.5 8.34 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm -102.47 103.76 14.16 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -111.95 136.71 50.93 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.789 0.836 . . . . 0.0 110.537 -173.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.3 m -127.88 106.24 8.97 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -176.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.9 mm -97.21 120.14 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.5 p . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 174.713 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 90.4 mt . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -116.22 130.98 57.06 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.02 0.928 . . . . 0.0 110.478 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -143.01 173.65 11.37 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.872 0.869 . . . . 0.0 109.212 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -143.11 134.06 25.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.983 -1.073 . . . . 0.0 112.313 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -110.25 149.16 30.55 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.8 0.84 . . . . 0.0 111.315 172.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.1 m -108.55 125.45 51.83 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 169.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.9 t -69.5 123.9 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 C-N-CA 123.831 0.852 . . . . 0.0 109.595 -176.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.42 -44.58 2.11 Favored Glycine 0 CA--C 1.552 2.356 0 N-CA-C 116.857 1.503 . . . . 0.0 116.857 -172.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -102.42 132.67 48.29 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.277 1.031 . . . . 0.0 110.145 -173.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -50.81 134.73 24.98 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 116.466 2.025 . . . . 0.0 116.466 -172.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 20.6 p -133.71 137.84 45.5 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 122.187 0.994 . . . . 0.0 111.039 -174.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -96.13 95.21 8.0 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.22 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.1 mt . . . . . 0 N--CA 1.489 1.494 0 C-N-CA 123.591 0.756 . . . . 0.0 109.665 179.458 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 87.7 mttt . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 122.76 1.266 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.5 p -145.42 125.84 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.318 0 CA-C-N 113.925 -1.488 . . . . 0.0 107.659 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -83.04 107.62 15.76 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 171.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.402 HG21 ' CD2' ' A' ' 95' ' ' PHE . 6.9 t -155.72 105.8 2.44 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 -170.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.252 11.2 p -103.98 136.52 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-O 122.893 1.33 . . . . 0.0 110.718 -176.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.1 t -90.25 136.35 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 CA-C-N 113.346 -1.752 . . . . 0.0 108.742 -172.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -107.0 134.93 49.42 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 171.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 33.5 tp -105.06 110.07 22.31 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.23 -175.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -105.69 128.04 53.43 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.485 0.714 . . . . 0.0 109.198 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.53 7.51 64.74 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 121.344 3.297 . . . . 0.0 121.344 172.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.292 5.0 t70 54.91 45.62 26.13 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 -161.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -157.48 -44.64 0.07 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -92.81 125.6 37.49 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 120.086 1.312 . . . . 0.0 110.934 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.0 mt -111.29 102.05 10.49 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 170.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.1 m -109.05 126.6 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 C-N-CA 123.5 0.72 . . . . 0.0 109.533 -172.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.0 t -149.03 156.25 41.97 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.262 0.553 . . . . 0.0 112.29 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 89.4 m -112.5 105.42 13.64 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 175.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.402 ' CD2' HG21 ' A' ' 81' ' ' THR 0.266 36.7 t80 -91.3 -101.05 0.11 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.109 0.964 . . . . 0.0 108.928 -163.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -110.39 78.12 1.1 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 170.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.4 m120 50.32 42.15 25.44 Favored 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -166.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 23.4 mt -133.79 115.25 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 103.455 -2.795 . . . . 0.0 103.455 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -85.73 93.92 8.98 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 174.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.4 t -86.37 96.25 9.94 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.821 0.849 . . . . 0.0 109.901 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 62.3 t -104.19 105.04 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 -174.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 62.9 m -116.24 90.84 3.43 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -168.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -96.12 140.53 30.7 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.132 0.573 . . . . 0.0 110.906 -172.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 tt -105.94 110.56 22.88 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -110.94 91.77 3.79 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -178.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.52 -110.7 3.1 Favored Glycine 0 CA--C 1.544 1.857 0 CA-C-O 119.757 -0.468 . . . . 0.0 113.407 176.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -118.86 52.63 1.04 Allowed 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.272 0.558 . . . . 0.0 111.686 171.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.7 pt -134.87 -166.21 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.783 0 C-N-CA 124.554 1.142 . . . . 0.0 108.136 166.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.3 tt -157.94 126.34 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 O-C-N 120.352 -1.467 . . . . 0.0 107.426 159.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 t -83.44 149.5 26.62 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 120.627 0.251 . . . . 0.0 110.724 164.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -133.83 97.12 3.82 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 169.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.3 m -104.2 91.46 3.94 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -173.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 40.2 mtt -93.79 103.34 15.48 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.211 1.004 . . . . 0.0 109.078 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 75.1 p -99.98 106.57 18.38 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -172.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 42.0 tp -102.95 82.26 2.08 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.94 -99.81 0.88 Allowed Glycine 0 CA--C 1.545 1.925 0 N-CA-C 114.326 0.49 . . . . 0.0 114.326 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -89.72 -25.8 21.0 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 171.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 14.0 mm -67.2 138.76 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.651 0 C-N-CA 125.057 1.343 . . . . 0.0 109.751 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.95 93.94 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 172.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -87.65 98.92 11.69 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.487 0.715 . . . . 0.0 109.752 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -108.9 104.97 14.31 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 123.605 0.566 . . . . 0.0 110.056 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -85.59 142.19 29.29 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.522 164.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -125.41 105.56 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 103.37 -2.826 . . . . 0.0 103.37 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 62.5 m -120.84 120.86 36.78 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.168 0.587 . . . . 0.0 109.459 -174.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -86.03 139.93 30.73 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.317 0.647 . . . . 0.0 111.941 -170.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -69.59 113.9 7.3 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.662 0.785 . . . . 0.0 111.741 -176.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.5 mt . . . . . 0 N--CA 1.482 1.173 0 N-CA-C 102.428 -3.175 . . . . 0.0 102.428 -163.424 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 . . . . . 0 N--CA 1.495 1.812 0 N-CA-C 117.711 2.486 . . . . 0.0 117.711 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.2 m -69.73 107.74 3.61 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 120.857 1.662 . . . . 0.0 110.909 176.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.97 162.11 24.5 Favored Glycine 0 CA--C 1.544 1.873 0 CA-C-O 122.425 1.014 . . . . 0.0 114.233 -171.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -105.36 115.43 30.24 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -113.64 98.49 7.08 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 -169.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -93.51 138.91 31.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.936 -0.478 . . . . 0.0 111.067 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.1 tp -63.82 137.96 58.27 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -171.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -121.57 -64.8 1.19 Allowed 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.536 -175.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.8 t -128.77 115.36 17.83 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.617 0.767 . . . . 0.0 109.263 -174.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -105.3 128.72 53.6 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.958 0.903 . . . . 0.0 109.654 175.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -88.52 -70.18 0.66 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.607 -177.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -114.63 68.66 0.7 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.278 0.631 . . . . 0.0 110.398 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -74.61 -52.32 12.07 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 118.496 -0.764 . . . . 0.0 112.448 169.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -63.39 -47.61 81.3 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -173.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.5 -39.67 94.21 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 171.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -66.52 -50.95 61.49 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 176.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 20.7 mmt -62.72 -42.17 99.53 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -175.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -61.75 -45.31 94.45 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 168.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.5 -29.63 70.69 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.262 39.5 pt -76.02 -53.43 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 119.901 1.228 . . . . 0.0 112.132 170.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.31 67.77 0.01 OUTLIER Glycine 0 CA--C 1.538 1.493 0 CA-C-O 118.887 -0.952 . . . . 0.0 112.33 173.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.8 mt -130.06 141.28 41.32 Favored Pre-proline 0 CA--C 1.568 1.637 0 CA-C-N 117.918 0.859 . . . . 0.0 110.561 175.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.66 151.62 84.08 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 123.306 2.671 . . . . 0.0 114.034 172.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -49.93 -37.21 30.77 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 116.5 2.037 . . . . 0.0 116.5 172.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -63.11 -51.06 68.05 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 169.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.5 mt -70.98 -14.31 62.31 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 174.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.3 mt -71.66 -54.68 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-N 120.191 1.36 . . . . 0.0 110.267 166.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -64.2 -27.1 68.83 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 174.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -79.96 -49.47 11.81 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 119.612 1.096 . . . . 0.0 112.594 170.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.55 -24.72 68.08 Favored Glycine 0 CA--C 1.551 2.314 0 N-CA-C 118.951 2.34 . . . . 0.0 118.951 174.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -65.2 -44.42 88.43 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-N 120.509 2.154 . . . . 0.0 114.194 167.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -66.94 -31.4 71.95 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 171.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.0 mt -75.69 107.18 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 172.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.33 105.25 17.44 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -172.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.0 127.97 8.58 Favored Glycine 0 CA--C 1.54 1.618 0 N-CA-C 115.036 0.774 . . . . 0.0 115.036 -160.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.2 t -81.13 116.45 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 172.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.4 m -106.65 105.41 15.42 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -79.62 143.06 35.04 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 121.865 0.841 . . . . 0.0 110.782 175.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 54.2 mt -142.02 124.18 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 103.676 -2.713 . . . . 0.0 103.676 170.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.6 t -122.1 103.72 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -89.82 127.79 36.04 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 121.202 0.525 . . . . 0.0 110.252 176.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -126.72 82.25 2.07 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 165.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.91 -123.62 10.99 Favored Glycine 0 CA--C 1.547 2.058 0 C-N-CA 123.286 0.469 . . . . 0.0 113.939 -176.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -73.62 -35.15 65.3 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 169.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -73.44 147.88 43.78 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 122.724 1.249 . . . . 0.0 111.731 176.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -137.91 148.9 45.74 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 113.613 -1.63 . . . . 0.0 109.498 -177.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.21 110.98 8.71 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 164.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -104.05 147.38 27.46 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.069 172.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.5 m -135.59 92.53 2.84 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.0 tt -96.14 126.88 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 123.437 0.695 . . . . 0.0 109.809 -177.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.6 p . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 175.016 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.7 mt . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -118.33 137.02 53.37 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.296 0.638 . . . . 0.0 111.224 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -137.81 145.98 42.97 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.941 0.877 . . . . 0.0 109.786 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -106.28 128.18 53.79 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.251 169.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -134.75 159.48 41.18 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.722 0.773 . . . . 0.0 111.479 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.5 m -124.2 131.83 53.56 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 173.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.9 m -74.11 130.41 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 123.582 0.753 . . . . 0.0 111.7 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.38 -48.21 1.72 Allowed Glycine 0 CA--C 1.549 2.206 0 N-CA-C 114.964 0.746 . . . . 0.0 114.964 -168.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -67.7 146.44 53.79 Favored 'General case' 0 CA--C 1.564 1.517 0 C-N-CA 124.536 1.134 . . . . 0.0 112.159 172.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -78.86 92.2 4.85 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.872 0.869 . . . . 0.0 109.615 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 25.5 p -107.2 140.08 40.62 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -154.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -67.23 127.49 32.85 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.635 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.5 mt . . . . . 0 N--CA 1.486 1.339 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -178.257 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.2 mptt . . . . . 0 N--CA 1.486 1.349 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.2 m -92.67 126.09 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.379 -177.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -84.6 96.37 9.16 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.5 p -138.34 125.45 21.45 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -162.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.6 t -85.6 125.22 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -160.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.0 t -100.59 118.97 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -99.71 134.27 42.84 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.735 0.779 . . . . 0.0 109.754 176.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.1 tp -101.53 112.31 24.82 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.443 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -118.08 121.28 40.17 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.37 12.76 66.81 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 121.215 3.246 . . . . 0.0 121.215 175.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.302 9.0 t70 52.16 48.75 22.06 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -162.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -155.6 -43.34 0.08 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 117.651 -1.166 . . . . 0.0 113.584 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -98.73 122.0 41.39 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 120.469 1.486 . . . . 0.0 110.373 -175.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 77.3 mt -110.69 98.95 7.99 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 168.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.7 m -103.71 124.57 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 123.707 0.803 . . . . 0.0 109.525 -172.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.1 t -148.22 132.39 17.36 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.047 0.451 . . . . 0.0 110.971 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.7 p -95.66 119.83 34.85 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 172.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -84.64 -85.05 0.14 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.074 0.55 . . . . 0.0 109.909 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.74 -75.28 0.59 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 167.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -100.89 -19.07 16.07 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 167.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 mp -82.03 115.99 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-N 120.275 1.398 . . . . 0.0 108.106 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -99.31 101.78 13.19 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 168.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.9 t -85.66 99.4 11.27 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.617 0.767 . . . . 0.0 110.458 -177.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 70.2 t -99.52 97.76 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.7 m -105.52 86.24 2.38 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -166.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -97.04 131.6 43.68 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.888 0.875 . . . . 0.0 110.106 -171.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 tt -101.68 106.28 17.29 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -175.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -106.18 86.66 2.4 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -172.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.74 -108.09 2.68 Favored Glycine 0 N--CA 1.482 1.74 0 O-C-N 122.101 -0.374 . . . . 0.0 112.882 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -121.46 52.65 1.22 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.314 0.578 . . . . 0.0 111.615 170.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.5 pt -131.21 -163.17 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 C-N-CA 124.337 1.055 . . . . 0.0 108.163 163.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.3 tt -154.88 119.57 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 120.363 -1.46 . . . . 0.0 107.952 157.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 29.3 m -95.06 101.02 12.75 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -94.81 99.34 11.43 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 30.3 m -101.93 91.17 4.24 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -172.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 36.3 mtt -93.17 103.36 15.64 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.224 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.3 p -97.86 95.94 7.87 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.489 -171.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 19.3 tp -93.72 81.97 4.3 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.723 0.809 . . . . 0.0 109.079 177.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.8 -101.95 1.16 Allowed Glycine 0 CA--C 1.544 1.879 0 CA-C-N 116.191 -0.458 . . . . 0.0 113.043 -174.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -98.06 -11.52 22.84 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 170.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 62.4 mt -86.71 106.46 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -174.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.9 t -98.84 94.17 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -175.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -82.3 92.73 7.0 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.231 0.613 . . . . 0.0 109.659 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -92.41 109.47 20.86 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.3 ttt-85 -118.23 104.9 11.23 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -164.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.9 mp -98.44 116.33 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 105.593 -2.002 . . . . 0.0 105.593 -172.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.9 m -130.33 115.14 16.51 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -176.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -87.38 137.33 32.43 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.228 0.611 . . . . 0.0 112.135 -168.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.3 ttt85 -67.58 124.88 24.46 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 123.914 0.886 . . . . 0.0 111.524 177.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.5 pt . . . . . 0 N--CA 1.484 1.258 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 -172.576 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 . . . . . 0 N--CA 1.495 1.801 0 N-CA-C 117.027 2.232 . . . . 0.0 117.027 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.7 m -73.29 109.21 6.64 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 120.704 1.593 . . . . 0.0 110.648 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.15 162.21 23.09 Favored Glycine 0 CA--C 1.544 1.877 0 CA-C-O 122.306 0.948 . . . . 0.0 114.134 -171.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -97.18 125.88 41.98 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 114.402 -0.899 . . . . 0.0 108.605 175.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -121.52 104.37 9.6 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -172.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -95.62 137.85 34.11 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.129 0.49 . . . . 0.0 110.892 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.7 tp -66.11 130.69 44.11 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.082 0.953 . . . . 0.0 112.987 -173.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -114.64 -64.79 1.26 Allowed 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.879 -175.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.7 m -125.49 112.05 15.78 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -105.74 110.4 22.69 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -97.41 127.42 43.36 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.263 85.5 m-20 67.4 52.51 0.8 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 173.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -78.65 -43.95 24.94 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 168.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -68.65 -50.86 47.83 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -175.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.91 -40.74 85.44 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 170.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -69.44 -56.54 7.13 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -44.24 96.61 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -61.96 -38.13 87.37 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 170.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.66 -34.39 77.74 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.819 2.155 . . . . 0.0 116.819 172.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.5 pt -82.33 -53.8 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 CA-C-N 119.327 0.967 . . . . 0.0 112.384 176.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.52 68.68 0.01 OUTLIER Glycine 0 CA--C 1.539 1.535 0 CA-C-N 119.017 0.826 . . . . 0.0 112.894 172.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.32 153.11 81.56 Favored Pre-proline 0 CA--C 1.57 1.721 0 C-N-CA 123.513 0.725 . . . . 0.0 111.813 175.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.81 152.84 25.53 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 123.264 2.643 . . . . 0.0 113.489 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -59.18 -28.84 66.99 Favored 'General case' 0 CA--C 1.565 1.526 0 N-CA-C 116.723 2.119 . . . . 0.0 116.723 168.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -63.02 -51.81 65.35 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 120.543 1.52 . . . . 0.0 114.055 170.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.4 mt -67.93 -28.28 67.35 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 116.604 2.075 . . . . 0.0 116.604 173.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.3 mt -70.38 -49.94 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 C-N-CA 124.297 1.039 . . . . 0.0 111.621 173.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -64.23 -22.62 67.01 Favored 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 116.315 1.969 . . . . 0.0 116.315 170.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -73.08 -57.99 3.63 Favored 'General case' 0 CA--C 1.565 1.519 0 CA-C-N 119.272 0.942 . . . . 0.0 111.74 167.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.5 -22.16 67.46 Favored Glycine 0 CA--C 1.548 2.143 0 N-CA-C 120.418 2.927 . . . . 0.0 120.418 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -64.68 -43.53 93.24 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 119.661 1.731 . . . . 0.0 114.64 170.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -67.24 -27.85 67.57 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 168.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 53.1 mt -83.03 121.75 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-N 120.144 1.338 . . . . 0.0 107.506 178.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.64 102.46 15.09 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 173.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.54 132.74 11.42 Favored Glycine 0 CA--C 1.541 1.707 0 N-CA-C 114.509 0.564 . . . . 0.0 114.509 -167.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.3 t -85.33 110.21 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 54.2 p -109.79 112.16 24.03 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.5 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -89.63 152.32 21.44 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 121.632 0.729 . . . . 0.0 111.058 -177.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.2 mt -136.35 132.8 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 105.437 -2.06 . . . . 0.0 105.437 173.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.6 t -126.57 102.77 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -80.18 120.7 24.65 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.122 0.569 . . . . 0.0 110.148 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -122.99 73.0 1.12 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 169.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.83 -117.48 7.56 Favored Glycine 0 CA--C 1.546 1.996 0 C-N-CA 123.117 0.389 . . . . 0.0 113.67 -175.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -76.87 -34.36 57.8 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 169.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -79.95 112.99 17.78 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 119.941 1.246 . . . . 0.0 110.761 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -105.74 117.98 35.42 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -104.12 104.65 14.62 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 176.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -133.29 134.45 43.9 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.297 -166.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.96 147.71 22.84 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.669 0.747 . . . . 0.0 110.029 165.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.0 tp -130.68 121.91 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.5 m . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 172.74 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.3 tt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.857 0.837 . . . . 0.0 109.361 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -94.81 125.48 39.49 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.774 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -127.38 159.19 35.21 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 124.007 0.923 . . . . 0.0 110.257 -177.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -139.34 136.69 35.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.543 -0.723 . . . . 0.0 110.244 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.493 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 28.5 p90 -126.96 159.71 33.23 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 122.012 0.91 . . . . 0.0 112.324 167.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 96.3 m -116.07 139.7 50.03 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 163.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.6 t -75.62 123.35 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.13 34.21 21.49 Favored Glycine 0 CA--C 1.549 2.198 0 N-CA-C 117.044 1.578 . . . . 0.0 117.044 -168.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -149.89 138.57 20.83 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -177.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -69.32 105.71 2.65 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.176 0.512 . . . . 0.0 109.954 160.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 63' ' ' PHE . 3.2 p -129.25 131.76 47.09 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 122.402 1.096 . . . . 0.0 110.649 -162.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -79.65 123.75 27.92 Favored 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 113.962 -1.472 . . . . 0.0 112.631 -168.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.8 mt . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 -177.926 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.302 0 CA-C-O 121.045 0.45 . . . . 0.0 110.676 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.9 p -140.12 121.19 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -169.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -92.85 123.63 36.26 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.189 0.596 . . . . 0.0 109.985 -175.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.2 p -132.84 128.65 37.13 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -164.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.5 t -93.39 108.68 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -175.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.3 t -96.56 127.09 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -172.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -115.52 132.16 56.71 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 168.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.9 tp -98.67 108.62 21.36 Favored 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -102.79 125.5 49.56 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.78 0.8 . . . . 0.0 109.159 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.09 11.13 66.57 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 121.173 3.229 . . . . 0.0 121.173 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.274 25.9 m-20 57.77 43.52 21.77 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -166.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -158.65 -38.79 0.06 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 117.744 -1.122 . . . . 0.0 114.0 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -103.99 119.33 38.71 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 120.458 1.481 . . . . 0.0 110.411 -172.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.6 mt -101.03 99.46 9.92 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 174.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.1 t -100.68 110.59 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -170.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.6 t -137.26 159.58 41.51 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 122.863 1.316 . . . . 0.0 113.629 -167.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 58.9 m -80.47 -78.42 0.17 Allowed 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.914 -161.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 65.0 171.38 0.2 Allowed 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 119.613 1.097 . . . . 0.0 113.749 -169.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -79.21 95.06 5.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.195 -0.94 . . . . 0.0 108.569 165.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 55.8 t30 47.44 47.41 17.16 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.9 mt -137.81 88.54 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 102.926 -2.99 . . . . 0.0 102.926 174.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -84.5 98.41 10.09 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -174.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.9 t -96.62 117.65 31.42 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.933 -165.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 56.1 t -113.36 101.83 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 104.832 -2.285 . . . . 0.0 104.832 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.7 m -98.36 83.96 3.14 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -89.99 130.97 36.12 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.967 0.907 . . . . 0.0 110.214 -172.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 tt -101.27 110.38 22.38 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -110.68 85.52 2.13 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -174.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.82 -108.31 2.72 Favored Glycine 0 N--CA 1.483 1.771 0 O-C-N 122.081 -0.387 . . . . 0.0 112.952 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -121.36 56.5 1.04 Allowed 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.337 0.589 . . . . 0.0 111.188 168.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.8 pt -131.39 -166.11 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.687 0 C-N-CA 124.331 1.052 . . . . 0.0 108.522 161.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.6 tt -154.62 123.04 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.305 0 O-C-N 120.196 -1.565 . . . . 0.0 108.545 158.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 46.1 m -101.64 103.13 13.92 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 -176.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -93.0 98.56 11.43 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.5 m -99.34 87.25 3.58 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.662 0.744 . . . . 0.0 109.018 -171.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 33.5 mtt -92.46 105.43 17.61 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.129 0.972 . . . . 0.0 109.704 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.9 p -98.89 101.27 12.61 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -172.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.5 tp -95.25 83.77 3.93 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.57 -97.31 0.78 Allowed Glycine 0 CA--C 1.543 1.83 0 CA-C-N 116.437 -0.347 . . . . 0.0 112.685 -171.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -106.95 -9.3 16.31 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.319 1.599 . . . . 0.0 115.319 169.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 48.5 mt -85.75 107.31 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-N 120.692 1.587 . . . . 0.0 107.091 -173.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.3 t -94.7 95.61 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -174.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -86.74 100.75 12.72 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.905 0.882 . . . . 0.0 109.245 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -111.18 107.72 17.15 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.76 -172.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -99.72 114.33 27.37 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 75.6 mt -102.75 103.09 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 -177.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.4 m -120.47 114.98 22.58 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -171.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -84.2 135.83 34.2 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.172 0.589 . . . . 0.0 112.168 -168.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -69.91 133.46 47.35 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-O 122.014 0.912 . . . . 0.0 112.184 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.7 pt . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 -172.281 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.365 90.7 m-85 . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 117.381 2.363 . . . . 0.0 117.381 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.9 m -71.94 107.22 4.57 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 120.496 1.498 . . . . 0.0 111.248 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.69 161.31 24.28 Favored Glycine 0 CA--C 1.544 1.88 0 CA-C-O 122.652 1.14 . . . . 0.0 114.044 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -96.58 125.67 41.21 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 168.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -121.05 116.66 25.45 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -174.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -91.83 125.78 36.67 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 122.943 0.497 . . . . 0.0 110.092 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 28.6 tp -64.02 131.79 48.64 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.75 0.82 . . . . 0.0 112.781 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -126.33 -58.22 1.36 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 118.569 -0.729 . . . . 0.0 110.742 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.8 m -107.35 136.99 46.22 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 119.067 0.849 . . . . 0.0 109.664 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -139.53 106.35 5.4 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -96.47 134.2 39.95 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.081 0.952 . . . . 0.0 109.365 176.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.26 13.5 m-20 66.67 47.65 1.55 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 174.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -77.82 -49.51 14.15 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 176.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -62.79 -46.78 86.41 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 177.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.74 -42.39 93.06 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 173.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -72.49 -52.8 14.17 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -52.09 66.81 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -56.92 -39.24 74.09 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 171.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.12 -37.48 87.59 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 116.588 2.069 . . . . 0.0 116.588 174.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.278 48.5 pt -77.36 -48.88 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-N 119.516 1.053 . . . . 0.0 112.955 175.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.81 57.72 0.01 OUTLIER Glycine 0 N--CA 1.483 1.815 0 CA-C-N 119.473 1.033 . . . . 0.0 114.5 166.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -110.3 154.03 43.1 Favored Pre-proline 0 CA--C 1.566 1.575 0 CA-C-N 118.009 0.904 . . . . 0.0 112.084 -175.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.16 154.93 33.0 Favored 'Trans proline' 0 CA--C 1.557 1.659 0 C-N-CA 123.296 2.664 . . . . 0.0 113.384 172.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -61.62 -35.49 78.04 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 170.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.05 -54.18 50.03 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 173.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.6 mt -70.97 -24.07 62.34 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 116.558 2.058 . . . . 0.0 116.558 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 60.6 mt -70.2 -52.14 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-N 119.94 1.245 . . . . 0.0 110.974 169.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -62.84 -19.7 64.36 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 116.912 2.19 . . . . 0.0 116.912 173.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -81.38 -53.91 5.91 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-N 119.483 1.038 . . . . 0.0 112.182 167.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.45 -7.2 57.36 Favored Glycine 0 CA--C 1.553 2.463 0 N-CA-C 120.279 2.872 . . . . 0.0 120.279 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.77 -47.03 61.73 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 120.21 2.005 . . . . 0.0 113.273 170.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -69.43 -31.91 70.56 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 168.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.2 mt -78.29 119.79 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -85.13 116.25 23.39 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.86 131.16 10.59 Favored Glycine 0 CA--C 1.54 1.608 0 CA-C-N 116.096 -0.502 . . . . 0.0 113.723 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.8 t -81.26 114.53 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 175.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.2 m -96.51 110.98 23.26 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 176.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.39 141.3 30.64 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.81 0.814 . . . . 0.0 109.954 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 67.2 mt -141.53 132.34 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 170.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.8 t -120.87 113.39 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 174.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -82.41 123.73 29.4 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.262 0.625 . . . . 0.0 110.168 173.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -128.07 72.02 1.4 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 163.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.88 -114.43 5.29 Favored Glycine 0 CA--C 1.545 1.933 0 C-N-CA 123.4 0.524 . . . . 0.0 113.385 -177.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -77.53 -33.51 54.22 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 167.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -76.54 102.94 6.27 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 120.072 1.305 . . . . 0.0 111.008 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -109.13 109.21 20.14 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.95 127.89 44.98 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 168.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -116.34 152.14 34.49 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.747 178.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.1 m -136.28 92.63 2.8 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 173.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.8 mm -91.12 116.61 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 -175.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.4 m . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -174.816 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.4 mt . . . . . 0 N--CA 1.493 1.706 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -117.09 130.72 56.83 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.768 0.827 . . . . 0.0 110.966 -176.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -148.31 149.13 31.27 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.553 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -118.4 128.36 54.55 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.826 0.85 . . . . 0.0 110.222 -176.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -116.12 144.47 44.11 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.962 0.905 . . . . 0.0 111.425 170.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.2 m -105.3 124.11 48.98 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 166.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.4 t -67.04 124.88 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 C-N-CA 123.735 0.814 . . . . 0.0 110.662 -174.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.18 -49.97 2.45 Favored Glycine 0 CA--C 1.549 2.167 0 N-CA-C 115.999 1.16 . . . . 0.0 115.999 -170.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -93.22 124.13 36.98 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.728 0.811 . . . . 0.0 110.231 -172.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -57.44 123.81 16.75 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 -168.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 72.6 m -144.08 146.53 32.88 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.099 0.96 . . . . 0.0 109.609 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -80.04 134.59 36.23 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.2 mt . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 175.107 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 49.5 mttm . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 122.393 1.092 . . . . 0.0 109.685 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.8 p -114.39 134.52 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 113.157 -1.838 . . . . 0.0 108.773 -164.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -78.02 106.39 9.85 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.14 0.576 . . . . 0.0 110.794 -171.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.6 t -152.64 130.81 11.94 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -173.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.25 145.26 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 123.374 1.559 . . . . 0.0 110.587 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.8 t -98.49 142.18 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.302 0 CA-C-N 112.985 -1.916 . . . . 0.0 108.347 -167.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -112.48 132.98 54.79 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 172.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.7 tp -98.07 109.71 22.42 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.841 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -95.65 114.93 26.73 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 122.127 0.965 . . . . 0.0 108.929 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.44 -128.64 10.65 Favored Glycine 0 CA--C 1.545 1.919 0 CA-C-N 114.019 -1.446 . . . . 0.0 112.265 -168.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -135.82 58.55 1.75 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 156.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -158.49 -32.0 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -173.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -114.39 106.21 14.03 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 120.925 1.693 . . . . 0.0 108.976 -174.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 42.4 mt -95.78 103.91 15.81 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.0 m -102.35 125.56 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 C-N-CA 123.372 0.669 . . . . 0.0 109.87 -172.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 t -149.66 151.43 33.71 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.324 0.583 . . . . 0.0 111.771 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 29.7 p -119.71 112.72 19.64 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.405 0.682 . . . . 0.0 109.215 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -83.38 37.43 0.56 Allowed 'General case' 0 CA--C 1.58 2.106 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 168.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.344 11.8 tmtt? 69.99 -81.04 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.952 1.301 . . . . 0.0 111.236 -163.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -81.14 -42.6 20.63 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.8 mp -85.64 123.05 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-N 119.585 1.084 . . . . 0.0 108.167 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -102.57 98.77 8.78 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 172.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.9 t -89.67 132.88 34.94 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.478 0.711 . . . . 0.0 110.958 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.1 t -132.95 102.3 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 20.6 m -93.14 95.71 9.58 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -80.84 145.21 31.51 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.111 0.964 . . . . 0.0 110.703 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.2 tt -128.35 109.37 11.38 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 174.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -113.21 80.49 1.36 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -175.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.93 -109.24 3.26 Favored Glycine 0 N--CA 1.484 1.861 0 O-C-N 121.835 -0.541 . . . . 0.0 113.068 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.47 50.39 0.95 Allowed 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 122.965 0.506 . . . . 0.0 111.362 173.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.6 pt -133.8 -168.74 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.786 0 C-N-CA 124.047 0.939 . . . . 0.0 108.938 171.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.1 tt -156.85 115.44 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.272 -1.517 . . . . 0.0 107.45 159.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 90.0 m -103.15 99.7 9.58 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -90.19 108.81 19.98 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 39.7 m -108.48 100.14 9.45 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 -173.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.8 mtt -101.28 100.39 10.89 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.2 p -88.65 113.38 24.16 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.009 -173.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.3 tp -117.87 75.43 1.0 Allowed 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.35 -107.4 2.34 Favored Glycine 0 CA--C 1.545 1.958 0 CA-C-N 116.404 -0.362 . . . . 0.0 112.369 -172.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -93.62 -10.7 33.7 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 167.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 61.8 mt -86.52 103.67 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -173.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 48.4 t -97.81 97.78 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -85.55 96.33 9.6 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.163 0.585 . . . . 0.0 109.446 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -105.26 101.67 11.19 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -176.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.6 113.98 27.22 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 50.2 mt -107.02 112.91 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -172.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 54.5 m -114.76 119.03 35.26 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 176.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -83.81 147.3 27.66 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.965 -0.459 . . . . 0.0 110.937 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -76.03 107.18 8.06 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 121.538 0.685 . . . . 0.0 111.295 -169.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.7 mt . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 102.336 -3.209 . . . . 0.0 102.336 -158.505 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 . . . . . 0 N--CA 1.494 1.743 0 N-CA-C 117.569 2.433 . . . . 0.0 117.569 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.2 m -69.39 112.26 5.81 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 120.822 1.646 . . . . 0.0 110.792 173.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.03 145.22 4.95 Favored Glycine 0 CA--C 1.541 1.675 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.062 -171.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -102.21 106.8 17.69 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -107.64 104.05 13.49 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -162.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -83.19 131.24 35.13 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.123 0.487 . . . . 0.0 111.633 -177.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.9 tp -76.14 115.71 16.13 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.675 -168.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -98.6 -65.24 0.97 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.507 0.723 . . . . 0.0 111.444 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.0 m -131.89 135.66 46.83 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.245 0.618 . . . . 0.0 110.336 -163.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -129.29 134.68 48.05 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.649 0.737 . . . . 0.0 109.799 -175.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -76.28 -58.55 3.22 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.356 171.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -127.35 68.94 1.29 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.584 0.629 . . . . 0.0 110.799 -176.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -75.12 -54.26 7.45 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.526 -0.734 . . . . 0.0 112.553 170.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -65.21 -49.55 69.3 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.22 -39.21 82.0 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 116.89 2.182 . . . . 0.0 116.89 174.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -65.96 -54.07 30.89 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 174.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 37.4 mtt -60.7 -45.61 93.52 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -55.67 -42.1 74.63 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 167.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.4 -34.47 78.02 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 117.06 2.244 . . . . 0.0 117.06 175.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.7 pt -78.48 -43.94 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-N 119.822 1.192 . . . . 0.0 113.599 175.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.36 62.78 0.09 OUTLIER Glycine 0 N--CA 1.481 1.664 0 CA-C-N 118.881 0.764 . . . . 0.0 112.682 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.42 151.33 46.8 Favored Pre-proline 0 CA--C 1.568 1.649 0 C-N-CA 123.8 0.84 . . . . 0.0 110.745 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -75.65 156.99 40.21 Favored 'Trans proline' 0 CA--C 1.555 1.559 0 C-N-CA 123.264 2.642 . . . . 0.0 113.637 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -60.35 -29.53 68.96 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.692 1.738 . . . . 0.0 115.692 168.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -60.2 -57.75 11.48 Favored 'General case' 0 CA--C 1.564 1.495 0 CA-C-O 117.297 -1.335 . . . . 0.0 113.803 169.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.8 mt -68.69 -24.16 64.47 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 117.19 2.293 . . . . 0.0 117.19 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.4 mt -73.38 -54.29 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-N 119.491 1.042 . . . . 0.0 110.711 173.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -69.18 -27.85 65.88 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 177.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -76.69 -53.77 7.54 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.04 0.936 . . . . 0.0 112.109 171.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.9 -19.78 69.99 Favored Glycine 0 CA--C 1.551 2.316 0 N-CA-C 119.652 2.621 . . . . 0.0 119.652 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -65.72 -43.71 88.24 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 120.251 2.025 . . . . 0.0 114.434 170.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -68.4 -31.47 70.83 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 170.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.9 mt -77.33 129.86 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-N 119.532 1.06 . . . . 0.0 108.508 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.52 94.97 9.94 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 171.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.12 131.06 10.36 Favored Glycine 0 N--CA 1.481 1.635 0 CA-C-N 116.558 -0.292 . . . . 0.0 113.322 -172.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.7 t -79.75 120.81 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.9 m -108.29 100.21 9.54 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 107.167 -1.419 . . . . 0.0 107.167 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -83.89 147.9 27.26 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.842 0.829 . . . . 0.0 111.011 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.9 mt -143.91 129.42 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 172.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 67.8 t -120.88 117.49 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 176.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -81.2 122.11 26.98 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.404 0.681 . . . . 0.0 111.31 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -131.0 64.11 1.58 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 171.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.58 -113.73 5.9 Favored Glycine 0 CA--C 1.547 2.059 0 O-C-N 121.629 -0.669 . . . . 0.0 113.746 -174.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -73.29 -40.46 64.54 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 169.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -69.63 135.59 50.12 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 119.407 1.003 . . . . 0.0 111.387 175.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -127.6 108.72 11.02 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -87.04 92.59 9.1 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.673 0.749 . . . . 0.0 109.017 176.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -104.64 136.5 44.05 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.42 -175.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.8 m -131.55 102.58 5.98 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -177.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.6 mm -95.22 105.08 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 174.34 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.8 mp . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.78 120.85 42.22 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.203 0.601 . . . . 0.0 110.538 -177.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -149.62 161.33 42.38 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.175 0.99 . . . . 0.0 109.968 -175.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -117.47 128.58 55.13 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.57 0.748 . . . . 0.0 109.871 175.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -107.89 145.07 34.25 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.467 0.651 . . . . 0.0 110.392 158.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.4 m -109.15 131.89 54.64 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 171.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.2 t -73.55 130.1 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 123.797 0.839 . . . . 0.0 109.702 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.27 8.52 87.52 Favored Glycine 0 CA--C 1.553 2.452 0 N-CA-C 118.706 2.242 . . . . 0.0 118.706 -170.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -139.73 135.7 33.41 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 119.272 1.536 . . . . 0.0 108.251 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.75 121.93 18.18 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.257 0.623 . . . . 0.0 112.5 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -136.86 126.85 25.93 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.693 0.797 . . . . 0.0 110.479 -165.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.3 128.3 34.09 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.03 -0.987 . . . . 0.0 111.685 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.9 mt . . . . . 0 N--CA 1.487 1.421 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -175.43 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 mptt . . . . . 0 N--CA 1.487 1.408 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.7 m -80.54 -47.43 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -168.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . 0.265 53.9 mtpt 64.36 86.32 0.13 Allowed 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 124.821 1.248 . . . . 0.0 111.648 -172.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.7 t -134.68 147.17 50.06 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.707 0.803 . . . . 0.0 110.033 -171.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.8 t -85.5 -56.98 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.776 -0.578 . . . . 0.0 111.427 -169.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . 0.307 3.1 t 80.25 127.24 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 125.382 1.473 . . . . 0.0 109.866 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -121.26 135.17 55.16 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 39.2 tp -96.68 102.57 14.37 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -86.23 114.43 23.05 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 121.799 0.809 . . . . 0.0 109.309 173.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.53 -122.42 8.54 Favored Glycine 0 CA--C 1.542 1.724 0 CA-C-N 114.394 -1.276 . . . . 0.0 112.89 -175.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -142.04 60.42 1.46 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 155.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -151.51 -39.29 0.12 Allowed 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 117.267 -1.349 . . . . 0.0 114.218 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -106.27 126.65 52.49 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 120.686 1.584 . . . . 0.0 110.288 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 37.2 mt -107.74 100.0 9.43 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 165.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.8 m -94.9 122.85 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 123.876 0.871 . . . . 0.0 109.274 -172.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.2 t -152.51 132.82 13.65 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 120.92 0.39 . . . . 0.0 111.907 -172.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 44.8 p -100.58 121.54 41.78 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -84.18 -70.74 0.55 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.031 0.532 . . . . 0.0 111.339 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -120.7 -77.3 0.58 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 165.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -126.74 66.98 1.25 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 159.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 62.9 mt -142.33 101.21 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 103.411 -2.811 . . . . 0.0 103.411 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -88.08 98.4 11.51 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.345 0.593 . . . . 0.0 109.571 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.3 t -88.25 102.64 15.02 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.307 1.043 . . . . 0.0 109.947 -176.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.7 t -101.0 97.23 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 -177.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.9 m -91.65 83.49 5.33 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -168.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -98.66 129.13 45.14 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.626 0.77 . . . . 0.0 110.129 -161.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 tt -113.09 114.07 26.31 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -167.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -119.27 103.33 9.41 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.01 -118.18 4.65 Favored Glycine 0 N--CA 1.484 1.862 0 C-N-CA 123.123 0.392 . . . . 0.0 112.714 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -124.93 60.16 1.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.986 0.898 . . . . 0.0 110.107 161.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.6 pt -123.62 -164.64 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.789 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 157.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.3 tt -155.9 125.19 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 120.147 -1.596 . . . . 0.0 108.283 160.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 88.9 m -109.76 98.65 7.95 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -93.86 123.79 37.44 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.371 0.605 . . . . 0.0 109.691 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 27.8 m -114.59 93.84 4.51 Favored 'General case' 0 CA--C 1.557 1.236 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 -170.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 63.5 mtt -93.22 99.81 12.3 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.813 0.845 . . . . 0.0 109.102 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 73.8 p -94.84 100.22 12.14 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -171.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 35.0 tp -96.4 84.96 3.81 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.31 -100.0 0.93 Allowed Glycine 0 CA--C 1.544 1.881 0 CA-C-N 116.743 -0.208 . . . . 0.0 112.852 -174.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -102.36 -10.5 19.4 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 169.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 71.9 mt -87.09 108.19 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-N 120.601 1.546 . . . . 0.0 107.453 -172.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.3 t -97.83 93.13 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -172.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -82.84 109.18 16.75 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 122.967 0.507 . . . . 0.0 110.285 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -88.77 142.79 27.37 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.818 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 45.7 mtm180 -134.62 93.57 3.06 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 174.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 58.3 mt -94.73 104.87 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 105.499 -2.038 . . . . 0.0 105.499 -174.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.5 m -130.75 112.92 13.51 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -163.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -90.87 138.95 31.2 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.351 0.595 . . . . 0.0 112.186 -172.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.2 136.71 56.29 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 123.748 0.819 . . . . 0.0 113.114 -177.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.9 pt . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 -175.53 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 . . . . . 0 CA--C 1.57 1.74 0 N-CA-C 110.17 -0.307 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.2 m 62.0 88.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.04 1.336 . . . . 0.0 112.848 -176.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.44 167.05 31.93 Favored Glycine 0 CA--C 1.54 1.646 0 CA-C-O 122.993 1.33 . . . . 0.0 115.095 -177.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -94.26 122.22 36.58 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 113.313 -1.444 . . . . 0.0 107.658 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -114.62 105.58 13.24 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -175.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -77.58 117.09 18.67 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.121 0.969 . . . . 0.0 111.052 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 55.5 tp -69.67 107.15 3.33 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.112 0.565 . . . . 0.0 112.185 -174.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -85.89 -58.86 2.48 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.903 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.2 t -134.14 142.32 47.43 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.682 0.793 . . . . 0.0 110.016 -169.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -120.97 133.88 55.28 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.841 0.829 . . . . 0.0 108.931 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -76.03 -61.86 1.8 Allowed 'General case' 0 CA--C 1.561 1.387 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.835 169.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -128.28 67.89 1.36 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 118.628 0.649 . . . . 0.0 111.132 -172.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -75.06 -52.08 11.94 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 175.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -66.74 -43.22 84.75 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 -175.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.25 -44.0 95.64 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 169.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -67.82 -51.93 42.85 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.28 -49.07 75.31 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -60.97 -42.35 98.16 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 171.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.64 -29.61 69.67 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 117.242 2.312 . . . . 0.0 117.242 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.267 37.8 pt -77.29 -48.84 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 120.1 1.318 . . . . 0.0 112.587 171.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 137.22 65.13 0.05 OUTLIER Glycine 0 CA--C 1.541 1.686 0 C-N-CA 123.826 0.727 . . . . 0.0 112.312 175.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.4 mt -131.25 147.74 67.4 Favored Pre-proline 0 CA--C 1.568 1.64 0 C-N-CA 123.958 0.903 . . . . 0.0 110.437 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.44 149.04 80.25 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 123.39 2.727 . . . . 0.0 114.397 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -59.47 -28.09 66.69 Favored 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 171.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -61.95 -46.43 89.35 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 166.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.14 -16.49 64.02 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 116.984 2.216 . . . . 0.0 116.984 167.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 72.9 mt -74.62 -55.35 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-N 120.414 1.461 . . . . 0.0 110.534 168.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -67.2 -29.28 68.91 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -75.73 -56.4 4.72 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 119.546 1.066 . . . . 0.0 111.517 168.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.22 -19.74 59.85 Favored Glycine 0 CA--C 1.55 2.223 0 N-CA-C 120.619 3.008 . . . . 0.0 120.619 178.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -67.16 -44.84 78.74 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 119.654 1.727 . . . . 0.0 113.852 168.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -68.71 -37.95 79.89 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 169.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.6 mt -74.33 126.41 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 119.455 1.025 . . . . 0.0 108.355 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.08 99.25 11.36 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.69 111.48 3.72 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-N 116.023 -0.535 . . . . 0.0 113.13 -172.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.7 t -67.15 129.26 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 123.813 0.845 . . . . 0.0 110.481 -176.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.0 p -98.82 105.7 17.88 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -86.61 151.06 23.77 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.473 176.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.6 mt -140.84 138.8 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.7 t -129.8 103.93 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 171.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -90.22 113.13 24.88 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 172.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -121.64 62.63 0.92 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.173 0.589 . . . . 0.0 109.523 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.12 -111.53 3.86 Favored Glycine 0 CA--C 1.546 1.975 0 O-C-N 121.852 -0.53 . . . . 0.0 113.161 -173.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -75.65 -43.0 49.93 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 169.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -73.73 110.73 8.26 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 119.42 1.009 . . . . 0.0 109.814 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.61 97.47 2.98 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -155.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.27 160.35 19.88 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.019 0.928 . . . . 0.0 111.463 -172.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -145.38 130.35 18.3 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.796 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.4 m -99.83 93.88 6.03 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 174.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.9 tp -86.6 118.55 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.4 p . . . . . 0 N--CA 1.487 1.382 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 174.745 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.6 mt . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -92.94 120.62 33.45 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 167.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -123.32 113.23 18.58 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -176.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -97.98 124.11 42.29 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.321 0.648 . . . . 0.0 109.256 -171.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -125.12 149.81 47.5 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.567 0.698 . . . . 0.0 111.351 176.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.0 m -105.94 132.17 52.36 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 168.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.8 t -79.53 119.35 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 175.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.32 0.22 73.86 Favored Glycine 0 CA--C 1.556 2.609 0 N-CA-C 118.885 2.314 . . . . 0.0 118.885 -171.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -145.46 132.14 19.95 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 120.278 2.039 . . . . 0.0 108.605 167.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -73.08 113.26 9.93 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -174.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 90.9 m -96.72 156.02 16.53 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.745 173.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -77.66 101.65 6.7 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.455 0.702 . . . . 0.0 111.145 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.6 mt . . . . . 0 N--CA 1.486 1.374 0 CA-C-O 121.299 0.571 . . . . 0.0 110.942 -165.592 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.9 127.78 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -169.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -75.96 119.68 20.25 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.368 0.604 . . . . 0.0 111.383 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.7 t -145.9 141.6 27.96 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.485 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.14 136.4 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-O 122.515 1.15 . . . . 0.0 109.311 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.5 t -91.0 129.84 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.256 0 CA-C-N 113.833 -1.53 . . . . 0.0 107.833 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -100.56 134.97 42.72 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.062 0.935 . . . . 0.0 109.112 171.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.5 tp -97.84 102.66 14.47 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 114.352 -1.294 . . . . 0.0 107.961 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -101.55 116.96 33.94 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.91 11.38 85.55 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 120.946 3.138 . . . . 0.0 120.946 171.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.283 20.3 m-20 57.85 43.29 21.88 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -165.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -158.63 -43.55 0.06 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 118.118 -0.944 . . . . 0.0 113.521 -177.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -95.8 138.43 33.46 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 120.142 1.337 . . . . 0.0 111.237 -175.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.0 mt -123.36 101.91 7.62 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 172.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.2 m -106.27 117.53 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 123.439 0.696 . . . . 0.0 109.181 -171.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.6 t -151.7 142.1 22.51 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 122.421 0.288 . . . . 0.0 111.346 -175.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 83.7 m -120.68 113.53 20.35 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -70.03 -76.82 0.09 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.796 0.838 . . . . 0.0 111.42 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -120.97 -72.58 0.68 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 165.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -128.73 60.17 1.53 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 118.662 0.665 . . . . 0.0 109.69 161.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 77.0 mt -131.47 97.5 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 102.615 -3.106 . . . . 0.0 102.615 172.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -92.02 91.07 7.67 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.7 t -84.41 109.62 18.01 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.983 0.913 . . . . 0.0 109.377 -174.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 72.0 t -116.77 97.16 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 -175.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.0 m -110.68 87.1 2.45 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -166.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -91.92 133.8 35.36 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.131 0.972 . . . . 0.0 110.621 -174.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.4 tt -102.36 110.01 21.83 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -175.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -110.51 90.47 3.33 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -172.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.71 -109.91 2.91 Favored Glycine 0 CA--C 1.544 1.85 0 CA-C-O 119.926 -0.374 . . . . 0.0 113.03 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -121.51 53.16 1.19 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.304 0.573 . . . . 0.0 111.694 167.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.4 pt -126.77 -165.44 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.799 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 159.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.5 tt -154.26 124.89 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 O-C-N 120.532 -1.355 . . . . 0.0 108.37 160.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 55.4 m -100.76 97.78 8.38 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -91.08 104.28 16.88 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.8 m -108.57 93.18 4.38 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -176.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 49.6 mtt -93.02 105.15 17.3 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.726 0.81 . . . . 0.0 109.098 177.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.4 p -95.33 100.64 12.39 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 51.3 tp -94.66 82.92 3.99 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 175.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.21 -99.75 0.9 Allowed Glycine 0 CA--C 1.542 1.751 0 CA-C-N 116.288 -0.415 . . . . 0.0 113.104 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -98.59 -15.9 19.3 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 170.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 62.4 mt -83.77 107.67 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 120.343 1.428 . . . . 0.0 107.563 -173.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.8 t -95.71 96.5 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -88.87 99.04 12.08 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.981 0.512 . . . . 0.0 109.999 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -102.27 109.67 21.41 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.046 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 25.2 mtm180 -101.64 125.79 48.36 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.73 0.812 . . . . 0.0 108.864 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.59 103.39 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 104.74 -2.318 . . . . 0.0 104.74 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 54.8 m -120.78 114.82 22.19 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 122.686 0.394 . . . . 0.0 110.065 -173.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -92.64 133.03 36.39 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.127 0.571 . . . . 0.0 111.628 -170.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -66.47 136.69 56.07 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 121.789 0.804 . . . . 0.0 113.087 -174.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.7 pt . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 -175.393 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 . . . . . 0 N--CA 1.495 1.776 0 N-CA-C 117.489 2.403 . . . . 0.0 117.489 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.7 m -70.44 109.67 4.91 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 121.093 1.769 . . . . 0.0 110.67 172.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.43 156.91 13.86 Favored Glycine 0 CA--C 1.543 1.79 0 CA-C-O 122.11 0.839 . . . . 0.0 113.873 -173.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.18 114.01 27.95 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 176.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -112.51 97.99 6.96 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -167.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -92.13 138.32 31.63 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.492 0.663 . . . . 0.0 111.003 -176.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.8 tp -74.78 126.46 30.95 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.515 -167.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.5 mm-40 -104.88 -64.68 1.1 Allowed 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.768 -175.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.5 m -129.36 140.36 51.4 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.657 0.783 . . . . 0.0 109.831 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -125.47 130.66 52.26 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.496 1.141 . . . . 0.0 110.841 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -99.44 129.12 45.6 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 113.594 -1.639 . . . . 0.0 107.221 168.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.251 69.8 m-20 67.28 40.47 2.75 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 170.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -67.64 -62.97 1.16 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.029 -1.044 . . . . 0.0 113.795 170.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -59.98 -34.98 74.03 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 117.18 2.289 . . . . 0.0 117.18 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.69 -47.17 84.81 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 166.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -65.99 -47.76 73.46 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -45.01 95.06 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 176.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -57.13 -48.26 79.11 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 166.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.71 -26.19 68.55 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 117.757 2.502 . . . . 0.0 117.757 177.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.3 pt -88.63 -49.28 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-N 119.178 0.899 . . . . 0.0 112.005 174.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 141.36 73.64 0.04 OUTLIER Glycine 0 CA--C 1.539 1.591 0 CA-C-N 118.903 0.774 . . . . 0.0 112.427 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.87 153.41 78.67 Favored Pre-proline 0 CA--C 1.571 1.763 0 C-N-CA 123.359 0.664 . . . . 0.0 112.602 176.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -76.44 158.78 36.46 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 123.354 2.703 . . . . 0.0 113.55 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -62.55 -31.6 72.41 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 169.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -60.06 -52.25 66.19 Favored 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 171.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 88.8 mt -72.43 -18.6 61.69 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 117.071 2.248 . . . . 0.0 117.071 175.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 93.3 mt -67.81 -61.28 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-N 119.631 1.105 . . . . 0.0 110.017 165.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -64.82 -25.27 67.83 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -78.58 -52.03 9.06 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.878 0.871 . . . . 0.0 112.376 171.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.78 -18.98 72.86 Favored Glycine 0 CA--C 1.551 2.33 0 N-CA-C 119.89 2.716 . . . . 0.0 119.89 177.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -65.06 -42.84 93.84 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 120.087 1.944 . . . . 0.0 114.732 169.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -66.46 -37.21 84.64 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 168.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.5 mt -72.01 115.46 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -85.98 106.72 17.36 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -174.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.04 131.76 10.91 Favored Glycine 0 CA--C 1.54 1.643 0 CA-C-N 115.966 -0.561 . . . . 0.0 114.471 -167.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.3 t -89.64 117.81 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 175.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.5 m -100.49 101.61 12.6 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 174.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.22 146.61 30.38 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.379 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 55.4 mt -142.1 123.3 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 104.5 -2.408 . . . . 0.0 104.5 174.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.6 t -115.54 108.87 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -93.99 120.31 34.07 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.012 0.525 . . . . 0.0 109.813 176.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 -122.25 74.85 1.19 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 164.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.42 -118.77 9.56 Favored Glycine 0 CA--C 1.548 2.127 0 C-N-CA 123.215 0.436 . . . . 0.0 113.757 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -75.47 -32.67 60.67 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 167.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -78.12 135.38 37.67 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 120.116 1.325 . . . . 0.0 111.592 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -137.19 150.77 48.13 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.97 0.89 . . . . 0.0 111.26 -175.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -136.78 115.15 11.78 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 161.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -107.41 125.72 51.58 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.559 173.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 50.8 m -119.44 99.92 6.98 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -173.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 88.1 mt -91.21 126.76 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.9 p . . . . . 0 N--CA 1.485 1.31 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 170.584 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 80.5 mt . . . . . 0 N--CA 1.494 1.76 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -107.97 127.06 53.42 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.549 0.74 . . . . 0.0 109.057 173.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -139.61 142.69 37.05 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.137 0.975 . . . . 0.0 109.822 -170.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -126.64 148.77 49.77 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.146 0.974 . . . . 0.0 110.543 -176.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -151.65 144.78 24.61 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.537 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.3 m -101.91 132.19 47.85 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 164.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.8 t -75.93 131.71 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.57 0.7 . . . . 0.0 109.863 -175.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.85 6.18 89.19 Favored Glycine 0 CA--C 1.553 2.435 0 N-CA-C 118.669 2.228 . . . . 0.0 118.669 -169.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -137.32 140.75 41.71 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 119.233 1.517 . . . . 0.0 108.332 -175.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -76.62 117.0 17.82 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.147 0.579 . . . . 0.0 111.019 -173.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.6 p -126.42 149.43 49.27 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 122.335 1.064 . . . . 0.0 112.871 -162.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -84.82 118.88 24.74 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.271 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 C-N-CA 123.654 0.781 . . . . 0.0 109.843 175.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 45.2 tptt . . . . . 0 N--CA 1.486 1.35 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.5 p -117.25 136.82 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 121.894 0.855 . . . . 0.0 110.489 -157.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -81.75 120.55 25.28 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.119 -177.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.4 t -148.07 135.5 20.6 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.932 0.493 . . . . 0.0 111.089 -167.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 75.5 t -88.99 119.44 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.1 t -104.28 112.54 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -116.3 143.41 45.57 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.803 0.811 . . . . 0.0 110.907 -176.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.6 tp -101.61 130.95 48.05 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.953 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -128.83 125.75 38.37 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 174.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.4 12.52 73.1 Favored Glycine 0 CA--C 1.55 2.265 0 N-CA-C 120.688 3.035 . . . . 0.0 120.688 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.268 24.2 m-20 58.74 37.92 24.98 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -167.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -160.84 -18.47 0.05 Allowed 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -176.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -119.1 101.22 7.85 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 121.101 1.773 . . . . 0.0 109.279 -171.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 79.3 mt -94.73 101.89 13.75 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 171.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.4 m -104.21 124.75 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 123.961 0.905 . . . . 0.0 108.744 -171.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.9 t -143.57 133.56 24.15 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.514 0.673 . . . . 0.0 111.425 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.8 t -131.79 134.67 46.07 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.211 1.005 . . . . 0.0 109.081 -175.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.334 14.2 p90 -136.03 -116.4 0.17 Allowed 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 118.612 -0.709 . . . . 0.0 109.497 -171.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -73.59 -68.5 0.5 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 119.6 1.091 . . . . 0.0 111.227 -178.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -126.86 -27.0 3.1 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 176.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 mp -86.34 121.95 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.574 0 CA-C-N 119.91 1.232 . . . . 0.0 108.417 -171.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -78.57 153.53 31.11 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.545 155.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.2 t -143.31 97.16 3.03 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 172.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 73.7 t -100.21 100.24 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.8 m -95.49 94.0 7.53 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -171.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -104.82 117.51 34.25 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.504 0.722 . . . . 0.0 109.073 -162.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 tt -106.47 117.8 34.99 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 -170.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -94.33 -99.77 0.15 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 118.236 -0.888 . . . . 0.0 108.88 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -103.05 -105.93 3.01 Favored Glycine 0 N--CA 1.485 1.912 0 CA-C-N 119.53 1.059 . . . . 0.0 111.276 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -96.39 49.26 1.11 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.074 0.464 . . . . 0.0 112.001 168.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.7 pt -142.38 -174.95 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.678 0 C-N-CA 124.64 1.176 . . . . 0.0 109.459 176.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.4 tt -150.1 127.69 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 120.917 -1.114 . . . . 0.0 108.719 161.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 29.8 m -103.61 92.24 4.37 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -88.7 106.81 18.59 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -177.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 39.1 m -111.9 97.49 6.72 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -169.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 46.0 mtt -98.48 104.26 16.28 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.351 0.66 . . . . 0.0 109.371 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 59.6 p -97.12 102.08 13.78 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.292 0.567 . . . . 0.0 109.765 -172.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 50.1 tp -101.51 83.94 2.52 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.45 -99.91 1.03 Allowed Glycine 0 CA--C 1.543 1.832 0 CA-C-N 116.437 -0.347 . . . . 0.0 112.793 -174.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -99.52 -16.34 18.34 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 169.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 70.1 mt -84.26 108.54 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-N 120.476 1.489 . . . . 0.0 107.86 -172.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.6 t -97.03 95.46 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -85.84 96.13 9.66 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.201 0.6 . . . . 0.0 109.739 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -104.36 106.54 17.08 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.871 -175.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -89.04 127.21 35.68 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.777 0.831 . . . . 0.0 109.014 170.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -108.64 104.01 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 174.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.5 m -127.92 116.73 20.55 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -171.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.256 17.3 ptpt -88.6 148.54 24.01 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 122.098 0.951 . . . . 0.0 113.538 -172.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -81.15 124.58 29.37 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.028 -172.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.0 pt . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 -169.499 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 . . . . . 0 N--CA 1.492 1.628 0 N-CA-C 116.985 2.217 . . . . 0.0 116.985 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.6 p -65.74 125.31 24.89 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 120.77 1.623 . . . . 0.0 113.612 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 153.98 167.16 15.74 Favored Glycine 0 CA--C 1.545 1.946 0 CA-C-O 122.54 1.078 . . . . 0.0 113.862 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -89.88 145.12 25.37 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 114.243 -0.978 . . . . 0.0 109.994 169.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -142.01 104.87 4.56 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -175.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.6 tm0? -87.92 127.32 35.36 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.592 -0.693 . . . . 0.0 111.356 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 50.8 tp -69.75 109.79 4.58 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.888 0.875 . . . . 0.0 113.228 -174.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -100.19 -60.63 1.49 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.331 0.653 . . . . 0.0 112.231 -172.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.1 t -127.74 138.56 52.81 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.566 0.746 . . . . 0.0 110.28 -168.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -133.26 133.46 42.68 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.521 0.677 . . . . 0.0 109.706 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -74.18 -64.5 1.0 Allowed 'General case' 0 CA--C 1.561 1.38 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.773 168.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -122.29 67.1 0.93 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.217 0.607 . . . . 0.0 110.746 -174.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -75.23 -52.04 11.86 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.416 -0.803 . . . . 0.0 111.993 168.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -60.6 -46.44 90.26 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.09 -36.22 82.61 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 174.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -73.37 -55.88 5.8 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 119.973 1.261 . . . . 0.0 113.672 175.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.25 -42.94 82.47 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.4 tmtm? -62.99 -43.97 97.31 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 169.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.7 -29.01 69.07 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 117.688 2.477 . . . . 0.0 117.688 173.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.25 38.2 pt -82.59 -54.53 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 119.248 0.931 . . . . 0.0 111.844 173.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.32 67.11 0.01 OUTLIER Glycine 0 N--CA 1.479 1.564 0 CA-C-O 118.898 -0.946 . . . . 0.0 113.134 171.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.8 mt -130.38 146.08 60.15 Favored Pre-proline 0 CA--C 1.569 1.695 0 CA-C-N 117.918 0.859 . . . . 0.0 111.138 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -69.11 150.65 72.43 Favored 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 123.577 2.851 . . . . 0.0 114.791 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -52.61 -36.49 56.47 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 171.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -63.22 -53.27 55.65 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 171.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.7 mt -66.85 -24.91 66.2 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.707 2.114 . . . . 0.0 116.707 176.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 87.3 mt -67.42 -53.9 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 124.347 1.059 . . . . 0.0 111.142 170.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -61.34 -24.01 66.15 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 172.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -75.69 -59.19 2.86 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 119.594 1.088 . . . . 0.0 111.503 169.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.39 -21.44 59.96 Favored Glycine 0 CA--C 1.552 2.355 0 N-CA-C 119.947 2.739 . . . . 0.0 119.947 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -66.95 -46.23 75.35 Favored 'General case' 0 CA--C 1.569 1.702 0 CA-C-N 120.28 2.04 . . . . 0.0 114.202 170.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -71.55 -36.96 71.13 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 174.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.9 mt -66.77 135.22 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-N 119.687 1.131 . . . . 0.0 109.612 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -74.87 104.42 5.47 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.603 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -98.19 102.97 2.73 Favored Glycine 0 N--CA 1.478 1.436 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.805 -175.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.8 t -84.49 114.85 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -176.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.6 m -98.6 104.85 16.92 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.087 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.17 149.49 26.13 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.026 174.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 55.5 mt -140.42 131.52 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 172.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.4 t -119.03 101.78 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -83.17 115.84 22.1 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.966 0.507 . . . . 0.0 109.8 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -124.98 69.62 1.13 Allowed 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 167.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.07 -112.17 4.65 Favored Glycine 0 CA--C 1.546 2.01 0 C-N-CA 123.272 0.463 . . . . 0.0 113.699 -174.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -74.14 -33.4 63.53 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 171.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -79.31 129.33 34.36 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 119.276 0.944 . . . . 0.0 110.726 -177.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -132.05 105.82 7.63 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -177.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -95.24 106.24 18.25 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 170.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -104.31 120.23 40.73 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.017 174.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 78.7 m -108.45 91.98 3.87 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.6 tt -99.32 120.86 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.362 -167.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.0 m . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.55 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.4 mt . . . . . 0 N--CA 1.488 1.462 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -89.07 126.15 35.32 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.39 0.614 . . . . 0.0 109.868 175.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -134.77 106.9 7.13 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -174.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.51 132.15 56.59 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.919 0.887 . . . . 0.0 110.389 -175.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -141.6 173.69 11.27 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.942 -172.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.0 m -127.58 132.91 49.77 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 166.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.3 m -68.66 132.47 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 122.979 0.511 . . . . 0.0 111.616 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 107.59 -58.09 0.42 Allowed Glycine 0 CA--C 1.545 1.952 0 CA-C-N 115.583 -0.735 . . . . 0.0 113.233 -160.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -85.92 148.49 25.76 Favored 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 124.117 0.967 . . . . 0.0 112.101 -172.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -83.6 117.07 22.91 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.844 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 77.3 m -116.1 147.99 40.74 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 122.07 0.938 . . . . 0.0 111.664 -174.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -84.24 97.82 9.62 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.847 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 61.5 mt . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.597 0.713 . . . . 0.0 109.679 -171.091 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 85.4 mttt . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 121.866 0.841 . . . . 0.0 109.848 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 19.5 m -100.19 -13.46 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 117.236 2.31 . . . . 0.0 117.236 -164.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . 0.25 93.4 mttt 76.85 112.4 0.07 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 121.06 1.755 . . . . 0.0 110.242 -173.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.4 t -150.02 129.82 13.3 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.121 0.568 . . . . 0.0 109.548 -168.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.2 t -100.64 118.34 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.6 t -102.74 135.97 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -115.87 155.06 28.61 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.513 0.673 . . . . 0.0 110.591 166.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.4 tp -106.29 103.57 13.07 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 173.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -103.25 120.1 40.12 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.66 6.27 84.54 Favored Glycine 0 CA--C 1.549 2.164 0 N-CA-C 120.744 3.058 . . . . 0.0 120.744 173.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.316 4.7 t70 71.92 -10.38 0.87 Allowed 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 -167.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -116.15 -18.34 10.61 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 116.574 2.065 . . . . 0.0 116.574 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -112.65 124.85 53.48 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 121.151 1.796 . . . . 0.0 109.784 -176.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 47.3 mt -103.31 103.07 13.05 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 166.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.8 t -101.53 118.92 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -167.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.5 t -149.45 155.68 40.8 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.536 0.684 . . . . 0.0 112.363 -173.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 91.9 m -122.06 107.72 12.54 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 174.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -71.81 -81.83 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.435 0.694 . . . . 0.0 111.143 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -139.3 87.9 2.23 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 170.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.259 70.2 m-80 53.56 43.28 31.43 Favored 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -169.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 44.0 mm -125.24 105.37 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 104.462 -2.421 . . . . 0.0 104.462 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -79.96 94.14 5.84 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.571 0.7 . . . . 0.0 109.653 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.6 t -106.42 95.91 6.09 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.478 -165.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 73.8 t -101.44 107.8 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.9 m -93.86 85.42 4.78 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -173.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -94.66 127.53 40.69 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.357 0.663 . . . . 0.0 109.717 -165.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 tt -112.86 111.12 21.66 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -173.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -98.94 -101.84 0.22 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 118.406 -0.807 . . . . 0.0 109.291 -170.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -87.15 -110.58 0.91 Allowed Glycine 0 N--CA 1.484 1.877 0 CA-C-N 119.698 1.135 . . . . 0.0 112.395 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -101.36 61.4 0.92 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.567 0.698 . . . . 0.0 110.145 166.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 11.9 pt -148.94 -176.77 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.759 0 C-N-CA 124.619 1.167 . . . . 0.0 108.927 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.1 tt -148.54 125.32 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 120.753 -1.217 . . . . 0.0 108.217 155.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.0 m -111.1 106.99 16.21 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.02 110.56 23.12 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 34.7 m -96.91 99.65 11.2 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -176.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 66.3 mtt -104.2 97.15 7.15 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 -176.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.9 p -96.44 113.58 25.17 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -174.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.2 tp -103.08 83.08 2.16 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 170.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.77 -103.69 1.25 Allowed Glycine 0 CA--C 1.545 1.952 0 N-CA-C 114.571 0.588 . . . . 0.0 114.571 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -82.09 -27.02 33.11 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 114.708 1.374 . . . . 0.0 114.708 171.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 29.7 mm -65.34 136.1 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.542 0 C-N-CA 124.904 1.281 . . . . 0.0 109.562 174.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.4 t -127.94 96.47 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 172.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -86.56 102.47 14.16 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -102.91 104.85 15.11 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -113.72 122.35 46.84 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.869 0.868 . . . . 0.0 109.199 -175.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.7 mp -111.14 102.95 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 -171.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.0 m -102.23 112.43 25.11 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -84.08 142.29 30.51 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.817 0.447 . . . . 0.0 110.774 -169.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -74.14 134.06 42.82 Favored 'General case' 0 CA--C 1.559 1.304 0 CA-C-O 121.916 0.865 . . . . 0.0 112.725 -169.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 45.0 mm . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 -162.581 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 . . . . . 0 N--CA 1.496 1.831 0 N-CA-C 117.616 2.451 . . . . 0.0 117.616 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 75.6 m -71.45 115.22 10.37 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 121.437 1.926 . . . . 0.0 111.025 172.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.44 160.29 19.64 Favored Glycine 0 CA--C 1.54 1.655 0 CA-C-O 122.217 0.898 . . . . 0.0 114.295 -175.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -111.14 106.56 15.63 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -111.48 105.77 14.46 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -162.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -93.18 135.63 34.2 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 122.941 0.496 . . . . 0.0 111.583 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.5 tp -71.46 115.04 10.17 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.478 0.711 . . . . 0.0 112.584 -171.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -99.23 -55.33 2.72 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.164 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.1 m -125.07 110.51 14.24 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -173.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -111.48 119.58 39.25 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 122.075 0.941 . . . . 0.0 109.844 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -109.2 120.29 42.07 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 170.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.259 69.1 m-80 67.37 50.49 0.95 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -175.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -72.13 -63.26 1.18 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.922 . . . . 0.0 111.289 162.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -65.58 -35.23 80.21 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 117.33 2.344 . . . . 0.0 117.33 -174.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.41 -45.57 93.76 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 166.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -65.11 -51.91 58.55 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 174.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 23.5 mmt -62.18 -43.02 99.77 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -176.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -60.15 -47.28 86.6 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 167.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.57 -29.5 70.63 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 117.729 2.492 . . . . 0.0 117.729 176.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.8 pt -80.5 -47.04 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 CA-C-N 119.781 1.173 . . . . 0.0 112.706 173.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 142.67 69.62 0.03 OUTLIER Glycine 0 CA--C 1.54 1.595 0 CA-C-N 119.134 0.879 . . . . 0.0 113.034 174.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.55 153.37 79.4 Favored Pre-proline 0 CA--C 1.568 1.668 0 C-N-CA 123.456 0.702 . . . . 0.0 111.84 172.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.79 152.59 47.44 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 123.168 2.579 . . . . 0.0 113.031 172.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -61.03 -24.69 66.37 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 173.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -61.86 -57.19 12.75 Favored 'General case' 0 CA--C 1.563 1.455 0 CA-C-O 117.489 -1.243 . . . . 0.0 113.433 165.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.8 mt -68.93 -18.39 64.09 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.1 mt -74.23 -55.45 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-N 119.727 1.149 . . . . 0.0 110.477 170.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -67.93 -24.56 65.2 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -79.13 -51.21 9.84 Favored 'General case' 0 CA--C 1.562 1.419 0 CA-C-N 119.547 1.067 . . . . 0.0 112.217 167.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.2 -14.79 59.94 Favored Glycine 0 CA--C 1.552 2.366 0 N-CA-C 119.864 2.706 . . . . 0.0 119.864 176.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -71.34 -49.86 38.16 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 119.957 1.879 . . . . 0.0 113.88 171.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -63.8 -30.76 71.82 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.533 2.049 . . . . 0.0 116.533 167.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 53.8 mt -75.69 113.7 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 173.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -81.22 108.57 14.97 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.64 123.77 6.31 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 116.299 -0.41 . . . . 0.0 113.884 -167.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t -83.05 110.99 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.3 t -92.57 103.26 15.68 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 166.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.85 142.83 36.53 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.162 169.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.0 mt -142.17 125.96 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 90.6 t -114.15 105.21 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -81.75 118.23 22.69 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.059 0.544 . . . . 0.0 109.816 174.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -123.98 68.35 1.05 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 165.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.3 -107.51 2.1 Favored Glycine 0 CA--C 1.546 1.986 0 C-N-CA 123.24 0.448 . . . . 0.0 113.362 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -78.22 -29.35 48.24 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 170.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -84.57 104.61 14.71 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 120.394 1.452 . . . . 0.0 109.605 -173.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -105.69 95.32 5.73 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.052 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -93.7 106.7 18.65 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -103.76 132.24 50.19 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.941 -176.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.7 m -107.27 98.62 8.23 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 172.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.4 tp -87.16 127.91 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.41 0.684 . . . . 0.0 109.568 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 48.1 p . . . . . 0 N--CA 1.486 1.367 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 174.942 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.3 tt . . . . . 0 N--CA 1.495 1.821 0 CA-C-O 121.367 0.604 . . . . 0.0 110.431 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -112.31 127.05 55.88 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.002 0.921 . . . . 0.0 109.025 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -139.87 128.95 23.65 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -171.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.25 135.45 54.27 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.458 0.703 . . . . 0.0 112.3 -175.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -125.27 149.11 48.34 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.044 0.938 . . . . 0.0 111.021 171.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.3 m -111.62 132.6 54.46 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 169.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.0 t -70.26 132.61 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 123.805 0.842 . . . . 0.0 110.274 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.76 10.88 85.93 Favored Glycine 0 CA--C 1.554 2.473 0 N-CA-C 118.987 2.355 . . . . 0.0 118.987 -170.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -138.59 150.7 46.58 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 119.29 1.545 . . . . 0.0 109.828 -171.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -80.89 103.0 10.42 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.519 0.728 . . . . 0.0 109.118 177.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 63.1 m -134.44 134.29 41.43 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.692 0.758 . . . . 0.0 110.766 -171.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.55 143.38 40.36 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -171.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.9 mt . . . . . 0 N--CA 1.486 1.33 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 175.123 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.7 mptt . . . . . 0 N--CA 1.486 1.37 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . 0.261 8.4 p -86.57 -43.84 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.607 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . 0.253 5.6 ttpm? 76.06 107.49 0.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.751 1.221 . . . . 0.0 111.747 173.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . 0.49 HG22 ' HA ' ' A' ' 95' ' ' PHE . 16.4 p -128.38 139.5 52.34 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.033 0.533 . . . . 0.0 110.381 -165.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 89.7 t -109.76 101.44 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 173.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.3 t -94.9 138.48 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -173.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -114.89 135.49 54.15 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.839 0.828 . . . . 0.0 109.302 176.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 50.7 tp -94.69 102.68 14.59 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 173.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -88.08 114.16 24.42 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 121.891 0.853 . . . . 0.0 109.112 174.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.41 -117.28 5.48 Favored Glycine 0 CA--C 1.542 1.729 0 CA-C-N 114.354 -1.293 . . . . 0.0 113.047 -176.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -130.25 -8.58 4.26 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 170.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -134.34 35.02 3.24 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -173.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -147.41 116.77 6.97 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 119.996 1.271 . . . . 0.0 108.077 175.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 67.0 mt -107.66 101.73 11.02 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 171.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 32.7 m -99.42 124.3 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -171.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.3 t -151.48 135.95 16.94 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.243 0.545 . . . . 0.0 111.482 -174.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 67.9 p -83.55 -41.88 17.43 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 177.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.49 ' HA ' HG22 ' A' ' 81' ' ' THR 0.378 22.5 m-85 74.21 -94.48 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 119.259 0.936 . . . . 0.0 109.676 -169.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -116.38 -76.18 0.57 Allowed 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 163.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -135.63 71.6 1.43 Allowed 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 119.276 0.944 . . . . 0.0 109.317 170.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.1 mp -143.66 93.46 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 102.87 -3.011 . . . . 0.0 102.87 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -80.74 97.2 7.2 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 119.156 0.889 . . . . 0.0 109.818 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.4 t -100.29 102.34 13.58 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.266 -171.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.8 t -96.05 106.63 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.2 m -93.56 83.87 4.57 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -174.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.63 118.42 32.29 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.415 0.686 . . . . 0.0 109.251 -168.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tt -106.72 112.06 24.87 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -172.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -81.19 -59.05 2.79 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -172.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -158.83 -87.74 0.06 OUTLIER Glycine 0 N--CA 1.479 1.505 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 175.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -71.35 -37.98 71.65 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 166.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.8 pt -87.52 178.54 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.553 0 CA-C-N 119.636 1.107 . . . . 0.0 112.785 -171.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.5 tt -141.59 118.83 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 165.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.0 m -99.57 99.98 10.92 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -97.03 104.32 16.32 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -178.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.9 m -102.44 94.85 5.89 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -168.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 28.1 mtt -93.37 99.28 11.82 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.59 0.71 . . . . 0.0 109.377 -178.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 48.0 p -94.18 103.83 15.86 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.003 -174.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.0 tp -102.73 82.86 2.18 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.51 -99.62 1.01 Allowed Glycine 0 CA--C 1.544 1.879 0 O-C-N 122.348 -0.22 . . . . 0.0 113.12 -174.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -102.95 -12.29 17.6 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 170.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 72.4 mt -85.3 108.92 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-N 120.526 1.512 . . . . 0.0 107.157 -175.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.2 t -100.34 96.47 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 -175.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -82.77 97.6 8.67 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -93.06 107.44 19.23 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -108.15 98.78 8.29 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -172.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 85.2 mt -97.93 104.71 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 -173.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 67.9 m -121.53 114.96 21.96 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -172.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -91.05 139.74 30.48 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 122.941 0.496 . . . . 0.0 111.131 -172.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.4 ttp85 -68.37 130.01 41.61 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.331 0.653 . . . . 0.0 112.509 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.2 pt . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 123.047 1.403 . . . . 0.0 108.365 -173.959 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.353 84.1 m-85 . . . . . 0 N--CA 1.496 1.83 0 N-CA-C 117.973 2.583 . . . . 0.0 117.973 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.2 m -72.23 103.53 3.38 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 120.527 1.512 . . . . 0.0 110.924 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.1 149.27 8.69 Favored Glycine 0 CA--C 1.541 1.709 0 CA-C-O 122.016 0.787 . . . . 0.0 113.624 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -92.31 117.51 29.97 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 171.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -116.62 104.54 11.49 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -172.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -86.68 140.03 30.19 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-O 121.675 0.75 . . . . 0.0 111.622 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.2 tp -66.25 137.3 56.86 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -170.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -116.13 -65.48 1.18 Allowed 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.58 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.5 p -126.94 137.58 53.15 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.906 0.882 . . . . 0.0 109.401 174.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -132.35 101.96 5.56 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.807 0.813 . . . . 0.0 109.136 -178.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -90.94 135.47 33.72 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.606 1.162 . . . . 0.0 109.722 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 m120 62.24 40.39 11.59 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -72.51 -45.77 57.8 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.921 -1.112 . . . . 0.0 113.048 172.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -62.37 -45.92 90.99 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.52 -43.58 96.76 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -76.16 -55.14 5.86 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 118.325 -0.845 . . . . 0.0 113.24 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -44.71 95.83 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -178.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -61.97 -42.77 99.5 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 171.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.92 -36.3 76.71 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 116.925 2.194 . . . . 0.0 116.925 175.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.275 46.2 pt -79.34 -47.17 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 119.086 0.857 . . . . 0.0 112.768 174.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 142.92 52.57 0.03 OUTLIER Glycine 0 N--CA 1.485 1.935 0 N-CA-C 115.678 1.031 . . . . 0.0 115.678 165.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.45 155.51 36.71 Favored Pre-proline 0 CA--C 1.566 1.563 0 CA-C-N 118.211 1.006 . . . . 0.0 111.673 175.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.38 146.59 45.3 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.99 2.46 . . . . 0.0 113.256 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -62.87 -22.45 66.71 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 116.072 1.879 . . . . 0.0 116.072 171.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -59.43 -53.29 59.81 Favored 'General case' 0 CA--C 1.566 1.565 0 CA-C-N 119.754 1.161 . . . . 0.0 113.969 164.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.29 -24.47 63.96 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 117.072 2.249 . . . . 0.0 117.072 174.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.3 mt -75.18 -51.66 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-N 119.623 1.101 . . . . 0.0 111.305 175.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -67.84 -28.52 67.62 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.91 -51.21 14.4 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.603 0.761 . . . . 0.0 112.348 169.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.78 -18.58 72.45 Favored Glycine 0 CA--C 1.546 2.011 0 N-CA-C 120.226 2.85 . . . . 0.0 120.226 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -65.34 -41.82 93.51 Favored 'General case' 0 CA--C 1.57 1.712 0 CA-C-N 120.334 2.067 . . . . 0.0 114.427 168.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -67.68 -39.83 84.45 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 170.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.5 mt -73.19 130.36 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 119.292 0.951 . . . . 0.0 108.929 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -89.73 98.59 11.86 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 170.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.58 140.01 15.42 Favored Glycine 0 CA--C 1.542 1.722 0 CA-C-N 116.056 -0.52 . . . . 0.0 113.949 -172.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.3 t -83.18 115.7 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 71.2 m -102.33 109.17 20.76 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.776 177.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.86 148.89 21.71 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-O 122.064 0.935 . . . . 0.0 111.094 -177.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.4 mt -138.61 133.16 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 166.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.7 t -114.33 112.25 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 175.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -78.58 118.53 20.78 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 170.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -133.52 67.27 1.53 Allowed 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.64 -122.54 9.41 Favored Glycine 0 CA--C 1.548 2.107 0 O-C-N 121.975 -0.453 . . . . 0.0 113.533 -173.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.03 -35.58 74.41 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 164.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -69.43 139.01 53.99 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 119.291 0.95 . . . . 0.0 111.99 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -138.5 97.27 3.32 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -91.32 106.08 18.24 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 175.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -83.65 148.94 26.83 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.128 169.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.8 m -133.96 87.06 2.33 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 166.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.5 pp -91.07 127.67 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -173.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.4 m . . . . . 0 N--CA 1.486 1.34 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 177.483 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -116.06 131.31 56.98 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.441 0.696 . . . . 0.0 111.822 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -151.32 149.94 29.94 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 123.399 0.68 . . . . 0.0 109.831 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -109.39 132.3 54.26 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.646 0.778 . . . . 0.0 110.833 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -117.25 141.07 48.74 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.919 0.888 . . . . 0.0 111.189 170.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.6 m -94.88 135.87 35.87 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 169.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.0 t -86.18 117.76 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 174.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.25 -5.44 63.01 Favored Glycine 0 CA--C 1.556 2.653 0 N-CA-C 119.057 2.383 . . . . 0.0 119.057 -171.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -142.23 134.48 27.68 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 120.38 2.09 . . . . 0.0 108.593 169.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.98 119.76 17.67 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -174.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 80.6 m -116.99 148.16 41.68 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 122.326 1.06 . . . . 0.0 110.557 -177.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.65 121.86 22.31 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.058 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.1 mt . . . . . 0 N--CA 1.486 1.371 0 C-N-CA 123.827 0.851 . . . . 0.0 108.857 -175.909 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? . . . . . 0 N--CA 1.485 1.32 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.1 t -123.14 121.07 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -169.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -86.17 99.97 11.9 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.1 t -135.73 145.9 47.12 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.654 0.782 . . . . 0.0 110.016 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.0 p -109.76 138.02 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-O 122.798 1.285 . . . . 0.0 109.461 175.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.7 t -99.74 138.89 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.437 0 CA-C-N 113.413 -1.721 . . . . 0.0 107.78 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 -109.58 133.26 53.32 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 50.1 tp -98.55 113.49 25.54 Favored 'General case' 0 CA--C 1.553 1.076 0 CA-C-N 115.175 -0.921 . . . . 0.0 108.573 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -114.64 121.84 44.63 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.719 0.808 . . . . 0.0 109.041 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.88 14.45 73.14 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 120.667 3.027 . . . . 0.0 120.667 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.282 15.9 t70 59.7 33.3 21.83 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -168.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -158.87 -26.07 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -103.91 104.27 14.23 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 121.324 1.875 . . . . 0.0 109.368 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 44.1 mt -96.64 101.97 13.68 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 171.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.0 m -111.49 128.8 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 123.896 0.878 . . . . 0.0 109.966 -167.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.8 t -152.42 148.85 27.94 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.258 0.552 . . . . 0.0 111.956 -176.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 33.7 p -113.38 120.47 41.19 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -82.69 -86.14 0.11 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.13 0.572 . . . . 0.0 109.785 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -120.7 -71.71 0.72 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 171.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -127.54 64.19 1.35 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 118.88 0.764 . . . . 0.0 109.036 160.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.1 mp -135.7 108.23 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 174.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.23 93.49 9.4 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.6 t -97.67 104.11 16.1 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.669 0.787 . . . . 0.0 109.513 -168.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.9 t -120.44 98.44 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 -168.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.5 m -95.96 100.24 11.94 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -174.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.37 128.95 38.4 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.884 0.874 . . . . 0.0 109.992 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -97.94 111.15 23.56 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -110.65 178.55 4.33 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.534 0.734 . . . . 0.0 110.448 174.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -68.1 112.8 4.95 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 116.477 1.351 . . . . 0.0 116.477 -166.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.263 19.6 m-20 50.1 25.83 1.87 Allowed 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 117.38 2.363 . . . . 0.0 117.38 -166.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.3 pt -139.36 -178.46 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.619 0 C-N-CA 124.366 1.067 . . . . 0.0 109.866 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.1 tt -150.54 127.72 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.826 -1.172 . . . . 0.0 108.839 168.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.2 m -111.13 104.7 13.26 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -93.91 111.45 23.16 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 176.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 39.8 m -109.4 101.3 10.29 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -175.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 29.5 mtt -105.95 103.29 12.75 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.9 p -95.75 105.4 17.39 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 32.3 tp -96.52 84.73 3.73 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.09 -103.44 1.15 Allowed Glycine 0 CA--C 1.544 1.893 0 C-N-CA 122.954 0.312 . . . . 0.0 113.627 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -94.92 -16.42 22.85 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 171.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 66.2 mt -80.14 114.23 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 120.084 1.311 . . . . 0.0 107.563 -177.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.4 t -101.92 94.97 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -77.26 127.05 31.93 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 169.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -136.6 109.41 7.58 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -110.31 110.02 20.67 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -174.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.6 mp -104.25 115.66 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 104.983 -2.228 . . . . 0.0 104.983 -177.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.9 m -131.97 122.16 25.11 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -175.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -96.18 137.64 34.96 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.734 0.814 . . . . 0.0 110.992 -171.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.7 ttp180 -63.18 123.95 19.94 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 124.372 1.069 . . . . 0.0 113.165 -175.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 13.3 pt . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 123.007 1.384 . . . . 0.0 108.858 -178.382 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 118.359 2.726 . . . . 0.0 118.359 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.5 m -70.8 112.32 6.91 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 121.179 1.809 . . . . 0.0 110.784 172.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.4 149.49 7.37 Favored Glycine 0 CA--C 1.542 1.73 0 CA-C-O 121.926 0.737 . . . . 0.0 113.343 -175.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -96.25 122.74 39.43 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 170.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -118.11 102.24 8.86 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -167.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.6 tm0? -88.28 122.88 32.31 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.14 0.576 . . . . 0.0 110.013 -175.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.6 tp -61.94 115.45 4.06 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -175.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -95.99 -63.07 1.19 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.496 0.718 . . . . 0.0 110.748 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.7 m -120.88 108.56 14.06 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -89.11 123.84 33.76 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 122.524 1.154 . . . . 0.0 109.15 164.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -115.24 117.28 30.05 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 -178.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.278 7.7 m-20 70.23 43.74 0.82 Allowed 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 -174.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -68.15 -60.27 2.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.158 -0.964 . . . . 0.0 113.06 168.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -62.24 -33.96 75.59 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 117.345 2.35 . . . . 0.0 117.345 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.57 -46.31 86.45 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 166.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -67.19 -51.81 49.01 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 177.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.29 -49.85 74.77 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -59.15 -42.22 90.22 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 170.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.57 -32.2 73.59 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 117.305 2.335 . . . . 0.0 117.305 174.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.28 37.7 pt -78.53 -53.51 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-N 119.747 1.158 . . . . 0.0 111.599 172.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.68 69.98 0.01 OUTLIER Glycine 0 CA--C 1.538 1.516 0 CA-C-O 119.17 -0.794 . . . . 0.0 112.468 169.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mp -121.21 155.76 58.09 Favored Pre-proline 0 CA--C 1.57 1.733 0 C-N-CA 123.408 0.683 . . . . 0.0 112.591 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.29 158.56 33.27 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 123.367 2.712 . . . . 0.0 113.655 177.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -56.51 -32.86 65.48 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 168.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -61.59 -58.3 8.63 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 117.786 -1.102 . . . . 0.0 113.604 171.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.8 mt -68.67 -17.61 64.12 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 88.3 mt -75.67 -55.03 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 119.592 1.087 . . . . 0.0 110.619 169.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -70.81 -27.27 63.75 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -80.61 -50.12 10.39 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 119.8 1.182 . . . . 0.0 111.802 167.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.59 -18.17 58.49 Favored Glycine 0 CA--C 1.551 2.329 0 N-CA-C 120.16 2.824 . . . . 0.0 120.16 176.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -66.15 -43.7 86.24 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 120.401 2.1 . . . . 0.0 114.446 170.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.89 -35.74 80.7 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 167.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 42.7 mt -77.69 113.26 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -108.27 102.67 11.78 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -171.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.96 163.29 34.63 Favored Glycine 0 CA--C 1.544 1.902 0 N-CA-C 115.581 0.993 . . . . 0.0 115.581 -172.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.2 t -98.46 120.46 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.9 p -100.08 116.45 32.13 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.45 0.7 . . . . 0.0 109.171 172.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.77 149.71 23.07 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 121.902 0.858 . . . . 0.0 110.759 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.7 mt -141.93 130.21 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 170.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 85.6 t -118.35 104.09 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 -178.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -79.4 122.53 26.52 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.102 0.561 . . . . 0.0 111.138 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -132.45 68.18 1.51 Allowed 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 170.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.85 -114.07 5.64 Favored Glycine 0 CA--C 1.547 2.038 0 O-C-N 121.625 -0.672 . . . . 0.0 113.788 -176.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -77.62 -34.15 53.43 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 169.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -71.84 135.31 46.57 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 119.872 1.214 . . . . 0.0 111.211 173.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -139.47 105.97 5.32 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -91.84 103.32 15.88 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -80.58 147.83 30.59 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.882 169.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.9 m -138.77 88.92 2.33 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 170.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.5 tt -93.25 119.49 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 123.283 0.633 . . . . 0.0 109.44 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 39.0 m . . . . . 0 N--CA 1.487 1.405 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 179.378 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -128.62 129.49 45.96 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.321 0.648 . . . . 0.0 111.4 -177.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -153.02 143.63 22.71 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 123.609 0.764 . . . . 0.0 109.385 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -103.03 117.98 35.79 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.024 0.53 . . . . 0.0 110.276 176.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.409 ' HB3' HD21 ' A' ' 71' ' ' LEU . 50.5 p90 -101.47 141.29 34.56 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.664 0.786 . . . . 0.0 111.307 172.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.9 m -97.69 129.68 44.73 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 167.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.6 t -73.84 131.09 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 123.586 0.754 . . . . 0.0 109.718 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.31 -54.21 0.56 Allowed Glycine 0 CA--C 1.549 2.218 0 CA-C-N 115.09 -0.959 . . . . 0.0 114.222 -165.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -78.84 147.4 33.21 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.805 0.842 . . . . 0.0 112.506 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -77.14 98.29 5.02 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.955 169.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 59.4 m -98.74 140.62 32.67 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.143 -173.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.19 114.35 19.95 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.144 0.578 . . . . 0.0 110.297 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.409 HD21 ' HB3' ' A' ' 63' ' ' PHE . 69.0 mt . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -165.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 N-CA-C 109.3 -0.629 . . . . 0.0 109.3 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.9 t -132.91 126.25 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -73.26 105.97 4.89 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.152 0.501 . . . . 0.0 109.764 170.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.9 t -142.93 134.96 27.08 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.932 -169.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.7 t -83.77 120.21 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.8 t -94.57 117.48 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 169.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -109.01 141.93 40.42 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 122.05 0.928 . . . . 0.0 110.339 176.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.6 tp -101.08 110.08 22.06 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.165 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -109.67 119.62 39.94 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.71 14.85 75.49 Favored Glycine 0 CA--C 1.548 2.134 0 N-CA-C 120.487 2.955 . . . . 0.0 120.487 176.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.321 7.9 t70 66.9 1.1 2.15 Favored 'General case' 0 CA--C 1.577 1.996 0 N-CA-C 117.392 2.367 . . . . 0.0 117.392 -168.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -142.24 33.75 1.51 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -150.23 104.65 3.28 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 120.877 1.671 . . . . 0.0 107.757 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.9 mt -98.68 102.74 14.56 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 173.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.0 m -109.5 124.26 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 123.735 0.814 . . . . 0.0 109.685 -165.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.1 t -151.01 129.32 12.0 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 122.249 -0.282 . . . . 0.0 111.066 -178.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 52.4 m -103.58 111.52 24.02 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 175.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -69.62 -79.02 0.06 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.702 0.801 . . . . 0.0 110.49 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -116.25 -75.94 0.58 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 169.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -112.45 3.59 16.96 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 162.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.0 mp -85.98 100.47 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -92.91 90.93 7.18 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -84.33 97.03 9.23 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.878 0.871 . . . . 0.0 110.596 -173.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 81.3 t -97.19 96.76 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.5 m -94.02 90.12 6.31 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -171.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -103.51 129.85 50.78 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.865 0.466 . . . . 0.0 109.851 -169.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 tt -109.71 107.7 17.82 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -176.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -95.16 -93.46 0.19 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 118.671 -0.681 . . . . 0.0 109.611 -170.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -85.4 -96.81 0.73 Allowed Glycine 0 N--CA 1.483 1.767 0 CA-C-N 119.028 0.831 . . . . 0.0 112.211 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -126.74 55.93 1.51 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.448 0.642 . . . . 0.0 110.28 166.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.09 -156.89 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.539 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 174.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.0 tt -155.93 119.36 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.192 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 159.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.1 m -97.76 93.94 6.65 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -92.07 112.12 23.93 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.4 m -111.4 94.5 5.0 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -168.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 37.3 mtt -92.14 98.67 11.68 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.743 0.817 . . . . 0.0 108.818 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.6 p -92.09 104.94 17.28 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -174.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.4 tp -102.86 81.54 2.01 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.71 -101.27 1.17 Allowed Glycine 0 CA--C 1.545 1.929 0 CA-C-N 116.479 -0.328 . . . . 0.0 112.92 -173.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -98.82 -16.08 19.01 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 169.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 55.7 mt -82.66 111.97 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 120.274 1.397 . . . . 0.0 107.782 -173.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 61.9 t -99.31 95.73 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -175.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -86.63 94.61 9.52 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.265 0.626 . . . . 0.0 109.84 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -103.36 109.54 21.21 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.286 -173.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -101.53 117.82 35.71 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.791 0.837 . . . . 0.0 109.046 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.9 mp -104.75 102.87 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 -178.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.9 m -122.87 110.74 15.81 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -168.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.9 tttp -81.66 136.92 35.5 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -166.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 71.9 ttt-85 -70.78 120.49 16.45 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 124.175 0.99 . . . . 0.0 111.474 -176.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.0 pt . . . . . 0 N--CA 1.484 1.248 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -173.078 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 . . . . . 0 N--CA 1.493 1.707 0 N-CA-C 118.175 2.658 . . . . 0.0 118.175 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.6 m -68.77 110.73 4.47 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 120.865 1.666 . . . . 0.0 111.525 176.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.78 155.64 10.67 Favored Glycine 0 CA--C 1.541 1.671 0 CA-C-O 122.252 0.918 . . . . 0.0 113.798 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -89.01 124.45 34.28 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 166.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -111.35 102.82 11.18 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -174.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -81.71 130.38 35.04 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.264 1.026 . . . . 0.0 110.764 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.4 tp -62.21 131.3 48.99 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -170.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -91.24 -62.76 1.37 Allowed 'General case' 0 CA--C 1.561 1.382 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.967 169.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.6 m -150.61 144.66 25.39 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.459 0.704 . . . . 0.0 110.968 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -111.83 115.66 29.39 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.605 0.762 . . . . 0.0 108.951 169.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -95.25 122.61 38.12 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 160.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.286 84.2 m-20 67.85 41.01 2.24 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 178.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -70.48 -44.79 66.99 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.667 -1.271 . . . . 0.0 113.306 157.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -63.13 -50.85 68.84 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.74 -40.28 96.73 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 173.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -70.5 -51.44 28.95 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -43.9 98.19 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -178.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -60.42 -40.71 92.02 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 167.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.41 -23.5 65.55 Favored 'General case' 0 CA--C 1.564 1.512 0 N-CA-C 117.516 2.413 . . . . 0.0 117.516 174.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.262 28.2 pt -92.01 -49.73 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 CA-C-N 120.082 1.31 . . . . 0.0 112.414 173.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 142.96 71.18 0.02 OUTLIER Glycine 0 N--CA 1.482 1.703 0 CA-C-N 119.699 1.136 . . . . 0.0 113.393 173.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 mp -128.58 157.17 75.86 Favored Pre-proline 0 CA--C 1.572 1.806 0 C-N-CA 123.555 0.742 . . . . 0.0 112.109 177.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -76.64 155.11 35.38 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 123.331 2.687 . . . . 0.0 113.884 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -59.64 -31.33 69.42 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 170.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -62.45 -49.62 74.71 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 171.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.6 mt -68.74 -26.24 65.15 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 116.986 2.217 . . . . 0.0 116.986 173.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 81.3 mt -78.06 -49.7 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 124.329 1.052 . . . . 0.0 111.256 178.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -75.7 -29.72 59.09 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 178.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -78.65 -47.07 17.76 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.568 1.076 . . . . 0.0 112.397 169.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.41 -22.41 65.55 Favored Glycine 0 CA--C 1.549 2.185 0 N-CA-C 120.09 2.796 . . . . 0.0 120.09 175.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -65.43 -42.07 92.84 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-N 120.252 2.026 . . . . 0.0 114.771 170.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -64.41 -40.88 96.64 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 167.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.27 128.9 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-N 119.39 0.995 . . . . 0.0 108.88 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -80.23 105.1 11.25 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 171.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -84.99 121.11 5.5 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-N 115.718 -0.674 . . . . 0.0 113.141 -173.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.6 t -79.49 118.88 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.4 m -98.62 115.59 28.99 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -101.15 148.2 25.36 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 121.823 0.821 . . . . 0.0 110.737 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 74.0 mt -140.67 130.33 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 169.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 88.9 t -115.08 103.13 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -81.01 120.93 25.42 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.321 0.582 . . . . 0.0 111.124 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -130.21 72.06 1.48 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 163.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.04 -115.96 7.68 Favored Glycine 0 CA--C 1.546 2.03 0 C-N-CA 123.305 0.479 . . . . 0.0 113.848 -173.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -34.12 63.31 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 171.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -73.89 117.81 16.11 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 119.92 1.236 . . . . 0.0 110.55 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -124.2 103.17 8.09 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -90.87 105.18 17.65 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 122.426 1.108 . . . . 0.0 108.619 175.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -106.29 123.9 48.76 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 113.536 -1.665 . . . . 0.0 109.508 -172.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.9 m -120.62 90.69 3.37 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -172.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.6 mm -101.75 112.46 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 -165.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.9 m . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.509 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.5 mm . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -113.23 121.77 45.44 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.377 0.608 . . . . 0.0 110.008 -172.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -142.03 178.31 7.62 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 124.02 0.928 . . . . 0.0 109.302 173.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -141.22 135.65 30.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.802 -1.186 . . . . 0.0 111.236 169.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -118.28 141.85 48.09 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.045 0.938 . . . . 0.0 110.798 175.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.4 m -99.29 125.84 45.0 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 167.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.9 133.3 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 123.667 0.787 . . . . 0.0 110.345 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.27 -55.82 0.55 Allowed Glycine 0 CA--C 1.548 2.147 0 CA-C-N 115.172 -0.922 . . . . 0.0 113.856 -165.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -86.89 151.9 22.91 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.903 0.881 . . . . 0.0 112.307 -174.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -80.67 114.88 19.87 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.82 173.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 60.0 m -114.46 140.03 49.05 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.389 0.675 . . . . 0.0 110.349 -175.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.82 107.42 16.21 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.824 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.1 mt . . . . . 0 N--CA 1.487 1.42 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -167.344 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 86.5 mttt . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.715 0.769 . . . . 0.0 110.601 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.1 m -139.44 125.61 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.305 -167.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -75.61 114.02 13.72 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.165 0.586 . . . . 0.0 110.653 -177.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.3 t -141.51 133.84 28.07 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.483 -166.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.9 t -89.94 124.16 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.4 t -99.79 126.15 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 170.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -119.96 140.22 51.25 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 122.141 0.972 . . . . 0.0 110.017 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.4 tp -101.27 116.79 33.62 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 114.545 -1.207 . . . . 0.0 109.081 -175.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -102.96 115.71 31.13 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 172.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.97 -133.11 13.71 Favored Glycine 0 CA--C 1.545 1.922 0 CA-C-N 114.783 -1.099 . . . . 0.0 113.394 -171.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -131.49 59.33 1.7 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 162.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -161.38 -40.66 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -174.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -109.74 99.02 8.25 Favored 'General case' 0 CA--C 1.558 1.263 0 CA-C-N 119.844 1.202 . . . . 0.0 111.118 -162.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 64.2 mt -95.24 105.78 17.75 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.5 t -105.79 125.09 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -169.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.2 t -151.87 136.83 17.26 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 22.8 p -111.2 106.56 15.6 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.809 0.844 . . . . 0.0 108.897 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -65.78 -69.6 0.29 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 123.824 0.849 . . . . 0.0 113.239 -173.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -127.72 -78.45 0.58 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 170.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -124.43 73.39 1.25 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 156.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 17.0 mt -148.33 105.63 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 103.646 -2.724 . . . . 0.0 103.646 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -75.01 142.14 43.87 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 171.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.0 t -143.05 99.8 3.52 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -178.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 84.4 t -102.62 98.28 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 177.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.0 m -95.26 90.92 6.03 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -174.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -108.98 126.98 53.67 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -165.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 tt -100.56 104.43 15.78 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -173.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -102.28 94.9 5.96 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -173.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.63 -111.58 3.31 Favored Glycine 0 N--CA 1.485 1.949 0 CA-C-O 119.864 -0.409 . . . . 0.0 112.252 -177.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -127.96 58.93 1.5 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.779 0.8 . . . . 0.0 110.615 160.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.8 pt -123.06 -154.62 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.762 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 159.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.5 tt -159.61 116.87 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 O-C-N 120.368 -1.457 . . . . 0.0 107.319 161.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 67.9 m -99.76 99.47 10.29 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 176.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -94.32 103.23 15.24 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.8 m -106.37 97.6 7.38 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -172.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 68.0 mtp -101.91 106.91 17.92 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.8 p -100.5 107.68 19.44 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -173.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 28.9 tp -71.93 -70.49 0.33 Allowed 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.159 0.583 . . . . 0.0 112.195 -176.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -123.52 -87.36 0.79 Allowed Glycine 0 CA--C 1.538 1.499 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 158.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -89.9 -11.11 42.81 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 167.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 68.5 mt -85.09 110.79 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -172.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.77 95.11 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 -175.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -82.07 93.04 6.92 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.076 0.55 . . . . 0.0 109.785 177.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -95.77 110.78 22.88 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -113.74 103.82 11.59 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -175.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.0 mp -98.9 121.16 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 -172.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.7 m -141.62 122.83 14.75 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 122.765 0.426 . . . . 0.0 109.962 -172.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -94.41 135.75 35.47 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.673 0.789 . . . . 0.0 112.276 -170.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.5 ttp180 -68.87 133.71 48.63 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.17 0.588 . . . . 0.0 112.569 -177.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.2 pt . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 -173.846 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 118.497 2.777 . . . . 0.0 118.497 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.6 m -73.83 112.12 9.64 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 121.631 2.014 . . . . 0.0 110.643 173.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.84 139.32 4.17 Favored Glycine 0 CA--C 1.542 1.739 0 CA-C-O 121.221 0.345 . . . . 0.0 113.561 -174.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -89.73 113.92 25.51 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 169.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -107.85 105.71 15.65 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -167.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -79.28 124.02 27.99 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.034 0.934 . . . . 0.0 110.837 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.9 tp -65.73 124.45 22.46 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.384 0.611 . . . . 0.0 112.576 -176.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -106.12 -65.84 1.04 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.095 0.958 . . . . 0.0 109.801 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.8 t -130.22 115.79 17.49 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -175.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -106.49 108.05 19.37 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -90.64 135.92 33.4 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.944 0.898 . . . . 0.0 110.171 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.7 m120 61.81 46.07 7.19 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 174.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -77.44 -46.25 23.22 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.27 -50.99 67.94 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 171.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.58 -38.91 78.91 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 177.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -76.67 -56.34 4.7 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 119.096 0.862 . . . . 0.0 112.903 178.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.07 -53.29 59.76 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -59.24 -36.05 74.77 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 174.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.42 -36.01 80.4 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 171.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.274 45.7 pt -78.79 -48.75 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 119.972 1.26 . . . . 0.0 112.975 175.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 143.73 61.62 0.02 OUTLIER Glycine 0 CA--C 1.543 1.824 0 CA-C-N 119.116 0.871 . . . . 0.0 113.253 171.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.8 151.97 58.38 Favored Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 123.828 0.851 . . . . 0.0 111.123 -174.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.04 144.53 30.21 Favored 'Trans proline' 0 C--N 1.369 1.654 0 C-N-CA 123.226 2.618 . . . . 0.0 113.633 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -65.07 -20.24 66.38 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 171.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -62.46 -54.64 37.09 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 120.28 1.4 . . . . 0.0 113.483 166.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.85 -21.32 66.77 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 117.258 2.318 . . . . 0.0 117.258 173.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.3 mt -78.61 -50.74 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 124.237 1.015 . . . . 0.0 110.927 173.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -74.88 -26.6 59.78 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -78.38 -48.36 15.69 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 119.673 1.124 . . . . 0.0 111.67 165.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.18 -17.02 60.88 Favored Glycine 0 CA--C 1.55 2.258 0 N-CA-C 120.445 2.938 . . . . 0.0 120.445 176.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -68.2 -43.39 78.18 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 120.473 2.136 . . . . 0.0 114.036 168.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -66.44 -31.75 72.7 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 167.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.3 mt -85.27 113.87 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -87.06 107.84 18.61 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.77 128.56 8.97 Favored Glycine 0 CA--C 1.54 1.599 0 CA-C-N 115.984 -0.553 . . . . 0.0 113.683 -170.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.6 t -80.01 114.58 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 174.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 51.4 m -113.88 118.08 33.22 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -173.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -95.54 153.84 17.51 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 122.122 0.963 . . . . 0.0 111.801 -174.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 69.1 mt -138.03 126.08 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 103.585 -2.746 . . . . 0.0 103.585 160.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 69.0 t -111.1 102.37 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -80.33 120.0 23.81 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.132 0.573 . . . . 0.0 110.781 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -129.75 72.6 1.48 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 165.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.62 -111.48 4.1 Favored Glycine 0 CA--C 1.545 1.963 0 C-N-CA 123.35 0.5 . . . . 0.0 114.181 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -74.65 -37.21 62.8 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 172.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -72.39 139.51 47.86 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 119.625 1.102 . . . . 0.0 111.624 175.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -141.65 96.66 3.01 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -87.99 102.99 15.28 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 122.015 0.912 . . . . 0.0 108.852 174.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -97.0 130.42 44.33 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.053 178.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.9 m -120.18 84.72 2.26 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 176.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.6 tt -91.26 115.47 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 C-N-CA 123.395 0.678 . . . . 0.0 109.515 -169.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 39.1 m . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.067 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.0 mp . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -101.1 122.95 44.5 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.27 0.557 . . . . 0.0 109.876 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -145.46 165.08 29.61 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.936 0.895 . . . . 0.0 109.155 169.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.18 143.18 48.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.407 -0.808 . . . . 0.0 110.716 164.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -118.5 138.76 52.29 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.999 0.904 . . . . 0.0 110.072 166.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.3 m -97.32 125.32 41.84 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 168.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.3 t -72.23 131.75 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 C-N-CA 123.662 0.785 . . . . 0.0 109.525 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.27 -56.41 0.66 Allowed Glycine 0 CA--C 1.547 2.076 0 CA-C-N 115.44 -0.8 . . . . 0.0 113.534 -163.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -71.83 147.9 46.72 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.175 0.99 . . . . 0.0 112.965 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -81.19 103.39 10.94 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.086 169.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 56.6 m -100.54 137.86 38.38 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 121.752 0.787 . . . . 0.0 111.837 -166.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -80.15 115.38 19.68 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.903 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 N--CA 1.486 1.357 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -167.146 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.275 38.2 ttmt . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.318 0.104 . . . . 0.0 111.016 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.3 t -112.35 124.5 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -83.85 106.42 15.52 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 171.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.9 t -141.35 139.84 33.64 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.854 0.862 . . . . 0.0 110.462 -168.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.4 t -91.12 130.13 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -174.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.6 t -106.14 126.17 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -106.95 154.29 21.29 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.691 0.758 . . . . 0.0 111.402 170.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.0 tp -119.62 123.37 43.72 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -122.33 127.52 49.91 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.688 0.756 . . . . 0.0 109.083 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.25 13.68 67.76 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 120.877 3.111 . . . . 0.0 120.877 175.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.279 4.4 t70 54.08 41.4 32.03 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -163.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -157.91 -26.18 0.08 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 115.672 1.731 . . . . 0.0 115.672 -176.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -113.75 101.22 9.09 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 121.112 1.778 . . . . 0.0 109.293 -173.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 57.7 mt -95.25 103.37 15.22 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 172.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.7 m -112.17 124.34 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 123.784 0.834 . . . . 0.0 109.477 -165.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 t -155.62 133.81 11.53 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 122.693 0.397 . . . . 0.0 110.384 -176.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 42.6 m -103.73 113.92 27.8 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -83.16 79.38 9.4 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.744 0.818 . . . . 0.0 109.768 176.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.351 12.0 tmtt? 69.93 -81.22 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.544 1.137 . . . . 0.0 111.836 -173.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -104.51 -34.05 8.35 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 170.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.0 mp -84.75 117.86 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-N 119.754 1.161 . . . . 0.0 108.685 -161.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -91.22 103.62 16.27 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 122.371 0.268 . . . . 0.0 110.496 -169.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.7 m -88.0 117.19 26.7 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.331 0.652 . . . . 0.0 109.243 178.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 78.7 t -120.58 103.23 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.9 m -100.49 91.8 4.85 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -172.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -84.7 146.48 27.41 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.29 1.036 . . . . 0.0 111.421 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 tt -131.04 106.94 8.72 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -85.99 -89.96 0.11 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.243 -170.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.23 -108.05 2.56 Favored Glycine 0 N--CA 1.483 1.795 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -106.69 63.06 0.64 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.765 0.793 . . . . 0.0 109.606 164.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.4 pt -140.3 -161.71 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.83 0 C-N-CA 124.7 1.2 . . . . 0.0 108.284 176.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.9 tt -159.8 130.65 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.372 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 160.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.7 m -111.93 89.04 2.95 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -84.07 103.25 13.15 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.719 0.808 . . . . 0.0 109.179 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.3 m -109.85 96.17 6.08 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -169.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 59.6 mtt -96.84 104.75 16.78 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 44.7 p -92.22 110.0 21.38 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -174.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.9 tp -104.23 76.97 1.37 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 175.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.18 -105.84 1.74 Allowed Glycine 0 CA--C 1.546 2.008 0 C-N-CA 123.025 0.345 . . . . 0.0 113.228 -171.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -94.42 -7.96 40.04 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 169.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 78.0 mt -89.28 101.43 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -174.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 39.2 t -98.19 97.47 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -172.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -85.51 98.51 10.66 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.494 0.717 . . . . 0.0 109.351 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -109.29 105.24 14.56 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.387 -173.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 45.1 mtp85 -87.01 120.98 28.85 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 172.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 73.1 mt -109.32 100.8 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 103.471 -2.789 . . . . 0.0 103.471 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.8 m -126.06 116.64 21.72 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -168.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -88.77 132.92 34.42 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.596 0.758 . . . . 0.0 112.04 -168.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -68.64 134.25 49.63 Favored 'General case' 0 CA--C 1.556 1.191 0 CA-C-O 121.934 0.873 . . . . 0.0 112.587 -175.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.0 pt . . . . . 0 N--CA 1.485 1.3 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 -174.459 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 117.856 2.539 . . . . 0.0 117.856 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.9 p -68.47 114.93 7.31 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 121.176 1.807 . . . . 0.0 112.171 176.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 166.23 167.73 27.33 Favored Glycine 0 CA--C 1.543 1.806 0 CA-C-N 114.634 -1.166 . . . . 0.0 113.731 -168.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -126.24 106.72 9.74 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 106.841 -1.541 . . . . 0.0 106.841 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -107.15 102.45 11.77 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -159.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -94.96 141.91 28.1 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.808 0.813 . . . . 0.0 111.704 -176.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 31.9 tp -66.98 128.45 36.4 Favored 'General case' 0 CA--C 1.558 1.261 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -167.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -94.72 -62.74 1.27 Allowed 'General case' 0 CA--C 1.561 1.382 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.926 169.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.2 t -139.34 135.56 33.88 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.666 0.786 . . . . 0.0 109.751 -170.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -131.92 119.8 21.64 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -173.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -93.45 -70.95 0.68 Allowed 'General case' 0 CA--C 1.556 1.185 0 CA-C-O 118.068 -0.967 . . . . 0.0 112.336 -164.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -105.24 76.8 1.25 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 119.591 1.087 . . . . 0.0 110.032 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -88.14 -47.06 8.76 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.575 0.75 . . . . 0.0 112.935 170.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -64.35 -51.09 65.07 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.3 -38.97 88.71 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 116.675 2.102 . . . . 0.0 116.675 173.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -70.14 -54.75 11.6 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 119.318 0.963 . . . . 0.0 113.555 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 32.9 mtt -60.53 -47.13 87.51 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -58.27 -37.45 74.99 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 115.948 1.832 . . . . 0.0 115.948 169.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.5 -38.43 84.33 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 173.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.5 pt -76.96 -39.88 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.55 59.44 0.13 Allowed Glycine 0 CA--C 1.543 1.834 0 C-N-CA 124.223 0.915 . . . . 0.0 112.91 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.24 149.75 52.47 Favored Pre-proline 0 CA--C 1.566 1.58 0 C-N-CA 124.213 1.005 . . . . 0.0 109.889 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -71.73 141.12 36.93 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 123.109 2.54 . . . . 0.0 113.528 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -61.08 -33.47 73.38 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -60.56 -47.32 86.7 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 170.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.5 mt -67.77 -18.9 65.02 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 172.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.0 mt -68.92 -53.51 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-N 119.79 1.177 . . . . 0.0 110.756 169.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -63.96 -27.56 69.22 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 173.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.7 ttpm? -74.37 -56.7 4.56 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-N 119.733 1.152 . . . . 0.0 112.091 172.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.95 -16.42 66.28 Favored Glycine 0 CA--C 1.552 2.397 0 N-CA-C 119.822 2.689 . . . . 0.0 119.822 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -69.08 -44.62 72.16 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 120.37 2.085 . . . . 0.0 114.264 171.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -66.74 -34.89 78.83 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 170.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 55.6 mt -73.2 123.43 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 175.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -84.01 104.94 14.49 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 174.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -85.1 131.67 10.58 Favored Glycine 0 CA--C 1.539 1.587 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.715 -170.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.2 t -84.99 113.51 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.4 m -96.55 100.46 12.03 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.92 142.16 31.64 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.402 0.62 . . . . 0.0 110.181 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.5 mt -142.43 119.91 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 174.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 94.3 t -109.58 109.73 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 175.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -85.65 123.1 30.67 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.18 0.592 . . . . 0.0 110.261 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -123.6 69.57 1.04 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 166.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.95 -114.35 6.06 Favored Glycine 0 CA--C 1.545 1.941 0 C-N-CA 123.41 0.528 . . . . 0.0 113.981 -177.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -77.68 -31.86 52.75 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 170.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -75.27 114.6 13.98 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 119.723 1.147 . . . . 0.0 110.136 175.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -112.44 105.83 14.18 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -84.17 138.48 32.97 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.705 162.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -141.48 146.65 36.71 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.819 0.448 . . . . 0.0 110.993 172.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.1 m -132.25 97.55 4.15 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 176.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.3 tt -94.56 115.54 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 75.8 p . . . . . 0 N--CA 1.487 1.387 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.753 -170.111 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.5 mm . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -105.67 131.64 52.79 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.993 0.517 . . . . 0.0 110.825 173.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -136.73 137.33 39.81 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.727 0.775 . . . . 0.0 109.04 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -118.46 126.84 52.9 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -174.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -139.81 173.13 11.84 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.838 0.828 . . . . 0.0 112.406 -176.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.2 m -133.11 131.8 40.94 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 170.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.1 m -69.12 134.01 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 123.262 0.625 . . . . 0.0 111.793 175.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.73 -53.24 0.77 Allowed Glycine 0 CA--C 1.546 2.03 0 CA-C-O 119.681 -0.511 . . . . 0.0 114.095 -166.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -75.21 152.66 38.35 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.742 0.817 . . . . 0.0 112.368 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -87.03 99.48 11.93 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 173.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.0 m -100.97 150.67 22.64 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 121.515 0.674 . . . . 0.0 112.203 -172.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.96 127.76 35.67 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.92 174.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mp . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -175.863 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.4 mptt . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.5 m -98.36 119.07 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -175.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -87.78 98.79 11.66 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -177.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.8 t -139.78 144.33 37.34 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.307 0.643 . . . . 0.0 110.745 -167.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.0 t -97.6 124.21 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -176.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.3 t -106.3 133.1 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -112.11 137.6 49.93 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.516 0.674 . . . . 0.0 109.902 174.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.4 tp -94.72 117.58 30.36 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 171.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -119.03 119.38 34.11 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 177.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.09 12.16 79.31 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 121.378 3.311 . . . . 0.0 121.378 173.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.276 5.9 t70 55.9 43.82 26.82 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -164.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -156.67 -40.91 0.07 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 117.91 -1.043 . . . . 0.0 113.749 -176.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -101.75 132.82 47.27 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 120.193 1.36 . . . . 0.0 110.458 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 38.6 mt -116.78 99.48 7.14 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 165.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 29.0 m -98.93 121.27 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 123.564 0.745 . . . . 0.0 109.659 -170.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.1 t -154.49 128.87 9.1 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 122.212 -0.305 . . . . 0.0 110.983 -177.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.6 t -109.79 129.04 55.67 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.37 0.668 . . . . 0.0 110.219 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -148.51 120.68 8.32 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.63 0.772 . . . . 0.0 109.226 -169.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.321 28.1 mtpp 74.6 -94.66 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 124.389 1.076 . . . . 0.0 108.239 -170.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -146.3 66.77 1.19 Allowed 'General case' 0 CA--C 1.562 1.405 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 151.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 57.9 mt -135.35 96.47 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 103.787 -2.672 . . . . 0.0 103.787 -172.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -88.25 95.28 10.12 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.388 0.613 . . . . 0.0 109.425 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.0 t -84.04 102.09 12.25 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.803 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 69.3 t -100.28 98.47 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 175.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.7 m -94.69 84.2 4.2 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -172.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -97.42 125.91 42.35 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.542 0.737 . . . . 0.0 109.215 -166.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 tt -103.28 103.45 13.48 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -172.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -100.99 92.35 4.98 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -171.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.79 -109.8 2.97 Favored Glycine 0 CA--C 1.543 1.824 0 N-CA-C 112.056 -0.418 . . . . 0.0 112.056 -176.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -126.75 58.31 1.41 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.614 0.721 . . . . 0.0 110.822 162.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.8 pt -125.06 -158.55 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.688 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 160.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.0 tt -157.78 118.84 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 120.06 -1.65 . . . . 0.0 108.861 163.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.0 m -102.48 94.55 5.73 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -91.08 110.96 22.24 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.491 0.716 . . . . 0.0 109.299 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.6 m -113.93 95.39 5.29 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -168.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 42.4 mtt -96.66 101.2 12.76 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.754 0.822 . . . . 0.0 109.09 -178.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.6 p -93.05 103.17 15.49 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -173.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.2 tp -99.51 82.48 2.65 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 175.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.85 -104.67 1.66 Allowed Glycine 0 CA--C 1.544 1.847 0 CA-C-N 116.427 -0.351 . . . . 0.0 112.623 -173.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -100.2 -2.82 32.95 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 168.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 61.2 mt -90.18 103.09 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -175.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.1 t -97.72 91.67 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -172.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -80.97 92.68 6.22 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.584 0.754 . . . . 0.0 109.661 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -111.83 105.76 14.32 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.63 -171.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -111.88 122.15 46.99 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.76 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.7 mp -102.83 118.42 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 -172.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.7 m -137.65 117.56 13.28 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -171.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.9 ttpp -88.16 138.18 31.67 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -171.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -68.46 122.93 19.47 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.793 0.837 . . . . 0.0 112.081 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 24.4 pt . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 123.102 1.43 . . . . 0.0 108.438 -174.655 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 . . . . . 0 N--CA 1.494 1.736 0 N-CA-C 118.016 2.599 . . . . 0.0 118.016 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.3 m -73.66 116.16 13.92 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 121.275 1.852 . . . . 0.0 110.399 168.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.88 158.53 22.25 Favored Glycine 0 CA--C 1.541 1.708 0 CA-C-O 122.34 0.967 . . . . 0.0 114.516 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.9 mptt -98.75 116.79 31.78 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 166.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -108.4 101.91 11.05 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -168.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -88.8 121.97 31.72 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.713 0.805 . . . . 0.0 109.779 -173.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.8 tp -61.7 119.36 8.55 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -92.88 -67.19 0.87 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.354 173.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.6 m -122.4 144.3 49.12 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.184 0.994 . . . . 0.0 109.625 -176.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -134.27 103.4 5.73 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -178.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -85.53 137.51 32.83 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.224 1.01 . . . . 0.0 110.329 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.8 m120 60.03 46.7 10.55 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 175.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -76.32 -49.45 16.88 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -64.52 -44.07 92.07 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 171.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.0 -46.36 88.37 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 173.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -71.93 -55.48 7.4 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 119.16 0.891 . . . . 0.0 113.184 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.93 -46.4 90.81 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -177.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -60.03 -40.31 88.88 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.192 1.552 . . . . 0.0 115.192 170.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.14 -28.74 66.72 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 117.371 2.36 . . . . 0.0 117.371 174.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.264 20.1 pt -81.08 -48.04 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-N 120.313 1.415 . . . . 0.0 112.776 172.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 143.59 66.61 0.02 OUTLIER Glycine 0 N--CA 1.48 1.623 0 CA-C-N 119.12 0.873 . . . . 0.0 112.975 173.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mp -130.47 154.99 81.73 Favored Pre-proline 0 CA--C 1.567 1.619 0 C-N-CA 123.558 0.743 . . . . 0.0 111.806 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.35 155.87 32.66 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.079 2.519 . . . . 0.0 113.383 175.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -63.38 -24.16 67.72 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 165.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -59.63 -53.49 57.44 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 119.974 1.261 . . . . 0.0 114.265 168.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 98.6 mt -69.58 -24.9 63.75 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 117.077 2.251 . . . . 0.0 117.077 175.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 41.3 mt -75.71 -53.76 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-N 119.725 1.148 . . . . 0.0 110.485 173.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 46.1 mm-40 -71.67 -22.86 61.61 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 116.485 2.031 . . . . 0.0 116.485 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.66 -45.47 12.45 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.736 1.153 . . . . 0.0 112.717 167.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.52 -20.34 55.63 Favored Glycine 0 CA--C 1.553 2.454 0 N-CA-C 119.881 2.713 . . . . 0.0 119.881 173.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -64.71 -43.65 92.76 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 120.144 1.972 . . . . 0.0 114.772 168.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -63.11 -38.86 92.86 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 167.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 69.7 mt -72.94 128.7 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 123.943 0.897 . . . . 0.0 108.706 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -76.78 111.92 12.82 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.307 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.66 105.89 3.14 Favored Glycine 0 N--CA 1.478 1.437 0 CA-C-N 115.865 -0.607 . . . . 0.0 113.553 -170.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.0 t -94.61 111.62 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 174.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 70.6 m -117.25 109.16 16.52 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.89 159.87 22.25 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.98 -173.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.3 mt -136.02 131.56 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 160.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.6 t -115.09 102.43 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -79.29 120.99 24.53 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.195 0.598 . . . . 0.0 110.684 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -127.26 73.22 1.41 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 166.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.14 -119.08 9.22 Favored Glycine 0 CA--C 1.546 2.031 0 C-N-CA 123.209 0.433 . . . . 0.0 113.598 -174.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.252 0.0 OUTLIER -71.41 -28.7 64.19 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 116.568 2.062 . . . . 0.0 116.568 169.294 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -75.55 132.01 40.42 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 120.015 1.28 . . . . 0.0 110.965 175.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -132.99 99.98 4.75 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -93.95 104.99 17.03 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 121.944 0.878 . . . . 0.0 108.875 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -90.46 134.26 34.47 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.927 176.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.7 m -119.54 98.91 6.36 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.4 mt -82.71 141.91 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 173.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.5 p . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 170.352 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.2 mp . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -108.54 124.89 51.15 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.53 0.732 . . . . 0.0 109.939 -176.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -150.87 144.84 25.27 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 122.76 0.424 . . . . 0.0 110.9 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -118.12 132.59 56.33 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.937 0.895 . . . . 0.0 110.534 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -117.55 142.58 47.01 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.787 0.835 . . . . 0.0 111.509 171.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.8 m -89.38 140.5 29.45 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 159.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.7 t -76.37 122.3 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 172.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.22 40.31 9.29 Favored Glycine 0 CA--C 1.549 2.167 0 N-CA-C 116.784 1.473 . . . . 0.0 116.784 -168.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -151.62 143.16 23.55 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.184 0.994 . . . . 0.0 108.318 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -74.0 106.88 5.89 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.325 0.583 . . . . 0.0 109.659 168.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 40.8 m -110.51 136.32 49.83 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.048 -171.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -83.58 93.49 7.87 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.863 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.8 mt . . . . . 0 N--CA 1.485 1.315 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -171.277 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.058 0.456 . . . . 0.0 111.596 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.9 m -139.84 136.69 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 123.734 0.814 . . . . 0.0 109.407 -169.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -72.05 133.66 45.39 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.023 0.929 . . . . 0.0 112.461 -176.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 t -154.14 142.0 20.1 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 122.974 0.51 . . . . 0.0 110.287 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.29 123.16 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.4 t -99.32 137.03 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -177.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 17.1 mp0 -124.41 136.78 54.32 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 173.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 42.0 tp -91.16 105.97 18.18 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 174.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -93.98 115.35 27.69 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.59 -127.51 9.14 Favored Glycine 0 CA--C 1.546 1.981 0 CA-C-N 114.428 -1.26 . . . . 0.0 113.021 -170.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -118.54 -11.95 9.85 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 173.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -123.87 -13.0 7.48 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 117.424 2.379 . . . . 0.0 117.424 -173.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -113.51 96.46 5.89 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 121.398 1.908 . . . . 0.0 110.472 -165.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 70.5 mt -86.37 105.16 16.52 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.1 m -99.0 125.88 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 123.862 0.865 . . . . 0.0 109.225 -174.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.6 t -152.65 125.93 8.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 122.138 -0.351 . . . . 0.0 110.376 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.3 t -112.62 131.29 55.7 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.487 0.715 . . . . 0.0 110.16 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -84.45 -82.37 0.17 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.623 0.769 . . . . 0.0 108.967 175.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -130.57 -77.69 0.53 Allowed 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 167.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -86.42 -36.25 19.24 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 174.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 52.4 mt -69.45 129.25 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 C-N-CA 124.455 1.102 . . . . 0.0 109.01 176.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -128.18 97.14 4.66 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.7 t -89.97 106.07 18.23 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.719 0.807 . . . . 0.0 110.717 -170.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.9 t -105.08 95.7 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.2 m -97.28 88.17 4.37 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -168.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -87.7 139.98 29.98 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.03 0.932 . . . . 0.0 110.194 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 tt -119.86 98.33 6.05 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -99.47 94.51 6.45 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -172.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.94 -112.7 3.51 Favored Glycine 0 N--CA 1.483 1.789 0 CA-C-O 119.879 -0.4 . . . . 0.0 112.118 -176.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -123.77 59.3 1.13 Allowed 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.397 0.618 . . . . 0.0 111.134 169.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.73 -154.09 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.736 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 164.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.5 tt -160.23 117.01 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 157.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.5 m -98.41 95.89 7.64 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -94.6 106.84 18.83 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.6 m -105.36 101.79 11.31 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -173.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 44.5 mtt -97.71 101.68 13.25 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.0 p -90.98 115.4 27.96 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . 0.265 24.3 tp -84.5 -104.36 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -177.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -90.97 -94.94 1.26 Allowed Glycine 0 N--CA 1.48 1.596 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 168.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -88.83 -8.09 54.98 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 164.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 42.2 mt -84.21 119.32 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-N 119.808 1.186 . . . . 0.0 107.809 -173.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.1 t -102.73 97.41 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -76.61 135.49 39.18 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 166.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -145.6 101.52 3.58 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -95.05 129.24 42.22 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.2 0.6 . . . . 0.0 110.152 173.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 88.8 mt -110.88 112.54 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 104.083 -2.562 . . . . 0.0 104.083 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.0 m -131.88 118.01 19.26 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -172.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -79.82 130.03 34.98 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -166.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 55.4 ttp85 -73.66 119.04 17.34 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.316 0.646 . . . . 0.0 111.141 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 33.0 pt . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 123.013 1.387 . . . . 0.0 109.026 -170.131 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 . . . . . 0 N--CA 1.494 1.747 0 N-CA-C 117.522 2.416 . . . . 0.0 117.522 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.8 m -69.21 120.29 14.81 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 121.222 1.828 . . . . 0.0 111.622 174.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.67 156.79 8.51 Favored Glycine 0 CA--C 1.54 1.653 0 CA-C-O 122.507 1.06 . . . . 0.0 113.898 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -79.93 140.94 36.49 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 113.979 -1.111 . . . . 0.0 108.934 162.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -135.51 105.97 6.43 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.32 122.68 28.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 122.032 -0.417 . . . . 0.0 110.658 -176.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.8 tp -66.65 120.28 13.2 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.348 0.659 . . . . 0.0 112.114 -178.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -109.64 -63.53 1.36 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 118.556 -0.735 . . . . 0.0 110.499 -176.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.9 m -110.07 107.96 18.0 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -178.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -100.11 121.34 41.26 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 122.189 0.995 . . . . 0.0 108.485 170.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -85.75 -64.6 1.13 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.115 -169.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -115.67 67.06 0.7 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 118.379 0.536 . . . . 0.0 110.73 175.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -72.02 -51.7 20.52 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 166.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -63.67 -48.78 75.79 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.34 -40.01 92.67 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 116.498 2.036 . . . . 0.0 116.498 171.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -66.54 -51.9 51.49 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 177.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.9 -47.94 70.64 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 174.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -57.22 -41.29 79.2 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 169.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.76 -33.21 72.1 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 117.056 2.243 . . . . 0.0 117.056 175.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.3 pt -76.74 -41.85 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 CA-C-N 120.129 1.331 . . . . 0.0 113.481 172.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.58 62.05 0.15 Allowed Glycine 0 CA--C 1.542 1.765 0 C-N-CA 124.205 0.907 . . . . 0.0 112.674 175.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.17 150.39 51.26 Favored Pre-proline 0 CA--C 1.568 1.669 0 C-N-CA 124.026 0.93 . . . . 0.0 110.764 -176.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.53 148.47 37.6 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 123.205 2.604 . . . . 0.0 113.84 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -61.86 -26.05 67.9 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 173.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -61.28 -50.14 74.23 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 166.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.3 mt -70.99 -16.88 62.65 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 116.916 2.191 . . . . 0.0 116.916 171.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 84.8 mt -73.82 -54.06 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 120.152 1.342 . . . . 0.0 110.584 169.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -66.79 -27.96 68.0 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 116.353 1.982 . . . . 0.0 116.353 176.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -73.86 -60.92 2.03 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-N 119.463 1.028 . . . . 0.0 111.097 166.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.94 -15.32 57.97 Favored Glycine 0 CA--C 1.553 2.415 0 N-CA-C 120.53 2.972 . . . . 0.0 120.53 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -66.99 -47.31 71.91 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 119.985 1.892 . . . . 0.0 113.862 169.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -72.78 -35.65 67.45 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 171.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 37.8 mt -73.5 121.33 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.021 -1.104 . . . . 0.0 108.021 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -89.77 119.12 29.89 Favored 'General case' 0 CA--C 1.557 1.225 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.52 135.3 12.72 Favored Glycine 0 CA--C 1.542 1.76 0 CA-C-N 116.714 -0.221 . . . . 0.0 113.593 -177.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.35 116.23 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.1 p -94.35 102.63 14.62 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 121.477 0.656 . . . . 0.0 109.262 174.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.02 142.33 27.88 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.829 176.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.1 mt -139.1 128.9 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.3 t -117.39 103.98 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 -178.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -85.06 131.68 34.42 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.302 0.641 . . . . 0.0 110.771 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -135.99 72.63 1.44 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 168.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.81 -105.15 1.82 Allowed Glycine 0 CA--C 1.544 1.902 0 O-C-N 121.886 -0.509 . . . . 0.0 113.571 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.253 0.0 OUTLIER -97.54 -15.56 20.48 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 166.123 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -77.71 149.99 34.52 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 119.772 1.169 . . . . 0.0 111.412 171.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -146.23 142.66 28.6 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.754 0.822 . . . . 0.0 110.1 -174.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -136.33 113.44 10.54 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 165.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -91.82 148.19 22.42 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.502 169.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.5 m -133.9 91.85 2.88 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 173.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.1 mm -91.92 110.62 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.9 p . . . . . 0 N--CA 1.487 1.396 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -176.484 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.3 mp . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -110.72 117.69 34.14 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -147.74 133.61 19.07 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -108.16 145.64 33.88 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 122.193 0.997 . . . . 0.0 111.7 -175.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -133.26 167.14 20.92 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.631 174.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.0 m -129.56 132.22 46.76 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 169.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.3 t -71.41 127.47 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 C-N-CA 123.467 0.707 . . . . 0.0 109.508 -177.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.73 -55.66 0.8 Allowed Glycine 0 CA--C 1.545 1.949 0 CA-C-N 115.606 -0.725 . . . . 0.0 113.891 -166.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -81.15 147.16 30.17 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.715 0.769 . . . . 0.0 112.219 -177.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -84.08 116.05 22.68 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.087 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.7 m -130.31 150.21 51.64 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.773 0.797 . . . . 0.0 111.987 -174.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.97 128.13 35.58 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.839 0.856 . . . . 0.0 113.055 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.2 mt . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.771 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.2 mptt . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.311 0.576 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.0 m -80.87 -38.79 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 177.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . 0.286 37.5 ttmt 74.0 106.06 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.909 1.284 . . . . 0.0 111.113 -177.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.3 t -145.06 152.03 39.46 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.844 0.831 . . . . 0.0 110.4 -172.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.4 t -98.5 127.89 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 -176.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 t -104.91 129.79 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -178.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.7 mp0 -110.91 134.58 52.44 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 172.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.1 tp -95.84 104.39 16.32 Favored 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -98.96 121.0 40.35 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 122.135 0.969 . . . . 0.0 108.914 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.14 9.68 72.38 Favored Glycine 0 CA--C 1.55 2.269 0 N-CA-C 120.563 2.985 . . . . 0.0 120.563 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.305 2.3 t70 64.61 16.5 10.36 Favored 'General case' 0 CA--C 1.577 2.007 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 -165.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -157.39 44.84 0.36 Allowed 'General case' 0 CA--C 1.568 1.655 0 O-C-N 121.018 -1.051 . . . . 0.0 113.401 175.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -160.28 112.69 2.03 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 173.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 38.8 mt -98.74 98.24 9.38 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 173.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.8 t -98.27 113.84 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -167.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.7 t -153.51 134.82 14.17 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -176.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.9 m -103.31 112.51 25.42 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -74.84 -84.45 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.061 0.544 . . . . 0.0 110.984 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -93.73 -82.77 0.34 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 169.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -127.59 62.69 1.38 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 152.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 69.0 mt -120.73 95.3 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 103.246 -2.872 . . . . 0.0 103.246 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -84.28 90.97 7.64 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 122.138 0.97 . . . . 0.0 109.21 -174.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.0 t -95.83 117.52 30.72 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.185 -168.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 74.5 t -116.9 106.28 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 104.616 -2.364 . . . . 0.0 104.616 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.3 m -91.77 88.5 6.7 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -175.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -96.37 119.88 35.65 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.232 0.613 . . . . 0.0 109.866 -166.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 tt -101.59 106.56 17.65 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -176.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -90.13 -87.39 0.18 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 118.926 -0.559 . . . . 0.0 110.237 -170.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -101.67 -109.7 3.27 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 178.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -106.05 64.06 0.67 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.95 0.881 . . . . 0.0 109.5 163.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.5 pt -144.19 -170.41 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.574 1.887 0 C-N-CA 125.184 1.394 . . . . 0.0 107.713 175.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.3 tt -152.11 125.02 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 120.326 -1.483 . . . . 0.0 108.866 156.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 81.7 m -103.69 99.65 9.45 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -93.38 107.66 19.45 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 32.6 m -107.46 100.68 10.09 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -170.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 40.7 mtt -101.88 100.79 11.15 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.903 0.881 . . . . 0.0 109.194 -176.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 73.8 p -94.63 104.47 16.41 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -175.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 49.4 tp -103.66 84.88 2.35 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.88 -102.71 1.46 Allowed Glycine 0 CA--C 1.545 1.94 0 CA-C-N 116.231 -0.441 . . . . 0.0 112.12 -171.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -103.92 -4.98 22.73 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 169.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 80.6 mt -90.35 109.5 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-N 120.543 1.52 . . . . 0.0 107.048 -172.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 49.7 t -97.78 95.08 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -173.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -84.42 96.39 9.07 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.353 0.661 . . . . 0.0 109.419 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -101.33 109.07 20.85 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.549 -173.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.9 mtm180 -103.08 109.04 20.45 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.0 mp -99.79 99.19 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 105.037 -2.208 . . . . 0.0 105.037 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.4 m -110.73 115.76 30.13 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -177.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -79.08 146.01 33.48 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 122.933 0.493 . . . . 0.0 110.89 -174.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -79.39 139.58 37.69 Favored 'General case' 0 CA--C 1.559 1.319 0 CA-C-O 121.895 0.855 . . . . 0.0 112.142 -171.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.9 mm . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 -159.193 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.5 m 59.0 93.6 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.168 1.387 . . . . 0.0 113.897 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.13 150.35 7.0 Favored Glycine 0 CA--C 1.542 1.736 0 CA-C-O 121.916 0.731 . . . . 0.0 114.266 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -83.83 130.8 34.92 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.72 -0.74 . . . . 0.0 109.357 170.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -132.47 105.13 7.07 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -173.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -92.67 134.49 34.97 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 122.962 0.505 . . . . 0.0 111.554 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.2 tp -73.44 114.24 11.44 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.344 0.658 . . . . 0.0 112.557 -170.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -95.86 -61.88 1.38 Allowed 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.88 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.2 t -117.42 114.21 23.19 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -98.3 138.8 35.03 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 123.091 1.424 . . . . 0.0 109.433 167.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -128.77 113.06 14.85 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.292 18.7 m-20 72.68 50.94 0.17 Allowed 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -173.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -76.22 -64.23 1.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.383 -0.823 . . . . 0.0 112.101 174.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.03 -28.26 69.67 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 117.163 2.282 . . . . 0.0 117.163 174.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.8 -44.26 86.23 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 168.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -67.28 -57.3 6.93 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 173.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 38.1 mtt -59.45 -45.78 90.62 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -176.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -62.05 -39.09 91.18 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 169.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.96 -33.18 73.81 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 117.25 2.315 . . . . 0.0 117.25 172.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.255 20.9 pt -81.55 -53.77 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 CA-C-N 119.328 0.967 . . . . 0.0 112.31 176.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.1 61.23 0.01 OUTLIER Glycine 0 CA--C 1.542 1.78 0 CA-C-N 119.019 0.827 . . . . 0.0 113.416 172.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.12 153.42 42.59 Favored Pre-proline 0 CA--C 1.568 1.645 0 C-N-CA 123.648 0.779 . . . . 0.0 111.277 -179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.86 155.2 43.61 Favored 'Trans proline' 0 CA--C 1.556 1.582 0 C-N-CA 123.168 2.579 . . . . 0.0 113.338 173.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -56.95 -34.59 68.19 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 169.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -59.82 -54.26 48.34 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 172.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.9 mt -71.2 -26.2 62.85 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 116.84 2.163 . . . . 0.0 116.84 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.1 mt -69.39 -55.36 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-N 119.683 1.129 . . . . 0.0 110.627 171.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -70.05 -25.22 63.45 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -76.01 -57.67 3.74 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 119.753 1.161 . . . . 0.0 111.537 168.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.38 -15.96 62.07 Favored Glycine 0 CA--C 1.553 2.414 0 N-CA-C 119.869 2.708 . . . . 0.0 119.869 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -68.02 -44.68 75.98 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 120.145 1.972 . . . . 0.0 114.138 170.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -68.34 -40.82 81.43 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 168.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.1 mt -74.17 124.09 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-N 119.484 1.038 . . . . 0.0 108.317 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -84.26 107.51 16.6 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -88.1 128.77 9.22 Favored Glycine 0 CA--C 1.541 1.659 0 CA-C-N 116.359 -0.382 . . . . 0.0 113.771 -171.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.0 t -88.56 115.01 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -177.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 62.7 m -96.87 106.21 18.48 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 170.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.54 150.05 23.97 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.794 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 86.8 mt -132.96 134.92 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 170.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 43.7 t -132.29 96.19 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 104.008 -2.589 . . . . 0.0 104.008 169.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -84.1 124.08 30.74 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.239 0.615 . . . . 0.0 110.354 -176.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -118.21 74.62 0.96 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 171.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.66 -116.89 8.23 Favored Glycine 0 CA--C 1.546 2.004 0 C-N-CA 123.374 0.511 . . . . 0.0 113.488 -173.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? -81.9 -33.19 30.59 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 169.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -73.41 116.64 14.22 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 119.825 1.193 . . . . 0.0 109.877 174.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -126.74 91.83 3.43 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -151.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -94.43 96.9 9.8 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.17 0.509 . . . . 0.0 110.193 -167.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -110.01 133.27 53.37 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.904 -176.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.8 m -116.13 99.09 6.99 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 -177.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.3 tt -89.31 118.21 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.7 0.8 . . . . 0.0 109.437 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 49.4 m . . . . . 0 N--CA 1.486 1.36 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 176.44 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.9 mp . . . . . 0 N--CA 1.492 1.644 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -91.12 124.83 35.64 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.673 0.749 . . . . 0.0 109.877 170.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -131.75 155.27 48.0 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.313 172.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -139.97 139.1 36.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.347 -0.846 . . . . 0.0 112.304 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -117.68 150.75 38.54 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.98 0.912 . . . . 0.0 111.23 173.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.2 m -98.51 128.42 44.84 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 166.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 86.7 t -74.72 128.96 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 123.539 0.735 . . . . 0.0 109.762 -173.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.51 10.34 84.58 Favored Glycine 0 CA--C 1.554 2.512 0 N-CA-C 118.716 2.246 . . . . 0.0 118.716 -170.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -137.67 153.35 49.83 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 119.087 1.443 . . . . 0.0 109.29 -176.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -69.63 115.3 8.72 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.312 0.577 . . . . 0.0 111.143 177.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.7 p -122.04 135.81 54.86 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.642 -175.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.03 106.92 18.18 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 113.937 -1.483 . . . . 0.0 110.215 -175.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.3 mt . . . . . 0 N--CA 1.49 1.56 0 C-N-CA 123.42 0.688 . . . . 0.0 110.11 -166.645 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.557 1.23 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.9 m -96.73 130.67 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 C-N-CA 123.516 0.726 . . . . 0.0 110.094 -171.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -75.6 114.99 14.81 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.177 0.591 . . . . 0.0 110.895 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.5 t -146.2 140.33 26.51 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.717 0.807 . . . . 0.0 109.421 -173.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.4 t -87.11 117.1 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.43 100.62 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -100.21 141.09 33.51 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.185 0.993 . . . . 0.0 110.423 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.6 tp -95.92 104.89 16.86 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 114.155 -1.384 . . . . 0.0 108.313 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -96.23 113.16 24.73 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 122.259 1.028 . . . . 0.0 108.641 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.44 -129.81 9.87 Favored Glycine 0 CA--C 1.546 1.98 0 CA-C-N 113.683 -1.599 . . . . 0.0 111.975 -165.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -135.19 51.69 2.07 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 120.863 0.363 . . . . 0.0 110.216 160.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -158.16 -20.76 0.08 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -177.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -118.32 113.34 21.29 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 121.963 2.165 . . . . 0.0 109.851 -174.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 15.6 mt -97.86 104.79 16.85 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 175.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 66.8 t -105.48 113.73 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -167.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.8 t -146.05 133.99 21.36 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.895 0.478 . . . . 0.0 110.592 -174.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 53.4 m -106.46 107.35 18.32 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -84.31 76.7 10.09 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.175 0.59 . . . . 0.0 109.786 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.341 38.4 ttmt 69.53 -75.96 0.07 Allowed 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 124.56 1.144 . . . . 0.0 112.659 -167.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -115.47 -23.47 8.81 Favored 'General case' 0 CA--C 1.567 1.628 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 174.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.2 mt -79.0 106.61 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-N 120.592 1.542 . . . . 0.0 108.657 -171.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -82.52 96.01 7.9 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-O 121.802 0.81 . . . . 0.0 109.694 176.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.4 m -93.09 116.75 29.33 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.307 1.043 . . . . 0.0 109.707 -176.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.1 t -118.39 102.75 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 104.786 -2.301 . . . . 0.0 104.786 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.2 m -92.01 92.16 8.17 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -174.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -83.16 140.49 32.56 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.65 0.78 . . . . 0.0 110.43 -175.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.67 107.47 13.73 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 172.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -88.81 -98.74 0.09 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 118.432 -0.794 . . . . 0.0 109.128 -176.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -92.31 -103.79 1.49 Allowed Glycine 0 N--CA 1.485 1.924 0 CA-C-N 119.466 1.03 . . . . 0.0 111.394 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -111.03 59.61 0.61 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.825 0.821 . . . . 0.0 109.798 164.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.7 pt -139.4 -163.62 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.809 0 C-N-CA 124.903 1.281 . . . . 0.0 108.048 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.6 tt -157.29 116.36 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.362 -1.461 . . . . 0.0 107.336 165.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.4 m -100.03 87.49 3.5 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -177.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -88.06 106.82 18.41 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 109.416 -0.586 . . . . 0.0 109.416 -176.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 19.1 m -108.08 97.78 7.43 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -167.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 82.1 mtp -99.6 94.57 6.45 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -172.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 59.2 p -97.65 112.2 24.17 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.668 -167.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.1 tp -112.49 86.18 2.31 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 174.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.45 -103.97 1.8 Allowed Glycine 0 CA--C 1.544 1.876 0 C-N-CA 122.848 0.261 . . . . 0.0 113.657 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -86.29 -24.28 25.99 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 169.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 24.7 mm -67.59 137.36 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.597 0 C-N-CA 124.945 1.298 . . . . 0.0 109.725 176.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.7 t -131.22 93.98 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 172.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -89.2 95.06 10.15 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 120.96 0.409 . . . . 0.0 110.704 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -97.29 108.44 21.16 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 121.356 0.598 . . . . 0.0 109.567 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 88.0 mtt180 -94.01 120.04 33.72 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.969 0.908 . . . . 0.0 108.615 171.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -105.64 99.28 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 175.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.4 m -114.49 115.44 27.26 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -175.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -88.51 140.54 29.35 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.279 0.561 . . . . 0.0 111.709 -170.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.8 ttm-85 -64.21 119.69 10.72 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.794 -176.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.7 pt . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -178.002 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.366 96.2 m-85 . . . . . 0 N--CA 1.499 1.991 0 N-CA-C 118.26 2.689 . . . . 0.0 118.26 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 72.1 m -75.37 114.42 13.88 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 121.157 1.799 . . . . 0.0 110.071 170.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.67 145.86 5.31 Favored Glycine 0 CA--C 1.542 1.755 0 CA-C-O 121.84 0.689 . . . . 0.0 112.831 -173.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -97.75 121.79 40.08 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 170.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -117.29 103.11 9.83 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -166.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.8 tp60 -80.56 121.92 26.4 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.749 0.82 . . . . 0.0 110.614 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.7 tp -62.77 127.39 31.04 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -110.78 -66.38 1.08 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.812 0.845 . . . . 0.0 109.606 -176.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.3 t -118.89 114.64 22.92 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.827 0.851 . . . . 0.0 108.847 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -104.2 105.11 15.15 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -102.61 133.79 47.03 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.83 0.852 . . . . 0.0 109.074 -171.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.252 22.2 m120 63.88 47.98 3.32 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -171.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -81.92 -46.17 14.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.827 -1.171 . . . . 0.0 113.956 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.29 -48.54 77.67 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 176.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.3 -40.62 96.89 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 116.566 2.061 . . . . 0.0 116.566 172.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -70.94 -52.74 18.07 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 118.005 -0.997 . . . . 0.0 113.647 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -40.89 93.08 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 177.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -40.82 94.86 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 167.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.57 -35.99 80.07 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 174.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.259 36.0 pt -79.58 -48.26 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-N 119.829 1.195 . . . . 0.0 112.846 175.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.68 58.28 0.12 Allowed Glycine 0 CA--C 1.546 2.003 0 C-N-CA 124.128 0.871 . . . . 0.0 113.631 -178.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.07 152.5 56.81 Favored Pre-proline 0 CA--C 1.571 1.776 0 C-N-CA 124.37 1.068 . . . . 0.0 110.24 173.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.32 154.08 31.79 Favored 'Trans proline' 0 C--N 1.366 1.495 0 C-N-CA 123.104 2.536 . . . . 0.0 114.103 -173.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -60.88 -24.92 66.32 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 168.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -57.5 -55.73 31.02 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 119.669 1.122 . . . . 0.0 113.5 164.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.1 mt -71.87 -16.42 62.14 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 175.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.0 mt -73.54 -56.85 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-N 120.165 1.348 . . . . 0.0 110.165 167.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -70.31 -27.56 64.48 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 116.477 2.028 . . . . 0.0 116.477 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -81.99 -50.72 8.81 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 119.155 0.889 . . . . 0.0 112.447 170.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.18 -7.18 62.54 Favored Glycine 0 CA--C 1.554 2.517 0 N-CA-C 119.932 2.733 . . . . 0.0 119.932 177.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -69.12 -45.19 70.79 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 120.137 1.968 . . . . 0.0 114.087 170.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -68.23 -36.06 78.89 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 169.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 42.8 mt -75.28 120.52 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 119.542 1.065 . . . . 0.0 108.232 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -88.75 114.83 25.79 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 176.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.1 133.25 11.38 Favored Glycine 0 CA--C 1.542 1.742 0 CA-C-N 116.473 -0.33 . . . . 0.0 113.291 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.7 t -81.91 122.3 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.0 m -96.0 105.34 17.35 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 170.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.78 144.78 26.43 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.582 0.706 . . . . 0.0 109.989 177.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 40.3 mt -146.68 129.24 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.1 t -125.94 115.31 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 -178.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -79.2 131.5 36.22 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.205 0.602 . . . . 0.0 111.048 172.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -135.55 64.92 1.56 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 172.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.38 -104.67 1.88 Allowed Glycine 0 CA--C 1.546 1.997 0 O-C-N 121.211 -0.931 . . . . 0.0 113.401 -177.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -89.35 -39.44 13.43 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 161.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -62.47 152.55 34.16 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.656 1.182 . . . . 0.0 113.806 178.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -139.49 150.61 45.36 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.905 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -134.32 109.54 8.88 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 164.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -117.49 131.64 56.69 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.475 -178.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.2 m -123.69 97.71 5.5 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -172.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.4 mm -88.06 113.44 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.6 p . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.853 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 67.1 mt . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -115.85 118.04 31.88 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -175.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -136.5 171.99 13.68 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.0 0.905 . . . . 0.0 110.1 178.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -136.05 137.27 40.96 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.484 -0.76 . . . . 0.0 110.079 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -133.64 134.89 43.76 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.551 0.691 . . . . 0.0 112.274 176.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.3 m -92.11 127.89 37.75 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 163.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.0 t -74.31 124.52 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.28 -53.67 0.59 Allowed Glycine 0 CA--C 1.548 2.109 0 CA-C-N 115.237 -0.892 . . . . 0.0 114.124 -165.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -81.87 155.98 25.05 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.793 0.837 . . . . 0.0 112.809 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -76.38 111.79 12.2 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.079 0.552 . . . . 0.0 110.62 169.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 61.6 m -108.7 143.07 38.29 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.605 0.762 . . . . 0.0 111.421 -167.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -81.62 98.16 8.22 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.345 -176.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.2 mt . . . . . 0 N--CA 1.489 1.496 0 C-N-CA 123.295 0.638 . . . . 0.0 109.906 -167.175 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.301 31.8 ttmt . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.7 m -125.87 142.93 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 C-N-CA 124.188 0.995 . . . . 0.0 109.472 -168.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.75 108.97 14.86 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.1 t -140.27 133.4 29.54 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.441 0.696 . . . . 0.0 109.642 -168.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 64.3 t -84.85 120.03 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -175.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.6 t -97.94 111.9 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 172.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -112.46 145.16 40.69 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.93 0.872 . . . . 0.0 110.853 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 54.2 tp -96.44 105.31 17.37 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.67 178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -90.92 120.13 31.68 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 170.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.4 -124.16 8.71 Favored Glycine 0 CA--C 1.544 1.876 0 CA-C-N 114.327 -1.306 . . . . 0.0 113.276 -174.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -122.75 -14.64 7.66 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 171.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -132.87 27.77 4.25 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 -172.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -138.15 103.14 4.86 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 121.446 1.93 . . . . 0.0 108.508 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 57.4 mt -96.79 106.05 18.28 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 173.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 87.4 t -106.62 122.96 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -165.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.4 t -150.56 127.61 11.17 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 122.589 0.356 . . . . 0.0 111.047 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.8 t -104.24 122.89 46.33 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.215 0.606 . . . . 0.0 109.848 175.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -80.76 -79.7 0.15 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 123.28 0.632 . . . . 0.0 110.189 -173.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -98.08 -78.88 0.48 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 163.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -130.86 61.47 1.63 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 156.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.9 mp -123.49 91.91 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 103.367 -2.827 . . . . 0.0 103.367 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -87.66 92.06 8.97 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.142 0.496 . . . . 0.0 110.303 -172.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.3 t -83.99 103.7 13.46 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.156 0.982 . . . . 0.0 110.49 -175.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 88.1 t -103.34 103.86 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 -177.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.4 HG22 HD11 ' A' ' 109' ' ' ILE . 18.8 m -93.48 92.69 7.73 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -166.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -94.45 109.4 21.27 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.153 0.581 . . . . 0.0 110.498 -166.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.71 98.13 10.24 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 118.726 0.694 . . . . 0.0 109.504 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -83.34 -74.58 0.36 Allowed 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 122.981 0.512 . . . . 0.0 111.606 -172.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -168.78 107.02 0.26 Allowed Glycine 0 N--CA 1.479 1.542 0 CA-C-O 121.796 0.665 . . . . 0.0 112.191 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.275 23.8 m-20 48.71 32.53 3.63 Favored 'General case' 0 CA--C 1.57 1.712 0 N-CA-C 116.944 2.202 . . . . 0.0 116.944 -165.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.7 pt -142.15 -171.09 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.815 0 C-N-CA 124.806 1.242 . . . . 0.0 108.604 175.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.4 HD11 HG22 ' A' ' 102' ' ' THR . 7.5 tt -154.39 124.16 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 120.4 -1.438 . . . . 0.0 107.902 160.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.5 m -102.02 88.75 3.42 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -87.65 105.45 17.36 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.6 m -109.07 99.05 8.41 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -165.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 59.3 mtt -92.51 102.34 14.79 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.72 0.808 . . . . 0.0 109.268 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 77.5 p -94.09 103.14 15.21 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -176.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.2 tp -101.26 83.81 2.53 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 174.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.88 -104.77 1.6 Allowed Glycine 0 CA--C 1.544 1.882 0 CA-C-N 116.375 -0.375 . . . . 0.0 113.181 -176.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -97.15 -12.35 23.2 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 169.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 51.6 mt -84.55 112.39 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -175.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.8 t -103.29 90.71 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -174.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -83.6 94.12 8.01 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.428 0.691 . . . . 0.0 110.483 -177.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -106.6 108.14 19.5 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.075 -169.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 -96.53 110.72 23.06 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 63.2 mt -103.45 102.55 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 104.344 -2.465 . . . . 0.0 104.344 -173.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.7 m -127.79 116.67 20.55 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -163.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.5 mttm -77.8 138.28 38.89 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.55 0.74 . . . . 0.0 112.431 -171.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 70.9 ttt-85 -75.25 116.5 16.04 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.821 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 16.7 pt . . . . . 0 N--CA 1.486 1.336 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -174.858 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 . . . . . 0 N--CA 1.494 1.753 0 N-CA-C 117.619 2.452 . . . . 0.0 117.619 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.0 m -76.59 114.34 15.22 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 121.066 1.757 . . . . 0.0 111.116 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.98 169.23 31.21 Favored Glycine 0 CA--C 1.545 1.926 0 CA-C-O 122.821 1.234 . . . . 0.0 114.368 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -92.01 123.01 35.05 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 113.739 -1.23 . . . . 0.0 108.337 170.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -116.11 97.55 6.13 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -175.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.7 tm0? -91.86 125.53 36.6 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 122.987 0.515 . . . . 0.0 110.36 -170.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 38.6 tp -65.37 114.74 5.01 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -169.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -93.54 -65.78 0.97 Allowed 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.219 -176.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.6 m -121.55 117.09 25.92 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -177.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -104.06 130.44 51.75 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.234 1.013 . . . . 0.0 109.128 176.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.63 -69.12 0.75 Allowed 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.357 -177.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -115.38 69.93 0.74 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.25 0.62 . . . . 0.0 110.522 178.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -75.94 -60.88 2.13 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.522 0.729 . . . . 0.0 111.561 171.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.12 -31.65 72.24 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 176.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.55 -44.5 78.14 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 169.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -67.49 -56.68 8.58 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 176.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 51.2 mtt -59.17 -48.45 81.58 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -177.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -57.42 -44.58 84.76 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 170.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.18 -29.63 70.73 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 117.338 2.347 . . . . 0.0 117.338 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 47.0 pt -81.24 -49.33 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-N 119.549 1.068 . . . . 0.0 112.503 173.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.77 67.27 0.03 OUTLIER Glycine 0 CA--C 1.541 1.666 0 CA-C-N 118.79 0.723 . . . . 0.0 112.471 173.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.73 152.32 45.42 Favored Pre-proline 0 CA--C 1.568 1.651 0 C-N-CA 123.967 0.907 . . . . 0.0 110.714 178.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.14 155.04 52.32 Favored 'Trans proline' 0 CA--C 1.557 1.652 0 C-N-CA 123.199 2.599 . . . . 0.0 113.394 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -57.08 -33.22 67.06 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 169.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -60.72 -55.57 31.64 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 117.227 -1.368 . . . . 0.0 113.961 170.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.99 -21.81 63.19 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 178.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.2 mt -76.1 -55.3 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-N 119.846 1.203 . . . . 0.0 110.509 171.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 52.3 mm-40 -76.21 -29.06 57.47 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -176.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -79.88 -45.7 18.16 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 118.832 0.742 . . . . 0.0 112.181 168.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.63 -28.01 67.17 Favored Glycine 0 CA--C 1.547 2.033 0 N-CA-C 119.678 2.631 . . . . 0.0 119.678 174.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -62.79 -41.01 99.08 Favored 'General case' 0 CA--C 1.568 1.66 0 CA-C-N 119.537 1.668 . . . . 0.0 114.965 170.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -68.77 -37.3 79.23 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 167.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.3 mt -68.22 139.43 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-N 119.651 1.114 . . . . 0.0 110.077 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -72.5 108.88 5.8 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.206 174.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.62 101.62 2.82 Favored Glycine 0 N--CA 1.479 1.526 0 CA-C-N 116.059 -0.518 . . . . 0.0 112.228 -174.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.2 t -85.95 107.32 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -176.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.0 m -99.43 95.11 6.8 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 114.269 -1.332 . . . . 0.0 107.517 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -80.56 148.73 30.23 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 121.88 0.848 . . . . 0.0 111.092 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.7 mt -140.56 122.41 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 173.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.0 t -118.45 100.53 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -83.43 126.74 33.07 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.161 0.584 . . . . 0.0 110.625 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -123.8 77.59 1.54 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 167.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.59 -119.0 6.36 Favored Glycine 0 CA--C 1.546 1.995 0 C-N-CA 123.092 0.377 . . . . 0.0 113.154 -173.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -76.6 -16.81 59.48 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 167.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -78.94 148.4 32.66 Favored 'General case' 0 CA--C 1.557 1.218 0 CA-C-N 119.335 0.971 . . . . 0.0 111.577 176.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -142.5 109.39 5.48 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -101.36 95.7 6.68 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 173.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -94.65 129.56 41.47 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.846 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.9 m -113.74 92.46 3.99 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.3 tp -85.06 120.91 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.804 0.841 . . . . 0.0 110.09 -175.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 56.8 m . . . . . 0 N--CA 1.488 1.43 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 171.834 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.0 mm . . . . . 0 N--CA 1.492 1.654 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -92.08 126.77 37.3 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.451 0.643 . . . . 0.0 110.139 173.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -138.81 131.9 29.74 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -126.66 150.06 49.18 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 122.077 0.941 . . . . 0.0 112.56 -171.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -147.15 155.27 41.99 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.334 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.1 m -107.37 137.73 44.88 Favored 'General case' 0 CA--C 1.565 1.533 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 166.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.7 t -75.08 126.1 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 170.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.91 -54.23 0.56 Allowed Glycine 0 CA--C 1.547 2.057 0 CA-C-N 115.659 -0.701 . . . . 0.0 114.353 -167.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -88.62 154.52 20.25 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.599 0.76 . . . . 0.0 112.418 -173.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -77.5 106.63 9.4 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.151 0.501 . . . . 0.0 109.927 164.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 68.7 m -110.03 140.68 43.81 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.756 0.789 . . . . 0.0 111.07 -169.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.44 125.16 30.1 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.484 -177.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 mp . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 122.105 0.955 . . . . 0.0 109.796 179.874 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 70.3 t -117.86 -77.97 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt 61.29 90.49 0.07 Allowed 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 124.355 1.062 . . . . 0.0 112.04 -164.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.2 t -143.39 145.12 32.39 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.543 0.687 . . . . 0.0 110.58 -175.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.1 t -98.17 125.06 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -178.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.1 t -107.38 136.22 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.7 mp0 -119.18 137.88 53.32 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.495 0.718 . . . . 0.0 109.082 172.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.1 tp -104.55 119.48 39.08 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.981 0.912 . . . . 0.0 108.976 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -97.88 122.86 41.5 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 167.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.02 -125.73 11.3 Favored Glycine 0 CA--C 1.544 1.904 0 CA-C-N 114.664 -1.153 . . . . 0.0 113.478 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -137.96 63.06 1.55 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 155.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -152.72 -44.39 0.1 Allowed 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 117.204 -1.379 . . . . 0.0 114.067 -178.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -108.33 111.3 23.16 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 120.536 1.516 . . . . 0.0 111.461 -168.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 24.2 mt -106.72 109.07 20.88 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 174.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.2 t -105.52 121.51 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -174.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 t -156.45 135.43 11.91 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 45.8 m -103.11 113.79 27.55 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -75.9 -83.51 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.225 0.61 . . . . 0.0 111.226 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -133.4 81.83 1.95 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 173.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.257 33.4 t30 49.85 44.87 25.21 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 115.691 1.738 . . . . 0.0 115.691 -163.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 55.7 mt -137.13 95.1 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 -177.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -85.43 98.31 10.51 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.398 0.618 . . . . 0.0 109.691 -178.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.2 t -82.77 102.81 11.81 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.209 1.004 . . . . 0.0 109.542 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 79.8 t -103.24 92.19 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 52.3 m -96.37 97.09 9.19 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -166.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -106.88 124.26 49.36 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.364 1.066 . . . . 0.0 110.681 -165.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.9 107.17 17.91 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -177.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -89.96 -103.23 0.09 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 118.24 -0.886 . . . . 0.0 109.271 -174.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -90.5 -106.41 1.3 Allowed Glycine 0 N--CA 1.485 1.937 0 CA-C-N 119.942 1.246 . . . . 0.0 111.803 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -102.72 56.87 0.77 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.097 0.475 . . . . 0.0 110.437 165.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.2 pt -142.5 -170.66 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.574 1.866 0 C-N-CA 124.557 1.143 . . . . 0.0 108.879 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.4 tt -148.73 125.13 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 120.526 -1.359 . . . . 0.0 107.885 155.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 55.9 m -93.15 96.27 9.92 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 174.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.81 101.6 13.22 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -174.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.2 m -105.17 92.12 4.08 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -165.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 16.8 mtp -91.95 102.48 15.05 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.487 0.715 . . . . 0.0 109.5 -177.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 60.7 p -97.18 104.05 16.04 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -171.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.2 tp -90.89 80.63 5.78 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 176.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.22 -97.67 0.68 Allowed Glycine 0 CA--C 1.546 1.993 0 O-C-N 122.297 -0.252 . . . . 0.0 113.046 -171.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -102.27 -12.37 18.02 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 171.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 95.1 mt -85.84 106.36 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-N 120.854 1.661 . . . . 0.0 107.467 -175.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 96.8 t -94.91 98.73 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -173.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -84.6 94.84 8.7 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.331 0.586 . . . . 0.0 109.554 176.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -96.14 109.36 21.81 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.787 -175.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 30.7 mtm180 -104.62 107.89 19.06 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.0 mp -96.47 107.13 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.2 m -131.1 114.34 15.02 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -164.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -75.33 131.4 40.25 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.595 0.758 . . . . 0.0 112.623 -168.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -74.34 117.6 16.33 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.936 0.895 . . . . 0.0 110.643 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.9 pt . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 -168.601 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 . . . . . 0 N--CA 1.494 1.767 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.5 m -74.41 104.61 5.21 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 121.605 2.002 . . . . 0.0 110.918 175.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.55 148.93 8.66 Favored Glycine 0 CA--C 1.542 1.765 0 CA-C-O 121.84 0.689 . . . . 0.0 113.201 -173.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -102.6 110.1 21.93 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -112.34 105.01 13.19 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -163.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -91.93 137.12 32.62 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.151 0.501 . . . . 0.0 111.322 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.1 tp -72.48 117.62 14.37 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.553 0.741 . . . . 0.0 112.342 -169.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -100.39 -61.96 1.3 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.54 0.736 . . . . 0.0 110.992 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.3 m -119.61 148.86 42.84 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.79 0.836 . . . . 0.0 110.058 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -142.59 134.6 27.2 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 122.039 0.923 . . . . 0.0 109.95 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -87.88 -67.94 0.79 Allowed 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.546 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 50.0 m-20 -120.93 68.9 0.88 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 118.534 0.606 . . . . 0.0 110.711 -175.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -76.46 -54.38 6.8 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.377 0.671 . . . . 0.0 112.335 172.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.44 -49.22 77.69 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 178.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.39 -40.1 85.5 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -67.02 -52.9 36.66 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 175.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -58.94 -51.85 68.28 Favored 'General case' 0 CA--C 1.562 1.423 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -58.02 -38.64 76.59 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 171.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.04 -29.81 69.71 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 116.909 2.189 . . . . 0.0 116.909 174.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.271 46.4 pt -80.65 -54.34 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-N 119.868 1.213 . . . . 0.0 111.768 171.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.83 67.06 0.01 OUTLIER Glycine 0 CA--C 1.543 1.795 0 CA-C-N 119.264 0.938 . . . . 0.0 112.971 170.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.75 154.85 55.15 Favored Pre-proline 0 CA--C 1.57 1.744 0 C-N-CA 123.653 0.781 . . . . 0.0 111.839 -175.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -76.36 152.03 34.17 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 123.326 2.684 . . . . 0.0 113.844 176.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -56.72 -37.2 70.62 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 171.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -64.01 -54.28 36.79 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.8 mt -67.0 -23.77 65.96 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 116.716 2.117 . . . . 0.0 116.716 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 74.9 mt -68.72 -55.43 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 124.176 0.99 . . . . 0.0 110.663 169.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -64.87 -25.64 67.98 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 116.893 2.183 . . . . 0.0 116.893 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -74.8 -59.7 2.61 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 119.346 0.975 . . . . 0.0 111.681 168.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.48 -11.72 60.12 Favored Glycine 0 CA--C 1.553 2.417 0 N-CA-C 119.995 2.758 . . . . 0.0 119.995 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -71.27 -46.18 61.49 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 120.272 2.036 . . . . 0.0 114.174 170.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -69.83 -35.66 74.95 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 170.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.2 mt -73.89 126.19 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.27 105.44 16.64 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -85.53 129.57 9.38 Favored Glycine 0 CA--C 1.54 1.614 0 CA-C-N 116.338 -0.392 . . . . 0.0 113.3 -174.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.9 t -85.72 113.49 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.2 t -99.86 112.26 24.53 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 172.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -88.59 151.68 22.33 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 114.614 -1.176 . . . . 0.0 110.309 175.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.2 mt -142.97 131.39 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 166.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.3 t -114.98 109.3 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -78.1 117.6 19.55 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.999 0.52 . . . . 0.0 110.908 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -129.58 62.85 1.53 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.818 169.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.9 -108.69 2.57 Favored Glycine 0 CA--C 1.547 2.035 0 O-C-N 121.614 -0.679 . . . . 0.0 113.714 -177.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -74.18 -42.96 59.03 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 169.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -73.96 121.48 21.08 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 119.24 0.927 . . . . 0.0 111.236 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -122.27 97.11 5.32 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -84.86 100.27 11.47 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 121.676 0.751 . . . . 0.0 109.569 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -87.9 137.91 31.92 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.386 174.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.1 m -128.15 89.46 2.92 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 173.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.0 tt -91.66 119.53 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 121.37 0.605 . . . . 0.0 109.643 -176.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.3 p . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -178.184 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.3 mm . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -119.37 119.72 34.78 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -170.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -144.96 148.03 33.35 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.531 0.733 . . . . 0.0 109.231 173.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.97 122.28 46.92 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.536 0.734 . . . . 0.0 110.724 175.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -101.9 134.32 45.29 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 121.619 0.723 . . . . 0.0 111.38 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.1 m -97.97 131.18 44.64 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 175.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.5 t -82.18 119.07 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 174.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.99 0.71 71.05 Favored Glycine 0 CA--C 1.557 2.701 0 N-CA-C 119.063 2.385 . . . . 0.0 119.063 -170.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -144.21 138.14 27.84 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 120.176 1.988 . . . . 0.0 109.079 166.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.66 123.32 21.6 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.37 0.605 . . . . 0.0 112.45 -176.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 99.7 m -108.95 150.9 27.05 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.614 171.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.85 115.08 22.08 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.948 175.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.4 mt . . . . . 0 N--CA 1.492 1.626 0 C-N-CA 122.812 0.445 . . . . 0.0 109.91 -162.811 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.1 mptt . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.1 p -116.58 132.71 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.011 0.925 . . . . 0.0 109.23 -171.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -84.03 112.22 20.0 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.243 0.617 . . . . 0.0 109.976 -171.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.0 t -145.16 149.5 35.08 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.407 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.3 p -112.31 136.37 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 CA-C-O 122.538 1.161 . . . . 0.0 108.506 174.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.08 139.2 18.51 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 CA-C-N 113.931 -1.486 . . . . 0.0 108.166 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -111.61 133.26 54.0 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.4 tp -94.0 107.87 19.74 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -87.84 114.27 24.29 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 170.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.72 -119.12 8.07 Favored Glycine 0 CA--C 1.543 1.826 0 CA-C-N 114.52 -1.218 . . . . 0.0 113.635 -175.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -126.85 -5.45 6.29 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 171.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -123.42 -13.33 7.63 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.342 2.349 . . . . 0.0 117.342 -173.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -116.91 94.36 4.56 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-N 121.493 1.951 . . . . 0.0 110.351 -166.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 39.4 mt -93.19 107.31 19.14 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.557 0.743 . . . . 0.0 110.008 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 29.8 m -106.77 131.34 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 123.937 0.895 . . . . 0.0 110.801 -171.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.1 t -153.74 145.12 23.08 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.6 p -109.89 110.06 20.9 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 174.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -76.14 -87.45 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.235 0.614 . . . . 0.0 110.957 -177.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -112.81 -74.56 0.63 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 174.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -129.05 65.08 1.45 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 154.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.4 mp -137.96 103.31 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 176.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -92.04 94.21 9.14 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -95.09 110.61 22.52 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.59 -167.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.0 t -107.2 100.6 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 -177.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.6 m -96.24 91.25 5.8 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -172.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -87.99 141.83 28.27 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.914 0.885 . . . . 0.0 110.46 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 tt -121.91 102.95 8.5 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 172.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -81.07 -82.11 0.12 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.123 0.569 . . . . 0.0 110.988 -168.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.65 -103.63 2.26 Favored Glycine 0 N--CA 1.482 1.739 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 176.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -111.66 54.02 0.7 Allowed 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.676 0.75 . . . . 0.0 109.833 159.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.4 pp -149.75 136.49 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -175.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.9 tt -108.11 117.4 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.4 m -103.92 98.58 8.4 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 177.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -93.79 116.33 28.79 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.5 m -113.14 94.23 4.79 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -170.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 27.2 mtt -94.2 99.06 11.39 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.735 0.814 . . . . 0.0 109.381 -177.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.4 p -90.94 107.0 18.91 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.246 -174.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.3 tp -101.41 79.86 2.02 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.43 -100.97 1.01 Allowed Glycine 0 CA--C 1.545 1.908 0 CA-C-N 116.579 -0.282 . . . . 0.0 112.772 -171.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -103.1 -6.07 22.63 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 169.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 76.3 mt -87.18 103.86 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 120.668 1.576 . . . . 0.0 106.914 -176.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 49.1 t -93.8 96.58 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -84.83 93.59 8.53 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.199 0.523 . . . . 0.0 109.774 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -99.17 103.02 14.87 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.552 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -107.12 122.86 47.33 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.876 0.87 . . . . 0.0 109.141 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.0 mp -111.16 107.92 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 -171.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.3 m -118.91 119.93 35.78 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -175.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -89.85 141.91 28.19 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.659 0.742 . . . . 0.0 111.414 -174.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 33.3 ttm-85 -66.63 124.76 23.74 Favored 'General case' 0 CA--C 1.559 1.316 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.263 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 16.6 pt . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 123.05 1.405 . . . . 0.0 108.542 -176.638 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.4 t . . . . . 0 CA--C 1.55 0.943 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -85.93 -11.0 54.26 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 117.348 2.351 . . . . 0.0 117.348 -175.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.6 m -76.82 101.82 6.04 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 121.43 1.923 . . . . 0.0 111.004 -176.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.75 168.19 39.0 Favored Glycine 0 CA--C 1.546 2.011 0 CA-C-O 122.34 0.966 . . . . 0.0 112.86 -172.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.69 97.39 5.61 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -173.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -100.55 105.54 16.98 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -160.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -92.13 138.93 31.13 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-O 121.557 0.694 . . . . 0.0 111.612 -175.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.0 tp -65.86 130.17 42.34 Favored 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 124.304 1.042 . . . . 0.0 113.389 -172.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -109.37 -65.53 1.14 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.069 0.948 . . . . 0.0 109.745 -178.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 30.5 t -127.36 121.2 30.35 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 123.895 0.878 . . . . 0.0 108.94 -176.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -114.93 120.13 38.89 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -79.51 -70.44 0.51 Allowed 'General case' 0 N--CA 1.486 1.333 0 CA-C-O 118.485 -0.769 . . . . 0.0 112.789 -171.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 46.7 m-20 -121.64 73.82 1.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 118.848 0.749 . . . . 0.0 110.774 -170.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -81.98 -46.37 14.08 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 172.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -59.03 -50.02 75.66 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 172.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.08 -38.28 90.54 Favored 'General case' 0 CA--C 1.564 1.501 0 N-CA-C 116.636 2.087 . . . . 0.0 116.636 175.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -77.54 -51.21 11.07 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.22 -43.71 98.21 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 115.321 1.6 . . . . 0.0 115.321 -179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 31.9 mtmm -65.04 -35.65 81.86 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 168.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.6 -30.46 70.7 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 117.239 2.311 . . . . 0.0 117.239 169.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.266 24.7 pt -88.59 -59.55 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 CA-C-N 119.717 1.144 . . . . 0.0 111.214 177.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.01 71.55 0.01 OUTLIER Glycine 0 CA--C 1.54 1.644 0 CA-C-N 118.642 0.655 . . . . 0.0 111.909 178.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -134.93 153.28 78.51 Favored Pre-proline 0 CA--C 1.571 1.768 0 C-N-CA 123.617 0.767 . . . . 0.0 111.675 178.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -76.95 151.05 30.67 Favored 'Trans proline' 0 C--N 1.372 1.786 0 C-N-CA 123.254 2.636 . . . . 0.0 114.048 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -59.48 -31.82 69.69 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 116.623 2.083 . . . . 0.0 116.623 170.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -61.73 -51.1 69.75 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 117.301 -1.333 . . . . 0.0 114.583 170.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.7 mt -68.36 -23.81 64.72 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 173.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 84.9 mt -68.42 -55.0 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 124.356 1.062 . . . . 0.0 111.197 170.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -66.1 -23.05 66.43 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 116.804 2.15 . . . . 0.0 116.804 175.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -77.52 -56.5 4.48 Favored 'General case' 0 CA--C 1.563 1.472 0 C-N-CA 124.356 1.063 . . . . 0.0 112.037 170.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.37 -15.54 70.42 Favored Glycine 0 CA--C 1.553 2.454 0 N-CA-C 119.667 2.627 . . . . 0.0 119.667 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -65.45 -44.04 88.48 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 120.317 2.058 . . . . 0.0 114.654 168.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -67.65 -35.96 79.86 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 170.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 53.3 mt -75.43 122.24 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -86.34 107.27 17.91 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 174.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.56 130.9 10.3 Favored Glycine 0 CA--C 1.54 1.621 0 CA-C-N 116.178 -0.465 . . . . 0.0 113.561 -173.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.1 t -80.8 114.85 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 71.0 m -104.62 99.37 9.04 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 179.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -81.66 145.53 30.52 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.532 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 35.2 mt -143.45 128.89 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 104.839 -2.282 . . . . 0.0 104.839 176.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 87.4 t -124.02 107.42 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 178.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -88.26 122.07 31.38 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.548 0.689 . . . . 0.0 109.444 170.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -87.35 -60.49 1.96 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 114.685 -1.143 . . . . 0.0 109.406 159.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -162.56 -88.94 0.07 OUTLIER Glycine 0 N--CA 1.476 1.312 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 170.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -74.0 -39.6 63.51 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 164.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -75.23 135.61 40.99 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 119.897 1.226 . . . . 0.0 111.527 176.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -134.12 108.5 8.34 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.6 mtmm -102.47 103.76 14.16 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -111.95 136.71 50.93 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 123.789 0.836 . . . . 0.0 110.537 -173.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 86.3 m -127.88 106.24 8.97 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -176.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 21.9 mm -97.21 120.14 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 106.398 -1.705 . . . . 0.0 106.398 -178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.5 p -90.87 90.64 8.0 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 174.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -101.01 92.8 5.18 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.006 0.522 . . . . 0.0 110.655 -167.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.26 -102.04 1.32 Allowed Glycine 0 CA--C 1.543 1.821 0 CA-C-N 116.202 -0.454 . . . . 0.0 112.991 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 66.5 m -96.28 -57.34 2.36 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 123.442 0.697 . . . . 0.0 112.053 169.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -80.89 137.95 36.16 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 119.21 0.914 . . . . 0.0 112.336 -173.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 60.9 t -95.82 119.89 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 90.4 mt -111.33 107.63 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 105.371 -2.085 . . . . 0.0 105.371 -176.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -116.22 130.98 57.06 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 124.02 0.928 . . . . 0.0 110.478 -178.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -143.01 173.65 11.37 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 123.872 0.869 . . . . 0.0 109.212 178.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -143.11 134.06 25.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.983 -1.073 . . . . 0.0 112.313 176.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -110.25 149.16 30.55 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.8 0.84 . . . . 0.0 111.315 172.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.1 m -108.55 125.45 51.83 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 169.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 72.9 t -69.5 123.9 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 C-N-CA 123.831 0.852 . . . . 0.0 109.595 -176.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.42 -44.58 2.11 Favored Glycine 0 CA--C 1.552 2.356 0 N-CA-C 116.857 1.503 . . . . 0.0 116.857 -172.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -102.42 132.67 48.29 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 124.277 1.031 . . . . 0.0 110.145 -173.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -50.81 134.73 24.98 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 116.466 2.025 . . . . 0.0 116.466 -172.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 20.6 p -133.71 137.84 45.5 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 122.187 0.994 . . . . 0.0 111.039 -174.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -96.13 95.21 8.0 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 114.089 -1.414 . . . . 0.0 110.22 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.1 mt -98.05 144.78 27.2 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.591 0.756 . . . . 0.0 109.665 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -72.72 116.93 13.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.746 -0.596 . . . . 0.0 111.265 177.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.5 t -82.66 150.92 26.52 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 123.012 1.387 . . . . 0.0 110.861 166.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -65.39 -55.09 20.06 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 113.238 -1.801 . . . . 0.0 114.096 -172.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.2 m -71.63 -48.34 48.56 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 118.366 -0.826 . . . . 0.0 112.832 175.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -82.48 -112.63 0.46 Allowed Glycine 0 CA--C 1.544 1.87 0 CA-C-N 119.357 0.981 . . . . 0.0 114.153 -179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -166.88 -46.07 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 123.893 0.877 . . . . 0.0 112.501 -169.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -145.08 146.79 31.98 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 122.76 1.266 . . . . 0.0 109.707 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 7.5 p -145.42 125.84 7.07 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.318 0 CA-C-N 113.925 -1.488 . . . . 0.0 107.659 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -83.04 107.62 15.76 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 171.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.402 HG21 ' CD2' ' A' ' 95' ' ' PHE . 6.9 t -155.72 105.8 2.44 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 106.082 -1.821 . . . . 0.0 106.082 -170.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . 0.252 11.2 p -103.98 136.52 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 CA-C-O 122.893 1.33 . . . . 0.0 110.718 -176.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 59.1 t -90.25 136.35 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.285 0 CA-C-N 113.346 -1.752 . . . . 0.0 108.742 -172.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -107.0 134.93 49.42 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 171.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 33.5 tp -105.06 110.07 22.31 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.23 -175.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.7 tt0 -105.69 128.04 53.43 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.485 0.714 . . . . 0.0 109.198 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.53 7.51 64.74 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 121.344 3.297 . . . . 0.0 121.344 172.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.292 5.0 t70 54.91 45.62 26.13 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 -161.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.2 p-10 -157.48 -44.64 0.07 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -92.81 125.6 37.49 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 120.086 1.312 . . . . 0.0 110.934 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.0 mt -111.29 102.05 10.49 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 106.609 -1.626 . . . . 0.0 106.609 170.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.1 m -109.05 126.6 66.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 C-N-CA 123.5 0.72 . . . . 0.0 109.533 -172.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.0 t -149.03 156.25 41.97 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.262 0.553 . . . . 0.0 112.29 177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 89.4 m -112.5 105.42 13.64 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 175.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.402 ' CD2' HG21 ' A' ' 81' ' ' THR 0.266 36.7 t80 -91.3 -101.05 0.11 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 124.109 0.964 . . . . 0.0 108.928 -163.766 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -110.39 78.12 1.1 Allowed 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 170.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 16.4 m120 50.32 42.15 25.44 Favored 'General case' 0 CA--C 1.576 1.943 0 N-CA-C 116.082 1.882 . . . . 0.0 116.082 -166.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 23.4 mt -133.79 115.25 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 N-CA-C 103.455 -2.795 . . . . 0.0 103.455 -173.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -85.73 93.92 8.98 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 174.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.4 t -86.37 96.25 9.94 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 123.821 0.849 . . . . 0.0 109.901 -175.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 62.3 t -104.19 105.04 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 -174.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 62.9 m -116.24 90.84 3.43 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 -168.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -96.12 140.53 30.7 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 123.132 0.573 . . . . 0.0 110.906 -172.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 tt -105.94 110.56 22.88 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 24.8 m-80 -110.94 91.77 3.79 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -178.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.52 -110.7 3.1 Favored Glycine 0 CA--C 1.544 1.857 0 CA-C-O 119.757 -0.468 . . . . 0.0 113.407 176.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -118.86 52.63 1.04 Allowed 'General case' 0 N--CA 1.496 1.872 0 CA-C-O 121.272 0.558 . . . . 0.0 111.686 171.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.7 pt -134.87 -166.21 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.783 0 C-N-CA 124.554 1.142 . . . . 0.0 108.136 166.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 13.3 tt -157.94 126.34 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 O-C-N 120.352 -1.467 . . . . 0.0 107.426 159.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.9 t -83.44 149.5 26.62 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-O 120.627 0.251 . . . . 0.0 110.724 164.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -133.83 97.12 3.82 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 105.762 -1.94 . . . . 0.0 105.762 169.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 23.3 m -104.2 91.46 3.94 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.851 -1.166 . . . . 0.0 107.851 -173.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 40.2 mtt -93.79 103.34 15.48 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 124.211 1.004 . . . . 0.0 109.078 -178.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 75.1 p -99.98 106.57 18.38 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -172.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 42.0 tp -102.95 82.26 2.08 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.94 -99.81 0.88 Allowed Glycine 0 CA--C 1.545 1.925 0 N-CA-C 114.326 0.49 . . . . 0.0 114.326 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -89.72 -25.8 21.0 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 171.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 14.0 mm -67.2 138.76 22.2 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.651 0 C-N-CA 125.057 1.343 . . . . 0.0 109.751 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.7 t -127.95 93.94 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 172.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -87.65 98.92 11.69 Favored 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 123.487 0.715 . . . . 0.0 109.752 178.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 81.8 tttt -108.9 104.97 14.31 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 123.605 0.566 . . . . 0.0 110.056 -177.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -85.59 142.19 29.29 Favored 'General case' 0 N--CA 1.487 1.403 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.522 164.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.3 mp -125.41 105.56 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 103.37 -2.826 . . . . 0.0 103.37 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 62.5 m -120.84 120.86 36.78 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.168 0.587 . . . . 0.0 109.459 -174.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -86.03 139.93 30.73 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.317 0.647 . . . . 0.0 111.941 -170.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 71.8 ttt180 -69.59 113.9 7.3 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.662 0.785 . . . . 0.0 111.741 -176.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 43.5 mt . . . . . 0 N--CA 1.482 1.173 0 N-CA-C 102.428 -3.175 . . . . 0.0 102.428 -163.424 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.9 m . . . . . 0 CA--C 1.549 0.915 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 58.7 m-85 -70.98 -22.24 62.21 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 117.711 2.486 . . . . 0.0 117.711 -177.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.2 m -69.73 107.74 3.61 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-N 120.857 1.662 . . . . 0.0 110.909 176.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.97 162.11 24.5 Favored Glycine 0 CA--C 1.544 1.873 0 CA-C-O 122.425 1.014 . . . . 0.0 114.233 -171.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -105.36 115.43 30.24 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 179.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -113.64 98.49 7.08 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.193 -1.039 . . . . 0.0 108.193 -169.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 58.7 tt0 -93.51 138.91 31.32 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.936 -0.478 . . . . 0.0 111.067 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.1 tp -63.82 137.96 58.27 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -171.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 11.3 mm100 -121.57 -64.8 1.19 Allowed 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.536 -175.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.8 t -128.77 115.36 17.83 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 123.617 0.767 . . . . 0.0 109.263 -174.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -105.3 128.72 53.6 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.958 0.903 . . . . 0.0 109.654 175.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -88.52 -70.18 0.66 Allowed 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 114.794 -1.094 . . . . 0.0 110.607 -177.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.6 m-80 -114.63 68.66 0.7 Allowed 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 123.278 0.631 . . . . 0.0 110.398 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.0 t80 -74.61 -52.32 12.07 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 118.496 -0.764 . . . . 0.0 112.448 169.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -63.39 -47.61 81.3 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -173.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.5 -39.67 94.21 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 116.139 1.903 . . . . 0.0 116.139 171.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -66.52 -50.95 61.49 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 176.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 20.7 mmt -62.72 -42.17 99.53 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 -175.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -61.75 -45.31 94.45 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 168.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.5 -29.63 70.69 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.262 39.5 pt -76.02 -53.43 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 119.901 1.228 . . . . 0.0 112.132 170.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.31 67.77 0.01 OUTLIER Glycine 0 CA--C 1.538 1.493 0 CA-C-O 118.887 -0.952 . . . . 0.0 112.33 173.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 17.8 mt -130.06 141.28 41.32 Favored Pre-proline 0 CA--C 1.568 1.637 0 CA-C-N 117.918 0.859 . . . . 0.0 110.561 175.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -65.66 151.62 84.08 Favored 'Trans proline' 0 C--N 1.369 1.635 0 C-N-CA 123.306 2.671 . . . . 0.0 114.034 172.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -49.93 -37.21 30.77 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 116.5 2.037 . . . . 0.0 116.5 172.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -63.11 -51.06 68.05 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 114.732 1.382 . . . . 0.0 114.732 169.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.5 mt -70.98 -14.31 62.31 Favored 'General case' 0 N--CA 1.5 2.042 0 N-CA-C 117.3 2.333 . . . . 0.0 117.3 174.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 66.3 mt -71.66 -54.68 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 CA-C-N 120.191 1.36 . . . . 0.0 110.267 166.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -64.2 -27.1 68.83 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 174.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 57.2 tptt -79.96 -49.47 11.81 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-N 119.612 1.096 . . . . 0.0 112.594 170.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.55 -24.72 68.08 Favored Glycine 0 CA--C 1.551 2.314 0 N-CA-C 118.951 2.34 . . . . 0.0 118.951 174.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -65.2 -44.42 88.43 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-N 120.509 2.154 . . . . 0.0 114.194 167.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -66.94 -31.4 71.95 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 115.849 1.796 . . . . 0.0 115.849 171.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 38.0 mt -75.69 107.18 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 172.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.33 105.25 17.44 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -172.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.0 127.97 8.58 Favored Glycine 0 CA--C 1.54 1.618 0 N-CA-C 115.036 0.774 . . . . 0.0 115.036 -160.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 49.2 t -81.13 116.45 25.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 172.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.4 m -106.65 105.41 15.42 Favored 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -178.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -79.62 143.06 35.04 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 121.865 0.841 . . . . 0.0 110.782 175.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 54.2 mt -142.02 124.18 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 103.676 -2.713 . . . . 0.0 103.676 170.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.6 t -122.1 103.72 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 105.461 -2.052 . . . . 0.0 105.461 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -89.82 127.79 36.04 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 121.202 0.525 . . . . 0.0 110.252 176.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -126.72 82.25 2.07 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 165.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.91 -123.62 10.99 Favored Glycine 0 CA--C 1.547 2.058 0 C-N-CA 123.286 0.469 . . . . 0.0 113.939 -176.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -73.62 -35.15 65.3 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 169.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 8.6 m-70 -73.44 147.88 43.78 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 122.724 1.249 . . . . 0.0 111.731 176.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -137.91 148.9 45.74 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-N 113.613 -1.63 . . . . 0.0 109.498 -177.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -136.21 110.98 8.71 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 164.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -104.05 147.38 27.46 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.069 172.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.5 m -135.59 92.53 2.84 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.0 tt -96.14 126.88 48.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 C-N-CA 123.437 0.695 . . . . 0.0 109.809 -177.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 59.6 p -84.29 99.78 10.81 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 175.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -92.5 85.74 5.42 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-O 121.455 0.645 . . . . 0.0 109.866 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.59 -116.05 6.71 Favored Glycine 0 CA--C 1.545 1.934 0 CA-C-N 115.602 -0.726 . . . . 0.0 112.265 -169.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 69.8 m -82.25 -54.4 5.28 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 173.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -80.62 125.06 29.54 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 119.114 0.87 . . . . 0.0 111.27 -173.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.9 p -84.76 133.41 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 C-N-CA 123.922 0.889 . . . . 0.0 111.067 -179.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 76.7 mt -121.44 114.61 43.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 105.109 -2.182 . . . . 0.0 105.109 -175.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 20.7 pt20 -118.33 137.02 53.37 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.296 0.638 . . . . 0.0 111.224 178.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -137.81 145.98 42.97 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.941 0.877 . . . . 0.0 109.786 177.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -106.28 128.18 53.79 Favored 'General case' 0 N--CA 1.484 1.249 0 CA-C-N 114.666 -1.152 . . . . 0.0 108.251 169.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 22.5 p90 -134.75 159.48 41.18 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.722 0.773 . . . . 0.0 111.479 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.5 m -124.2 131.83 53.56 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 173.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.9 m -74.11 130.41 35.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 C-N-CA 123.582 0.753 . . . . 0.0 111.7 -179.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 96.38 -48.21 1.72 Allowed Glycine 0 CA--C 1.549 2.206 0 N-CA-C 114.964 0.746 . . . . 0.0 114.964 -168.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.0 tm-20 -67.7 146.44 53.79 Favored 'General case' 0 CA--C 1.564 1.517 0 C-N-CA 124.536 1.134 . . . . 0.0 112.159 172.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -78.86 92.2 4.85 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 123.872 0.869 . . . . 0.0 109.615 -177.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 25.5 p -107.2 140.08 40.62 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 -154.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -67.23 127.49 32.85 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 114.441 -1.254 . . . . 0.0 112.635 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.5 mt -143.67 109.7 5.31 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 -178.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -83.51 145.26 29.01 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -174.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 12.0 t -86.29 -175.72 5.61 Favored 'General case' 0 CA--C 1.568 1.65 0 CA-C-O 122.118 0.961 . . . . 0.0 111.506 170.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 24.5 ptp -85.76 52.16 2.39 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.038 1.496 . . . . 0.0 115.038 175.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . 0.291 7.6 t -164.22 -71.39 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 173.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 166.14 85.76 0.06 OUTLIER Glycine 0 N--CA 1.478 1.453 0 CA-C-N 118.955 0.798 . . . . 0.0 111.377 171.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -153.33 112.69 3.81 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 172.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -92.88 101.24 13.6 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 15.2 m -92.67 126.09 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.379 -177.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.6 mtmt -84.6 96.37 9.16 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.5 p -138.34 125.45 21.45 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -162.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 5.6 t -85.6 125.22 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 -160.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.0 t -100.59 118.97 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 178.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.1 mp0 -99.71 134.27 42.84 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.735 0.779 . . . . 0.0 109.754 176.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.1 tp -101.53 112.31 24.82 Favored 'General case' 0 CA--C 1.552 1.052 0 CA-C-N 114.662 -1.154 . . . . 0.0 108.443 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -118.08 121.28 40.17 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.37 12.76 66.81 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 121.215 3.246 . . . . 0.0 121.215 175.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.302 9.0 t70 52.16 48.75 22.06 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 -162.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.1 p-10 -155.6 -43.34 0.08 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-O 117.651 -1.166 . . . . 0.0 113.584 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -98.73 122.0 41.39 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 120.469 1.486 . . . . 0.0 110.373 -175.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 77.3 mt -110.69 98.95 7.99 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 168.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 24.7 m -103.71 124.57 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 C-N-CA 123.707 0.803 . . . . 0.0 109.525 -172.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.1 t -148.22 132.39 17.36 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-O 121.047 0.451 . . . . 0.0 110.971 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.7 p -95.66 119.83 34.85 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 172.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -84.64 -85.05 0.14 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 123.074 0.55 . . . . 0.0 109.909 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.74 -75.28 0.59 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 167.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -100.89 -19.07 16.07 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 167.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 mp -82.03 115.99 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-N 120.275 1.398 . . . . 0.0 108.106 -177.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -99.31 101.78 13.19 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 168.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.9 t -85.66 99.4 11.27 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.617 0.767 . . . . 0.0 110.458 -177.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 70.2 t -99.52 97.76 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 105.578 -2.008 . . . . 0.0 105.578 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.7 m -105.52 86.24 2.38 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 -166.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -97.04 131.6 43.68 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.888 0.875 . . . . 0.0 110.106 -171.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 tt -101.68 106.28 17.29 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -175.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -106.18 86.66 2.4 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -172.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.74 -108.09 2.68 Favored Glycine 0 N--CA 1.482 1.74 0 O-C-N 122.101 -0.374 . . . . 0.0 112.882 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -121.46 52.65 1.22 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.314 0.578 . . . . 0.0 111.615 170.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.5 pt -131.21 -163.17 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.748 0 C-N-CA 124.337 1.055 . . . . 0.0 108.163 163.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.3 tt -154.88 119.57 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 120.363 -1.46 . . . . 0.0 107.952 157.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 29.3 m -95.06 101.02 12.75 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -94.81 99.34 11.43 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 -178.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 30.3 m -101.93 91.17 4.24 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 -172.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 36.3 mtt -93.17 103.36 15.64 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.224 -176.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.3 p -97.86 95.94 7.87 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.489 -171.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 19.3 tp -93.72 81.97 4.3 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.723 0.809 . . . . 0.0 109.079 177.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.8 -101.95 1.16 Allowed Glycine 0 CA--C 1.544 1.879 0 CA-C-N 116.191 -0.458 . . . . 0.0 113.043 -174.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -98.06 -11.52 22.84 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 115.309 1.596 . . . . 0.0 115.309 170.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 62.4 mt -86.71 106.46 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 -174.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.9 t -98.84 94.17 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -175.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -82.3 92.73 7.0 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.231 0.613 . . . . 0.0 109.659 177.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -92.41 109.47 20.86 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.3 ttt-85 -118.23 104.9 11.23 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -164.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.9 mp -98.44 116.33 40.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 105.593 -2.002 . . . . 0.0 105.593 -172.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.9 m -130.33 115.14 16.51 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -176.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -87.38 137.33 32.43 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 123.228 0.611 . . . . 0.0 112.135 -168.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 7.3 ttt85 -67.58 124.88 24.46 Favored 'General case' 0 CA--C 1.56 1.333 0 C-N-CA 123.914 0.886 . . . . 0.0 111.524 177.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.5 pt . . . . . 0 N--CA 1.484 1.258 0 N-CA-C 106.301 -1.74 . . . . 0.0 106.301 -172.576 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.0 m . . . . . 0 CA--C 1.549 0.915 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -68.2 -23.71 64.86 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 117.027 2.232 . . . . 0.0 117.027 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.7 m -73.29 109.21 6.64 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 120.704 1.593 . . . . 0.0 110.648 175.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.15 162.21 23.09 Favored Glycine 0 CA--C 1.544 1.877 0 CA-C-O 122.306 0.948 . . . . 0.0 114.134 -171.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.4 mtmp? -97.18 125.88 41.98 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 114.402 -0.899 . . . . 0.0 108.605 175.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -121.52 104.37 9.6 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 -172.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -95.62 137.85 34.11 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-O 121.129 0.49 . . . . 0.0 110.892 -178.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 29.7 tp -66.11 130.69 44.11 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 124.082 0.953 . . . . 0.0 112.987 -173.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.8 mm100 -114.64 -64.79 1.26 Allowed 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.879 -175.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.7 m -125.49 112.05 15.78 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -177.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.1 tt0 -105.74 110.4 22.69 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 -178.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -97.41 127.42 43.36 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 176.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.263 85.5 m-20 67.4 52.51 0.8 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 173.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 17.6 t80 -78.65 -43.95 24.94 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 113.83 1.048 . . . . 0.0 113.83 168.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -68.65 -50.86 47.83 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -175.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.91 -40.74 85.44 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 170.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 40.2 t80 -69.44 -56.54 7.13 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 178.269 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.64 -44.24 96.61 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.2 mtpm? -61.96 -38.13 87.37 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 170.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.66 -34.39 77.74 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 116.819 2.155 . . . . 0.0 116.819 172.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 33.5 pt -82.33 -53.8 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 CA-C-N 119.327 0.967 . . . . 0.0 112.384 176.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 150.52 68.68 0.01 OUTLIER Glycine 0 CA--C 1.539 1.535 0 CA-C-N 119.017 0.826 . . . . 0.0 112.894 172.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.32 153.11 81.56 Favored Pre-proline 0 CA--C 1.57 1.721 0 C-N-CA 123.513 0.725 . . . . 0.0 111.813 175.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.81 152.84 25.53 Favored 'Trans proline' 0 C--N 1.372 1.802 0 C-N-CA 123.264 2.643 . . . . 0.0 113.489 175.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -59.18 -28.84 66.99 Favored 'General case' 0 CA--C 1.565 1.526 0 N-CA-C 116.723 2.119 . . . . 0.0 116.723 168.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -63.02 -51.81 65.35 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 120.543 1.52 . . . . 0.0 114.055 170.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.4 mt -67.93 -28.28 67.35 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 116.604 2.075 . . . . 0.0 116.604 173.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.3 mt -70.38 -49.94 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 C-N-CA 124.297 1.039 . . . . 0.0 111.621 173.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -64.23 -22.62 67.01 Favored 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 116.315 1.969 . . . . 0.0 116.315 170.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -73.08 -57.99 3.63 Favored 'General case' 0 CA--C 1.565 1.519 0 CA-C-N 119.272 0.942 . . . . 0.0 111.74 167.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.5 -22.16 67.46 Favored Glycine 0 CA--C 1.548 2.143 0 N-CA-C 120.418 2.927 . . . . 0.0 120.418 179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -64.68 -43.53 93.24 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 119.661 1.731 . . . . 0.0 114.64 170.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -67.24 -27.85 67.57 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.865 1.802 . . . . 0.0 115.865 168.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 53.1 mt -83.03 121.75 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-N 120.144 1.338 . . . . 0.0 107.506 178.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.64 102.46 15.09 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 173.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.54 132.74 11.42 Favored Glycine 0 CA--C 1.541 1.707 0 N-CA-C 114.509 0.564 . . . . 0.0 114.509 -167.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.3 t -85.33 110.21 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 54.2 p -109.79 112.16 24.03 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.5 178.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -89.63 152.32 21.44 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 121.632 0.729 . . . . 0.0 111.058 -177.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 68.2 mt -136.35 132.8 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 105.437 -2.06 . . . . 0.0 105.437 173.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 63.6 t -126.57 102.77 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 64.0 tt0 -80.18 120.7 24.65 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.122 0.569 . . . . 0.0 110.148 176.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -122.99 73.0 1.12 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 169.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.83 -117.48 7.56 Favored Glycine 0 CA--C 1.546 1.996 0 C-N-CA 123.117 0.389 . . . . 0.0 113.67 -175.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -76.87 -34.36 57.8 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.689 1.366 . . . . 0.0 114.689 169.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 46.6 m80 -79.95 112.99 17.78 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 119.941 1.246 . . . . 0.0 110.761 178.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -105.74 117.98 35.42 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 176.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 mtpp -104.12 104.65 14.62 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 176.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 10.0 p90 -133.29 134.45 43.9 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.297 -166.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -93.96 147.71 22.84 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.669 0.747 . . . . 0.0 110.029 165.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.0 tp -130.68 121.91 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.5 m -94.02 105.68 17.68 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 172.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.22 82.93 4.55 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 171.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.67 -101.96 1.95 Allowed Glycine 0 CA--C 1.54 1.621 0 CA-C-N 115.941 -0.572 . . . . 0.0 113.556 -177.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 93.0 p -89.08 -55.62 3.61 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 177.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -81.64 130.48 35.07 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 119.171 0.896 . . . . 0.0 111.673 -173.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.6 p -101.99 129.13 53.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.279 175.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.3 tt -129.92 143.22 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 123.799 0.84 . . . . 0.0 109.361 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -94.81 125.48 39.49 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.774 -179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -127.38 159.19 35.21 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 124.007 0.923 . . . . 0.0 110.257 -177.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -139.34 136.69 35.07 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.543 -0.723 . . . . 0.0 110.244 -179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.493 ' HB2' ' SG ' ' A' ' 69' ' ' CYS . 28.5 p90 -126.96 159.71 33.23 Favored 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 122.012 0.91 . . . . 0.0 112.324 167.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 96.3 m -116.07 139.7 50.03 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 163.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 87.6 t -75.62 123.35 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 175.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.13 34.21 21.49 Favored Glycine 0 CA--C 1.549 2.198 0 N-CA-C 117.044 1.578 . . . . 0.0 117.044 -168.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -149.89 138.57 20.83 Favored 'General case' 0 N--CA 1.485 1.277 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 -177.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -69.32 105.71 2.65 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.176 0.512 . . . . 0.0 109.954 160.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 63' ' ' PHE . 3.2 p -129.25 131.76 47.09 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 122.402 1.096 . . . . 0.0 110.649 -162.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -79.65 123.75 27.92 Favored 'General case' 0 CA--C 1.559 1.297 0 CA-C-N 113.962 -1.472 . . . . 0.0 112.631 -168.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.8 mt -118.51 119.56 34.9 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.305 -1.368 . . . . 0.0 107.305 -177.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -86.67 92.54 8.96 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-O 121.647 0.737 . . . . 0.0 109.228 178.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.8 m -90.89 159.44 16.23 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.446 1.098 . . . . 0.0 109.707 -172.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . 0.282 55.4 mtt 68.74 -100.27 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 124.623 1.169 . . . . 0.0 109.674 -175.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.8 p -127.9 -44.05 1.49 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 124.716 1.206 . . . . 0.0 110.725 162.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -141.82 82.02 0.23 Allowed Glycine 0 N--CA 1.481 1.645 0 CA-C-N 120.033 1.288 . . . . 0.0 111.55 173.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -142.57 99.75 3.55 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 177.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.96 122.08 31.96 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.045 0.45 . . . . 0.0 110.676 -171.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 12.9 p -140.12 121.19 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -169.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -92.85 123.63 36.26 Favored 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 123.189 0.596 . . . . 0.0 109.985 -175.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.2 p -132.84 128.65 37.13 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 -164.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 47.5 t -93.39 108.68 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -175.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.3 t -96.56 127.09 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 -172.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 14.2 mp0 -115.52 132.16 56.71 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 168.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 29.9 tp -98.67 108.62 21.36 Favored 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 177.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -102.79 125.5 49.56 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-O 121.78 0.8 . . . . 0.0 109.159 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.09 11.13 66.57 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 121.173 3.229 . . . . 0.0 121.173 175.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.274 25.9 m-20 57.77 43.52 21.77 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -166.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -158.65 -38.79 0.06 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 117.744 -1.122 . . . . 0.0 114.0 -179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -103.99 119.33 38.71 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 120.458 1.481 . . . . 0.0 110.411 -172.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 26.6 mt -101.03 99.46 9.92 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 174.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 47.1 t -100.68 110.59 28.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 106.375 -1.713 . . . . 0.0 106.375 -170.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.6 t -137.26 159.58 41.51 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 122.863 1.316 . . . . 0.0 113.629 -167.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 58.9 m -80.47 -78.42 0.17 Allowed 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 113.939 -1.482 . . . . 0.0 111.914 -161.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 65.0 171.38 0.2 Allowed 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 119.613 1.097 . . . . 0.0 113.749 -169.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -79.21 95.06 5.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.195 -0.94 . . . . 0.0 108.569 165.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 55.8 t30 47.44 47.41 17.16 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 116.722 2.119 . . . . 0.0 116.722 -175.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 72.9 mt -137.81 88.54 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 102.926 -2.99 . . . . 0.0 102.926 174.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 17.2 tptp -84.5 98.41 10.09 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -174.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 17.9 t -96.62 117.65 31.42 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.933 -165.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 56.1 t -113.36 101.83 13.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 104.832 -2.285 . . . . 0.0 104.832 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.7 m -98.36 83.96 3.14 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -89.99 130.97 36.12 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.967 0.907 . . . . 0.0 110.214 -172.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 tt -101.27 110.38 22.38 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -177.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -110.68 85.52 2.13 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -174.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.82 -108.31 2.72 Favored Glycine 0 N--CA 1.483 1.771 0 O-C-N 122.081 -0.387 . . . . 0.0 112.952 -179.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -121.36 56.5 1.04 Allowed 'General case' 0 N--CA 1.495 1.78 0 CA-C-O 121.337 0.589 . . . . 0.0 111.188 168.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 5.8 pt -131.39 -166.11 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.687 0 C-N-CA 124.331 1.052 . . . . 0.0 108.522 161.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.6 tt -154.62 123.04 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.559 1.305 0 O-C-N 120.196 -1.565 . . . . 0.0 108.545 158.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 46.1 m -101.64 103.13 13.92 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 -176.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 33.8 t30 -93.0 98.56 11.43 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -178.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.5 m -99.34 87.25 3.58 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.662 0.744 . . . . 0.0 109.018 -171.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 33.5 mtt -92.46 105.43 17.61 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.129 0.972 . . . . 0.0 109.704 -177.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.9 p -98.89 101.27 12.61 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -172.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.5 tp -95.25 83.77 3.93 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.57 -97.31 0.78 Allowed Glycine 0 CA--C 1.543 1.83 0 CA-C-N 116.437 -0.347 . . . . 0.0 112.685 -171.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -106.95 -9.3 16.31 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.319 1.599 . . . . 0.0 115.319 169.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 48.5 mt -85.75 107.31 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 CA-C-N 120.692 1.587 . . . . 0.0 107.091 -173.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 31.3 t -94.7 95.61 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 -174.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -86.74 100.75 12.72 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.905 0.882 . . . . 0.0 109.245 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -111.18 107.72 17.15 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.582 -0.735 . . . . 0.0 109.76 -172.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 60.6 mtm180 -99.72 114.33 27.37 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 177.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 75.6 mt -102.75 103.09 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 104.608 -2.367 . . . . 0.0 104.608 -177.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.4 m -120.47 114.98 22.58 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -171.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 53.3 tttm -84.2 135.83 34.2 Favored 'General case' 0 N--CA 1.482 1.125 0 C-N-CA 123.172 0.589 . . . . 0.0 112.168 -168.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -69.91 133.46 47.35 Favored 'General case' 0 CA--C 1.555 1.169 0 CA-C-O 122.014 0.912 . . . . 0.0 112.184 -178.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 21.7 pt . . . . . 0 N--CA 1.483 1.209 0 N-CA-C 105.967 -1.864 . . . . 0.0 105.967 -172.281 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 CA--C 1.553 1.079 0 CA-C-O 119.01 -0.519 . . . . 0.0 110.771 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.365 90.7 m-85 80.39 -35.4 0.13 Allowed 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 117.381 2.363 . . . . 0.0 117.381 173.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.9 m -71.94 107.22 4.57 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 120.496 1.498 . . . . 0.0 111.248 178.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 174.69 161.31 24.28 Favored Glycine 0 CA--C 1.544 1.88 0 CA-C-O 122.652 1.14 . . . . 0.0 114.044 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -96.58 125.67 41.21 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 168.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -121.05 116.66 25.45 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 -174.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 21.0 tp60 -91.83 125.78 36.67 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 122.943 0.497 . . . . 0.0 110.092 -177.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 28.6 tp -64.02 131.79 48.64 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 123.75 0.82 . . . . 0.0 112.781 -179.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -126.33 -58.22 1.36 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 118.569 -0.729 . . . . 0.0 110.742 -178.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 73.8 m -107.35 136.99 46.22 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 119.067 0.849 . . . . 0.0 109.664 177.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -139.53 106.35 5.4 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -96.47 134.2 39.95 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 124.081 0.952 . . . . 0.0 109.365 176.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.26 13.5 m-20 66.67 47.65 1.55 Allowed 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.43 1.641 . . . . 0.0 115.43 174.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -77.82 -49.51 14.15 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 176.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -62.79 -46.78 86.41 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 177.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.74 -42.39 93.06 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 173.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.7 t80 -72.49 -52.8 14.17 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 178.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.48 -52.09 66.81 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.8 mmmt -56.92 -39.24 74.09 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.83 1.789 . . . . 0.0 115.83 171.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.12 -37.48 87.59 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 116.588 2.069 . . . . 0.0 116.588 174.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.278 48.5 pt -77.36 -48.88 23.68 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 CA-C-N 119.516 1.053 . . . . 0.0 112.955 175.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.81 57.72 0.01 OUTLIER Glycine 0 N--CA 1.483 1.815 0 CA-C-N 119.473 1.033 . . . . 0.0 114.5 166.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -110.3 154.03 43.1 Favored Pre-proline 0 CA--C 1.566 1.575 0 CA-C-N 118.009 0.904 . . . . 0.0 112.084 -175.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.16 154.93 33.0 Favored 'Trans proline' 0 CA--C 1.557 1.659 0 C-N-CA 123.296 2.664 . . . . 0.0 113.384 172.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -61.62 -35.49 78.04 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 170.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.05 -54.18 50.03 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 114.713 1.375 . . . . 0.0 114.713 173.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 80.6 mt -70.97 -24.07 62.34 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 116.558 2.058 . . . . 0.0 116.558 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 60.6 mt -70.2 -52.14 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 CA-C-N 119.94 1.245 . . . . 0.0 110.974 169.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -62.84 -19.7 64.36 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 116.912 2.19 . . . . 0.0 116.912 173.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 64.8 mttm -81.38 -53.91 5.91 Favored 'General case' 0 CA--C 1.561 1.398 0 CA-C-N 119.483 1.038 . . . . 0.0 112.182 167.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -69.45 -7.2 57.36 Favored Glycine 0 CA--C 1.553 2.463 0 N-CA-C 120.279 2.872 . . . . 0.0 120.279 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.77 -47.03 61.73 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-N 120.21 2.005 . . . . 0.0 113.273 170.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -69.43 -31.91 70.56 Favored 'General case' 0 CA--C 1.566 1.595 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 168.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.2 mt -78.29 119.79 27.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 178.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -85.13 116.25 23.39 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 175.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.86 131.16 10.59 Favored Glycine 0 CA--C 1.54 1.608 0 CA-C-N 116.096 -0.502 . . . . 0.0 113.723 -176.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.8 t -81.26 114.53 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 175.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.2 m -96.51 110.98 23.26 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 176.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -97.39 141.3 30.64 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 121.81 0.814 . . . . 0.0 109.954 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 67.2 mt -141.53 132.34 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 N-CA-C 104.983 -2.229 . . . . 0.0 104.983 170.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.8 t -120.87 113.39 39.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 174.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -82.41 123.73 29.4 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.262 0.625 . . . . 0.0 110.168 173.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -128.07 72.02 1.4 Allowed 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 163.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.88 -114.43 5.29 Favored Glycine 0 CA--C 1.545 1.933 0 C-N-CA 123.4 0.524 . . . . 0.0 113.385 -177.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -77.53 -33.51 54.22 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 167.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -76.54 102.94 6.27 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 120.072 1.305 . . . . 0.0 111.008 -179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -109.13 109.21 20.14 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 178.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.95 127.89 44.98 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 109.344 -0.614 . . . . 0.0 109.344 168.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 9.9 p90 -116.34 152.14 34.49 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.747 178.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 89.1 m -136.28 92.63 2.8 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 173.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.8 mm -91.12 116.61 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 106.584 -1.635 . . . . 0.0 106.584 -175.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.4 m -93.91 102.14 14.24 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 -174.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -92.06 140.9 29.18 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 162.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -44.57 -39.02 5.67 Favored Glycine 0 CA--C 1.555 2.581 0 N-CA-C 119.805 2.682 . . . . 0.0 119.805 175.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 19.5 t -69.44 -59.74 2.79 Favored 'General case' 0 CA--C 1.565 1.529 0 N-CA-C 114.023 1.12 . . . . 0.0 114.023 168.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -145.49 135.12 23.34 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 119.223 0.92 . . . . 0.0 109.913 -176.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.7 p -75.7 125.18 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 123.482 0.713 . . . . 0.0 110.236 169.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 95.4 mt -119.71 110.51 29.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 105.463 -2.051 . . . . 0.0 105.463 -173.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 20.9 pt20 -117.09 130.72 56.83 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.768 0.827 . . . . 0.0 110.966 -176.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -148.31 149.13 31.27 Favored 'General case' 0 N--CA 1.497 1.896 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.553 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 9.4 tm-20 -118.4 128.36 54.55 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 123.826 0.85 . . . . 0.0 110.222 -176.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -116.12 144.47 44.11 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.962 0.905 . . . . 0.0 111.425 170.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 33.2 m -105.3 124.11 48.98 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 166.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.4 t -67.04 124.88 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 C-N-CA 123.735 0.814 . . . . 0.0 110.662 -174.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 93.18 -49.97 2.45 Favored Glycine 0 CA--C 1.549 2.167 0 N-CA-C 115.999 1.16 . . . . 0.0 115.999 -170.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -93.22 124.13 36.98 Favored 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.728 0.811 . . . . 0.0 110.231 -172.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -57.44 123.81 16.75 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 -168.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 72.6 m -144.08 146.53 32.88 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.099 0.96 . . . . 0.0 109.609 -177.635 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -80.04 134.59 36.23 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -176.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.2 mt -130.04 127.4 39.84 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 175.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -85.22 141.73 29.93 Favored 'General case' 0 N--CA 1.486 1.331 0 CA-C-O 121.423 0.63 . . . . 0.0 111.473 -178.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.2 p -73.06 172.95 10.07 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.767 164.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 90.3 mtp -61.06 -53.83 52.29 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 120.555 -1.341 . . . . 0.0 114.142 175.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.6 p -127.54 111.02 13.31 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 167.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 173.26 -108.11 0.27 Allowed Glycine 0 CA--C 1.535 1.335 0 N-CA-C 111.979 -0.449 . . . . 0.0 111.979 175.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -149.79 151.17 33.12 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-O 121.613 0.721 . . . . 0.0 109.544 -168.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 49.5 mttm -71.4 103.56 2.94 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-O 122.393 1.092 . . . . 0.0 109.685 167.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 9.8 p -114.39 134.52 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 CA-C-N 113.157 -1.838 . . . . 0.0 108.773 -164.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.5 tptm -78.02 106.39 9.85 Favored 'General case' 0 N--CA 1.487 1.38 0 C-N-CA 123.14 0.576 . . . . 0.0 110.794 -171.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.6 t -152.64 130.81 11.94 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -173.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 7.4 p -121.25 145.26 28.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 CA-C-O 123.374 1.559 . . . . 0.0 110.587 -176.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.8 t -98.49 142.18 15.09 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.302 0 CA-C-N 112.985 -1.916 . . . . 0.0 108.347 -167.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 18.2 mp0 -112.48 132.98 54.79 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 172.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.7 tp -98.07 109.71 22.42 Favored 'General case' 0 CA--C 1.552 1.021 0 CA-C-N 115.365 -0.834 . . . . 0.0 108.841 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -95.65 114.93 26.73 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 122.127 0.965 . . . . 0.0 108.929 177.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.44 -128.64 10.65 Favored Glycine 0 CA--C 1.545 1.919 0 CA-C-N 114.019 -1.446 . . . . 0.0 112.265 -168.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -135.82 58.55 1.75 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 156.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -158.49 -32.0 0.07 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.306 1.595 . . . . 0.0 115.306 -173.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -114.39 106.21 14.03 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 120.925 1.693 . . . . 0.0 108.976 -174.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 42.4 mt -95.78 103.91 15.81 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 31.0 m -102.35 125.56 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 C-N-CA 123.372 0.669 . . . . 0.0 109.87 -172.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.5 t -149.66 151.43 33.71 Favored 'General case' 0 N--CA 1.497 1.891 0 CA-C-O 121.324 0.583 . . . . 0.0 111.771 179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 29.7 p -119.71 112.72 19.64 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 123.405 0.682 . . . . 0.0 109.215 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -83.38 37.43 0.56 Allowed 'General case' 0 CA--C 1.58 2.106 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 168.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.344 11.8 tmtt? 69.99 -81.04 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 124.952 1.301 . . . . 0.0 111.236 -163.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -81.14 -42.6 20.63 Favored 'General case' 0 CA--C 1.566 1.582 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -177.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.8 mp -85.64 123.05 39.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 CA-C-N 119.585 1.084 . . . . 0.0 108.167 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -102.57 98.77 8.78 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 172.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.9 t -89.67 132.88 34.94 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.478 0.711 . . . . 0.0 110.958 -176.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.1 t -132.95 102.3 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 104.787 -2.301 . . . . 0.0 104.787 176.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 20.6 m -93.14 95.71 9.58 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -80.84 145.21 31.51 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 124.111 0.964 . . . . 0.0 110.703 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.2 tt -128.35 109.37 11.38 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 174.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -113.21 80.49 1.36 Allowed 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -175.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 84.93 -109.24 3.26 Favored Glycine 0 N--CA 1.484 1.861 0 O-C-N 121.835 -0.541 . . . . 0.0 113.068 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -114.47 50.39 0.95 Allowed 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 122.965 0.506 . . . . 0.0 111.362 173.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.6 pt -133.8 -168.74 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.786 0 C-N-CA 124.047 0.939 . . . . 0.0 108.938 171.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.1 tt -156.85 115.44 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.272 -1.517 . . . . 0.0 107.45 159.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 90.0 m -103.15 99.7 9.58 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -90.19 108.81 19.98 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 176.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 39.7 m -108.48 100.14 9.45 Favored 'General case' 0 N--CA 1.483 1.202 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 -173.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 12.8 mtt -101.28 100.39 10.89 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.2 p -88.65 113.38 24.16 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 115.291 -0.868 . . . . 0.0 109.009 -173.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 58.3 tp -117.87 75.43 1.0 Allowed 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 -175.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.35 -107.4 2.34 Favored Glycine 0 CA--C 1.545 1.958 0 CA-C-N 116.404 -0.362 . . . . 0.0 112.369 -172.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -93.62 -10.7 33.7 Favored 'General case' 0 N--CA 1.497 1.909 0 N-CA-C 115.261 1.578 . . . . 0.0 115.261 167.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 61.8 mt -86.52 103.67 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 -173.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 48.4 t -97.81 97.78 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 -177.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 32.7 t80 -85.55 96.33 9.6 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.163 0.585 . . . . 0.0 109.446 -179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -105.26 101.67 11.19 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -176.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.6 113.98 27.22 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 50.2 mt -107.02 112.91 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 -172.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 54.5 m -114.76 119.03 35.26 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 176.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -83.81 147.3 27.66 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.965 -0.459 . . . . 0.0 110.937 -175.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 31.9 ttp180 -76.03 107.18 8.06 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-O 121.538 0.685 . . . . 0.0 111.295 -169.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 68.7 mt . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 102.336 -3.209 . . . . 0.0 102.336 -158.505 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.5 t . . . . . 0 CA--C 1.55 0.947 0 CA-C-O 121.249 0.547 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -65.8 -17.24 64.5 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 117.569 2.433 . . . . 0.0 117.569 174.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.2 m -69.39 112.26 5.81 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 120.822 1.646 . . . . 0.0 110.792 173.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.03 145.22 4.95 Favored Glycine 0 CA--C 1.541 1.675 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.062 -171.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -102.21 106.8 17.69 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 179.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -107.64 104.05 13.49 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 -162.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -83.19 131.24 35.13 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-O 121.123 0.487 . . . . 0.0 111.633 -177.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.9 tp -76.14 115.71 16.13 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.675 -168.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -98.6 -65.24 0.97 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.507 0.723 . . . . 0.0 111.444 -176.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 71.0 m -131.89 135.66 46.83 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.245 0.618 . . . . 0.0 110.336 -163.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -129.29 134.68 48.05 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 121.649 0.737 . . . . 0.0 109.799 -175.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -76.28 -58.55 3.22 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.356 171.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -127.35 68.94 1.29 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 118.584 0.629 . . . . 0.0 110.799 -176.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -75.12 -54.26 7.45 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.526 -0.734 . . . . 0.0 112.553 170.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -65.21 -49.55 69.3 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.22 -39.21 82.0 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 116.89 2.182 . . . . 0.0 116.89 174.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -65.96 -54.07 30.89 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 113.617 0.969 . . . . 0.0 113.617 174.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 37.4 mtt -60.7 -45.61 93.52 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 -179.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -55.67 -42.1 74.63 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.736 1.754 . . . . 0.0 115.736 167.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.4 -34.47 78.02 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 117.06 2.244 . . . . 0.0 117.06 175.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 30.7 pt -78.48 -43.94 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 CA-C-N 119.822 1.192 . . . . 0.0 113.599 175.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 131.36 62.78 0.09 OUTLIER Glycine 0 N--CA 1.481 1.664 0 CA-C-N 118.881 0.764 . . . . 0.0 112.682 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -116.42 151.33 46.8 Favored Pre-proline 0 CA--C 1.568 1.649 0 C-N-CA 123.8 0.84 . . . . 0.0 110.745 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -75.65 156.99 40.21 Favored 'Trans proline' 0 CA--C 1.555 1.559 0 C-N-CA 123.264 2.642 . . . . 0.0 113.637 177.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -60.35 -29.53 68.96 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 115.692 1.738 . . . . 0.0 115.692 168.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -60.2 -57.75 11.48 Favored 'General case' 0 CA--C 1.564 1.495 0 CA-C-O 117.297 -1.335 . . . . 0.0 113.803 169.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.8 mt -68.69 -24.16 64.47 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 117.19 2.293 . . . . 0.0 117.19 178.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.4 mt -73.38 -54.29 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-N 119.491 1.042 . . . . 0.0 110.711 173.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 87.2 mm-40 -69.18 -27.85 65.88 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 177.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -76.69 -53.77 7.54 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 124.04 0.936 . . . . 0.0 112.109 171.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.9 -19.78 69.99 Favored Glycine 0 CA--C 1.551 2.316 0 N-CA-C 119.652 2.621 . . . . 0.0 119.652 177.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -65.72 -43.71 88.24 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 120.251 2.025 . . . . 0.0 114.434 170.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -68.4 -31.47 70.83 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 170.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.9 mt -77.33 129.86 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-N 119.532 1.06 . . . . 0.0 108.508 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.52 94.97 9.94 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 171.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.12 131.06 10.36 Favored Glycine 0 N--CA 1.481 1.635 0 CA-C-N 116.558 -0.292 . . . . 0.0 113.322 -172.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.7 t -79.75 120.81 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -176.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 69.9 m -108.29 100.21 9.54 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 107.167 -1.419 . . . . 0.0 107.167 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -83.89 147.9 27.26 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 121.842 0.829 . . . . 0.0 111.011 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.9 mt -143.91 129.42 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 N-CA-C 104.456 -2.424 . . . . 0.0 104.456 172.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 67.8 t -120.88 117.49 53.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 176.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -81.2 122.11 26.98 Favored 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 123.404 0.681 . . . . 0.0 111.31 -178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -131.0 64.11 1.58 Allowed 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 171.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 66.58 -113.73 5.9 Favored Glycine 0 CA--C 1.547 2.059 0 O-C-N 121.629 -0.669 . . . . 0.0 113.746 -174.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -73.29 -40.46 64.54 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 114.585 1.328 . . . . 0.0 114.585 169.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 55.0 m80 -69.63 135.59 50.12 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 119.407 1.003 . . . . 0.0 111.387 175.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 65.2 m-85 -127.6 108.72 11.02 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp -87.04 92.59 9.1 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.673 0.749 . . . . 0.0 109.017 176.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -104.64 136.5 44.05 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.42 -175.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 95.8 m -131.55 102.58 5.98 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 -177.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.6 mm -95.22 105.08 16.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 9.1 t -105.05 102.3 11.81 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 174.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -106.11 86.39 2.36 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 174.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.28 -107.49 2.63 Favored Glycine 0 CA--C 1.541 1.688 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.852 -176.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 63.2 m -87.95 -47.76 8.31 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.0 mtmt -75.21 133.6 41.37 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 119.438 1.017 . . . . 0.0 111.698 -174.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.5 t -117.95 109.21 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 -175.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.8 mp -104.36 97.12 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 105.883 -1.895 . . . . 0.0 105.883 -174.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.78 120.85 42.22 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.203 0.601 . . . . 0.0 110.538 -177.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -149.62 161.33 42.38 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 124.175 0.99 . . . . 0.0 109.968 -175.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -117.47 128.58 55.13 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 123.57 0.748 . . . . 0.0 109.871 175.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 18.2 p90 -107.89 145.07 34.25 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-O 121.467 0.651 . . . . 0.0 110.392 158.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.4 m -109.15 131.89 54.64 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 171.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.2 t -73.55 130.1 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 C-N-CA 123.797 0.839 . . . . 0.0 109.702 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 80.27 8.52 87.52 Favored Glycine 0 CA--C 1.553 2.452 0 N-CA-C 118.706 2.242 . . . . 0.0 118.706 -170.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -139.73 135.7 33.41 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 119.272 1.536 . . . . 0.0 108.251 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -69.75 121.93 18.18 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.257 0.623 . . . . 0.0 112.5 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -136.86 126.85 25.93 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.693 0.797 . . . . 0.0 110.479 -165.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.3 128.3 34.09 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.03 -0.987 . . . . 0.0 111.685 -178.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 39.9 mt -129.36 112.71 14.11 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 -175.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -71.81 121.27 18.67 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.5 0.72 . . . . 0.0 110.191 176.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 56.1 p -83.11 171.07 14.11 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.818 0.818 . . . . 0.0 111.703 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 17.2 ptt? -55.1 -44.07 74.59 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 117.136 2.273 . . . . 0.0 117.136 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 48.9 p -73.67 -63.44 1.2 Allowed 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 118.584 0.629 . . . . 0.0 111.598 168.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 152.96 92.92 0.09 OUTLIER Glycine 0 N--CA 1.478 1.467 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 177.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -155.69 119.66 4.52 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -88.84 109.49 20.25 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.529 -1.286 . . . . 0.0 107.529 170.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 29.7 m -80.54 -47.43 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 N-CA-C 114.64 1.348 . . . . 0.0 114.64 -168.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . 0.265 53.9 mtpt 64.36 86.32 0.13 Allowed 'General case' 0 N--CA 1.493 1.697 0 C-N-CA 124.821 1.248 . . . . 0.0 111.648 -172.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.7 t -134.68 147.17 50.06 Favored 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.707 0.803 . . . . 0.0 110.033 -171.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 57.8 t -85.5 -56.98 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.776 -0.578 . . . . 0.0 111.427 -169.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . 0.307 3.1 t 80.25 127.24 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 125.382 1.473 . . . . 0.0 109.866 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.8 mp0 -121.26 135.17 55.16 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 174.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 39.2 tp -96.68 102.57 14.37 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -86.23 114.43 23.05 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-O 121.799 0.809 . . . . 0.0 109.309 173.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.53 -122.42 8.54 Favored Glycine 0 CA--C 1.542 1.724 0 CA-C-N 114.394 -1.276 . . . . 0.0 112.89 -175.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -142.04 60.42 1.46 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 155.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.7 p-10 -151.51 -39.29 0.12 Allowed 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 117.267 -1.349 . . . . 0.0 114.218 -178.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -106.27 126.65 52.49 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 120.686 1.584 . . . . 0.0 110.288 -179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 37.2 mt -107.74 100.0 9.43 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 165.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.8 m -94.9 122.85 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 123.876 0.871 . . . . 0.0 109.274 -172.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.2 t -152.51 132.82 13.65 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 120.92 0.39 . . . . 0.0 111.907 -172.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 44.8 p -100.58 121.54 41.78 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -84.18 -70.74 0.55 Allowed 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.031 0.532 . . . . 0.0 111.339 -177.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -120.7 -77.3 0.58 Allowed 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 165.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 45.5 t30 -126.74 66.98 1.25 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 159.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 62.9 mt -142.33 101.21 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 103.411 -2.811 . . . . 0.0 103.411 -178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -88.08 98.4 11.51 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 121.345 0.593 . . . . 0.0 109.571 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 33.3 t -88.25 102.64 15.02 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.307 1.043 . . . . 0.0 109.947 -176.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.7 t -101.0 97.23 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 -177.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 30.9 m -91.65 83.49 5.33 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -168.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -98.66 129.13 45.14 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.626 0.77 . . . . 0.0 110.129 -161.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 tt -113.09 114.07 26.31 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -167.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -119.27 103.33 9.41 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 -178.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.01 -118.18 4.65 Favored Glycine 0 N--CA 1.484 1.862 0 C-N-CA 123.123 0.392 . . . . 0.0 112.714 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -124.93 60.16 1.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 121.986 0.898 . . . . 0.0 110.107 161.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.6 pt -123.62 -164.64 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.789 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 157.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.3 tt -155.9 125.19 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 O-C-N 120.147 -1.596 . . . . 0.0 108.283 160.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 88.9 m -109.76 98.65 7.95 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.1 t-20 -93.86 123.79 37.44 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-O 121.371 0.605 . . . . 0.0 109.691 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 27.8 m -114.59 93.84 4.51 Favored 'General case' 0 CA--C 1.557 1.236 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 -170.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 63.5 mtt -93.22 99.81 12.3 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.813 0.845 . . . . 0.0 109.102 -177.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 73.8 p -94.84 100.22 12.14 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -171.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 35.0 tp -96.4 84.96 3.81 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 177.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.31 -100.0 0.93 Allowed Glycine 0 CA--C 1.544 1.881 0 CA-C-N 116.743 -0.208 . . . . 0.0 112.852 -174.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -102.36 -10.5 19.4 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 169.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 71.9 mt -87.09 108.19 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 CA-C-N 120.601 1.546 . . . . 0.0 107.453 -172.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.3 t -97.83 93.13 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 -172.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -82.84 109.18 16.75 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 122.967 0.507 . . . . 0.0 110.285 -178.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -88.77 142.79 27.37 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.818 175.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 45.7 mtm180 -134.62 93.57 3.06 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.795 -1.558 . . . . 0.0 106.795 174.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 58.3 mt -94.73 104.87 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 N-CA-C 105.499 -2.038 . . . . 0.0 105.499 -174.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.5 m -130.75 112.92 13.51 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 -163.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 24.7 ttpp -90.87 138.95 31.2 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 121.351 0.595 . . . . 0.0 112.186 -172.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.2 136.71 56.29 Favored 'General case' 0 CA--C 1.556 1.206 0 C-N-CA 123.748 0.819 . . . . 0.0 113.114 -177.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.9 pt . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 -175.53 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 87.7 p . . . . . 0 CA--C 1.551 1.006 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -87.45 -152.52 0.2 Allowed 'General case' 0 CA--C 1.57 1.74 0 C-N-CA 123.517 0.727 . . . . 0.0 110.17 -176.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.2 m 62.0 88.19 0.09 Allowed 'General case' 0 N--CA 1.491 1.616 0 C-N-CA 125.04 1.336 . . . . 0.0 112.848 -176.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 172.44 167.05 31.93 Favored Glycine 0 CA--C 1.54 1.646 0 CA-C-O 122.993 1.33 . . . . 0.0 115.095 -177.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -94.26 122.22 36.58 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 113.313 -1.444 . . . . 0.0 107.658 175.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -114.62 105.58 13.24 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 -175.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.2 tp60 -77.58 117.09 18.67 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 124.121 0.969 . . . . 0.0 111.052 -174.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 55.5 tp -69.67 107.15 3.33 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.112 0.565 . . . . 0.0 112.185 -174.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -85.89 -58.86 2.48 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.903 -176.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.2 t -134.14 142.32 47.43 Favored 'General case' 0 N--CA 1.486 1.332 0 C-N-CA 123.682 0.793 . . . . 0.0 110.016 -169.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -120.97 133.88 55.28 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-O 121.841 0.829 . . . . 0.0 108.931 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -76.03 -61.86 1.8 Allowed 'General case' 0 CA--C 1.561 1.387 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.835 169.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -128.28 67.89 1.36 Allowed 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 118.628 0.649 . . . . 0.0 111.132 -172.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -75.06 -52.08 11.94 Favored 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 175.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -66.74 -43.22 84.75 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 -175.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.25 -44.0 95.64 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 169.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -67.82 -51.93 42.85 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 114.357 1.243 . . . . 0.0 114.357 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.28 -49.07 75.31 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -60.97 -42.35 98.16 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 171.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.64 -29.61 69.67 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 117.242 2.312 . . . . 0.0 117.242 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.267 37.8 pt -77.29 -48.84 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 120.1 1.318 . . . . 0.0 112.587 171.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 137.22 65.13 0.05 OUTLIER Glycine 0 CA--C 1.541 1.686 0 C-N-CA 123.826 0.727 . . . . 0.0 112.312 175.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.4 mt -131.25 147.74 67.4 Favored Pre-proline 0 CA--C 1.568 1.64 0 C-N-CA 123.958 0.903 . . . . 0.0 110.437 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -67.44 149.04 80.25 Favored 'Trans proline' 0 C--N 1.37 1.679 0 C-N-CA 123.39 2.727 . . . . 0.0 114.397 -179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -59.47 -28.09 66.69 Favored 'General case' 0 CA--C 1.563 1.473 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 171.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -61.95 -46.43 89.35 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 166.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.9 mt -68.14 -16.49 64.02 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 116.984 2.216 . . . . 0.0 116.984 167.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 72.9 mt -74.62 -55.35 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-N 120.414 1.461 . . . . 0.0 110.534 168.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 4.1 mp0 -67.2 -29.28 68.91 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 4.8 mmpt? -75.73 -56.4 4.72 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 119.546 1.066 . . . . 0.0 111.517 168.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.22 -19.74 59.85 Favored Glycine 0 CA--C 1.55 2.223 0 N-CA-C 120.619 3.008 . . . . 0.0 120.619 178.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.1 ptmm? -67.16 -44.84 78.74 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 119.654 1.727 . . . . 0.0 113.852 168.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -68.71 -37.95 79.89 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 169.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 35.6 mt -74.33 126.41 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 119.455 1.025 . . . . 0.0 108.355 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.08 99.25 11.36 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.69 111.48 3.72 Favored Glycine 0 CA--C 1.538 1.531 0 CA-C-N 116.023 -0.535 . . . . 0.0 113.13 -172.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 53.7 t -67.15 129.26 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 C-N-CA 123.813 0.845 . . . . 0.0 110.481 -176.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 58.0 p -98.82 105.7 17.88 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 170.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -86.61 151.06 23.77 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.473 176.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.6 mt -140.84 138.8 34.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.7 t -129.8 103.93 9.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 104.968 -2.234 . . . . 0.0 104.968 171.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 -90.22 113.13 24.88 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 172.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -121.64 62.63 0.92 Allowed 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.173 0.589 . . . . 0.0 109.523 175.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.12 -111.53 3.86 Favored Glycine 0 CA--C 1.546 1.975 0 O-C-N 121.852 -0.53 . . . . 0.0 113.161 -173.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.4 mtpp -75.65 -43.0 49.93 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 113.664 0.987 . . . . 0.0 113.664 169.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 9.3 m170 -73.73 110.73 8.26 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 119.42 1.009 . . . . 0.0 109.814 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -145.61 97.47 2.98 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 -155.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.27 160.35 19.88 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.019 0.928 . . . . 0.0 111.463 -172.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 11.8 p90 -145.38 130.35 18.3 Favored 'General case' 0 N--CA 1.486 1.351 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.796 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.4 m -99.83 93.88 6.03 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 174.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.9 tp -86.6 118.55 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.4 p -96.38 95.43 8.05 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 174.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -90.18 86.2 6.47 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.343 0.592 . . . . 0.0 110.522 -171.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.32 -98.3 1.11 Allowed Glycine 0 CA--C 1.54 1.654 0 CA-C-N 115.573 -0.739 . . . . 0.0 112.297 -170.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.4 t -127.08 81.46 2.02 Favored 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 163.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.99 100.18 0.87 Allowed 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 178.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.0 t -85.44 114.54 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 -174.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 13.6 mt -130.49 104.92 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 105.411 -2.07 . . . . 0.0 105.411 -167.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 37.7 tt0 -92.94 120.62 33.45 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 167.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 52.6 t30 -123.32 113.23 18.58 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -176.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -97.98 124.11 42.29 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 123.321 0.648 . . . . 0.0 109.256 -171.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -125.12 149.81 47.5 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.567 0.698 . . . . 0.0 111.351 176.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.0 m -105.94 132.17 52.36 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 168.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.8 t -79.53 119.35 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 175.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.32 0.22 73.86 Favored Glycine 0 CA--C 1.556 2.609 0 N-CA-C 118.885 2.314 . . . . 0.0 118.885 -171.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -145.46 132.14 19.95 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-N 120.278 2.039 . . . . 0.0 108.605 167.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -73.08 113.26 9.93 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -174.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 90.9 m -96.72 156.02 16.53 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.745 173.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -77.66 101.65 6.7 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.455 0.702 . . . . 0.0 111.145 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 22.6 mt -109.95 129.18 55.7 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.299 0.571 . . . . 0.0 110.942 -165.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 20.6 pm0 -83.61 141.86 31.23 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 115.404 -0.817 . . . . 0.0 111.499 174.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 67.0 p -67.99 -65.88 0.64 Allowed 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 123.097 0.559 . . . . 0.0 111.732 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 21.7 mmt -118.1 -72.8 0.67 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 106.8 -1.556 . . . . 0.0 106.8 155.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 9.5 t -149.15 119.32 7.24 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.389 -1.338 . . . . 0.0 107.389 163.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 149.67 -75.84 0.25 Allowed Glycine 0 N--CA 1.48 1.624 0 CA-C-N 115.904 -0.589 . . . . 0.0 112.572 -174.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -83.6 99.44 10.18 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 123.166 0.586 . . . . 0.0 110.737 -171.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -91.28 105.66 17.95 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.2 m -137.9 127.78 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 -169.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -75.96 119.68 20.25 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 121.368 0.604 . . . . 0.0 111.383 -177.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.7 t -145.9 141.6 27.96 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 115.102 -0.954 . . . . 0.0 108.485 177.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.14 136.4 37.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 CA-C-O 122.515 1.15 . . . . 0.0 109.311 177.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 38.5 t -91.0 129.84 41.14 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.256 0 CA-C-N 113.833 -1.53 . . . . 0.0 107.833 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.8 mp0 -100.56 134.97 42.72 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 122.062 0.935 . . . . 0.0 109.112 171.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 66.5 tp -97.84 102.66 14.47 Favored 'General case' 0 CA--C 1.552 1.042 0 CA-C-N 114.352 -1.294 . . . . 0.0 107.961 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -101.55 116.96 33.94 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.91 11.38 85.55 Favored Glycine 0 N--CA 1.487 2.08 0 N-CA-C 120.946 3.138 . . . . 0.0 120.946 171.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.283 20.3 m-20 57.85 43.29 21.88 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 114.826 1.417 . . . . 0.0 114.826 -165.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -158.63 -43.55 0.06 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 118.118 -0.944 . . . . 0.0 113.521 -177.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 52.2 mtpt -95.8 138.43 33.46 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 120.142 1.337 . . . . 0.0 111.237 -175.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 87.0 mt -123.36 101.91 7.62 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 106.952 -1.499 . . . . 0.0 106.952 172.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.2 m -106.27 117.53 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 C-N-CA 123.439 0.696 . . . . 0.0 109.181 -171.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.6 t -151.7 142.1 22.51 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 122.421 0.288 . . . . 0.0 111.346 -175.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 83.7 m -120.68 113.53 20.35 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 178.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -70.03 -76.82 0.09 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.796 0.838 . . . . 0.0 111.42 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -120.97 -72.58 0.68 Allowed 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 165.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -128.73 60.17 1.53 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 118.662 0.665 . . . . 0.0 109.69 161.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 77.0 mt -131.47 97.5 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 102.615 -3.106 . . . . 0.0 102.615 172.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -92.02 91.07 7.67 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 15.7 t -84.41 109.62 18.01 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.983 0.913 . . . . 0.0 109.377 -174.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 72.0 t -116.77 97.16 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 104.448 -2.427 . . . . 0.0 104.448 -175.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.0 m -110.68 87.1 2.45 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -166.074 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -91.92 133.8 35.36 Favored 'General case' 0 N--CA 1.485 1.284 0 C-N-CA 124.131 0.972 . . . . 0.0 110.621 -174.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.4 tt -102.36 110.01 21.83 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -175.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -110.51 90.47 3.33 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -172.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 77.71 -109.91 2.91 Favored Glycine 0 CA--C 1.544 1.85 0 CA-C-O 119.926 -0.374 . . . . 0.0 113.03 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -121.51 53.16 1.19 Allowed 'General case' 0 N--CA 1.495 1.791 0 CA-C-O 121.304 0.573 . . . . 0.0 111.694 167.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.4 pt -126.77 -165.44 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.799 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 159.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.5 tt -154.26 124.89 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.557 1.22 0 O-C-N 120.532 -1.355 . . . . 0.0 108.37 160.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 55.4 m -100.76 97.78 8.38 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -91.08 104.28 16.88 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 28.8 m -108.57 93.18 4.38 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.118 -1.068 . . . . 0.0 108.118 -176.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 49.6 mtt -93.02 105.15 17.3 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.726 0.81 . . . . 0.0 109.098 177.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 82.4 p -95.33 100.64 12.39 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 -177.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 51.3 tp -94.66 82.92 3.99 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 175.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.21 -99.75 0.9 Allowed Glycine 0 CA--C 1.542 1.751 0 CA-C-N 116.288 -0.415 . . . . 0.0 113.104 -175.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -98.59 -15.9 19.3 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 170.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 62.4 mt -83.77 107.67 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 CA-C-N 120.343 1.428 . . . . 0.0 107.563 -173.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.8 t -95.71 96.5 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 -177.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -88.87 99.04 12.08 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 122.981 0.512 . . . . 0.0 109.999 -178.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.8 tttm -102.27 109.67 21.41 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.046 -177.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 25.2 mtm180 -101.64 125.79 48.36 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 123.73 0.812 . . . . 0.0 108.864 176.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.0 mp -109.59 103.39 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 104.74 -2.318 . . . . 0.0 104.74 -177.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 54.8 m -120.78 114.82 22.19 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 122.686 0.394 . . . . 0.0 110.065 -173.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.2 tttm -92.64 133.03 36.39 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 123.127 0.571 . . . . 0.0 111.628 -170.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 3.2 tmt_? -66.47 136.69 56.07 Favored 'General case' 0 N--CA 1.485 1.284 0 CA-C-O 121.789 0.804 . . . . 0.0 113.087 -174.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.7 pt . . . . . 0 N--CA 1.484 1.267 0 N-CA-C 105.951 -1.87 . . . . 0.0 105.951 -175.393 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.8 m . . . . . 0 CA--C 1.547 0.839 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -68.49 -18.52 64.41 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 117.489 2.403 . . . . 0.0 117.489 -177.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.7 m -70.44 109.67 4.91 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 121.093 1.769 . . . . 0.0 110.67 172.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.43 156.91 13.86 Favored Glycine 0 CA--C 1.543 1.79 0 CA-C-O 122.11 0.839 . . . . 0.0 113.873 -173.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -104.18 114.01 27.95 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.278 -1.379 . . . . 0.0 107.278 176.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -112.51 97.99 6.96 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -167.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -92.13 138.32 31.63 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.492 0.663 . . . . 0.0 111.003 -176.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.8 tp -74.78 126.46 30.95 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.515 -167.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.5 mm-40 -104.88 -64.68 1.1 Allowed 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 114.644 -1.162 . . . . 0.0 109.768 -175.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 75.5 m -129.36 140.36 51.4 Favored 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 123.657 0.783 . . . . 0.0 109.831 177.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -125.47 130.66 52.26 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-O 122.496 1.141 . . . . 0.0 110.841 177.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -99.44 129.12 45.6 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 113.594 -1.639 . . . . 0.0 107.221 168.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.251 69.8 m-20 67.28 40.47 2.75 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 116.569 2.063 . . . . 0.0 116.569 170.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -67.64 -62.97 1.16 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.029 -1.044 . . . . 0.0 113.795 170.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -59.98 -34.98 74.03 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 117.18 2.289 . . . . 0.0 117.18 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.69 -47.17 84.81 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 166.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -65.99 -47.76 73.46 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 177.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.38 -45.01 95.06 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 176.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.4 mmtm -57.13 -48.26 79.11 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 166.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.71 -26.19 68.55 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 117.757 2.502 . . . . 0.0 117.757 177.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.3 pt -88.63 -49.28 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-N 119.178 0.899 . . . . 0.0 112.005 174.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 141.36 73.64 0.04 OUTLIER Glycine 0 CA--C 1.539 1.591 0 CA-C-N 118.903 0.774 . . . . 0.0 112.427 176.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.87 153.41 78.67 Favored Pre-proline 0 CA--C 1.571 1.763 0 C-N-CA 123.359 0.664 . . . . 0.0 112.602 176.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -76.44 158.78 36.46 Favored 'Trans proline' 0 C--N 1.372 1.794 0 C-N-CA 123.354 2.703 . . . . 0.0 113.55 175.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -62.55 -31.6 72.41 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 169.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -60.06 -52.25 66.19 Favored 'General case' 0 CA--C 1.561 1.396 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 171.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 88.8 mt -72.43 -18.6 61.69 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 117.071 2.248 . . . . 0.0 117.071 175.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 93.3 mt -67.81 -61.28 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 CA-C-N 119.631 1.105 . . . . 0.0 110.017 165.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -64.82 -25.27 67.83 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.5 tppp? -78.58 -52.03 9.06 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 123.878 0.871 . . . . 0.0 112.376 171.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.78 -18.98 72.86 Favored Glycine 0 CA--C 1.551 2.33 0 N-CA-C 119.89 2.716 . . . . 0.0 119.89 177.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -65.06 -42.84 93.84 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 120.087 1.944 . . . . 0.0 114.732 169.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -66.46 -37.21 84.64 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 168.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 61.5 mt -72.01 115.46 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 178.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -85.98 106.72 17.36 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -174.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -90.04 131.76 10.91 Favored Glycine 0 CA--C 1.54 1.643 0 CA-C-N 115.966 -0.561 . . . . 0.0 114.471 -167.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.3 t -89.64 117.81 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 175.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 64.5 m -100.49 101.61 12.6 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 174.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -81.22 146.61 30.38 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.379 177.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 55.4 mt -142.1 123.3 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 104.5 -2.408 . . . . 0.0 104.5 174.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 98.6 t -115.54 108.87 26.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 -179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -93.99 120.31 34.07 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.012 0.525 . . . . 0.0 109.813 176.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 73.6 m-80 -122.25 74.85 1.19 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 164.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.42 -118.77 9.56 Favored Glycine 0 CA--C 1.548 2.127 0 C-N-CA 123.215 0.436 . . . . 0.0 113.757 -175.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -75.47 -32.67 60.67 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 167.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -78.12 135.38 37.67 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-N 120.116 1.325 . . . . 0.0 111.592 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -137.19 150.77 48.13 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.97 0.89 . . . . 0.0 111.26 -175.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -136.78 115.15 11.78 Favored 'General case' 0 N--CA 1.484 1.269 0 N-CA-C 106.68 -1.6 . . . . 0.0 106.68 161.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -107.41 125.72 51.58 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.559 173.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 50.8 m -119.44 99.92 6.98 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 -173.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 88.1 mt -91.21 126.76 43.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 37.9 p -103.47 114.27 28.42 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 170.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -127.49 147.1 50.31 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.67 0.748 . . . . 0.0 110.081 178.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -53.84 -30.44 44.61 Favored Glycine 0 CA--C 1.555 2.586 0 N-CA-C 118.838 2.295 . . . . 0.0 118.838 167.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 50.6 m -68.45 -63.22 1.1 Allowed 'General case' 0 CA--C 1.565 1.521 0 CA-C-N 118.438 1.119 . . . . 0.0 112.994 165.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -155.08 136.24 13.91 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 119.338 0.972 . . . . 0.0 110.158 -178.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.2 p -77.17 123.0 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 C-N-CA 123.329 0.651 . . . . 0.0 109.755 166.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 80.5 mt -131.04 119.41 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 -169.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.2 tt0 -107.97 127.06 53.42 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.549 0.74 . . . . 0.0 109.057 173.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -139.61 142.69 37.05 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 124.137 0.975 . . . . 0.0 109.822 -170.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -126.64 148.77 49.77 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.146 0.974 . . . . 0.0 110.543 -176.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 53.9 p90 -151.65 144.78 24.61 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.537 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.3 m -101.91 132.19 47.85 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 164.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 78.8 t -75.93 131.71 34.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 CA-C-O 121.57 0.7 . . . . 0.0 109.863 -175.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.85 6.18 89.19 Favored Glycine 0 CA--C 1.553 2.435 0 N-CA-C 118.669 2.228 . . . . 0.0 118.669 -169.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -137.32 140.75 41.71 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 119.233 1.517 . . . . 0.0 108.332 -175.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -76.62 117.0 17.82 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 123.147 0.579 . . . . 0.0 111.019 -173.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 16.6 p -126.42 149.43 49.27 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-O 122.335 1.064 . . . . 0.0 112.871 -162.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -84.82 118.88 24.74 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.271 -178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.72 142.61 22.98 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.654 0.781 . . . . 0.0 109.843 175.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -91.3 127.57 36.78 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.907 -172.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.8 t -68.91 173.79 5.03 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.954 0.883 . . . . 0.0 112.855 170.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 68.5 mtp -85.47 54.87 3.27 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.9 m -151.0 -76.71 0.14 Allowed 'General case' 0 CA--C 1.563 1.478 0 N-CA-C 104.695 -2.335 . . . . 0.0 104.695 172.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 168.19 75.3 0.04 OUTLIER Glycine 0 CA--C 1.539 1.551 0 CA-C-N 118.593 0.633 . . . . 0.0 111.631 172.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -155.43 114.03 3.5 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -81.21 99.41 8.57 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 175.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.5 p -117.25 136.82 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 121.894 0.855 . . . . 0.0 110.489 -157.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -81.75 120.55 25.28 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 114.965 -1.016 . . . . 0.0 110.119 -177.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.4 t -148.07 135.5 20.6 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 122.932 0.493 . . . . 0.0 111.089 -167.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 75.5 t -88.99 119.44 36.09 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.1 t -104.28 112.54 38.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.255 -1.757 . . . . 0.0 106.255 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -116.3 143.41 45.57 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.803 0.811 . . . . 0.0 110.907 -176.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.6 tp -101.61 130.95 48.05 Favored 'General case' 0 CA--C 1.556 1.208 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.953 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -128.83 125.75 38.37 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.261 -1.015 . . . . 0.0 108.261 174.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.4 12.52 73.1 Favored Glycine 0 CA--C 1.55 2.265 0 N-CA-C 120.688 3.035 . . . . 0.0 120.688 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.268 24.2 m-20 58.74 37.92 24.98 Favored 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 115.516 1.673 . . . . 0.0 115.516 -167.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 23.7 p-10 -160.84 -18.47 0.05 Allowed 'General case' 0 CA--C 1.566 1.57 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 -176.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.9 mtpp -119.1 101.22 7.85 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 121.101 1.773 . . . . 0.0 109.279 -171.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 79.3 mt -94.73 101.89 13.75 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 171.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 18.4 m -104.21 124.75 58.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 123.961 0.905 . . . . 0.0 108.744 -171.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.9 t -143.57 133.56 24.15 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.514 0.673 . . . . 0.0 111.425 -177.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 13.8 t -131.79 134.67 46.07 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 124.211 1.005 . . . . 0.0 109.081 -175.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . 0.334 14.2 p90 -136.03 -116.4 0.17 Allowed 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 118.612 -0.709 . . . . 0.0 109.497 -171.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -73.59 -68.5 0.5 Allowed 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 119.6 1.091 . . . . 0.0 111.227 -178.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -126.86 -27.0 3.1 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 176.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.3 mp -86.34 121.95 38.1 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.574 0 CA-C-N 119.91 1.232 . . . . 0.0 108.417 -171.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 19.8 mmtp -78.57 153.53 31.11 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.545 155.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.2 t -143.31 97.16 3.03 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 172.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 73.7 t -100.21 100.24 10.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 105.14 -2.17 . . . . 0.0 105.14 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.8 m -95.49 94.0 7.53 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 -171.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -104.82 117.51 34.25 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 123.504 0.722 . . . . 0.0 109.073 -162.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.5 tt -106.47 117.8 34.99 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.314 -0.625 . . . . 0.0 109.314 -170.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -94.33 -99.77 0.15 Allowed 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 118.236 -0.888 . . . . 0.0 108.88 -176.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -103.05 -105.93 3.01 Favored Glycine 0 N--CA 1.485 1.912 0 CA-C-N 119.53 1.059 . . . . 0.0 111.276 -178.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -96.39 49.26 1.11 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-O 121.074 0.464 . . . . 0.0 112.001 168.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.7 pt -142.38 -174.95 0.72 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.678 0 C-N-CA 124.64 1.176 . . . . 0.0 109.459 176.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.4 tt -150.1 127.69 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 120.917 -1.114 . . . . 0.0 108.719 161.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 29.8 m -103.61 92.24 4.37 Favored 'General case' 0 CA--C 1.559 1.305 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -88.7 106.81 18.59 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 -177.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 39.1 m -111.9 97.49 6.72 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -169.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 46.0 mtt -98.48 104.26 16.28 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.351 0.66 . . . . 0.0 109.371 -177.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 59.6 p -97.12 102.08 13.78 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.292 0.567 . . . . 0.0 109.765 -172.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 50.1 tp -101.51 83.94 2.52 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.45 -99.91 1.03 Allowed Glycine 0 CA--C 1.543 1.832 0 CA-C-N 116.437 -0.347 . . . . 0.0 112.793 -174.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -99.52 -16.34 18.34 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 169.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 70.1 mt -84.26 108.54 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-N 120.476 1.489 . . . . 0.0 107.86 -172.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.6 t -97.03 95.46 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 -177.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -85.84 96.13 9.66 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.201 0.6 . . . . 0.0 109.739 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -104.36 106.54 17.08 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.871 -175.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 93.2 mtt180 -89.04 127.21 35.68 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.777 0.831 . . . . 0.0 109.014 170.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -108.64 104.01 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 104.125 -2.546 . . . . 0.0 104.125 174.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.5 m -127.92 116.73 20.55 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -171.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . 0.256 17.3 ptpt -88.6 148.54 24.01 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 122.098 0.951 . . . . 0.0 113.538 -172.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 42.5 ttp180 -81.15 124.58 29.37 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-N 114.491 -1.231 . . . . 0.0 111.028 -172.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 25.0 pt . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 105.64 -1.985 . . . . 0.0 105.64 -169.499 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.8 t . . . . . 0 CA--C 1.549 0.93 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -69.02 -29.1 67.21 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 116.985 2.217 . . . . 0.0 116.985 175.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.6 p -65.74 125.31 24.89 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 120.77 1.623 . . . . 0.0 113.612 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 153.98 167.16 15.74 Favored Glycine 0 CA--C 1.545 1.946 0 CA-C-O 122.54 1.078 . . . . 0.0 113.862 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -89.88 145.12 25.37 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 114.243 -0.978 . . . . 0.0 109.994 169.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -142.01 104.87 4.56 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -175.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 9.6 tm0? -87.92 127.32 35.36 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.592 -0.693 . . . . 0.0 111.356 -176.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 50.8 tp -69.75 109.79 4.58 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 123.888 0.875 . . . . 0.0 113.228 -174.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -100.19 -60.63 1.49 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.331 0.653 . . . . 0.0 112.231 -172.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.1 t -127.74 138.56 52.81 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 123.566 0.746 . . . . 0.0 110.28 -168.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -133.26 133.46 42.68 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.521 0.677 . . . . 0.0 109.706 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -74.18 -64.5 1.0 Allowed 'General case' 0 CA--C 1.561 1.38 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.773 168.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -122.29 67.1 0.93 Allowed 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 123.217 0.607 . . . . 0.0 110.746 -174.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 39.1 t80 -75.23 -52.04 11.86 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.416 -0.803 . . . . 0.0 111.993 168.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -60.6 -46.44 90.26 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.09 -36.22 82.61 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 174.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -73.37 -55.88 5.8 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 119.973 1.261 . . . . 0.0 113.672 175.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -57.25 -42.94 82.47 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 115.424 1.639 . . . . 0.0 115.424 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.4 tmtm? -62.99 -43.97 97.31 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 114.188 1.181 . . . . 0.0 114.188 169.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.7 -29.01 69.07 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 117.688 2.477 . . . . 0.0 117.688 173.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.25 38.2 pt -82.59 -54.53 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 119.248 0.931 . . . . 0.0 111.844 173.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 149.32 67.11 0.01 OUTLIER Glycine 0 N--CA 1.479 1.564 0 CA-C-O 118.898 -0.946 . . . . 0.0 113.134 171.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.8 mt -130.38 146.08 60.15 Favored Pre-proline 0 CA--C 1.569 1.695 0 CA-C-N 117.918 0.859 . . . . 0.0 111.138 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -69.11 150.65 72.43 Favored 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 123.577 2.851 . . . . 0.0 114.791 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -52.61 -36.49 56.47 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 171.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -63.22 -53.27 55.65 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 171.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.7 mt -66.85 -24.91 66.2 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 116.707 2.114 . . . . 0.0 116.707 176.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 87.3 mt -67.42 -53.9 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 C-N-CA 124.347 1.059 . . . . 0.0 111.142 170.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -61.34 -24.01 66.15 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 172.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -75.69 -59.19 2.86 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 119.594 1.088 . . . . 0.0 111.503 169.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.39 -21.44 59.96 Favored Glycine 0 CA--C 1.552 2.355 0 N-CA-C 119.947 2.739 . . . . 0.0 119.947 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 17.5 pttp -66.95 -46.23 75.35 Favored 'General case' 0 CA--C 1.569 1.702 0 CA-C-N 120.28 2.04 . . . . 0.0 114.202 170.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -71.55 -36.96 71.13 Favored 'General case' 0 CA--C 1.567 1.599 0 N-CA-C 115.145 1.535 . . . . 0.0 115.145 174.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 49.9 mt -66.77 135.22 28.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 CA-C-N 119.687 1.131 . . . . 0.0 109.612 -179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.2 mttm -74.87 104.42 5.47 Favored 'General case' 0 N--CA 1.485 1.323 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.603 179.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -98.19 102.97 2.73 Favored Glycine 0 N--CA 1.478 1.436 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.805 -175.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 35.8 t -84.49 114.85 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -176.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 43.6 m -98.6 104.85 16.92 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 114.776 -1.102 . . . . 0.0 108.087 177.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -84.17 149.49 26.13 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 115.623 -0.717 . . . . 0.0 110.026 174.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 55.5 mt -140.42 131.52 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 105.285 -2.117 . . . . 0.0 105.285 172.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 91.4 t -119.03 101.78 12.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 105.369 -2.086 . . . . 0.0 105.369 178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 -83.17 115.84 22.1 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 122.966 0.507 . . . . 0.0 109.8 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -124.98 69.62 1.13 Allowed 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 167.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.07 -112.17 4.65 Favored Glycine 0 CA--C 1.546 2.01 0 C-N-CA 123.272 0.463 . . . . 0.0 113.699 -174.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -74.14 -33.4 63.53 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 171.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -79.31 129.33 34.36 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-N 119.276 0.944 . . . . 0.0 110.726 -177.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -132.05 105.82 7.63 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 -177.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 24.4 ttmm -95.24 106.24 18.25 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 170.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 37.3 p90 -104.31 120.23 40.73 Favored 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 115.47 -0.787 . . . . 0.0 110.017 174.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 78.7 m -108.45 91.98 3.87 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 -177.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.6 tt -99.32 120.86 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.362 -167.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.0 m -89.98 101.02 13.73 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.56 88.03 4.92 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.53 -108.99 2.66 Favored Glycine 0 CA--C 1.542 1.773 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.382 -173.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 23.5 t -86.59 -56.12 3.56 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.283 0.846 . . . . 0.0 113.283 175.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -80.64 125.05 29.53 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 119.021 0.828 . . . . 0.0 111.342 -169.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 11.3 p -89.1 131.36 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 C-N-CA 123.534 0.733 . . . . 0.0 110.93 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.4 mt -119.52 111.21 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 105.773 -1.936 . . . . 0.0 105.773 -167.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -89.07 126.15 35.32 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-O 121.39 0.614 . . . . 0.0 109.868 175.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -134.77 106.9 7.13 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 -174.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -117.51 132.15 56.59 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 123.919 0.887 . . . . 0.0 110.389 -175.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 40.4 p90 -141.6 173.69 11.27 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.942 -172.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.0 m -127.58 132.91 49.77 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 166.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.3 m -68.66 132.47 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 C-N-CA 122.979 0.511 . . . . 0.0 111.616 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 107.59 -58.09 0.42 Allowed Glycine 0 CA--C 1.545 1.952 0 CA-C-N 115.583 -0.735 . . . . 0.0 113.233 -160.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -85.92 148.49 25.76 Favored 'General case' 0 CA--C 1.559 1.318 0 C-N-CA 124.117 0.967 . . . . 0.0 112.101 -172.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -83.6 117.07 22.91 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.844 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 77.3 m -116.1 147.99 40.74 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 122.07 0.938 . . . . 0.0 111.664 -174.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -84.24 97.82 9.62 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.847 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 61.5 mt -123.0 133.55 54.36 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.597 0.713 . . . . 0.0 109.679 -171.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -80.66 135.8 36.1 Favored 'General case' 0 CA--C 1.557 1.248 0 C-N-CA 123.65 0.78 . . . . 0.0 111.468 -171.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.1 p -83.19 173.92 11.23 Favored 'General case' 0 CA--C 1.569 1.692 0 CA-C-O 121.784 0.802 . . . . 0.0 112.168 -175.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 26.0 mmt -59.81 -41.03 90.34 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 169.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 54.1 p -62.41 -51.84 65.96 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 162.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 139.19 166.28 10.55 Favored Glycine 0 CA--C 1.545 1.96 0 CA-C-O 122.692 1.162 . . . . 0.0 111.847 -168.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . 0.279 9.6 tm-20 76.31 139.91 0.07 Allowed 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 125.109 1.364 . . . . 0.0 113.187 175.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -89.64 115.9 27.37 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.848 -176.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 19.5 m -100.19 -13.46 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.076 0 N-CA-C 117.236 2.31 . . . . 0.0 117.236 -164.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . 0.25 93.4 mttt 76.85 112.4 0.07 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 121.06 1.755 . . . . 0.0 110.242 -173.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.4 t -150.02 129.82 13.3 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.121 0.568 . . . . 0.0 109.548 -168.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.2 t -100.64 118.34 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 -178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.6 t -102.74 135.97 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 177.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 75.4 mm-40 -115.87 155.06 28.61 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 121.513 0.673 . . . . 0.0 110.591 166.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.4 tp -106.29 103.57 13.07 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 173.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -103.25 120.1 40.12 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.66 6.27 84.54 Favored Glycine 0 CA--C 1.549 2.164 0 N-CA-C 120.744 3.058 . . . . 0.0 120.744 173.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.316 4.7 t70 71.92 -10.38 0.87 Allowed 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 -167.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.7 p-10 -116.15 -18.34 10.61 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 116.574 2.065 . . . . 0.0 116.574 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -112.65 124.85 53.48 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 121.151 1.796 . . . . 0.0 109.784 -176.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 47.3 mt -103.31 103.07 13.05 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.583 -1.265 . . . . 0.0 107.583 166.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 57.8 t -101.53 118.92 49.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 -167.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.5 t -149.45 155.68 40.8 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 121.536 0.684 . . . . 0.0 112.363 -173.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 91.9 m -122.06 107.72 12.54 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 107.3 -1.371 . . . . 0.0 107.3 174.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 49.6 m-85 -71.81 -81.83 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 123.435 0.694 . . . . 0.0 111.143 176.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -139.3 87.9 2.23 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 105.202 -2.147 . . . . 0.0 105.202 170.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.259 70.2 m-80 53.56 43.28 31.43 Favored 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -169.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 44.0 mm -125.24 105.37 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 104.462 -2.421 . . . . 0.0 104.462 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -79.96 94.14 5.84 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 121.571 0.7 . . . . 0.0 109.653 178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 42.6 t -106.42 95.91 6.09 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 115.002 -0.999 . . . . 0.0 109.478 -165.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 73.8 t -101.44 107.8 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.9 m -93.86 85.42 4.78 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -173.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -94.66 127.53 40.69 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 123.357 0.663 . . . . 0.0 109.717 -165.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 tt -112.86 111.12 21.66 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 -173.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -98.94 -101.84 0.22 Allowed 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 118.406 -0.807 . . . . 0.0 109.291 -170.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -87.15 -110.58 0.91 Allowed Glycine 0 N--CA 1.484 1.877 0 CA-C-N 119.698 1.135 . . . . 0.0 112.395 -177.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -101.36 61.4 0.92 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.567 0.698 . . . . 0.0 110.145 166.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 11.9 pt -148.94 -176.77 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.759 0 C-N-CA 124.619 1.167 . . . . 0.0 108.927 -179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.1 tt -148.54 125.32 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 120.753 -1.217 . . . . 0.0 108.217 155.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 94.0 m -111.1 106.99 16.21 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -98.02 110.56 23.12 Favored 'General case' 0 N--CA 1.485 1.312 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 34.7 m -96.91 99.65 11.2 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 -176.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 66.3 mtt -104.2 97.15 7.15 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.32 -0.992 . . . . 0.0 108.32 -176.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.9 p -96.44 113.58 25.17 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 -174.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 47.2 tp -103.08 83.08 2.16 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 170.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.77 -103.69 1.25 Allowed Glycine 0 CA--C 1.545 1.952 0 N-CA-C 114.571 0.588 . . . . 0.0 114.571 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -82.09 -27.02 33.11 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 114.708 1.374 . . . . 0.0 114.708 171.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 29.7 mm -65.34 136.1 27.25 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.542 0 C-N-CA 124.904 1.281 . . . . 0.0 109.562 174.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.4 t -127.94 96.47 3.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 172.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -86.56 102.47 14.16 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -102.91 104.85 15.11 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -113.72 122.35 46.84 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.869 0.868 . . . . 0.0 109.199 -175.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.7 mp -111.14 102.95 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 104.97 -2.233 . . . . 0.0 104.97 -171.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.0 m -102.23 112.43 25.11 Favored 'General case' 0 N--CA 1.482 1.139 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -84.08 142.29 30.51 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 122.817 0.447 . . . . 0.0 110.774 -169.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -74.14 134.06 42.82 Favored 'General case' 0 CA--C 1.559 1.304 0 CA-C-O 121.916 0.865 . . . . 0.0 112.725 -169.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 45.0 mm . . . . . 0 N--CA 1.483 1.196 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 -162.581 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 73.4 m . . . . . 0 CA--C 1.549 0.907 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -69.19 -15.84 63.49 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 117.616 2.451 . . . . 0.0 117.616 -178.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 75.6 m -71.45 115.22 10.37 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 121.437 1.926 . . . . 0.0 111.025 172.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.44 160.29 19.64 Favored Glycine 0 CA--C 1.54 1.655 0 CA-C-O 122.217 0.898 . . . . 0.0 114.295 -175.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 9.7 mptt -111.14 106.56 15.63 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 179.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -111.48 105.77 14.46 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -162.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -93.18 135.63 34.2 Favored 'General case' 0 N--CA 1.492 1.659 0 C-N-CA 122.941 0.496 . . . . 0.0 111.583 -177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 21.5 tp -71.46 115.04 10.17 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 123.478 0.711 . . . . 0.0 112.584 -171.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -99.23 -55.33 2.72 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.164 -179.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.1 m -125.07 110.51 14.24 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -173.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -111.48 119.58 39.25 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 122.075 0.941 . . . . 0.0 109.844 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -109.2 120.29 42.07 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 170.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.259 69.1 m-80 67.37 50.49 0.95 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -175.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 62.7 t80 -72.13 -63.26 1.18 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.922 . . . . 0.0 111.289 162.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -65.58 -35.23 80.21 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 117.33 2.344 . . . . 0.0 117.33 -174.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.41 -45.57 93.76 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 166.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -65.11 -51.91 58.55 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 174.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 23.5 mmt -62.18 -43.02 99.77 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -176.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -60.15 -47.28 86.6 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 167.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.57 -29.5 70.63 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 117.729 2.492 . . . . 0.0 117.729 176.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 45.8 pt -80.5 -47.04 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 CA-C-N 119.781 1.173 . . . . 0.0 112.706 173.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 142.67 69.62 0.03 OUTLIER Glycine 0 CA--C 1.54 1.595 0 CA-C-N 119.134 0.879 . . . . 0.0 113.034 174.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.55 153.37 79.4 Favored Pre-proline 0 CA--C 1.568 1.668 0 C-N-CA 123.456 0.702 . . . . 0.0 111.84 172.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.79 152.59 47.44 Favored 'Trans proline' 0 C--N 1.372 1.777 0 C-N-CA 123.168 2.579 . . . . 0.0 113.031 172.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -61.03 -24.69 66.37 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 116.475 2.028 . . . . 0.0 116.475 173.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -61.86 -57.19 12.75 Favored 'General case' 0 CA--C 1.563 1.455 0 CA-C-O 117.489 -1.243 . . . . 0.0 113.433 165.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.8 mt -68.93 -18.39 64.09 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 117.329 2.344 . . . . 0.0 117.329 176.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 71.1 mt -74.23 -55.45 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 CA-C-N 119.727 1.149 . . . . 0.0 110.477 170.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 87.4 mm-40 -67.93 -24.56 65.2 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 177.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -79.13 -51.21 9.84 Favored 'General case' 0 CA--C 1.562 1.419 0 CA-C-N 119.547 1.067 . . . . 0.0 112.217 167.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.2 -14.79 59.94 Favored Glycine 0 CA--C 1.552 2.366 0 N-CA-C 119.864 2.706 . . . . 0.0 119.864 176.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.3 ptmm? -71.34 -49.86 38.16 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 119.957 1.879 . . . . 0.0 113.88 171.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -63.8 -30.76 71.82 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.533 2.049 . . . . 0.0 116.533 167.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 53.8 mt -75.69 113.7 14.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 173.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -81.22 108.57 14.97 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -83.64 123.77 6.31 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 116.299 -0.41 . . . . 0.0 113.884 -167.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t -83.05 110.99 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 25.3 t -92.57 103.26 15.68 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 166.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.85 142.83 36.53 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 114.076 -1.42 . . . . 0.0 109.162 169.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.0 mt -142.17 125.96 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 90.6 t -114.15 105.21 18.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -81.75 118.23 22.69 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.059 0.544 . . . . 0.0 109.816 174.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -123.98 68.35 1.05 Allowed 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 165.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.3 -107.51 2.1 Favored Glycine 0 CA--C 1.546 1.986 0 C-N-CA 123.24 0.448 . . . . 0.0 113.362 -172.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -78.22 -29.35 48.24 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 170.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -84.57 104.61 14.71 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 120.394 1.452 . . . . 0.0 109.605 -173.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -105.69 95.32 5.73 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 114.795 -1.093 . . . . 0.0 108.052 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 39.7 ttpt -93.7 106.7 18.65 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 176.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -103.76 132.24 50.19 Favored 'General case' 0 N--CA 1.483 1.206 0 CA-C-N 114.549 -1.205 . . . . 0.0 110.941 -176.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.7 m -107.27 98.62 8.23 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 172.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.4 tp -87.16 127.91 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 123.41 0.684 . . . . 0.0 109.568 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 48.1 p -111.36 87.35 2.53 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 106.843 -1.539 . . . . 0.0 106.843 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -99.0 91.44 5.02 Favored 'General case' 0 N--CA 1.488 1.466 0 C-N-CA 122.902 0.481 . . . . 0.0 110.228 -174.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.72 -100.74 1.12 Allowed Glycine 0 CA--C 1.543 1.787 0 CA-C-N 116.162 -0.472 . . . . 0.0 113.113 -178.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.0 m -87.17 -51.42 6.0 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 174.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -79.12 131.78 36.35 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 119.095 0.861 . . . . 0.0 113.021 -167.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 92.8 t -106.87 119.91 57.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 175.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 12.3 tt -140.46 144.26 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 CA-C-O 121.367 0.604 . . . . 0.0 110.431 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 41.9 tt0 -112.31 127.05 55.88 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 124.002 0.921 . . . . 0.0 109.025 179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 -139.87 128.95 23.65 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -171.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.25 135.45 54.27 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 123.458 0.703 . . . . 0.0 112.3 -175.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -125.27 149.11 48.34 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 124.044 0.938 . . . . 0.0 111.021 171.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.3 m -111.62 132.6 54.46 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 169.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.0 t -70.26 132.61 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 C-N-CA 123.805 0.842 . . . . 0.0 110.274 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 77.76 10.88 85.93 Favored Glycine 0 CA--C 1.554 2.473 0 N-CA-C 118.987 2.355 . . . . 0.0 118.987 -170.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 28.5 mm-40 -138.59 150.7 46.58 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 119.29 1.545 . . . . 0.0 109.828 -171.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -80.89 103.0 10.42 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.519 0.728 . . . . 0.0 109.118 177.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 63.1 m -134.44 134.29 41.43 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.692 0.758 . . . . 0.0 110.766 -171.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.55 143.38 40.36 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 113.685 0.994 . . . . 0.0 113.685 -171.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 93.9 mt -129.75 121.63 27.25 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 175.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -84.45 114.04 21.63 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.102 0.477 . . . . 0.0 109.945 -173.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 76.8 p -80.71 -78.02 0.19 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 118.27 -0.872 . . . . 0.0 112.707 -158.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 66.5 mtt -118.13 -80.18 0.61 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-N 119.291 0.951 . . . . 0.0 108.858 -173.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.8 p -81.07 -67.61 0.76 Allowed 'General case' 0 N--CA 1.492 1.653 0 CA-C-N 118.88 0.764 . . . . 0.0 110.877 177.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -169.81 76.63 0.1 Allowed Glycine 0 N--CA 1.476 1.302 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 172.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -129.06 131.46 47.33 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -178.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 11.7 mptt -96.49 112.88 24.46 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 114.981 -1.008 . . . . 0.0 108.862 -179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . 0.261 8.4 p -86.57 -43.84 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.607 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . 0.253 5.6 ttpm? 76.06 107.49 0.08 Allowed 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.751 1.221 . . . . 0.0 111.747 173.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.49 HG22 ' HA ' ' A' ' 95' ' ' PHE . 16.4 p -128.38 139.5 52.34 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.033 0.533 . . . . 0.0 110.381 -165.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 89.7 t -109.76 101.44 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 N-CA-C 105.038 -2.208 . . . . 0.0 105.038 173.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.3 t -94.9 138.48 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 -173.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.3 mp0 -114.89 135.49 54.15 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.839 0.828 . . . . 0.0 109.302 176.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 50.7 tp -94.69 102.68 14.59 Favored 'General case' 0 CA--C 1.553 1.065 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 173.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -88.08 114.16 24.42 Favored 'General case' 0 N--CA 1.483 1.208 0 CA-C-O 121.891 0.853 . . . . 0.0 109.112 174.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.41 -117.28 5.48 Favored Glycine 0 CA--C 1.542 1.729 0 CA-C-N 114.354 -1.293 . . . . 0.0 113.047 -176.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -130.25 -8.58 4.26 Favored 'General case' 0 CA--C 1.572 1.792 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 170.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -134.34 35.02 3.24 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 115.299 1.592 . . . . 0.0 115.299 -173.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -147.41 116.77 6.97 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 119.996 1.271 . . . . 0.0 108.077 175.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 67.0 mt -107.66 101.73 11.02 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 171.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 32.7 m -99.42 124.3 52.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 -171.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.3 t -151.48 135.95 16.94 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.243 0.545 . . . . 0.0 111.482 -174.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 67.9 p -83.55 -41.88 17.43 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 177.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.49 ' HA ' HG22 ' A' ' 81' ' ' THR 0.378 22.5 m-85 74.21 -94.48 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 119.259 0.936 . . . . 0.0 109.676 -169.939 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -116.38 -76.18 0.57 Allowed 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 163.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -135.63 71.6 1.43 Allowed 'General case' 0 N--CA 1.491 1.575 0 CA-C-N 119.276 0.944 . . . . 0.0 109.317 170.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.1 mp -143.66 93.46 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 N-CA-C 102.87 -3.011 . . . . 0.0 102.87 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -80.74 97.2 7.2 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 119.156 0.889 . . . . 0.0 109.818 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 32.4 t -100.29 102.34 13.58 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 114.867 -1.061 . . . . 0.0 109.266 -171.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 71.8 t -96.05 106.63 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 N-CA-C 105.338 -2.097 . . . . 0.0 105.338 177.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.2 m -93.56 83.87 4.57 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 -174.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -95.63 118.42 32.29 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.415 0.686 . . . . 0.0 109.251 -168.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.7 tt -106.72 112.06 24.87 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -172.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -81.19 -59.05 2.79 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 -172.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -158.83 -87.74 0.06 OUTLIER Glycine 0 N--CA 1.479 1.505 0 N-CA-C 109.298 -1.521 . . . . 0.0 109.298 175.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -71.35 -37.98 71.65 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 166.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.8 pt -87.52 178.54 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.553 0 CA-C-N 119.636 1.107 . . . . 0.0 112.785 -171.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.5 tt -141.59 118.83 7.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 165.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 59.0 m -99.57 99.98 10.92 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -97.03 104.32 16.32 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -178.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 15.9 m -102.44 94.85 5.89 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -168.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 28.1 mtt -93.37 99.28 11.82 Favored 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 121.59 0.71 . . . . 0.0 109.377 -178.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 48.0 p -94.18 103.83 15.86 Favored 'General case' 0 N--CA 1.487 1.38 0 CA-C-N 115.318 -0.856 . . . . 0.0 109.003 -174.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 60.0 tp -102.73 82.86 2.18 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 178.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.51 -99.62 1.01 Allowed Glycine 0 CA--C 1.544 1.879 0 O-C-N 122.348 -0.22 . . . . 0.0 113.12 -174.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -102.95 -12.29 17.6 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 115.22 1.563 . . . . 0.0 115.22 170.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 72.4 mt -85.3 108.92 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 CA-C-N 120.526 1.512 . . . . 0.0 107.157 -175.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.2 t -100.34 96.47 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 -175.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -82.77 97.6 8.67 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 176.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -93.06 107.44 19.23 Favored 'General case' 0 N--CA 1.483 1.224 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 23.2 ttt180 -108.15 98.78 8.29 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -172.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 85.2 mt -97.93 104.71 16.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 -173.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 67.9 m -121.53 114.96 21.96 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -172.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 57.2 tttm -91.05 139.74 30.48 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 122.941 0.496 . . . . 0.0 111.131 -172.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 47.4 ttp85 -68.37 130.01 41.61 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 123.331 0.653 . . . . 0.0 112.509 -178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.2 pt . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 123.047 1.403 . . . . 0.0 108.365 -173.959 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.3 m . . . . . 0 CA--C 1.552 1.021 0 CA-C-O 118.888 -0.577 . . . . 0.0 110.073 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.414 ' H ' HD11 ' A' ' 104' ' ' LEU 0.353 84.1 m-85 75.69 -32.34 0.21 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 117.973 2.583 . . . . 0.0 117.973 172.815 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 71.2 m -72.23 103.53 3.38 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-N 120.527 1.512 . . . . 0.0 110.924 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.1 149.27 8.69 Favored Glycine 0 CA--C 1.541 1.709 0 CA-C-O 122.016 0.787 . . . . 0.0 113.624 -174.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.8 mtpt -92.31 117.51 29.97 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 171.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.6 m-85 -116.62 104.54 11.49 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 -172.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -86.68 140.03 30.19 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-O 121.675 0.75 . . . . 0.0 111.622 -179.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 18.2 tp -66.25 137.3 56.86 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 -170.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 21.4 mm100 -116.13 -65.48 1.18 Allowed 'General case' 0 N--CA 1.485 1.286 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.58 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.5 p -126.94 137.58 53.15 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.906 0.882 . . . . 0.0 109.401 174.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -132.35 101.96 5.56 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.807 0.813 . . . . 0.0 109.136 -178.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -90.94 135.47 33.72 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 124.606 1.162 . . . . 0.0 109.722 -177.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.8 m120 62.24 40.39 11.59 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 115.697 1.74 . . . . 0.0 115.697 -178.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -72.51 -45.77 57.8 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.921 -1.112 . . . . 0.0 113.048 172.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -62.37 -45.92 90.99 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 115.57 1.693 . . . . 0.0 115.57 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.52 -43.58 96.76 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 115.844 1.794 . . . . 0.0 115.844 174.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -76.16 -55.14 5.86 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 118.325 -0.845 . . . . 0.0 113.24 -177.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.38 -44.71 95.83 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 -178.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -61.97 -42.77 99.5 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 171.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.92 -36.3 76.71 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 116.925 2.194 . . . . 0.0 116.925 175.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.275 46.2 pt -79.34 -47.17 22.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 CA-C-N 119.086 0.857 . . . . 0.0 112.768 174.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 142.92 52.57 0.03 OUTLIER Glycine 0 N--CA 1.485 1.935 0 N-CA-C 115.678 1.031 . . . . 0.0 115.678 165.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -103.45 155.51 36.71 Favored Pre-proline 0 CA--C 1.566 1.563 0 CA-C-N 118.211 1.006 . . . . 0.0 111.673 175.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.38 146.59 45.3 Favored 'Trans proline' 0 C--N 1.37 1.668 0 C-N-CA 122.99 2.46 . . . . 0.0 113.256 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -62.87 -22.45 66.71 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 116.072 1.879 . . . . 0.0 116.072 171.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -59.43 -53.29 59.81 Favored 'General case' 0 CA--C 1.566 1.565 0 CA-C-N 119.754 1.161 . . . . 0.0 113.969 164.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.1 mt -69.29 -24.47 63.96 Favored 'General case' 0 N--CA 1.5 2.025 0 N-CA-C 117.072 2.249 . . . . 0.0 117.072 174.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 68.3 mt -75.18 -51.66 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-N 119.623 1.101 . . . . 0.0 111.305 175.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 42.2 mm-40 -67.84 -28.52 67.62 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 174.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.91 -51.21 14.4 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.603 0.761 . . . . 0.0 112.348 169.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -68.78 -18.58 72.45 Favored Glycine 0 CA--C 1.546 2.011 0 N-CA-C 120.226 2.85 . . . . 0.0 120.226 178.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -65.34 -41.82 93.51 Favored 'General case' 0 CA--C 1.57 1.712 0 CA-C-N 120.334 2.067 . . . . 0.0 114.427 168.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -67.68 -39.83 84.45 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 114.834 1.42 . . . . 0.0 114.834 170.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.5 mt -73.19 130.36 35.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 119.292 0.951 . . . . 0.0 108.929 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -89.73 98.59 11.86 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 170.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -89.58 140.01 15.42 Favored Glycine 0 CA--C 1.542 1.722 0 CA-C-N 116.056 -0.52 . . . . 0.0 113.949 -172.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 26.3 t -83.18 115.7 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 71.2 m -102.33 109.17 20.76 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.776 177.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -93.86 148.89 21.71 Favored 'General case' 0 CA--C 1.553 1.062 0 CA-C-O 122.064 0.935 . . . . 0.0 111.094 -177.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.4 mt -138.61 133.16 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 166.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.7 t -114.33 112.25 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 N-CA-C 105.621 -1.992 . . . . 0.0 105.621 175.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 43.9 tt0 -78.58 118.53 20.78 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 109.531 -0.544 . . . . 0.0 109.531 170.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -133.52 67.27 1.53 Allowed 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.64 -122.54 9.41 Favored Glycine 0 CA--C 1.548 2.107 0 O-C-N 121.975 -0.453 . . . . 0.0 113.533 -173.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -70.03 -35.58 74.41 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 114.596 1.332 . . . . 0.0 114.596 164.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 57.1 m80 -69.43 139.01 53.99 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 119.291 0.95 . . . . 0.0 111.99 178.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -138.5 97.27 3.32 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -91.32 106.08 18.24 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 175.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 29.4 p90 -83.65 148.94 26.83 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 114.613 -1.176 . . . . 0.0 111.128 169.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 92.8 m -133.96 87.06 2.33 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 166.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.5 pp -91.07 127.67 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 -173.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 55.4 m -100.49 102.31 13.46 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -92.74 85.14 5.14 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 172.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.68 -109.67 2.89 Favored Glycine 0 CA--C 1.538 1.499 0 CA-C-N 115.705 -0.68 . . . . 0.0 113.679 -175.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 91.1 p -91.96 -44.16 9.05 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 171.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.3 tttp -77.02 123.25 26.08 Favored 'General case' 0 N--CA 1.488 1.444 0 CA-C-N 119.393 0.997 . . . . 0.0 111.225 -176.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 14.5 p -102.19 128.98 54.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 C-N-CA 123.903 0.881 . . . . 0.0 109.671 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 96.2 mt -123.79 116.47 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 -174.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 21.2 pt20 -116.06 131.31 56.98 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.441 0.696 . . . . 0.0 111.822 178.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -151.32 149.94 29.94 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 123.399 0.68 . . . . 0.0 109.831 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -109.39 132.3 54.26 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 123.646 0.778 . . . . 0.0 110.833 179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -117.25 141.07 48.74 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.919 0.888 . . . . 0.0 111.189 170.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.6 m -94.88 135.87 35.87 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 169.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 48.0 t -86.18 117.76 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 174.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.25 -5.44 63.01 Favored Glycine 0 CA--C 1.556 2.653 0 N-CA-C 119.057 2.383 . . . . 0.0 119.057 -171.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -142.23 134.48 27.68 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-N 120.38 2.09 . . . . 0.0 108.593 169.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -72.98 119.76 17.67 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -174.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 80.6 m -116.99 148.16 41.68 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 122.326 1.06 . . . . 0.0 110.557 -177.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.65 121.86 22.31 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-N 114.659 -1.155 . . . . 0.0 112.058 179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 88.1 mt -123.44 125.41 44.89 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.827 0.851 . . . . 0.0 108.857 -175.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 6.2 tm-20 -84.43 122.79 29.46 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 173.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 59.7 p -75.11 174.27 9.64 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.651 0.738 . . . . 0.0 112.513 -175.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 1.4 mpt? -51.05 -42.16 60.35 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 172.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.3 m -71.26 -75.35 0.13 Allowed 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 123.33 0.652 . . . . 0.0 110.51 165.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 157.15 85.87 0.05 OUTLIER Glycine 0 N--CA 1.476 1.347 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -176.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -148.96 115.38 5.86 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 -170.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.8 tpmt? -86.34 105.14 16.48 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -175.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 60.1 t -123.14 121.07 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -169.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -86.17 99.97 11.9 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 176.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.1 t -135.73 145.9 47.12 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 123.654 0.782 . . . . 0.0 110.016 -175.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.0 p -109.76 138.02 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-O 122.798 1.285 . . . . 0.0 109.461 175.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.7 t -99.74 138.89 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.437 0 CA-C-N 113.413 -1.721 . . . . 0.0 107.78 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 12.6 mp0 -109.58 133.26 53.32 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 174.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 50.1 tp -98.55 113.49 25.54 Favored 'General case' 0 CA--C 1.553 1.076 0 CA-C-N 115.175 -0.921 . . . . 0.0 108.573 177.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -114.64 121.84 44.63 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 123.719 0.808 . . . . 0.0 109.041 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.88 14.45 73.14 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 120.667 3.027 . . . . 0.0 120.667 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.282 15.9 t70 59.7 33.3 21.83 Favored 'General case' 0 CA--C 1.577 1.992 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -168.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -158.87 -26.07 0.07 Allowed 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 -177.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -103.91 104.27 14.23 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 121.324 1.875 . . . . 0.0 109.368 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 44.1 mt -96.64 101.97 13.68 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 171.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 27.0 m -111.49 128.8 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 C-N-CA 123.896 0.878 . . . . 0.0 109.966 -167.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 12.8 t -152.42 148.85 27.94 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-O 121.258 0.552 . . . . 0.0 111.956 -176.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 33.7 p -113.38 120.47 41.19 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 174.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -82.69 -86.14 0.11 Allowed 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 123.13 0.572 . . . . 0.0 109.785 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -120.7 -71.71 0.72 Allowed 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 171.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 31.3 t30 -127.54 64.19 1.35 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-N 118.88 0.764 . . . . 0.0 109.036 160.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.1 mp -135.7 108.23 8.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 103.835 -2.654 . . . . 0.0 103.835 174.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -87.23 93.49 9.4 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 176.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 34.6 t -97.67 104.11 16.1 Favored 'General case' 0 N--CA 1.483 1.19 0 C-N-CA 123.669 0.787 . . . . 0.0 109.513 -168.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 51.9 t -120.44 98.44 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 -168.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.5 m -95.96 100.24 11.94 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -174.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -92.37 128.95 38.4 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 123.884 0.874 . . . . 0.0 109.992 -179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.414 HD11 ' H ' ' A' ' 3' ' ' PHE . 0.8 OUTLIER -97.94 111.15 23.56 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 176.91 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -110.65 178.55 4.33 Favored 'General case' 0 N--CA 1.493 1.684 0 C-N-CA 123.534 0.734 . . . . 0.0 110.448 174.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -68.1 112.8 4.95 Favored Glycine 0 N--CA 1.484 1.834 0 N-CA-C 116.477 1.351 . . . . 0.0 116.477 -166.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.263 19.6 m-20 50.1 25.83 1.87 Allowed 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 117.38 2.363 . . . . 0.0 117.38 -166.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.3 pt -139.36 -178.46 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.619 0 C-N-CA 124.366 1.067 . . . . 0.0 109.866 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.1 tt -150.54 127.72 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 120.826 -1.172 . . . . 0.0 108.839 168.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 48.2 m -111.13 104.7 13.26 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -179.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -93.91 111.45 23.16 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 176.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 39.8 m -109.4 101.3 10.29 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -175.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 29.5 mtt -105.95 103.29 12.75 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.9 p -95.75 105.4 17.39 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 32.3 tp -96.52 84.73 3.73 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 174.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 70.09 -103.44 1.15 Allowed Glycine 0 CA--C 1.544 1.893 0 C-N-CA 122.954 0.312 . . . . 0.0 113.627 -177.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -94.92 -16.42 22.85 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 171.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 66.2 mt -80.14 114.23 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 CA-C-N 120.084 1.311 . . . . 0.0 107.563 -177.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 59.4 t -101.92 94.97 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 -179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -77.26 127.05 31.93 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 169.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -136.6 109.41 7.58 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 65.7 ttp85 -110.31 110.02 20.67 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -174.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.6 mp -104.25 115.66 46.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 104.983 -2.228 . . . . 0.0 104.983 -177.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.9 m -131.97 122.16 25.11 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -175.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 20.1 ttpp -96.18 137.64 34.96 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 123.734 0.814 . . . . 0.0 110.992 -171.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 24.7 ttp180 -63.18 123.95 19.94 Favored 'General case' 0 CA--C 1.562 1.434 0 C-N-CA 124.372 1.069 . . . . 0.0 113.165 -175.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 13.3 pt . . . . . 0 N--CA 1.488 1.458 0 CA-C-O 123.007 1.384 . . . . 0.0 108.858 -178.382 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.0 t . . . . . 0 CA--C 1.553 1.078 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -76.37 -5.95 49.47 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 118.359 2.726 . . . . 0.0 118.359 -172.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.5 m -70.8 112.32 6.91 Favored 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 121.179 1.809 . . . . 0.0 110.784 172.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 175.4 149.49 7.37 Favored Glycine 0 CA--C 1.542 1.73 0 CA-C-O 121.926 0.737 . . . . 0.0 113.343 -175.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -96.25 122.74 39.43 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 170.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -118.11 102.24 8.86 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -167.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 19.6 tm0? -88.28 122.88 32.31 Favored 'General case' 0 N--CA 1.491 1.6 0 C-N-CA 123.14 0.576 . . . . 0.0 110.013 -175.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.6 tp -61.94 115.45 4.06 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 -175.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -95.99 -63.07 1.19 Allowed 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.496 0.718 . . . . 0.0 110.748 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.7 m -120.88 108.56 14.06 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -89.11 123.84 33.76 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 122.524 1.154 . . . . 0.0 109.15 164.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -115.24 117.28 30.05 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 105.77 -1.937 . . . . 0.0 105.77 -178.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.278 7.7 m-20 70.23 43.74 0.82 Allowed 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 -174.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -68.15 -60.27 2.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.158 -0.964 . . . . 0.0 113.06 168.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -62.24 -33.96 75.59 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 117.345 2.35 . . . . 0.0 117.345 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.57 -46.31 86.45 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 166.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 53.8 t80 -67.19 -51.81 49.01 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.149 1.166 . . . . 0.0 114.149 177.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.29 -49.85 74.77 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -59.15 -42.22 90.22 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 114.831 1.419 . . . . 0.0 114.831 170.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.57 -32.2 73.59 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 117.305 2.335 . . . . 0.0 117.305 174.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.28 37.7 pt -78.53 -53.51 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 CA-C-N 119.747 1.158 . . . . 0.0 111.599 172.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.68 69.98 0.01 OUTLIER Glycine 0 CA--C 1.538 1.516 0 CA-C-O 119.17 -0.794 . . . . 0.0 112.468 169.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 mp -121.21 155.76 58.09 Favored Pre-proline 0 CA--C 1.57 1.733 0 C-N-CA 123.408 0.683 . . . . 0.0 112.591 178.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.29 158.56 33.27 Favored 'Trans proline' 0 C--N 1.369 1.656 0 C-N-CA 123.367 2.712 . . . . 0.0 113.655 177.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -56.51 -32.86 65.48 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 168.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -61.59 -58.3 8.63 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 117.786 -1.102 . . . . 0.0 113.604 171.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 82.8 mt -68.67 -17.61 64.12 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 117.248 2.314 . . . . 0.0 117.248 177.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 88.3 mt -75.67 -55.03 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 CA-C-N 119.592 1.087 . . . . 0.0 110.619 169.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 54.6 mm-40 -70.81 -27.27 63.75 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -80.61 -50.12 10.39 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 119.8 1.182 . . . . 0.0 111.802 167.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.59 -18.17 58.49 Favored Glycine 0 CA--C 1.551 2.329 0 N-CA-C 120.16 2.824 . . . . 0.0 120.16 176.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -66.15 -43.7 86.24 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 120.401 2.1 . . . . 0.0 114.446 170.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -66.89 -35.74 80.7 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 115.29 1.589 . . . . 0.0 115.29 167.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 42.7 mt -77.69 113.26 16.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 -178.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -108.27 102.67 11.78 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -171.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.96 163.29 34.63 Favored Glycine 0 CA--C 1.544 1.902 0 N-CA-C 115.581 0.993 . . . . 0.0 115.581 -172.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.2 t -98.46 120.46 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 59.9 p -100.08 116.45 32.13 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 123.45 0.7 . . . . 0.0 109.171 172.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.77 149.71 23.07 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-O 121.902 0.858 . . . . 0.0 110.759 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.7 mt -141.93 130.21 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 170.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 85.6 t -118.35 104.09 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 -178.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -79.4 122.53 26.52 Favored 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 123.102 0.561 . . . . 0.0 111.138 -179.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -132.45 68.18 1.51 Allowed 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 170.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 68.85 -114.07 5.64 Favored Glycine 0 CA--C 1.547 2.038 0 O-C-N 121.625 -0.672 . . . . 0.0 113.788 -176.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -77.62 -34.15 53.43 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 169.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 57.2 m80 -71.84 135.31 46.57 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 119.872 1.214 . . . . 0.0 111.211 173.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -139.47 105.97 5.32 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -91.84 103.32 15.88 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 176.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 20.3 p90 -80.58 147.83 30.59 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.882 169.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.9 m -138.77 88.92 2.33 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 170.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 15.5 tt -93.25 119.49 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 C-N-CA 123.283 0.633 . . . . 0.0 109.44 -177.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 39.0 m -92.87 96.98 10.46 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -94.11 93.24 7.7 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.388 0.675 . . . . 0.0 109.45 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.33 -109.62 2.84 Favored Glycine 0 CA--C 1.543 1.792 0 CA-C-N 115.857 -0.61 . . . . 0.0 112.538 -174.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 99.3 p -92.65 -49.74 5.94 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 169.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -75.0 130.62 39.67 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 119.181 0.9 . . . . 0.0 111.992 -173.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.5 p -102.45 129.16 54.39 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.446 0 C-N-CA 123.921 0.888 . . . . 0.0 110.0 -177.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.2 mp -114.12 116.06 51.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 105.845 -1.909 . . . . 0.0 105.845 -175.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 3.2 pm0 -128.62 129.49 45.96 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.321 0.648 . . . . 0.0 111.4 -177.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -153.02 143.63 22.71 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 123.609 0.764 . . . . 0.0 109.385 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -103.03 117.98 35.79 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.024 0.53 . . . . 0.0 110.276 176.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.409 ' HB3' HD21 ' A' ' 71' ' ' LEU . 50.5 p90 -101.47 141.29 34.56 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.664 0.786 . . . . 0.0 111.307 172.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 25.9 m -97.69 129.68 44.73 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 167.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.6 t -73.84 131.09 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 C-N-CA 123.586 0.754 . . . . 0.0 109.718 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 108.31 -54.21 0.56 Allowed Glycine 0 CA--C 1.549 2.218 0 CA-C-N 115.09 -0.959 . . . . 0.0 114.222 -165.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.6 tp10 -78.84 147.4 33.21 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 123.805 0.842 . . . . 0.0 112.506 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -77.14 98.29 5.02 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.955 169.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 59.4 m -98.74 140.62 32.67 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.143 -173.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.19 114.35 19.95 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 123.144 0.578 . . . . 0.0 110.297 178.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.409 HD21 ' HB3' ' A' ' 63' ' ' PHE . 69.0 mt -133.34 123.06 24.75 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -165.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -70.64 129.8 40.11 Favored 'General case' 0 CA--C 1.559 1.312 0 CA-C-O 121.522 0.677 . . . . 0.0 110.744 176.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 90.1 m -81.24 -76.96 0.22 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.567 -171.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 18.8 ptp -146.74 86.4 1.66 Allowed 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 173.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . 0.254 2.8 m 65.54 92.3 0.07 Allowed 'General case' 0 CA--C 1.564 1.519 0 C-N-CA 125.278 1.431 . . . . 0.0 111.7 -177.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 75.22 56.75 4.6 Favored Glycine 0 CA--C 1.547 2.061 0 N-CA-C 118.942 2.337 . . . . 0.0 118.942 170.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -152.81 102.45 2.69 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 119.24 1.52 . . . . 0.0 108.755 160.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.66 125.51 43.97 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 123.691 0.797 . . . . 0.0 109.3 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 40.9 t -132.91 126.25 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 106.439 -1.689 . . . . 0.0 106.439 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -73.26 105.97 4.89 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 121.152 0.501 . . . . 0.0 109.764 170.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.9 t -142.93 134.96 27.08 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 115.31 -0.859 . . . . 0.0 108.932 -169.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.7 t -83.77 120.21 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.8 t -94.57 117.48 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 169.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -109.01 141.93 40.42 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 122.05 0.928 . . . . 0.0 110.339 176.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.6 tp -101.08 110.08 22.06 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.165 179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -109.67 119.62 39.94 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 178.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 71.71 14.85 75.49 Favored Glycine 0 CA--C 1.548 2.134 0 N-CA-C 120.487 2.955 . . . . 0.0 120.487 176.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.321 7.9 t70 66.9 1.1 2.15 Favored 'General case' 0 CA--C 1.577 1.996 0 N-CA-C 117.392 2.367 . . . . 0.0 117.392 -168.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -142.24 33.75 1.51 Allowed 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -150.23 104.65 3.28 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 120.877 1.671 . . . . 0.0 107.757 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 61.9 mt -98.68 102.74 14.56 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 173.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.0 m -109.5 124.26 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 C-N-CA 123.735 0.814 . . . . 0.0 109.685 -165.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.1 t -151.01 129.32 12.0 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 122.249 -0.282 . . . . 0.0 111.066 -178.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 52.4 m -103.58 111.52 24.02 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 175.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -69.62 -79.02 0.06 Allowed 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.702 0.801 . . . . 0.0 110.49 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -116.25 -75.94 0.58 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 169.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -112.45 3.59 16.96 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 162.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 4.0 mp -85.98 100.47 9.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.5 ttmp? -92.91 90.93 7.18 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 178.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -84.33 97.03 9.23 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.878 0.871 . . . . 0.0 110.596 -173.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 81.3 t -97.19 96.76 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.5 m -94.02 90.12 6.31 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -171.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -103.51 129.85 50.78 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 122.865 0.466 . . . . 0.0 109.851 -169.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 tt -109.71 107.7 17.82 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -176.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -95.16 -93.46 0.19 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 118.671 -0.681 . . . . 0.0 109.611 -170.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -85.4 -96.81 0.73 Allowed Glycine 0 N--CA 1.483 1.767 0 CA-C-N 119.028 0.831 . . . . 0.0 112.211 -179.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -126.74 55.93 1.51 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.448 0.642 . . . . 0.0 110.28 166.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.09 -156.89 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.539 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 174.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.0 tt -155.93 119.36 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.192 0 N-CA-C 105.981 -1.859 . . . . 0.0 105.981 159.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 52.1 m -97.76 93.94 6.65 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 57.2 t30 -92.07 112.12 23.93 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -179.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.4 m -111.4 94.5 5.0 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 -168.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 37.3 mtt -92.14 98.67 11.68 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.743 0.817 . . . . 0.0 108.818 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 80.6 p -92.09 104.94 17.28 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -174.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 61.4 tp -102.86 81.54 2.01 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.71 -101.27 1.17 Allowed Glycine 0 CA--C 1.545 1.929 0 CA-C-N 116.479 -0.328 . . . . 0.0 112.92 -173.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -98.82 -16.08 19.01 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 169.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 55.7 mt -82.66 111.97 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 CA-C-N 120.274 1.397 . . . . 0.0 107.782 -173.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 61.9 t -99.31 95.73 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 -175.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -86.63 94.61 9.52 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.265 0.626 . . . . 0.0 109.84 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -103.36 109.54 21.21 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.286 -173.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 39.0 mtm180 -101.53 117.82 35.71 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 123.791 0.837 . . . . 0.0 109.046 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.9 mp -104.75 102.87 14.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 -178.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.9 m -122.87 110.74 15.81 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 -168.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.9 tttp -81.66 136.92 35.5 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -166.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 71.9 ttt-85 -70.78 120.49 16.45 Favored 'General case' 0 CA--C 1.559 1.306 0 C-N-CA 124.175 0.99 . . . . 0.0 111.474 -176.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.0 pt . . . . . 0 N--CA 1.484 1.248 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 -173.078 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 98.5 p . . . . . 0 CA--C 1.553 1.069 0 CA-C-O 121.88 0.848 . . . . 0.0 112.022 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -63.51 -24.77 67.96 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 118.175 2.658 . . . . 0.0 118.175 -176.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 67.6 m -68.77 110.73 4.47 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 120.865 1.666 . . . . 0.0 111.525 176.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 170.78 155.64 10.67 Favored Glycine 0 CA--C 1.541 1.671 0 CA-C-O 122.252 0.918 . . . . 0.0 113.798 -179.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -89.01 124.45 34.28 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 166.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 94.5 m-85 -111.35 102.82 11.18 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -174.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.3 tp60 -81.71 130.38 35.04 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.264 1.026 . . . . 0.0 110.764 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.4 tp -62.21 131.3 48.99 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -170.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 -91.24 -62.76 1.37 Allowed 'General case' 0 CA--C 1.561 1.382 0 CA-C-N 114.195 -1.366 . . . . 0.0 109.967 169.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.6 m -150.61 144.66 25.39 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 123.459 0.704 . . . . 0.0 110.968 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -111.83 115.66 29.39 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 123.605 0.762 . . . . 0.0 108.951 169.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -95.25 122.61 38.12 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 160.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.286 84.2 m-20 67.85 41.01 2.24 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 116.414 2.005 . . . . 0.0 116.414 178.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -70.48 -44.79 66.99 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.667 -1.271 . . . . 0.0 113.306 157.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -63.13 -50.85 68.84 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.74 -40.28 96.73 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 173.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -70.5 -51.44 28.95 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.03 -43.9 98.19 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -178.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -60.42 -40.71 92.02 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 167.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.41 -23.5 65.55 Favored 'General case' 0 CA--C 1.564 1.512 0 N-CA-C 117.516 2.413 . . . . 0.0 117.516 174.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.262 28.2 pt -92.01 -49.73 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 CA-C-N 120.082 1.31 . . . . 0.0 112.414 173.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 142.96 71.18 0.02 OUTLIER Glycine 0 N--CA 1.482 1.703 0 CA-C-N 119.699 1.136 . . . . 0.0 113.393 173.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 mp -128.58 157.17 75.86 Favored Pre-proline 0 CA--C 1.572 1.806 0 C-N-CA 123.555 0.742 . . . . 0.0 112.109 177.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -76.64 155.11 35.38 Favored 'Trans proline' 0 C--N 1.371 1.718 0 C-N-CA 123.331 2.687 . . . . 0.0 113.884 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -59.64 -31.33 69.42 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 115.768 1.766 . . . . 0.0 115.768 170.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -62.45 -49.62 74.71 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 171.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.6 mt -68.74 -26.24 65.15 Favored 'General case' 0 N--CA 1.501 2.098 0 N-CA-C 116.986 2.217 . . . . 0.0 116.986 173.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 81.3 mt -78.06 -49.7 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 124.329 1.052 . . . . 0.0 111.256 178.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 48.5 mm-40 -75.7 -29.72 59.09 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 178.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 15.9 tppt? -78.65 -47.07 17.76 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.568 1.076 . . . . 0.0 112.397 169.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.41 -22.41 65.55 Favored Glycine 0 CA--C 1.549 2.185 0 N-CA-C 120.09 2.796 . . . . 0.0 120.09 175.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.1 pttt -65.43 -42.07 92.84 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-N 120.252 2.026 . . . . 0.0 114.771 170.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -64.41 -40.88 96.64 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 114.891 1.441 . . . . 0.0 114.891 167.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 51.9 mt -71.27 128.9 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 CA-C-N 119.39 0.995 . . . . 0.0 108.88 179.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -80.23 105.1 11.25 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 171.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -84.99 121.11 5.5 Favored Glycine 0 CA--C 1.538 1.509 0 CA-C-N 115.718 -0.674 . . . . 0.0 113.141 -173.015 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.6 t -79.49 118.88 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 -178.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 66.4 m -98.62 115.59 28.99 Favored 'General case' 0 N--CA 1.483 1.185 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -101.15 148.2 25.36 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-O 121.823 0.821 . . . . 0.0 110.737 -179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 74.0 mt -140.67 130.33 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 169.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 88.9 t -115.08 103.13 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 105.866 -1.901 . . . . 0.0 105.866 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -81.01 120.93 25.42 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 121.321 0.582 . . . . 0.0 111.124 179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 72.8 m-80 -130.21 72.06 1.48 Allowed 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 163.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.04 -115.96 7.68 Favored Glycine 0 CA--C 1.546 2.03 0 C-N-CA 123.305 0.479 . . . . 0.0 113.848 -173.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.35 -34.12 63.31 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 114.761 1.393 . . . . 0.0 114.761 171.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 72.6 m80 -73.89 117.81 16.11 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 119.92 1.236 . . . . 0.0 110.55 178.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -124.2 103.17 8.09 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 -177.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -90.87 105.18 17.65 Favored 'General case' 0 N--CA 1.488 1.438 0 CA-C-O 122.426 1.108 . . . . 0.0 108.619 175.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -106.29 123.9 48.76 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 113.536 -1.665 . . . . 0.0 109.508 -172.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.9 m -120.62 90.69 3.37 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -172.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 29.6 mm -101.75 112.46 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 107.47 -1.308 . . . . 0.0 107.47 -165.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.9 m -91.05 91.49 8.31 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.443 -1.318 . . . . 0.0 107.443 176.509 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -86.6 89.36 7.89 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.398 0.618 . . . . 0.0 110.134 -177.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.94 -104.69 1.93 Allowed Glycine 0 CA--C 1.54 1.634 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.344 -169.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 61.0 m -93.31 -55.23 3.38 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 175.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -81.56 137.02 35.58 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 119.477 1.035 . . . . 0.0 112.679 -170.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 12.6 p -95.74 132.61 39.45 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.473 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.07 -178.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 39.5 mm -118.71 102.26 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 104.854 -2.276 . . . . 0.0 104.854 -175.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -113.23 121.77 45.44 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.377 0.608 . . . . 0.0 110.008 -172.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -142.03 178.31 7.62 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 124.02 0.928 . . . . 0.0 109.302 173.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -141.22 135.65 30.93 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.802 -1.186 . . . . 0.0 111.236 169.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -118.28 141.85 48.09 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.045 0.938 . . . . 0.0 110.798 175.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.4 m -99.29 125.84 45.0 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 167.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.4 t -69.9 133.3 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 C-N-CA 123.667 0.787 . . . . 0.0 110.345 -179.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.27 -55.82 0.55 Allowed Glycine 0 CA--C 1.548 2.147 0 CA-C-N 115.172 -0.922 . . . . 0.0 113.856 -165.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -86.89 151.9 22.91 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.903 0.881 . . . . 0.0 112.307 -174.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -80.67 114.88 19.87 Favored 'General case' 0 N--CA 1.488 1.453 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.82 173.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 60.0 m -114.46 140.03 49.05 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 123.389 0.675 . . . . 0.0 110.349 -175.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -83.82 107.42 16.21 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.824 -179.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 82.1 mt -120.32 122.29 40.51 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -167.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -75.67 125.55 29.28 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.586 0.707 . . . . 0.0 110.559 177.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 77.5 p -74.5 173.98 9.6 Favored 'General case' 0 CA--C 1.566 1.578 0 CA-C-O 121.971 0.891 . . . . 0.0 112.25 -178.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 54.7 mtm -60.06 -28.85 68.12 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 171.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 98.4 m -68.52 -68.79 0.37 Allowed 'General case' 0 CA--C 1.568 1.642 0 CA-C-N 119.396 0.998 . . . . 0.0 110.261 158.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 140.32 83.91 0.09 OUTLIER Glycine 0 N--CA 1.481 1.7 0 N-CA-C 110.531 -1.027 . . . . 0.0 110.531 174.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -154.25 111.8 3.45 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -172.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -81.51 118.21 22.55 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-O 121.715 0.769 . . . . 0.0 110.601 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 6.1 m -139.44 125.61 22.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 CA-C-N 114.249 -1.341 . . . . 0.0 108.305 -167.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -75.61 114.02 13.72 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.165 0.586 . . . . 0.0 110.653 -177.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 12.3 t -141.51 133.84 28.07 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.483 -166.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.9 t -89.94 124.16 42.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.4 t -99.79 126.15 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.325 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 170.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -119.96 140.22 51.25 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 122.141 0.972 . . . . 0.0 110.017 177.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.4 tp -101.27 116.79 33.62 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 114.545 -1.207 . . . . 0.0 109.081 -175.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -102.96 115.71 31.13 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 172.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.97 -133.11 13.71 Favored Glycine 0 CA--C 1.545 1.922 0 CA-C-N 114.783 -1.099 . . . . 0.0 113.394 -171.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -131.49 59.33 1.7 Allowed 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 162.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 18.0 p-10 -161.38 -40.66 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 -174.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -109.74 99.02 8.25 Favored 'General case' 0 CA--C 1.558 1.263 0 CA-C-N 119.844 1.202 . . . . 0.0 111.118 -162.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 64.2 mt -95.24 105.78 17.75 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 61.5 t -105.79 125.09 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 -169.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.2 t -151.87 136.83 17.26 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 22.8 p -111.2 106.56 15.6 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 123.809 0.844 . . . . 0.0 108.897 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -65.78 -69.6 0.29 Allowed 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 123.824 0.849 . . . . 0.0 113.239 -173.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -127.72 -78.45 0.58 Allowed 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 170.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 25.2 t30 -124.43 73.39 1.25 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 156.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 17.0 mt -148.33 105.63 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 103.646 -2.724 . . . . 0.0 103.646 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp -75.01 142.14 43.87 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 171.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 35.0 t -143.05 99.8 3.52 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -178.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 84.4 t -102.62 98.28 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 N-CA-C 104.896 -2.261 . . . . 0.0 104.896 177.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.0 m -95.26 90.92 6.03 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 -174.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -108.98 126.98 53.67 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 -165.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 tt -100.56 104.43 15.78 Favored 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -173.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 21.6 m-80 -102.28 94.9 5.96 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 -173.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 80.63 -111.58 3.31 Favored Glycine 0 N--CA 1.485 1.949 0 CA-C-O 119.864 -0.409 . . . . 0.0 112.252 -177.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 56.8 m-20 -127.96 58.93 1.5 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.779 0.8 . . . . 0.0 110.615 160.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.8 pt -123.06 -154.62 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.762 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 159.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.5 tt -159.61 116.87 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 O-C-N 120.368 -1.457 . . . . 0.0 107.319 161.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 67.9 m -99.76 99.47 10.29 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 176.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -94.32 103.23 15.24 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 -179.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 37.8 m -106.37 97.6 7.38 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -172.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 68.0 mtp -101.91 106.91 17.92 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 68.8 p -100.5 107.68 19.44 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -173.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 28.9 tp -71.93 -70.49 0.33 Allowed 'General case' 0 N--CA 1.49 1.548 0 C-N-CA 123.159 0.583 . . . . 0.0 112.195 -176.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -123.52 -87.36 0.79 Allowed Glycine 0 CA--C 1.538 1.499 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 158.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -89.9 -11.11 42.81 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 167.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 68.5 mt -85.09 110.79 19.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -172.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 57.4 t -97.77 95.11 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 -175.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 12.2 t80 -82.07 93.04 6.92 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 123.076 0.55 . . . . 0.0 109.785 177.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -95.77 110.78 22.88 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 -179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 61.9 ttt180 -113.74 103.82 11.59 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -175.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 4.0 mp -98.9 121.16 49.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 -172.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 66.7 m -141.62 122.83 14.75 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 122.765 0.426 . . . . 0.0 109.962 -172.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -94.41 135.75 35.47 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 123.673 0.789 . . . . 0.0 112.276 -170.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 25.5 ttp180 -68.87 133.71 48.63 Favored 'General case' 0 CA--C 1.56 1.338 0 C-N-CA 123.17 0.588 . . . . 0.0 112.569 -177.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 15.2 pt . . . . . 0 N--CA 1.484 1.235 0 N-CA-C 105.791 -1.929 . . . . 0.0 105.791 -173.846 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 27.5 t . . . . . 0 CA--C 1.548 0.873 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -74.36 -9.7 58.85 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 118.497 2.777 . . . . 0.0 118.497 -175.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 73.6 m -73.83 112.12 9.64 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 121.631 2.014 . . . . 0.0 110.643 173.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -177.84 139.32 4.17 Favored Glycine 0 CA--C 1.542 1.739 0 CA-C-O 121.221 0.345 . . . . 0.0 113.561 -174.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -89.73 113.92 25.51 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 169.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -107.85 105.71 15.65 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 -167.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -79.28 124.02 27.99 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 124.034 0.934 . . . . 0.0 110.837 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.9 tp -65.73 124.45 22.46 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.384 0.611 . . . . 0.0 112.576 -176.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -106.12 -65.84 1.04 Allowed 'General case' 0 N--CA 1.488 1.427 0 C-N-CA 124.095 0.958 . . . . 0.0 109.801 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.8 t -130.22 115.79 17.49 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -175.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -106.49 108.05 19.37 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -177.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -90.64 135.92 33.4 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.944 0.898 . . . . 0.0 110.171 -179.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.7 m120 61.81 46.07 7.19 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 115.868 1.803 . . . . 0.0 115.868 174.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -77.44 -46.25 23.22 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -63.27 -50.99 67.94 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 171.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.58 -38.91 78.91 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 117.062 2.245 . . . . 0.0 117.062 177.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -76.67 -56.34 4.7 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 119.096 0.862 . . . . 0.0 112.903 178.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.07 -53.29 59.76 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -59.24 -36.05 74.77 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 115.66 1.726 . . . . 0.0 115.66 174.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.42 -36.01 80.4 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 116.581 2.067 . . . . 0.0 116.581 171.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.274 45.7 pt -78.79 -48.75 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 CA-C-N 119.972 1.26 . . . . 0.0 112.975 175.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 143.73 61.62 0.02 OUTLIER Glycine 0 CA--C 1.543 1.824 0 CA-C-N 119.116 0.871 . . . . 0.0 113.253 171.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -121.8 151.97 58.38 Favored Pre-proline 0 N--CA 1.492 1.654 0 C-N-CA 123.828 0.851 . . . . 0.0 111.123 -174.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -75.04 144.53 30.21 Favored 'Trans proline' 0 C--N 1.369 1.654 0 C-N-CA 123.226 2.618 . . . . 0.0 113.633 177.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -65.07 -20.24 66.38 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 116.032 1.864 . . . . 0.0 116.032 171.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -62.46 -54.64 37.09 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-N 120.28 1.4 . . . . 0.0 113.483 166.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.85 -21.32 66.77 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 117.258 2.318 . . . . 0.0 117.258 173.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 47.3 mt -78.61 -50.74 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 C-N-CA 124.237 1.015 . . . . 0.0 110.927 173.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 44.3 mm-40 -74.88 -26.6 59.78 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -78.38 -48.36 15.69 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 119.673 1.124 . . . . 0.0 111.67 165.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.18 -17.02 60.88 Favored Glycine 0 CA--C 1.55 2.258 0 N-CA-C 120.445 2.938 . . . . 0.0 120.445 176.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 24.5 pttm -68.2 -43.39 78.18 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 120.473 2.136 . . . . 0.0 114.036 168.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -66.44 -31.75 72.7 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 115.578 1.696 . . . . 0.0 115.578 167.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 31.3 mt -85.27 113.87 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -87.06 107.84 18.61 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 177.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -86.77 128.56 8.97 Favored Glycine 0 CA--C 1.54 1.599 0 CA-C-N 115.984 -0.553 . . . . 0.0 113.683 -170.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.6 t -80.01 114.58 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 174.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 51.4 m -113.88 118.08 33.22 Favored 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -173.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -95.54 153.84 17.51 Favored 'General case' 0 N--CA 1.481 1.106 0 CA-C-O 122.122 0.963 . . . . 0.0 111.801 -174.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 69.1 mt -138.03 126.08 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 103.585 -2.746 . . . . 0.0 103.585 160.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 69.0 t -111.1 102.37 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 51.5 tt0 -80.33 120.0 23.81 Favored 'General case' 0 N--CA 1.488 1.447 0 C-N-CA 123.132 0.573 . . . . 0.0 110.781 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -129.75 72.6 1.48 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 165.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.62 -111.48 4.1 Favored Glycine 0 CA--C 1.545 1.963 0 C-N-CA 123.35 0.5 . . . . 0.0 114.181 -178.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -74.65 -37.21 62.8 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 172.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -72.39 139.51 47.86 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 119.625 1.102 . . . . 0.0 111.624 175.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -141.65 96.66 3.01 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -87.99 102.99 15.28 Favored 'General case' 0 N--CA 1.486 1.375 0 CA-C-O 122.015 0.912 . . . . 0.0 108.852 174.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -97.0 130.42 44.33 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 114.191 -1.368 . . . . 0.0 110.053 178.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.9 m -120.18 84.72 2.26 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 106.345 -1.724 . . . . 0.0 106.345 176.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.6 tt -91.26 115.47 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 C-N-CA 123.395 0.678 . . . . 0.0 109.515 -169.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 39.1 m -90.46 96.25 10.56 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.805 -1.183 . . . . 0.0 107.805 178.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.421 ' HA ' HH12 ' A' ' 122' ' ' ARG . . . -90.11 91.75 8.68 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 123.153 0.581 . . . . 0.0 110.084 -179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 75.24 -108.16 2.47 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.245 -171.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 91.8 p -87.97 -51.99 5.52 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 167.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -80.43 127.73 32.75 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 118.974 0.806 . . . . 0.0 111.678 -165.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.9 p -95.43 129.88 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 123.722 0.809 . . . . 0.0 110.984 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.0 mp -114.19 105.86 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 105.518 -2.03 . . . . 0.0 105.518 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -101.1 122.95 44.5 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 121.27 0.557 . . . . 0.0 109.876 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -145.46 165.08 29.61 Favored 'General case' 0 N--CA 1.494 1.762 0 C-N-CA 123.936 0.895 . . . . 0.0 109.155 169.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -120.18 143.18 48.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.407 -0.808 . . . . 0.0 110.716 164.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 21.2 p90 -118.5 138.76 52.29 Favored 'General case' 0 N--CA 1.486 1.372 0 CA-C-O 121.999 0.904 . . . . 0.0 110.072 166.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.3 m -97.32 125.32 41.84 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 168.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.3 t -72.23 131.75 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 C-N-CA 123.662 0.785 . . . . 0.0 109.525 178.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.27 -56.41 0.66 Allowed Glycine 0 CA--C 1.547 2.076 0 CA-C-N 115.44 -0.8 . . . . 0.0 113.534 -163.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -71.83 147.9 46.72 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.175 0.99 . . . . 0.0 112.965 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -81.19 103.39 10.94 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.086 169.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 56.6 m -100.54 137.86 38.38 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-O 121.752 0.787 . . . . 0.0 111.837 -166.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -80.15 115.38 19.68 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.903 177.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.7 mt -136.08 110.92 8.75 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -167.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -75.62 138.58 41.51 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.986 0.898 . . . . 0.0 111.15 171.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 70.6 p -91.09 -174.44 3.98 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 114.953 -1.022 . . . . 0.0 111.287 -170.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 51.9 mtt -62.02 -32.04 72.48 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 167.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 69.0 p -68.29 -52.67 31.12 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 119.559 1.072 . . . . 0.0 113.275 163.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 106.72 94.43 2.36 Favored Glycine 0 N--CA 1.479 1.553 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 -176.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -148.65 -36.22 0.19 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 115.602 1.704 . . . . 0.0 115.602 -171.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.275 38.2 ttmt 75.38 96.61 0.07 Allowed 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 125.522 1.529 . . . . 0.0 111.016 -176.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 22.3 t -112.35 124.5 69.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -179.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -83.85 106.42 15.52 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 171.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.9 t -141.35 139.84 33.64 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 123.854 0.862 . . . . 0.0 110.462 -168.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 24.4 t -91.12 130.13 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -174.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 7.6 t -106.14 126.17 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 177.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -106.95 154.29 21.29 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.691 0.758 . . . . 0.0 111.402 170.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.0 tp -119.62 123.37 43.72 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 -179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -122.33 127.52 49.91 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.688 0.756 . . . . 0.0 109.083 176.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.25 13.68 67.76 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 120.877 3.111 . . . . 0.0 120.877 175.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.279 4.4 t70 54.08 41.4 32.03 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 115.6 1.704 . . . . 0.0 115.6 -163.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -157.91 -26.18 0.08 Allowed 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 115.672 1.731 . . . . 0.0 115.672 -176.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -113.75 101.22 9.09 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 121.112 1.778 . . . . 0.0 109.293 -173.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 57.7 mt -95.25 103.37 15.22 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 172.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.7 m -112.17 124.34 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 123.784 0.834 . . . . 0.0 109.477 -165.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 t -155.62 133.81 11.53 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 122.693 0.397 . . . . 0.0 110.384 -176.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 42.6 m -103.73 113.92 27.8 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -83.16 79.38 9.4 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 123.744 0.818 . . . . 0.0 109.768 176.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.351 12.0 tmtt? 69.93 -81.22 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 124.544 1.137 . . . . 0.0 111.836 -173.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -104.51 -34.05 8.35 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 170.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.0 mp -84.75 117.86 30.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 CA-C-N 119.754 1.161 . . . . 0.0 108.685 -161.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -91.22 103.62 16.27 Favored 'General case' 0 N--CA 1.49 1.542 0 C-N-CA 122.371 0.268 . . . . 0.0 110.496 -169.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 57.7 m -88.0 117.19 26.7 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 123.331 0.652 . . . . 0.0 109.243 178.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 78.7 t -120.58 103.23 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 28.9 m -100.49 91.8 4.85 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 -172.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -84.7 146.48 27.41 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 124.29 1.036 . . . . 0.0 111.421 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 tt -131.04 106.94 8.72 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 175.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -85.99 -89.96 0.11 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.243 -170.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.23 -108.05 2.56 Favored Glycine 0 N--CA 1.483 1.795 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 178.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 44.5 m-20 -106.69 63.06 0.64 Allowed 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.765 0.793 . . . . 0.0 109.606 164.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.4 pt -140.3 -161.71 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.83 0 C-N-CA 124.7 1.2 . . . . 0.0 108.284 176.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 11.9 tt -159.8 130.65 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.372 0 N-CA-C 107.686 -1.228 . . . . 0.0 107.686 160.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 30.7 m -111.93 89.04 2.95 Favored 'General case' 0 CA--C 1.561 1.385 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -84.07 103.25 13.15 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.719 0.808 . . . . 0.0 109.179 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.3 m -109.85 96.17 6.08 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -169.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 59.6 mtt -96.84 104.75 16.78 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 44.7 p -92.22 110.0 21.38 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 -174.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 40.9 tp -104.23 76.97 1.37 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 175.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.18 -105.84 1.74 Allowed Glycine 0 CA--C 1.546 2.008 0 C-N-CA 123.025 0.345 . . . . 0.0 113.228 -171.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -94.42 -7.96 40.04 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 169.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 78.0 mt -89.28 101.43 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -174.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 39.2 t -98.19 97.47 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 -172.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -85.51 98.51 10.66 Favored 'General case' 0 N--CA 1.485 1.324 0 C-N-CA 123.494 0.717 . . . . 0.0 109.351 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -109.29 105.24 14.56 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.387 -173.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.421 HH12 ' HA ' ' A' ' 54' ' ' ALA . 45.1 mtp85 -87.01 120.98 28.85 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 172.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 73.1 mt -109.32 100.8 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 103.471 -2.789 . . . . 0.0 103.471 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 49.8 m -126.06 116.64 21.72 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 -168.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -88.77 132.92 34.42 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.596 0.758 . . . . 0.0 112.04 -168.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -68.64 134.25 49.63 Favored 'General case' 0 CA--C 1.556 1.191 0 CA-C-O 121.934 0.873 . . . . 0.0 112.587 -175.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 18.0 pt . . . . . 0 N--CA 1.485 1.3 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 -174.459 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 67.1 m . . . . . 0 CA--C 1.547 0.862 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -69.21 -21.79 63.92 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 117.856 2.539 . . . . 0.0 117.856 -176.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.9 p -68.47 114.93 7.31 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 121.176 1.807 . . . . 0.0 112.171 176.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 166.23 167.73 27.33 Favored Glycine 0 CA--C 1.543 1.806 0 CA-C-N 114.634 -1.166 . . . . 0.0 113.731 -168.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -126.24 106.72 9.74 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 106.841 -1.541 . . . . 0.0 106.841 -176.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -107.15 102.45 11.77 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -159.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -94.96 141.91 28.1 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.808 0.813 . . . . 0.0 111.704 -176.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 31.9 tp -66.98 128.45 36.4 Favored 'General case' 0 CA--C 1.558 1.261 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -167.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -94.72 -62.74 1.27 Allowed 'General case' 0 CA--C 1.561 1.382 0 CA-C-N 114.571 -1.195 . . . . 0.0 110.926 169.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.2 t -139.34 135.56 33.88 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.666 0.786 . . . . 0.0 109.751 -170.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 31.4 tt0 -131.92 119.8 21.64 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -173.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -93.45 -70.95 0.68 Allowed 'General case' 0 CA--C 1.556 1.185 0 CA-C-O 118.068 -0.967 . . . . 0.0 112.336 -164.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -105.24 76.8 1.25 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 119.591 1.087 . . . . 0.0 110.032 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -88.14 -47.06 8.76 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 123.575 0.75 . . . . 0.0 112.935 170.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -64.35 -51.09 65.07 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 177.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.3 -38.97 88.71 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 116.675 2.102 . . . . 0.0 116.675 173.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -70.14 -54.75 11.6 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-N 119.318 0.963 . . . . 0.0 113.555 179.019 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 32.9 mtt -60.53 -47.13 87.51 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -58.27 -37.45 74.99 Favored 'General case' 0 N--CA 1.498 1.961 0 N-CA-C 115.948 1.832 . . . . 0.0 115.948 169.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.5 -38.43 84.33 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 116.822 2.156 . . . . 0.0 116.822 173.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 26.5 pt -76.96 -39.88 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 N-CA-C 114.529 1.307 . . . . 0.0 114.529 176.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.55 59.44 0.13 Allowed Glycine 0 CA--C 1.543 1.834 0 C-N-CA 124.223 0.915 . . . . 0.0 112.91 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.24 149.75 52.47 Favored Pre-proline 0 CA--C 1.566 1.58 0 C-N-CA 124.213 1.005 . . . . 0.0 109.889 -179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -71.73 141.12 36.93 Favored 'Trans proline' 0 C--N 1.368 1.569 0 C-N-CA 123.109 2.54 . . . . 0.0 113.528 177.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -61.08 -33.47 73.38 Favored 'General case' 0 CA--C 1.568 1.668 0 N-CA-C 116.054 1.872 . . . . 0.0 116.054 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -60.56 -47.32 86.7 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 170.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 74.5 mt -67.77 -18.9 65.02 Favored 'General case' 0 N--CA 1.499 1.983 0 N-CA-C 116.723 2.12 . . . . 0.0 116.723 172.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 78.0 mt -68.92 -53.51 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 CA-C-N 119.79 1.177 . . . . 0.0 110.756 169.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -63.96 -27.56 69.22 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 116.56 2.059 . . . . 0.0 116.56 173.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 2.7 ttpm? -74.37 -56.7 4.56 Favored 'General case' 0 CA--C 1.564 1.499 0 CA-C-N 119.733 1.152 . . . . 0.0 112.091 172.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.95 -16.42 66.28 Favored Glycine 0 CA--C 1.552 2.397 0 N-CA-C 119.822 2.689 . . . . 0.0 119.822 178.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.9 ptmm? -69.08 -44.62 72.16 Favored 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 120.37 2.085 . . . . 0.0 114.264 171.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -66.74 -34.89 78.83 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 115.182 1.549 . . . . 0.0 115.182 170.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 55.6 mt -73.2 123.43 28.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 175.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -84.01 104.94 14.49 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 174.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -85.1 131.67 10.58 Favored Glycine 0 CA--C 1.539 1.587 0 CA-C-N 115.996 -0.547 . . . . 0.0 113.715 -170.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.2 t -84.99 113.51 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 178.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 47.4 m -96.55 100.46 12.03 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.92 142.16 31.64 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-O 121.402 0.62 . . . . 0.0 110.181 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.5 mt -142.43 119.91 7.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 104.093 -2.558 . . . . 0.0 104.093 174.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 94.3 t -109.58 109.73 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 175.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -85.65 123.1 30.67 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 123.18 0.592 . . . . 0.0 110.261 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -123.6 69.57 1.04 Allowed 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 166.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.95 -114.35 6.06 Favored Glycine 0 CA--C 1.545 1.941 0 C-N-CA 123.41 0.528 . . . . 0.0 113.981 -177.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -77.68 -31.86 52.75 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 170.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 65.6 m80 -75.27 114.6 13.98 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 119.723 1.147 . . . . 0.0 110.136 175.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -112.44 105.83 14.18 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 -179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.3 ttpt -84.17 138.48 32.97 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 115.036 -0.984 . . . . 0.0 108.705 162.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -141.48 146.65 36.71 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 122.819 0.448 . . . . 0.0 110.993 172.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 91.1 m -132.25 97.55 4.15 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 176.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.3 tt -94.56 115.54 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 75.8 p -89.37 99.16 12.21 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.753 -170.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -97.96 143.87 28.08 Favored 'General case' 0 N--CA 1.481 1.08 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.724 170.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -47.62 -50.35 19.42 Favored Glycine 0 CA--C 1.549 2.198 0 N-CA-C 119.682 2.633 . . . . 0.0 119.682 -171.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 22.7 t -73.16 -61.01 1.97 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 118.032 0.916 . . . . 0.0 113.444 173.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 85.8 tttt -126.99 129.07 47.38 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 119.14 0.882 . . . . 0.0 109.154 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.9 t -79.06 127.4 39.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 172.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 50.5 mm -113.62 103.61 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -171.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -105.67 131.64 52.79 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 122.993 0.517 . . . . 0.0 110.825 173.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 73.2 m-20 -136.73 137.33 39.81 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 121.727 0.775 . . . . 0.0 109.04 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -118.46 126.84 52.9 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.099 -1.074 . . . . 0.0 108.099 -174.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -139.81 173.13 11.84 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.838 0.828 . . . . 0.0 112.406 -176.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 32.2 m -133.11 131.8 40.94 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 170.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.1 m -69.12 134.01 30.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 C-N-CA 123.262 0.625 . . . . 0.0 111.793 175.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 102.73 -53.24 0.77 Allowed Glycine 0 CA--C 1.546 2.03 0 CA-C-O 119.681 -0.511 . . . . 0.0 114.095 -166.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -75.21 152.66 38.35 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.742 0.817 . . . . 0.0 112.368 177.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -87.03 99.48 11.93 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 173.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.0 m -100.97 150.67 22.64 Favored 'General case' 0 N--CA 1.485 1.292 0 CA-C-O 121.515 0.674 . . . . 0.0 112.203 -172.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.96 127.76 35.67 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.92 174.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.7 mp -134.24 124.36 25.81 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -175.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -75.12 114.19 13.33 Favored 'General case' 0 N--CA 1.491 1.594 0 C-N-CA 123.135 0.574 . . . . 0.0 110.115 176.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 4.7 t -77.41 -177.53 4.72 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-O 122.425 1.107 . . . . 0.0 112.827 -176.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 90.6 mmm -62.29 -38.0 87.67 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.6 m -72.26 -69.28 0.41 Allowed 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 119.935 1.243 . . . . 0.0 109.932 168.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 154.54 83.38 0.04 OUTLIER Glycine 0 N--CA 1.478 1.455 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 174.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -155.07 126.32 7.24 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -175.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -75.95 103.55 6.07 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 171.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 14.5 m -98.36 119.07 45.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -175.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.6 mptp? -87.78 98.79 11.66 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 -177.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.8 t -139.78 144.33 37.34 Favored 'General case' 0 N--CA 1.49 1.549 0 C-N-CA 123.307 0.643 . . . . 0.0 110.745 -167.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 41.0 t -97.6 124.21 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -176.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.3 t -106.3 133.1 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 -178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -112.11 137.6 49.93 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-O 121.516 0.674 . . . . 0.0 109.902 174.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.4 tp -94.72 117.58 30.36 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 171.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -119.03 119.38 34.11 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 177.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.09 12.16 79.31 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 121.378 3.311 . . . . 0.0 121.378 173.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.276 5.9 t70 55.9 43.82 26.82 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.008 1.484 . . . . 0.0 115.008 -164.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -156.67 -40.91 0.07 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 117.91 -1.043 . . . . 0.0 113.749 -176.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -101.75 132.82 47.27 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 120.193 1.36 . . . . 0.0 110.458 -177.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 38.6 mt -116.78 99.48 7.14 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 165.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 29.0 m -98.93 121.27 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 C-N-CA 123.564 0.745 . . . . 0.0 109.659 -170.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.1 t -154.49 128.87 9.1 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 122.212 -0.305 . . . . 0.0 110.983 -177.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.6 t -109.79 129.04 55.67 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 123.37 0.668 . . . . 0.0 110.219 178.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -148.51 120.68 8.32 Favored 'General case' 0 N--CA 1.49 1.555 0 C-N-CA 123.63 0.772 . . . . 0.0 109.226 -169.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.321 28.1 mtpp 74.6 -94.66 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 124.389 1.076 . . . . 0.0 108.239 -170.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -146.3 66.77 1.19 Allowed 'General case' 0 CA--C 1.562 1.405 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 151.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 57.9 mt -135.35 96.47 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 103.787 -2.672 . . . . 0.0 103.787 -172.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -88.25 95.28 10.12 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-O 121.388 0.613 . . . . 0.0 109.425 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 25.0 t -84.04 102.09 12.25 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 115.087 -0.96 . . . . 0.0 109.803 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 69.3 t -100.28 98.47 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 175.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.7 m -94.69 84.2 4.2 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -172.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -97.42 125.91 42.35 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.542 0.737 . . . . 0.0 109.215 -166.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 tt -103.28 103.45 13.48 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -172.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -100.99 92.35 4.98 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -171.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 79.79 -109.8 2.97 Favored Glycine 0 CA--C 1.543 1.824 0 N-CA-C 112.056 -0.418 . . . . 0.0 112.056 -176.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -126.75 58.31 1.41 Allowed 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 121.614 0.721 . . . . 0.0 110.822 162.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.8 pt -125.06 -158.55 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.688 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 160.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.0 tt -157.78 118.84 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 120.06 -1.65 . . . . 0.0 108.861 163.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 69.0 m -102.48 94.55 5.73 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -91.08 110.96 22.24 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 123.491 0.716 . . . . 0.0 109.299 -178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.6 m -113.93 95.39 5.29 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 -168.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 42.4 mtt -96.66 101.2 12.76 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 123.754 0.822 . . . . 0.0 109.09 -178.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 70.6 p -93.05 103.17 15.49 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -173.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 38.2 tp -99.51 82.48 2.65 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 175.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 73.85 -104.67 1.66 Allowed Glycine 0 CA--C 1.544 1.847 0 CA-C-N 116.427 -0.351 . . . . 0.0 112.623 -173.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -100.2 -2.82 32.95 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 115.281 1.586 . . . . 0.0 115.281 168.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 61.2 mt -90.18 103.09 13.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -175.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.1 t -97.72 91.67 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -172.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -80.97 92.68 6.22 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.584 0.754 . . . . 0.0 109.661 179.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -111.83 105.76 14.32 Favored 'General case' 0 N--CA 1.484 1.229 0 CA-C-N 115.047 -0.979 . . . . 0.0 108.63 -171.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 16.6 ptm180 -111.88 122.15 46.99 Favored 'General case' 0 N--CA 1.485 1.288 0 CA-C-N 115.074 -0.966 . . . . 0.0 109.76 -176.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 3.7 mp -102.83 118.42 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 104.641 -2.355 . . . . 0.0 104.641 -172.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.7 m -137.65 117.56 13.28 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -171.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 22.9 ttpp -88.16 138.18 31.67 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -171.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 19.6 ttp180 -68.46 122.93 19.47 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 123.793 0.837 . . . . 0.0 112.081 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 24.4 pt . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 123.102 1.43 . . . . 0.0 108.438 -174.655 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 98.0 p . . . . . 0 CA--C 1.549 0.916 0 CA-C-O 120.975 0.417 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.2 m-85 -67.31 -14.43 62.91 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 118.016 2.599 . . . . 0.0 118.016 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 69.3 m -73.66 116.16 13.92 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 121.275 1.852 . . . . 0.0 110.399 168.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -179.88 158.53 22.25 Favored Glycine 0 CA--C 1.541 1.708 0 CA-C-O 122.34 0.967 . . . . 0.0 114.516 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 14.9 mptt -98.75 116.79 31.78 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 166.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -108.4 101.91 11.05 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -168.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.9 tm0? -88.8 121.97 31.72 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.713 0.805 . . . . 0.0 109.779 -173.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 36.8 tp -61.7 119.36 8.55 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -92.88 -67.19 0.87 Allowed 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.354 173.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.6 m -122.4 144.3 49.12 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.184 0.994 . . . . 0.0 109.625 -176.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 40.9 tt0 -134.27 103.4 5.73 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 -178.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -85.53 137.51 32.83 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 124.224 1.01 . . . . 0.0 110.329 179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.8 m120 60.03 46.7 10.55 Favored 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 175.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -76.32 -49.45 16.88 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 -176.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -64.52 -44.07 92.07 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 171.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.0 -46.36 88.37 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 116.3 1.963 . . . . 0.0 116.3 173.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 63.9 t80 -71.93 -55.48 7.4 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-N 119.16 0.891 . . . . 0.0 113.184 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -60.93 -46.4 90.81 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -177.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -60.03 -40.31 88.88 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 115.192 1.552 . . . . 0.0 115.192 170.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.14 -28.74 66.72 Favored 'General case' 0 CA--C 1.564 1.483 0 N-CA-C 117.371 2.36 . . . . 0.0 117.371 174.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.264 20.1 pt -81.08 -48.04 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 CA-C-N 120.313 1.415 . . . . 0.0 112.776 172.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 143.59 66.61 0.02 OUTLIER Glycine 0 N--CA 1.48 1.623 0 CA-C-N 119.12 0.873 . . . . 0.0 112.975 173.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mp -130.47 154.99 81.73 Favored Pre-proline 0 CA--C 1.567 1.619 0 C-N-CA 123.558 0.743 . . . . 0.0 111.806 178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.35 155.87 32.66 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 123.079 2.519 . . . . 0.0 113.383 175.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -63.38 -24.16 67.72 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 115.658 1.725 . . . . 0.0 115.658 165.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -59.63 -53.49 57.44 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-N 119.974 1.261 . . . . 0.0 114.265 168.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 98.6 mt -69.58 -24.9 63.75 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 117.077 2.251 . . . . 0.0 117.077 175.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 41.3 mt -75.71 -53.76 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 CA-C-N 119.725 1.148 . . . . 0.0 110.485 173.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 46.1 mm-40 -71.67 -22.86 61.61 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 116.485 2.031 . . . . 0.0 116.485 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.66 -45.47 12.45 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.736 1.153 . . . . 0.0 112.717 167.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.52 -20.34 55.63 Favored Glycine 0 CA--C 1.553 2.454 0 N-CA-C 119.881 2.713 . . . . 0.0 119.881 173.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.4 pttp -64.71 -43.65 92.76 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 120.144 1.972 . . . . 0.0 114.772 168.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -63.11 -38.86 92.86 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 167.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 69.7 mt -72.94 128.7 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 C-N-CA 123.943 0.897 . . . . 0.0 108.706 179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -76.78 111.92 12.82 Favored 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.307 177.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -87.66 105.89 3.14 Favored Glycine 0 N--CA 1.478 1.437 0 CA-C-N 115.865 -0.607 . . . . 0.0 113.553 -170.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.0 t -94.61 111.62 25.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 174.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 70.6 m -117.25 109.16 16.52 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 177.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.89 159.87 22.25 Favored 'General case' 0 CA--C 1.554 1.105 0 CA-C-N 115.206 -0.906 . . . . 0.0 111.98 -173.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 73.3 mt -136.02 131.56 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 104.175 -2.528 . . . . 0.0 104.175 160.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.6 t -115.09 102.43 13.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 105.552 -2.018 . . . . 0.0 105.552 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -79.29 120.99 24.53 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 123.195 0.598 . . . . 0.0 110.684 178.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -127.26 73.22 1.41 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 166.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.14 -119.08 9.22 Favored Glycine 0 CA--C 1.546 2.031 0 C-N-CA 123.209 0.433 . . . . 0.0 113.598 -174.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.252 0.0 OUTLIER -71.41 -28.7 64.19 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 116.568 2.062 . . . . 0.0 116.568 169.294 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -75.55 132.01 40.42 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 120.015 1.28 . . . . 0.0 110.965 175.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -132.99 99.98 4.75 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.2 tmmt? -93.95 104.99 17.03 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 121.944 0.878 . . . . 0.0 108.875 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -90.46 134.26 34.47 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 114.173 -1.376 . . . . 0.0 110.927 176.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 97.7 m -119.54 98.91 6.36 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 175.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 76.4 mt -82.71 141.91 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 173.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 73.5 p -119.92 92.66 3.84 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 170.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.34 95.53 6.01 Favored 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 123.168 0.587 . . . . 0.0 109.545 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.32 -112.71 3.84 Favored Glycine 0 CA--C 1.545 1.907 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.903 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 99.1 p -87.77 -41.68 13.13 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 168.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -79.26 137.6 37.45 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 119.003 0.82 . . . . 0.0 112.118 -171.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.8 t -110.52 107.51 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 -176.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.2 mp -97.09 104.74 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 -172.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -108.54 124.89 51.15 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 123.53 0.732 . . . . 0.0 109.939 -176.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 65.7 m-80 -150.87 144.84 25.27 Favored 'General case' 0 N--CA 1.498 1.958 0 C-N-CA 122.76 0.424 . . . . 0.0 110.9 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -118.12 132.59 56.33 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 123.937 0.895 . . . . 0.0 110.534 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -117.55 142.58 47.01 Favored 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 123.787 0.835 . . . . 0.0 111.509 171.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 89.8 m -89.38 140.5 29.45 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 159.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.7 t -76.37 122.3 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 172.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 83.22 40.31 9.29 Favored Glycine 0 CA--C 1.549 2.167 0 N-CA-C 116.784 1.473 . . . . 0.0 116.784 -168.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -151.62 143.16 23.55 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.184 0.994 . . . . 0.0 108.318 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -74.0 106.88 5.89 Favored 'General case' 0 N--CA 1.492 1.648 0 CA-C-O 121.325 0.583 . . . . 0.0 109.659 168.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 40.8 m -110.51 136.32 49.83 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.048 -171.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -83.58 93.49 7.87 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.863 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 57.8 mt -117.39 122.5 44.0 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -171.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -81.65 121.5 26.44 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 121.327 0.585 . . . . 0.0 110.267 179.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 71.1 p -69.16 157.4 36.96 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.315 170.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 29.9 ttm -40.79 -50.51 3.15 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 118.514 2.783 . . . . 0.0 118.514 -167.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.7 m -129.75 115.02 16.68 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 157.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 173.98 -129.8 1.7 Allowed Glycine 0 CA--C 1.542 1.779 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.241 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -147.91 164.31 34.11 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 123.58 0.752 . . . . 0.0 111.28 -176.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.1 mptp? -65.98 125.06 24.25 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 123.393 0.677 . . . . 0.0 111.596 175.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 1.9 m -139.84 136.69 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 C-N-CA 123.734 0.814 . . . . 0.0 109.407 -169.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -72.05 133.66 45.39 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 124.023 0.929 . . . . 0.0 112.461 -176.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.2 t -154.14 142.0 20.1 Favored 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 122.974 0.51 . . . . 0.0 110.287 178.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.29 123.16 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.4 t -99.32 137.03 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -177.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 17.1 mp0 -124.41 136.78 54.32 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 173.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 42.0 tp -91.16 105.97 18.18 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 174.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -93.98 115.35 27.69 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 177.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 75.59 -127.51 9.14 Favored Glycine 0 CA--C 1.546 1.981 0 CA-C-N 114.428 -1.26 . . . . 0.0 113.021 -170.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -118.54 -11.95 9.85 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 173.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.1 p-10 -123.87 -13.0 7.48 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 117.424 2.379 . . . . 0.0 117.424 -173.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -113.51 96.46 5.89 Favored 'General case' 0 N--CA 1.484 1.231 0 CA-C-N 121.398 1.908 . . . . 0.0 110.472 -165.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 70.5 mt -86.37 105.16 16.52 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 175.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.1 m -99.0 125.88 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 C-N-CA 123.862 0.865 . . . . 0.0 109.225 -174.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.6 t -152.65 125.93 8.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 122.138 -0.351 . . . . 0.0 110.376 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 11.3 t -112.62 131.29 55.7 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.487 0.715 . . . . 0.0 110.16 179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -84.45 -82.37 0.17 Allowed 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 123.623 0.769 . . . . 0.0 108.967 175.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -130.57 -77.69 0.53 Allowed 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 106.625 -1.62 . . . . 0.0 106.625 167.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -86.42 -36.25 19.24 Favored 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 174.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 52.4 mt -69.45 129.25 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 C-N-CA 124.455 1.102 . . . . 0.0 109.01 176.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -128.18 97.14 4.66 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.7 t -89.97 106.07 18.23 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 123.719 0.807 . . . . 0.0 110.717 -170.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 91.9 t -105.08 95.7 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.2 m -97.28 88.17 4.37 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -168.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -87.7 139.98 29.98 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.03 0.932 . . . . 0.0 110.194 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 tt -119.86 98.33 6.05 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -99.47 94.51 6.45 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 -172.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 78.94 -112.7 3.51 Favored Glycine 0 N--CA 1.483 1.789 0 CA-C-O 119.879 -0.4 . . . . 0.0 112.118 -176.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -123.77 59.3 1.13 Allowed 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 121.397 0.618 . . . . 0.0 111.134 169.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.73 -154.09 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.736 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 164.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.5 tt -160.23 117.01 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 157.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 41.5 m -98.41 95.89 7.64 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 176.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -94.6 106.84 18.83 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.6 m -105.36 101.79 11.31 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -173.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 44.5 mtt -97.71 101.68 13.25 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 76.0 p -90.98 115.4 27.96 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . 0.265 24.3 tp -84.5 -104.36 0.05 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -177.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . -90.97 -94.94 1.26 Allowed Glycine 0 N--CA 1.48 1.596 0 N-CA-C 110.243 -1.143 . . . . 0.0 110.243 168.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -88.83 -8.09 54.98 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 164.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 42.2 mt -84.21 119.32 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 CA-C-N 119.808 1.186 . . . . 0.0 107.809 -173.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 60.1 t -102.73 97.41 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 106.28 -1.748 . . . . 0.0 106.28 177.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -76.61 135.49 39.18 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 166.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -145.6 101.52 3.58 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 177.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -95.05 129.24 42.22 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 123.2 0.6 . . . . 0.0 110.152 173.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 88.8 mt -110.88 112.54 41.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 104.083 -2.562 . . . . 0.0 104.083 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.0 m -131.88 118.01 19.26 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 -172.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 30.3 tttt -79.82 130.03 34.98 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -166.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 55.4 ttp85 -73.66 119.04 17.34 Favored 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 123.316 0.646 . . . . 0.0 111.141 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 33.0 pt . . . . . 0 N--CA 1.488 1.426 0 CA-C-O 123.013 1.387 . . . . 0.0 109.026 -170.131 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.8 t . . . . . 0 CA--C 1.55 0.976 0 CA-C-O 121.2 0.524 . . . . 0.0 109.872 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -68.28 -18.56 64.56 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 117.522 2.416 . . . . 0.0 117.522 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.8 m -69.21 120.29 14.81 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 121.222 1.828 . . . . 0.0 111.622 174.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 161.67 156.79 8.51 Favored Glycine 0 CA--C 1.54 1.653 0 CA-C-O 122.507 1.06 . . . . 0.0 113.898 178.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.6 mptt -79.93 140.94 36.49 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-N 113.979 -1.111 . . . . 0.0 108.934 162.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -135.51 105.97 6.43 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 -179.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -82.32 122.68 28.27 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 122.032 -0.417 . . . . 0.0 110.658 -176.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.8 tp -66.65 120.28 13.2 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 123.348 0.659 . . . . 0.0 112.114 -178.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -109.64 -63.53 1.36 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 118.556 -0.735 . . . . 0.0 110.499 -176.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.9 m -110.07 107.96 18.0 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 -178.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -100.11 121.34 41.26 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 122.189 0.995 . . . . 0.0 108.485 170.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -85.75 -64.6 1.13 Allowed 'General case' 0 N--CA 1.488 1.43 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.115 -169.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -115.67 67.06 0.7 Allowed 'General case' 0 N--CA 1.488 1.428 0 CA-C-N 118.379 0.536 . . . . 0.0 110.73 175.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -72.02 -51.7 20.52 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 166.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -63.67 -48.78 75.79 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 114.734 1.383 . . . . 0.0 114.734 -176.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.34 -40.01 92.67 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 116.498 2.036 . . . . 0.0 116.498 171.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 60.1 t80 -66.54 -51.9 51.49 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 177.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -53.9 -47.94 70.64 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 174.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -57.22 -41.29 79.2 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 169.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -69.76 -33.21 72.1 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 117.056 2.243 . . . . 0.0 117.056 175.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.3 pt -76.74 -41.85 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 CA-C-N 120.129 1.331 . . . . 0.0 113.481 172.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 126.58 62.05 0.15 Allowed Glycine 0 CA--C 1.542 1.765 0 C-N-CA 124.205 0.907 . . . . 0.0 112.674 175.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.17 150.39 51.26 Favored Pre-proline 0 CA--C 1.568 1.669 0 C-N-CA 124.026 0.93 . . . . 0.0 110.764 -176.264 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.53 148.47 37.6 Favored 'Trans proline' 0 C--N 1.368 1.573 0 C-N-CA 123.205 2.604 . . . . 0.0 113.84 179.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -61.86 -26.05 67.9 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 116.205 1.928 . . . . 0.0 116.205 173.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -61.28 -50.14 74.23 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 114.48 1.289 . . . . 0.0 114.48 166.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 93.3 mt -70.99 -16.88 62.65 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 116.916 2.191 . . . . 0.0 116.916 171.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 84.8 mt -73.82 -54.06 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 CA-C-N 120.152 1.342 . . . . 0.0 110.584 169.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 90.2 mm-40 -66.79 -27.96 68.0 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 116.353 1.982 . . . . 0.0 116.353 176.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -73.86 -60.92 2.03 Favored 'General case' 0 CA--C 1.561 1.402 0 CA-C-N 119.463 1.028 . . . . 0.0 111.097 166.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.94 -15.32 57.97 Favored Glycine 0 CA--C 1.553 2.415 0 N-CA-C 120.53 2.972 . . . . 0.0 120.53 -179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -66.99 -47.31 71.91 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 119.985 1.892 . . . . 0.0 113.862 169.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -72.78 -35.65 67.45 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 171.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 37.8 mt -73.5 121.33 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 N-CA-C 108.021 -1.104 . . . . 0.0 108.021 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -89.77 119.12 29.89 Favored 'General case' 0 CA--C 1.557 1.225 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 178.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.52 135.3 12.72 Favored Glycine 0 CA--C 1.542 1.76 0 CA-C-N 116.714 -0.221 . . . . 0.0 113.593 -177.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.7 t -86.35 116.23 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.1 p -94.35 102.63 14.62 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 121.477 0.656 . . . . 0.0 109.262 174.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -91.02 142.33 27.88 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.829 176.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 65.1 mt -139.1 128.9 31.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 105.302 -2.11 . . . . 0.0 105.302 176.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 93.3 t -117.39 103.98 15.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 -178.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.5 tp-100 -85.06 131.68 34.42 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.302 0.641 . . . . 0.0 110.771 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -135.99 72.63 1.44 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 168.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.81 -105.15 1.82 Allowed Glycine 0 CA--C 1.544 1.902 0 O-C-N 121.886 -0.509 . . . . 0.0 113.571 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . 0.253 0.0 OUTLIER -97.54 -15.56 20.48 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.932 1.827 . . . . 0.0 115.932 166.123 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -77.71 149.99 34.52 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 119.772 1.169 . . . . 0.0 111.412 171.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 25.7 m-85 -146.23 142.66 28.6 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.754 0.822 . . . . 0.0 110.1 -174.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.5 ttmm -136.33 113.44 10.54 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 165.79 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 12.0 p90 -91.82 148.19 22.42 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.502 169.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 31.5 m -133.9 91.85 2.88 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 173.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.1 mm -91.92 110.62 22.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.9 p -100.03 97.23 8.1 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -176.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -96.83 84.3 3.57 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-O 121.293 0.568 . . . . 0.0 109.806 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.73 -109.99 2.97 Favored Glycine 0 CA--C 1.541 1.683 0 CA-C-N 115.814 -0.63 . . . . 0.0 113.348 -176.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 96.0 p -82.88 -44.87 14.92 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 175.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -72.82 133.04 44.3 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 119.528 1.058 . . . . 0.0 111.679 -176.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 85.2 t -103.62 111.69 34.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 177.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.3 mp -100.64 92.8 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 N-CA-C 105.766 -1.938 . . . . 0.0 105.766 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -110.72 117.69 34.14 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 57.3 m-80 -147.74 133.61 19.07 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -108.16 145.64 33.88 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-O 122.193 0.997 . . . . 0.0 111.7 -175.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -133.26 167.14 20.92 Favored 'General case' 0 N--CA 1.488 1.441 0 CA-C-N 114.437 -1.256 . . . . 0.0 111.631 174.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.0 m -129.56 132.22 46.76 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 106.711 -1.589 . . . . 0.0 106.711 169.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 77.3 t -71.41 127.47 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 C-N-CA 123.467 0.707 . . . . 0.0 109.508 -177.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 100.73 -55.66 0.8 Allowed Glycine 0 CA--C 1.545 1.949 0 CA-C-N 115.606 -0.725 . . . . 0.0 113.891 -166.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -81.15 147.16 30.17 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.715 0.769 . . . . 0.0 112.219 -177.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -84.08 116.05 22.68 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.087 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 73.7 m -130.31 150.21 51.64 Favored 'General case' 0 N--CA 1.489 1.486 0 CA-C-O 121.773 0.797 . . . . 0.0 111.987 -174.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.97 128.13 35.58 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 123.839 0.856 . . . . 0.0 113.055 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 94.2 mt -141.01 126.32 18.6 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -96.45 143.02 27.86 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.854 0.835 . . . . 0.0 110.831 178.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 25.0 m -73.68 175.24 7.34 Favored 'General case' 0 CA--C 1.578 2.051 0 C-N-CA 124.194 0.998 . . . . 0.0 110.846 173.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 61.0 mtt -52.22 -51.7 56.74 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 116.303 1.964 . . . . 0.0 116.303 -174.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 60.9 p -135.17 98.81 4.08 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 165.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -175.23 -130.35 1.3 Allowed Glycine 0 CA--C 1.541 1.689 0 N-CA-C 113.779 0.272 . . . . 0.0 113.779 -179.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -137.87 155.0 49.42 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.019 0.928 . . . . 0.0 109.884 -169.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -65.94 108.89 2.33 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 123.501 0.72 . . . . 0.0 111.14 177.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.0 m -80.87 -38.79 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 177.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . 0.286 37.5 ttmt 74.0 106.06 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 C-N-CA 124.909 1.284 . . . . 0.0 111.113 -177.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.3 t -145.06 152.03 39.46 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.844 0.831 . . . . 0.0 110.4 -172.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.4 t -98.5 127.89 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 -176.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 14.6 t -104.91 129.79 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -178.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.7 mp0 -110.91 134.58 52.44 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 172.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.1 tp -95.84 104.39 16.32 Favored 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 174.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -98.96 121.0 40.35 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 122.135 0.969 . . . . 0.0 108.914 -179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.14 9.68 72.38 Favored Glycine 0 CA--C 1.55 2.269 0 N-CA-C 120.563 2.985 . . . . 0.0 120.563 178.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . 0.305 2.3 t70 64.61 16.5 10.36 Favored 'General case' 0 CA--C 1.577 2.007 0 N-CA-C 116.661 2.097 . . . . 0.0 116.661 -165.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -157.39 44.84 0.36 Allowed 'General case' 0 CA--C 1.568 1.655 0 O-C-N 121.018 -1.051 . . . . 0.0 113.401 175.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -160.28 112.69 2.03 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 106.669 -1.604 . . . . 0.0 106.669 173.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 38.8 mt -98.74 98.24 9.38 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 173.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 48.8 t -98.27 113.84 34.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -167.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 13.7 t -153.51 134.82 14.17 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -176.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 35.9 m -103.31 112.51 25.42 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 177.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -74.84 -84.45 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.061 0.544 . . . . 0.0 110.984 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 62.3 tttm -93.73 -82.77 0.34 Allowed 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 169.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -127.59 62.69 1.38 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 152.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 69.0 mt -120.73 95.3 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 103.246 -2.872 . . . . 0.0 103.246 -177.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -84.28 90.97 7.64 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-O 122.138 0.97 . . . . 0.0 109.21 -174.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.0 t -95.83 117.52 30.72 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.112 -1.404 . . . . 0.0 109.185 -168.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 74.5 t -116.9 106.28 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 104.616 -2.364 . . . . 0.0 104.616 179.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 4.3 m -91.77 88.5 6.7 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 -175.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -96.37 119.88 35.65 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 123.232 0.613 . . . . 0.0 109.866 -166.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.3 tt -101.59 106.56 17.65 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -176.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -90.13 -87.39 0.18 Allowed 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 118.926 -0.559 . . . . 0.0 110.237 -170.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -101.67 -109.7 3.27 Favored Glycine 0 N--CA 1.483 1.783 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 178.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -106.05 64.06 0.67 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.95 0.881 . . . . 0.0 109.5 163.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 8.5 pt -144.19 -170.41 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.574 1.887 0 C-N-CA 125.184 1.394 . . . . 0.0 107.713 175.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.3 tt -152.11 125.02 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 120.326 -1.483 . . . . 0.0 108.866 156.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 81.7 m -103.69 99.65 9.45 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 -177.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -93.38 107.66 19.45 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 32.6 m -107.46 100.68 10.09 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 -170.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 40.7 mtt -101.88 100.79 11.15 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 123.903 0.881 . . . . 0.0 109.194 -176.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 73.8 p -94.63 104.47 16.41 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -175.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 49.4 tp -103.66 84.88 2.35 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 74.88 -102.71 1.46 Allowed Glycine 0 CA--C 1.545 1.94 0 CA-C-N 116.231 -0.441 . . . . 0.0 112.12 -171.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -103.92 -4.98 22.73 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 115.473 1.657 . . . . 0.0 115.473 169.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 80.6 mt -90.35 109.5 20.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-N 120.543 1.52 . . . . 0.0 107.048 -172.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 49.7 t -97.78 95.08 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 -173.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -84.42 96.39 9.07 Favored 'General case' 0 N--CA 1.488 1.46 0 C-N-CA 123.353 0.661 . . . . 0.0 109.419 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -101.33 109.07 20.85 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.549 -173.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 56.9 mtm180 -103.08 109.04 20.45 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 -178.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.0 mp -99.79 99.19 8.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 105.037 -2.208 . . . . 0.0 105.037 -179.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.4 m -110.73 115.76 30.13 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -177.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -79.08 146.01 33.48 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 122.933 0.493 . . . . 0.0 110.89 -174.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -79.39 139.58 37.69 Favored 'General case' 0 CA--C 1.559 1.319 0 CA-C-O 121.895 0.855 . . . . 0.0 112.142 -171.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 42.9 mm . . . . . 0 N--CA 1.486 1.372 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 -159.193 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.1 t . . . . . 0 CA--C 1.547 0.857 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 60.1 m-85 -135.9 -107.25 0.21 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -176.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.5 m 59.0 93.6 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 125.168 1.387 . . . . 0.0 113.897 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 171.13 150.35 7.0 Favored Glycine 0 CA--C 1.542 1.736 0 CA-C-O 121.916 0.731 . . . . 0.0 114.266 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -83.83 130.8 34.92 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 114.72 -0.74 . . . . 0.0 109.357 170.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -132.47 105.13 7.07 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 -173.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 34.0 tt0 -92.67 134.49 34.97 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 122.962 0.505 . . . . 0.0 111.554 -178.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.2 tp -73.44 114.24 11.44 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.344 0.658 . . . . 0.0 112.557 -170.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -95.86 -61.88 1.38 Allowed 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.88 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 34.2 t -117.42 114.21 23.19 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -177.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -98.3 138.8 35.03 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-O 123.091 1.424 . . . . 0.0 109.433 167.164 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -128.77 113.06 14.85 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.292 18.7 m-20 72.68 50.94 0.17 Allowed 'General case' 0 N--CA 1.499 2.017 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 -173.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -76.22 -64.23 1.15 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.383 -0.823 . . . . 0.0 112.101 174.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -64.03 -28.26 69.67 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 117.163 2.282 . . . . 0.0 117.163 174.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.8 -44.26 86.23 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 115.208 1.559 . . . . 0.0 115.208 168.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 59.8 t80 -67.28 -57.3 6.93 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 173.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 38.1 mtt -59.45 -45.78 90.62 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 -176.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -62.05 -39.09 91.18 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 169.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.96 -33.18 73.81 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 117.25 2.315 . . . . 0.0 117.25 172.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.255 20.9 pt -81.55 -53.77 11.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 CA-C-N 119.328 0.967 . . . . 0.0 112.31 176.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.1 61.23 0.01 OUTLIER Glycine 0 CA--C 1.542 1.78 0 CA-C-N 119.019 0.827 . . . . 0.0 113.416 172.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -109.12 153.42 42.59 Favored Pre-proline 0 CA--C 1.568 1.645 0 C-N-CA 123.648 0.779 . . . . 0.0 111.277 -179.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -74.86 155.2 43.61 Favored 'Trans proline' 0 CA--C 1.556 1.582 0 C-N-CA 123.168 2.579 . . . . 0.0 113.338 173.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -56.95 -34.59 68.19 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 115.52 1.674 . . . . 0.0 115.52 169.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -59.82 -54.26 48.34 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 172.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.9 mt -71.2 -26.2 62.85 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 116.84 2.163 . . . . 0.0 116.84 177.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 70.1 mt -69.39 -55.36 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-N 119.683 1.129 . . . . 0.0 110.627 171.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -70.05 -25.22 63.45 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 -179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -76.01 -57.67 3.74 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 119.753 1.161 . . . . 0.0 111.537 168.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.38 -15.96 62.07 Favored Glycine 0 CA--C 1.553 2.414 0 N-CA-C 119.869 2.708 . . . . 0.0 119.869 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -68.02 -44.68 75.98 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 120.145 1.972 . . . . 0.0 114.138 170.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -68.34 -40.82 81.43 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 168.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.1 mt -74.17 124.09 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 CA-C-N 119.484 1.038 . . . . 0.0 108.317 -178.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -84.26 107.51 16.6 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -88.1 128.77 9.22 Favored Glycine 0 CA--C 1.541 1.659 0 CA-C-N 116.359 -0.382 . . . . 0.0 113.771 -171.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.0 t -88.56 115.01 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 -177.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 62.7 m -96.87 106.21 18.48 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 170.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.54 150.05 23.97 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.794 179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 86.8 mt -132.96 134.92 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 170.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 43.7 t -132.29 96.19 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 104.008 -2.589 . . . . 0.0 104.008 169.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -84.1 124.08 30.74 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.239 0.615 . . . . 0.0 110.354 -176.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -118.21 74.62 0.96 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 171.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 67.66 -116.89 8.23 Favored Glycine 0 CA--C 1.546 2.004 0 C-N-CA 123.374 0.511 . . . . 0.0 113.488 -173.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 10.6 ptpp? -81.9 -33.19 30.59 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 169.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -73.41 116.64 14.22 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 119.825 1.193 . . . . 0.0 109.877 174.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -126.74 91.83 3.43 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -151.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -94.43 96.9 9.8 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.17 0.509 . . . . 0.0 110.193 -167.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 20.6 p90 -110.01 133.27 53.37 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.904 -176.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 88.8 m -116.13 99.09 6.99 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 -177.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 16.3 tt -89.31 118.21 34.16 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 C-N-CA 123.7 0.8 . . . . 0.0 109.437 -176.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 49.4 m -101.57 100.68 11.13 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 106.494 -1.669 . . . . 0.0 106.494 176.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -101.39 99.97 10.39 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.259 0.624 . . . . 0.0 109.355 -177.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.09 -114.47 4.19 Favored Glycine 0 CA--C 1.542 1.726 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.894 -173.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.2 m -120.57 69.0 0.86 Allowed 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 121.476 0.655 . . . . 0.0 109.897 169.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 57.5 tttp -161.22 122.55 2.88 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 177.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 89.8 t -99.89 124.58 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -177.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.9 mp -130.87 114.42 27.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 -177.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -91.12 124.83 35.64 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.673 0.749 . . . . 0.0 109.877 170.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -131.75 155.27 48.0 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 114.845 -1.07 . . . . 0.0 108.313 172.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -139.97 139.1 36.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.347 -0.846 . . . . 0.0 112.304 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -117.68 150.75 38.54 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 123.98 0.912 . . . . 0.0 111.23 173.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.2 m -98.51 128.42 44.84 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 166.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 86.7 t -74.72 128.96 36.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 C-N-CA 123.539 0.735 . . . . 0.0 109.762 -173.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 81.51 10.34 84.58 Favored Glycine 0 CA--C 1.554 2.512 0 N-CA-C 118.716 2.246 . . . . 0.0 118.716 -170.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -137.67 153.35 49.83 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 119.087 1.443 . . . . 0.0 109.29 -176.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -69.63 115.3 8.72 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.312 0.577 . . . . 0.0 111.143 177.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 10.7 p -122.04 135.81 54.86 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 114.73 -1.123 . . . . 0.0 110.642 -175.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -87.03 106.92 18.18 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-N 113.937 -1.483 . . . . 0.0 110.215 -175.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 97.3 mt -124.37 126.75 46.49 Favored 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 123.42 0.688 . . . . 0.0 110.11 -166.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -73.81 131.14 41.23 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.219 0.608 . . . . 0.0 111.037 179.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 7.3 p -85.23 -165.8 1.32 Allowed 'General case' 0 CA--C 1.575 1.906 0 C-N-CA 123.069 0.548 . . . . 0.0 111.025 -176.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 56.7 mtt -61.64 -50.13 73.77 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 171.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 61.5 p -70.87 -67.9 0.47 Allowed 'General case' 0 N--CA 1.494 1.743 0 CA-C-N 119.104 0.865 . . . . 0.0 111.494 168.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -179.87 -145.65 6.51 Favored Glycine 0 CA--C 1.542 1.759 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 67.0 112.59 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 124.862 1.265 . . . . 0.0 112.757 173.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -86.26 97.66 10.51 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -178.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 18.9 m -96.73 130.67 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 C-N-CA 123.516 0.726 . . . . 0.0 110.094 -171.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -75.6 114.99 14.81 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 123.177 0.591 . . . . 0.0 110.895 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.5 t -146.2 140.33 26.51 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.717 0.807 . . . . 0.0 109.421 -173.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 97.4 t -87.11 117.1 30.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 -178.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 21.5 t -101.43 100.62 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 178.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -100.21 141.09 33.51 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 122.185 0.993 . . . . 0.0 110.423 -178.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 52.6 tp -95.92 104.89 16.86 Favored 'General case' 0 CA--C 1.551 1.004 0 CA-C-N 114.155 -1.384 . . . . 0.0 108.313 178.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -96.23 113.16 24.73 Favored 'General case' 0 N--CA 1.48 1.067 0 CA-C-O 122.259 1.028 . . . . 0.0 108.641 179.252 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.44 -129.81 9.87 Favored Glycine 0 CA--C 1.546 1.98 0 CA-C-N 113.683 -1.599 . . . . 0.0 111.975 -165.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -135.19 51.69 2.07 Favored 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 120.863 0.363 . . . . 0.0 110.216 160.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -158.16 -20.76 0.08 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 116.152 1.908 . . . . 0.0 116.152 -177.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -118.32 113.34 21.29 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 121.963 2.165 . . . . 0.0 109.851 -174.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 15.6 mt -97.86 104.79 16.85 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 175.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 66.8 t -105.48 113.73 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 -167.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.8 t -146.05 133.99 21.36 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 122.895 0.478 . . . . 0.0 110.592 -174.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 53.4 m -106.46 107.35 18.32 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -84.31 76.7 10.09 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 123.175 0.59 . . . . 0.0 109.786 177.332 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . 0.341 38.4 ttmt 69.53 -75.96 0.07 Allowed 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 124.56 1.144 . . . . 0.0 112.659 -167.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -115.47 -23.47 8.81 Favored 'General case' 0 CA--C 1.567 1.628 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 174.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.2 mt -79.0 106.61 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 CA-C-N 120.592 1.542 . . . . 0.0 108.657 -171.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.5 tttp -82.52 96.01 7.9 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-O 121.802 0.81 . . . . 0.0 109.694 176.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 31.4 m -93.09 116.75 29.33 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.307 1.043 . . . . 0.0 109.707 -176.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.1 t -118.39 102.75 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 N-CA-C 104.786 -2.301 . . . . 0.0 104.786 -178.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.2 m -92.01 92.16 8.17 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -174.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -83.16 140.49 32.56 Favored 'General case' 0 N--CA 1.485 1.321 0 C-N-CA 123.65 0.78 . . . . 0.0 110.43 -175.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.67 107.47 13.73 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 172.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -88.81 -98.74 0.09 Allowed 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 118.432 -0.794 . . . . 0.0 109.128 -176.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -92.31 -103.79 1.49 Allowed Glycine 0 N--CA 1.485 1.924 0 CA-C-N 119.466 1.03 . . . . 0.0 111.394 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -111.03 59.61 0.61 Allowed 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.825 0.821 . . . . 0.0 109.798 164.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 3.7 pt -139.4 -163.62 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.809 0 C-N-CA 124.903 1.281 . . . . 0.0 108.048 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.6 tt -157.29 116.36 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 120.362 -1.461 . . . . 0.0 107.336 165.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 60.4 m -100.03 87.49 3.5 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -177.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -88.06 106.82 18.41 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 109.416 -0.586 . . . . 0.0 109.416 -176.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 19.1 m -108.08 97.78 7.43 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 -167.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 82.1 mtp -99.6 94.57 6.45 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -172.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 59.2 p -97.65 112.2 24.17 Favored 'General case' 0 N--CA 1.486 1.346 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.668 -167.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 57.1 tp -112.49 86.18 2.31 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 174.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 76.45 -103.97 1.8 Allowed Glycine 0 CA--C 1.544 1.876 0 C-N-CA 122.848 0.261 . . . . 0.0 113.657 175.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -86.29 -24.28 25.99 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 169.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 24.7 mm -67.59 137.36 24.84 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.597 0 C-N-CA 124.945 1.298 . . . . 0.0 109.725 176.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 95.7 t -131.22 93.98 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 172.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -89.2 95.06 10.15 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 120.96 0.409 . . . . 0.0 110.704 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -97.29 108.44 21.16 Favored 'General case' 0 N--CA 1.484 1.263 0 CA-C-O 121.356 0.598 . . . . 0.0 109.567 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 88.0 mtt180 -94.01 120.04 33.72 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 123.969 0.908 . . . . 0.0 108.615 171.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.1 mp -105.64 99.28 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 175.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.4 m -114.49 115.44 27.26 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -175.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 53.0 tttm -88.51 140.54 29.35 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-O 121.279 0.561 . . . . 0.0 111.709 -170.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 29.8 ttm-85 -64.21 119.69 10.72 Favored 'General case' 0 CA--C 1.561 1.366 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.794 -176.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 17.7 pt . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 -178.002 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.4 m . . . . . 0 CA--C 1.549 0.907 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . 0.366 96.2 m-85 80.48 -13.05 0.97 Allowed 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 118.26 2.689 . . . . 0.0 118.26 172.285 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 72.1 m -75.37 114.42 13.88 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 121.157 1.799 . . . . 0.0 110.071 170.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.67 145.86 5.31 Favored Glycine 0 CA--C 1.542 1.755 0 CA-C-O 121.84 0.689 . . . . 0.0 112.831 -173.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.1 mptt -97.75 121.79 40.08 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 106.976 -1.49 . . . . 0.0 106.976 170.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 96.4 m-85 -117.29 103.11 9.83 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -166.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.8 tp60 -80.56 121.92 26.4 Favored 'General case' 0 N--CA 1.487 1.416 0 C-N-CA 123.749 0.82 . . . . 0.0 110.614 -177.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.7 tp -62.77 127.39 31.04 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 113.327 0.862 . . . . 0.0 113.327 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 12.4 mm100 -110.78 -66.38 1.08 Allowed 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.812 0.845 . . . . 0.0 109.606 -176.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 37.3 t -118.89 114.64 22.92 Favored 'General case' 0 N--CA 1.485 1.313 0 C-N-CA 123.827 0.851 . . . . 0.0 108.847 -179.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.7 tt0 -104.2 105.11 15.15 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -102.61 133.79 47.03 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 123.83 0.852 . . . . 0.0 109.074 -171.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . 0.252 22.2 m120 63.88 47.98 3.32 Favored 'General case' 0 N--CA 1.502 2.133 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -171.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 17.2 t80 -81.92 -46.17 14.43 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.827 -1.171 . . . . 0.0 113.956 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -63.29 -48.54 77.67 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 176.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.3 -40.62 96.89 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 116.566 2.061 . . . . 0.0 116.566 172.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 48.8 t80 -70.94 -52.74 18.07 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 118.005 -0.997 . . . . 0.0 113.647 -179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.51 -40.89 93.08 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 177.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -40.82 94.86 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.126 1.528 . . . . 0.0 115.126 167.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.57 -35.99 80.07 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 116.842 2.164 . . . . 0.0 116.842 174.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.259 36.0 pt -79.58 -48.26 21.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-N 119.829 1.195 . . . . 0.0 112.846 175.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 127.68 58.28 0.12 Allowed Glycine 0 CA--C 1.546 2.003 0 C-N-CA 124.128 0.871 . . . . 0.0 113.631 -178.065 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -121.07 152.5 56.81 Favored Pre-proline 0 CA--C 1.571 1.776 0 C-N-CA 124.37 1.068 . . . . 0.0 110.24 173.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.32 154.08 31.79 Favored 'Trans proline' 0 C--N 1.366 1.495 0 C-N-CA 123.104 2.536 . . . . 0.0 114.103 -173.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -60.88 -24.92 66.32 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 116.041 1.867 . . . . 0.0 116.041 168.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -57.5 -55.73 31.02 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 119.669 1.122 . . . . 0.0 113.5 164.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.1 mt -71.87 -16.42 62.14 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 117.183 2.29 . . . . 0.0 117.183 175.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.0 mt -73.54 -56.85 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 CA-C-N 120.165 1.348 . . . . 0.0 110.165 167.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -70.31 -27.56 64.48 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 116.477 2.028 . . . . 0.0 116.477 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -81.99 -50.72 8.81 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 119.155 0.889 . . . . 0.0 112.447 170.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -71.18 -7.18 62.54 Favored Glycine 0 CA--C 1.554 2.517 0 N-CA-C 119.932 2.733 . . . . 0.0 119.932 177.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -69.12 -45.19 70.79 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 120.137 1.968 . . . . 0.0 114.087 170.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -68.23 -36.06 78.89 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 169.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 42.8 mt -75.28 120.52 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-N 119.542 1.065 . . . . 0.0 108.232 179.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -88.75 114.83 25.79 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 176.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.1 133.25 11.38 Favored Glycine 0 CA--C 1.542 1.742 0 CA-C-N 116.473 -0.33 . . . . 0.0 113.291 -177.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 44.7 t -81.91 122.3 36.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 67.0 m -96.0 105.34 17.35 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 170.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -87.78 144.78 26.43 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 121.582 0.706 . . . . 0.0 109.989 177.221 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 40.3 mt -146.68 129.24 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 179.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.1 t -125.94 115.31 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 -178.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -79.2 131.5 36.22 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 123.205 0.602 . . . . 0.0 111.048 172.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.8 m120 -135.55 64.92 1.56 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 172.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.38 -104.67 1.88 Allowed Glycine 0 CA--C 1.546 1.997 0 O-C-N 121.211 -0.931 . . . . 0.0 113.401 -177.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -89.35 -39.44 13.43 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 161.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -62.47 152.55 34.16 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 124.656 1.182 . . . . 0.0 113.806 178.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -139.49 150.61 45.36 Favored 'General case' 0 N--CA 1.488 1.434 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.905 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.3 ttpp -134.32 109.54 8.88 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 106.48 -1.674 . . . . 0.0 106.48 164.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -117.49 131.64 56.69 Favored 'General case' 0 N--CA 1.486 1.374 0 CA-C-N 115.297 -0.865 . . . . 0.0 109.475 -178.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 13.2 m -123.69 97.71 5.5 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 -172.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.4 mm -88.06 113.44 25.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 76.6 p -102.92 86.11 2.66 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -103.74 94.67 5.56 Favored 'General case' 0 N--CA 1.485 1.296 0 C-N-CA 123.125 0.57 . . . . 0.0 110.047 -174.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.13 -108.89 2.63 Favored Glycine 0 CA--C 1.543 1.816 0 CA-C-N 116.15 -0.477 . . . . 0.0 113.165 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 94.5 p -87.74 -46.72 9.22 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 171.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -80.53 134.45 35.94 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 119.146 0.885 . . . . 0.0 112.216 -171.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 95.0 t -104.73 112.77 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 N-CA-C 105.915 -1.883 . . . . 0.0 105.915 177.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 67.1 mt -106.75 98.99 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 105.45 -2.056 . . . . 0.0 105.45 -176.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -115.85 118.04 31.88 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -175.061 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 56.6 m-80 -136.5 171.99 13.68 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 122.0 0.905 . . . . 0.0 110.1 178.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -136.05 137.27 40.96 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.484 -0.76 . . . . 0.0 110.079 -174.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -133.64 134.89 43.76 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.551 0.691 . . . . 0.0 112.274 176.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 50.3 m -92.11 127.89 37.75 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 163.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 74.0 t -74.31 124.52 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -177.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.28 -53.67 0.59 Allowed Glycine 0 CA--C 1.548 2.109 0 CA-C-N 115.237 -0.892 . . . . 0.0 114.124 -165.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -81.87 155.98 25.05 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 123.793 0.837 . . . . 0.0 112.809 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -76.38 111.79 12.2 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 123.079 0.552 . . . . 0.0 110.62 169.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 61.6 m -108.7 143.07 38.29 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 123.605 0.762 . . . . 0.0 111.421 -167.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -81.62 98.16 8.22 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.345 -176.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.2 mt -128.41 123.23 33.25 Favored 'General case' 0 N--CA 1.489 1.496 0 C-N-CA 123.295 0.638 . . . . 0.0 109.906 -167.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -92.46 130.12 38.21 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 123.604 0.762 . . . . 0.0 111.311 -175.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 30.8 m -83.76 167.06 17.49 Favored 'General case' 0 CA--C 1.57 1.732 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.965 174.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 80.4 mtp -56.95 -50.48 72.51 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.4 m -80.38 -44.48 19.33 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-O 118.349 -0.834 . . . . 0.0 112.605 162.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -66.54 -175.24 6.52 Favored Glycine 0 CA--C 1.545 1.927 0 N-CA-C 118.172 2.029 . . . . 0.0 118.172 -166.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -123.0 19.42 10.04 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 117.354 2.354 . . . . 0.0 117.354 -157.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . 0.301 31.8 ttmt 82.63 100.77 0.05 Allowed 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 125.23 1.412 . . . . 0.0 110.109 178.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 16.7 m -125.87 142.93 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 C-N-CA 124.188 0.995 . . . . 0.0 109.472 -168.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.75 108.97 14.86 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 13.1 t -140.27 133.4 29.54 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.441 0.696 . . . . 0.0 109.642 -168.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 64.3 t -84.85 120.03 34.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 -175.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.6 t -97.94 111.9 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 106.159 -1.793 . . . . 0.0 106.159 172.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -112.46 145.16 40.69 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.93 0.872 . . . . 0.0 110.853 -179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 54.2 tp -96.44 105.31 17.37 Favored 'General case' 0 CA--C 1.552 1.053 0 CA-C-N 114.796 -1.093 . . . . 0.0 108.67 178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -90.92 120.13 31.68 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 170.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.4 -124.16 8.71 Favored Glycine 0 CA--C 1.544 1.876 0 CA-C-N 114.327 -1.306 . . . . 0.0 113.276 -174.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -122.75 -14.64 7.66 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 171.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 10.9 p-10 -132.87 27.77 4.25 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 -172.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -138.15 103.14 4.86 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 121.446 1.93 . . . . 0.0 108.508 -179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 57.4 mt -96.79 106.05 18.28 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 173.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 87.4 t -106.62 122.96 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -165.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.4 t -150.56 127.61 11.17 Favored 'General case' 0 N--CA 1.495 1.789 0 C-N-CA 122.589 0.356 . . . . 0.0 111.047 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 10.8 t -104.24 122.89 46.33 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 123.215 0.606 . . . . 0.0 109.848 175.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -80.76 -79.7 0.15 Allowed 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 123.28 0.632 . . . . 0.0 110.189 -173.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -98.08 -78.88 0.48 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 163.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -130.86 61.47 1.63 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 156.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.9 mp -123.49 91.91 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 103.367 -2.827 . . . . 0.0 103.367 178.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -87.66 92.06 8.97 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 121.142 0.496 . . . . 0.0 110.303 -172.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.3 t -83.99 103.7 13.46 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 124.156 0.982 . . . . 0.0 110.49 -175.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 88.1 t -103.34 103.86 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 104.864 -2.273 . . . . 0.0 104.864 -177.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.4 HG22 HD11 ' A' ' 109' ' ' ILE . 18.8 m -93.48 92.69 7.73 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -166.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -94.45 109.4 21.27 Favored 'General case' 0 N--CA 1.483 1.187 0 C-N-CA 123.153 0.581 . . . . 0.0 110.498 -166.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.71 98.13 10.24 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-N 118.726 0.694 . . . . 0.0 109.504 179.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -83.34 -74.58 0.36 Allowed 'General case' 0 N--CA 1.491 1.575 0 C-N-CA 122.981 0.512 . . . . 0.0 111.606 -172.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -168.78 107.02 0.26 Allowed Glycine 0 N--CA 1.479 1.542 0 CA-C-O 121.796 0.665 . . . . 0.0 112.191 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . 0.275 23.8 m-20 48.71 32.53 3.63 Favored 'General case' 0 CA--C 1.57 1.712 0 N-CA-C 116.944 2.202 . . . . 0.0 116.944 -165.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 4.7 pt -142.15 -171.09 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.815 0 C-N-CA 124.806 1.242 . . . . 0.0 108.604 175.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.4 HD11 HG22 ' A' ' 102' ' ' THR . 7.5 tt -154.39 124.16 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 120.4 -1.438 . . . . 0.0 107.902 160.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.5 m -102.02 88.75 3.42 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 178.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -87.65 105.45 17.36 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -176.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 25.6 m -109.07 99.05 8.41 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -165.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 59.3 mtt -92.51 102.34 14.79 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 123.72 0.808 . . . . 0.0 109.268 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 77.5 p -94.09 103.14 15.21 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -176.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 48.2 tp -101.26 83.81 2.53 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 174.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.88 -104.77 1.6 Allowed Glycine 0 CA--C 1.544 1.882 0 CA-C-N 116.375 -0.375 . . . . 0.0 113.181 -176.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -97.15 -12.35 23.2 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.244 1.572 . . . . 0.0 115.244 169.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 51.6 mt -84.55 112.39 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 -175.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 55.8 t -103.29 90.71 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 -174.338 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -83.6 94.12 8.01 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.428 0.691 . . . . 0.0 110.483 -177.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -106.6 108.14 19.5 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 115.1 -0.954 . . . . 0.0 109.075 -169.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 72.7 mtm180 -96.53 110.72 23.06 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.029 -1.101 . . . . 0.0 108.029 179.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 63.2 mt -103.45 102.55 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 104.344 -2.465 . . . . 0.0 104.344 -173.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 51.7 m -127.79 116.67 20.55 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -163.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 16.5 mttm -77.8 138.28 38.89 Favored 'General case' 0 N--CA 1.487 1.399 0 C-N-CA 123.55 0.74 . . . . 0.0 112.431 -171.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 70.9 ttt-85 -75.25 116.5 16.04 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.821 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 16.7 pt . . . . . 0 N--CA 1.486 1.336 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 -174.858 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.9 t . . . . . 0 CA--C 1.549 0.906 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -71.01 -12.67 61.66 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 117.619 2.452 . . . . 0.0 117.619 178.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.0 m -76.59 114.34 15.22 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 121.066 1.757 . . . . 0.0 111.116 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 167.98 169.23 31.21 Favored Glycine 0 CA--C 1.545 1.926 0 CA-C-O 122.821 1.234 . . . . 0.0 114.368 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -92.01 123.01 35.05 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 113.739 -1.23 . . . . 0.0 108.337 170.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -116.11 97.55 6.13 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -175.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 4.7 tm0? -91.86 125.53 36.6 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 122.987 0.515 . . . . 0.0 110.36 -170.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 38.6 tp -65.37 114.74 5.01 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -169.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 10.5 mm100 -93.54 -65.78 0.97 Allowed 'General case' 0 N--CA 1.487 1.388 0 CA-C-N 114.713 -1.13 . . . . 0.0 110.219 -176.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 74.6 m -121.55 117.09 25.92 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -177.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -104.06 130.44 51.75 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 124.234 1.013 . . . . 0.0 109.128 176.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -91.63 -69.12 0.75 Allowed 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.859 -1.064 . . . . 0.0 110.357 -177.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.9 m-20 -115.38 69.93 0.74 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.25 0.62 . . . . 0.0 110.522 178.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -75.94 -60.88 2.13 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 123.522 0.729 . . . . 0.0 111.561 171.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -67.12 -31.65 72.24 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 117.229 2.307 . . . . 0.0 117.229 176.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.55 -44.5 78.14 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 169.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -67.49 -56.68 8.58 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 176.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 51.2 mtt -59.17 -48.45 81.58 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 -177.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 14.1 tmtt? -57.42 -44.58 84.76 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 170.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.18 -29.63 70.73 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 117.338 2.347 . . . . 0.0 117.338 176.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 47.0 pt -81.24 -49.33 18.13 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 CA-C-N 119.549 1.068 . . . . 0.0 112.503 173.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 140.77 67.27 0.03 OUTLIER Glycine 0 CA--C 1.541 1.666 0 CA-C-N 118.79 0.723 . . . . 0.0 112.471 173.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -113.73 152.32 45.42 Favored Pre-proline 0 CA--C 1.568 1.651 0 C-N-CA 123.967 0.907 . . . . 0.0 110.714 178.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -73.14 155.04 52.32 Favored 'Trans proline' 0 CA--C 1.557 1.652 0 C-N-CA 123.199 2.599 . . . . 0.0 113.394 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -57.08 -33.22 67.06 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 115.331 1.604 . . . . 0.0 115.331 169.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -60.72 -55.57 31.64 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 117.227 -1.368 . . . . 0.0 113.961 170.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 92.5 mt -69.99 -21.81 63.19 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 117.339 2.348 . . . . 0.0 117.339 178.148 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 52.2 mt -76.1 -55.3 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 CA-C-N 119.846 1.203 . . . . 0.0 110.509 171.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 52.3 mm-40 -76.21 -29.06 57.47 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 115.968 1.84 . . . . 0.0 115.968 -176.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -79.88 -45.7 18.16 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 118.832 0.742 . . . . 0.0 112.181 168.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -60.63 -28.01 67.17 Favored Glycine 0 CA--C 1.547 2.033 0 N-CA-C 119.678 2.631 . . . . 0.0 119.678 174.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.5 pttm -62.79 -41.01 99.08 Favored 'General case' 0 CA--C 1.568 1.66 0 CA-C-N 119.537 1.668 . . . . 0.0 114.965 170.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -68.77 -37.3 79.23 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 115.335 1.606 . . . . 0.0 115.335 167.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.3 mt -68.22 139.43 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-N 119.651 1.114 . . . . 0.0 110.077 -179.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -72.5 108.88 5.8 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.206 174.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -91.62 101.62 2.82 Favored Glycine 0 N--CA 1.479 1.526 0 CA-C-N 116.059 -0.518 . . . . 0.0 112.228 -174.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 61.2 t -85.95 107.32 16.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -176.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.0 m -99.43 95.11 6.8 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 114.269 -1.332 . . . . 0.0 107.517 179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -80.56 148.73 30.23 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 121.88 0.848 . . . . 0.0 111.092 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 71.7 mt -140.56 122.41 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 N-CA-C 103.791 -2.67 . . . . 0.0 103.791 173.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 79.0 t -118.45 100.53 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 N-CA-C 105.537 -2.023 . . . . 0.0 105.537 -178.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -83.43 126.74 33.07 Favored 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 123.161 0.584 . . . . 0.0 110.625 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -123.8 77.59 1.54 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 167.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.59 -119.0 6.36 Favored Glycine 0 CA--C 1.546 1.995 0 C-N-CA 123.092 0.377 . . . . 0.0 113.154 -173.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -76.6 -16.81 59.48 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 167.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 11.3 t-80 -78.94 148.4 32.66 Favored 'General case' 0 CA--C 1.557 1.218 0 CA-C-N 119.335 0.971 . . . . 0.0 111.577 176.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 79.6 m-85 -142.5 109.39 5.48 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -101.36 95.7 6.68 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 173.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 25.0 p90 -94.65 129.56 41.47 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.846 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.9 m -113.74 92.46 3.99 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 8.3 tp -85.06 120.91 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 C-N-CA 123.804 0.841 . . . . 0.0 110.09 -175.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 56.8 m -100.69 98.78 9.29 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 171.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -101.43 80.4 2.07 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-O 121.465 0.65 . . . . 0.0 110.125 178.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 66.18 76.15 0.37 Allowed Glycine 0 CA--C 1.541 1.672 0 CA-C-O 119.076 -0.847 . . . . 0.0 115.149 -178.181 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . 0.308 7.6 t 79.46 -53.68 0.42 Allowed 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 -174.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -79.82 121.71 25.72 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 119.079 0.854 . . . . 0.0 111.593 -166.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 55.3 t -99.91 120.11 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 -170.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.0 mm -127.1 117.22 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 -174.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -92.08 126.77 37.3 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.451 0.643 . . . . 0.0 110.139 173.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -138.81 131.9 29.74 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -178.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -126.66 150.06 49.18 Favored 'General case' 0 N--CA 1.488 1.435 0 CA-C-O 122.077 0.941 . . . . 0.0 112.56 -171.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -147.15 155.27 41.99 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 114.756 -1.111 . . . . 0.0 112.334 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 22.1 m -107.37 137.73 44.88 Favored 'General case' 0 CA--C 1.565 1.533 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 166.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 41.7 t -75.08 126.1 35.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 170.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.91 -54.23 0.56 Allowed Glycine 0 CA--C 1.547 2.057 0 CA-C-N 115.659 -0.701 . . . . 0.0 114.353 -167.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -88.62 154.52 20.25 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.599 0.76 . . . . 0.0 112.418 -173.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -77.5 106.63 9.4 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.151 0.501 . . . . 0.0 109.927 164.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 68.7 m -110.03 140.68 43.81 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-O 121.756 0.789 . . . . 0.0 111.07 -169.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.44 125.16 30.1 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.109 -0.95 . . . . 0.0 111.484 -177.526 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 mp -134.7 160.49 37.98 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 122.105 0.955 . . . . 0.0 109.796 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.72 125.54 31.99 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.611 -0.681 . . . . 0.0 109.683 166.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 m -74.53 149.52 40.19 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 122.976 0.511 . . . . 0.0 109.753 173.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 91.6 mtp -54.93 -43.22 73.17 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 115.726 1.751 . . . . 0.0 115.726 178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 34.5 m -115.06 110.55 19.74 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 105.184 -2.154 . . . . 0.0 105.184 151.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . 143.76 -155.62 26.24 Favored Glycine 0 CA--C 1.543 1.796 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.872 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -148.93 -35.71 0.19 Allowed 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 -169.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.61 137.64 51.79 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 124.15 0.98 . . . . 0.0 109.262 -174.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 70.3 t -117.86 -77.97 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt 61.29 90.49 0.07 Allowed 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 124.355 1.062 . . . . 0.0 112.04 -164.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.2 t -143.39 145.12 32.39 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.543 0.687 . . . . 0.0 110.58 -175.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 55.1 t -98.17 125.06 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -178.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 8.1 t -107.38 136.22 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -178.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.7 mp0 -119.18 137.88 53.32 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 123.495 0.718 . . . . 0.0 109.082 172.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 60.1 tp -104.55 119.48 39.08 Favored 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 123.981 0.912 . . . . 0.0 108.976 177.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -97.88 122.86 41.5 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 167.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 72.02 -125.73 11.3 Favored Glycine 0 CA--C 1.544 1.904 0 CA-C-N 114.664 -1.153 . . . . 0.0 113.478 -179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -137.96 63.06 1.55 Allowed 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 155.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -152.72 -44.39 0.1 Allowed 'General case' 0 N--CA 1.485 1.293 0 CA-C-O 117.204 -1.379 . . . . 0.0 114.067 -178.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -108.33 111.3 23.16 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 120.536 1.516 . . . . 0.0 111.461 -168.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 24.2 mt -106.72 109.07 20.88 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 174.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 71.2 t -105.52 121.51 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -174.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.7 t -156.45 135.43 11.91 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 45.8 m -103.11 113.79 27.55 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -75.9 -83.51 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.225 0.61 . . . . 0.0 111.226 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt -133.4 81.83 1.95 Allowed 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.335 -1.728 . . . . 0.0 106.335 173.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . 0.257 33.4 t30 49.85 44.87 25.21 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 115.691 1.738 . . . . 0.0 115.691 -163.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 55.7 mt -137.13 95.1 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 103.092 -2.929 . . . . 0.0 103.092 -177.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 4.1 ttmp? -85.43 98.31 10.51 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-O 121.398 0.618 . . . . 0.0 109.691 -178.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 19.2 t -82.77 102.81 11.81 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.209 1.004 . . . . 0.0 109.542 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 79.8 t -103.24 92.19 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 104.67 -2.344 . . . . 0.0 104.67 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 52.3 m -96.37 97.09 9.19 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -166.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -106.88 124.26 49.36 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 124.364 1.066 . . . . 0.0 110.681 -165.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.9 107.17 17.91 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -177.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 -89.96 -103.23 0.09 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 118.24 -0.886 . . . . 0.0 109.271 -174.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -90.5 -106.41 1.3 Allowed Glycine 0 N--CA 1.485 1.937 0 CA-C-N 119.942 1.246 . . . . 0.0 111.803 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -102.72 56.87 0.77 Allowed 'General case' 0 N--CA 1.494 1.751 0 CA-C-O 121.097 0.475 . . . . 0.0 110.437 165.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 6.2 pt -142.5 -170.66 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.574 1.866 0 C-N-CA 124.557 1.143 . . . . 0.0 108.879 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 12.4 tt -148.73 125.13 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 120.526 -1.359 . . . . 0.0 107.885 155.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 55.9 m -93.15 96.27 9.92 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 174.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.81 101.6 13.22 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 -174.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 31.2 m -105.17 92.12 4.08 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -165.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 16.8 mtp -91.95 102.48 15.05 Favored 'General case' 0 N--CA 1.489 1.495 0 C-N-CA 123.487 0.715 . . . . 0.0 109.5 -177.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 60.7 p -97.18 104.05 16.04 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -171.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 39.2 tp -90.89 80.63 5.78 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 176.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 71.22 -97.67 0.68 Allowed Glycine 0 CA--C 1.546 1.993 0 O-C-N 122.297 -0.252 . . . . 0.0 113.046 -171.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -102.27 -12.37 18.02 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 171.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 95.1 mt -85.84 106.36 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 CA-C-N 120.854 1.661 . . . . 0.0 107.467 -175.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 96.8 t -94.91 98.73 8.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 -173.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -84.6 94.84 8.7 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 121.331 0.586 . . . . 0.0 109.554 176.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -96.14 109.36 21.81 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.787 -175.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 30.7 mtm180 -104.62 107.89 19.06 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 -177.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.0 mp -96.47 107.13 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 50.2 m -131.1 114.34 15.02 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -164.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.2 tppp? -75.33 131.4 40.25 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 123.595 0.758 . . . . 0.0 112.623 -168.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -74.34 117.6 16.33 Favored 'General case' 0 CA--C 1.558 1.264 0 C-N-CA 123.936 0.895 . . . . 0.0 110.643 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 31.9 pt . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 -168.601 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 93.8 p . . . . . 0 CA--C 1.549 0.937 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -86.17 -4.31 59.14 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 -175.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 74.5 m -74.41 104.61 5.21 Favored 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 121.605 2.002 . . . . 0.0 110.918 175.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.55 148.93 8.66 Favored Glycine 0 CA--C 1.542 1.765 0 CA-C-O 121.84 0.689 . . . . 0.0 113.201 -173.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.3 mptt -102.6 110.1 21.93 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -112.34 105.01 13.19 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -163.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -91.93 137.12 32.62 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.151 0.501 . . . . 0.0 111.322 -178.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.1 tp -72.48 117.62 14.37 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.553 0.741 . . . . 0.0 112.342 -169.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -100.39 -61.96 1.3 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.54 0.736 . . . . 0.0 110.992 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 69.3 m -119.61 148.86 42.84 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 123.79 0.836 . . . . 0.0 110.058 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -142.59 134.6 27.2 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-O 122.039 0.923 . . . . 0.0 109.95 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -87.88 -67.94 0.79 Allowed 'General case' 0 N--CA 1.485 1.299 0 CA-C-N 114.757 -1.11 . . . . 0.0 110.546 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 50.0 m-20 -120.93 68.9 0.88 Allowed 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 118.534 0.606 . . . . 0.0 110.711 -175.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -76.46 -54.38 6.8 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 123.377 0.671 . . . . 0.0 112.335 172.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -61.44 -49.22 77.69 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 178.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.39 -40.1 85.5 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 174.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 52.5 t80 -67.02 -52.9 36.66 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 175.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -58.94 -51.85 68.28 Favored 'General case' 0 CA--C 1.562 1.423 0 N-CA-C 114.803 1.409 . . . . 0.0 114.803 179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -58.02 -38.64 76.59 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 171.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.04 -29.81 69.71 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 116.909 2.189 . . . . 0.0 116.909 174.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . 0.271 46.4 pt -80.65 -54.34 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-N 119.868 1.213 . . . . 0.0 111.768 171.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.83 67.06 0.01 OUTLIER Glycine 0 CA--C 1.543 1.795 0 CA-C-N 119.264 0.938 . . . . 0.0 112.971 170.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.75 154.85 55.15 Favored Pre-proline 0 CA--C 1.57 1.744 0 C-N-CA 123.653 0.781 . . . . 0.0 111.839 -175.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -76.36 152.03 34.17 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 123.326 2.684 . . . . 0.0 113.844 176.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -56.72 -37.2 70.62 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 115.724 1.75 . . . . 0.0 115.724 171.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -64.01 -54.28 36.79 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 175.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 83.8 mt -67.0 -23.77 65.96 Favored 'General case' 0 N--CA 1.5 2.059 0 N-CA-C 116.716 2.117 . . . . 0.0 116.716 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 74.9 mt -68.72 -55.43 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 C-N-CA 124.176 0.99 . . . . 0.0 110.663 169.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -64.87 -25.64 67.98 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 116.893 2.183 . . . . 0.0 116.893 177.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 69.9 mmtt -74.8 -59.7 2.61 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-N 119.346 0.975 . . . . 0.0 111.681 168.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -67.48 -11.72 60.12 Favored Glycine 0 CA--C 1.553 2.417 0 N-CA-C 119.995 2.758 . . . . 0.0 119.995 179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -71.27 -46.18 61.49 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 120.272 2.036 . . . . 0.0 114.174 170.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -69.83 -35.66 74.95 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 170.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 32.2 mt -73.89 126.19 34.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 177.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.27 105.44 16.64 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 -178.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -85.53 129.57 9.38 Favored Glycine 0 CA--C 1.54 1.614 0 CA-C-N 116.338 -0.392 . . . . 0.0 113.3 -174.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.9 t -85.72 113.49 24.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.2 t -99.86 112.26 24.53 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 172.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -88.59 151.68 22.33 Favored 'General case' 0 CA--C 1.552 1.03 0 CA-C-N 114.614 -1.176 . . . . 0.0 110.309 175.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 38.2 mt -142.97 131.39 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 N-CA-C 104.126 -2.546 . . . . 0.0 104.126 166.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.3 t -114.98 109.3 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 -78.1 117.6 19.55 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 122.999 0.52 . . . . 0.0 110.908 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 76.7 m-20 -129.58 62.85 1.53 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.818 169.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.9 -108.69 2.57 Favored Glycine 0 CA--C 1.547 2.035 0 O-C-N 121.614 -0.679 . . . . 0.0 113.714 -177.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -74.18 -42.96 59.03 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 169.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -73.96 121.48 21.08 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-N 119.24 0.927 . . . . 0.0 111.236 -179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -122.27 97.11 5.32 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 -179.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -84.86 100.27 11.47 Favored 'General case' 0 N--CA 1.484 1.239 0 CA-C-O 121.676 0.751 . . . . 0.0 109.569 -179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 23.9 p90 -87.9 137.91 31.92 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.386 174.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.1 m -128.15 89.46 2.92 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 106.566 -1.642 . . . . 0.0 106.566 173.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 18.0 tt -91.66 119.53 39.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-O 121.37 0.605 . . . . 0.0 109.643 -176.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 81.3 p -103.59 103.25 13.17 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 -178.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -104.85 80.47 1.64 Allowed 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 121.534 0.683 . . . . 0.0 110.89 -174.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.29 60.58 8.33 Favored Glycine 0 CA--C 1.547 2.086 0 N-CA-C 115.865 1.106 . . . . 0.0 115.865 -175.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 41.0 m 54.76 60.36 3.55 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 114.595 1.331 . . . . 0.0 114.595 -166.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -152.31 97.83 2.33 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 30.8 t -92.12 104.44 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 -166.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.3 mm -110.31 104.24 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 105.628 -1.99 . . . . 0.0 105.628 -177.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -119.37 119.72 34.78 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -170.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 53.9 m-80 -144.96 148.03 33.35 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.531 0.733 . . . . 0.0 109.231 173.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -108.97 122.28 46.92 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.536 0.734 . . . . 0.0 110.724 175.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -101.9 134.32 45.29 Favored 'General case' 0 N--CA 1.487 1.397 0 CA-C-O 121.619 0.723 . . . . 0.0 111.38 176.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 31.1 m -97.97 131.18 44.64 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 175.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.5 t -82.18 119.07 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 174.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.99 0.71 71.05 Favored Glycine 0 CA--C 1.557 2.701 0 N-CA-C 119.063 2.385 . . . . 0.0 119.063 -170.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -144.21 138.14 27.84 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 120.176 1.988 . . . . 0.0 109.079 166.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -70.66 123.32 21.6 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 121.37 0.605 . . . . 0.0 112.45 -176.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' CYS . . . . . . . . . . . . . 99.7 m -108.95 150.9 27.05 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.614 171.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.85 115.08 22.08 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.948 175.001 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 68.4 mt -131.42 128.13 38.9 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 122.812 0.445 . . . . 0.0 109.91 -162.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -79.65 134.84 36.44 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 121.721 0.772 . . . . 0.0 111.317 174.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 66.8 p -76.29 -75.22 0.2 Allowed 'General case' 0 CA--C 1.562 1.43 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.658 176.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . . . . . . . . . 57.1 tpp -128.96 -77.0 0.56 Allowed 'General case' 0 CA--C 1.561 1.368 0 CA-C-N 118.904 0.775 . . . . 0.0 109.757 -173.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.1 p -92.73 -60.74 1.74 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 118.279 -0.867 . . . . 0.0 113.013 -169.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . -163.51 78.11 0.15 Allowed Glycine 0 N--CA 1.48 1.592 0 CA-C-N 119.536 1.062 . . . . 0.0 114.188 -176.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -138.47 169.06 18.46 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 123.851 0.86 . . . . 0.0 109.622 163.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.1 mptt -142.08 108.38 5.27 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 162.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 10.1 p -116.58 132.71 65.44 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 124.011 0.925 . . . . 0.0 109.23 -171.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.8 mppt? -84.03 112.22 20.0 Favored 'General case' 0 N--CA 1.487 1.407 0 C-N-CA 123.243 0.617 . . . . 0.0 109.976 -171.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.0 t -145.16 149.5 35.08 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.407 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 14.3 p -112.31 136.37 48.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 CA-C-O 122.538 1.161 . . . . 0.0 108.506 174.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.0 t -93.08 139.2 18.51 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 CA-C-N 113.931 -1.486 . . . . 0.0 108.166 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -111.61 133.26 54.0 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 174.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 61.4 tp -94.0 107.87 19.74 Favored 'General case' 0 CA--C 1.553 1.073 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -87.84 114.27 24.29 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 170.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 70.72 -119.12 8.07 Favored Glycine 0 CA--C 1.543 1.826 0 CA-C-N 114.52 -1.218 . . . . 0.0 113.635 -175.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -126.85 -5.45 6.29 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 171.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 11.9 p-10 -123.42 -13.33 7.63 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.342 2.349 . . . . 0.0 117.342 -173.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -116.91 94.36 4.56 Favored 'General case' 0 CA--C 1.56 1.34 0 CA-C-N 121.493 1.951 . . . . 0.0 110.351 -166.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 39.4 mt -93.19 107.31 19.14 Favored 'General case' 0 N--CA 1.493 1.706 0 C-N-CA 123.557 0.743 . . . . 0.0 110.008 179.692 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 29.8 m -106.77 131.34 56.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 C-N-CA 123.937 0.895 . . . . 0.0 110.801 -171.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.1 t -153.74 145.12 23.08 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 34.6 p -109.89 110.06 20.9 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 174.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -76.14 -87.45 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 123.235 0.614 . . . . 0.0 110.957 -177.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -112.81 -74.56 0.63 Allowed 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 174.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -129.05 65.08 1.45 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 154.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 5.4 mp -137.96 103.31 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 103.566 -2.753 . . . . 0.0 103.566 176.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 1.6 tmmt? -92.04 94.21 9.14 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 22.7 t -95.09 110.61 22.52 Favored 'General case' 0 N--CA 1.482 1.157 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.59 -167.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 93.0 t -107.2 100.6 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 105.7 -1.963 . . . . 0.0 105.7 -177.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.6 m -96.24 91.25 5.8 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -172.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -87.99 141.83 28.27 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 123.914 0.885 . . . . 0.0 110.46 178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 tt -121.91 102.95 8.5 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 172.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.7 m-80 -81.07 -82.11 0.12 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 123.123 0.569 . . . . 0.0 110.988 -168.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -97.65 -103.63 2.26 Favored Glycine 0 N--CA 1.482 1.739 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 176.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -111.66 54.02 0.7 Allowed 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.676 0.75 . . . . 0.0 109.833 159.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.4 pp -149.75 136.49 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 -175.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.9 tt -108.11 117.4 53.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 89.4 m -103.92 98.58 8.4 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 177.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -93.79 116.33 28.79 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' THR . . . . . . . . . . . . . 26.5 m -113.14 94.23 4.79 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -170.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 27.2 mtt -94.2 99.06 11.39 Favored 'General case' 0 N--CA 1.487 1.379 0 C-N-CA 123.735 0.814 . . . . 0.0 109.381 -177.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' THR . . . . . . . . . . . . . 69.4 p -90.94 107.0 18.91 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.246 -174.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 59.3 tp -101.41 79.86 2.02 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 72.43 -100.97 1.01 Allowed Glycine 0 CA--C 1.545 1.908 0 CA-C-N 116.579 -0.282 . . . . 0.0 112.772 -171.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -103.1 -6.07 22.63 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 115.342 1.608 . . . . 0.0 115.342 169.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 76.3 mt -87.18 103.86 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 CA-C-N 120.668 1.576 . . . . 0.0 106.914 -176.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 49.1 t -93.8 96.58 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 -174.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -84.83 93.59 8.53 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 121.199 0.523 . . . . 0.0 109.774 177.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -99.17 103.02 14.87 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.552 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -107.12 122.86 47.33 Favored 'General case' 0 N--CA 1.486 1.365 0 C-N-CA 123.876 0.87 . . . . 0.0 109.141 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ILE . . . . . . . . . . . . . 5.0 mp -111.16 107.92 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 -171.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 69.3 m -118.91 119.93 35.78 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -175.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -89.85 141.91 28.19 Favored 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 121.659 0.742 . . . . 0.0 111.414 -174.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ARG . . . . . . . . . . . . . 33.3 ttm-85 -66.63 124.76 23.74 Favored 'General case' 0 CA--C 1.559 1.316 0 CA-C-N 115.098 -0.955 . . . . 0.0 112.263 178.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . . . . . . . . . 16.6 pt . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 123.05 1.405 . . . . 0.0 108.542 -176.638 . . . . . . . . 0 0 . 1 stop_ save_